This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 1  EN EN 
 
ANNEX I  
Annex I contains the following model official certificates for the movement between Member 
States  
Model   
ungulates  
BOV -INTRA -X Chapter 1: Model official certificate for the movement between Member States 
of bovine animals not intended for slaughter  
BOV -INTRA -Y Chapter 2: Model official certificate for the movement between Member States 
of bovine animals intended for slaughter  
POR -INTRA -X Chapter 3: Model official certificate for the movement between Member States 
of porcine animals not intended for slaughter  
POR -INTRA -Y Chapter 4: Model official certificate for the movement between Member States 
of porcine animals intended for slaughter  
OV/CAP -INTRA -X Chapter 5: Model official certificate for the movement between Member States 
of ovine and caprine animals not intended for slaughter  
OV/CAP -INTRA -Y Chapter 6: Model official certificate for the movement between Member States 
of ovine and caprine animals intended for  slaughter  
EQUI -INTRA -IND Chapter 7: Model official certificate for the movement between Member States 
of an individual equine animal not intended for slaughter  
EQUI -INTRA -CON  Chapter 8: Model official certificate for the movement between Member States 
of a consignment of equine animals  
CAM -INTRA -X Chapter 9: Model official certificate for the movement between Member States 
of camelid animals not intended for slaughter  
CAM -INTRA -Y Chapter 10: Model official certificate for the movement between Member 
States of camelid animals intended for slaughter  
CER -INTRA -X Chapter 1 1: Model official certificate for the movement between Member 
States of cervid animals not intended for slaughter  
CER -INTRA -Y Chapter 12: Model official certificate for the movement between Member 
States of cervid animals intended for slaughter  
OTHER -UNGULATES -
INTRA -X Chapter 13: Model official certificate for the movement between Member 
States of kept ungulates other than bovine, ovine, caprine, porcine, equine, 
camelid and cervid a nimals not intended for slaughter  
OTHER -UNGULATES -
INTRA -Y Chapter 14: Model official certificate for the movement between Member 
State s of kept ungulates other than bovine, ovine, caprine, porcine, equine, 
camelid and cervid animals intended for slaughter  
birds and germinal products thereof  
POU -INTRA -HEP  Chapter 15: Model official certificate for the movement between Member 
States of hatching eggs of poultry  
POU -INTRA -DOC  Chapter 16: Model official certificate for the movement between Member 
States of day-old chicks  
POU -INTRA -X Chapter 17: Model official certificate for the movement between Member This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 2  EN States of breeding poultry and productive poultry  
POU -INTRA -LT20  Chapter 18: Model official certificate for the movement between Member 
States of  less than 20 heads of poultry other than ratites or less than 20 hatching 
eggs of poultry other than ratites  
POU -INTRA -Y Chapter 19: Model official certificate for the movement between Member 
States of poultry  intended fo r slaughter  
POU -INTRA -SPF Chapter 20: Model official certificate for the movement between Member 
States of  specified pathogen -free eggs  
CAPTIVE -BIRDS -INTRA  Chapter 21: Model official certificate for the movement between Member 
States of  captive birds  
HE-CAPTIVE -BIRDS -
INTRA  Chapte r 22: Model official certificate for the movement between Member 
States of  hatching eggs of captive birds  
  
germinal products of bovine  animals  
BOV -SEM -A-INTRA  Chapter 23: Model official certificate for the movement between Member 
States of semen of bovine animals  collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 after 20 April 2021 , and dispatched from a semen collection centre 
where the semen was collected  
BOV -SEM -B-INTRA  Chapter 24: Model official certificate for the movement between Member 
States of stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC , as amended by Council 
Directive 2003/43/EC,  after 31 December 2004 and  before 21 April 2021, and 
dispatched after 20 April 2021 from a semen collection centre where the semen 
was collected  
BOV -SEM -C-INTRA  Chapter 25: Model official certificate for the movement between Member 
States of stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005 in accordance with Council Directive 88/407/EEC 
applying until 1 July 2004 , and dispatched after 20 April 2021 from a semen 
collection centre where the semen was collected  
 
BOV -OOCYTES -EMB -A-
INTRA  Chapter 26: Model official certificate for the movement between Member 
States of oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020 /686 after 20 A pril 2021 , and dispatched by an 
embryo collection or production team by which the oocytes or embryos were 
collected or produced  
BOV -EMB -B-INTRA  Chapter 27: Model official certificate for the movement between Member 
States of stocks of embryos of bovine animals collected  or produced , processed 
and stored before 21 April 2021 in accordance with Council Directive 
89/556/EEC , and dispatched after 20 April 2021 by an embryo collection or 
production team by which the embryos were collected  or produced  
BOV -GP-PROCESSING -
INTRA  Chapter 28: Model official certificate for the movement between Member 
States of c onsignments of:  
- semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 3  EN Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine ani mals collected, processed and stored 
before 1 January 2005 in accordance with Council Directive 
88/407/EEC applying until 1 July 2004;  
- oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016 /429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of embryos of bovine animals collected  or produced , processed 
and stored in accordance with Directive 89/556/EEC  before 21 April 
2021,  
and dispatched after 20 April 2021 from a germinal product processing 
establishment  
BOV -GP-STORAGE -INTRA  Chapter 29: Model official certificate for the movement between Member 
States of c onsignments of:  
- semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, before 21 Ap ril 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005 in accordance with Council Directive 
88/407/EEC applying until 1 July 2004;  
- oocytes and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of embryos of bovine animals collected  or produced , processed 
and stored in  accordance with Directive 89/556/EEC  before 21 April 
2021,  
and dispatched after 20 April 2021 from a germinal product storage centre  
germinal products of ovine and caprine  animals  
OV/CAP -SEM -A-INTRA  Chapter 30: Model official certificate for the movement between Member 
States of consignments of semen of ovine and caprine animals collected , 
processed and stored  in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020 /686 after 20 April 2021 , and dispatched from 
a semen collection centre where the semen was collected  
OV/CAP -SEM -B-INTRA  Chapter 31: Model official certificate for the movement between Member 
States of consignments of stocks of semen of ovine and caprine animals 
collected , proce ssed and stored  in accordance with Directive 92/65/EEC before 
21 April 2021 and after 31 August 2010, and dispatched after 20 April 2021 
from a semen collection centre where the semen was collected  
OV/CAP -SEM -C-INTRA  Chapter  32: Model official certificate for the movement between Member 
States of consignments of stocks of semen of ovine and caprine animals 
collected , processed and stored  in accordance with Directive 92/65/EEC before 
1 September 2010, and dispatched after 20 Apri l 2021 from a semen collection 
centre where the semen was collected  
OV/CAP -OOCYTES -EMB -
A-INTRA  Chapter 33: Model official certificate for the movement between Member 
States of consignments of oocytes and embryos of ovine and caprine animals 
collected or produced, processed and stored in accordance with Regulation This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 4  EN (EU) 2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 2021 , 
and dispatched by an embryo collection or p roduction team  by which the 
oocytes or embryos were collected or produced  
OV/CAP -OOCYTES -EMB -
B-INTRA  Chapter 34: Model official certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of ovine and caprine 
animal s collected or produced, processed and stored in accordance with 
Directive 92/65/EEC before 21 April 2021 and after 31 August 2010, and 
dispatched after 20 April 2021 by an embryo collection or production team  by 
which the oocytes or embryos were collected  or produced  
OV/CAP -OOCYTES -EMB -
C-INTRA  Chapter 35: Model official certificate for the movement between Member 
States of  consignments of stocks of oocytes and embryos of ovine and caprine 
animals collected or produced, processed and stored in accordance with 
Directive 92/65/EEC before 1 September 2010, and dispatched after 20 April 
2021 by an embryo collection or production  team  by which the oocytes or 
embryos were collected or produced  
OV/CAP -GP-PROCESSING -
INTRA  Chapter 36: Model official certificate for the movement between Member 
States of  consignments of:  
- semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accor dance with Council Directive 92/65/EEC before 21 
April 2021 and after 31 August 2010;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 
September 2010;  
- oocytes and embryos o f ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 
2021 ; 
- stocks of oocytes and embryos of ovine and caprine animals collected 
or produced , processed and stored in accordance with Council 
Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directiv e 92/65/EEC before 1 September 2010,  
and dispatched after 20 April 2021 from a germinal product processing 
establishment  
OV/CAP -GP-STORAGE -
INTRA  Chapter 37: Model official certificate for the movement between Member 
States of  consignments of:  
- semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 
April 2021 and after 31 August 2010;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 
September 2010;  
- oocytes and embr yos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 5  EN 2021 ; 
- stocks of oocytes and embryos of ovine and caprine animals collected 
or pro duced, processed and stored in accordance with Council 
Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 1 September 2010,  
and dispatched after 20 April 2021 from a germinal product storage centre  
germinal products of porcine  animals  
POR -SEM -A-INTRA  Chapter 38: Model official certificate for the movement between Member 
States of consignments of semen of porcine animals collected , processed and 
stored  in accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021 , and dispatched from a semen collection 
centre where the semen was collected  
POR -SEM -B-INTRA  Chapter 39: Model official certificate for the movement between Member 
States of  consignments of stocks of semen of porcine animals collected , 
processed and stored  in accordance with Directive 90/429/EEC before 21 April 
2021, and dispatched  after 20 April 2021 from a semen collection centre where 
the semen was collected  
POR -OOCYTES -EMB -A-
INTRA  Chapter 40: Model official certificate for the movement between Member 
States  of consignments of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 , and dispatched 
by an embryo collection or production team  by which the oocytes or embryos 
were collected or produced  
POR -OOCYTES -EMB -B-
INTRA  Chapter 41: Model official certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of porcine animals 
collected or produced , processed and stored in accordance with Directive 
92/65/EEC before  21 April 2021 and after 31 August 2010, and dispatched 
after 20 April 2021 by an embryo collection or production team  by which the 
oocytes or embryos were collected or produced  
POR -OOCYTES -EMB -C-
INTRA  Chapter 42: Model official certificate for the movement between Member 
States of  consignments of stocks of oocytes and embryos of porcine animals 
collected or produced, processed and stored in accordance with Directive 
92/65/EEC before  1 September 2010 and dispatched after 20 April 2021 by an 
embryo collection or production team  by which the oocytes or embryos were 
collected or produced  
POR -GP-PROCESSING -
INTRA  Chapter 43: Model official certificate for the movement between Member  
States of  consignments of:  
- semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021;  
- stocks of semen of porcine animals collected, processed and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;  
- oocytes and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of oocytes  and embryos of porcine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of porcine animals collected or This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 6  EN produced, proc essed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
and dispatched after 20 April 2021 from a germinal product processing 
establishment  
POR -GP-STORAGE -INTRA  Chapter 44: Model official certificate for the movement between Member 
States of  consignments of:  
- semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021;  
- stocks of semen of porcine animals collected, processed and s tored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;  
- oocytes and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April  2021 ; 
- stocks of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of porcine animals collected or 
produced , processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
and dispatched after 20 April 2021 from a germinal product storage centre  
germinal products of equine animals  
EQUI -SEM -A-INTRA  Chapter 45: Model official certificate for the movement between Member 
States of consignments of semen of equine animals collected , processed and 
stored  in accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020 /686 after 20 April 2021 , and dispa tched from a semen collection 
centre where the semen was collected  
EQUI -SEM -B-INTRA  Chapter 46: Model official certificate for the movement between Member 
States of consignments of stocks of semen of equine animals collected, 
processed and stored in accor dance with Directive 92/65/EEC after 
30 September 2014 and before 21 April 2021, and dispatched after 20 April 
2021 from a semen collection centre where the semen was collected  
EQUI -SEM -C-INTRA  Chapter 47: Model official certificate for the movement between Member 
States of consignments of stocks of semen of equine animals collected, 
processed and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014, and dispatched a fter 20 April 2021 from a 
semen collection centre where the semen was collected  
EQUI -SEM -D-INTRA  Chapter 48: Model official certificate for the movement between Member 
States of consignments of stocks of semen of equine animals collected, 
processed and st ored in accordance with Directive 92/65/EEC before 1 
September 2010 and dispatched after 20 April 2021 from a semen collection 
centre where the semen was collected  
EQUI -OOCYTES -EMB-A-
INTRA  Chapter 49: Model official certificate for the movement between Me mber 
States of consignments of oocytes and embryos of equine animals collected or 
produced , processed and stored  in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 , and dispatched 
by an embryo collection or production team  by which the oocytes or embryos 
were collected or produced  
EQUI -OOCYTES -EMB-B-
INTRA  Chapter 50: Model official certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of equine animals 
collected or produced, processed and stored in accordance with Directive This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 7  EN 92/65/EEC after 30 September 2014 and before 21 April 2021, and dispatched 
after 20 April 2021 by an embryo collection or production team  by which the 
oocytes or embryos were collecte d or produced  
EQUI -OOCYTES -EMB-C-
INTRA  Chapter 51: Model official certificate for the movement between Member 
States of consignments of stocks of oocytes and embryos of equine animals 
collected, processed and stored in accordance with Directive 92/65/EEC after 
31 August 2010 and before 1 October 2014, and dispatched after 20 April 2021 
by an embryo collection or production team  by which the oocytes or embryos 
were collected or produced  
EQUI -OOCYTES -EMB -D-
INTRA  Chapter 52: Model official certificate for th e movement between Member 
States of c onsignments of stocks of oocytes and embryos of equine animals 
collected, processed and stored in accordance with Directive 92/65/EEC before 
1 September 2010 and dispatched after 20 April 2021 by an embryo collection 
or production team  by which the oocytes or embryos were collected or 
produced  
EQUI -GP-PROCESSSING -
INTRA  Chapter 53: Model official certificate for the movement between Member 
States of c onsignments of:  
- semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and 
before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;  
- stocks of semen of equine animals collected , processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected,  processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014;  
- stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC before 1 
September 2010,  
and dispatched after 20 April 2021 from a germinal product processing 
establishment  
EQUI -GP-STORAGE -
INTRA  Chapter 54: Model official certificate for the movement between Member 
States of c onsignments of:  
- semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 9 2/65/EEC after 30 September 2014 and 
before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 8  EN 1 October 2014;  
- stocks of semen of equine animals collected,  processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014;  
- stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC before 1 
September 2010,  
and dispatched after 20 April 2021 from a germinal product storage centre  
bees 
HBEE -INTRA  Chapter 55: Model official certificate for the movement between Member 
States  of honey bees  
QUE -INTRA  Chapter 56: Model official certificate for the movement between Member 
States of queen honeybee s under derogation  
BBEE -INTRA  Chapter 57: Model official certificate for the movement between Member 
States  of bumble bees  
other categories of terrestrial animals and certain germinal products  
CONFINED -LIVE -INTRA  Chapter 58: Model official certificate for the movement between Member 
States  of terrestrial animals between confined establishments  
CONFINED -PRIMATE -
INTRA  Chapter 59: Model official certificate for the movement between Member 
States  of primates into a confined establishment  
GP-CONFINED -INTRA  Chapter 60: Model official certificate for the movement between Member 
States  of semen, oocytes and embryos of terrestrial animals kept at confined 
establishment  which were collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686 
CANIS -FELIS -FERRETS -
INTRA  Chapter 61: Model official certificate for the movement between Member 
States of dogs, cat s and ferrets  
GP-CANIS -FELIS -INTRA  Chapter 62: Model official certificate for the movement between Member 
States of semen, oocytes and embryos of dogs (Canis lupus familiaris ) and cats  
(Felis silvestris catus ) which were collected or produced, processed and stored 
in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686  
OTHCARN -INTRA  Chapter 63: Model official certificate for the movement between Member 
States of other carnivores  
WILD -ANIMALS -INTRA  Chapter 64: Model official certificate for the movement between Member 
States of wild terrestrial animals  
GP-CAM -CER -INTRA  Chapter 65: Model official  certificate for the movement between Member 
States of semen, oocytes and embryos of animals of the families Camelidae  and 
Cervidae  which were collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020 /686  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 9  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 10  EN CHAPTER 1: MODEL OFF ICIAL CERTIFIC ATE FOR THE MOVEMENT  
BETWEEN MEMBER STATE S OF BOVINE ANIMALS NO T INTENDED FOR 
SLAUGHTER (MODEL ‘BOV -INTRA -X’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 11  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 12  EN EUROPEAN UNION  Certificate model BOV -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
 
II.1. The bovine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 38 of Delegated Regulation (EU) 2019/2035.  
II.1.2.  They, for at least the last 30 days prior to the departure of the consignment , or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident in the establishment of origin;  
II.1.2.2.  have not been in contact with kept bovine animals of a lower health status or 
subject to movement restrictions fo r animal health reasons;  
II.1.2.3.  have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory  during the last 30 days prior to the 
departure of the animals . 
II.1.3.  They have not shown clinic al signs or symptoms of diseases listed for bovine animals during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
 
II.2. According to official information, the animals described in Part I meet the following health requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for bovine animals.  
II.2.2.  They come from establishments free from infection with Brucella abortus, B. melitensis  and 
B. suis  without vaccination regarding bovine animals, and  
(2)either  [the establishments  of origin are situated in a Member State or zone thereof with the status fre e 
from infection with Brucella abortus, B. melitensis  and B. suis  regarding the bovine 
population; 
(2)and/or  [they have been subjected to a test for infection with Brucella abortus, B. melitensis  and B. suis  
with one of the diagnostic methods provided for in Part 1 of Annex I  to Delegated  Regulation 
(EU) 2020/688, carried out, with negative results, on a sample taken during the last 30 days 
prior to departure, and in the case of post -parturient females taken at least 30 days after 
parturition;  
(2)and/or  [they are less than 12 months old;  
(2)and/or  [they are castrated.]  
II.2.3.  They come from establishments free from infection with Mycobacterium tuberculosis  complex 
(M. bovis, M. caprae  and M. tuberculosis ), and  
(2)either  [the establishments of origin are situated in a Member State or zone thereof with the status 
free from infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae  and M. 
tuberculosis ); 
(2)and/or  [they have been subjected to a test for infection w ith Mycobacterium tuberculosis  complex 
(M. bovis, M. caprae  and M. tuberculosis ) with one of the diagnostic methods provided for in 
Part 2 of Annex I  to Delegated Regulation (EU) 2020 /688, carried out, with negative results, 
during the last 30 days prior t o departure ; 
(2)and/or  [they are less than 6 weeks old.]  
II.2.4.  They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during the last 30 days prior to departure.  
II.2.5.  They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in kept animals of listed species for that disease during the last 2 years prior to 
departure.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 13  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
II.2.6.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.7.  They come from establishments  in which surra ( Trypanosoma evansi ) has not been reported 
during the last  30 days prior to departure , and  
(2)either  [surra has not been  reported in the establishments during the last 2 years 
prior to their departure.]  
(2)or  [surra has been reported during the last 2 years prior to departure, following 
the last outbreak the a ffected establishment has remained under movement 
restrictions until:  
– the infected animals have been removed  from the establishment, and  
– the remaining animals on the establishment have been subjected to a 
test for surra ( Trypanosoma evansi ) with one of the  diagnostic 
methods provided for in part 3 of Annex I  to Delegated Regulation 
(EU) 2020 /688, carried out, with negative results, on samples taken at 
least 6 months after the infected animals have been removed from the 
establishment.]  
 (2)either [II.2.8.  They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation 
(EU) 2020/688 are fulfilled .] 
(2)and/or [II.2.8.  They originate from a Member State or a zone covered by the eradication programme for 
infection with blu etongue virus (serotype 1 -24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they 
(2)either  [II.2.8.1. have been kept in a Member State or zone seasonally free from infection with 
bluetongue virus (serotype 1 -24) in accordance with Article 40(3) of Delegated  
Regulation (EU) 2020 /689 
 (2)either  [II.2.8.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.8.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free frominfection 
with bluetongue virus (serotype 1 -24).]]]  
(2)and/or  [II.2.8.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free from infection with 
bluetongue virus (serotype 1 -24).]]]  
(2)and/or [II.2.8.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and ha ve been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.8.2.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.8. 2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or  [II.2.8.2.3.  for at least 14 days prior to the  date of movement and have been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 14  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors.]]]  
(2)and/or [II.2.8.3.  have be en vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and  
(2)either  [II.2.8.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.8.3.2.  have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.8.4. have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reporte d during the past 2 years in that Member State or zone and  
(2)either  [II.2.8.4.1.  the serological test has been carried out on samples collected at least 
60 days before the date of movement.]]]  
(2)or [II.2.8.4.2.  the serological test has been carried out o n samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement.]]]  
(2)and/or [II.2.8.  They or iginate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor covered by the eradication programme for infection with bluetongue 
virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and they 
(2)either  [II.2.8.1.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vec tors in a 
vector protected establishment  
(2)either  [II.2.8.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or [II.2.8.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or [II.2.8.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors.]]]  
(2)and/or [II.2.8. 2. have been kept for the last 60 days prior to depa rture in an establishment situated 
in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated  Regulation 
(EU) 2020 /689 has been carried out during that period, and 
(2)either  [II.2.8. 2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at  least 150 km radius centred on the place 
where the animals were kept  and are within the immunity period 
guaranteed in the specifications of the vaccine and  
(2)either  [II.2.8. 2.1.1. have been vaccinated more than 60 days before the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 15  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
date of movement.]]]]  
(2)and/or  [II.2.8. 2.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine.]]]]  
(2)and/or  [II.2.8.2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept, and   
(2)eithe r [II.2.8. 2.2.1. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 60 days before the date of movement.]]]]  
(2) and/or  [II.2.8. 2.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 30 days before the date of the movement and to a 
PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement.]]]]  
(2)and/or [II.2.8.  They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Delegated  Regulation (EU) 2020 /689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Me mber State 
or zone thereof  
(2)either  [II.2.8.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred to 
in Article 43(2)(a), (b) and (c) of Delegated  Regulation  (EU) 2020 /689, and 
(2)either  [II.2.8.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.8.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.8.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex  V to that 
Regulation , and  
(2)and/or  [II.2.8.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.8.1.  with an approved eradication program for infection with bluetongue virus 
(serotype 1 -24) and the Member State of destination has informed the 
Commission a nd the other Member States that such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated  
Regulation  (EU) 2020 /689  and 
(2)either  [II.2.8.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.8.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.8.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.8.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 16  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.8.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered by 
the eradication programme for infection with bluetongue virus (serotype 1 -24) 
and the Member State of destination has informed the Commiss ion and the other 
Member States that such movement is authorised  
(2)either  [II.2.8.1.1.  without any conditions , and ]] 
(2)and/or  [II.2.8.1.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of Annex V to  Delegated  Regulation  (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.4.  under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Rwgulation  are fulfilled .]]] 
 (2)[II.2.9.  They are moved to a Member State or zone thereof with the status free from enzootic bovine 
leukosis, and  
 (2)either  [II.2.9.1.  they come from establishments free from enzootic bovine leukosis.]]  
(2)or [II.2.9.1.  they come from establishments not free from enzootic bovine leukosis, and  
enzootic bovine leukosis  has not been reported in those establishments during the 
last 24 months prior to departure, and  
(2)either  [II.2.9.1.1.  they are over 24 months of age and they have been subjected to a 
serological test for enzootic bovine leukosis with one of the 
diagnosti c methods provided for in Part 4 of Annex I  to Delegated  
Regulation (EU) 2020 /688, carried out with negative results  
(2)either  [II.2.9.1.1.1.  on samples taken on two occasions at an interval of at 
least four months while kept in isolation from the 
other bovine animals of the establishment]]]  
(2)and/or  [II.2.9.1.1.2.  on a sample taken during the last 30 days prior to the 
departure of the consignment, and all bovine animals 
over 24 months kept in the establishment have been 
subjected to a serological test f or enzootic bovine 
leukosis with one of the diagnostic methods provided 
for in Part 4 of Annex I  to Delegated  Regulation (EU) 
2020 /688, carried out, with negative results, on 
samples taken on two occasions at an interval of not 
less than four months during  the last 12 months prior 
to the departure of the consignment.]]]]  
(2)and/or [II.2.9.1.2.  they are less than 24 months of age and it was born to dam subjected 
to a serological test for enzootic bovine leukosis with one of the 
diagnostic methods provided f or in Part 4 of Annex I  to Delegated  
Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken on two occasions at an interval of not less than four 
months during the last 12 months prior to the departure of the 
consignment.]]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 17  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
(2)or[II.2.10.  They are moved to a Member State or zone thereof with an approved eradication programme 
for enzootic bovine leukosis, and  
(2)either  [II.2.10.1.  they come from establishments free from enzootic bovine leukosis.]]  
(2)or [II.2.10.1.  they come from es tablishments not free from enzootic bovine leukosis, and  
enzootic bovine leukosis has not been reported in those establishments during the 
last 24 months prior to departure, and  
(2)either  [II.2.10.1.1.  they are over 24 months of age and they have been subjected to a 
serological test for enzootic bovine leukosis with one of the 
diagnostic methods provided for in Part 4 of Annex I  to Delegated  
Regulation (EU) 2020 /688, carried out with negative results  
(2)either  [II.2.10.1.1.1.  on samples taken on two occ asions at an interval of at 
least four months while kept in isolation from the 
other bovine animals of the establishment]]]  
(2)and/or  [II.2.10.1.1.2.  on a sample taken during the last 30 days prior to the 
departure of the consignment, and all bovine animal s 
over 24 months kept in the establishment have been 
subjected to a serological test for enzootic bovine 
leukosis with one of the diagnostic methods provided 
for in Part 4 of Annex I  to Delegated  Regulation (EU) 
2020 /688, carried out, with negative results , on 
samples taken on two occasions at an interval of not 
less than four months during the last 12 months prior 
to the departure of the consignment.]]]]  
(2)and/or [II.2.10.1.2.  they are less than 24 months of age and it was born to dam, which 
has been sub jected to a serological test for enzootic bovine leukosis 
with one of the diagnostic methods provided for in Part 4 of Annex I  
to Delegated  Regulation (EU) 2020 /688, carried out, with negative 
results, on samples taken on two occasions at an interval of no t less 
than four months during the last 12 months prior to the departure of 
the consignment.]]]  
(2)[II.2.11.  They are moved to Member State or zone thereof with the status free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis and t hey have not been vaccinated against 
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and  
 (2)either  [II.2.11.1.  they come from establishments free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and  
(2)either  [II.2.11.1.1.  the establishments of origin are situated in a Member State or zone 
thereof with the status free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis]]  
(2)and/or [II.2.11.1.2  the animals have been subjected to quar antine for at least 30 days 
prior to departure and have been subjected to a serological test for 
the detection of antibodies against whole bovine herpes virus -1 
(BoHV -1) with one of the diagnostic methods provided for in Part 5 
of Annex I  to Delegated  Regulation (EU) 2020 /688, with a negative 
result, carried out on a sample taken during the last 15 days prior to 
the departure of the consignment.]]]  
(2)or [II.2.11.1.  they come from establishments not free from infectious bovine 
rhinotracheitis/infectious  pustular vulvovaginitis and they have been kept in an 
approved quarantine establishment for at least 30 days prior to departure and 
have been subjected to a serological test for the detection of antibodies against 
whole BoHV -1, with one of the diagnostic methods provided for in Part 5 of 
Annex I  to Delegated  Regulation (EU) 2020 /688, with a negative result, carried This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 18  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
out on a sample taken not less than 21 days after commencement of the 
quarantine.]]  
(2)[II.2.12.  They are moved to Member State or zone thereof  with an approved eradication programme 
for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, and  
 (2)either  [II.2.12.1.  they come from establishments free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and  
(2)either  [II.2.12.1.1.  the establishments of origin are situated in a Member State or zone 
thereof with the status free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis]]   
(2)and/or [II.2.12.1.2.  the establishments of origin are situated in a Member State or zone 
thereof with an approved eradication programme for infectious 
bovine rhinotracheitis/infectious pustular vulvovaginitis]]  
(2)and/or [II.2.12.1.3.  the animals have been subjected to quarantine for at least 30 days 
prior to  departure and have been subjected to a serological test for 
the detection of antibodies against whole bovine herpes virus -1 
(BoHV -1) with one of the diagnostic methods provided for in Part 5 
of Annex I  to Delegated  Regulation (EU) 2020 /688 with a negative 
result, carried out on a sample taken during the last 15 days prior to 
the departure of the consignment]]  
(2)and/or [II.2.12.1.4.  the animals are destined for an establishment which keeps bovine 
animals for meat production without contact to bovine animals of 
other establishments, and from which they are directly moved to the 
slaughterhouse.]]]  
(2)or [II.2.12.2.  they come from establishments not free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and  
– they have be en kept in an approved quarantine establishment for at least 30 
days prior to departure, and  
– they have been subjected to a serological test for the detection of antibodies 
against whole BoHV -1, with one of the diagnostic methods provided for in 
Part 5 of A nnex I  to Delegated  Regulation (EU) 2020 /688, with a negative 
result, carried out on a sample taken not less than 21 days after 
commencement of the quarantine.]]  
(2)[II.2.13.  Animals in the consignment are moved to Member State or zone thereof with the st atus free 
from bovine viral diarrhoea and they have not been vaccinated against bovine viral diarrhoea, 
and 
 (2)either  [II.2.13.1.  they come from establishments free from bovine viral diarrhoea, and  
(2)either  [II.2.13.1.1.  the establishments of origin are situated in a Member State or zone 
thereof with the status free from bovine viral diarrhoea]]  
(2)and/or [II.2.13.1.2.  the establishments of origin have been subjected to a testing regime 
as referred in point 1(c)(ii) or (iii) of Section 2 of Chapter 1 of Part 
VI of Annex IV to Delegated  Regulation (EU) 2020 /689, carried out, 
with negative results, within the last four mon ths prior to the 
departure of the consignment]]  
(2)and/or [II.2.13.1.3.  the animals have been tested individually to exclude the presence of 
bovine viral diarrhoea virus prior to the departure of the 
consignment.]]]  
(2)or [II.2.13.1.  they come from establishments not free from bovine viral diarrhoea and they 
have been subjected to a test for bovine viral diarrhoea virus antigen or genome 
with one of the diagnostic methods provided for in Part 6 of Annex I  to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 19  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
Delegated  Regulation (EU) 2020 /688, carrie d out with negative results, and  
(2)either  [II.2.13.1.1.  they have been kept in an approved quarantine establishment for a 
period of at least 21 days prior to the departure of the consignment  
(2)[and in case of pregnant dams, they have been subjected to a  
serological test for the detection of antibodies against bovine viral 
diarrhoea virus with one of the diagnostic methods provided for in 
Part 6 of Annex I  to Delegated  Regulation (EU) 2020 /688, carried 
out, with negative results, on samples taken not less  than 21 days 
after commencement of the quarantine]]]  
(2)and/or [II.2.13.1.2.  they have been subjected to a serological test for the detection of 
antibodies against bovine viral diarrhoea virus with one of the 
diagnostic methods provided for in Part 6 of A nnex I  to Delegated  
Regulation (EU) 2020 /688, with positive results,  
(2)either  [II.2.13.1.2.1.  in case of non -pregnant animals, carried out on 
samples taken prior to departure of the consignment]]  
(2)and/or [II.2.13.1.2.1.  in case of pregnant dams, carried  out on samples taken 
before insemination preceding the current gestation.]]]  
(2)[II.2.14.  They are moved to Member State or zone thereo f with an approved eradication programme 
for bovine viral diarrhoea , and  
(2)either  [II.2.14.1.  they come from establishments free from bovine viral diarrhoea, and  
(2)either  [II.2.14.1.1.  the establishments of origin are situated in a Member State or zone 
thereof with the status free from bovine viral diarrhoea]]   
(2)and/or [II.2.14.1.2.  the establishments of origi n are situated in a Member State or zone 
thereof with an approved eradication programme for bovine viral 
diarrhoea ]]  
 (2)and/or [II.2.14.1.3.  the establishments of origin have been subjected to a testing regime 
as referred  in point 1(c)(ii) or (iii) of Se ction 2 of Chapter 1 of Part 
VI of Annex IV to Delegated  Regulation (EU) 2020 /689, carried out, 
with negative results, within the last 4 months prior to the departure 
of the consignment]]  
(2)and/or [II.2.14.1.4.  the animals have been tested individually to  exclude the presence of 
bovine viral diarrhoea virus prior to the departure of the 
consignment]]  
(2)and/or [II.2.14.1.5.  the animals are destined for an establishment which keeps bovine 
animals for meat production separate from bovine animals of other 
establishments, and from which they are directly moved to the 
slaughterhouse.]]]  
(2)and/or [II.2.14.2.  they come from establishments not free from bovine viral diarrhoea and they 
have been subjected to a test for bovine viral diarrhoea virus antigen or genome  
with one of the diagnostic methods provided for in Part 6 of Annex I  to 
Delegated  Regulation (EU) 2020 /688, carried out with negative results, and  
(2)either  [II.2.14.2.1.  they have been kept in an approved quarantine establishment for a 
period of at least 21 days prior to the departure of the consignment  
(2)[and in case of pregnant dams, they have been subjected to a 
serological test for the detection of antibodies against  bovine viral 
diarrhoea virus with one of the diagnostic methods provided for in 
Part 6 of Annex I  to Delegated  Regulation (EU) 2020 /688, carried 
out, with negative results, on samples taken not less than 21 days 
after commencement of the quarantine]]]  
(2)and/or [II.2.14.2.2.  they have been subjected to a serological test for the detection of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 20  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
antibodies against bovine viral diarrhoea virus with one of the 
diagnostic methods provided for in Part 6 of Annex I  to Delegated  
Regulation (EU) 2020 /688, with positi ve results,  
(2)either  [II.2.13.2.2.1.  in case of non -pregnant animals, carried out on 
samples taken prior to departure of the consignment]]  
(2)and/or [II.2.13.2.2.1.  in case of pregnant dams, carried out on samples taken 
before insemination preceding the c urrent 
gestation.]]]]  
 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
 
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin .]] 
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment .]] 
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey tim es and resting periods  (4)(5). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 21  EN EUROPEAN UNION  Certificate model BOV -INTRA -X 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishmen t approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate  for this consignment is issued in this 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 3 8 of Delegated Regulation (EU) 
2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
(4) In the case where a consignment is grouped in a n establishment approved for assembly operations  and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when any part of the consignment left the 
establishment of origin.  
(5) This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 22  EN CHAPTER 2: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF BOVINE ANIMALS IN TENDED FOR 
SLAUGHTER (MODEL ‘BOV -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 23  EN  Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 24  EN EUROPEAN UNION   Certificate model BOV -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
 
II.1. The bovine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 38 of Delegated Regulation (EU) 2019/2035.  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed f or bovine animals during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are intended to be slaughtered for disease eradication purposes as part of an eradication 
programme, as p rovided for in Article 31(1) or (2) of Regulation (EU) 2016/429, and the 
Member State of destination and, where applicable, the Member State of passage authorised 
the movement in advance.]  
 
II.2. According to official information, the animals described in Part I meet the following health requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for bovine animals.  
 (2)either [II.2.2.  They come from establishments free from infection with Brucella abortus, B. melitensis  and 
B. suis  with or without vaccination regarding bovine animals.]  
(2)and/or[II.2.2.  They are castrated.]  
(2)and/or[II.2.2.  They are less than 12 months old.]  
(2)and/or[II.2.2.  They are entire bovine animals older than 12 months of age and have been subjected to a test 
for infection with Brucella abortus, B. melitensis  and B. suis  with one of the diagnostic 
methods provided for in Part 1 of Annex I  to Delegated  Regulation  (EU) 2020 /688, carried 
out, with negative results, on a sample taken during the last 30 days prior to departure, and in 
the case of post -parturient females taken at least 30 days after parturition.]  
(2)either [II.2.3.  They come from establishments free fro m infection with Mycobacterium tuberculosis  
complex ( M. bovis, M. caprae  and M. tuberculosis ).] 
(2)and/or[II.2.3.  They have been subjected to a test for infection with Mycobacterium tuberculosis  complex 
(M. bovis, M. caprae  and M. tuberculosis ) with one of  the diagnostic methods provided for in 
Part 2 of Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, with negative results, 
during the last 30 days prior to departure.]  
II.2.4.  They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during the last 30 days prior to departure.  
II.2.5.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.6.  They come from establis hments  in which infection with bluetongue virus (serotype 1 -24) has 
not been reported during the last 30 days prior to departure.  
(2)[II.2.7.  The requirements  as regards  infection with bluetongue virus (serotype 1 -24) laid down in 
Article 33 of Delegated R egulation (EU) 2020 /688 are fulfilled .] 
 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 25  EN EUROPEAN UNION   Certificate model BOV -INTRA -Y 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before a rriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]] 
(2)or [at least one of the animals of t he consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey tim es and resting periods  (4)(5). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched fr om an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for assembly operations, m ay be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignment is issued in th is 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 38 of Delegated Regulation (EU) 
2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 26  EN EUROPEAN UNION   Certificate model BOV -INTRA -Y 
(4) In the case where a consignment is grouped in an establishment approved for assembly operations  and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when any part of the consignment left the 
establishment of origin.  
(5) This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 27  EN CHAPTER 3: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF PORCINE ANIMALS N OT INTENDED FOR 
SLAUGHTER (MODEL ‘POR -INTRA -X’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No 
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 28  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log  yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 29  EN EUROPEAN UNION   Certificate model POR -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
 
II.1. The porcine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 52 or 54(2) of Delegated Regulation (EU) 
2019/2035.  
II.1.2.  They, for at least the last 30 days prior to the departure of the co nsignment, or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident in the establishment of origin;  
II.1.2.2.  have not been in contact with kept porcine animals of a lower health status or 
subject to movement restr ictions for animal health reasons;  
II.1.2.3.  have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory  during the last 30 days prior to the 
departure of the animals . 
II.1.3.  They have not sho wn clinical signs or symptoms of diseases listed for porcine animals during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
(2)[II.1.4.  They come from one or more holdings officially recognised a s applying controlled housing 
conditions in accordance with Article 8 of Regulation (EU) 2015/1375  and have not transited 
an establishment approved for assembly operations in accordance with Article 99(3) of 
Regulation (EU) 2016/429 that does not meet the requirements set out in Chapter I(A)(j) of 
Annex IV of Regulation (EU) 2015/1375.]  
 
II.2. According to official information, the animals described in Part I meet the following health requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases li sted for porcine animals.  
II.2.2.  They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during the last 30 days prior to departure.  
II.2.3.  They come from establishments  in which anthrax in ung ulates has not been reported during 
the last 15 days prior to departure.  
II.2.4.  They come from establishments  in which infection with Brucella abortus, B. melitensis  and 
B. suis  in porcine animals has not been reported during the last 42 days prior to dep arture, and 
in which during at least the last 12 months prior to departure  
(2)either  [II.2.4.1.  biosecurity and risk mitigating measures set out in Article 19(1)(f)(i) of 
Delegated Regulation (EU) 2020 /688 have been introduced;  
(2)and/or  [II.2.4.2.  survei llance for infection with  Brucella abortus, B. melitensis and B. suis has 
been  carried out on the porcine animals kept on the establishments in accordance 
with Article 19(1)(f)(ii) of  Delegated Regulation (EU) 2020 /688.  
II.2.5.  They come from establishments in which infection with Aujeszky’s disease virus has not been 
reported during the last 30 days prior to departure of the consignment.  
 (2)[II.2.6.  They are moved to a Member State or zone thereof with the status free from infection with 
Auje szky’s disease virus and have not been vaccinated against infection with Aujeszky’s 
disease virus, and  
 (2)either  [II.2.6.1.  come from establishments free from infection with Aujeszky’s disease virus, and  
(2)either  [II.2.6.1.1.  the establishments of origin  are situated in a Member State or zone 
with the status free from infection with Aujeszky’s disease virus;]]  
(2)and/or [II.2.6.1.2.  the animals in the consignment have been subjected to a serological 
test for the detection of antibodies against whole Aujes zky’s disease This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 30  EN EUROPEAN UNION   Certificate model POR -INTRA -X 
virus with one of the diagnostic methods provided for in Part 7 of 
Annex I  to Delegated Regulation (EU) 2020 /688(3)(4), with a negative 
result, on a sample taken during the last 15 days prior to departure ;]]] 
(2)and/or  [II.2.6.2.  come from es tablishments not free from infection with Aujeszky’s disease virus, 
and 
– have been kept in an approved quarantine establishment for a period of at 
least 30 days; and  
– have been subjected to a serological test for the detection of antibodies 
against whole Auj eszky’s disease virus with the diagnostic method 
provided for in Part 7 of Annex I to Delegated Regulation (EU) 2020 /688, 
with a negative result, carried out on samples taken on two occasions at an 
interval of not less than 30 days, the last sample taken during the last 15 
days prior to departure.]]  
(2)[II.2.6.  They are moved to a Member State or zone thereof with an approved eradication programme 
for infection with Aujeszky’s disease virus, and  
 (2)either  [II.2.6.1.  come from establishments free from infe ction with Aujeszky’s disease virus, and  
(2)either  [II.2.6.1.1.  the establishments of origin are situated in a Member State or zone 
thereof with the status free from infection with Aujeszky’s disease 
virus;]]  
(2)and/or [II.2.6.1.2.  the establishments of o rigin are situated in a Member State or zone 
thereof with an approved eradication programme for infection with 
Aujeszky’s disease virus;]]  
(2)and/or [II.2.6.1.3.  the animals in the consignment have been subjected to a serological 
test for the detection of antibodies against whole Aujeszky’s disease 
virus or antibodies against Aujeszky’s disease virus -gE protein, 
where applicable, with one of the diagnostic methods provided for in 
Part 7 of Annex I  to Delegated Regulation (EU) 2020 /688(4), with a 
negative re sult, on a sample taken during the last 15 days prior to 
departure .]]] 
(2) and/or  [II.2.6.2.  come from an establishment not free from infection with Aujeszky’s disease 
virus, and  
– have been kept in an approved quarantine establishment for a period of at 
least 30 days; and  
– have been subjected to a serological test for the detection of antibodies 
against whole Aujeszky’s disease virus with the diagnostic method 
provided for in Part 7 of Annex I to Delegated Regulation 2020 /688, with a 
negative result, carried  out on samples taken on two occasions at an interval 
of not less than 30 days, the last sample taken during the last 15 days prior 
to departure.]]  
 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause.  
 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
 
II.5. This certificate is valid  for 10 days from the date of  issuing. In the case of transport by waterway/sea of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 31  EN EUROPEAN UNION   Certificate model POR -INTRA -X 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
 
(2)(5)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment h as undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey tim es and resting periods  (6)(7). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I. 12: “Place of destination ”: Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishmen t approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate  for this consignment is issued in this 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 5 2 or 54(2) of Delegated Regulation 
(EU) 2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) For porcine animals less than four months old born to dams vaccinated with a gE -deleted vaccine, the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 32  EN EUROPEAN UNION   Certificate model POR -INTRA -X 
diagnostic method for the detection of antibodies against Aujeszky’s disease virus gE protein provided for 
in Part 7 of Annex I to Delegated Regulation (EU) 2020 /688 may be used.  
(4) The number of porcine animals tested must allow at least for the detection of 10% seroprevalence of the 
consignment with 95% confidence.  
(5) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
(6) In the case where a consignment is grouped in an establishment approved for asse mbly operations  and 
comprises animals that were loaded on different dates, the date which the journey commenced for the 
whole consignment is considered to be the earliest date when any part of the consignment left the 
establishment of origin.  
(7) This stat ement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 33  EN CHAPTER 4: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF PORCINE ANIMALS I NTENDED FOR 
SLAUGHTER (MODEL ‘POR -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 34  EN  Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey  log  yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 35  EN EUROPEAN UNION   Certificate model POR -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
 
II.1. The porcine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 52 or 54(2) of Delegated Regulation (EU) 
2019/2035.  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed fo r porcine animals during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are intended to be slaughtered for disease eradication purposes as part of an eradication 
programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, and the 
Member State of destination and, where applicable, the Member State of passage authorised 
the movement in advance.]  
(2)[II.1.4.  They  are 
(2)either  [II.1.4.1.  not weaned and less than  5 weeks of age;]]  
(2)or [II.1.4.1.  coming from one or more holdings officially recognised as applying controlled 
housing conditions in accordance with Article 8(1) of Regulation (EU) 
2015/1375  
(2)either  [II.1.4.1.1  of which the carcases of all sows and boars are examined for 
Trichinella ;]] 
(2)and/or [II.1.4.1.1.  of which 10% of the carcases of the animals sent for slaughter are 
examined for Trichinella ;]] 
(2)or [II.1.4.1.1.  situated in a Member State in which no autochthonous Trichinella 
infestations in domestic swine kept on holdings officially recognised 
as applying controlled housing conditions have been detected during 
the past 3 years, during which time continuous testin g has been 
conducted in accordance with Article 2 of Regulation (EU) 
2015/1375; ]] 
(2)or [II.1.4.1.1.  situated in a Member State for which historical data on continuous 
testing carried out on slaughtered swine population of those holdings 
or compartment to which they belong provide at least 95% 
confidence that the prevalence of Trichinella  does not exceed 1 per 
million in that population; ]] 
(2)or [II.1.4.1.  come from one or more holdings officially recognised as applying controlled 
housing conditions in acco rdance with Article 8(2) of Regulation (EU) 
2015/1375 and situated in Belgium or Denmark. ]] 
 
II.2. According to official information, the animals described in Part I meet the following health requirements:  
II.2.1.  They do not come from establishments subje ct to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for porcine animals.  
II.2.2.  They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported during  the last 30 days prior to departure.  
II.2.3.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
 (2)[II.2.4.  They  are moved to a Member State or zone thereof with the status free f rom infection with 
Aujeszky’s disease virus or with an approved eradication programme for infection with 
Aujeszky’s disease , and 
 come from establishments in which infection with Aujeszky’s disease virus has This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 36  EN EUROPEAN UNION   Certificate model POR -INTRA -Y 
not been reported during the last 30 days prior to departure;  
 are transported directly to the slaughterhouse in the Member State of destination 
without undergoing any assembly operations in that Member State or zone 
thereof, or any Member State or zone thereof of passage, which is free from 
infection wi th Aujeszky’s disease virus.]  
 
II.3. To the best of my knowledge, and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
 
II.4. Arrangements  are made to transport the consi gnment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended  by the duration of the journey by 
waterway/sea.  
 
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assem bly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport,  the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey times and resting periods  (4)(5). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an es tablishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved f or assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishmen t approved for assembly operations, may be This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 37  EN EUROPEAN UNION   Certificate model POR -INTRA -Y 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate  for this consignment is issued in this 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 5 2 or 54(2) of Delegated Regulation 
(EU) 2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operation s. 
(4) This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.  
(5) To be completed in case of consignment grouped in an establishment approved for assembly operations  
located in the Member State of transit.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 38  EN CHAPTER 5: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF OVINE AND CAPRINE  ANIMALS NOT 
INTENDED FOR SLAUGHT ER (MODEL ‘ OV/CAP -INTRA -X’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 39  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 40  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The ovine/caprine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 45(2) or (4) or Article 46(1) of Delegated 
Regulation (EU) 2019/2035.  
II.1.2.  They, for at least the last 30 days prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident in the establishment of origin;  
II.1.2.2.  have not been in contact with kept ovine or caprine animals of a lower health 
status or subject to movement restrictions for animal health reasons;  
II.1.2.3.  have not been in direct or indirect contact with kept animals that have entered the 
Union from a third country or t erritory  during the last 30 days prior to the 
departure of the animals . 
II.1.3.  They have not shown clinical signs or symptoms of diseases listed for ovine/caprine animals 
during the clinical examination carried out within 24 hours prior to departure on 
…… …………. ( insert date  dd/mm/yyyy ). 
II.2. According to official information, the animals described in Part I meet the following health requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for ovine/caprine animals.  
 (2)either [II.2.2.  They come from establishments free from infection with Brucella abortus, B. melitensis  and 
B. suis  without vaccination regarding ovine and caprine animals, and  
(2)either [the establishments  of origin are situated in a Member State or zone thereof with the status 
free from infection with Brucella abortus, B. melitensis  and B. suis  regarding the ovine and 
caprine population; 
(2)and/or  [they have been subjected to a test for infection with Brucella abortus, B. melitensis  and B. 
suis with one of the diagnostic methods provided for in Part 1 of Annex I  to Delegated  
Regulation (EU) 2020 /688, carried out, with negative results, on a sample taken during the 
last 30 days prior to departure, and in the case of post -parturient females taken at least 30 
days after parturition; 
(2)and/or  [they are less than 6 months old; 
(2)and/or  [they are castrated.]  
(2)or[II.2.2.  They come from establishments free from infection with Brucella abo rtus, B. melitensis  and 
B. suis  with vaccination regarding ovine and caprine animals and they are moved to a 
Member State or zone thereof without the status free from infection with Brucella abortus, B. 
melitensis  and B. suis  regarding ovine and caprine an imals.]  
(2)either [II.2.3.  They are kept ovine animals and come from establishments in which infection with 
Mycobacterium tuberculosis  complex ( M. bovis, M. caprae and M. tuberculosis ) has not been 
reported during the last 42 days prior to departure.]  
(2)and/or[II.2.3.  They are kept caprine animals and come from establishments in which surveillance for 
infection with  Mycobacterium tuberculosis complex  (M. bovis, M. caprae and M. 
tuberculosis) has been  carried out on the caprine animals kept on the establishm ents during at 
least the last 12 months prior to departure, as referred to in Article 15(3) of Delegated  
Regulation (EU) 2020 /688.] 
II.2.4.  They come from establishments in which infection with rabies virus in kept terrestrial animals 
has not been reported  during the last 30 days prior to departure.  
II.2.5.  They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in kept animals of listed species for that disease during the last 2 years prior to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 41  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
departure.  
II.2.6.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.7.  They come from establishments  in wh ich surra ( Trypanosoma evansi ) has not been reported 
during the last 30 days prior to departure , and  
(2)either  [surra has not been  reported in the establishments during the last 2 years prior to their 
departure.]  
(2)or [surra has been reported during the last 2 years prior to departure, following the last outbreak 
the affected establishment has remained under movement restrictions until:  
– the infected animals have been removed  from the establishment, and  
– the remaining animals on the establishment have been subjected to a test for surra 
(Trypanosoma evansi ) with one of the diagnostic methods provided for in part 3 of 
Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals  have been removed from the 
establishment.]  
(2)[II.2.8.  They  are kept uncastrated male ovine animals, and  
– come from establishments in which ovine epididymitis ( Brucella ovis ) has not been 
reported during the last 12 months prior to departure, and  
– have be en subjected to a serological test for ovine epididymitis ( Brucella ovis ), carried 
out, with negative results, on a sample taken during the last 30 days prior to departure.]  
(2)either [II.2.9.  They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b)  or (c) or Article 32(2) of Delegated Regulation 
(EU) 2020/688 are fulfilled .] 
(2)and/or [II.2.9.  They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotype 1 -24) and the requirements laid  down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and 
they 
(2)either  [II.2.9.1.  have been kept in a Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24) in accor dance with Article 40(3) of Delegated  
Regulation (EU) 2020 /689 
 (2)either  [II.2.9.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or [II.2.9.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological  test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free f rom infection 
with bluetongue virus (serotype 1 -24).]]]  
(2)and/or [II.2.9.1.3.  for at leas t 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free f rom infection with  
bluetongue virus (serotype 1 -24).]]]  
(2)and/or [II.2.9.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.2.1.  for at least 60 days prior to the date of movement.]]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 42  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
(2)and/or [II.2.9. 2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at le ast 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or [II.2.9.2.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried ou t on samples 
collected at least 14 days following the date of the commencement of 
the period of protection against attacks by vectors.]]]  
(2)and/or [II.2.9.3.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus whic h were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and  
(2)either  [II.2.9.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.9.3.2.  have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.9.4.  have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and  
(2)either  [II.2.9.4.1.  the se rological test has been carried out on samples collected at least 
60 days before the date of movement.]]]  
(2) and/or [II.2.9.4.2.  the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal  has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement.]]]  
(2)and/or [II.2.9.  They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor covered by the eradication programme for infection with bluetongue 
virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and they 
(2)either  [II.2.9.1.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.1.1.  for at least 60 da ys prior to the date of movement.]]]  
(2)and/or [II.2.9.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the  
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or [II.2.9.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 da ys following the date of the commencement of 
the period of protection against attacks by vectors.]]]  
(2)and/or [II.2.9. 2. have been kept for the last 60 days prior to departure in an establishment situated 
in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated  Regulati on 
(EU) 2020 /689 has been carried out during that period,  and This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 43  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
(2)either  [II.2.9. 2.1. the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least  150 km radius centred on the place 
where the animals were kept  and are within the immunity period 
guaranteed in the specifications of the vaccine and  
(2)either  [II.2.9. 2.1.1. have been vaccinated more than 60 days before the 
date of movement.]]]]  
(2)and/or [II.2.9. 2.1.2. have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine.]]]]  
(2)and/or [II.2.9. 2.2. the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept, and   
(2)either  [II.2.9. 2.2.1. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 60 days before the date of movement.]]]]  
(2)and/or [II.2.9. 2.2.2. the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 30 days before the date of the movement and to a 
PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement.]]]]  
(2)and/or [II.2.9.  They  do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Delegated  Regulation (EU) 2020 /689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Membe r State 
or zone thereof  
(2)either  [II.2.9.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred to 
in Article 43(2)(a), (b) and (c) of Delegated  Regulation  (EU) 2020 /689, and 
(2)either  [II.2.9.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Section 1 of Chapter 2 of Part II of An nex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the r equirements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.9.1.  with an approved eradication program for infection with bluetongue virus 
(serotype 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated  
Regulation  (EU) 2020 /689, and 
(2)either  [II.2.9.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 44  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex  V to that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requ irements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.9.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered by 
the eradication programme for infection with bluetongue virus (serotype 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised  
(2)either  [II.2.9.1.1.  without any conditions , and  
(2)and/or  [II.2.9.1.2.  under the conditions referred to in point 5 of Section 1  of Chapter 2 
of Part II of Annex V to  Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1 .4. under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688  
and the  requirements laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
(2)either  [II.2.10.  The animals are intended for a Member State or zone of a Member 
State listed in point 2.3. of Section A of Chapter A of Annex VIII to Regulation (EC) N o 
999/2001 as having a negligible risk status for classical scrapie  or for a Member State listed in 
point 3.2. of that Section as having an approved national scrapie control programme, and  
(2)either  [come from a holding situated in a Member State or zone of a Member State listed in 
point 2.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 
as having a negligible risk status for classical scrapie.]  
(2)and/or  [come from a holding recognised as having a negligible risk of classical scra pie in 
accordance with point 1.2. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of that Section.]  
(2)and/or  [come from a holding not su bject to the measures laid down in points 3 and 4 of 
Chapter B of Annex VII to Regulation (EC) No 999/2001 and the animals are of the 
ovine species and are of the ARR/ARR prion protein genotype , or the animals are of 
the caprine s pecies and carry at least one of the K222, D146 or S146 alleles .] 
(2)and/or  [come from and are destined for an approved body, institute or centre as defined in 
Article 2(1)(c) of Directive 92/65/EEC.]  
(2)or [comply with the conditions set out in point 4.1.(d) of Section A of Chapte r A of 
Annex VIII to Regulation (EC) No 999/2001.]]  
(2)or [II.2.10.  The animals are for breeding and  are intended for a Member State or zone of a Member State 
other than those listed in point 2.3. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 as having a negligible risk status for classical scrapie  or other than those 
listed in point 3.2. of that Section as having an approved national scrapie control programme, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 45  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
and  
(2)either  [come from a holding situated in a Member State or zone of a Member State listed in 
point 2.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001 
as having a negligible risk status for classical scrapie.]  
(2)and/or  [come from a holding recognised as having a negligible risk of classical scra pie in 
accordance with point 1.2. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of that Section.]  
(2)and/or  [come from a holding recogn ised as having a controlled risk of classical scrapie in 
accordance with point 1.3. of Section A of Chapter A of Annex VIII to Regulation 
(EC) No 999/2001 and listed as such by the competent authority of the Member State 
in accordance with point 1.1. of th at Section.]  
(2)and/or  [come from a holding not subject to the measures laid down in points 3 and 4 of 
Chapter B of Annex VII to Regulation (EC) No 999/2001 and the animals are of the 
ovine species and are of the ARR/ARR prion protein genotype , or the anim als are of 
the caprine s pecies and carry at least one of the K222, D146 or S146 alleles .] 
(2)and/or  [come from and are destined for an approved body, institute or centre as defined in 
Article 2(1)(c) of Directive 92/65/EEC.]  
(2)or [comply with the conditio ns set out in point 4.1.(d) of Section A of Chapter A of 
Annex VIII to Regulation (EC) No 999/2001.]]  
(2)or [II.2.10.  The animals are not for breeding and are intended for a Member State or zone of a Member 
State other than those listed in point 2.3. of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having a negligible risk status for classical scrapie  or other 
than those listed in point 3.2. of that Section as having an approved nat ional scrapie control 
programme.]  
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the peri od of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of t he consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined toda y and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transpor t, the loading and unloading facilities, the competence of the personnel, the space This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 46  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -X 
allowances, as well as watering, feeding intervals, journey times and resting periods  (4)(5). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an es tablishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I. 12: “Place of destination ”: Indicate an establishment of the final destination of the 
consignment or an establishment approved f or assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishmen t approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate  for this consignment is issued in this 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 4 5(2) or (4) or Article 46(1) of 
Delegated Regulation (EU) 2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
(4) This statement does not exempt transporters from their obligation in accordance with Union rules in force 
in particular regarding the fitness to be transported.  
(5) To be completed in case of consignment grouped in an establishment  approved for assembly operations  
located in the Member State of transit.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 47  EN CHAPTER 6: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF OVINE AND CAPRINE  ANIMALS INTENDED 
FOR SLAUGHTER (MODEL ‘ OV/CAP -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 48  EN  Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 49  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The ovine/caprine animals(1) of the consignment described in Part I meet the following requirements:  
(2)either  [II.1.1.  All of the animals are individually identified in accordance with Article 45 (2) of Delegated 
Regulation (EU) 2019/2035 .] 
(2)or [II.1.1.  They are identified in accordance with Article 45 of Delegated Regulation (EU) 2019/2035 
and they have been continuously  resident in the establishment for at least 21 days prior to 
departure, or since birth, if they are younger than 21 days of age.]  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed for ovine/caprine animals 
during the clinical examin ation carried out within 24 hours prior to departure on 
………………. ( insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regul ation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]  
II.2. According to official information, the animals described in Part I meet the following health 
requirements : 
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for ovine/caprine animals.  
 (2)either  [II.2.2.  They come from establishments free from infection with Brucella abortus, B. melitensis  and 
B. suis  with or without vaccination regarding ovine and caprine animals;  
(2)and/or  [II.2.2.  They are older than 6 months of age and have been subjected to a test for infection with 
Brucella abortus, B. melitensis  and B. suis  with one of the diagnostic methods provided for 
in Part 1 of Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, wi th negative 
results, on a sample taken during the last 30 days prior to departure, and in the case of post -
parturient females taken at least 30 days after parturition;  
((2)and/or  [II.2.2.  They are castrated.]  
II.2.3.  They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.  
II.2.4.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.5.  They come from establishments  in which infection with bluetongue virus (serotype 1 -24) 
has not been reported during the last 30 days prior to departure.  
(2)[II.2.6.  The requirements  as regards  infection with bluetongue virus (serotype 1 -24) laid down in 
Article 33 of Delegated Regulation (EU) 2020 /688 are fulfilled. ] 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnor mal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of tr ansport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 50  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -Y 
(2)(3)  [II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare a ttestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requi rements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey times and resting periods  (4). 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals  are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for asse mbly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignme nt is issued in this 
establishment approved for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 45 of Delegated Regu lation (EU) 
2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
(4) This statement does not exempt transporters from their obligation in accordance with Union rules in force This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 51  EN EUROPEAN UNION   Certificate model OV /CAP -INTRA -Y 
in particular regarding the fitness to be transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control  Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 52  EN CHAPTER 7: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF AN INDIVIDUAL EQUINE ANIMAL NOT 
INTENDED FOR SLAUGHT ER (MODEL ‘EQUI -INTRA -IND’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Event or activity near borders  
 Registered equine animal     Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 53  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 54  EN EUROPEAN UNION   Certificate model EQUI -INTRA -IND Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animal described in Part I meets the following requirements:  
II.1.1.  The animal is accompanied by its single lifetime identification document as provided 
for in Article 65 , 67 or 68  of Delegated Regulation (EU) 2019/2035 , or by a 
temporary document issued in accordance with Article 61(2) thereof . 
(1)[The single lifetime identification document was issued in accordance wit h Article  
65(2) or 67(1) of Delegated Regulation (EU) 2019/2035, or the temporary document 
was issued in accordance with Article 61(2) of that Regulation , for a registered 
equine animal as defined in Article 2(30) of that Delegated Regulation.]  
(1)[The sin gle lifetime identification document includes a current validation  mark in 
accordance with Article 65(1)(i)(i) of Delegated Regulation (EU) 2019/2035.]  
(1)[The single lifetime identification document includes a current license in accordance 
with Article 65(1)(i)(ii) of Delegated Regulation (EU) 2019/2035.]  
II.1.2.  The animal has not shown clinical signs or symptoms of diseases listed for equine 
animals during the clinical examination carried out within 48 hours prior to 
departure, or on the last working d ay prior to departure(2), from the registered 
establishment,  on ………………. ( insert date  dd/mm/yyyy ). 
II.2. According to official information, the animal described in Part I meets the following health 
requirements:  
II.2.1.  The animal does not come from an esta blishment subject to movement restrictions or 
situated in a restricted zone  established for reasons of diseases listed for equine 
animals, including African horse sickness and infection with Burkholderia mallei  
(glanders).  
II.2.2.  The animal comes  from  an establishment in which surra ( Trypanosoma evansi ) has 
not been reported during the last 30 days prior to its departure, and  
(1)either  [surra has not been  reported in the establishment during the last 2 years prior to 
departure.]  
(1)or [surra has been repo rted in the establishment during the last 2 years prior to its 
departure and  following the last outbreak the establishment has remained under 
movement restriction  
(1)either  [until the  remaining animals in the establishment have been subjected to a 
test for  surra with one of the diagnostic methods provided for in Part 3 of 
Annex I to  Delegated Regulation (EU) 2020 /688, carried out, with 
negative results, on samples taken at least 6 months after the last infected 
animal has been removed from the establishment .]] 
(1)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either killed and 
destroyed or slaughtered.]]  
II.2.3.  The animal comes from an establishment  in which dourine has not been reported 
during the last 6 months prior to its departure, and  
(1)either  [dourine  has not been reported in the establishment during the last 2 years prior to its 
departure.]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 55  EN EUROPEAN UNION   Certificate model EQUI -INTRA -IND 
(1)or [dourine has been reported in the establishmen t during the last 2 years prior to its 
departure and following the last outbreak, the establishment has remained under 
movement restriction until   
(1)either  [the remaining equine  animals in the establishment, except castrated male  
equine animals , have been  subjected to a test for dourine with the 
diagnostic method provided for in Part 8 of Annex I to  Delegated 
Regulation (EU) 2020 /688, carried out, with negative results, on samples 
taken at least 6 months after the infected animals have been killed and 
destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]  
(1)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]  
II.2.4.  The animal comes from an establishment in which equine infectious anaemia has not 
been reported during the last 90 days prior to its departure, and  
(1)either  [equine infectious anaemia has not been reported on the establishment durin g the last 
12 months prior to its departure.]  
(1)or [equine infectious anaemia has been reported on the establishment during the last 12 
months prior to its departure and following  the last outbreak the establishment has 
remained under movement restriction  until 
(1)either  [the remaining equine  animals in the establishment have been subjected to 
a test for equine infectious anaemia with the diagnostic method provided 
for in Part 9 of Annex I to Delegated Regulation (EU) 2020 /688, carried 
out, with negative r esults, on samples taken on two occasions with a 
minimum interval of 90 days following cleaning and disinfection of the 
establishment after the infected animals have been killed and destroyed or 
slaughtered.]]  
(1)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]  
II.2.5.  The animal comes from an establishment in which Venezuelan equine 
encephalomyelitis has not been reported  during the last 6 months prior to its departure, 
and 
(1)either  [during the last 2 years prior to its departure, Venezuelan equine encephalomyelitis has 
not been reported in the Member State or zone thereof in which the establishment is 
situated.]  
(1)or [during the last 2 years prior to its departure, Venezuelan equine encephalomyelitis has 
been reported in the Member State or zone thereof in which the establishment is 
situated, and during the period of at least 21 days prior to departure of the animal 
referred to in point II.1 all equine animals in the establishment have remained 
clinically healthy, and  
(1)either  [the animal referred to in point II.1 was kept protected from attacks by 
insect vectors in a quarantine, in which any equine animal that showed a  
rise in daily taken body temperature has been subjected with negative 
result to a diagnostic test for Venezuelan equine encephalomyelitis with 
the diagnostic method provided for in Part 10(1)(a) of Annex I to 
Delegated Regulation (EU) 2020 /688, and the an imal referred to in point This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 56  EN EUROPEAN UNION   Certificate model EQUI -INTRA -IND 
II.1 has been  
(1)either  [vaccinated against Venezuelan equine encephalomyelitis 
with a complete primary course and revaccinated according to 
manufacturer's recommendations not less than 60 days and 
not more than 12 months prior t o the date of its departure.]]]  
(1)or [subjected to a serological test for Venezuelan equine 
encephalomyelitis with the diagnostic method provided for in 
Part 10(1)(b) of Annex I  to Delegated Regulation (EU) 
2020 /688, carried out, with negative results, on  a sample 
taken not less than 14 days after the date of its entry into 
quarantine.]]]  
(1)or [the body temperature of the animal referred to in point II.1 has been 
taken daily, either without a rise or the animal has been subjected to a 
diagnostic test for Venezuelan equine encephalomyelitis with the 
diagnostic method provided for in Part 10(1)(a) of Annex I to Delegated 
Regulation (EU) 2020 /688, with negative results, and the animal referred 
to in point II.1 has been subjected to tests for Venezuelan equine  
encephalomyelitis with the diagnostic methods provided for in:  
 Part 10(1)(b) of Annex I to  Delegated Regulation (EU) 2020 /688, 
without an increase in antibody titre, carried out on paired samples 
taken on two occasions with an interval of 21 days, the sec ond of 
which was taken during a period of 10 days prior to the date of its 
departure, and  
 Part 10(2) of Annex I to Delegated Regulation (EU) 2020 /688, 
with negative result, carried out on a sample taken within 48 hours 
prior to its departure, and the anima l has been protected from 
attacks by insect vectors after sampling until its departure.]]]  
II.2.6.  The animal comes  from an establishment in which infection with rabies virus in kept 
terrestrial animals has not been reported during the last 30 days prior t o its departure.  
II.2.7.  The animal comes from an establishment  in which anthrax in ungulates has not been 
reported during the last 15 days prior to its departure.  
II.3. To the best of my knowledge, after due inquiry, and as declared by the operator, the a nimal comes 
from an establishment where there were no abnormal mortalities with an undetermined cause and 
the animal has not been in contact with kept animals  of listed species which did not comply with 
the requirements referred to in points II.2. 1. to II. 2.6. during the last 30 days prior to its departure, 
and with the requirement referred to in point II.2.7. during the last 15 days prior to its departure.  
II.4. Arrangements  are made to  
(1)either  [transport the animal in accordance  with Article 4 of Delegated Regulation (EU) 
2020 /688.] 
(1)or [move the animal on foot.]  
II.5. This animal health  certificate is valid  for  
(1)either  [10 days from the date of issuing, and]  
(1)or [30 days from the date of issuing, and a current validation mark or license is attested in 
point II.1.1, and]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 57  EN EUROPEAN UNION   Certificate model EQUI -INTRA -IND 
in the case of transport by waterway/sea of the animal, the period of validity of the animal health 
certificate may be extended by the duration of the journey by waterway/sea.  
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animal described above was examined today and 
found  fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU  legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as the watering, feeding intervals, journey t imes and resting periods.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a registered establishment of dispatch of the equine 
animal or, provided the animal is transported, an establishment approved for assembly 
operations in accordance with Articles 97 and 99 of Regulation (EU) 2019/429.  
Box reference I. 12: “Place of  destination ”: Indicate a registered establishment of destination or, provided 
the animal is transported, an establishment approved for assembly operations in 
accordance with Articles 97 and 99 of Regulation (EU) 2019/429.  
Box reference I. 30: “Identificati on number ”: Indicate the unique code of the equine animal referred to in 
Article 65(1)(b) of Delegated Regulation (EU) 2019/2035 , or the code displayed by the 
injectable transponder if the animal is unweaned and accompanies its dam or foster 
mare.  
 
Part II : 
(1) Delete if not applicable.  
(2) Only applicable in case of equine animals moved in accordance with Article 92(2) of Delegated 
Regulation (EU) 2020 /688. 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 58  EN CHAPTER 8: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF A CONSIG NMENT OF EQUINE ANIMALS 
(MODEL ‘EQUI -INTRA -CON’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Event or activity near borders  
 Registered equine animal   Slaughter    Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 59  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 60  EN EUROPEAN UNION   Certificate model EQUI -INTRA -CON  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are accompanied by their single lifetime identification documents as provided for in  
(2)either  [Article 65 , 67 or 68  of Delegated Regulation (EU) 2019/2035, and are not intended for 
slaughter for human consumption.]  
(2)or [Article 65 or 67(1)  of Delegated Regulation (EU) 2019/2035 , and are intended for 
slaughter for human consumption.]  
(2)[Their single lifetime identification documents were issued in accordance with Article 65(2) 
or 67(1) of Delegated Regulation (EU) 2019/2035 for registered equine animals as defined 
in Article 2( 30) of that Delegated Regulation.]  
(2)[Their single lifetime identification documents include a current validation  mark in 
accordance with Article 65(1)(i)(i) of Delegated Regulation (EU) 2019/2035.]  
II.1.2.  They have not shown clinical signs or symptoms o f diseases listed for equine animals during 
the clinical examination carried out within 48 hours prior to departure, or on the last 
working day prior to departure(3) from the registered establishment,  on ………………. 
(insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They a re intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]  
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone established for reasons of diseases listed for equine animals, including 
African horse sickness and infection with Burkholderia mallei  (glanders).  
II.2.2.  They come  from  establishments in which surra ( Trypanosoma evansi ) has not been reported 
during t he last 30 days prior to their departure, and  
(2)either  [surra has not been  reported in the establishments during the last 2 years prior to their 
departure.]  
(2)or [surra has been reported in the establishments during the last 2 years prior to their departure 
and following the last outbreak the establishments have remained under movement 
restriction  
(2)either  [until the  remaining animals in the establishment have been subjected to a test for 
surra with one of the diagnostic methods provided for in Par t 3 of Annex I to  
Delegated Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken at least 6 months after the last infected animal has been removed 
from the establishment.]]  
(2)or [for at least 30 days from the date of cleaning and  disinfection, after the last 
animal of listed species on the establishment was either killed and destroyed, or 
slaughtered .]] 
II.2.3.  They come from establishments  in which dourine has not been reported during the last 6 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 61  EN EUROPEAN UNION   Certificate model EQUI -INTRA -CON  
months prior to their departure, a nd 
(2)either  [dourine  has not been reported in the establishments during the last 2 years prior to their 
departure.]  
(2)or [dourine has been reported in the establishments during the last 2 years prior to their 
departure and following the last outbreak, th e establishments have remained under movement 
restriction  
(2)either  [until the  remaining equine  animals in the establishment, except castrated male  
equine animals , have been subjected to a test for dourine with the diagnostic 
method provided for in Part 8  of Annex I to  Delegated Regulation (EU) 
2020 /688, carried out, with negative results, on samples taken at least 6 months 
after the infected animals have been killed and destroyed or slaughtered, or the 
infected entire male equine animals have been castrated.]]  
(2)or [for at least 30 days days from the da te of cleaning and disinfection, after the last 
animal of listed species on the establishment was either killed and destroyed, or 
slaughtered .]] 
II.2.4.  They come from establishments in which equine infectious anaemia has not been reported 
during the last 90 days prior to their departure, and  
(2)either  [equine infectious anaemia has not been reported on the establishments during the last 12 
months prior to their departure.]  
(2)or [equine infectious anaemia has been reported on the establishments during the last 12 months 
prior to their departure and following  the last outbreak the establishments has remained under 
movement restriction  
(2)either  [until the  remaining equine  animals in the establishment have been subjected to a 
test for equine infectious anaem ia with the diagnostic method provided for in Part 
9 of Annex I to Delegated Regulation (EU) 2020 /688, carried out, with negative 
results, on samples taken on two occasions with a minimum interval of 90 days 
following cleaning and disinfection of the estab lishment after the infected 
animals have been killed and destroyed, or slaughtered .]] 
(2)or [for at least 30 days from the date of cleaning and disinfection, after the last 
animal of listed species on the establishment was either killed and destroyed, or 
slaughtered .]] 
II.2.5.  They come from establishments in which Venezuelan equine encephalomyelitis has not been 
reported during the last 6 months prior to their departure, and  
(2)either  [during the last 2 years prior to their departure, Venezuelan equine en cephalomyelitis has not 
been reported in the Member State or zone thereof in which the establishments are situated.]  
(2)or [during the last 2 years prior to their departure, Venezuelan equine encephalomyelitis has 
been reported in the Member State or zone thereof in which the establishments are situated, 
and during the period of at least 21 days prior to departure of the animals referred to in point 
II.1 all equine animals in the establishments have remained clinically healthy, and  
(2)either  [the animals r eferred to in point II.1 were kept protected from attacks by insect 
vectors in a quarantine, in which any equine animal that showed a rise in daily 
taken body temperature has been subjected with negative result to a diagnostic 
test for Venezuelan equine en cephalomyelitis with the diagnostic method 
provided for in Part 10(1)(a) of Annex I to Delegated Regulation (EU) 2020 /688, 
and the animals referred to in point II.1 have been  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 62  EN EUROPEAN UNION   Certificate model EQUI -INTRA -CON  
(2)either  [vaccinated against Venezuelan equine encephalomyelitis with a 
complet e primary course and revaccinated according to 
manufacturer's recommendations not less than 60 days and not more 
than 12 months prior to the date of their departure.]]]  
(2)or [subjected to a serological test for Venezuelan equine 
encephalomyelitis with the  diagnostic method provided for in Part 
10(1)(b) of Annex I  to Delegated Regulation (EU) 2020 /688, carried 
out, with negative results, on a sample taken not less than 14 days 
after the date of their entry into quarantine.]]]  
(2)or [the body temperature of the animals referred to in point II.1 has been taken 
daily, either without a rise or the animals have been subjected to a diagnostic test 
for Venezuelan equine encephalomyelitis with the diagnostic method provided 
for in Part 10(1)( a) of Annex I to Delegated Regulation (EU) 2020/688, with  
negative results, and the animals referred to in point II.1 have been subjected to 
tests for Venezuelan equine encephalomyelitis with the diagnostic methods 
provided for in:  
 Part 10(1)(b) of Annex I  to Delegated Regulation (EU) 2020 /688, without 
an increase in antibody titre, carried out on paired samples taken on two 
occasions with an interval of 21 days, the second of which was taken 
during a period of 10 days prior to the date of their departure, and 
 Part 10(2) of Annex I to Delegated Regulation (EU) 2020 /688, with 
negative result, carried out on a sample taken within 48 hours prior to 
their departure, and the animals have been protected from attacks by 
insect vectors after sampling until their dep arture.]]]  
II.2.6.  They come  from establishments i n which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to their departure.  
II.2.7.  They come from establishments  in which anthrax in ungulates ha s not been reported during 
the last 15 days prior to their departure.  
II.3. To the best of my knowledge  and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause and they  have not been in contact 
with kept animals of listed species which did not comply with the requirements referred to in points 
II.2.1. to II.2.6. during the last 30 days prior to their departure, and with the requirement referred to in 
point II.2.7. during the l ast 15 days prior to their departure.  
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transpor t by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(4)[II.6.  Since leaving their registered establishments of departure  and before arriving to this establishment 
approved for assembly operations , none of the animals of the consignment has undergone more than 
two assembly operations, and  
(2)either  [they come from registered establishments of departure .]] 
(2)or [at least one of the animals of the consignment has und ergone one assembly operation on an 
approved establishment .]] 
(2)or [at least one of the animals of the consignment has undergone two assembly operations on This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 63  EN EUROPEAN UNION   Certificate model EQUI -INTRA -CON  
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, he reby certify, that the animals(1) described above were examined today 
and found fit for the intended journey and all necessary arrangements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especial ly as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space 
allowances, as well as watering, feeding intervals, journey times and resting periods.  
 
Notes:  
Guidance on the completion of this officia l certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a registered establishment of dispatch of the equine 
animals or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2019/429.  
Box reference I.12:  “Place of destination”:  Indicate a registered  establishment of destination or an 
establishment approved for assembly operations in accordance with Articles 97 and 99 
of Regulation (EU) 2019/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignment is issued in this 
establishment approv ed for assembly operations, must be indicated. . 
Box reference I. 30: “Identification number ”: Indicate for each animal of the consignment the unique code 
referred to in Article 65(1)(b) of Delegated Regulation (EU) 2019/2035 , or the code 
displayed by the in jectable transponder if the animal is unweaned and accompanies its 
dam or foster mare.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Only applicable in case of equine animals moved in accordance with Article 92(2) of Delegated 
Regulation (EU) 2020 /688. 
(4) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 64  EN EUROPEAN UNION   Certificate model EQUI -INTRA -CON  
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 65  EN CHAPTER 9: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CAMELID ANIMALS N OT INTENDED FOR 
SLAUGHTER (MODEL ‘CAM -INTRA -X’) 
EUROPEAN UNION  INTRA  Part I: Description of  consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 66  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 67  EN EUROPEAN UNION   Certificate model CAM -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The camelid animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 73 of Delegated Regulation (EU) 2019/2035.  
II.1.2.  They, for at least the last 30 days prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident in the establishment of origin;  
II.1.2.2.  have not been in contact with  kept camelid animals of a lower health status or 
subject to movement restrictions for animal health reasons;  
II.1.2.3.  have not been in direct or indirect contact with kept animals that have entered 
the Union from a third country or territory  during the l ast 30 days prior to the 
departure of the animals . 
II.1.3.  They have not shown clinical signs or symptoms of diseases listed for camelid animals 
during the clinical examination carried out within 24 hours prior to departure on 
………………. ( insert date  dd/mm/yy yy). 
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for camelid animals.  
II.2.2.  They come from establishments in which infection with Brucella abortus, B. melitensis  and 
B. suis  in camelid animals has not been reported during the last 42 days prior to departure, 
and the animals in the consi gnment have been subjected to a test for infection with Brucella 
abortus, B. melitensis  and B. suis  with one of the diagnostic methods provided for in Part 1 
of Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, with negative results, on a 
sample taken during the last 30 days prior to departure, and in the case of post -parturient 
females taken at least 30 days after parturition.  
II.2.3.  They come from establishments in which surveillance for infection with  Mycobacterium 
tuberculosis complex  (M. bov is, M. caprae and M. tuberculosis) has been  carried out on the 
camelid animals kept on the establishments during at least the last 12 months prior to 
departure, as referred to in Article 23(1)(e) of Delegated  Regulation (EU) 2020 /688. 
II.2.4.  They come fro m establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.  
(2)[II.2.5.  They  are moved to Member State or zone thereof with the status free from infectious bovine 
rhino tracheitis/infectious pustular vulvovaginitis or with an approved eradication 
programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine 
animals and they come from an establishment in which infectious bovine 
rhinotracheiti s/infectious pustular vulvovaginitis in camelid animals has not been reported 
during the last 30 days prior to departure.]  
II.2.6.  They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection wi th epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prior to departure.  
II.2.7.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 68  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
II.2.8.  They come from establishments  in which surra ( Trypanosoma evansi ) has not been reported 
during the last 30 days prior to departure , and  
(2)either  [surra has not been  reported in the establishments during the last 2 years prior to their 
departure.]  
(2)or  [surra has been reported during the last 2 years prior to departure, following the last 
outbreak the affected establishment has remained under movement restrictions u ntil: 
– the infected animals have been removed  from the establishment, and  
– the remaining animals on the establishment have been subjected to a test for surra 
(Trypanosoma evansi ) with one of the diagnostic methods provided for in part 3 of 
Annex I  to Delegat ed Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishment.]  
(2)either  [II.2.9.  They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or  Article 32(2) of Delegated 
Regulation (EU) 2020/688 are fulfilled .] 
(2)and/or  [II.2.9.  They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotype 1 -24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and 
they 
(2)either  [II.2.9.1.  have been kept in a Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24) in accordance wit h Article 40(3) of Delegated  
Regulation (EU) 2020 /689 
 (2)either  [II.2.9.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)or [II.2.9.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free f rom 
infection with bluetongue virus (serotype 1 -24).]]]  
(2)or [II.2.9.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the entry date of the 
animal into the Member State or zone seasonally free f rom 
infection with bluetongue viru s (serotype 1 -24).]]]  
(2)and/or [II.2.9.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.2. 1. for at least 60 days prior to the date of movement.]]]  
(2)or [II.2.9. 2.2. for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days followin g the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)or [II.2.9.2.3.  for at least 14 days prior to the date of movement and have been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 69  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
subjected to a PCR test, with negative results, carried out on 
samples collected a t least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or [II.2.9.3.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during t he past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vaccine and  
(2)either  [II.2.9.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.9.3.2.  have b een vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 
days after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.9.4.  have been subjected with p ositive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and  
(2)either  [II.2.9.4.1.  the serological test has been ca rried out on samples collected at 
least 60 days before the date of movement.]]]  
(2)or [II.2.9.4.2.  the serological test has been carried out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the date of 
movement.]]]  
(2)and/or [II.2.9.  They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor cove red by the eradication programme for infection with 
bluetongue virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and they 
(2)either  [II.2.9.1.  have bee n protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.1.1.  for at least 60 days prior to the date of moveme nt.]]]  
(2) and/or  [II.2.9.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period o f protection against attacks by 
vectors.]]]  
(2) and/or  [II.2.9.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the  
commencement of the period of protection against attacks by 
vectors.]]]  
(2)or [II.2.9.1.  have been kept for the last 60 days prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establish ment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated  Regulation This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 70  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
(EU) 2020 /689 has been carried out during that period,  and 
(2)either  [II.2.9.1.1.  the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept  and are within the im munity 
period guaranteed in the specifications of the vaccine and  
(2)either  [II.2.9.1.1.1.  have been vaccinated more than 60 days before the 
date of movement.]]]]  
(2)and/or  [II.2.9.1.1.2.  have been vaccinated with an inactivated vaccine 
and subjected to a  PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine.]]]]  
(2)or [II.2.9.1.2.  the animals have been immunised against those serotypes from 1 to 
24 of infection with b luetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and   
(2)either  [II.2.9.1.2.1.  the animals have been subjected with positive results 
to a serological test car ried out on samples collected 
at least 60 days before the date of movement.]]]]  
(2) and/or  [II.2.9.1.2.2.  the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 30 days before the date of the m ovement and 
to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the 
date of movement.]]]]  
(2)and/or [II.2.9.  They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Delegated  Regulation (EU) 2020 /689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof  
(2)either  [II.2.9.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred 
to in Article 43(2)(a), (b) and (c) of Delegated  Regulation  (EU) 202 0/689, and 
(2)either  [II.2.9.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Secti on 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 71  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
fulfilled .]]] 
 (2)or [II.2.9.1.  with an approved eradication program for infection with bluetongue virus 
(serotype 1 -24) and the Member State of destinat ion has informed the 
Commission and the other Member States that such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated  
Regulation  (EU) 2020 /689 and 
(2)either  [II.2.9.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article  33 of that Delegated Regulation  are 
fulfilled .]]] 
 (2)or [II.2.9.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered 
by the eradication programme for infection with bluetongue virus (serotype 1 -
24) and the Member State of destination has informed the Commission and the 
other Member States that such movement is authorised  
(2)either  [II.2.9.1.1.  without any conditions , and  
(2)and/or  [II.2.9.1.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of Annex V to  Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.4.  under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 
2020/688  and the requirements laid down in Article 33  of that Delegated Regulation  are fulfilled .]]]II.3.
 To the best of my knowledg e and as declared by the operator, the animals come from 
establishments where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 72  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
(2)either  [they come from their establishm ents of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishme nts.]] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animal(s) described above was/were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the requirements of EU legislation on the protection of animals during transport, and 
especially as regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as  watering, feeding intervals, journey times and resting periods . 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In cas e the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment appr oved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for t his consignment is issued in this 
establishment approved for assembly operations, must be indicated . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 of De legated Regulation (EU) 
2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 73  EN EUROPEAN UNION   Certificate model CAM -INTRA -X 
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 74  EN CHAPTER 10: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CAMELID ANIMALS I NTENDED FOR 
SLAUGHTER (MODEL ‘CAM -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No 
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 75  EN  Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 76  EN EUROPEAN UNION   Certificate model CAM -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The camelid animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 73 of Delegated Regulation (EU) 2019/2035.  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed for camelid animals 
during the clinical examination carried out within 24 hours prior to departure on 
………………. ( insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are intended to be slaughtered for disease eradicat ion purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]  
II.2. Accordi ng to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed fo r camelid animals.  
II.2.2.  They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.  
II.2.3.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.4.  They come from establishments  in which infection with bluetongue virus (serotype 1 -24) 
has not been reported during the last 30 days prior to departure.  
(2)[II.2.5.  The requirements  as regards  infection with bluetongue virus (serotype 1 -24) laid down in 
Article 33 of Delegated Regulation (EU) 2020 /688 are fulfilled .] 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This animal  is valid  for 10 days from the date of issuing. In the ca se of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approv ed for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one ass embly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animal(s) described above was/were examined This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 77  EN EUROPEAN UNION   Certificate model CAM -INTRA -Y 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the requiremen ts of EU legislation on the protection of animals during transport, and 
especially as regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as watering, feeding intervals, journ ey times and resting periods . 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals  are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for asse mbly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignme nt is issued in this 
establishment approved for assembly operations, must be indicated . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 of Delegated Regulation (EU) 
2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 78  EN CHAPTER 11: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CERVID ANIMALS NO T INTENDED FOR 
SLAUGHTER (MODEL ‘CER -INTRA -X’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No 
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild    Exhibition   
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 79  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log  yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 80  EN EUROPEAN UNION   Certificate model CER -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The cervid animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 73 or Article 74 of Delegated Regulation (EU) 
2019/2035.  
II.1.2.  They, for at least the last 30 days prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident in the establishment of origin;  
II.1.2.2.  have not been in contact with kept cervid animals of a lower health status or 
subject to movement restrictions for animal health reasons;  
II.1.2.3.  have not been in direct  or indirect contact with kept animals that have entered 
the Union from a third country or territory  during the last 30 days prior to the 
departure of the animals . 
II.1.3.  They have not shown clinical signs or symptoms of diseases listed for cervid animals  during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come f rom establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for cervid animals.  
II.2.2.  They come from establishments in which infection with Brucella abortus, B. melitensis  and 
B. suis  in cervid animals has not been reported during the last 42 days prior to departure.  
II.2.3.  They come from establishments in which surveillance for infection with  Mycobacterium 
tuberculosis complex  (M. bovis, M. caprae and M. tuberculosis) has been  carried out on the 
cervid animals kept on the establishments during at least the last 12 months prior to 
departure, as referred to in Article 26(1)(e) of Delegated Regulation (EU) 2020 /688. 
II.2.4.  They come from establishments in which infection with rabi es virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.  
(2)[II.2.5.  They  are moved to Member State or zone thereof with the status free from infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis  or with an approved eradication 
programme for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis in bovine 
animals and they come from an establishment in which infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis in cervi d animals has not been reported 
during the last 30 days prior to departure.]  
II.2.6.  They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prior to departure.  
II.2.7.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.8.  They come from establishments  in which surra ( Trypanosoma evansi ) has not been reported 
during the last 30 days prior to departure , and  
(2)either  [surra has not been  reported in the establishments during the last 2 years prior to their This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 81  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
departure.]  
 (2)or [surra has been reported during  the last 2 years prior to departure, following the last 
outbreak the affected establishment has remained under movement restrictions until:  
– the infected animals have been removed  from the establishment, and  
– the remaining animals on the establishment have been subjected to a test for surra 
(Trypanosoma evansi ) with one of the diagnostic methods provided for in part 3 of 
Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken at least 6 months after the infected an imals have been removed from the 
establishment.]  
(2)either  [II.2.9.  They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated 
Regulation (EU) 2020/688 are fulfilled .] 
(2)and/or  [II.2.9.  They originate from a Member Stat e or a zone covered by the eradication programme for 
infection with bluetongue virus (serotype 1 -24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and 
they  
(2)either  [II.2.9.1.  have been kept in a Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24) in accordance with Article 40(3) of Delegated  
Regulation (EU) 2020 /689 
 (2)either  [II.2.9.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.9.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the M ember State or zone seasonally free f rom 
infection with bluetongue virus (serotype 1 -24).]]]  
(2) and/or  [II.2.9.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples col lected at least 14 days following the entry date of the 
animal into the Member State or zone seasonally free f rom 
infection with bluetongue virus (serotype 1 -24).]]]  
(2)and/or [II.2.9.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.2.1.  for at least 60 days prior to the date of movement.]]]  
(2) and/or  [II.2.9. 2.2. for at least 28 day s prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2) and/or [II.2.9.2.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 82  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
vectors.]]]  
(2)and/or [II.2.9.3.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vaccine and  
(2)either  [II.2.9.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.9.3.2.  have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative resul ts on samples collected at least 14 
days after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.9.4.  have been subjected with positive results to a serological test able to detect 
specific antibodies against all seroty pes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and  
(2)either  [II.2.9.4.1.  the serological test has been carried out on samples collected at 
least 60 days before the date of movement.]]]  
(2) and/or  [II.2.9.4.2.  the serological test has been carried out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days b efore the date of 
movement.]]]  
(2)and/or  [II.2.9.  They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and they 
(2)either  [II.2.9.1.  have been protected against attacks by the vectors during transportation to the 
place of destin ation and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.9.1.1.  for at least 60 days prior to the date of movement.]]]  
(2) and/or  [II.2.9.1.2.  for at least 28 days prior to the date of movement and h ave been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2) and/or  [II.2.9.1.3.  for at least 14 day s prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)or [II.2.9. 1. have been kept for the last 60 days prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegated  Regulation 
(EU) 2020 /689 has been carried out during that period, and 
(2)either  [II.2.9.1.1.  the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 83  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept  and are within the immunity 
period guaranteed in the s pecifications of the vaccine and  
(2)either  [II.2.9.1.1.1.  have been vaccinated more than 60 days before the 
date of movement.]]]]  
(2)and/or  [II.2.9.1.1.2.  have been vaccinated with an inactivated vaccine 
and subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine.]]]]  
(2)or [II.2.9.1.2.  the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were report ed during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and   
(2)either  [II.2.9.1.2.1.  the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 60 days before the date of movement.]]]]  
(2) and/or  [II.2.9.1.2.2.  the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 30 days before the date of the movement and 
to a PCR test, with n egative results, carried out on 
samples collected not earlier than 14 days before the 
date of movement.]]]]  
(2)and/or  [II.2.9.  They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Delegated  Regulation (EU) 2020 /689 and the competent authority of 
the Member State of origin authorised movement of those animals to another Member State 
or zone thereof  
(2)either  [II.2.9.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred 
to in Article 43(2)(a), (b) and (c) of Delegated  Regulation  (EU) 2020 /689, and 
(2)either  [II.2.9.1.1 . point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the  requirements 
laid down in Article 33  of that Delegated Regulation  are 
fulfilled .]]] 
 (2)or [II.2.9.1.  with an approved eradication program for infection with bluetongue virus 
(serotype 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 84  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Delegated  
Regulation  (EU) 2020 /689 and 
(2)either  [II.2.9.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.9.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are 
fulfilled .]]] 
 (2)or [II.2.9.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered 
by the eradication programme for infection with bluetongue virus (serotype 1 -
24) and the Member State of destination has informed the Commission and the 
other Member States that such movement is authorised  
(2)either  [II.2.9.1.1.  without any conditions , and  
(2)and/or  [II.2.9.1.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of Annex V to  Delegated  Regul ation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.4.  under the conditions referred to in point 7 of Sec tion 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.9.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 
2020/688  and the requirements laid down in Article 33  of that Delegated Regulation  are fulfilled .]]]II.3.
 To the best of my knowledge and as declared by th e operator, the animals come from 
establishments where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establi shments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 85  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
approved establishments.] ] 
 
Animal welfare a ttestation  
I, the undersigned official veterinarian, hereby certify, that the animal(s) described above was/were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the  requirements of EU legislation on the protection of animals during transport, and 
especially as regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as watering, feeding inter vals, journey times and resting periods . 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I. 12: “Place of destination ”: Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.17:  “Accompanying documents” : In case the animals  are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for asse mbly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignme nt is issued in this 
establishment approved for assembly operations, must be indicated . 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 73 or Article 74 of Delegated 
Regulation (EU) 2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 86  EN EUROPEAN UNION   Certificate model CER -INTRA -X 
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 87  EN CHAPTER 12: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CERVID ANIMALS IN TENDED FOR 
SLAUGHTER (MODEL ‘CER -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No 
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 88  EN  Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 89  EN EUROPEAN UNION   Certificate model CER -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The cervid animals(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 73 or Article 74 of Delegated Regulation (EU) 
2019/2035.  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed for cervid animals during 
the clinical examination carried out within 24 hours prior to departure on ………………. 
(insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are intended to be slaughtered for dise ase eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]  
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zone  established for reasons of diseas es listed for cervid animals.  
II.2.2.  They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.  
II.2.3.  They come from establishments  in which anthrax in  ungulates has not been reported during 
the last 15 days prior to departure.  
II.2.4.  They come from establishments  in which infection with bluetongue virus (serotype 1 -24) 
has not been reported during the last 30 days prior to departure.  
(2)[II.2.5.  The requirements  as regards  infection with bluetongue virus (serotype 1 -24) laid down in 
Article 33 of Delegated Regulation (EU) 2020 /688 are fulfilled .] 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of i ssuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment h as undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 
Animal welfare attestation  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 90  EN EUROPEAN UNION   Certificate model CER -INTRA -Y 
I, the undersigned official veterinarian, hereby certify, that the animal(s) described above was/were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the requiremen ts of EU legislation on the protection of animals during transport, and 
especially as regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as watering, feeding intervals, journ ey times and resting periods . 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD SANTE/7086/2020] . 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016 /429.  
Box reference I.12:  “Place of destination”:  Indicate an estab lishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishmen t approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate  for this consignment is issued in this 
establishment approved for assembly operations, must be indicated . 
 
Box reference I. 30: “Identification number ”: Indicate identification codes of the animals in the 
consignment identified in accordance with Article 7 3 or Article 74 of Delegated 
Regulation (EU) 2019/2035.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 91  EN EUROPEAN UNION   Certificate model CER -INTRA -Y 
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 92  EN CHAPTER 13: MODEL OF FICIAL CERTIFICATE F OR THE MOVEMENT 
BETWEEN MEMBER STATE S OF KEPT  UNGULATES OTHER THAN  BOVINE, 
OVINE, CAPRINE, PORC INE, EQUINE, CAMELID  AND CERVID ANIMALS N OT 
INTENDED FOR SLAUGHT ER (MODEL ‘OTHER -UNGULATES -INTRA -X’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
 Further keeping   Travelling circus/animal act   Confined 
establishment   Quarantine or similar 
establishment  
 Release into the wild   Exhibition    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 93  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 94  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The animals(1) of the consignment described in Part I  are kept ungulates other than bovine, ovine, 
caprine, porcine, equine, camelid and cervid animals and meet the following requirements:  
II.1.1.  They are identified as provided for in Article 117 of Regulation (EU) 2016/429.  
II.1.2.  They, for at least the last 30 days prior to the departure of the consignment, or since birth, if 
they are younger than 30 days of age,  
II.1.2.1.  have been continuously resident  in the establishment of origin;  
II.1.2.2.  have not been in contact with other kept ungulates of a lower health status or 
subject to movement restrictions for animal health reasons;  
II.1.2.3.  have not been in direct or indirect contact with kept animals th at have entered 
the Union from a third country or territory during the last 30 days prior to the 
departure of the animals.  
II.1.3.  They have not shown clinical signs or symptoms of diseases listed for ungulates of the 
species concerned during the clinical examination carried out within 24 hours prior to 
departure on ………………. ( insert date  dd/mm/yyyy ). 
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments su bject to movement restrictions or situated in a 
restricted zone  established for reasons of diseases listed for ungulates of the species 
concerned.  
(2)[II.2.2.  They come from establishments in which infection with Brucella abortus, B. melitensis  and 
B. suis  in kept animals of listed species has not been reported during the last 42 days prior to 
departure.]  
(2)[II.2.3.  They come from establishments in which infection with  Mycobacterium tuberculosis 
complex  (M. bovis, M. caprae and M. tuberculosis) in kept ani mals of listed species has not 
been reported during the last 42 days prior to departure.]  
(2)[II.2.4.  They come from establishments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to depa rture.]  
(2)[II.2.5.  They come from establishments situated in an area of at least 150 km radius around those 
establishments in which infection with epizootic haemorrhagic disease virus has not been 
reported in any establishment during the last 2 years prio r to departure.]  
II.2.6.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
(2)[II.2.7.  They come from establishments  in which surra ( Trypanosoma evansi ) has not been reported 
during the last 30 days prior to departure, and  
(2)either  [surra has not been  reported in the establishments during the last 2 years prior to their 
departure.]]  
(2or [surra has been reported during the last 2 years prior to departu re, following the last 
outbreak the affected establishment has remained under movement restrictions until:  
– the infected animals have been removed  from the establishment, and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 95  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X 
– the remaining animals on the establishment have been subjected to a test for surra  
(Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of 
Annex I  to Delegated  Regulation (EU) 2020 /688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishment.]]  
(2)[(2)either [II.2.8.  They originate from a Member State or a zone free from infection with bluetongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the la st 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated 
Regulation (EU) 2020/688 are fulfilled .] 
(2)and/or [II.2.8.  They originate from a Member State or a zone covered by the eradi cation programme for 
infection with bluetongue virus (serotype 1 -24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they  
(2)either  [II.2.8.1.  have been kept in a Mem ber State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24) in accordance with Article 40(3) of Delegated  
Regulation (EU) 2020 /689 
 (2)either  [II.2.8.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.8.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone sea sonally free f rom 
infection with bluetongue virus (serotype 1 -24).]]]  
(2and/)or [II.2.8.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the entry date of the 
animal into the Member State or zone seasonally free f rom 
infection with bluetongue virus (serotype 1 -24).]]]  
(2)and/or [II.2.8.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.8.2.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.8.2.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or  [II.2.8.2.3.  for at least 14  days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or [II.2.8.3.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the 
specifications of the vacc ine and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 96  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X 
(2)either  [II.2.8.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.8.3.2.  have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 
days after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.8.4.  have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with blueto ngue virus 
reported during the past 2 years in that Member State or zone and  
(2)either  [II.2.8.4.1.  the serological test has been carried out on samples collected at 
least 60 days before the date of movement.]]]  
(2)and/or  [II.2.8.4.2.  the serological test has been carried out on samples collected at 
least 30 days before the date of the movement and the animal has 
been subjected to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the date of 
movement.]]]  
(2)and/or [II.2.8.  They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotype 1 -24) and the requirements laid down in Art icle 32(1)(a), (b) or 
(c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled , and they 
(2)either  [II.2.8.1.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.8.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)and/or  [II.2.8.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)and/or  [II.2.8.1.3.  for at least 14 days prior to the date of movement and h ave been 
subjected to a PCR test, with negative results, carried out on 
samples collected at least 14 days following the date of the 
commencement of the period of protection against attacks by 
vectors.]]]  
(2)or [II.2.8.1.  have been kept for the last 60 day s prior to in an establishment situated in a 
Member State or in an area of at least 150 km radius centred on the 
establishment, where surveillance in compliance with the requirements set out 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Delegat ed Regulation 
(EU) 2020 /689 has been carried out during that period, and  
(2)either  [II.2.8.1.1.  the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept  and are within the immunity 
period guaranteed in the specifications of the vaccine and  
(2)either  [II.2.8.1.1.1.  have been vaccinated more than 60 days before the 
date of movement.] ]]] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 97  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X 
(2)and/or  [II.2.8.1.1.2.  have been vaccinated with an inactivated vaccine 
and subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of 
the immunity set in the specifications of the 
vaccine.]]]]  
(2)and/or  [II.2.8.1.2.  the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during 
the past 2 years in an area of at least 150 km radius centred on the 
place where the animals were kept, and   
(2)either  [II.2.8.1.2.1.  the animals have been subjected with positive results 
to a serological test carried out on samples collected 
at least 60 days before the date of movement.]]]]  
(2)and/or  [II.2.8.1.2.2.  the animals have been subjected with positive resul ts 
to a serological test carried out on samples collected 
at least 30 days before the date of the movement and 
to a PCR test, with negative results, carried out on 
samples collected not earlier than 14 days before the 
date of movement.]]]]  
(2)and/or [II.2.8 . They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Delegated  Regulation (EU) 2020 /689 and the competent authority of 
the Member State of origin authorised movement of those animals to another  Member State 
or zone thereof  
(2)either  [II.2.8.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and 
the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred 
to in Article 43(2)(a), (b) and (c) of Delegated  Regulation  (EU) 2020 /689, and  
(2)either  [II.2.8.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
(2)and/or  [II.2.8.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
(2)and/or  [II.2.8.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
(2)and/or  [II.2.8.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are 
fulfilled .]]] 
 (2)or [II.2.8.1.  with an approved eradication program for infection with bluetongue virus 
(serotype 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) a nd (c) of Regulation  
(EU) 2020 /689, and  
(2)either  [II.2.8.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
(2)and/or  [II.2.8.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 98  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X 
Regulation, and  
(2)and/or  [II.2.8.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
(2)and/or  [II.2.8.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation, and  
the requirements laid down in Article 32(1)(a), (b) or (c) o r Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are 
fulfilled .]]] 
 (2)or [II.2.8.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered 
by the eradica tion programme for infection with bluetongue virus (serotype 1 -
24) and the Member State of destination has informed the Commission and the 
other Member States that such movement is authorised  
(2)either  [II.2.8.1.1.  without any conditions , and  
(2)and/or  [II.2.8.1.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of Annex V to  Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of An nex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.4.  under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
(2)and/or  [II.2.8.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Delegated  Regulation (EU) 2020 /689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the  
requirements laid down in Article 33  of that Delegated Regulation  
are fulfilled .]]]] 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, t he period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 99  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -X 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animal(s) describ ed above was/were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the requirements of EU legislation on the protection of animals during transport, and 
especially a s regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as watering, feeding intervals, journey times and resting periods.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate an establishment of the origin of the animals in the 
consignment or an es tablishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.12:  “Place of destination”:  Indicate an establishment of the final destination of the 
consignment or an establishment approved f or assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from  an establishment 
approved for assembly operations in the Member State of origin,  the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved for assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approv ed for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this consignment is issued in this 
establishment approved for assembly operations, must be indicated . 
Box reference  I.30:  “Identification number” : Indicate identification number of each animal.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 100  EN CHAPTER 14: MODEL OF FICIAL CERTIFICATE F OR THE MOVEMENT 
BETWEEN MEMBER STATES OF KEP T UNGULATES OTHER TH AN BOVINE, 
OVINE, CAPRINE, PORC INE, EQUINE, CAMELID  AND CERVID ANIMALS 
INTENDED FOR SLAUGHT ER (MODEL ‘OTHER -UNGULATES -INTRA -Y’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18  
I.19  
 
I.20 Certified as or for  
  Slaughter    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 101  EN  Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 102  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The animals(1) of the consignment described in Part I are kept ungulates other than bovine, ovine, 
caprine, porcine, equine, camelid and cervid animals and meet the following requirements:  
II.1.1.  They are identified as provided for in  Article 117 of Regulation (EU) 201 6/429.  
II.1.2.  They have not shown clinical signs or symptoms of diseases listed for ungulates of the 
species concerned during the clinical examination carried out within 24 hours prior to 
departure on ………………. ( insert date  dd/mm/yyyy ). 
(2)[II.1.3.  They are  intended to be slaughtered for disease eradication purposes as part of an 
eradication programme, as provided for in Article 31(1) or (2) of Regulation (EU) 2016/429, 
and the Member State of destination and, where applicable, the Member State of passage 
authorised the movement in advance.]  
II.2. According to official information, the animals described in Part I meet the following health 
requirements:  
II.2.1.  They do not come from establishments subject to movement restrictions or situated in a 
restricted zo ne established for reasons of diseases listed for ungulates of the species 
concerned.  
II.2.2.  They come from establishments  in which anthrax in ungulates has not been reported during 
the last 15 days prior to departure.  
(2)[II.2.3.  They  come from establish ments in which infection with rabies virus in kept terrestrial 
animals has not been reported during the last 30 days prior to departure.]  
 (2)[II.2.4.  They come  from establishments  in which infection with bluetongue virus (serotype 1 -24) 
has not been repor ted during the last 30 days prior to departure.]  
(2)[II.2.5.  The requirements  as regards  infection with bluetongue virus (serotype 1 -24) laid down in 
Article 33 of Delegated Regulation (EU) 2020 /688 are fulfilled .] 
II.3. To the best of my knowledge and as declared by the operator, the animals come from establishments 
where there were no abnormal mortalities with an undetermined cause . 
II.4. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020 /688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
(2)(3)[II.6.  Since leaving  their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two assembly 
operations, and  
(2)either  [they come from their establishments of origi n;]] 
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 103  EN EUROPEAN UNION  Certificate model OTHER -UNGULATES -INTRA -Y 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animal(s) described above was/were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before and 
during the journey with the requirements of EU legislation on the protection of animals during transport, and 
especially as regards the means of transport, the loading and unloading facilities, the competence of the personnel, 
the space allowances, as well as waterin g, feeding intervals, journey times and resting periods.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate an establishment of the origin of the animals in the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.12:  “Place of destination” : Indicate an establishment of the final destination of the 
consignment or an establishment approved for assembly operations in accordance with 
Articles 97 and 99 of Regulation (EU) 2016/429.  
Box reference I.17:  “Accompanying documents” : In case the animals are dispatched from  an establishment 
approved for assembly operations in the Member State of origin, the reference 
number(s) of the official document(s), based on which the certificate for this 
consignment is issued in this establishment approved f or assembly operations, may be 
indicated.  
  In case the animals are dispatched from an establishment approved for assembly 
operations in the Member State of passage, the reference number(s) of the 
certificate(s), based on which the certificate for this co nsignment is issued in this 
establishment approved for assembly operations, must be indicated . 
Box reference I.30:  “Identification number” : Indicate identification number of each animal.  
 
Part II:  
(1) There can be one or more animals in the consignment. 
(2) Delete if not applicable.  
(3) Applicable in case the consignment is dispatched from the establishment approved for assembly 
operations.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 104  EN CHAPTER 15: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF HATCHING EGGS OF POULTRY (MODEL 
‘POU -INTRA -HEP’)   
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical use   Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 105  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 106  EN EUROPEAN UNION   Certificate model POU -INTRA -HEP  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the hatching eggs(1) of poultry described in this certificate  come from  
(2)either  [an establishment approved in accordance with Article 8 of Commission Delegated Regulation 
(EU) 2019/2035 , which is not subject to movement restrictions or situated in a restricted zone 
established for reasons of listed diseases relevant  for avian species ;] 
(2)or [a hatcher y approved in accordance with Article 7 of Commission Delegated Regulation (EU) 
2019/2035, which is not subject to movement restrictions or situated in a restricted zone 
established for reasons of listed diseases relevant  for avian species;]  
II.1.2.  they c ome from flocks:  
(a) in which infection with Salmonella  Pullorum, Salmonella  Gallinarum and 
Salmonella  arizonae has not been reported;  
(b) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has 
not been reported;  
(c) which have been  continuously resident in one or more establishments approved in 
accordance with Article 8 of Commission Delegated Regulation (EU) 2019/2035 
since hatching or for at least the last 42 days prior to the collection of the hatching 
eggs, and : 
(2)either  [(i) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae 
was not confirmed during the last 12 months prior to the collection of the 
hatching eggs;]  
(2)or [(i) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae 
was confirmed during the last 12 months prior to th e collection of  the 
hatching eggs and the measures provided for in Article 34(b) of 
Commission Delegated Regulation (EU) 2020/ 688 have been applied;]  
(2)either  [(ii) in which avian mycoplasmosis (Mycoplasma ga llisepticum and M. 
meleagridis) was not confirmed during the last 12 mo nths prior to the 
collection of  the hatching eggs;]  
(2)or [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was confirmed during the last 12 mo nths prior to the 
collection of  the hatching eggs and the measures provided for in Article 
34(c) of Commission Delegated Regulation (EU) 2020/ 688 have been 
applied;]]  
(2)(3)either  [(d) which have not been vaccinated against infection with Newcastle disease virus;]  
(2)(3)or [(d) which  have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2) [live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………… ……..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(e) which, on the basis of  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 107  EN EUROPEAN UNION   Certificate model POU -INTRA -HEP  
(2)either  [a clinical inspection within the last 72 hours before departure of the consignment 
and the health and production records kept on  the establishment, checked within the 
last 72 hours before departure of the consignment, show no clinical signs or 
suspicion of listed diseases relevant for the species;]  
(2)or [monthly health inspection visits, the most recent being within the last 31 da ys 
before departure of the consignment, and the health and production records kept on 
the establishment, checked within the last 72 hours before departure of the 
consignment, show no clinical signs or suspicion of listed diseases relevant for the 
species;]  
II.1.3.  they:  
(a) are individually marked with the approval number of the establishment of the flock 
of origin;  
(b) have been disinfected;  
(2)(3)either  [(c) have not been vaccinated against infection with Newcastle disease virus;]  
(2)(3)or  [(c) have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2) [live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in  the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
II.1.4.  arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with 
Article 4 of Delegated Regulation (EU) 2020/ 688; 
(4)[II.1.5.  they are intended for a Member State or zone which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they:  
(a) have not been vaccinated against infecti on with Newcastle disease virus;  
(b) come from flocks which  
(2)either  [have not been vaccinated against infecti on with Newcastle disease virus. ] 
(2)or [have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2) [live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation (EU) 2020/ 688 and vaccination has 
taken place at least 30 days before the collection of the hatching eggs](2)] 
…………………………………………………..  
(name of strain use d in the vaccine)  
on ………………. (date) at the age of ……………. weeks.] 
II.2. Public health attestation  
(5)[II.2.1. The Salmonella  control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and the 
specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No  1177/2006, have 
been applied to the parent flock of origin and this parent flock has been tested for Salmonella  serotypes 
of pub lic health significance:  
Identification of 
the flock  Age of the 
birds  Date of last sampling of 
the flock from which the Result of all testing in the 
flock(6) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 108  EN EUROPEAN UNION   Certificate model POU -INTRA -HEP  
testing result is 
known[dd/mm/yyyy]  Positive  Negative  
     
 
(5)[II.2.2. Neither Salmonella  Enteritidis nor Salmonella  Typhimurium were detected within the control programme 
referred to in point II. 2.1.] 
(7)[II.2.3. If the Member States of destination is Finland or Sweden, the hatching eggs come from flocks which 
have tested negative for Salmonella  in accordance with the rules laid down in Decision 2003/644/EC;]  
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.  
 “Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.  
 “Age” : provide the date of collection.  
 
Part II:  
(1) ‘Hatching eggs’ as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Keep as appropriate.  
(3) Delete when the consignments is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle diseas e virus without 
vaccination and complies with II.1.5.  
(4) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination.  Delete reference if not applicable to the consignment.  
(5) This guarantee applies only for hatching eggs belonging to the spe cies of Gallus gallus  and turkeys.  
(6) If any of the results were positive for the following serotypes during the life of the parent flock, indicate 
as positive: below during the life of the flock, indicate as positive: Salmonella hadar, Salmonella 
virchow  and Salmonella infantis . 
(7) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 109  EN EUROPEAN UNION   Certificate model POU -INTRA -HEP  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 110  EN CHAPTER 16: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF DAY -OLD CHICKS (MODEL ‘POU -INTRA -
DOC’)   
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical  use  Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 111  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log  yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 112  EN EUROPEAN UNION   Certificate model POU -INTRA -DOC  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the day -old chicks(1) described in this certificate  have been hatched on and come from a 
hatchery approved in accordance with Article 7 of Commission Delegated Regulation (EU) 
2019/2035, which is not subject to movement restrictions or situated in a restricted zone 
established for reasons of listed disease s relevant  for avian species;  
II.1.2.  to the best of my knowledge, and as declared by the operator, they come from a hatchery where 
there were no abnormal mortalities with an undetermined cause ; 
(2)either  [II.1.3.  they have been hatched from eggs coming fr om flocks:  
(a) in which infection with Salmonella  Pullorum, Salmonella  Gallinarum and 
Salmonella  arizonae has not been reported;  
(b) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has 
not been reported;  
(c) which have been conti nuously resident in one or more establishments approved in 
accordance with Article 8 of Commission Delegated Regulation (EU) 2019/2035 
since hatching or for at least the last 42 days prior to the collection of the eggs from 
which the day -old chicks have be en hatched and : 
(2)either  [(i) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae 
was not confirmed during the last 12 mo nths prior to the collection of  the 
hatching eggs;]  
(2)or [(i) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae 
was confirmed during the last 12 mo nths prior to the collection of  the 
hatching eggs and the measures provided for in Article 34(b) of 
Commission Delegated Regulation (EU) 2020/ 688 have been applied;]  
(2)either  [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was not confirmed during the last 12 months prior to the 
collection of the hatching eggs;]  
(2)or [(ii) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. 
meleagridis) was confirme d during the last 12 months prior to the 
collection of the hatching eggs and the measures provided for in Article 
34(c) of Commission Delegated Regulation (EU) 2020/ 688 have been 
applied;]]  
(2)(3)either  [(d) which have not been vaccinated against infection  with Newcastle disease virus;]  
(2)(3)or  [(d) which  have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2) [live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation ( EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(e) which according to the health and production records kept on the establishment, 
checked within the last 24 hours before departur e of the consignment, show no This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 113  EN EUROPEAN UNION   Certificate model POU -INTRA -DOC  
clinical signs or suspicion of listed diseases relevant for the species;  
(2)(4)or [II.1.3.  they have been hatched from eggs which have entered the Union from a third country or 
territory or zone thereof in accordance with the provisions of Commission Delegated 
Regulation (EU) 2020/ 692;] 
II.1.4.  they:  
(a) show no clinical signs or suspicion of listed diseases relevant for the species;  
(2)(3)either  [(b) have not been vaccinated against infection with Newcastle disease virus;]  
(2)(3)or [(b) have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](2) [live attenuated vaccines that comply with the criteria of 
Annex VI to Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
II.1.5.  arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with 
Article 4 of Delegated Regulation (EU) 2020/ 688; 
(5)[II.1.6.  they are intended for a Member State or zone thereof which has been granted the status free 
from infection with Newcastle disease virus without vaccina tion, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) come from hatching eggs which:  
(i) are not vaccinated against infection with Newcastle disease virus;  
(ii) come from clocks which  
(2)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(2)or [have been vaccinated against infection with Newcastle disease virus with 
[live inactivated vaccines](2) [live attenuated vaccines that comply with the 
criteria of Annex VI to Commission Del egated Regulation (EU) 
2020/ 688](2) and vaccination has taken place at least 30 days before the 
collection of the hatching eggs  
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(c) come from a hatche ry where working practice ensures that the hatching eggs are 
incubated at completely separate times and locations from hatching eggs not 
satisfy ing the conditions in point (b). ] 
II.2. Public health attestation  
(6)[II.2.1. The Salmonella  control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Regulation (EC) 
No 1177/2006, have been applied to the parent flock of origin and this parent flock has been tested 
for Salmonella  serotypes of public health significance:  
Identification of Age of the Date of last sampling of Result of all testing in the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 114  EN EUROPEAN UNION   Certificate model POU -INTRA -DOC  
the flock  birds  the flock from which the 
testing result is 
known[dd/mm/yyyy]  flock(7) 
positive  negative  
     
 
The specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No  1177/2006 
have been applied to the day -old chicks.  
For reasons other than the  Salmonella control programme:  
(2)either  [antimicrobials were not administered to the day -old chicks (including in -ovo 
injection);]  
(2)(8)or [the following antimicrobials were administered to the day -old chicks (including in -ovo 
injection)…………………………………………………………..;]]  
(6)[II.2.2. If the day -old chicks are intended for breeding, neither Salmonella  Enteritidis nor Salmonella  
Typhimurium were detected within the control programme referred to in point II. 2.1.] 
(9)[II.2.3. If the Member States of destination is Finland or Sweden, the da y-old chicks for introduction into 
flocks of breeding poultry or flocks of productive poultry come from flocks which have tested 
negative for Salmonella in accordance with the rules laid down in Decision 2003/644/EC;]  
 
Notes:  
This animal  health  certificate  is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the animal health certificate may be extended by the duration of the journey by 
waterway/sea.  
Guidance on the completion of th is official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.30:  Description of consignment:  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.  
 “Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.  
 “Age” : provide the date the animals were hatched.  
 
Part II:  
(1) ‘Day -old chicks’ means poultry less than 72 hours old , as defined in Article 3 of Commission Delegated 
Regulation (EU) 2020/ 688. 
(2) Keep as appropriate.  
(3) Delete when the consignments is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease  virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccination and complies with II.1.6.  
(4) Where the day -old chicks have been hatched from eggs which hav e entered the Union from a third 
country or territory or zone , the specific animal healt h requirements for movement and  handling of 
those animals in the establishment of destination, laid down in Commission Delegated Regulation (EU) 
2020/ 692, must be respe cted. 
(5) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 115  EN EUROPEAN UNION   Certificate model POU -INTRA -DOC  
Member State or zone thereof which has been grante d the status free from infection with Newcastle 
disease virus without vaccination.  Delete reference if not applicable to the consignment.  
(6) This guarantee applies only for day -old chicks belonging to the species of Gallus gallus and turkeys.  
(7) If any o f the results were positive for the serotypes below during the life of the flock, indicate as 
positive:  
- flocks of breeding poultry: Salmonella  hadar , Salmonella  Virchow and Salmonella  infantis ; 
- flocks of productive poultry: Salmonella  enteritidis  and Salmonella  typhimurium . 
 (8) Keep if appropriate: indicate the name and active substance of antimicrobials used.  
(9) Delete if consignment is not intended f or Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 116  EN CHAPTER 17: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF BREEDING POULTRY AND  PRODUCTIVE 
POULTRY (MODEL ‘ POU -INTRA -X’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical use   Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 117  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 118  EN EUROPEAN UNION   Certificate model POU -INTRA -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the [breeding poultry(1)](2) [productive poultry(3)](2) described in this certificate  have been 
continuously resident in one or more establishments approved in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2019/2035  
(2)(4)either [since hatching or for at least the last 42 days prior to the departure of the consignment;]  
(2)(5)or [since hatching or for at least the last 21 days prior to the departure of the consignment, during 
which time they had no contact with birds of lower health status;]  
II.1.2.  they come fr om an establishment:  
(a) which is not subject to movement restrictions or situated in a restricted zone established for 
reasons of listed diseases relevant  for avian species;  
(2)either  [(b) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae was not 
confirmed during the last 12 months prior to the departure of the consignment;]  
(2)or [(b) in which infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae was confirmed 
during the last 12 months prior to the departure of the consi gnment and the measures 
provided for in Article 34(b) of Commission Delegated Regulation (EU) 2020/ 688 have 
been applied;]  
(2)either  [(c) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months  prior to the departure of the consignment;]  
(2)or [(c) in which avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was 
confirmed during the last 12 months prior to the departure of the consignment and the 
measures provided for in Article 34 (c) of Commission Delegated Regulation (EU) 2020/ 688 
have been applied;]  
II.1.3.  to the best of my knowledge, and as declared by the operator, they come from an establishment 
where there were no abnormal mortalities with an undetermined cause ; 
II.1.4.  they come from a flock in which:  
(a) infection with Salmonella  Pullorum, Salmonella  Gallinarum and Salmonella  arizonae has 
not been reported;  
(b) avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) has not been 
reported ; 
(c) no confirmed case of low pathogenic avian influenza was detected during the last 21 days 
prior to departure of the consignment , in accordance with the surveillance provided for in 
Article 3(1) of Commission Delegated Regulation (EU) 2020/ 689; 
II.1.5.  they:  
(2)(6)either  [(a) have not been vaccinated against infection with Newcastle disease virus;]  
(2)(6)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated 
vaccines](2) [live attenuated vaccines that comply with the criteria of Annex VI t o 
Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 119  EN EUROPEAN UNION   Certificate model POU -INTRA -X 
on ………………. (date) at the age of ……………. weeks;]  
(2)(7)or [(a) are intended for a Member State or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they:  
(i) have not been vaccinated against infection with Newcastle disease virus;  
(ii) were kept in isolation for at least 14 days prior to departure of the consignment in 
the estab lishment of origin under the supervision of an official veterinarian or in an 
approved quarantine establishment, where:  
- no poultry was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to departure;  
- no other birds have entered into the establishment during that time;  
- no vaccination has been carried out in the quarantine establishment;  
(iii) have tested negative to serological tests to detect antibodies against Newcastle 
disease virus, performed on b lood samples at a level which gives 95% confidence of 
detecting infection at 5% prevalence and which were taken during the period of at 
least 14 days prior to departure;]  
(8) [(b) are ducks or geese and have tested negative to a virological examination for highly 
pathogenic avian influenza, in accordance with the requirements of Annex IV to Delegated 
Regulation (EU) 2020/ 688, during the week prior to the time of loading for dispatch;]  
II.1.6.  the flock of  origin and the animals of the consignment and have  been subjected to a clinical 
inspection within the 48 hours prior to loading for dispatch to the Union, and showed no clinical 
signs or suspicion of listed diseases relevant for the species;  
II.1.7.  arran gements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/ 688; 
(9)[II.1.8.  Since leaving their e stablishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two 
assembly operations, and  
(2)either  [they come from  their establishments of origin. ]] 
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment. ]] 
(2)or [at least one of the animals of the consignment has undergone two assembly operations on 
approved establishments.] ] 
II.2. Public health attestation  
(10)[II.2.1. The Salmonella  control programme referred to in Article 5 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No 
1177/2006, have been applied to the flo ck of origin and the flock has been tested for Salmonella  
serotypes of public health significance:  
Identification of the 
flock  Age of the 
birds  Date of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]  Result of all testing in 
the flock(11) 
positive  negative  
     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 120  EN EUROPEAN UNION   Certificate model POU -INTRA -X 
For reasons other than the  Salmonella control programme, within the last three weeks prior to entry into 
the Union:  
(2)either  [antimicrobials were not administered to the breeding and productive poultry other than  
ratites;]  
(2)(12)or [the following antimicrobials were administered to the breeding and productive poultry other 
than ratites: ……………………………………;]]  
(10)[II.2.2. If breeding poultry, neither Salmonella  Enteritidis nor Salmonella  Typhimurium were detected within 
the control programme referred to in point II. 2.1.] 
(13)[II.2.3. If the Member States of Destination is Finland or Sweden:  
(2) either  [the breeding poultry has tested negative for Salmonella in accordance with the rules l aid down in 
Decision 2003/644/EC;]  
(2) or  [the laying hens (productive poultry reared in view to producing eggs for consumption)have tested 
negative in accordance with the rules laid down in Decision 2004/235/EC.]]  
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the animal health certificate may be extended by the duration of the journey by 
waterway/sea.  
Guidance on the complet ion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.17:      In case the animals are dispatched from an establishment approved for assembly operations in the 
Member State of origin, the reference number(s) of the official document(s), based on which the 
certificate for this consignment is issued in this establishmen t approved for assembly operations, 
may be indicated. In case the animals are dispatched from  an establishment approved for assembly 
operations in the Member State of passage,  the reference number(s) of the certificate(s), based on 
which the certificate fo r this consignment is issued in this establishment approved for assembly 
operations, must be indicated.  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.  
 “Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.  
 
Part II:  
(1) ‘Breeding poultry’ means poultry 72 hours old or more , intended for the production of hatching eggs, as 
defined in Article 3 of Commission Delegate d Regulation (EU) 2020/ 688. 
(2) Keep as appropriate.  
(3) ‘Productive poultry’ means poultry 72 hours old or more , reared for the production of meat, eggs for 
consumption or other products or for restocking supplies of game birds, as defined in Article 3 of  
Commission Delegated Regulation (EU) 2020/ 688. 
(4) Applicable for breeding poultry and productive poultry for the production of meat or eggs for 
consumption.  
(5) Applicable for productive poultry for restocking supplies of game birds.  
(6) Delete when the  consignments is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 121  EN EUROPEAN UNION   Certificate model POU -INTRA -X 
zone thereof which has been granted the status free from infection with  Newcastle disease virus without 
vaccination. 
(7) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member Sta te or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination.  
(8) Applicable for ducks and geese. Delete reference if not applicable to the consignment.  
(9) Applicable in case the consignment is dispatched from an establishment approved for assembly 
operations. The animal in the consignment which has undergone the highest number of assembly 
operation determines the number of remaining allowed assembly operations for this consignment.  
Delete refere nce if not applicable to the consignment.  
(10) This guarantee applies only for poultry belonging to the species of Gallus gallus  and turkeys .  
(11) If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positi ve: 
- flocks of breeding poultry: Salmonella  Hadar, Salmonella  Virchow and Salmonella Infantis;  
- flocks of productive poultry: Salmonella  Enteritidis and Salmonella  Typhimurium.  
(12) Complete if appropriate: indicate the name and active substance of antimicrobials used.  
(13) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 122  EN CHAPTER 18: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF LESS THAN 20 HEADS O F POULTRY OTHER 
THAN RATITES OR LESS  THAN 20 HATCHING EGGS OF POU LTRY OTHER 
THAN RATITES  (MODEL ‘ POU -INTRA -LT20 ’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil  Technical use   Quarantine or similar This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 123  EN improvers  establishment  
 Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 124  EN EUROPEAN UNION   Certificate model POU -INTRA -LT20  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the [poultry other than ratites](1) [hatching eggs of poultry other than ratites](1) described in this 
certificate come from a [registered](1) [approved](1) establishment, which is not subject to movement 
restrictions or situated in a restricted zone established for reasons of listed disease s relevant for 
avian species;  
II.1.2.  to the best of my knowledge, and as declared by the operator, they come from an establishment 
where there were no abnormal mortalities with an undetermined cause;  
II.1.3.  they come from a flock which has been continuou sly resident in the establishment of origin since 
hatching or for at least the last 21 days prior to  
(1)(2)(3)(4)either  [departure of the consignment;] 
(1)(5)or [the collection of the eggs;]  
II.1.4.  [they](2)(3) 
 [they come from a flock which](4)(5) 
 tested negative, within 21 days preceding the time of loading of the animals for dispatch, in 
serological and/or bacteriological tests(6)for: 
(1)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  (in case of Gallus 
gallus );] 
(1)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  Gallinarum, 
Mycoplasma meleagridis  and Mycoplasma  gallisepticum  (in case of Meleagris gallopavo );]  
(1)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );] 
(2)(3)(4)[II.1.5.  they  
II.1.5.1.  have had no contact with newly -arrived poultry or with birds of lower health status 
during the last 21 days prior to the departure of the con signment;  
II.1.5.2.  they come from a flock in which no confirmed case of low pathogenic avian influenza 
was detected during the last 21 days prior to departure of the consignment, in 
accordance with the surveillance provided for in Article 3(1) of Commissi on Delegated 
Regulation (EU) 2020/ 689; 
II.1.5.4.  they  
(1)(7)either  [(a) have not been vaccinated against infection with Newcastle disease virus;]  
(1)(7)or  [(a) have been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](1) [live attenuated vaccines that comply with the criteria 
of Annex VI to Commission Delegated Regulation (EU) 2020/ 688] (1) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(1)(8)or [(a) are intended for a Member State or zone thereof which has been granted the 
status free from infection with Newcastle disease virus without vaccination, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 125  EN EUROPEAN UNION   Certificate model POU -INTRA -LT20  
and they:  
(1)(2)either  [(i) have not been vaccinated against infection with Newcastle disease 
virus;  
(ii) were kept in isolation for at least 14 days prior to departure of the 
consignment in the establishment of origin under the supervision of 
an official veterinarian or in an approved quarantine establishment, 
where:  
- no poultry was vaccinated against infec tion with Newcastle 
disease virus during the period of at least 21 days prior to 
departure;  
- no other birds have entered into the establishment during that 
time;  
- no vaccination has been carried out in the quarantine 
establishment;  
(iii) have tested negative to serological tests to detect antibodies against 
Newcastle disease virus, performed on blood samples at a level 
which gives 95% confidence of detecting infection at 5% 
prevalence and which were taken during the period of at least 14 
days prior to  departure;]]  
(1)(3)or [come from a flock which:  
(1)either  [is not vaccinated against infection with Newcastle disease virus and 
tested negative, during the last 14 days prior to departure of the 
consignment, in serological tests to detect antibodies again st 
Newcastle disease virus performed on blood samples at a level which 
gives 95% confidence of detecting infection at 5% prevalence;]  
(1)or [is vaccinated against infection with Newcastle disease virus and tested 
negative, during the last 14 days prior to departure of the consignment, 
in a test to detect the presence of Newcastle disease virus, performed at 
a level which gives 95% confidence of detecting infection at 5% 
prevalence;]]]  
(1)(4)or [(i) have not been vaccinated against infection with Newcastle d isease 
virus;  
(ii) come from hatching eggs which:  
- are not vaccinated against infection with Newcastle disease 
virus;  
- come from clocks which  
(1)either  [have not been vaccinated against infection with 
Newcastle disease virus;]  
(1)or [have been vaccinated  against infection with 
Newcastle disease virus with [live inactivated 
vaccines](1) [live attenuated vaccines that comply 
with the criteria of Annex VI to Commission 
Delegated Regulation (EU) 2020/ 688](1) and 
vaccination has taken place at least 30 days before This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 126  EN EUROPEAN UNION   Certificate model POU -INTRA -LT20  
the collection of the hatching eggs  
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of 
……………. weeks;]  
(iii) come from a hatchery where working practice ensures that the 
hatching eggs are incubated at completel y separate times and 
locations from hatching eggs not satisfying the conditions in point 
(ii);]] 
(9) [(b) are ducks or geese and have tested negative to a virological examination for highly 
pathogenic avian influenza, in accordance with the requirements of  Annex IV to 
Delegated Regulation (EU) 2020/ 688, during the week prior to the time of loading 
for dispatch;]  
II.1.5.5.  the flock of origin and the animals of the consignment and have  been subjected to a 
clinical inspection within the 48 hours prior to load ing for dispatch to the Union, and 
showed no clinical signs or suspicion of listed diseases relevant for the species;]  
(5)[II.1.5.  they  
II.1.5.1.  come from a flock which on the basis of  
(1)either  [a clinical inspection within the last 72 hours before departure of the consignment and 
the health and production records kept on the establishment, checked within the last 72 
hours before departure of the consignment, show no clinical signs or suspicion of listed 
diseases relevant for the species;]  
(1)or [mon thly health inspection visits, the most recent being within the last 31 days before 
departure of the consignment, and the health and production records kept on the 
establishment, checked within the last 72 hours before departure of the consignment, 
show no  clinical signs or suspicion of listed diseases relevant for the species;]  
II.1.5.2.  and the flock they come from  
(1)(7)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(1)(7)or [have been vaccinated against infection with  Newcastle disease virus with [inactivated 
vaccines](1) [live attenuated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regulation (EU) 2020/ 688] (1) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) a t the age of ……………. weeks;]  
(1)(8)or [are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without vaccination, and they:  
(a) have not been vaccinated against infection with Newcastle disease vi rus; 
(b) come from a flock which  
(1)either  [has not been vaccinated against infection with Newcastle disease virus;]  
(1)or [has been vaccinated against infection with Newcastle disease virus with 
[inactivated vaccines](1) [live attenuated vaccines that com ply with the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 127  EN EUROPEAN UNION   Certificate model POU -INTRA -LT20  
criteria of Annex VI to Commission Delegated Regulation (EU) 2020/ 688] 
(1) and the vaccination has taken place at least 30 days before the collection 
of the hatching eggs  
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]]  
II.1.6.  arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with Article 4 of 
Delegated Regulatio n (EU) 2020/ 688. 
II.2. Public health attestation  
II.2.1. I, the undersigned official veterinarian, hereby certify that the [breeding poultry other than 
ratites](1) [productive poultry  other than ratites](1) [poultry intended for slaughter other than 
ratites](1) [day-old chicks other than ratites](1) described in this certificate:  
(10)[II.2.1.1. The Salmonella  control programme referred to in Article 5 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vacci nes in 
Regulation (EC) No 1177/2006, have been applied to the flock of origin and the flock 
has been tested for Salmonella  serotypes of public health significance:  
Identification of the 
flock  Age of the 
birds  Date of last sampling of the 
flock from which t he testing 
result is known 
[dd/mm/yyyy]  Result of all testing in 
the flock(11) 
positive  negative  
     
For reasons other than the  Salmonella control programme, within the last three weeks 
prior to entry into the Union:  
(1)either  [antimicrobials were not administered to the breeding and productive 
poultry other than ratites;]  
(1)(12)or [the following antimicrobials were administered to the breeding and 
productive poultry other than ratites: ……………………………………;]]  
(10)[II.2.1.2. If breeding poultry, neither Salmonella  Enteritidis nor Salmonella  Typhimurium 
were detected within the control programme referred to in point II. 2.1.1.] 
(13)[II.2.1.3. If the Member States of Destination is Finland or Sweden:  
(1) either  [the breeding poultry has tested negative for Salmonella in accordance 
with the rules laid down in Decision 2003/644/EC;]  
(1) or [the laying hens (productive poultry reared in view to producing eggs for 
consumption) have tested negative in accordance with the rules laid down 
in Decision 2004/235/EC.]]  
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing.  
Guidance on the completion of th is official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 128  EN EUROPEAN UNION   Certificate model POU -INTRA -LT20  
 
Part I:  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05, 01.06.39, 04.07.  
 “Category” : select one of the following: Pure line/grandparents/parents/laying pullets/others.  
 
Part II:  
(1) Keep as appropriate.  
(2) Applicable for breeding poultry and productive  poultry . Delete reference if not applicable to the 
consignment.  
(3) Applicable for poultry intended for slaughter. Delete reference if not applicable to the consignment. 
(4) Applicable for day -old chicks. Delete reference if not applicable to the consignment.  
(5) Applicable for hatching eggs. Delete reference if not applicable to the consignment.  
(6) If the animals have been vaccinated against infection wi th any serotype of Salmonella or Mycoplasma, 
only bacteriological testing must be used. The confirmation method must be capable of differentiating 
between live vaccinal strains and filed strains.  
(7) Delete when the consignments is dispatched from a Member  State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infection with Newcastle disease virus without 
vaccinat ion. 
(8) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted  the status free from infection with Newcastle 
disease virus without vaccination.  
(9) Applicable for ducks and geese, except those intended for slaughter. Delete reference if not applicable 
to the consignment.  
(10) This guarantee applies only for poultry belonging to the species of Gallus gallus  and turkeys . 
(11) If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:  
- flocks of breeding poultry: Salmonella  Hadar, Salmonella  Virchow and Salmonella Infantis;  
- flocks of productive poultry: Salmonella  Enteritidis and Salmonella  Typhimurium.  
(12) Complete if appropriate: indicate the name and active substance of antimicrobials used.  
(13) Delete if consignment i s not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 129  EN CHAPTER 19: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF POULTRY INTENDED FOR SLAUGHT ER 
(MODEL ‘ POU -INTRA -Y’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical  use  Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 130  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log  yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 131  EN EUROPEAN UNION   Certificate model POU -INTRA -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the poultry intended for slaughter(1) described in this certificate have been continuously resident in 
the establishment of origin since hatching or for at least the last 21 days prior to departure of the 
consignment;  
II.1.2.  they come from an establishment which is not subject to movement re strictions or situated in a 
restricted zone established for reasons of listed diseases relevant for avian species;  
II.1.3.  to the best of my knowledge, and as declared by the operator, they come from an establishment 
where there were no abnormal mortalitie s with an undetermined cause ; 
II.1.4.  they:  
(2)(3)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(2)(3)or [have been vaccinated against infection with Newcastle disease virus with [inactivated vaccines](2) 
[live attenuat ed vaccines that comply with the criteria of Annex VI to Commission Delegated 
Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(2)(4)or [are intended for a Member State or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they come from flocks which:  
(2)either  [are not vaccinated against infection with Newcastle disease virus and have tested 
negative, during the last 14 days prior to departure of the consignment, in serological tests 
to detect antibodies against Newcastle disease virus performed on blood samples at a level 
which gives 95% confidence of detecting infection at 5% prevalence;]  
(2)or [are vaccinated against infection with Newcastle disease virus and have tested negative, 
during the last 14 days prior to departure of the consignment, in a test to detect the 
presence of Newcastle disease virus, performed at a level which gives 95% confidence of 
detecting infection at 5% prevalence;]]  
 II.1.5.  the flock of origin and the animals of the consignment and have  been subjected to a clinical 
inspection within the last 5 days before departure of the consignment and showed no clinical signs 
or suspicion  of listed diseases relevant for the species;  
II.1.6.  arrangements have been made to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/ 688; 
(5)[II.1.7.  Since leaving their establishments of origin  and before arriving to this establishment approved for 
assembly operations , none of the animals of the consignment has undergone more than two 
assembly operations, and  
(2)either  [they come from their establishments of origin;]]  
(2)or [at least one of the animals of the consignment has undergone one assembly operation on an 
approved establishment;]]  
(2)or [at least one of the animals of the consignment has undergone two assem bly operations on This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 132  EN EUROPEAN UNION   Certificate model POU -INTRA -Y 
approved establishments.] ] 
II.2. Public health attestation  
 (6)[II.2.1. The Salmonella  control programme referred to in Article 5 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Regulation (EC) No  1177/2006, have been applied to the flock of origin and this parent 
flock has been tested for Salmonella  serotypes of public hea lth significance:  
Identification of 
the flock  Age of the 
birds  Date of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]  Result of all testing in the 
flock(7) 
positive  negative  
     
For reasons other than the  Salmonella control programme:  
(2)either  [antimicrobials were not administered to the slaughter poultry;]  
(2)(8)or [the following antimicrobials were administered to the slaughter poultry: 
…………………………………………………………..;]]  
(9)[II.2.2. If the Member States of destination is Finland or Sweden, the poultry underwent a 
microbiological test by sampling on the holding of origin and tested Salmonella negative in 
accordance with Decision 95/410/EC.]  
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing . In the case of transport by waterway/sea 
of animals, the period of validity of the animal health certificate may be extended by the duration of the journey by 
waterway/sea.  
Guidance on the completion of th is official certificate is available in Chapter 2  of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.17:      In case the animals are dispatched from an establishment approved for assembly operations in the 
Member State of origin, the reference number(s) of the official document(s), based on which the 
certificate for this consignment is issued in this establishmen t approved for assembly operations, 
may be indicated. In case the animals are dispatched from  an establishment approved for assembly 
operations in the Member State of passage,  the reference number(s) of the certificate(s), based on 
which the certificate fo r this consignment is issued in this establishment approved for assembly 
operations, must be indicated.  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.  
 
Part II:  
(1) ‘Poultry intended for slaughter’ means poultry to be transported directly or after undergoing an 
assembly operation to a slaughterhouse , as defined in Article 3 of Commission Delegated Regulation 
(EU) 2020/ 688. 
(2) Keep as appropriate.  
(3) Delete when the consignments is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 133  EN EUROPEAN UNION   Certificate model POU -INTRA -Y 
zone thereof which has been granted the status free from in fection with Newcastle disease virus without 
vaccination.  
(4) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus without vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination.  
(5) Applicable in case the consignment is dispatched from an establishment approved for assembly 
operations. The animal in the consignment which has undergone the highest number of assembly 
operation determines the number of remaining allowed assembly operations for this consignment. 
Delete reference if not applicable to the consignment.  
(6) This guarantee applie s only to poultry belonging to the species of Gallus gallus and turkeys.  
(7) If any of the results were positive for the following serotypes during the life of the flock, indicate as 
positive: Salmonella  enteritidis  and Salmonella  typhimurium . 
(8) Complete if appropriate: indicate the name and active substance of antimicrobials used.  
(9) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 134  EN CHAPTER 20: MODEL OF FICIAL CERTIFICATE F OR THE MOVEMENT 
BETWEEN MEMBER STATE S OF SPECIFIED PATHOGE N-FREE EGGS (MODEL 
‘POU -INTRA -SPF’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical use   Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 135  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight (kg)  I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 136  EN EUROPEAN UNION   Certificate model POU -INTRA -SPF Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. the specified pathogen -free eggs(1) described in this certificate have been dispatched from an 
establishment approved in accordance with Article 8 of Commission Delegated Regulation 
(EU) 2019/2035 , which is not subject to movement restrictions or situated in a restricted zone 
established fo r reasons of listed diseases relevant for avian species;  
II.2. to the best of my knowledge, and as declared by the operator, they come from an establishment 
where there were no abnormal mortalities with an undetermined cause ; 
II.3. they come from flocks which are free from specified pathogens as described in the European 
Pharmacopoeia and the results of all tests and clinical examinations required for this specific 
status have been favourable;  
II.4. are marked individually with the approval number of the establishment of origin;  
II.5. arrangements have been made to transport the consignment in containers that comply with 
Article 5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with 
Article 4 of Delegated Regulation (EU) 2020/ 688; 
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/202 0]. 
 
Part I:  
Box I.30:  Description of consignment  
 “Age” : provide the date of collection.  
 
Part II:  
(1) ‘Specified pathogen -free eggs’ , means hatching eggs derived from “chicken flocks free from specified 
pathogens”, as described in the European Pharmacopoeia and which are intended solely for diagnostic 
research or pharmaceutical use, as defined in Article 3 of Commission Delegated Regul ation (EU) 
2020/ 688. 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 137  EN CHAPTER 21: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CAPTIVE BIRDS (MODEL ‘CAPTIVE -BIRDS -
INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical  use  Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 138  EN  Products for human 
consumption    Live aquatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log  yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight (kg)  I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 139  EN EUROPEAN UNION   Certificate model CAPTIVE -BIRDS -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the captive birds described in this certificate have been continuously resident in the establishment 
of origin since hatching or for at least  the last 21 days prior to departure of the consignment;  
II.1.2.  they come from a [registered](1) [confined](1) establishment which is not subject to movement 
restrictions or situated in a restricted zone established for reasons of listed diseases relevant  for 
avian species;  
II.1.3.  to the best of my knowledge, and as declared by the operator, they come from an establishment 
where there were no abnormal mortalities with an undetermined cause ; 
II.1.4.  they:  
(1)(2)either  [(a) have not been vaccinated against  infection with Newcastle disease virus;]  
(1)(2)(3)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated 
vaccines](1) [live attenuated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regula tion (EU) 2020/ 688] (1) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(1)(4)or [(a) are captive birds of the galliformes species intended for a Member State or zone thereof 
which has been granted the status free from infection with Newcastle disease virus 
without vaccination, and they:  
(i) have not been vaccinated against infection with Newcastle disease virus;  
(ii) were kept in isolation for at least 14 days prior to departure of the consignment 
in the establishment of origin under the supervision of an official veterinarian 
or in an approved quarantine establishment, where:  
- no bird was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to depart ure; 
- no other birds have entered into the establishment during that time;  
- no vaccination has been carried out in the quarantine establishment;  
(iii) have tested negative to serological tests to detect antibodies against Newcastle 
disease virus, perfor med on blood samples at a level which gives 95% 
confidence of detecting infection at 5% prevalence and which were taken 
during the period of at least 14 days prior to departure;]  
(5)[(b) are psittacidae and they  
(i) have been individually identified in ac cordance with Article 76 of Commission 
Delegated Regulation (EU) 2019/2035;  
(ii) come from an establishment on which  
(1)either  [avian chlamydiosis has not been confirmed for a period of at least 6 months 
prior to departure of the consignment;]  
(1)or [avian chlamydiosis has been confirmed during the last 6 months prior to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 140  EN EUROPEAN UNION   Certificate model CAPTIVE -BIRDS -INTRA  
departure of the consignment, but not during the last 60 days, and the measures 
provided for in Article 59(2)b) of Commission Delegated Regulation (EU) 
2020/ 688 have been applied;]  
(iii) have 
(1)either  [not been in contact with captive birds from establishments on which avian 
chlamydiosis has been diagnosed during the last 60 days prior to departure;]  
(1)or [been in contact with captive birds from establishments on which avian 
chlamydiosis ha s been diagnosed during the last 60 days prior to departure and 
were found negative to laboratory testing for avian chlamydiosis performed at 
least 14 days after contact;]  
II.1.5.  the flock of origin and the animals of the consignment and have  been subjected to a clinical 
inspection within the last 48 hours before departure of the consignment and showed no clinical 
signs or suspicion of listed diseases relevant for the species;  
II.1.6.  arrangements have been made to transport the consignment in conta iners that comply with Article 
5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with Article 4 of 
Delegated Regulation (EU) 2020/ 688; 
(6)[II.1.7.  they have entered the Union from a third country or territory or zone thereof and  have been 
quarantined in the approved quarantine establishment of destination in the Union in accordance 
with the provisions of Commission Delegated Regulation (EU) 2020/ 692.] 
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the animal health certificate may be extended by the duration of the journey by 
waterway/sea.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.36.31, 01.06.32 or 01.06.39.  
 
Part II:  
(1) Keep as appropriate.  
(2) Delete in case of consignments of captive birds of the galliformes species dispatched from a Member 
State or zone thereof which does not have the status free from infection with Newcastle disease virus 
without vaccination to a Member State or zone thereof which has been granted the status free from 
infection with Newcastle disease virus without vaccination.  
(3) This guarantee is required for  consignments of pigeons. Delete referen ce if not applicable to the 
consignment.  
(4) This guarantee is required for  consignments of captive birds of the galliformes species dispatched from 
a Member State or zone thereof which does not have the status free from infection with Newcastle 
disease vi rus without vaccination to a Member State or zone thereof which has been granted the status 
free from infection with Newcastle disease virus without vaccination.  
(5) This guarantee is required only for  consignments of psittacidae. Delete reference if not a pplicable to the 
consignment.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 141  EN EUROPEAN UNION   Certificate model CAPTIVE -BIRDS -INTRA  
(6) This guarantee is required for  consignments of captive birds which have entered the Union from a third 
country or territory or zone thereof. Delete reference if not applicable to the consignment.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 142  EN CHAPTER 22: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF HATCHING EGGS OF CAPTIVE BIRDS 
(MODEL ‘HE-CAPTIVE -BIRDS -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equine animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further processing   Organic  fertilizers and soil 
improvers   Technical use   Quarantine or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 143  EN  Products for human 
consumption    Live aquatic animals  
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 144  EN EUROPEAN UNION   Certificate model HE -CAPTIVE -BIRDS -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  the hatching eggs(1) of captive birds described in this certificate  come from a [registered](2) 
[confined](2) establishment which is not subject to movement restrictions or situated in a restricted 
zone established for reasons of listed diseases relevant for avian species ; 
(2)(3)either  [II.1.2.  they:  
(2)either  [(a) have not been vaccinated against infection with Newcastle disease virus;]  
(2)or [(a) have been vaccinated against infection with Newcastle disease virus with [inactivated 
vaccines](2) [live attenu ated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
(2)either  [(b) come from flocks  which have not been vaccinated against infection with Newcastle 
disease virus;]  
(2)or [(b) come from flocks  which  have been vaccinated against infection with Newcastle 
disease virus with [inactivated vaccines](2) [live attenuated vaccines that comply with 
the criteria of Annex VI to Commission Delegated Regulation (EU) 2020/ 688] (2) 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]]  
(2)(4)or [II.1.2 . they are  intended for a Member State or zone which has been granted the status free from 
infection with Newcastle disease virus without vaccination, and they:  
(a) are not vaccinated against infection with Newcastle disease virus;  
(b) come from flocks which  
(2)either [have not been vaccinated against infection with Newcastle disease virus;]  
(2)or [have been vaccinated against infection with Newcastle disease virus with [inactivated 
vaccines](2) [live attenuated vaccines that comply with the criteria of Annex VI to 
Commission Delegated Regulation (EU) 2020/ 688 and vaccination has taken place at 
least 30 days before the collection of the hatching eggs](2)] 
…………………………………………………..  
(name of strain used in the vaccine)  
on ………………. (date) at the age of ……………. weeks;]  
II.1.3. they come from flocks  which have  been subjected to a clinical inspection within the last 48 hours 
before departure of the consignment and showed no clinical signs or suspicion of listed diseases 
relevant for the species;  
II.1.4.  arrangements have been made  to transport the consignment in containers that comply with Article 
5 of Delegated Regulation (EU) 2020/ 688 and in means of transport that comply with Article 4 of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 145  EN EUROPEAN UNION   Certificate model HE -CAPTIVE -BIRDS -INTRA  
Delegated Regulation (EU) 2020/ 688. 
 
Notes:  
This animal  health  certificate is valid  for 10 days from the date of issuing.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.30:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.  
 “Age” : provide the date of collection.  
 
Part II:  
(1) ‘Hatching eggs’ as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Keep as appropriate.  
(3) Delete when the consignments is dispatched from a Member State or zone thereof which does not have 
the status free from infection with Newcastle disease virus without vaccination to a Member State or 
zone thereof which has been granted the status free from infect ion with Newcastle disease virus without 
vaccination and complies with II.1.5.  
(4) This guarantee is required for  consignments dispatched from a Member State or zone thereof which 
does not have the status free from infection with Newcastle disease virus wi thout vaccination to a 
Member State or zone thereof which has been granted the status free from infection with Newcastle 
disease virus without vaccination.  Delete reference if not applicable to the consignment.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 146  EN CHAPTER 23: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF SEMEN OF BOVINE ANIMALS COLLE CTED, 
PROCESSED AND STORED  IN ACCORDANCE WITH R EGULATION (EU) 
2016/429 AND DELEGAT ED REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021 , 
AND DISPATCHED FROM A SE MEN COLLECTION CENTR E WHERE THE 
SEMEN WAS COLLECTED  (MODEL ‘BOV -SEM -A-INTRA ’) 
EUR OPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 147  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 148  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen of bovine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020 /686. 
II.2. The semen described in Part I is intended for artificial reproduction and was obtained  from the donor 
animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.2.2.  come, before the commencement of the quarantine referred to in point  II.2.6., from 
establishments  in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone thereof  
II.2.2.1.  situated in an area where foot -and-mouth disease has not  been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and 
in which foot -and-mouth disease has not been reported during a period of at 
least 3 months, and  
 (2)either  [they were  not vaccinated against foot -and-mouth disease;]  
(2)or [they were vaccinated against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the semen but not during the period of 
the last 30 days immediately prior to the date of collection  of the semen, and  5 
% (with a minimum of five straws) of each quantity of semen taken from a 
donor animal at any time is submitted to a virus isolation test for foot -and-
mouth disease with negative results;]  
II.2.2.2.  free from  infection with Mycobacterium tuberculosis  complex ( M. bovis, M. 
caprae  and M. tuberculosis ), and they have never been kept previously in any 
establishment of a lower health status;  
II.2.2.3.  free from  infection with Brucella abortus, B. melitensis  and B. suis , and  they 
have never been kept previo usly in any establishment of a lower health status;  
(2)either  [II.2.2.4.  free from enzootic bovine leukosis , and  they have never been kept previously 
in any establishment of a lower health status; ] 
(2)or [II.2.2.4.  not free from enzootic bovine leukosis and the donor animals are younger than 
2 years of age and have been produced by dams which have been subjected, 
with negative results, to a serological test for enzootic bovine leukosis after 
removal of the animal from the dam;]  
(2)or [II.2.2.4.  not free from enzootic bovine leukosis and the donor animals have reached the 
age of 2 years and have been subjected, with a negative result, to a serological 
test for enzootic bovine leukosis;]  
(2)either  [II.2.2.5.  free from infectious  bovine rhinotracheitis/infec tious pustular vulvovaginitis, 
and they have never been kept previously in any establishment of a lower 
health status;]  
(2)or [II.2.2.5.  not free from infectious bovine rhinotracheitis/infectious pustular This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 149  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
vulvovaginitis and the donor animals have been subj ected, with a negative 
result, to a serological test (whole virus) on a blood sample;]  
II.2.2.6.  in which surra ( Trypanosoma evansi ) has not been reported during the last 30 
days, a nd 
(2)either  [surra has not been  reported in the establishments during the last 2 years.]  
(2)or [surra has been reported in the establishments during the last 2 years and  
following the last outbreak the establishments have remained under movement 
restrictions until  
 the infected animals h ave been removed from the establishment, and  
 the remaining animals on the establishment have been subjected to a test for 
surra  (Trypanosoma evansi ) with one of the diagnostic methods provided 
for in Part 3 of Annex I  to Delegated Regulation (EU) 2020/ 688, carried 
out, with negative results, on samples taken at least 6 months after the 
infected animals have been removed from the establishment. ] 
II.2.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.2.4.  are individually identified as provided for in Article 38  of Delegated Regulation (EU) 
2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection o f the semen  and during 
the collection period  
II.2.5.1.  were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, cont agious bovine pleuropneumonia and 
lumpy skin disease or of an emerging disease relevant for the ovine and caprine 
animals;  
II.2.5.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax,  surra (Trypanosoma 
evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection wit h epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotype 1 -24), 
bovine genital campylobacteriosis and trichomonosis have not been reported;  
II.2.5.3.  were not in contact with animals from establishments situated in a restricted 
zone due to the occurrence of diseases referred to in point II.2.5.1. or from 
establishments which do not meet the conditions referred to in point II.2.5.2.;  
II.2.5.4.  were not used for natural breeding;  
II.2.6.  have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health 
status were present, which on the day of their admission to the semen collection centre 
complied with the following conditions:  
II.2.6.1.  it was not situated in a restricted zone established due to diseases referred to in 
point II.2.5.1.;  
II.2.6.2.  none of the diseases referred to in point II.2.5.2. has been reported for a period 
of at least 30 days;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 150  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
II.2.6.3.  it was situated in an ar ea where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;  
II.2.6.4.  has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months prec eding the date of admission of the animals into the semen 
collection centre;  
II.2.7.  were kept in the semen collection centre  
II.2.7.1.  which was not situated in a restricted zone established due to diseases referred 
to in point II.2.5.1.;  
II.2.7.2.  where none of the diseases referred to in point II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and  
(2)(3)[at least 30 days following the date of the collection;]  
(2)(4)[until the date of dispatch of the  consignment of semen to another Member 
State;]  
II.2.7.3.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and  
II.2.8.  comply with at least  one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24): 
(2)either  [II.2.8.1.  they have been kept in a Member State or zone thereof free from infection with 
bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and 
during collection of the semen;]  
(2)and/or  [II.2.8.2.  they have been kept in a seasonally disease -free zone, during the seasonally 
disease -free period, for a period of at least 60 days prior to and during collection of 
the semen, in a Memebr State or zone thereof with an approved eradication 
programme against infection with bluetongue virus (serotype 1 -24);]  
(2)and/or  [II.2.8.3.  they have been kept in a seasonally disease -free zone, during the seasonally 
disease -free period, for a perio d of at least 60 days prior to and during collection of 
the semen, in a Memebr State or zone thereof where the competent authority of the 
place of origin of the consignment of semen has obtained the prior written consent 
of the competent authority of the M ember State of destination to the conditions for 
establishment of that seasonally disease -free zone and to accept the consignment of 
semen;]  
(2)and/or  [II.2.8.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior  to and during collection of the semen;]  
(2)and/or  [II.2.8.5.  they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1 -24, with negative results, between 28 and 60 days from the date 
of each collection of the semen;]  
(2)and/or  [II.2.8.6.  they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of  
at least every 7 days, in the case of the virus isolation test, or of at least every 28 
days, in the case of PCR;]  
II.2.9.  comply with at least one of the following conditions as regards infection with epizootic This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 151  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
haemorrhagic disease virus ( serotypes 1 -7) (EHDV 1 -7): 
(2)either  [II.2.9.1.  they have been kept for a period of at least 60 days prior to and during collection 
of the semen in a Memebr State or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2  years within a radius of 150 km of 
the establishment;]  
(2)and/or  [II.2.9.2.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(2)and/or  [II.2.9.3.  were resident in the Me mebr State in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to  the following tests carried out in an 
official laboratory:  
(2)either  [II.2.9.3.1.  a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]  
(2)and/or  [II.2.9.3.2.  an agent identificatio n test for EHDV 1 -7, with 
negative results, on blood samples taken at the commencement and 
final collection of the semen and during the collection of the semen at 
intervals of at least every 7 days, in the case of virus isolation test, or 
of at least every  28 days, in the case of PCR.]]  
II.2.10.  have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.2.6., 
with negative results, except for  the bovine viral diarrhoea antibody test referred to in point 
II.2.10.5.2., required in accordance with point 1(b) of Chapter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020 /686: 
II.2.10.1.  for infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/ 688; 
II.2.10.2.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(2)(5)[II.2.10.3.  for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4 
of Annex I to Delegated Regulation (EU) 2020/ 688;] 
II.2.10.4.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample if the animals do not come 
from an establishment free from infectious bovine rhinotracheitis/infectious 
pustular vulvova ginitis;  
II.2.10.5.  for bovine  viral diarrhoea:  
II.2.10.5.1.  a virus isolation test, a test for virus genome or a test for virus 
antigen, and  
II.2.10.5.2.  a serological test to determine the presence or absence of 
antibodies;  
II.2.11.  have been subjected to the following tests, carried out on blood samples taken within a 
period of at least 21 days,  or 7 days in the case of the tests referred to in points II.2.11.4. and 
II.2.11.5., prior to the commencement of the quarantine referred to in point II.2.6., wi th This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 152  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.2.11.3.2., required in accordance with point 1(c) of Chapter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020 /686: 
II.2.11.1.  for infection  with Bruce lla abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
II.2.11.2.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole vir us) on a blood sample;  
II.2.11.3.  for bovine  viral diarrhoea:  
II.2.11.3.1.  a virus isolation test, a test for virus genome or a test for virus 
antigen, and  
II.2.11.3.2.  a serological test to determine the presence or absence of 
antibodies;  
II.2.11.4.  for bovine genital campylobacteriosis ( Campylobacter fetus ssp. venerealis ):  
(2)either  [II.2.11.4.1.  a single test carried out on a sample of artificial vagina washings 
or preputial specimen , in the case of animals less than 6 months 
old or kept since that ag e in a single sex group without contact 
with females prior to the quarantine referred to in point II.2.6.;]  
(2)or [II.2.11.4.2.  tests carried out on samples of artificial vagina washings or 
preputial specimens taken on three occasions at intervals of at le ast 
7 days;]  
II.2.11.5.  for trichomonosis ( Trichomonas foetus ): 
(2)either  [II.2.11.5.1.  a single test carried out on a sample of preputial specimen , in the 
case of animals less than 6 months old or kept since that age in a 
single sex group without contact with females prior to the 
quarantine referred to in point II.2.6.;]  
(2)or [II.2.11.5.2.  tests carried out on preputial specimens taken on three occasions at 
intervals of at least 7 days;]  
II.2.12.  have been subjected at semen collection centre, at least on ce a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 1 of 
Annex II to Delegated Regulation (EU) 2020 /686: 
II.2.12.1.  for infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/ 688; 
II.2.12.2.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
II.2.12.3.  for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4 
of Annex I to Delegated Regulation (EU) 2020/ 688; 
II.2.12.4.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;  
(2)(6)[II.2.12.5.  for bovine  viral diarrhoea, a serological test for detection of an antibody;]  
(2)(7)[II.2.12.6.  for b ovine genital campylobacteriosis ( Campylobacter fetus ssp. venerealis ), a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 153  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
test on a sample of preputial specimen;]  
(2)(7)[II.2.12.7.  for trichomonosis  (Trichomonas foetus ), a test on a sample of preputial 
specimen;]  
II.3. The semen described in Part I  
II.3.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1  of Annex III to Delegated Regulation (EU) 2020 /686; 
II.3.2.  are placed in straws or other packages on which the mark is appli ed in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686  and that 
mark is indicated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch from the seme n collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, 
and the seal bears the number as indicated in Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
contai ner; 
II.3.3.3.  has been filled in with the cryogenic agent which not have been previously 
used for other products.  
II.4. The semen is preserved by the addition of antibiotics as follows:  
II.4.1.  The following  antibiotic or mixture of antibiotics,  effective  in particular against campylobacters, 
leptospires and mycoplasmas, has been added to the semen after final dilution, or is contained in 
the used semen diluents, to reach the indicated concentration per ml of semen:  
(2)either  [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(2)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (2)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(2)or [an antibiotic  or a mixture of antibiotics(8) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg),  penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.4.2.  Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or under 
a time-temperature regime with a documented equivalent bactericidal activity.  
II.5. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 154  EN EUROPEAN UNION  Certificate model BOV -SEM -A-INTRA  
the semen collection centre of dispatch of the consignment of semen.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establi shment of destination of the consignment of semen.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: semen.  
  “Species ”: select amongst  “Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where semen of 
the consignment is placed.  
“Date of  collection/production ”: indicate the date on which semen of the consignment 
was collected.  
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
 (1) Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
(2) Delete if not applicable.  
(3) Applicable fo r frozen semen . 
(4) Applicable for fresh and chilled semen. 
(5) Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and 
which are less that 2 years of age as referred to in Article 20(2)(a) of Delegated Regulat ion (EU) 2020 /686. 
(6) Applicable only to seronegative animals. 
(7) Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls 
returning to collection after a lay -off period of more than 6 months shall be tested during a period of 30 days 
prior to resuming production.  
(8) Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 155  EN CHAPTER 24: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF STOCKS OF SEMEN OF B OVINE ANIMALS 
COLLECTED, PROCESSED  AND STORED IN ACCORD ANCE WITH COUNCIL 
DIRECTIVE 88/407/EEC , AS AMENDED BY COUN CIL DIRECTIVE 2003/4 3/EC, 
AFTER 31 DECEMBER 20 04 AND BEFORE 21 APRIL 2021, AND DISP ATCHED 
AFTER 20 APRIL 2021 FROM A SEMEN COLLECTION CENTRE WH ERE THE 
SEMEN WAS COLLECTED  (MODEL ‘BOV -SEM -B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 156  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 157  EN EUROPEAN UNION  Certificate model BOV -SEM -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official ve terinarian, hereby certify that t he semen described above:  
II.1.1. was collected, processed and stored in a semen collection centre(1) approved and 
supervised by the competent authority in accordance with Chapter I(1) and Chapter  
II(1) of Annex A to Directive 88/407/EEC;  
II.1.2. was collected from bulls, which:  
II.1.2.1. meet the requirements of Chapters I and II of Annex B to Directive 
88/407/EEC,  
(2)either  II.1.2.2. [have not been vaccinated against foot -and-mouth disease within 12 months 
prior to collection;]  
(2)or II.1.2.2. [have been vaccinated against foot -and-mouth disease less than 12 months and 
more than 30  days prior to the coll ection, and 5% of doses of semen of each 
collection, with a minimum of 5 straws, have been submitted to a virus 
isolation test for foot -an-mouth disease, carried out with negative results in the 
laboratory (………………………… )(3) situated in or designated by the 
Member State of destination;]  
II.1.3. was collected, processed, stored and transported under conditions which comply with 
the standards laid down in Annex C to Directive 88/407/EEC;  
II.1.4. was stored in approved conditions for a minimum period of 30 days immediately 
following collection(4). 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.1 1: Place of dispatch shall correspond  to the semen collection centre (as defined in Article 2(b) first indent 
of Directive 88/407/EEC) where the semen was collected.  
Box I.1 2: Place of destination shall correspond to the semen collection or storag e centre (as defined in Article 
2(b) of Direct ive 88/407/EEC), or to the holding of semen destination.  
Box I. 19: Identification of container and Seal number shall be indicated.  
Box I.30 : Donor identity shall correspond to the official identification of the animal.  
 Date of collection shall be indicate d in the following format: dd/mm/yyyy.  
 Approval number of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.12. where the semen was collected.  
 
Part II:  
(1) Only semen collection centres approved by the competent authority and listed in accordance with 
Article 5(2) of Council Directive 88/407/EEC.  
(2) Delete as appropriate.  
(3) Name of the laboratory.  
(4) May be deleted for fresh semen.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 158  EN EUROPEAN UNION  Certificate model BOV -SEM -B-INTRA  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 159  EN CHAPTER 25: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF STOCKS OF SEMEN OF B OVINE ANIMALS 
COLLECTED, PROCESSED  AND STORED BEFORE 1 JANUARY 2005 IN 
ACCORDANCE WITH COUN CIL DIRECTIVE 88/407 /EEC APPLYING UNTIL 
1 JULY 2004, AND DISPA TCHED AFTER 20 APRIL  2021 FROM A SEMEN 
COLLECTION CENTRE WH ERE THE SEMEN WAS CO LLECTED  (MODEL 
‘BOV -SEM -C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 160  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 161  EN EUROPEAN UNION  Certificate model BOV -SEM -C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1.1.  The semen described above was collected before the date of 31 December 2004 on a semen 
collection centre(1) which:  
(a) was approved under conditions laid down in Chapter I of Annex A to Directive 
88/407/EEC;  
(b) was operated and supervised under conditions la id down in Chapter II of Annex A to 
Directive 88/407/EEC.  
II.1.2.  At the time the semen described above was collected, all bovine animals at the semen 
collection centre:  
(a) came from herds and/or were born to dams which satisfy the conditions of points 1( b) 
and (c) in Chapter I of Annex B to Directive 88/407/EEC;  
(b) have, within the 30 days preceding the quarantine isolation period, un dergone, with 
negative results:  
- the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to 
Directive 88/407/EEC, and   
- a serum neutralization test or ELISA test for infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis, and   
- a virus isolation test (fluorescent antibody test or immunoperoxidase test) for 
bovine viral diarrhoea, which in the case of an animal less than six months of age 
has been deferred until that age was reached;  
(c) have satisfied the quarantine isolation period of 30 days and have been subjected with 
the required negative results to the following health tests:  
- a serological test for brucellosis carried out in accordance with the procedure 
described in Annex C to Directive 64/432/EEC;  
- either an immunofluorescent antibody test or a culture test for Campylobacter 
fetus  infection on a sample of preputial materi al or artificial vagina washings, or, 
in the case of a female animal, a vaginal mucus agglutination test;  
- a microscopic examination and culture test for Trichomonas foetus  on a sample 
of preputial material or artificial vagina washings, or in case of a f emale animal a 
vaginal mucus agglutination test;  
(d) have undergone, at least once a year, with negative results, the routine tests referred to 
in points  1(a), (b) and (c) in Chapter II of Annex B to Directive 88/407/EEC.  
II.1.3.  At the time the semen desc ribed above was collected,  
(a) all female bovine animals in the centre have undergone, at least once a year, a vaginal 
mucus agglutination test for Campylobacter fetus  infection with negative results, and  
(b) all bulls used for semen production have underg one with negative result either an 
immunofluorescent antibody test or a culture test for Campylobacter fetus  infection on a 
sample of preputial material or artificial vagina washings carried out within 12  months 
prior to collection.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 162  EN EUROPEAN UNION  Certificate model BOV -SEM -C-INTRA  
II.1.4.  The semen descr ibed above was collected from bulls standing in a semen collection centre in 
which:  
(2)either  [all bovine animals have not been vaccinated against infectious bovine rhinotracheitis and have 
undergone at least once a year with negative result a serum neutra lisation test or an ELISA test 
for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis;]  
(2)or [bovine animals not vaccinated against infectious bovine rhinotracheitis have undergone, at 
least once a year, with negative result a serum neut ralisation test or ELISA test for infectious 
bovine rhinotracheitis/infectious pustular vulvovaginitis, and testing for infectious bovine 
rhinotracheitis is not carried out on bulls which have received a first vaccination against 
infectious bovine rhinotra cheitis at the insemination centre after they have been tested with 
negative result in a serum neutralisation test or ELISA test for infectious bovine 
rhinotracheitis/infectious pustular vulvovaginitis and which since the first vaccination have 
been regula rly re -vaccinated with an interval of not more than six months;].  
II.1.5.  The semen described above was collected from bulls which:  
II.1.5.1.  
(2)either  [have not been vaccinated against foot -and-mouth disease within 12 months prior to 
collection;]  
(2)or [have been vaccinated against foot -and-mouth disease less than 12 months and more 
than 30  days prior to collection, and 5% of doses of the semen from each collection, 
with a minimum of five straws, have been submitted to a virus isolation test for foot -
and-mouth disease, carried out with negative results in the laboratory 
(…………………………………)(3), situated in or designated by the Member State of 
destination;]  
II.1.5.2.  
(2)either  [have not been vaccinated against infectious bovine rhinotracheitis,]  
(2)or [have bee n vaccinated against infectious bovine rhinotracheitis in accordance with 
point II.1.4,].  
II.1.6.  The semen described above was stored in approved conditions for a minimum period of 30  
days immediately following collection(4). 
II.1.7.  The semen described a bove was sent to the place of loading in a sealed container and bearing 
the number detailed in Box I. 19. 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11 : Place of dispatch shall correspond to the semen collection centre (as defined in Article 2(b) first indent 
of Directive 88/407/EEC) where the semen was collected.  
Box I. 12: Place of destination shall correspond to the semen collection or storage centre (as defined in 
Article  2(b) of Directive 88/407/EEC), or to the holding of semen destination.  
Box I. 19: Identification of container and Seal number  shall be indicated.  
Box I.30 : Donor identity shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy and shall be earlier than 31 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 163  EN EUROPEAN UNION  Certificate model BOV -SEM -C-INTRA  
December 2004.  
 Approval number of the centre shall correspond to the approval number of the semen centre  indicat ed 
in Box I.11 . where the semen was collected.  
 
Part II:  
(1) Only semen collection centres approved by the competent authority and listed in accordance with 
Article 5(2) of Council Directive 88/407/EEC.  
(2) Delete as appropriate.  
(3) Name of the laborator y. 
(4) May be deleted for fresh semen.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 164  EN CHAPTER 26: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF OOCYTES AND EMBRYOS OF BOVINE 
ANIMALS COLLECTED OR  PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021 , AND DISPATCHED BY AN  
EMBRYO COLLECTION OR  PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED  (MODEL ‘BOV -OOCYTES -
EMB -A-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for 
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 165  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 166  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)[II.1.  The in vivo  derived embryos of bovine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirement s as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 
2020 /686.] 
(1)[II.1.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) of bovine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements  as regards responsibilities, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020 /686.] 
II.2. The oocytes(1)/ embryos(1) described in Part I are intended for artificial reproduction and were 
obtained from the donor animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Unio n; 
II.2.2.  come from establishments  in a Member State or zone thereof, or from establishments 
under official control by the competent authority in a third country or territory, or a 
zone thereof  
II.2.2.1.  free from  infection with Mycobacterium tuberculosi s complex ( M. bovis, 
M. caprae  and M. tuberculosis ), and they have never been kept 
previously in any establishment of a lower health status;  
II.2.2.2.  free from infection with Brucella abortus, B. melitensis  and B. suis  and 
they have never been kept previously in any establishment of a lower 
health status;  
(1)either  [II.2.2.3.  free from enzootic bovine leukosis  and they have never been kept 
previously in any establishment of a lower health status;]  
(1)or [II.2.2.3.  not free from enzootic bovine leukosis and the donor animals are 
younger than 2 years of age and the official veterinarian responsible for 
the establishment of origin has certified that there has been no clinical 
case of enzootic bovine leukosis during a period  of at least the preceding 
3 years;]  
(1)either  [II.2.2.4.  free from infectious  bovine rhinotracheitis/infectious pustular 
vulvovaginitis  and they have never been kept previously in any 
establishment of a lower health status;]  
(1)or [II.2.2.4.  not free from  infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis and the official veterinarian responsible for the 
establishment of origin has certified that there has been no clinical case 
of infectious bovine rhinotracheitis/infectious pustular vulv ovaginitis 
during a period of at least the preceding 12 months;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 167  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  
II.2.2.5.  in which surra ( Trypanosoma evansi ) has not been reported during the 
last 30 days prior to  collection(1)/ production(1) of the oocytes(1)/ 
embryos(1), and  
(1)either  [surra has not been reported in the establishments during the last 2 years 
prior to  collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [surra has been reported in the establishments during the last 2 years 
prior to to  collection(1)/ production(1) of the oocytes(1)/ embryos(1) and 
following the last outbreak the establishments have remained under 
movement restrictions until  
 the infected animals have been removed from the establishment, and  
 the remaining animals on the establishment have been subjec ted to a 
test for surra  (Trypanosoma evansi ) with one of the diagnostic 
methods provided for in Part 3 of Annex I  to Delegated Regulation 
(EU) 2020/ 688, carried out, with negative results, on samples taken 
at least 6 months after the infected animals have been removed from 
the establishment; ] 
II.2.3.  were examined by the team veterinarian or its team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of 
collection(1)/ production(1) of the oocytes(1)/ embryos(1);  
II.2.4.  are individually identified as provided for in Article 38  of Delegated Regulation (EU) 
2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection(1)/ production(1) of 
the oocytes(1)/ embryos(1) and during the collection period  
II.2.5.1.  were kept on establishments not situated in a restricted zone established 
due to the occurrence of foot -and-mouth disease, infection with 
rinderpest virus, infection with Rift Valley fever virus, contagious 
bovin e pleuropneumonia and lumpy skin disease or of an emerging 
disease relevant for the ovine and caprine animals;  
II.2.5.2.  were kept on a single establishment where infection with  Brucella 
abortus, B. melitensis and B. suis , infection with Mycobacterium 
tuberculosis  complex ( M. bovis, M. caprae and M. tuberculosis ), rabies, 
anthrax,  surra (Trypanosoma evansi), enzootic bovine leukosis, 
infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, 
bovine viral diarrhoea, infection with epizootic haemor rhagic disease 
virus and infection with bluetongue virus (serotype 1 -24) have not been 
reported;  
II.2.5.3.  were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.5.1. o r from establishments which do not meet the conditions 
referred to in point II.2.5.2.;  
II.2.5.4.  were not used for natural breeding;  
II.2.6.  comply with the following conditions as regards foot -and-mouth disease  
II.2.6.1.  they come from establishments  
 situated in an area where foot -and-mouth disease has not been 
reported within a 10 -km radius centred on the establishment for a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 168  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  
period of at least 30 days immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 (1)either  [II.2.6.2.  they were  not vaccinated against foot -and-mouth disease;]  
(1)(3)or [II.2.6.2.  they were vaccinated  against foot -and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos 
and 
II.2.6.2.1.  have not been vaccinated against foot -and-mouth disease 
within the period of at least 30 days immediately prior to the 
date of collection of the embryos;  
II.2.6.2.2.  the semen used for fertilisation was collected from a male 
donor that complies with the conditions set out in point 1(b) 
or the semen complies with the conditions set out in point 2  
of Chapter I o f Part 5 of Annex II to Delegated Regulation 
(EU) 2020 /686; 
II.2.6.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the 
recommendations of the IETS Manual(4); 
II.2.6.2.4.  the embryos were stored deep  frozen for a period of at least 
30 days from the date of collection, and during this period 
the donor animal has not shown clinical signs of foot -and-
mouth disease;]  
(1)(5)[II.2.7.  comply with at least one of the following conditions as regards infection with 
bluetongue virus (serotypes 1 -24): 
(1)either  [II.2.7.1.  they have been kept in a third country, territory or zone thereof free from 
infection with bluetongue virus (serotypes 1 -24) for a period of at least 60 
days prior to and during collection of the  oocytes;]  
(1)and/or  [II.2.7.2.  they have been kept in a seasonally disease -free zone, during the seasonally 
disease -free period, for a period of at least 60 days prior to and during 
collection of the oocytes, in a third country, territory or zone thereof with an 
approved eradication programme against infection with bluetongue virus 
(serotype 1 -24);]  
(1)and/or  [II.2.7.3.  they have been kept in a seasonally disease -free zone, during the seasonally 
disease -free period, for a period of at least 60 days prior t o and during 
collection of the oocytes, in a third country, territory or zone thereof where 
the competent authority of the place of origin of the consignment of 
oocytes(1)/ in vitro  produced embryos(1) has obtained the prior written 
consent of the competen t authority of the Member State of destination to the 
conditions for establishment of that seasonally disease -free zone and to 
accept the consignment of oocytes(1)/ in vitro  produced embryos(1);] 
(1)and/or  [II.2.7.4.  they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes;]  
(1)and/or  [II.2.7.5.  they have been subjected to a serological test to detect antibodies to the 
bluetongue virus serogroup 1 -24, with negative results, between 28 and 60 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 169  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  
days from the date of each collection of the oocytes;]  
(1)and/or  [II.2.7.6.  they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood sample taken on the date of 
collection of the oocytes;]]  
(1)(5)[II.2.8.  comply with at least one of the following conditions as regards infection with 
epizootic haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.2.8.1.  they have been kept for a period of at least  60 days prior to and during 
collection of the oocytes in a third country, territory or zone thereof where 
EHDV 1 -7 has not been reported for a period of at least the preceding 2 
years within a radius of 150 km of the establishment;]  
(1)and/or  [II.2.8.2.  they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes;]  
(1)and/or  [II.2.8.3.  were resident in the exporting country in which according to official 
findings the following seroty pes of EHDV exist: ………………………… 
and have been subjected with negative results in each case to  the following 
tests carried out in an official laboratory:  
(1)either  [II.2.8.3.1.  a serological test to detect antibodies to EHDV 1 -7, 
with negative results, on blo od sample taken 
between 28 and 60 days from the date of the 
collection of the oocytes;]]  
(1)and/or  [II.2.8.3.2.  an agent identification test for EHDV 1 -7, with 
negative results, on blood sample taken on the date 
of collection of the oocytes.]]]  
(1)(5)[II.2.9.  comply with animal health requirements laid down in Chapter III of Part 1 of Annex 
II to Delegated Regulation (EU) 2020 /686.] 
II.3. The oocytes(1)/ embryos(1) described in Part I  
II.3.1.  has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to 
Delegated Regulation (EU) 2020 /686; 
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 
and that mark is indicated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch by the embryo collection 
or production team under  responsibility of the team veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.3.3.3.  has been fi lled in with the cryogenic agent which not have been 
previously used for other products.  
(1)(6)[II.3.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.3.5.  are transported in a container where they are separated from each other by physical This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 170  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  
compartments or by being placed in secondary protective bags.]  
(1)(7)[II.4.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using  semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by the competent authority of a 
Member State or by the competent auth ority of a third country, territory or zone thereof listed in 
Annex VII to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ].] 
(1)(8)[II.5. The following  antibiotic or mixture of antibiotics(9) has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]  
II.6. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond  to the number of containers.  
Box reference I.30:  “Species ”: select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
  “Type ”: specify if oocytes, in vivo  derived  embryos, in vitro  produced embryos or 
micromanipulated embryos.  
  “Species ”: select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where oocytes or 
embryos of the consig nment are placed.  
“Date of  collection/production ”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only embryo collection or production te ams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
(3) Option available only for  the consignment of  in vivo  derived embryos.  
(4) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 171  EN EUROPEAN UNION  Certificate model BOV -OOCYTES -EMB -A-INTRA  
Transfer Society 1 111 North Dunlap Avenu e, Savoy, Illinois 61 874 USA (http://www.iets.org/).  
(5) Applicable for the consignment of oocytes and in vitro  produced embryos.  
(6) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and mic romanipulated embryos of bovine animals are placed and transported.  
(7) Does  not apply to oocytes.  
(8) Mandatory attestation in case antibiotics were added.  
(9) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 172  EN CHAPTER 27: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF STOCKS OF EMBRY OS OF BOVINE  ANIMALS 
COLLECTED OR PRODUCE D, PROCESSED AND STO RED BEFORE 21 APRIL 
2021 IN ACCORDANCE W ITH COUNCIL DIRECTIV E 89/556/EEC, AND 
DISPATCHED AFTER 20 APRIL 2021 BY AN EMB RYO COLLECTION OR 
PRODUCTION TEAM BY W HICH THE EMBRYOS WER E COLLECTED OR 
PRODUCED  (MODEL ‘BOV -EMB -B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent  Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 173  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 174  EN EUROPEAN UNION  Certificate model BOV -EMB -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official  veterinarian, hereby certify that the embryos described in this certificate:  
II.1. were collected, processed and stored in compliance with Annex A to Directive 89/556/EEC;  
II.2. were sent to the place of loading in sealed containers in compliance with Annex A to Directive 
89/556/EEC;  
II.3. come from donors of the bovine species which comply  with Annex B to Directive 89/556/EEC;  
II.4. were conceived either by artificial insemination or by in vitro  fertilisation (1) using semen 
coming from semen collection or storage centres approved in accordance with Directive 
88/407/EEC and loaded in a Member State of the European Community or in a third country 
listed in Annex I to Comission Decision 2004/639/EC (1)(2). 
 
Notes  
Guidance on the completion of thi s official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.17:  In the case of imported embryos, insert the number of the import certificate.  
Box reference I.30:  “Identification mark ”: corresponding to the details identifying the donor cows and the 
date of collection on the straw.  
 “Type ”: specify whether there is (a) penetration or (b) non -penetration of zona 
pellucida . 
 
Part II:  
(1) Delete as nece ssary.  
(2) OJ L 292, 15.9.2004, p.21.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 175  EN CHAPTER 28: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGMENTS OF:  
- semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of  semen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed an d stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC applying until 1 July 2004;  
- oocytes and embryos of bovine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulatio n (EU) 2020 /686 after 20 April 2021 ; 
- stocks of embryos of bovine animals collected or produced, processed and stored in accordance with 
Directive 89/556/EEC  before 21 April 2021,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
PROCESSING ESTABLI SHMENT (MODEL ‘BOV -GP-PROCESSING -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 176  EN I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 177  EN EUROPEAN UNION  Certificate model BOV -GP-PROCESSING -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ 
oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) 
was/were processed and stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies  with requirements as regards responsibi lities, operational procedures, facilities 
and equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ 
micromanipluated embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage centre(2)(3) situated in the Member State of its/their collection 
or production and complying with requirements as regards responsi bilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020 /686, and  was/were moved to the germinal 
product processing establishment indicated in Box I .11. situated in the Member State of 
its/their collection or production under animal health certification requirements at least as 
strict as those provided for in:  
(2)either  [Model BOV -SEM -A-INTRA(4);] 
(2)and/or  [Model BOV -SEM -B-INTRA(4);] 
(2)and/or  [Model  BOV -SEM -C-INTRA(4);] 
 (2)and/or  [Model BOV -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  BOV -EMB -B-INTRA(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model BOV -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage c entre(2)(3) situated in the Member State of its/their collection 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Ann ex I to Delegated Regulation (EU) 2020 /686, and  was/were moved to the germinal 
product processing establishment indicated in Box I.11. situated in another Member State 
accompanied by certificate(s) in accordance with:  
(2)either  [Model BOV -SEM -A-INTRA(4);] 
(2)and/or  [Model BOV -SEM -B-INTRA(4);] 
(2)and/or  [Model BOV -SEM -C-INTRA(4);] 
 (2)and/or  [Model BOV -OOCTYES -EMB -A-INTRA4);] 
(2)and/or  [Model  BOV -EMB -B-INTRA(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 178  EN EUROPEAN UNION  Certificate model BOV -GP-PROCESSING -INTRA  
(2)and/or  [Model BOV -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model BOV -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage centre(2)(3) situated in a third country, territory or zone thereof 
listed in Annex VII to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] and 
complying with requirements as regards responsibilities , operational procedures, facilities 
and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to 
Delegated Regulation (EU) 2020 /686, and  entered the Union accompanied by 
certificate(s) in accordance with:  
(2)either  [Model BOV -SEM -A-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -B-ENTRY  (4);] 
(2)and/or  [Model BOV -SEM -C-ENTRY (4);] 
(2)and/or  [Model BOV -OOCYTES -EMB -A-ENTRY  (4);] 
(2)and/or  [Model  BOV -in-vivo-EMB -B-ENTRY(4);] 
(2)and/or  [Model  BOV -in-vitro -EMB -C-ENTRY(4);] 
(2)and/or  [Model  BOV -in-vitro -EMB -D-ENTRY(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model  BOV -GP-STORAGE -ENTRY(4);]] 
II.2.2.  has been  collected, processed and stored in accordance with animal health requirements 
set out in Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or 
Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box 
I.30; 
II.2.4.  are transported  in a container which:  
II.2.4.1.  was sealed and numbered prior to the dispatch  by the germinal product 
processing establishment under responsibility of the centre veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.4.2.  has been cleaned and either disinfected or sterilised befor e use, or is single -use 
container;  
II.2.54.3.  has been filled in with the cryogenic agent which not have been previously 
used for other products;  
(2)(5)[II.2.5.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.6.  are transported  in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.3. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 179  EN EUROPEAN UNION  Certificate model BOV -GP-PROCESSING -INTRA  
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
Box reference I.12:  “Place of destination”:  Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17:  “Accompanying documents” : Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s ) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were colle cted 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
process ing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type”:  specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species” : Select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
“Identification number” : Indicate identification number of each donor animal.  
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consign ment are placed.  
“Date of  collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity” : Indicate number of straws or other packages with the same ma rk. 
 
Part II:  
(1) Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 180  EN EUROPEAN UNION  Certificate model BOV -GP-PROCESSING -INTRA  
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collec tion or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the  semen, oocytes 
or embryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(5) Applicable  for the consignment where in one container seme n, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of bovine animals are placed and transported . 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 181  EN CHAPTER 29: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGMENTS OF:  
- semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, before 21 Ap ril 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC applying until 1 July 2004;  
- oocytes and embryos of bovine animals collected or prod uced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of embryos of bovine animals collected or produced, processed and stored in accordance with 
Directive 89/556/EEC  before 21 April 2021,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
STORAGE CENTRE (MODE L ‘BOV -GP-STORAGE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 182  EN I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 183  EN EUROPEAN UNION  Certificate model BOV -GP-STORAGE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that: 
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in 
vivo derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were 
stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies  with requirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derive d embryos(2)/ in vitro  produced embryos(2)/ 
micromanipluated embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage centre(2)(3) situated in the Member State of its/their colle ction 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020 /686, and  was/were mo ved to the germinal 
product storage centre indicated in Box I.11. situated in the Member State of its/their 
collection or production under animal health certification requirements at least as strict as 
those provided for in:  
(2)either  [Model BOV -SEM -A-INTRA(4);] 
(2)and/or  [Model BOV -SEM -B-INTRA(4);] 
(2)and/or  [Model BOV -SEM -C-INTRA(4) ;] 
(2)and/or  [Model in Annex D1 to Directive 88/407/EEC(4);] 
(2)and/or  [Model in Annex D2 to Directive 88/407/EEC(4);] 
(2)and/or  [Model in Annex D3 to Directive 88/407/EEC(4);] 
(2)and/or  [Model BOV -OOCTYES -EMB -A-INTRA(4) ;] 
(2)and/or  [Model  BOV -EMB -B-INTRA(4) ;] 
(2)and/or  [Model BOV -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model BOV -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage c entre(2)(3) situated in the Member State of its/their collection 
or production and complying with requirements as regards responsibilities, operational 
procedures, facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) 
of Annex I to Delegated Regulation (EU) 2020 /686, and  was/were moved to the germinal 
product storage centre indicated in Box I.11. situated in another Member State 
accompanied by certificate(s) in accordance with:  
(2)either  [Model BOV -SEM -A-INTRA(4);] 
(2)and/or [Model BOV -SEM -B-INTRA4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 184  EN EUROPEAN UNION  Certificate model BOV -GP-STORAGE -INTRA  
(2)and/or  [Model BOV -SEM -C-INTRA(4);] 
(2)and/or  [Model in Annex D1 to Directive 88/407/EEC(4);] 
(2)and/or  [Model in Annex D2 to Directive 88/407/EEC(4);] 
(2)and/or  [Model in Annex D3 to Directive 88/407/EEC(4);] 
(2)and/or  [Model BOV -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  BOV -EMB -B-INTRA(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model BOV -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or 
processed and stored in a germinal product processing establishment(2)(3), and/or stored in 
a germinal product storage centre(2)(3) situated in a third country, territory or zone thereof 
listed in Annex VII to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] and 
complying with requirements as regards responsibilities, operational procedures, facilities 
and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to 
Delegated Regulation (EU) 2020 /686, and  entered the Union accompanied by 
certificate(s) in accordance with:  
(2)either  [Model BOV -SEM -A-ENTRY(4) ;] 
(2)and/or  [Model BOV -SEM -B-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -C-ENTRY(4);] 
 (2)and/or  [Model 1 in Section A of Part 2 of Annex II to Decision 2011/630/EU(4);] 
(2)and/or  [Model 2 in Section B of Part 2 of Annex II to Decision 2011/630/EU(4);] 
 (2)and/or  [Model 3 in Section C of Part 2 of Annex II to Decision 2011/630/EU(4);] 
 (2)and/or  [Model BOV -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model  BOV -in-vivo-EMB -B-ENTRY(4);] 
(2)and/or  [Model  BOV -in-vitro -EMB -C-ENTRY(4);] 
(2)and/or  [Model  BOV -in-vitro -EMB -D-ENTRY(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model  BOV -GP-STORAGE -ENTRY(4);]] 
II.2.2.  has been  collected, processed and stored in accordance with animal health requirements 
set out in Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or 
Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box 
I.30; 
II.2.4.  are transported  in a container which:  
II.2.4.1.  was sealed and numbered prior to the dispatch by the germinal product storage 
centre under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 185  EN EUROPEAN UNION  Certificate model BOV -GP-STORAGE -INTRA  
II.2.4.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3.  has been filled in with the cryogenic agent which not have been previously 
used for other products;  
(2)(5)[II.2.5.  are placed  in straws or oth er packages which are securely and hermetically sealed;  
II.2.6.  are transported  in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.3. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I toImplementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in  the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
Box reference I.12:  “Place of destination”:  Indicate the address and unique registration or approval 
number of the establishment  of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17:  “Accompanying documents” : Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or prod uced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre desc ribed in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.26:  Total number of packages  shall correspond to the number of containers.  
Box reference I.30:  “Type”:  specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species” : Select amongst “ Bos taurus ”, “Bison bison " or "Bubalus bubalis ” as 
appropriate.  
“Identification number” : Indicate identification number of each donor animal.  
“Identification mark” : in Indicate dicate mark on the straw or other packages where 
semen, oocytes and/or embryos of the consignment are placed .  
“Date of  collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the sem en collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 186  EN EUROPEAN UNION  Certificate model BOV -GP-STORAGE -INTRA  
were collected or produced.  
“Quantity” : Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
(2) Delete if not applicable.  
(3) Only  approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document (s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(5) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of bovine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 187  EN CHAPTER 30: MODEL OFFICIAL CER TIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF SEME N OF OVINE AND 
CAPRINE ANIMALS COLL ECTED, PROCESSED AND  STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020 /686 BEFORE  21 APRIL 2021, AND DISPATCHED FROM 
A SEMEN COLLECTION C ENTRE WHERE THE SEME N WAS COLLECTED  
(MODEL ‘OV /CAP -SEM -A-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 188  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 189  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)[II.1.  The semen of ovine(1)/ caprine(1) animals described in Part I has been collected, processed and stored, and 
dispatched from the semen collection centre(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibil ities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020 /686.] 
(1)[II.1.  The semen of ovine(1)/ caprine(1) animals described in Part I has been collected, processed and stored, and 
dispatched fr om the establishment were donor animals are kept as referred to in Article 13 of Delegated 
Regulation (EU) 2020 /686, and  
II.1.1.  the operator obtained the prior consent of the competent authority of the Member State of 
destination to accept the consignment ; 
II.1.2.  the donor animals have been clinically examined by a veterinarian prior to semen collection;  
II.1.3.  the operator keeps records at the establishment which include at least the information 
provided for in Article 8(1)(a) of Delegated Regulation (EU) 2020 /686.] 
(1)either  [II.1.4.  was collected from animals which have been kept continuously since birth on a holding or 
holdings recognised as having a negligible or controlled risk of classical scrapie according to 
point 1 of Section A of Chapter A of  Annex VIII to Regulation (EC) No 999/2001 , except 
during the period when they were kept at a semen collection centre that complied during that 
period with the conditions set out in the four indents of point 1.3.(c)(iv) of that Section ;] 
(1)or [II.1.4.  was collected from animals which have been kept continuously for the last three years before 
the collection on a holding or holdings which has/have complied for the last three years 
before the collection with the requirements laid down in points 1.3. (a) to ( f) of Section A of 
Chapter A of Annex VIII to Regulation (EC) No 999/2001, except during the period when 
they were kept at a semen collection centre that complied during that period with the 
conditions set out in the four indents of point 1.3.(c)(iv) of th at Section;]  
(1)or [II.1.4.  was collected from animals which have been kept continuously since birth in a Member State 
or zone of a Member State  listed in point 2.3 . of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having a negligi ble risk status for classical scrapie;]  
(1)or [II.1.4.  was collected from ovine animals of the ARR/ARR prion protein genotype;]  
II.2. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.2.2.  come, before the commencement of the quarantine referred to in point II.2.6., from 
establishments  in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone thereof  
II.2.2.1.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and in 
which foot -and-mouth disease has not been reported during a period of at least 3 
months, and  
 (1)either  [they were  not vaccinated against foot -and-mouth disease;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 190  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
(1)or [they were  vaccinated against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the semen but not during the period of 
the last 30 days immediately prior to the date of collection  of the semen, and 5 % 
(with a minimum of five s traws) of each quantity of semen taken from a donor 
animal at any time is submitted to a virus isolation test for foot -and-mouth 
disease with negative results;]  
II.2.2.2.  free from infection with Brucella abortus, B. melitensis  and B. suis  and have 
never been kept previously in any establishment of a lower health status;  
(1)(3)[II.2.2.3.  in which infection with Mycobacterium tuberculosis  complex ( M. bovis, M. 
caprae and M. tuberculosis ) has not been reported during the last 42 days;]  
(1)(4)[II.2.2.3.  in which surveillance for infection with  Mycobacterium tuberculosis complex  
(M. bovis, M. caprae and M. tuberculosis) has been  carried out on the caprine 
animals kept on the establishments during at least the last 12 months, as referred 
to in Ar ticle 15(3) of Delegated Regulation (EU) 2020/ 688, and in case, during 
this period, infection with  Mycobacterium tuberculosis complex  (M. bovis, M. 
caprae and M. tuberculosis) has been reported in caprine animals kept on the 
establishment, measures were ta ken in accordance with Part 1(3) of Annex II to 
that Delegated Regulation;]  
II.2.2.4.  in which surra ( Trypanosoma evansi ) has not been reported during the last 30 
days, a nd 
(1)either  [surra has not been  reported in the establishments during the last 2 years;]  
(1)or [surra has been reported in the establishments during the last 2 years and  
following the last outbreak the establishments have remained under movement 
restrictions until  
 the infected animals have been removed from the establishment, and  
 the remaining animals on the establishment have been subjected to a test for 
surra  (Trypanosoma evansi ) with one of the diagnostic methods provided for 
in Part 3 of Annex I  to Delegated  Regulation (EU) 2020/ 688, carried out, 
with negative results, on samples taken at least 6 months after the infected 
animals have been removed from the establishment; ] 
(1)(3)[II.2.2.5.  in which ovine epidydimitis ( Brucella ovis ) has not been reported during the last 
12 months.]  
II.2.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.2.4.  are individually identified as provided for in Article 45(2) or (4), or Article 46(1)  of 
Delegated Regulation (EU) 2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection of the semen  and during the 
collection period  
II.2.5.1.  were kept on establishments not situated in a restricted z one established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants 
virus, sheep pox and goat pox and contagious caprine pleuropneumonia or of a n 
emerging disease relevant for the ovine and caprine animals;  
II.2.5.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tub erculosis ), rabies, anthrax,  surra (Trypanosoma This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 191  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
evansi), infection with epizootic haemorrhagic disease virus, infection with 
bluetongue virus (serotype 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine animals , ovine epidydimitis 
(Brucella ovis ) have not been reported;  
II.2.5.3.  were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.2.5.1. or from 
establishments which do not m eet the conditions referred to in point II.2.5.2.;  
II.2.5.4.  were not used for natural breeding;  
II.2.6.  have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the following conditions:  
II.2.6.1.  it was not situated in a restricted zone established due to diseases referred to in 
point II.2.5.1.;  
II.2.6.2.  none of the diseases referred to in point II.2.5.2. has been reported for a period of 
at least 30 days;  
II.2.6.3.  it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommo dation for a period of 
at least 30 days;  
II.2.6.4.  has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;  
II.2.7.  were kept in the semen c ollection centre  
II.2.7.1.  which was not situated in a restricted zone established due to diseases referred to 
in point II.2.5.1.;  
II.2.7.2.  where none of the diseases referred to in point II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and  
(1)(3)[at least 30 days following the date of the collection;]  
(1)(4)[until the date of dispatch of the consignment of semen to another Member 
State;]  
II.2.7.3.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and  
(1)(3)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30 days from  the date of collection;]  
(1)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to another Member State and the donor animals has be en kept at that 
semen collection centre for a continuous period of at least 30 days immediately 
prior to the date of collection of the semen;]  
II.2.8.  comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotype s 1-24): 
(1)either  [II.2.8.1.  they have been kept in a Member State or zone thereof free from infection with 
bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and during This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 192  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
collection of the semen;]  
(1)and/or  [II.2.8.2.  they have bee n kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a Memebr State or zone thereof with an approved eradication programme 
against infection wi th bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.2.8.3.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a Memebr State or zone thereof where the competent authority of the 
place of origin of the consignment of semen has obtained the prior written consent 
of the competent authority of the Member State of destination to the conditions for 
establishment of that seasonally diseas e-free zone and to accept the consignment of 
semen;]  
(1)and/or  [II.2.8.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.2.8.5.  they have been subjected t o a serological test to detect antibodies to the bluetongue 
virus serogroup 1 -24, with negative results, between 28 and 60 days from the date of 
each collection of the semen;]  
(1)and/or  [II.2.8.6.  they have been subjected to an agent identification test fo r bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of  at 
least every 7 days, in the case of the virus isolation test, or of at  least every 28 days, 
in the case of PCR;]  
II.2.9.  comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.2.9.1.  they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a Memebr State or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of 
the establishment;]  
(1)and/or  [II.2.9.2.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.2.9.3.  were resident in the Memebr State in which according to official findings the 
following serotypes of EHDV exis t: ………………………… and have been 
subjected with negative results in each case to  the following tests carried out in an 
official laboratory:  
(1)either  [II.2.9.3.1.  a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days  throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]  
(1)and/or  [II.2.9.3.2.  an agent identification test for EHDV 1 -7, with negative results, on 
blood samples taken at the commencement and final  collection of the 
semen and during the collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PCR.]]  
(1)(5)[II.2.10.  have been subjected to the following tests, carr ied out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.2.6., 
with negative results, required in accordance with point 1(c) of Chapter I of Part 3 of Annex This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 193  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
II to Delegated Regulation ( EU) 2020 /686: 
II.2.10.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(8)[II.2.10.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]  
II.2.11.  have been subjected to the following tests, carried out on blood samples taken within a period 
of at least 21 days prior to the commencement of the quar antine referred to in point II.2.6., 
with negative results, required in accordance with point 1(d) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020 /686: 
II.2.11.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serolo gical test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(8)[II.2.11.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]  
II.2.12 . have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020 /686: 
II.2.12.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(8)[II.2.12.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an 
equiva lent documented sensitivity and specificity.]]  
(1)(9)[II.2.13.  have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to collection of the semen, with negative results:  
II.2.13.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(8)[II.2.13.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]]  
II.3. The semen described in Part I  
(1)(5)[II.3.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1  of Annex III to Delegated Regulation (EU) 2020 /686;] 
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686  and that 
mark is indicated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I. 19; 
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.3.3.3.  has been filled in with the cryogenic agent which not have been previously used This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 194  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
for other products.  
(1)(10)[II.4. The semen is preserved by the addition of antibiotics as follows:  
II.4.1.  The following  antibiotic or mixture of antibiotics has been added to the semen after final dilution, 
or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:  
(1)either [gentamicin (250 μg);]  
(1)or [a mixture  of penicillin (500 IU) and streptomycin (500 μg);]  
(1)or [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (1)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(1)or [an antibiotic  or a mixture of antibiotics(11) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following  mixtures:  
- gentamicin (250 μg);  
- penicillin (500 IU) and streptomycin (500 μg);  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.4.2.  Immediately  after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature regime with a documented equivalent bactericidal activity.]  
II.5. This certificate is valid  for 10 days from the date of issuing.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
 
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre or, in case of establishment as referred in Articl e 13 of 
Delegated Regulation (EU) 2020 /686, the unique registration number and address of 
the establishment of dispatch of the consignment of semen.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: semen.  
  “Species ”: select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
Identification mark : indicate mark on the straw or other packages where semen of the 
consignment is placed.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 195  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -A-INTRA  
“Date of  collection/production ”: indicate the date on which semen of the consignment 
was collected.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre or, in case of establishment as referred 
in Article 13 of Delegated Regulation (EU) 2020 /686, the unique registration number 
of the establishment where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
(3) Applicable for ovine animals . 
(4) Applicabl e for caprine animals.  
(5) Applicable for semen collected at a semen collection centre.  
(6) Applicable for frozen semen . 
(7) Applicable for fresh and chilled semen. 
(8) Applicable for ovine animals and for those caprine animals which are kept together with  ovine animals. 
(9) Applicable for semen collected at a establishment were donor animals are kept as referred to in Article 13 of 
Delegated Regulation (EU) 2020 /686. 
(10) Mandatory attestation in case antibiotics were added.  
(11) Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 196  EN CHAPTER 31: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF SEMEN OF 
OVINE AND CAPRINE AN IMALS COLLECTED, PRO CESSED AND STORED IN  
ACCORDANCE WITH DIRE CTIVE 92/65/EEC BEFO RE 21 APRIL 2021 AND 
AFTER 31 AUGUST 2010 , AND DISPATCHED AFT ER 20 APRIL 2021 FRO M A 
SEMEN COLLECTION CEN TRE WHERE THE SEMEN WAS COLLECTED  
(MODEL ‘ OV/CAP -SEM -B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for 
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 197  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 198  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen described above:  
II.1.1.  was collected, processed and stored in a semen collection centre(1) approved and supervised by 
the competent authority in accordance with Chapter I(I)(1) and Chapter I(II)(1) of Annex  D to 
Directive 92/65/EEC;  
II.1.2.  comes from donor animals which meet the requirements of Chapter  II(II) of Annex D to 
Directive 92/65/EEC;  
II.1.3.  was collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(II) and III(I) of Annex D to Directive 92/65/EEC;  
(2)either  [II.1.4.  was collected from animals which have been kept continuously since birth on a holding or 
holdings recognised as having a negligible or controlled risk of classical scrapie according to 
point 1 of Section A of Chapter A of Annex VIII to Regulation (EC) No 9 99/2001;]  
(2)or [II.1.4.  was collected from animals which have been kept continuously for the last three years before 
the collection on a holding or holdings which has/have complied for the last three years 
before the collection with the requirements laid down in points 1.3. (a) to (f) of Section A of 
Chapter A of Annex VIII to Regulation (EC) No 999/2001;]  
(2)or [II.1.4.  was collected from animals which have been kept continuously since birth in a Member State 
or zone of a Member State  with a negligible ri sk status for classical scrapie approved in 
accordance with point 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 
999/2001. ;]  
(2)or [II.1.4.  was collected from ovine animals of the ARR/ARR prion protein genotype;]   
II.1.5.  was sent to th e place of loading in a sealed container in accordance with point 1.4. of 
Chapter  III(I) of Annex D to Directive 92/65/EEC and bearing the number detailed in 
Box I.23. 
(2)either  [II.2.  No antibiotics or no mixture of antibiotics were added to the semen.]  
(2)or [II.2.  The following antibiotic or combination of antibiotics was added to produce a concentration 
in the final diluted semen of not less than(3): 
 …………………………………………………………………………………….. .]  
 
Notes  
Guidance on the completion of this official certificate i s available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch  shall correspond to the semen collection centre of origin of the semen.  
Box I.12:  Place of destination  shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the establishment of semen destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  Identification number  shall correspond to the official identification of the animal.  
 Date of collection  shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the centre  shall correspond to the approval number of the semen centre indi cated 
in Box I.11. where the semen was collected.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 199  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -B-INTRA  
 
Part II:  
 (1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Directive 92/65/EEC.  
(2) Delete as appropriate.  
(3) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 200  EN CHAPTER 32: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF SEMEN OF 
OVINE AND CAPRINE AN IMALS COLLECTED, PRO CESSED AND STORED IN  
ACCORDANCE WITH DIRE CTIVE 92/65/EEC BEFO RE 1 SEPTEMBER 2010,  AND 
DISPATCHED AFTER 20 APRIL 2021 FROM A SE MEN COLLECTION CENTR E 
WHERE THE SEMEN WAS COLLECTED  (MO DEL ‘ OV/CAP -SEM -C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 201  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 202  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned  official veterinarian, hereby certify that the semen described above:  
II.1. was collected, processed and stored in a semen collection centre(1) approved and supervised 
by the competent authority in accordance with Chapter I(I) and Chapter I(II) of Annex D to 
Directive 92/65/EEC;  
II.2. comes from the donor animals which meet the requirements of Chapter II(II) of Annex D to 
Directive 92/65/EEC;  
II.3. was collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(II) and III of Annex D to Directive 92/65/EEC;  
(2)either  [II.4.  meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001, as 
applicable on 31 August 2010 ;] 
(2)or [II.4.  meets the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 , as 
applicable on 31 August 2010 , and is  destined for a Member State which benefits, for all or 
part of its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex 
VIII to Regulation (EC) No 999/2001 , as applicable on 31 August 2010 , and the donor 
animals comply reg arding scrapie with the guarantees provided for by the programmes 
referred to in that point and with the guarantees(3) requested by the Member State of 
destination .] 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
 
Box I.11:  Place of dispatch shall correspond to the semen collection centre of origin of the semen.  
Box I.12:  Place of destination shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the establishment of semen destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  Identification number shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the centre shall correspond to the approval number of the semen centre indicated 
in Box I.11. where the  semen was collected.  
 
Part II:  
(1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.  
(2) Delete as appropriate.  
(3) Additional guarantees as laid down in Article 2 of Regulation (EC) No 546/2006 [OJ L 94, 1.4.2006, 
p.28].  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 203  EN EUROPEAN UNION   Certificate model OV /CAP -SEM -C-INTRA  
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 204  EN CHAPTER 33: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF OOCY TES AND 
EMBRYOS OF OVINE AND  CAPRINE ANIMALS COLL ECTED OR PRODUCED, 
PROCESSED AND STORED  IN ACCORDANCE WITH R EGULATION (EU) 
2016/429 AND DELEGAT ED REGULATION (EU) 2020 /686 AFTER 20 APRIL 2021 
AND DISPATCHED BY AN  EMBRYO COLLECTION OR  PRODUCTION TEAM 
BY WHICH THE OOCYTES  OR EMBRYOS WERE COLL ECTED OR PRODUCED  
(MODEL ‘ OV/CAP -OOCYTES -EMB -A-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 205  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 206  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)[II.1.  The in vivo  derived embryos of ovine(1)/ caprine(1) animals described in Part I have been collected, 
processed and stored, and dispatched by the embryo collection team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilit ies, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 
2020 /686.] 
(1)[II.1.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) of ovine(1)/ caprine(1) 
animals described in Part  I have been collected or produced, processed and stored, and dispatched 
by the embryo production team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements  as regards responsibilities, operation al procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020 /686.] 
  II.2. The consignment consists of embryos of the ovine or caprine species which  comply with the 
following conditions as regards classical scrapie : 
(1)either  [they were collected from animals which have been kept continuously since birth on a 
holding or holdings recognised as having a negligible or a controlled risk of classical 
scrap ie in accordance with point 1 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 , except during the period when they were kept at a semen 
collection centre that complied during that period with the conditions set out in the four 
indents  of point 1.3.(c)(iv) of that Section ;] 
(1)or [they were collected from animals which have been kept continuously for the last three 
years before the collection on a holding or holdings which have complied for the last 
three years before collection with th e requirements laid down in points (a) to (f) of point 
1.3. of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, except 
during the period when they were kept at a semen collection centre that complied during 
that period with the conditio ns set out in the four indents of point 1.3.(c)(iv) of that 
Section;]  
(1)or [they were collected from animals which have been kept continuously since birth in a 
Member State or zone of a Member State listed in point 2.3 . of Section A of Chapter A 
of Annex VIII to Regulation (EC) No 999/2001 as having a negligible risk status for 
classical scrapie;]  
(1)or [they were collected from ovine animals  and 
(1)either  [are of the ARR/ARR prion protein genotype;]  
(1)or [carry at least one ARR allele;]]  
II.3. The oocytes(1)/ embryos(1) described in Part I are intended for artificial reproduction and were 
obtained from the donor animals which  
II.3.1. have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.3.2. come from establishments  in a Member State or zone thereof, or from establishments 
under official control by the competent authority in a third country or territory, or a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 207  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  
zone thereof  
II.3.2.1. free from infection with Brucella abortus, B. melitensis  and B. suis  and 
have never been kept previously in any establishment of a lower health 
status;  
(1)(3)[II.3.2.2. in which infection with Mycobacterium tuberculosis  complex ( M. bovis, 
M. caprae a nd M. tuberculosis ) has not been reported during the last 42 
days prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)(4)[II.3.2.2. in which surveillance for infection with  Mycobacterium tuberculosis 
complex  (M. bovis, M. caprae and M. tuberculosis) has been  carried out 
on the caprine animals kept on the establishments during at least the last 
12 months prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1), as referred to in Article 15(3) of Delegated Regulation (EU) 
2020/688, and in case, during this period, infection with  Mycobacterium 
tuberculosis complex  (M. bovis, M. caprae and M. tuberculosis) has 
been reported in caprine animals kept on the establishment, measures 
were taken in accordance with Part 1(3) of Annex I I to that Delegated 
Regulation;]  
II.3.2.3. in which surra ( Trypanosoma evansi ) has not been reported during the 
last 30 days prior to  collection(1)/ production(1) of the oocytes(1)/ 
embryos(1), and  
(1)either  [surra has not been  reported in the establishments during the last 2 years 
prior to  collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [surra has been reported in the establishments during the last 2 years 
prior to to  collection(1)/ production(1) of the oocyt es(1)/ embryos(1) and 
following the last outbreak the establishments have remained under 
movement restrictions until  
 the infected animals have been removed from the establishment, and  
 the remaining animals on the establishment have been subjected to a 
test for surra  (Trypanosoma evansi ) with one of the diagnostic 
methods provided for in Part 3 of Annex I  to Delegated  Regulation 
(EU) 2020/ 688, carried out, with negative results, on samples taken 
at least 6 months after the infected animals have been removed from 
the establishment; ] 
II.3.3. were examined by the team veterinarian or its team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of 
collection(1)/ production(1) of the oocytes(1)/ embryos(1);  
II.3.4. are individually identified as provided for in Article 45(2) or (4), or Article 46(1) or 
(3) of Delegated Regulation (EU) 2019/2035;  
II.3.5. for a period of at least 30 days prior to the date of first collection(1)/ production(1) of 
the oocytes(1)/ embryos(1) and during the collection period  
II.3.5.1. were kept on establishments not situated in a restricted zone established 
due to the occurrence of foot -and-mouth disease, infection with 
rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious 
caprine pleuropneumonia or of an emerging disease relevant for the 
ovine and caprine animals;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 208  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  
II.3.5.2. were kept on a single establishment where infection with  Brucella 
abortus, B. mel itensis and B. suis , infection with Mycobacterium 
tuberculosis  complex ( M. bovis, M. caprae and M. tuberculosis ), rabies, 
anthrax,  surra (Trypanosoma evansi), infection with epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotype 1 -
24) and, in case of ovine animals and those caprine animals which are 
kept together with ovine animals, ovine epidydimitis ( Brucella ovis ) 
have not been reported;  
II.3.5.3. were not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.3.5.1. or from establishments which do not meet the conditions 
referred to in point II. 3.5.2.;  
II.3.5.4. were not used for natural breeding;  
II.3.6. comply with the following conditions as regards f oot-and-mouth disease  
II.3.6.1. they come from establishments  
 situated in an area where foot -and-mouth disease has not been 
reported within a 10 -km radius centred on the establishment for a 
period of at least 30 days immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 (1)either  [II.3.6.2. they were  not vaccinated a gainst foot -and-mouth disease;]  
(1)(5)or [II.3.6.2. they were vaccinated  against foot -and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos 
and 
II.3.6.2.1.  have not been vaccinated against foot-and-mouth disease 
within the period of at least 30 days immediately prior to the 
date of collection of the embryos;  
II.3.6.2.2.  the semen used for fertilisation was collected from a male 
donor that complies with the conditions set out in point 1(b) 
or the semen complies with the conditions set out in point 2  
of Chapter I of Part 5 of Annex II to Delegated Regulation 
(EU) 2020 /686; 
II.3.6.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the 
recommendations of the IETS Manual(6); 
II.3.6.2.4.  the embryos were stored deep frozen for a period of at least 
30 days from the date of collection, and during this period 
the donor animal has not shown clinical signs of foot -and-
mouth disease;]  
II.3.7. comply with at least one of the following conditions as regards infection with 
bluetongue virus (serotypes 1 -24): 
(1)either  [II.3.7.1. they have been kept in a Memebr State or zone thereof free from 
infection with bluetongue virus (serotypes 1 -24) for a period of at least This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 209  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  
60 days prior to and during collection of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.7.2. they have been kept in a s easonally disease -free zone, during the 
seasonally disease -free period, for a period of at least 60 days prior to 
and during collection of the oocytes(1)/ embryos(1), in a Memebr State or 
zone thereof with an approved eradication programme against infectio n 
with bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.3.7.3. they have been kept in a seasonally disease -free zone, during the 
seasonally disease -free period, for a period of at least 60 days prior to 
and during collection of the oocytes(1)/ embryos(1), in a Memebr State or 
zone thereof where the competent authority of the place of origin of the 
consignment of oocytes(1)/ embryos(1) has obtained the prior written 
consent of the competent authority of the Member State of destination to 
the conditions for e stablishment of that seasonally disease -free zone and 
to accept the consignment of oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.7.4. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.7.5. they have been subjected to a serological test to detect antibodies to the 
bluetongue virus serogroup 1 -24, with negative results, between 28 and 
60 days from the date of each collection of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.7.6. they have been subjected to an agent identification test for bluetongue 
virus (serotypes 1 -24), with negative results, on blood sample taken on 
the date of collection of the oocytes(1)/ embryos(1);] 
II.3.8. comply with at least one of the following conditions as regards infection with 
epizootic haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.3.8.1. they have been kept for a period of at least 60 days prior to and during 
collection of the oocytes(1)/ emb ryos(1) in a Memebr State or zone thereof 
where EHDV 1 -7 has not been reported for a period of at least the 
preceding 2 years within a radius of 150 km of the establishment;]  
(1)and/or  [II.3.8.2. they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.8.3. were resident in a Memebr State or zone thereof in which according to 
official find ings the following serotypes of EHDV exist: 
………………………… and have been subjected with negative results 
in each case to  the following tests carried out in an official laboratory:  
(1)either  [II.3.8.3.1.  a serological test to detect antibodies to EHDV 1 -7, with 
negative results, on blood sample taken between 28 and 60 
days from the date of the collection of the oocytes(1)/ 
embryos(1);]] 
(1)and/or  [II.3.8.3.2.  an agent identification test for EHDV 1 -7, with  negative 
results, on blood sample taken on the date of collection of the 
oocytes(1)/ embryos(1).]] 
II.4. The oocytes(1)/ embryos(1) described in Part I  
II.4.1. has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to 
Delegated Regulation (EU) 2020 /686; This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 210  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  
II.4.2. are placed in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 
and that mark is indicated in Box I.30;  
II.4.3. are transported in a container which:  
II.4.3.1. was sealed and numbered prior to the dispatch by the embryo collection 
or production team under responsibility of the team veterinarian , or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;  
II.4.3.2. has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.4.3.3. has been filled in with the cryogenic agent which n ot have been 
previously used for other products.  
(1)(7)[II.4.4. are placed in straws or other packages which are securely and hermetically sealed;  
II.4.5. are transported in a container where they are separated from each other by physical 
compartments or b y being placed in secondary protective bags.]  
(1)(8)[II.5. The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by  the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex VIII to Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ].] 
(1)(9)[II.6. The following  antibiotic or mixture of antibiotics(10) has been added to the collection, processing, 
washing or storage media: ……………………………………… ……………………………… …] 
II.7. This certificate is valid  for 10 days from the date of issuing.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond  to the number of containers.  
Box reference I.30:  “Type ”: specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
  “Species ”: select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed.  
“Date of  collection/production ”: indicate the date on which oocytes or embryos of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 211  EN EUROPEAN UNION   Certificate model OV /CAP -OOCYTES -EMB-A-INTRA  
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were co llected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
(3) Applicable for ovine animals . 
(4) Applicable for caprine animals.  
(5) Option available only for  the consignment of  in vivo  derived embryos.  
(6) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emp hasising sanitary procedures, published by the International Embryo 
Transfer Society 1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).  
(7) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of ovine or caprine animals are placed and transported.  
(8) Does  not apply to oocytes.  
(9) Mandatory attestation in case antibiotics were added.  
(10) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 212  EN CHAPTER 34: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF OOCYTES 
AND EMBRYOS OF OVINE  AND CAPRINE ANIMALS COLLECTED OR 
PRODUCED, PROCESSED AND STORED IN ACCORD ANCE WITH DIRECTIVE 
92/65/EEC BEFORE 21 APRIL 2021 AND AF TER 31 AUGUST 2010, AND 
DISPATCHED AFTER 20 APRIL 2021 BY AN EMB RYO COLLECTION OR 
PRODUCTION TEAM BY W HICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘ OV/CAP -OOCYTES -EMB-B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 213  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 214  EN EUROPEAN UNION   Certificate model OV/CAP -OOCYTES -EMB -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)either  [II.1.  the in vivo  derived embryos(1)/in vivo  derived ova(1) described above were collected, 
processed and stored by an embryo collection team(2) approved and supervised in 
accordance with Chapter I(III)(1) of Annex D to Directive 92/65/EEC;]  
(1)or [II.1.  the in vitro  produ ced embryos(1)/micromanipulated embryos(1) described above were 
produced, processed and stored by an embryo production  team(2) approved and 
supervised in accordance with Chapter I(III)(1) and (2) of Annex D to Directive 
92/65/EEC;]  
(1)either  [II.2.  the in vivo derived embryos described above meet the requirements of Chapter III(II)(1) 
of Annex D to Directive 92/65/EEC;]  
(1)or [II.2.  the in vivo  derived ova described above meet the requirements of Chapter III(II)(2) of 
Annex D to Directive 92/65/EEC;]  
(1)or [II.2.  the in vitro  produced embryos described above meet the requirements of Chapter 
III(II)(3) of Annex D to Directive 92/65/EEC;]  
(1)or [II.2.  the micromanipulated embryos described above meet the requirements of Chapter 
III(II)(4) of Annex D to Directive 92/65/EEC;]  
 [II.3.  the consignment consists of embryos of the ovine or caprine species which  comply with 
the following conditions as regards classical scrapie : 
 (1)either  [they were collected from animals which have been kept continuously since birth on a 
holding or holdings recognised as having a negligible or a controlled risk of classical 
scrapie in accordance with point 1 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]  
 (1)or [they were collected from animals which ha ve been kept continuously for the last three 
years before the collection on a holding or holdings which have complied for the last 
three years before collection with the requirements laid down in points (a) to (f) of point 
1.3. of Section A of Chapter A of  Annex VIII to Regulation (EC) No 999/2001;]  
 (1)or [they were collected from animals which have been kept continuously since birth in a 
Member State or zone of a Member State with a negligible risk status for classical 
scrapie approved in accordance with the first subparagraph of point 2.2. of Section A of 
Chapter A of Annex VIII to Regulation (EC) No 999/2001 ;] 
 (1)or [they were collected from ovine animals  and 
(1)either  [are of the ARR/ARR prion protein genotype;]  
(1)or [carry at least one ARR allele  and were collected after the date of 1 January 
2015 ;]] 
 II.4. the ova or embryos described above come from female donors of the ovine(1)/caprine 
species(1) which meet the requirements of Chapter IV(3) of Annex D to Directive 
92/65/EEC;  
(1)either  [II.5.  the embryos described above were conceived as a result of artificial insemination of the 
donor females with semen which was collected, processed, stored and transported under 
conditions which comply with the requirements of Chapters I(I), II(I) and III(I) of 
Annex D to Directive 92/65/EEC ;] 
(1)or [II.5.  the embryos described above were conceived as a result of in vitro  fertilisation of ova This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 215  EN EUROPEAN UNION   Certificate model OV/CAP -OOCYTES -EMB -B-INTRA  
complying with the conditions in Chapter III(II)(2) of Annex D to Directive 92/65/EEC 
with semen which was collected, proce ssed, stored and transported under conditions 
which comply with the requirements of Chapters I(I), II(I) and III(I) of Annex D to 
Directive 92/65/EEC;]  
(1)or [II.5.  the ova have not been in contact with semen of the ovine and caprine species ;] 
 II.6. the ova or embryos described above were sent to the place of loading in a sealed 
container in accordance with point 6 of Chapter III(II) of Annex D to Directive 
92/65/EEC and bearing the number detailed in Box I.19.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch shall correspond to the embryo collection team or embryo production team of 
embryos collection/ production.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product storage centre or to the establishment 
of oocytes/embryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  “Type” : specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Identification number shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the team shall correspond to the embryo collection team or embryo production 
team of oocytes/embryos collection/production.  
 
Part II: 
(1) Delete as appropriate.  
(2) Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Directive 92/65/EEC.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 216  EN CHAPTER 35: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF OOCYTES 
AND EMBRYOS OF OVINE  AND CAPRINE ANIMALS COLLECTED OR 
PRODUCED, PROCESSED AND STORED IN ACCORD ANCE WITH DIRECTIVE 
92/65/EEC BEFORE 1 S EPTEMBER 2010, AND D ISPATCHED AFTER 20 A PRIL 
2021 BY AN EMBRYO CO LLECTION OR PRODUCTI ON TEAM BY WHICH THE  
OOCYTES OR EMBRYOS W ERE COLLECTED OR PRO DUCED (MODEL 
‘OV/CAP -OOCYTES -EMB-C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 217  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 218  EN EUROPEAN UNION  Certificate model OV/CAP -OOCYTES -EMB -C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the ova/embryos(1) described above:  
II.1. were collected, processed and stored under conditions which meet the requirements of Directive 
92/65/EEC;  
II.2. come from female donors of the ovine/caprine sp ecies(1) which meet the requirements of Chapter IV of 
Annex D to Directive 92/65/EEC;  
II.3. meet the requirements of Chapter III of Annex D to Directive 92/65/EEC;  
II.4. In the case of embryos, the semen used for fertilisation meets the requirements of Dir ective 92/65/EEC;  
II.5. the consignment consists of embryos of the ovine or caprine species which comply with the following 
conditions as regards classical scrapie:  
 (1)either  [they meet the requirements of Chapter III of Annex D to Directive 92/65/EEC and  of Chapter  A(I) 
of Annex VIII to Regulation (EC) No 999/2001 , as applicable on 31 August 2010 ;] 
 (1)or [they meet the requirements of Chapter III of Annex D to Directive 92/65/EEC and of Chapter  A(I) 
of Annex VIII to Regulation (EC) No 999/2001 , as applic able on 31 August 2010 , and are destined 
for a Member State which benefits, for all or part of its territory, from the provisions laid down in 
point (b) or (c) of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 , as applicable on 31 
August 2010  and the donor animals comply regarding scrapie with the guarantees provided for by 
the programmes referred to in that point and with the guarantees(2) requested by the Member State of 
destination ;] 
 (1)or [In the case of embryos, the semen used for fertilisa tion meets the requirements of Directive 
92/65/EEC and the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 , as 
applicable on 31 August 2010 ;] 
 (1)or [In the case of embryos, the semen used for fertilisation meets the requirements of Directive 
92/65/EEC and the requirements of Chapter A(I) of Annex VIII to Regulation (EC) No 999/2001 , as 
applicable on 31 August 2010 , and is destined for a Member State which benefits, for all or part of 
its territory, from the provisions laid down in point (b) or (c) of Chapter A(I) of Annex VIII to 
Regulation (EC) No 999/2001 , as applicable on 31 August 2010 , and the donor animals com ply 
regarding scrapie with the guarantees provided for by the programmes referred to in that point and 
with the guarantees(2) requested by the Member State of destination .] 
 
Notes  
Guidance on the completion of this official certificate is available in Chap ter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD SANTE/7086/2020] . 
 
Part I:  
 
Box I.11:  Place of dispatch shall correspond to the embryo collection team of oocytes/embryos collection.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team, 
germinal product processing establishment, germinal product storage centre or to the establishment of 
ova/embryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.3 0: ”Type” : specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Identification number shall correspond to the official identification of the animal.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 219  EN EUROPEAN UNION  Certificate model OV/CAP -OOCYTES -EMB -C-INTRA  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the team shall correspond to the embryo collection team of oocytes/embryos 
collection indicated in Box I.11.  
 
Part II:  
(1) Delete as appropriate.  
(2) Additional guarantees as laid down in Article 2 of R egulation (EC) No 546/2006 [OJ L 94, 1.4.2006, 
p. 28]. 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 220  EN CHAPTER 36: MODEL OFFICIAL CER TIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF : 
- semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 1 September 2010;  
- oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 
2021  
- stocks of oocytes and emb ryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of ovine and caprine animals collected or produced, p rocessed and 
stored in accordance with Council Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
PROCESSING ESTABLISH MENT  (MODEL ‘ OV/CAP -GP-PROCESSING -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 221  EN  Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 222  EN EUROPEAN UNION  Certificate model OV/CAP -GP-PROCESSING -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were 
processed and stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Pa rt 4 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated 
embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in the Member State of its/their collection or production under an imal health certification 
requirements at least as strict as those provided for in:  
(2)either  [Model OV/CAP -SEM -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -C-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model OV/CAP -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Ann ex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in another Member State accompanied by certificate(s) in accordance with:  
(2)either  [Model OV/CAP -SEM -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -C-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model OV/CAP -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -INTRA (4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3 ), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 223  EN EUROPEAN UNION  Certificate model OV/CAP -GP-PROCESSING -INTRA  
centre(2)(3) situated in a third country, territory or zone thereof listed in Annex VIII to 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] and complying with requirements as 
regards responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 
2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  enter ed the 
Union accompanied by certificate(s) in accordance with:  
(2)either  [Model OV/CAP -SEM -A-ENTRY(4) ;] 
(2)and/or  [Model OV/CAP -SEM -B-ENTRY(4);] 
 (2)and/or  [Model OV/CAP -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model OV/CAP -OOCYTES -EMB -B-ENTRY(4);] 
(2)and/or  [Model OV/CAP -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -ENTRY(4);]] 
II.2.2. has been collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3. are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or Article 
83(a) of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4. are transported in a container which:  
II.2.4.1. was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(5)[II.2. 5. are placed in straws or other packages which are securely and hermetically sealed;  
II.2.6. are transported in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
II.3. This certificate is valid for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD SANTE/7086/2020] . 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved b y the competent authority and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
Box reference I.12:  “Place of destination:  Indicate the address and unique registration  or approval number 
of the establishment of destination of the consignment of semen, oocytes, and/or 
embryos.  
Box reference I.17:  “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual  official document(s) or health This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 224  EN EUROPEAN UNION  Certificate model OV/CAP -GP-PROCESSING -INTRA  
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/o r embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germ inal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species” : indicate “ Ovis aries ” and/or “ Capra hircus ” as appropriate.  
“Identification number” : Indicate identification number of each donor animal.  
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consign ment are placed.  
“Date of  collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval nu mber of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity” : Indicate number of straws or other packages with the same mark . 
 
Part II:  
(1) Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collec tion or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the  semen, oocytes 
or embryos were stored to the germinal product processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(5) Applicable for the consignment where in one container seme n, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 225  EN EUROPEAN UNION  Certificate model OV/CAP -GP-PROCESSING -INTRA  
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 226  EN CHAPTER 37: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OFCONSIGNMENTS OF:  
- semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 1 September 2010;  
- oocytes and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020 /686 after 20 April 
2021  
- stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2 021 and after 31 August 2010;  
- stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL  PRODUCT 
STORAGE CENTRE  (MODEL ‘ OV/CAP -GP-STORAGE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 227  EN  Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 228  EN  
EUROPEAN UNION  Certificate model OV/CAP -GP-STORAGE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with r equirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ microma nipluated 
embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirem ents as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product storage centre indi cated in Box I.11. situated in the 
Member State of its/their collection or production under animal health certification requirements 
at least as strict as those provided for in:  
(2)either  [Model OV/CAP -SEM -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -C-INTRA(4);] 
(2)and/or  [Model in Part A of Annex III to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Part B of Annex III to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Part C of Annex III to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Decision  95/388/EC(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model OV/CAP -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures , facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product storage centre indicated in Box I.11. situated in another 
Member State accompanied by certificate(s) in accordance with:  
(2)either  [Model OV/CAP -SEM -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -SEM -C-INTRA(4);] 
 (2)and/or  [Model in Part A of Annex III to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Part B of Annex III to Decision 2010/470/EU(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 229  EN EUROPEAN UNION  Certificate model OV/CAP -GP-STORAGE -INTRA  
(2)and/or  [Model in Part C of Annex III to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Decision  95/388/EC(4);] 
 (2)and/or  [Model OV/CAP -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model OV/CAP -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model OV/CAP -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in a third country, territory or zone thereof listed in Annex VIII to 
Implementing Regulation (EU) 2020/xx [SANTE/7140/2020 ] and complying with requirements as 
regards responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 
2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  entered the 
Union accompanied by certificate(s) in accordance with:  
(2)either  [Model OV/CAP -SEM -A-ENTRY(4);] 
(2)and/or  [Model OV/CAP -SEM -B-ENTRY(4);] 
 (2)and/or  [Model 1 in Section A of Part 2 of Annex II to Decision 2010/472/EU(4);] 
(2)and/or  [Model 2 in Section B of Part 2 of Annex II to Decision 2010/472/EU(4);] 
 (2)and/or  [Model in Annex II to Decision 2008/635/EC(4);] 
(2)and/or  [Model OV/CAP -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model OV/CAP -OOCYTES -EMB -B-ENTRY(4);] 
(2)and/or  [Model OV/CAP -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -ENTRY(4);]] 
II.2.2. has been collected, processed and stored in accordance with animal heal th requirements set out in 
Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3. are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or Article 
83(a) of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4. are transported in a container which:  
II.2.4.1. was sealed and numbered prior to the dispatch by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3. has been f illed in with the cryogenic agent which not have been previously used for 
other products;  
(2)(5)[II.2. 5. are placed in straws or other packages which are securely and hermetically sealed;  
II.2.6. are transported in a container where they are separated from  each other by physical compartments 
or by being placed in secondary protective bags.]  
II.3. This certificate is valid for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD SANTE/7086/2020] . This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 230  EN EUROPEAN UNION  Certificate model OV/CAP -GP-STORAGE -INTRA  
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate the unique approval number and the name and address of 
the germinal produ ct storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Arti cle 7 of Delegated Regulation (EU) 2020 /686. 
Box reference I.12:  “Place of destination”:  Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference  I.17:  “Accompanying documents” : Number(s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embr yos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the offi cially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species” : indicate “ Ovis aries ” and/or “ Capra hircus ” as appropriate.  
“Identification number” : Indicate identification number of ea ch donor animal.  
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production”: Indicate the date on which semen, oocytes and/or 
embryos of the consig nment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team  by which the oocytes or embryos 
were collected or produced.  
“Quantity” : Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
registe r referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 231  EN EUROPEAN UNION  Certificate model OV/CAP -GP-STORAGE -INTRA  
accompanied the semen,  oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing estab lishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
describe d in Box I.11 must be attached to this certificate.  
(5) Applicable for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 232  EN CHAPTER 38: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF SEME N OF PORCINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED R EGULATION (EU) 2020 /686 
BEFORE 21 APRIL 2021 , AND DISPATCHED FROM A SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED  (MODEL ‘POR -SEM -A-
INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 233  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 234  EN EUROPEAN UNION   Certificate model POR -SEM -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen of porcine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020 /686. 
II.2. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accorda nce with the requirements for entry into the Union;  
II.2.2.  come, before the commencement of the quarantine referred to in point II.2.8., from 
establishments  in a Member State or zone thereof, or from establishments under official 
control by the competent authority in a third country or territory, or a zone thereof  
II.2.2.1.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the establishment for a period of at least 30 days and 
in which foot -and-mouth d isease has not been reported during a period of at 
least 3 months, and  
 (2)either  [they were  not vaccinated against foot -and-mouth disease;]  
(2)or [they were vaccinated against foot -and-mouth disease during the period of 12 
months prior to the date of col lection of the semen but not during the period of 
the last 30 days immediately prior to the date of collection  of the semen, and 5 
% (with a minimum of five straws) of each quantity of semen taken from a 
donor animal at any time is submitted to a virus iso lation test for foot -and-
mouth disease with negative results;]  
II.2.2.2.  free from infection with Brucella abortus, B. melitensis  and B. suis  in 
accordance with the requirements laid down in Chapter IV of Part 5 of Annex 
II to Delegated Regulation (EU) 2020 /686; 
II.2.2.3.  where no clinical, serological, virological or pathological evidence of infection 
with Aujeszky’s disease virus had been det ected during the period of at least 12 
months;  
II.2.2.4.  where, during the period of at least 3 months, no animal was vaccinated against 
infection with porcine reproductive and respiratory syndrome virus and no 
infection with porcine reproductive and respi ratory syndrome virus was 
detected;  
II.2.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.2.4.  are identified as provided f or in Article 52 or 54(2) of Delegated Regulation (EU) 
2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection of the semen  and during 
the collection period  
II.2.5.1.  were kept on establishments not situated in a restrict ed zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
classical swine fever and African swine fever or of an emerging disease 
relevant for the porcine animals;  
II.2.5.2.  were kept on a single establishment wh ere infection with  Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax,  infection with 
Aujeszky’s disease virus and infection with porcine reproductive and This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 235  EN EUROPEAN UNION   Certificate model POR -SEM -A-INTRA  
respiratory syndrome virus have not been reported;  
II.2.5.3.  were not in contact with animals from establishments situated in a restricted 
zone due to the occurrence of diseases referred to in point II.2.5.1. or from 
establishments which do not meet the conditions referred to in point II.2.5.2.;  
II.2.5.4.  were not used for n atural breeding;  
II.2.6.  have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health 
status were present, which on the day of their admission to the semen collection centre 
complied with the following conditions:  
II.2.6.1.  it was not situated in a restricted zone established due to diseases referred to in 
point II.2.5.1.;  
II.2.6.2.  none of the diseases referred to in point II.2.5.2. has been reported f or a period 
of at least 30 days;  
II.2.6.3.  it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;  
II.2.6.4.  has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;  
II.2.6.5.  it was free from infection with Brucella abortus, Brucella melitensis and 
Brucella suis  for the period  of at least the preceding 3 months ; 
II.2.7.  were kept in the semen collection centre  
II.2.7.1.  which was not situated in a restricted zone established due to diseases referred 
to in point II.2.5.1.;  
II.2.7.2.  where none of the diseases referred to in poin t II.2.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and  
(2)(3)[at least 30 days following the date of the collection;]  
(2)(4)[until the date of dispatch of the consignment of semen to another Member 
State;]  
II.2.7.3.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and  
(2)(3)[free from foot -and-mouth disease for a period of at least 3 m onths prior to the 
date of collection of the semen and 30 days from the date of collection;]  
(2)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the 
consig nment of semen to another Member State and the donor animals has 
been kept at that semen collection centre for a continuous period of at least 30 
days immediately prior to the date of collection of the semen;]  
II.2.7.4.  where no clinical, serological, viro logical or pathological evidence of infection 
with Aujeszky’s disease virus had been reported for a period comprising at 
least 30 days prior to the date of admission and at least 30 days immediately 
prior to the date of collection of the semen;  
II.2.8.  have been subjected to the following tests, carried out within the period of 30 days prior to 
the commencement of the quarantine referred to in point II.2.6., with negative results, 
required in accordance with point 1(b) of Chapter I of Part 2 of Annex II to Delegated 
Regulation (EU) 2020 /686: 
II.2.8.1.  as regards infection  with Brucella abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 236  EN EUROPEAN UNION   Certificate model POR -SEM -A-INTRA  
ELISA for the detection of antibodies to smooth Brucella  species;  
II.2.8.2.  as regards infection with Aujeszky’s disease virus  
(2)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]  
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
(2)[II.2.8.3.  as regards classical swine fever, an antibody ELISA  or serum neutralisation 
test, in case of animals coming from a Member State or zone thereof where 
classical swine fever has been reported or vaccination against this disease has 
been practiced for the period of the preceding 12 months;]  
II.2.8.4.  as regar ds infection with porcine reproductive and respiratory syndrome virus, 
a serological test (the immunoperoxidase monolayer assay (IPMA), 
immunofluorescence assay (IFA), or ELISA);  
II.2.9.  have been subjected to the following tests, carried out on samples ta ken within a period of at 
least 21 days from the date of commencement of the quarantine referred to in point II.2.6., 
with negative results, required in accordance with point 1(c) of Chapter I of Part 2 of Annex 
II to Delegated Regulation (EU) 2020 /686: 
II.2.9.1.  as regards infection  with Brucella abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella  species;  
II.2.9.2.  as regards infection with Aujeszky’s disease virus  
(2)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisati on test;]  
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
(2)[II.2.9.3.  as regards classical swine fever, an antibody ELISA or serum neutralisation 
test, in case of animals coming from a Member State or zone thereof where 
classical swine fever has not been reported and vaccination against this disease 
has not been practiced for the period of the preceding 12 months;]  
II.2.9.4.  as regards infection with po rcine reproductive and respiratory syndrome virus, 
a serological test (IPMA, IFA, or ELISA) and a test for virus genome (reverse -
transcription polymerase chain reaction (RT -PCR), nested set RT -PCR, real -
time RT -PCR);  
II.2.10.  have been subjected, at semen collection centre, to the following compulsory routine tests, 
required in accordance with point 2(a) of Chapter I of Part 2 of Annex II to Delegated 
Regulation (EU) 2020 /686: 
II.2.10.1.  as regards infection  with Brucella abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella  species;  
II.2.10.2.  as regards infection with Aujeszky’s disease virus  
(2)[in the case of non -vaccinated anim als, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]  
(2)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to 
detect antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
II.2.10.3.  as regards classical swine fever, an antibody ELISA or serum neutralisation 
test; This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 237  EN EUROPEAN UNION   Certificate model POR -SEM -A-INTRA  
II.2.10.4.  as regards infection with porcine reproductive and respiratory syndrome virus, 
a serological test (IPMA, IFA, or ELISA);  
II.2.11.  have been subjected to the tests referred to in point II.2.10. carried out, in accordance with 
point 2(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020 /686 , on 
samples taken from:  
 (2)either  [all animals immediately prior to leaving the semen collection centre, or upon arrival at the 
slaughterhouse, and in no case later than 12 months from the date of admission to the semen 
collection centre.]  
(2)or [at least 25 % of the animals in the semen collection centre every 3 months to test for 
infection with Brucella abortus, Brucella melitensis and Brucella suis , infection with 
Aujeszky’s disease virus and classical swine fever and from at least 10 % of the animals in 
the semen collection centre every month to test for infection with porcine reproductive and 
respiratory syndrome virus.]  
(2)or [at least 10  % of the animals in the semen collection centre every month to test for infection 
with Brucella abortus, Brucella melitensis and Brucella suis , infection with Aujeszky’s 
disease virus, classical swine fever and infection with porcine reproductive and respiratory 
syndrome virus.]  
II.3. The semen described in Part I  
II.3.1.  has been collected, processed and sto red in accordance with animal health requirements set 
out in points 1 and 2 of Part 1  of Annex III to Delegated Regulation (EU) 2020 /686; 
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided f or in Article 10 of Delegated Regulation (EU) 2020 /686 and that 
mark is indicated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of th e centre veterinarian, or by an official veterinarian, 
and the seal bears the number as indicated in Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.3.3.3.  has been filled in with the cr yogenic agent which not have been previously 
used for other products.  
II.4. The semen is preserved by the addition of antibiotics as follows:  
II.4.1.  The following  antibiotic or mixture of antibiotics,  effective in particular against leptospires, has 
been added to the semen after final dilution, or is contained in the used semen diluents, to reach 
the indicated concentration per ml of semen:  
(2)either  [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(2)or [a mix ture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (2)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(2)or [an antibiotic  or a mixture of antibiotics(5) …………………………………………………, with a 
bactericidal activi ty at least equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and diveka cin (25 μg).]  
II.4.2.  Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C or 15°C for a period of not less than 45 minutes, 
or under a time-temperature regime with  a documented equivalent bactericidal activity.  
II.5. This certificate is valid  for 10 days from the date of issuing.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 238  EN EUROPEAN UNION   Certificate model POR -SEM -A-INTRA  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I toImplementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: semen.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where semen of 
the consignment is placed.  
“Date of  collection/production ”: indicate the date on which semen of the consignment 
was collected.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
(2) Delete if not applicable.  
(3) Applicable for frozen semen . 
(4) Applicable for fresh and chilled semen.  
(5) Insert  the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 239  EN CHAPTER 39: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF  STOCKS OF SEMEN OF 
PORCINE ANIMALS COLLECTED, PROCESSED  AND STORED IN 
ACCORDANCE WITH DIRE CTIVE 90/429/EEC BEF ORE 21 APRIL 2021, A ND 
DISPATCHED AFTER 20 APRIL 2021 FROM A SE MEN COLLECTION CENTR E 
WHERE THE SEMEN WAS COLLECTED (MODEL ‘PO R-SEM -B-INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 240  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 241  EN EUROPEAN UNION   Certificate model POR -SEM -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the semen described above was:  
II.1. collected, processed and stored in a semen collection centre(1) approved and supervised by 
the competent authority in accordance with Chapter I and Chapter  II of Annex A to 
Directive 90/429/EEC;  
 (2)either  [II.2.  collected in a semen collection centre which only contains animals that have not been 
vaccinated against Aujeszky's disease and meet the requirements of Annex B to Directive 
90/429/EEC;]  
(2)(3)and/or [II.2.   collected in a semen collection centre in  which some or all of the animals have been 
vaccinated against Aujeszky's disease using a gE deleted vaccine  and meet the requirements 
of Annex B to Directive 90/429/EEC;]  
II.3. collected, processed, stored and transported under conditions which comply wit h the 
standards laid down in Annex C to Directive 90/429/EEC.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch  shall correspond to the semen collection centre of the semen dispatch.  
Box I.12:  Place of destination  shall correspond to the semen collection centre, germinal product processing 
establishment, germinal product storage centre or to the stablishmen t of semen destination.  
Box I.19:  Identification of container  and Seal number shall be indicated.  
Box I.30:  Identification number  shall include the official identification mark of the animal in accordance with 
Council Directive 2008/71/EC of 15  July 2008 o n the identification and registration of pigs ( OJ L 213, 
8.8.2008, p. 31. ) 
 Date of collection  shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the centre  shall correspond to the approval number of the semen centre where the 
seme n was collected.  
 
Part II:  
 (1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
5(2) of Council Directive 90/429/EEC.  
(2) Delete as appropriate.  
(3) This option must be deleted in case the Member State, or a region thereof, of destination is free of 
Aujeszky’s disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission 
in accordance with point 4 of Annex C to Directive 90 /429/EEC and is listed on the following website: 
http://ec.europa.eu/food/animal/semen_ova/porcine/index_en.htm  . 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 242  EN EUROPEAN UNION   Certificate model POR -SEM -B-INTRA  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 243  EN CHAPTER 40: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF OOCY TES AND 
EMBRYOS OF PORCINE A NIMALS COLLECTED OR PRODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH REGULATION  (EU) 2016/429 AND 
DELEGATED REGULATION  (EU) 2020/ 686 AFTER 20 APRIL 2021 , AND 
DISPATCHED BY AN EMB RYO COLLECTION OR PR ODUCTION TEAM BY 
WHICH THE OOCYTES OR  EMBRYOS WERE COLLECT ED OR PRODUCED  
(MODEL ‘ POR -OOCYTES -EMB -A-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for 
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 244  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 245  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)[II.1.  The in vivo  derived embryos of porcine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requiremen ts as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 
2020 /686.] 
(1)[II.1.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) of porcine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements  as regards responsibilit ies, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020 /686.] 
II.2. The oocytes(1)/ embryos(1) described in Part I are intended for artificial reproduction and were 
obtained from the donor  animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
(1)(3)[II.2.2.  come from a Member State or zone thereof which is free from infection with 
Aujeszky’s disease virus or where an approved eradication programme for infection 
with Aujeszky’s disease virus is carried out;]  
II.2.3.  come from establishments  in a Member State or zone thereof, or from establishments 
under official control by the compet ent authority in a third country or territory, or a 
zone thereof  
II.2.3.1.  in which infection  with Brucella abortus, B. melitensis  and B. suis  in 
porcine animals has not been reported during the last 42 days prior to 
collection of the oocytes(1)/ embryos(1), and in which during at least the 
last 12 months prior to collection of the oocytes(1)/ embryos(1)  
(1)either  [II.2.3.2.1.  biosecurity  and risk mitigating measures set out in Article 
19(1)(f)(i) of Delegated Regulation 2020/ 688 have been 
introduced;  
(1)and/or  [II.2.3.2.2.  surveillance  for infection with  Brucella abortus, B. melitensis 
and B. suis has been  carried out on the porcine animals kept 
on the establishments in accordance with Article 19(1)(f)(ii) 
of Delegated Regulation 2020/ 688;] 
II.2.3.2.  wher e no clinical, serological, virological or pathological evidence of 
infection with Aujeszky’s disease virus had been detected during the 
period of at least 12 months prior to collection of the oocytes(1)/ 
embryos(1). 
II.2.4.  were examined by the team veter inarian or its team member and did not show 
symptoms or clinical signs of transmissible animal diseases on the day of collection 
of the oocytes(1)/ embryos(1);  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 246  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -A-INTRA  
II.2.5.  are identified as provided for in Article 52 or 54(2) of Delegated Regulation (EU) 
2019/2035;  
II.2.6.  for a period of at least 30 days prior to the date of first collection of the oocytes(1)/ 
embryos(1) and during the collection period ;  
II.2.6.1.  were kept on establishments not situated in a restricted zone established 
due to the occurr ence of foot -and-mouth disease, infection with 
rinderpest virus, classical swine fever and African swine fever or of an 
emerging disease relevant for the porcine animals;  
II.2.6.2.  were kept on a single establishment where infection with  Brucella 
abortus, B. melitensis and B. suis , infection with rabies virus, anthrax,  
infection with Aujeszky’s disease virus and infection with porcine 
reproductive and respiratory syndrome virus  have not been reported;  
II.2.6.3.  were not in contact with animals from establis hments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.6.1. or from establishments which do not meet the conditions 
referred to in point II.2.6.2.;  
II.2.6.4.  were not used for natural breeding;  
II.2.7.  comply with the following conditions as regards foot -and-mouth disease  
II.2.7.1.  they come from establishments  
 situated in an area where foot -and-mouth disease has not been 
reported within a 10 -km radius centred on the establishment for a 
period of at least 30 days immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a 
period of at least 3 months immediately prior to the date of collection 
of the oocytes(1)/ embryos(1); 
 (1)either  [II.2.7.2.  they were  not vaccinated against foot -and-mouth disease;]  
(1)(4)or [II.2.7.2.  they were vaccinated  against foot -and-mouth disease during the period 
of 12 months prior to the date of collection or production of the embryos 
and 
II.2.7.2.1.  have not been vaccinated against foot -and-mouth disease 
within the period of at least 30 days immediately prior to the 
date of collection of the embryos;  
II.2.7.2.2.  the semen used for fertilisation was collected from a male 
donor that complies with the conditi ons set out in point 1(b) 
or the semen complies with the conditions set out in point 2  
of Chapter I of Part 5 of Annex II to Delegated Regulation 
(EU) 2020 /686; 
II.2.7.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out i n accordance with the 
recommendations of the IETS Manual(5); 
II.2.7.2.4.  the embryos were stored deep frozen for a period of at least 
30 days from the date of collection, and during this period 
the donor animal has not shown clinical signs of foot -and-This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 247  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -A-INTRA  
mout h disease;]  
(1)(6)[II.2.8.  were subjected to a serological test for infection with porcine reproductive and 
respiratory syndrome virus, with negative results, on two occasions, at an interval of 
not less than 21 days, the second test being performed within  a period of 15 days 
prior to embryo collection.]  
II.3. The oocytes(1)/ embryos(1) described in Part I  
II.3.1.  has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to 
Delegated Regulation (EU) 2020 /686; 
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 
and that mark is ind icated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch by the embryo collection 
or production team under responsibility of the team veterinarian, or by 
an official veterinarian, and the sea l bears the number as indicated in 
Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.3.3.3.  has been filled in with the cryogenic agent which not have been 
previously used for other produc ts; 
(1)(7)[II.3.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.3.5.  are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
(1)(8)[II.4.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by  the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex IX to Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ].] 
(1)(9)[II.5. The following  antibiotic or mixture of antibiotics(10) has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]  
II.6. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo co llection or production team of dispatch of the consignment of oocytes or 
embryos.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 248  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -A-INTRA  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond  to the number of containers.  
Box reference I.30:  “Type ”: specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed.  
“Date of  collection/production ”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
(3) Not applicable for in vivo  derived embryos subject to trypsin treatment. 
(4) Option available only for  the consignment of  in vivo  derived embryos.  
(5) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society 1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).  
(6) Applicable for in vivo  derived embryos.  
(7) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of porcine animals are placed and transported.  
(8) Does  not apply to oocytes.  
(9) Mandatory attestation in case antibiotics were added.  
(10) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 249  EN CHAPTER 41: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF  STOCKS OF  OOCYTES 
AND EMBRYOS OF PORCI NE ANIMALS COLLECTED  OR PRODUCED, 
PROCESSED AND STORED  IN ACCORDANCE WITH D IRECTIVE 92/65/EEC 
BEFORE 21 APRIL 2021  AND AFTER 31 AUGUST 2010, AND DISPATCHED  
AFTER 20 APRIL 2021 BY AN EMBRYO COLLECT ION OR PRODUCTION TE AM 
BY WHICH  THE OOCYTES OR EMBRY OS WERE COLLECTED OR  PRODUCED  
(MODEL ‘ POR -OOCYTES -EMB -B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 250  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 251  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the ova/embryos(1) described above:  
II.1. were produced/collected(1), processed and stored by an embryo collection/production(1) 
team(2) approved and supervised in accordance with Chapter I(III) of Annex D to 
Directive 92/65/EEC;  
II.2. meet the requirements of Chapter III(II) of Annex D to Directive 92/65/EEC;  
II.3. come from donor females of the porcine species which meet the requirements of 
Chapter  IV(2) of Annex D to Directive 92/65/EEC;  
(1)either  [II.4.  are in vivo  derived embryos which:  
II.4.1.  were conceived as a result of artificial insemination with semen meeting the 
requirements of Directive 90/429/EEC,  
II.4.2.  originate from a Member State or r egion thereof:  
(1)either  [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC;]  
(1)or [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or re gion thereof not listed in Annex I or II to Decision 2008/185/EC;]  
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and  have 
been washed with trypsin; ] 
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex II to Decision 2008/185/EC;]  
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof listed in Annex I or II to Decision 
2008/185/EC and have been washed with trypsin; ] 
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof not listed in Annex I or II to Decision 
2008/185/EC;];]  
(1)or [II.4.  are in vitro  produced/micromanipulated(1) embryos which:  
II.4.1.  were conceived as a result of in vitro  fertilisation with semen meeting the 
requirements of Directive 90/429/EEC,  
II.4.2.  originate from a Member State or region thereof:  
(1)either  [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC;]  
(1)or [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof not listed in Annex I or II to Decision 2008/185/EC;]  
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and the 
donor females of the ova used for their production comply w ith the conditions 
of Article 1 of Decision 2008/185/EC; ] 
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex II to Decision 2008/185/EC;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 252  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -B-INTRA  
(1)or [not listed in Annex I or II to Decision 20 08/185/EC and are destined for a 
Member State or region thereof listed in Annex I or II to Decision 
2008/185/EC and the donor females of the ova used for their production 
comply with the conditions of Article 1 of Decision 2008/185/EC; ] 
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof not listed in Annex I or II to Decision 
2008/185/EC;]]  
(1)or [II.4.  are in vivo  derived ova which originate from a Member State or region thereof:  
(1)either  [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC;]  
(1)or [listed in Annex I to Decision 2008/185/EC and are destined for a Member 
State or region thereof not listed in An nex I or II to Decision 2008/185/EC;]  
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex I to Decision 2008/185/EC and which 
come from donor females complying with the conditions of Artic le 1 of 
Decision 2008/185/EC; ] 
(1)or [listed in Annex II to Decision 2008/185/EC and are destined for a Member 
State or region thereof listed in Annex II to Decision 2008/185/EC;]  
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are destined for a 
Member State or region thereof listed in Annex I or II to Decision 
2008/185/EC and which come from donor females complying with the 
conditions of Article 1 of Decision 2008/185/EC; ] 
(1)or [not listed in Annex I or II to Decision 2008/185/EC and are d estined for a 
Member State or region thereof not listed in Annex I or II to Decision 
2008/185/EC;]]  
II.5. were sent to the place of loading in a sealed container under conditions complying 
with point  6 of Chapter III(II) of Annex D to Directive 92/65/EEC a nd bearing the 
number detailed in Box I.23.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch shall correspond to the embryo collection team or embryo production team of 
oocytes/embryos collection/production.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team,  
germinal product processing establishment, g erminal product storage centre or to the establishment 
of oocytes/embryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  “Type ”: specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Identification number shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the team shall correspond to the embryo collection team or embryo production This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 253  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -B-INTRA  
team of ova/embryos collection/production indicated in Box I.11.  
 
Part II:  
(1) Delete as appropriate.  
(2) Only embryo collection or production teams approved by the competent authority and listed in 
accord ance with Article 11(4) of Council Directive 92/65/EEC.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 254  EN CHAPTER 42: MODEL OFFICIAL CER TIFICATE FOR  THE MOVEMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF  STOCKS OF OOCYTES 
AND EMBRYOS OF PORCI NE ANIMALS COLLECTED  OR PRODUCED, 
PROCESSED AND STORED  IN ACCORDANCE WITH D IRECTIVE 92/65/EEC 
BEFORE 1 SEPTEMBER 2 010 AND DISPATCHED A FTER 20 APRIL 2021 B Y AN 
EMBR YO COLLECTION OR PRO DUCTION TEAM BY WHIC H THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (M ODEL ‘ POR -OOCYTES -
EMB -C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 255  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 256  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The ova/embryos(1) described above:  
II.1.1.  were collected, processed and stored under conditions which meet the requirements of 
Directive 92/65/EEC;  
II.1.2.  come from donor female swine which meet the requirements of Chapter IV of Annex D 
to Directive 92/65/EEC;  
II.1.3.  meet the requirements of Chapter III of Annex D to Directive 92/65/EEC.  
(1)either  [II.2.  In the case of embryos,  
II.2.1.  the semen used for fertilisation meets the requirements of Directive 90/429/EEC;  
II.2.2.  the embryos have been washed with trypsin(2).] 
(1)or [II.2.  In the case of ova, the ova comes from a donor female sw ine which meets the 
conditions of Article 1 of Decision 2008/185/EC(2).] 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11: Place of destination shall correspond to the embryo collection team of oocytes/embryos collection.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team,  
germinal product processing establishment, germinal product storage centre or to the establishment of 
oocytes/embryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  “Type”: specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Identification number shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the team shall correspond t o the embryo collection team of oocytes/embryos 
collection indicated in Box I.11.  
 
Part II:  
(1) Delete as appropriate.  
(2) This condition applies only to ova and embryos which originate in the Member States or regions thereof 
not listed in Annexes I and II  to Decision 2008/185/EC (OJ L 59, 4.3.2008, p. 19) and destined to the 
Member States or regions thereof so listed. It shall also apply to movements from Member States or 
regions thereof listed in Annex II of Decision 2008/185/EC to Member States or region s thereof listed in 
Annex I of Decision 2008/185/EC.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 257  EN EUROPEAN UNION   Certificate model POR -OOCYTES -EMB -C-INTRA  
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 258  EN CHAPTER 43: MODEL OFFICIAL CER TIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF : 
- semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of semen of porcine animals colle cted, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;  
- oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/686 after 20 April 2021 ; 
- stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
PROCESSING ESTABLISH MENT (MODEL ‘ POR -GP-PROCESSING -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 259  EN I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 260  EN EUROPEAN UNION   Certificate model POR -GP-PROCESSING -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishmment(1) described in Box I.11. at which the semen(2)/ 
oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) 
was/were processed and stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated 
embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embr yo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in the Member State of its/their collection or production under animal health certification 
requirements at least as strict as those provided for in:  
(2)either  [Model POR -SEM -A-INTRA(4);] 
(2)and/or  [Model POR -SEM -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  POR -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model POR -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product processing establishment indicated in Box I.11. situated 
in another Member State accompanied by certificate(s) in ac cordance with:  
(2)either  [Model POR -SEM -A-INTRA(4);] 
(2)and/or  [Model POR -SEM -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  POR -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -INTRA(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 261  EN EUROPEAN UNION   Certificate model POR -GP-PROCESSING -INTRA  
(2)and/or  [Model POR -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in a third country, territory or zone thereof listed in Annex IX to Commission 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] and complying with requirements as 
regards responsibilities, operational procedures, facilities and equipment set out in Part 1(2)/Part 
2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 202 0/686, and  entered the 
Union accompanied by certificate(s) in accordance with:  
(2)either  [Model POR -SEM -A-ENTRY(4);] 
(2)and/or  [Model POR -SEM -B-ENTRY(4);] 
(2)and/or  [Model POR -OOCYTES -EMB -ENTRY(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model  POR -GP-STORAGE -ENTRY(4);]] 
II.2.2.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or Article 
83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4. are transported  in a container which:  
II.2.4.1.  was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.4.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(5)[II.2.5.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.6.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
II.3. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ] 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishments 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 262  EN EUROPEAN UNION   Certificate model POR -GP-PROCESSING -INTRA  
Box reference I.12 : “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17 : “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal produ ct 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19 : Seal number shall be indicated.  
Box referenc e I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification numbers ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
Part II:  
(1) Only germinal product processing establishments approved by th e competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product processing esta blishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(5) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipu lated embryos of porcine animals are placed and transported.  
 
Official veterinarian  
Name (in capital letters)   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 263  EN EUROPEAN UNION   Certificate model POR -GP-PROCESSING -INTRA  
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 264  EN CHAPTER 44: MODEL OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF : 
- semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020 /686 after 20 April 2021;  
- stocks of semen of porci ne animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;  
- oocytes and embryos of porcine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Re gulation (EU) 2020 /686 after 20 April 2021 ; 
- stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 21 April 2021 and after 31 August 2010;  
- stocks of oocytes and embryos of porcine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
STORAGE ESTABLISHMEN T (MODEL ‘ POR -GP-STORAGE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 265  EN I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 266  EN EUROPEAN UNION   Certificate model POR -GP-STORAGE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020 /686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated 
embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have  been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in  a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out in 
Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020 /686, and  
was/were moved to the germinal product storage centre indicated in Box I.11. situated in the 
Member State of its/their collection or production under animal health certification r equirements 
at least as strict as those provided for in:  
(2)either  [Model POR -SEM -A-INTRA(4);] 
(2)and/or  [Model POR -SEM -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  POR -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model POR -GP-STORAGE -INTRA(4);]] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection 
centre(2)(3)/ by an embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed 
and stored in a germinal product processing establishment(2)(3), and/or stored in a germinal product 
storage centre(2)(3) situated in the Member State of its/their collection or pr oduction and complying 
with requirements as regards responsibilities, operational procedures, facilities and equipment set 
out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 
2020 /686, and  was/were moved to the germinal product storage centre indicated in Box I.11. 
situated in another Member State accompanied by certificate(s) in accordance with:  
(2)either  [Model POR -SEM -A-INTRA(4);] 
(2)and/or  [Model POR -SEM -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  POR -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model POR -OOCTYES -EMB -C-INTRA(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model POR -GP-STORAGE -INTRA(4);]] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 267  EN EUROPEAN UNION   Certificate model POR -GP-STORAGE -INTRA  
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3 ) situated in a third country, territory or zone thereof listed in Annex IX to Commission 
Implementing Regulation (EU) 2020/xx [ IA listing – semen, oocytes or embryos of porcine 
animals ] and complying with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to 
Delegated Regulation (EU) 2020 /686, and  entered the Union accompanied by certificate(s) in 
accordance with:  
(2)either  [Model POR -SEM -A-ENTRY(4);] 
(2)and/or  [Model POR -SEM -B-ENTRY(4);] 
(2)and/or  [Model POR -OOCYTES -EMB -ENTRY(4);] 
 (2)and/or  [Model POR -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model  POR -GP-STORAGE -ENTRY(4);]] 
II.2.2.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020 /686; 
II.2.3.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and/or Article 
83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4.  are transported  in a container which:  
II.2.4.1.  was sealed and numbered prior to the dispatch  by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.4.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(5)[II.2.5.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.6.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
II.3. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ] 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in  the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
Box reference I.12:  “Place of destination” : Indicate the address and unique registration or approval This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 268  EN EUROPEAN UNION   Certificate model POR -GP-STORAGE -INTRA  
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17 : “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I .19: Seal number shall be indicated.  
Box reference I.26: Total number of packages shall correspond to the number of containers.  
Box reference I.30 : “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification numbers ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are p laced.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
Part I I: 
(1) Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020 /686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(5) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived e mbryos, in vitro  
produced embryos and micromanipulated embryos of porcine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 269  EN EUROPEAN UNION   Certificate model POR -GP-STORAGE -INTRA  
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 270  EN CHAPTER 45: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF SEME N OF EQUINE 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED R EGULATION (EU) 2020/686  
BEFROE 21 APRIL 2021 2, AND DISPATCHED FROM A SEMEN COLLECTION 
CENTRE WHERE THE SEM EN WAS COLLECTED  (MODEL ‘EQUI -SEM -A-
INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 271  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 272  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen of equine animals described in Part I has been collected, processed and stored, and dispatched 
from the semen collection centre(1) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Del egated Regulation (EU) 2020 /686. 
II.2. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance  with the requirements for entry into the Union;  
II.2.2.  come, before entering the semen collection centre, from establishments  in a Member State or 
zone thereof, or from establishments under official control by the competent authority in a 
third country o r territory, or a zone thereof  
II.2.2.1.  in which  surra ( Trypanosoma evansi ) has not been reported during the period of the 
preceding 30 days prior to collection of the semen, and  
(2)either  [surra has not been  reported in the establishment during the period of the preceding 2 
years prior to collection of the semen;]  
(2)or [surra has been reported in the establishment during the period of the preceding 2 
years prior to collection of the semen and  following the l ast outbreak the 
establishment has remained under movement restriction  
(2)either  [until the remaining animals in the establishment have been subjected to a 
test for surra with one of the diagnostic methods provided for in Part 3 of 
Annex I to  Delegated Regulation (EU) 2020/ 688, carried out, with negative 
results, on samples taken at least 6 months after the last infected animal has 
been removed from the establishment;]]  
(2)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either killed and destroy ed 
or slaughtered .]] 
II.2.2.2.  in which dourine  has not been reported during the period of the preceding 6 months 
prior to collection of the semen, and  
(2)either  [dourine  has not been reported in the establishment during the period of the 
preceding 2 years prior to collection of the semen;]  
(2)or [dourine has been reported in the establishment during the period of the preceding 2 
years prior to collection of the sem en and following the last outbreak, the 
establishment has remained under movement restriction until  
(2)either  [the remaining equine  animals in the establishment, except castrated male  
equine animals , have been subjected to a test for dourine with the diagn ostic 
method provided for in Part 8 of Annex I to  Delegated Regulation (EU) 
2020/ 688, carried out, with negative results, on samples taken at least 6 
months after the infected animals have been killed and destroyed or 
slaughtered, or the infected entire ma le equine animals have been 
castrated;]]  
(2)or [for at least 30 days after the last equine animal on the establishment was 
either killed and destroyed or slaughtered, and the premises were cleaned 
and disinfected;]]  
II.2.2.3.  in which  equine infectious anaemia has not been reported during the period of the 
preceding 90 days prior to collection of the semen, and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 273  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
(2)either  [equine infectious  anaemia has not been reported on the establishment during the 
period of the preceding 12 months p rior to collection of the semen;]  
(2)or [equine infectious anaemia has been reported on the establishment during the period 
of the preceding 12 months prior to collection of the semen and following  the last 
outbreak the establishment has remained under mov ement restriction until  
(2)either  [the remaining equine  animals in the establishment have been subjected to a 
test for equine infectious anaemia with the diagnostic method provided for 
in Part 9 of Annex I to Delegated Regulation (EU) 2020/ 688, carried out , 
with negative results, on samples taken on two occasions with a minimum 
interval of 3 months after the infected animals have been killed and 
destroyed or slaughtered and the establishment was cleaned and 
disinfected;]]  
(2)or [for at least 30 days after the last equine animal on the establishment was 
either killed and destroyed or slaughtered, and the premises were cleaned 
and disinfected;]]  
II.2.2.4.  in which during  the period of 30 days prior  to the date of collection of the semen no 
equine animal has s hown signs of infection with equine arteritis virus and of 
contagious equine metritis ( Taylorella equigenitalis ); 
II.2.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre an d on the day of collection of the semen;  
II.2.4.  are identified as provided for in Article 58(1), 59(1) or 62(1) of Delegated Regulation (EU) 
2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection of the semen  and during the 
collection period  
II.2.5.1.  were  kept on establishments not situated in a restricted zone established due to the 
occurrence of African horse sickness, infection with Burkholderia mallei  (glanders) 
or of an emerging disease relevant for the equine animals;  
II.2.5.2.  were  kept on a single establishment where Venezuelan equine encephalomyelitis, 
dourine, surra ( Trypanosoma evansi ), equine infections anaemia, infection with 
equine arteritis virus , contagious equine metritis ( Taylorella equigenitalis ), infection 
with rabies virus and anthrax have not been reported;  
II.2.5.3.  were not in contact with animals from establishments situated in a restricted zone due 
to the occurrence of diseases referred to in point II.2.5.1. or from establishm ents 
which do not meet the conditions referred to in point II.2.5.2.;  
II.2.6.  were  not used for natural breeding during a period of at least 30 days prior to the date of first 
semen collection and between the dates of the first sample referred to in points  II.2.7.1., 
II.2.7.2. and/or II.2.7.3. and until the end of the collection period;  
II.2.7.  have  been subjected to the following tests, referred to in point 1(a) of Chapter I of Part 4 of 
Annex II to Delegated Regulation (EU) 2020 /686, as follows:  
II.2.7.1.  for infection  with equine infectious anaemia (EIA), an agar -gel immuno -diffusion 
test (AGID or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with 
a negative result;  
II.2.7.2.  for infection  with equine  arteritis virus  (EVA),  
(2)either  [II.2.7.2.1. a serum neutralisation test with a negative result at a serum dilution of one 
in four;]  
(2)and/or  [II.2.7.2.2. a virus isolation test, polymerase chain reaction (PCR) or real -time PCR 
with a negative result on an aliquot of the entire semen of  the donor 
stallion;]  
II.2.7.3.  for contagious  equine metritis (Taylorella equigenitalis ) (CEM), an agent This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 274  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
identification test carried out on three specimens (swabs) taken from the donor 
stallion on two occasions with an interval of not less than 7 days at least from the 
penile sheath (prepuce), the urethra and the fossa glandis;  
The samples were in no case taken earlier than 7 days (systemic treatment) or 21 
days (local treatment) after antimicrobial treatment of the donor stallion and were 
placed in transp ort medium with activated charcoal, such as Amies medium, before 
dispatch to the laboratory where they were subjected with a negative result to a test 
for: 
(2)either  [II.2.7.3.1. the isolation of Taylorella equigenitalis  after cultivation under 
microaeroph ilic conditions for a period of at least 7 days, set up within 24 
hours after taking the specimens from the donor animal, or 48 hours where 
the specimens are kept cool during transport;]  
(2)and/or  [II.2.7.3.2. the detection of genome of Taylorella equigeni talis by PCR or real -time 
PCR, carried out within 48 hours after taking the specimens from the 
donor animal;]  
II.2.8.  were subjected with the results specified in point II.2.7. in each case to at least one of the 
following testing programmes detailed respe ctively in points 1(b)(i), (ii) and (iii) of Chapter I 
of Part 4 of Annex II to Delegated Regulation (EU) 2020 /686: 
(3)[II.2.8.1.  The donor  stallion was continuously resident at the semen collection centre for a 
period of at least 30 days prior to the date of the first collection and during the 
period of collection of the semen described above, and no equine animals in the 
semen collection ce ntre came during that time into direct contact with equine 
animals of lower health status than the donor stallion.  The tests described in 
point II.2.7. were carried out on samples taken(4) from the donor stallion at least 
once a year at the beginning of th e breeding season or prior to the first collection 
of semen intended for movement to another Member State of fresh, chilled or 
frozen semen and not less than 14 days following the date of the commencement 
of the residence period of at least 30 days prior t o the first semen collection.]  
(3)[II.2.8.2.  The donor stallion was resident on the semen collection centre for a period of at 
least 30 days prior to the date of the first collection and during the period of 
collection of the semen described above, but lef t the semen collection centre 
under the responsibility of the centre veterinarian for a continuous period of less 
than 14  days during the collection period, or other equine animals in the semen 
collection centre came into direct contact with equine animals  of a lower health 
status.  The tests described in point II.2.7. were carried out on samples taken(4) 
from the donor stallion at least once a year at the beginning of the breeding 
season or prior to the date of the first collection of semen intended for mov ement 
to another Member State of fresh, chilled or frozen semen and not less than 14 
days following the date of the commencement of the residence period of at least 
30 days  prior to the first semen collection, and during the period of collection of 
the sem en intended for entry into the Union of fresh, chilled or frozen semen the 
donor stallion was subjected to the tests described in point II.2.7., as follows:  
(a) for equine infectious anaemia, one of the tests described in point II.2.7.1. 
was last carried o ut on a sample of blood taken(4) not more than 90 days 
prior to the collection of the semen described above;  
(b) for infection with equine arteritis virus , one of the tests described  
(2)either  [in point II.2.7.2. was last carried out on a sample taken(4) not more than 
30 days prior to the date of the collection of the semen described above;]  
(2)or [in point II.2.7.2.2., in case the non -shedder state of a donor stallion 
seropositive for infection with equine arteritis virus  is confirmed, was 
carried out on a n aliquot of the entire semen of the donor stallion taken(4) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 275  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
not more than 6 months prior to the date of the collection of the semen 
described above and a blood sample taken(4) from the donor stallion 
during the 6 months period reacted with a positive resu lt in a serum 
neutralisation test for infection with equine arteritis virus  at a serum 
dilution of more than one in four;]   
(c) for contagious equine metritis, the test described in point II.2.7.3. was last 
carried out on three specimens (swabs) taken(4) not more than 60 days 
prior to the date of the collection of semen described above  
(2)either  [on two occasions;]  
(2)or [on a single occasion and subjected to a PCR or real -time PCR.]]  
(3)[II.2.8.3.  The donor stallion does not meet the conditions set out i n points 1(b)(i) and (ii) 
of Chapter I of Part 4 of Annex II to Delegated Regulation (EU) 2020 /686  and the 
semen is collected for movement to another Member State as frozen semen.  
The tests described in points II.2.7.1, II.2.7.2 and II.2.7.3 were carried out on samples 
taken(4) from the donor stallion at least once a year at the beginning of the breeding 
season, and the tests described in points II.2.7.1 and II.2.7.3. were carried out on 
samples taken(4) from the donor stallion during the storage period of  the semen of a 
minimum period of 30 days from the date of the collection of the semen and before 
the semen is removed from the semen collection centre, not less than 14 days and not 
more than 90 days after the collection of the semen described above, and  
 (2)either  [the tests for infection with equine arteritis virus  described in point II.2.7.2. 
were carried out on samples taken(4) during the storage period of the semen of 
a minimum period of 30 days from the date of the collection of the semen and 
before the semen is removed from the semen collection centre or used, not 
less than 14 days and not more than 90 days after the date of the collection of 
the semen described above.]  
(2)or [the non -shedder state of a donor stallion seropositive for infection with 
equine arteritis virus  was confirmed by virus isolation test, PCR or real -time 
PCR carried out with a negative result on samples of an aliquot of the entire 
semen of the donor stallion taken(4) twice a year at an interval of at least 4 
months and the donor  stallion has reacted with a positive result at a serum 
dilution of at least one in four in a serum neutralisation test for infection with 
equine arteritis virus .] 
II.2.9.  underwent the testing provided for in point II.2.8. on samples taken on the followin g dates:  
 
Identification 
of semen  
Test 
programme  Start date(4) Date of sampling for health tests(4) 
Donor 
residence  Semen 
collection  EIA II.2.7.1.  EVA II.  
2.7.2.  CEM  
II.2.7.3.  
Blood 
sample  Semen 
sample  1.  
sample  2.  
sample  
          
      
          
      
          
      
II.3. The semen described in Part I  
II.3.1.  has been  collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020 /686; This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 276  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance  with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 and that mark 
is indicated in Box I.30;  
II.3.3.  is transported in a container which:  
II.3.3.1.  was sealed  and numbered prior to the dispatch from the semen collection centr e 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.3.3.3.  has been filled  in with the cryogenic agent which not have been previously used for 
other products.  
(2)(5)[II.4. The semen is preserved by the addition of antibiotics as follows:  
II.4.1.  The following  antibiotic or mixture of antibiotics has been added to th e semen after final 
dilution, or is contained in the used semen diluents, to reach the indicated concentration per 
ml of semen:  
(2)either  [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 
μg);]  
(2)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin 
(500 μg);]  
 (2)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(2)or [an antibiotic  or a mixture of antibiotics(6) …………………………………………………, 
with a bactericidal activity at le ast equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.4.2.  Immediately  after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or 
under a time-temperature regime with a documented eq uivalent bactericidal activity.]  
II.5. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval number 
of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the numbe r of containers.  
Box reference I.30:  “Type ”: semen.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen of the 
consignment is placed.  
“Date of  collection/production ”: Indicate the date on which semen of the consignment 
was collected.   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 277  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
Guidance for the completion of the table in point II.2.9.  
Abbreviations:  
EIA-1 Equine infectious anaemia (EIA) testing first occasion  
EIA-2 EIA testing second occasion  
EVA -B1 Equine arteritis virus  (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metr itis (CEM) testing first occasion first sample  
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identified in column A in correspondence with Box I.30, the test programme (points II.2.8.1., 
II.2.8.2. and/or II.2.8.3.) shall be specified in column B, and columns C and D shall be completed with the dates 
required.  
The dates  when samples were taken for laboratory testing prior to the first collection of the semen described 
above as required in points II.2.8.1., II.2.8.2. and II.2.8.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this being the boxes mar ked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the 
example below.  
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.2.8.2. 
or II.2.8.3. shall be entered in the lower line of columns 5 to 9 in  table , this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM -22 in the example below.  
 
Identification 
of semen  
Test 
programme  Start date  Date of sampling for health tests  
Donor 
residence  Semen 
collection  EIA II.2.7.1.  EVA  
II.2.7.2.  CEM  
II.2.7.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
 
(1) Only semen collection centres approved by the competent authority and included in the register referred to in 
Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020 /686. 
(2) Delete if not applicable.  
(3) Cross out the  programmes that do not apply to the consignment.  
(4) Insert date in table in point II.2.9. (follow Guidance in Part II of the Notes).  
(5) Mandatory attestation in case antibiotics were added. 
(6) Insert  the name(s) of the antibiotic(s) added and its(their ) concentration or the commercial name of the semen 
diluent containing antibiotics.  
Official veterinarian  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 278  EN EUROPEAN UNION  Certificate model EQUI -SEM -A-INTRA  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 279  EN CHAPTER 46: MODEL OFFICIAL CER TIFICATE THE MOVEMEN T BETWEEN 
MEMBER STATES OF CONSIGNMENTS OF STOC KS OF SEMEN OF EQUIN E 
ANIMALS COLLECTED, P ROCESSED AND STORED IN ACCORDANCE WITH 
DIRECTIVE 92/65/EEC AFTER 30  SEPTEMBER 2014 AND B EFORE 21 APRIL 
2021, AND DISPATCHED  AFT ER 20 APRIL 2021 FRO M A SEMEN COLLECTION  
CENTRE WHERE THE SEM EN WAS COLLECTED  (MODEL ‘ EQUI -SEM -B-
INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central  Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 280  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 281  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen collection centre(1), in which the semen described above was collected, processed and 
stored, for trade was approved and supervised by the competent authority in accordance with 
Chapters  I(I)(1) and I(II)(1) of Annex D to Directive 92/65/EEC(2); 
II.1.1.  during the period commencing 30 days prior to the date of first collection of the semen 
described ab ove until the date the fresh or chilled semen was dispatched or until the 30 
days minimum storage period for frozen semen elapsed, the semen collection centre:  
II.1.1.1.  was situated on the territory or in the case of regionalisation in a part of the 
territory(3) of a Member State which was not considered to be infected with 
African horse sickness in accordance with Article  5(2)(a) and(b) of Directive 
2009/156/EC(4); 
II.1.1.2.  fulfilled the conditions for a holding laid down in Article 4(5) of Directive 
2009/156/EC;  
II.1.1.3.  contained only equidae which were free of clinical signs of equine viral 
arteritis and contagious equine metritis;  
II.2. Only equidae satisfying the conditions laid down in Articles 4 and 5 or Articles 12 to 16 of 
Directive 2009/156/EC have been admitted onto the centre.  
II.3. The semen described above was collected from donor stallions, which:  
II.3.1.  did not show any clinical sign of an infectious or contagious disease at the time of 
admission onto the semen collection centre and on th e day the semen was collected;  
II.3.2.  were kept for a period of 30 days prior to the date of semen collection in holdings where 
no equine showed any clinical sign of equine viral arteritis or contagious equine metritis 
during that period;  
II.3.3.  were not  used for natural mating during a period of at least 30 days prior to the date of 
first semen collection and from the dates of the first sample referred to in point II.3.5.1., 
II.3.5.2. or II.3.5.3. until the end of the collection period;  
II.3.4.  underwent  the tests, which meet at least the requirements of the relevant Chapter of the 
Manual of Diagnostic  Tests and Vaccines for Terrestrial Animals of the OIE, carried out 
in a laboratory which is recognised by the competent authority and has the tests referre d to 
hereinafter included in its accreditation in accordance with Article 12 of Regulation (EC) 
No 882/2004(5), as follows:  
II.3.4.1.  for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test 
(AGID or Coggins test) or an enzyme -linked immunoso rbent assay (ELISA) 
for equine infectious anaemia with a negative result;  
II.3.4.2.  for equine viral arteritis (EVA),  
(3)either  [II.3.4.2.1. a serum neutralisation test with a negative result at a serum dilution 
of one in four;]  
(3)and/or  [II.3.4.2.2. a virus isolation test, polymerase chain reaction (PCR) or real -time 
PCR with a negative result on an aliquot of the entire semen of the 
donor stallion;]  
II.3.4.3.  for contagious equine metritis (CEM), an agent identification test carried out 
on three specim ens (swabs) taken from the donor stallion on two occasions This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 282  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  
with an interval of not less than 7 days at least from the penile sheath 
(prepuce), the urethra and the fossa glandis;  
The samples were in no case taken earlier than 7 days (systemic treatment) or 
21 days (local treatment) after antimicrobial treatment of the donor stallion 
and were placed in transport medium with activated charcoal, such as Amies 
medium, before dispatch to the laboratory where they were subjected with 
negative result to a test for:  
(3)either  [II.3.4.3.1. the isolation of Taylorella equigenitalis  after cultivation under 
microaerophilic conditions for at least 7 days, set up within 24 
hours after taking the specimens from the donor animal, or 48 
hours where the specimens are kept cool  during transport;]  
(3)and/or  [II.3.4.3.2. the detection of genome of Taylorella equigenitalis  by PCR or 
real-time PCR, carried out within 48 hours after taking the 
specimens from the donor animal;]  
II.3.5.  were subjected with the results specified in poin t II.3.4. in each case to at least one of the 
test programmes detailed in points II.3.5.1., II.3.5.2. and II.3.5.3., as follows:  
(6)[II.3.5.1.  The donor stallion was continuously resident on the semen collection centre 
for a period of at least 30 days prio r to the date of the first collection and 
during the period of collection of the semen described above and no equidae 
on the semen collection centre came into direct contact with equidae of lower 
health status than the donor stallion.  
The tests described in point II.3.4. were carried out on samples taken(7) from 
the donor stallion at least once a year at the beginning of the breeding season 
or prior to the first collection of semen intended for trade in fresh, chilled or 
frozen semen and not less than 14 d ays following the date of the 
commencement of the residence period of at least 30 days  prior to the date of 
first semen collection.]  
(6)[II.3.5.2.  The donor stallion was resident on the semen collection centre for a period of 
at least 30 days prior to the date of the first collection and during the period of 
collection of the semen described above, but has left the centre under the 
responsibility of the centre veterinarian for a continuous period of less than 14 
days, and/or other equidae on the semen colle ction centre came into direct 
contact with equidae of lower health status.  
The tests described in point II.3.4. were carried out on samples taken(7) from 
the donor stallion at least once a year at the beginning of the breeding season 
or prior to the first collection of semen intended for trade in fresh, chilled or 
frozen semen and not less than 14 days following the date of the 
commencement of the residence period of at least 30 days  prior to the date of 
first semen collection,  
and during the period of coll ection of the semen intended for trade in fresh, 
chilled or frozen semen the donor stallion was subjected to the tests described 
in point II.3.4., as follows:  
(a) for equine infectious anaemia, one of the tests described in point II.3.4.1. 
was last carried  out on a sample of blood taken(7) not more than 90 days 
prior to the date of the collection of the semen described above;  
(b) for equine viral arteritis:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 283  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  
(3)either  [one of the tests described in point II.3.4.2. was last carried out on a 
sample taken(7) not more than 30 days prior to the date of the collection 
of the semen described above;]  
(3)or [one of the tests described in point II.3.4.2.2 was carried out on an 
aliquot of the entire semen of the donor stallion taken(7) not more than 
six months prior to the date of the collection of the semen described 
above and a blood sample taken(7) from the donor stallion during the six 
months period reacted with a positive result in a serum neutralisation 
test for equine viral arteritis at a serum dilution of more  than one in 
four;]  
(c) for contagious equine metritis, one of the tests described in point 
II.3.4.3. was last carried out on three specimens (swabs) taken(7) not 
more than 60 days prior to the date of the collection of the semen 
described above  
(3)either  [on two occasions at least 7 days apart;]  
(3)or [on a single occasion and subjected to a PCR or real -time PCR.]]  
(6)[II.3.5.3.  The donor stallion does not meet the conditions set out in points 1.6(a) and (b) 
of Chapter II of Annex D to Directive 92/65/EEC and the semen is collected 
for trade in frozen semen.  
The tests described in points II.3.4.1, II.3.4.2. and II.3.4.3. were carried out on 
samples taken(7) from the donor stallion at least once a year at the beginning 
of the breeding season,  
and the tests d escribed in points II.3.4.1 and II.3.4.3. were carried out on samples 
taken(7) from the donor stallion during the storage period of the semen of a 
minimum period of 30 days from the date of the collection of the semen and 
before the semen is removed from t he semen collection centre, not less than 
14 days and not more than 90 days after the collection of the semen described 
above,  
and (3)either  [the tests for equine viral arteritis described in point II.3.4.2. were 
carried out on samples taken(7) during the storage period of the 
semen of a minimum period of 30 days from the date of the 
collection of the semen and before the semen is removed from the 
semen collection centre or used, not less than 14 days and not more 
than 90 days after the collection of the se men described above.]  
(3)or [the non -shedder state of a donor stallion seropositive for equine 
viral arteritis was confirmed by virus isolation test, PCR or real -
time PCR carried out with a negative result on samples of an 
aliquot of the entire semen of th e donor stallion taken(7) twice a 
year at an interval of at least four months and the donor stallion 
reacted with a positive result at a serum dilution of at least one in 
four in a serum neutralisation test for equine viral arteritis.]]  
II.3.6.  underwent t he testing provided for in point II.3.5. on samples taken on the following 
dates.  
 Id
ent
ifi
cat
io
n 
of 
se
me
n Te
st 
pr
og
ra
m
me 
Start date(7) Date of sampling for health tests(7) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 284  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  
Donor 
residence  Semen 
collection  EIA 
II.3.4.1.  EVA  
II.3.4.2.  CEM  
II.3.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
         
     
         
     
         
     
         
     
         
     
(3)either  [II.4.  No antibiotics were added to the semen;]  
(3)or [II.4.  The following antibiotic  or combination of antibiotics was added to produce a concentration in 
the final diluted semen of not less than(8): …………………………………………...  
…………………………………………………………………………………….. ;]  
II.5. The semen described above was:  
II.5.1.  collected, processed, stored and tran sported under conditions which comply with the 
requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;  
II.5.2.  in the case of frozen semen, stored for a minimum period of 30 days from the date of 
collection of the semen;  
II.5.3.  sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter 
III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the semen collection centre of origin of the semen.  
Box I.12:  The place  of destination shall correspond to the semen collection or storage centre or to the holding of 
semen destination.  
Box I.19:  The identification of container and Seal number shall be indicated.  
Box I.30:  The donor identity shall correspond to the official i dentification of the animal.  
 The date of collection shall be indicated in the following format: dd/mm/yyyy.  
 
Part II:  
Guidance for the completion of the table in point II.3.6.:  
Abbreviations:  
EIA-1 Equine infectious anaemia (EIA) testing first occasion  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 285  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  
EIA-2 EIA testing second occasion  
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample  
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identification in column A in the example below, the test programme (points II.3.5.1., II.3.5.2. 
and/or II.3.5.3.) shall be described in column B and columns C and D shall be completed with the dates required.  
The dates when samples were taken for laboratory testing prior to the first collection of the semen described 
above, as required in points II.3.5.1., II.3.5.2. and II.3.5.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this  being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the 
example below.  
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.3.5.2. or 
II.3.5.3. shall be entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM -22 in the example below.  
 
 
Identification 
of semen  
Test 
programme  Start date(7) Date of sampling for health tests(7) 
Donor 
residence  Semen 
collection  EIA 
II.3.4.1.  EVA  
II.3.4.2.  CEM  
II.3.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
 
(1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Directive 92/65/EEC.  
(2) OJ L 268, 14.9.1992, p. 54.  
(3) Delete as appropriate.  
(4) OJ L 192, 23.7.2010, p. 1.  
(5) OJ L 165, 30.4.2004, p. 1.  
(6) Cross out the programme(s) that do(es) not apply to the consignment . 
(7) Insert date in table in point II.3.6 (follow Guidance in Part II of the Notes).  
(8) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 286  EN EUROPEAN UNION  Certificate model EQUI -SEM -B-INTRA  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 287  EN CHAPTER 47: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF SEMEN OF 
EQUINE ANIMALS COLLE CTED, PROCESSED AND STORED IN ACCORDANCE  
WITH DIRECTIVE 92/65 /EEC AFTER 31 AUGUST  2010 AND BEFORE 1 
OCTOBER 2014, AND DI SPATCHED AFTER 20 AP RIL 2021 FROM A SEME N 
COLLECTION CENTRE WH ERE THE SEMEN WAS CO LLECTED  (MODEL 
‘EQUI -SEM -C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for 
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 288  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 289  EN EUROPEAN UNION  Certificate model EQUI -SEM -C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen collection centre(1), in which the semen described above was collected, processed and 
stored, for trade was approved and supervised by the competent authority in accordance with 
Chapter  I(I)(1) and Chapter I(II)(1) of Annex D to Directive 92/65/EEC;  
II.1.1.  during the period commencing 30 days prior to the  date of first collection of the semen 
described above until the date the fresh or chilled semen was dispatched or until the 30 
days storage period for frozen semen elapsed, the semen collection centre:  
II.1.1.1.  was situated on the territory or in the cas e of regionalisation in a part of the 
territory(2) of a Member State which was not considered to be infected with 
African horse sickness in accordance with Article  5(2)(a) and(b) of Directive 
2009/156/EC(3); 
II.1.1.2.  fulfilled the conditions for a holding  laid down in Article 4(5) of Directive 
2009/156/EC(3); 
II.1.1.3.  contained only equidae which were free of clinical signs of equine viral arteritis 
and contagious equine metritis;  
II.2. Only equidae satisfying the conditions laid down in Articles 4 and 5 or Articles 12 to 16 of 
Directive 2009/156/EC(3) have been admitted onto the centre.  
II.3. The semen described above was collected from donor stallions, which:  
II.3.1.  have not shown any clinical sign of an infectious or contagious disease at the time of 
admission onto the centre and on the day the semen was collected;  
II.3.2.  have been kept for 30 days prior to the date of semen collection in holdings where no 
equine has shown any clinical sign of equine viral arteritis or contagious equine metritis 
during  that period;  
II.3.3.  have not been used for natural mating during at least 30 days prior to the date of first 
semen collection and from the dates of the first sample referred to in points II.3.5.1., 
II.3.5.2. or II.3.5.3. until the end of the collection p eriod;  
II.3.4.  have undergone the following tests , which meet at least the requirements of the relevant 
Chapter of the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the 
OIE, carried out on samples taken in accordance with one of the p rogrammes specified in 
point II.3.5 in a laboratory recognised by the competent authority:  
 (2)either  [II.3.4.1.  an agar -gel immuno -diffusion test (Coggins test) for equine infectious anaemia 
(EIA) with negative result;]  
 (2)or [II.3.4.1.  an ELISA for equine infectious anaemia (EIA) with negative result;]  
and (2)either  [II.3.4.2.  a serum neutralisation test for equine viral arteritis (EVA) with negative result 
at a serum dilution of one in four;]  
 (2)or [II.3.4.2.  a virus isolation test for equine viral  arteritis (EVA) carried out with negative 
result on an aliquot of the entire semen of the donor stallion;]  
and II.3.4.3.  an agent identification test for contagious equine metritis (CEM) carried out on 
two occasions on samples taken with an interval of se ven days by isolation of 
Taylorella equigenitalis  after a cultivation of 7 to 14  days from pre -ejaculatory 
fluid or a semen sample and from genital swabs taken at least from the penile 
sheath, urethra and urethral fossa with negative result in each case;  
II.3.5.  have been subjected with the results specified in II.3.4. in each case to at least one of the 
test programmes(4) detailed in points II.3.5.1., II.3.5.2. and II.3.5.3. as follows:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 290  EN EUROPEAN UNION  Certificate model EQUI -SEM -C-INTRA  
II.3.5.1.  The donor stallion was continuously resident on the semen collection centre for 
at least 30 days prior to the date of the first collection and during the period of 
collection of the semen described above and no equidae on the semen 
collection centre came into direct contact with equidae of lower health status 
than the donor stallion.  
 The tests described in point II.3.4. have been carried out on samples taken(5) 
prior to the first semen collection and at least 14 days following the date of the 
commencement of the residence period of at least 30 days.  
II.3.5.2.  The donor stallion was resident on the semen collection centre for at least 30 
days prior to the date of the first collection and during the period of collection 
of the semen described above, but has left the centre under the responsibility of 
the centre vete rinarian for a continuous period of less than 14 days, and/or 
other equidae on the collection centre came into direct contact with equidae of 
lower health status.  
 The tests described in point II.3.4. have been carried out on samples taken(5) 
prior to the first semen collection of the breeding season or collection period in 
the year the semen described above was collected and at least 14 days 
following the date of the commencement of the residence period of at least 30 
days,  
and the test described in point  II.3.4.1. for equine infectious anaemia was last 
carried out on a sample of blood taken(5) not more than 90 days before the 
semen described above was collected,  
and (2)either  [one of the tests described in point II.3.4.2. for equine viral arteritis 
was l ast carried out on a sample taken(5) not more than 30 days before 
the semen  described above was collected, ] 
 (2)or [a virus isolation test for equine viral arteritis was carried out with 
negative result on an aliquot of the entire semen of the donor stalli on 
taken(5) not more than six months before the semen described above 
was collected and a blood sample taken on the same date(5) reacted 
positive in a serum neutralisation test for equine viral arteritis at a 
serum dilution of more than one in four,]  
and the test described in point II.3.4.3. for contagious equine metritis was last 
carried out on samples taken(5)not more than 60 days before the semen 
described above was collected.  
II.3.5.3.  The tests described in point II.3.4. have been carried out on samples taken(5) 
prior to the first semen collection of the breeding season or collection period in 
the year the semen described above was collected,  
and the tests described in point II.3.4. were last carried out on samples taken(5) not 
less than 14 days and not more than 90 days after the collection of the semen 
described above.  
II.3.6.  have undergone the testing provided for in point II.3.5. on samples taken on the following 
dates:  
 
Identifica tion of 
semen  
Test programme  
Start date(5) Date of sampling for health tests(5) 
Donor 
residence  Semen 
collection  EIA 
II.3.4.1.  EVA  
II.3.4.2.  CEM  
II.3.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
         This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 291  EN EUROPEAN UNION  Certificate model EQUI -SEM -C-INTRA  
     
         
     
         
     
         
     
         
     
(2)either  [II.4.  No antibiotics were added to the semen;]  
(2)or [II.4.  The following antibiotic or combination of antibiotics was added to produce a concentration in 
the final diluted semen of not less than(6): ……………………………………….  
…………………………………………………………………………………….. ;]  
II.5. The semen described above was:  
II.5.1.  collected, processed, stored and transported under conditions which comply with the 
requirements of Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;  
II.5.2.  sent to the place of loading in a sealed container in accordance with point 1.4 of Chapter 
III(I) of Annex D to Directive 92/65/EEC and bearing the number indicated in Box I.19.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch shall correspond to the semen collection centre of origin of the semen.  
Box I.12 : Place of destination shall correspond to the semen collection or storage centre or to the holding of semen 
destination.  
Box I.19 : Identification of container and Seal number shall be indicated.  
Box I.30 : Donor identity shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the centre shall correspond to the approval number of the semen centre indicated in 
Box I.11 where the semen was collected.  
 
Part II: 
Guidance for the completion of Table in II.3.6:  
Abbreviations:  
EIA-1 Equine infectious anaemia (EIA) testing first occasion  
EIA-2 EIA testing second occasion  
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 292  EN EUROPEAN UNION  Certificate model EQUI -SEM -C-INTRA  
CEM -12 CEM testing first occasion second sample  taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identification in column A in the example below, the test programme (II.3.5.1., II.3.5.2. and/or 
II.3.5.3.) must be described in column B and columns C and D must be completed with the dates required.  
The dates when samples where taken for laboratory testing prior to the first collection of the semen described 
above as req uired in II.3.5.1., II.3.5.2. and II.3.5.3., are entered in the upper line of columns 5 to 9 of the table, 
this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the example below.  
The dates when samples were taken for repeat lab oratory testing as required in accordance with II.3.5.2. or 
II.3.5.3. are entered in the lower line of columns 5 to 9 in table, this being the boxes EIA -2, EVA -B2 or EVA -S2 
and CEM -21 and CEM -22 in the example below.  
 
Identifica tion 
of semen  
Test 
programme  Start date(5) Date of sampling for health tests(5) 
Donor 
residence  Semen 
collection  EIA 
II.3.4.1.  EVA  
II.3.4.2.  CEM  
II.3.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
 
(1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.  
(2) Delete as appropriate.  
(3) OJ L 192, 23.7.2010, p. 1.  
(4) Cross out the programme(s) that do(es) not apply to the consignment.  
(5) Insert date in table in point II.3.6 (follow Guidance in Part II of the Notes).  
(6) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 293  EN CHAPTER 48: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF SEMEN OF 
EQUINE ANIMALS COLLE CTED, PROCESSED AND STORED IN ACCORDANCE 
WITH DIRECTIVE 92/65 /EEC BEFORE 1 SEPTEM BER 2010 AND DISPATC HED 
AFTER 20 APRIL 2021 FROM A SEMEN COLLECT ION CENTRE WHERE THE  
SEMEN WAS COLLECTED  (MODEL ‘ EQUI -SEM -D-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third countr y 
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 294  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 295  EN EUROPEAN UNION  Certificate model EQUI -SEM -D-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen collection centre(1), in which the semen described above was collected, processed and 
stored for trade:  
II.1.1.  was approved and supervised by the competent authority according to the conditions of 
Chapter I of Annex D to Directive 92/65/EEC;  
II.1.2.  was situated on the territory or in the case o f regionalisation in a part of the territory(2) of 
a Member State which was on the day semen was collected until the date the semen was 
dispatched as fresh/chilled(2) semen or until the 30 days mandatory storage period for 
frozen semen elapsed(2) not consi dered to be infected with African horse sickness in 
accordance with Article  5(2)(a) and(b) of Directive 2009/156/EC(3); 
II.1.3.  fulfilled during the period commencing 30 days prior to the date of semen collection 
until the date the semen was dispatched as fresh/chilled(2) semen or until the 30 days 
mandatory storage period for frozen semen elapsed(2), the conditions of Article 4 of 
Directive 2009/156/EC;  
II.1.4.  contained during the period commencing 30 days prior to the date of semen collection 
until the d ate the semen was dispatched as fresh/chilled(2) semen or until the 30 days 
mandatory storage period for frozen semen elapsed(2) only equidae which were free of 
clinical signs of equine viral arteritis and contagious equine metritis;  
II.2. All equidae have  been admitted onto the centre under the provisions of Article 4 and 5 of 
Directive 2009/156/EC(3); 
II.3. The semen described above was collected from donor stallions, which:  
II.3.1.  on the day the semen was collected have not shown clinical signs of an in fectious or 
contagious disease,  
II.3.2.  during at least 30 days prior to collection of the semen have not been used for natural 
service,  
II.3.3.  during the last 30 days prior to collection of the semen have been kept on holdings 
where no equidae showed cli nical signs of equine viral arteritis,  
II.3.4.  during the last 60 days prior to collection of the semen have been kept on holdings 
where no equidae showed clinical signs of contagious equine metritis,  
II.3.5.  to the best of my knowledge and as far as I cou ld ascertain, have not been in contact 
with equidae suffering from an infectious or contagious disease during 15 days 
immediately preceding collection of the semen,  
II.3.6.  have undergone the following animal health tests, carried out in a laboratory recog nised 
by the competent authority, in accordance with a test programme as specified in point 
II.3.7.  
II.3.6.1.  an agar -gel immuno -diffusion test (Coggins test) for equine infectious 
anaemia with negative result;  
and (2)either  [II.3.6.2.  a serum neutralisation test for equine viral arteritis with negative result at a 
serum dilution of one in four; and]  
(2)or [II.3.6.2.  a virus isolation test for equine viral arteritis carried out with negative result 
on an aliquot of the entire semen of the donor stallion;]  
and  II.3.6.3.  an agent identification test for contagious equine metritis carried out on two 
occasions on samples collected from the donor stallion with an interval of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 296  EN EUROPEAN UNION  Certificate model EQUI -SEM -D-INTRA  
seven days by isolation of Taylorella equigenitalis  from pre -ejaculatory flu id 
or a semen sample and from genital swabs taken at least from the penile 
sheath, urethra and urethral fossa with negative result in each case;  
II.3.7.  have been subject to the one of the following test programmes(4): 
II.3.7.1.  The donor stallion was cont inuously resident on the collection centre for at 
least 30 days prior to the semen collection, and during the collection period, 
and no equidae on the collection centre came during that time into direct 
contact with equidae of lower health status than the donor stallions.  
 The tests described in point II.3.6. have been carried out on samples taken on 
………………………..(5) and in the case of contagious equine metritis on a 
second sample taken on ………………………..(5), being at least 14 days after 
the commencement of the a bove residence period and at least at the beginning 
of the breeding season;  
II.3.7.2.  The donor stallion was not continuously resident on the collection centre or 
other equidae on the collection centre came into contact with equidae of 
lower health status than the donor stallion.  
 The tests described in point II.3.6. have been carried out on samples taken on 
………………………..(5) and in the case of contagious equine metritis on a 
second sample taken on ………………………..(5), being within the 14 days 
period before the first semen collection and at least at the beginning of the 
breeding season,  
and the test described in point II.3.6.1. for equine infectious anaemia was 
last carried out on a sample of blood taken on ………………………. .(5), 
being not more than 120 days before the semen described above was 
collected;  
and (2)either  [one of the tests described in point II.3.6.2. for equine viral arteritis was 
last carried out on a sample collected on …………………..(5), being not 
more than 30 d ays before the semen described above was collected,]  
 (2)or [the non -shedder state of the seropositive stallion for equine viral 
arteritis was confirmed by a virus isolation test which was carried out on 
an aliquot of the entire semen of the donor stallion  collected on 
………………………..(5), being not more than one year before the 
semen described above was collected;]  
II.3.7.3.  The tests described in point II.3.6. have been carried out during the 30 days 
mandatory storage period of frozen semen and not less than 14 days after the 
collection of the semen on samples taken on ……………………(5) and in the 
case of contagious equine metritis on a second sample taken 
on …………………….(5); 
II.4. The semen described above was collected, processed, stored and transported under conditi ons 
which comply with the requirements of Chapters II and III of Annex D to Directive 
92/65/EEC.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter  2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  place of dispatch shall correspond to the semen collection centre of origin of the semen.  
Box I.12:  place of destination shall correspond to the semen collection or storage centre or to the holding of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 297  EN EUROPEAN UNION  Certificate model EQUI -SEM -D-INTRA  
semen destination.  
Box I.19:  identification of container and Seal number shall be indicated.  
Box I.30:  donor identity shall correspond to the official identification of the animal.  
 date of collection shall be indicated in the following format: dd/mm/yyyy.  
 approval number of the centre shall correspond to the approval number of the semen centre 
indicated in Box I.11. where the semen was collected.  
 
Part II:  
(1) Only semen collection centres approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.  
(2) Delete as appropriate.  
(3) OJ L 192, 23.7.2010, p. 1.  
(4) Cross out the programme(s) that do(es) not apply to the consignment.  
(5) Insert date.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 298  EN CHAPTER 49: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF OOCY TES AND 
EMBRYOS OF EQUINE AN IMALS COLLECTED OR P RODUCED, PROCESSED 
AND STORED IN ACCORD ANCE WITH REGULATION  (EU) 2016/429 AND 
DELEGATED REGULATION  (EU) 2020 /686 AFTER 20 APRIL 2021 , AND 
DISPATCHED BY AN EMB RYO COLLECTION OR PR ODUCTION TEAM BY 
WHICH THE OOCYTES OR  EMBRYOS WERE COLLECT ED OR PRODUCED  
(MODEL ‘ EQUI -OOCYTES -EMB-A-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for 
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 299  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 300  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-A-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)[II.1.  The in vivo  derived embryos of equine animals described in Part I have been collected, processed 
and stored, and dispatched by the embryo collection team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirement s as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 
2020 /686.] 
(1)[II.1.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) of equine animals 
described in Part I have been collected or produced, processed and stored, and dispatched by the 
embryo production team(2) which  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements  as regards responsibilities, operational procedures, 
facilities and equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation 
(EU) 2020 /686.] 
II.2. The oocytes(1)/ embryos(1) described in Part I are intended for artificial reproduction and were 
obtained from the donor animals which  
II.2.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.2.2.  come from establishments  in a Member State or zone thereof, o r from establishments 
under official control by the competent authority in a third country or territory, or a 
zone thereof  
II.2.2.1.  in which  surra ( Trypanosoma evansi ) has not been reported during the 
period of the preceding 30 days prior to collection(1)/ production(1) of the 
oocytes(1)/ embryos(1), and  
(1)either  [surra has not been  reported in the establishment during the period of the 
preceding 2 years prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1);] 
(1)or [surra has been reported in the establishment during the period of the 
preceding 2 years prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and following the last outbreak the establishment has remained 
under movement restriction  
(1)either  [until the  remaining animals in the establishment have been 
subjected to a test for surra with one of the diagnostic methods 
provided for in Part 3 of Annex I to  Delegated Regulation (EU) 
2020/ 688, carried out, with negative results, on samples taken at 
least 6 months after the last infected animal has been removed 
from the establishment;]]  
(1)or  [for at least 30 days from the date of cleaning and disinfection 
after the last animal of listed species on the establishment was 
either killed and destroy ed or  slaughtered ;]] 
II.2.2.2.  in which  dourine has not been reported during the period of the preceding 
6 months prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1), This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 301  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-A-INTRA  
and 
(1)either  [dourine  has not been reported in the establishment during the period of 
the preceding 2 years prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1);] 
(1)or [dourine  has been reported in the establishment during the period of the 
preceding 2 years prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and following the last outbreak, the establishment has remained 
under movement restriction until  
(1)eithe r [the remaining equine  animals in the establishment, except male  
equine animals  have been subjected to a test for dourine with the 
diagnostic method provided for in Part 8 of Annex I to  Delegated 
Regulation (EU) 2020/ 688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have 
been killed and destroyed or slaughtered, or the infected entire 
male equine animals have been castrated;]]  
(1)or [for at least 30 days after the last e quine animal on the 
establishment was either killed and destroyed or slaughtered, and 
the premises were cleaned and disinfected;]]  
II.2.2.3.  in which equine infectious anaemia has not been reported during the 
period of the preceding 90 days prior to collec tion(1)/ production(1) of the 
oocytes(1)/ embryos(1), and  
(1)either  [equine infectious anaemia has not been reported on the establishment 
during the period of the preceding 12 months prior to collection(1)/ 
production(1) of the oocytes(1)/ embryos(1);] 
(1)or [equine infectious  anaemia has been reported on the establishment during 
the period of the preceding 12 months prior to collection(1)/ product ion(1) 
of the oocytes(1)/ embryos(1) and following  the last outbreak the 
establishment has remained under movem ent restriction until  
(1)either  [the remaining equine  animals in the establishment have been 
subjected to a test for equine infectious anaemia with the 
diagnostic method provided for in Part 9 of Annex I to Delegated 
Regulation (EU) 2020/ 688, carried out, with negative results, on 
samples taken on two occasions with a minimum interval of 3 
months after the infected animals have been killed and destroyed 
or slaughtered and the establishment was cleaned and 
disinfected;]]  
(1)or [for at least 30 days after the  last equine animal on the 
establishment was either killed and destroyed or slaughtered, and 
the premises were cleaned and disinfected;]]  
II.2.3.  were examined by the team veterinarian or its team member and did not show 
symptoms or clinical signs of trans missible animal diseases on the day of collection 
of the oocytes(1)/ embryos(1);  
II.2.4.  are identified as provided for in Article 58(1), 59(1) or 62(1) of Delegated Regulation 
(EU) 2019/2035;  
II.2.5.  for a period of at least 30 days prior to the date of first collection of the oocytes(1)/ 
embryos(1) and during the collection period  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 302  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-A-INTRA  
II.2.5.1.  were  kept on establishments not s ituated in a restricted zone established 
due to the occurrence of African horse sickness, infection with 
Burkholderia mallei  (glanders) or of an emerging disease relevant for the 
equine animals;  
II.2.5.2.  were  kept on a single establishment where Venezuelan equine 
encephalomyelitis, dourine, surra ( Trypanosoma evansi ), equine infections 
anaemia, contagious equine metritis ( Taylorella equigenitalis ), infection 
with rabies virus and anthrax have not been reported;  
II.2.5.3.  were  not in contact with animals from establishments situated in a 
restricted zone due to the occurrence of diseases referred to in point 
II.2.5.1. or from  establishments which do not meet the conditions referred 
to in point II.2.5.2.;  
II.2.6.  were not used for natural breeding during a period of at least 30 days prior to the date 
of the collection of the oocytes(1)/ embryos(1) and between the date of the fi rst 
samples referred to in points II.2.7.1. and II.2.7.2. and the date of the collection of the 
oocytes(1)/ embryos(1); 
II.2.7.  have  been subjected to the following tests, referred to in points 2(b) and (c) of 
Chapter II of Part 4 of Annex II to Delegated Regulation (EU) 2020/ 686, as follows:  
II.2.7.1.  for equine  infectious anaemia (EIA), an agar -gel immuno -diffusion test 
(AGID or Coggins test) or an enzyme -linked immunosorbent assay 
(ELISA) with a negative result carried out on a blood sample taken on 
………… …….(3), being not less than 14 days following the date of 
commencement of the period referred to in point II.2.6, and the test was 
last carried out on a blood sample taken on …………………….(3); being 
not more than 90  days prior to the date of the collection of the 
oocytes(1)/embryos(1) intended for movement to another Member State;]  
II.2.7.2.  for contagious equine metritis (CEM), an agent identification test carried 
out with a negative result on at least two specimens (swabs) taken during 
the period referred to in point II.2.6. from at least the mucosal surfaces of 
the clitoral fossa and the clitoral sinuses of the donor mare  
(1)either  [II.2.7.2.1.  on two occasions with an interval of not less than 7 days 
on…………(3) and on………………..(3), in the case of isolation 
of Taylorella equigenitalis  after cultivation under 
microaerophilic conditions for a period of at least 7 days, set up 
within 24 hours after taking the specimens from the donor 
animal, or 48 hours where the specimens are kept cool during 
transport.]  
(1)and/or  [II.2.7.2.2.  on one occasion on………………..(3), in the case of detection 
of genome of Taylorella equigenitalis  by a polymerase chain 
reaction (PCR) or real -time PCR , carried out within 48 hours 
after taking the specimens from the donor animal.]  
The samples re ferred to in points II.2.7.2.1. and II.2.7.2.2. were in no case 
taken earlier than 7 days (systemic treatment) or 21 days (local treatment) 
after antimicrobial treatment of the donor mare and were placed in 
transport medium with activated charcoal, such as  Amies medium, before 
dispatch to the laboratory.  
II.3. The oocytes(1)/ embryos(1) described in Part I  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 303  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-A-INTRA  
II.3.1.  has been collected, processed and stored in accordance with animal health 
requirements set out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to 
Delegated Regulation (EU) 2020 /686; 
II.3.2.  are placed in straws or other packages on which the mark is applied in accordance 
with requirements provided for in Article 10 of Delegated Regulation (EU) 2020 /686 
and that mark is ind icated in Box I.30;  
II.3.3.  are transported in a container which:  
II.3.3.1.  was sealed and numbered prior to the dispatch by the embryo collection 
or production team under responsibility of the team veterinarian, or by 
an official veterinarian, and the seal bears the number as indicated in 
Box I.19;  
II.3.3.2.  has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.3.3.3.  has been filled in with the cryogenic agent which not have been 
previously used for other pro ducts;  
(1)(4)[II.3.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.3.5.  are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bag s.] 
(1)(5)[II.4.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using semen coming from a semen 
collection centre, germinal product processing establishment or germinal product storage centre 
approved for the collection, processing and/or storage of semen by  the competent authority of a 
Member State or by the competent authority of a third country, territory or zone thereof listed in 
Annex … to Commission Implementing Regulation (EU) 2020/ … [IA listing – authorisation for 
equine  semen ].] 
(1)(6)[II.5. The following  antibiotic or mixture of antibiotics(7) has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]  
II.6. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the nam e and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos.  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond  to the number of containers.  
Box reference I.30:  “Type ”: Specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where oocytes or This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 304  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-A-INTRA  
embryos of the consignment are placed.  
“Date of  collection/production ”: indicate the date on which oocytes or embryos of the 
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only embryo collection or production teams approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020 /686. 
(3) Insert date in the following format: dd.mm.yyyy.  
(4) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of equine animals are placed and transported.  
(5) Does  not apply to oocytes.  
(6) Mandatory attestation in case antibiotics were added.  
(7) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 305  EN CHAPTER 50: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF OOCYTES 
AND EMBRYOS OF EQUIN E ANIMALS COLLECTED OR PRODUCED, 
PROCESSED AND STORED  IN ACCORDANCE WITH D IRECTIVE 92/65/EEC 
AFTER 30 SEPTEMBER 2 014 AND BEFORE 21 AP RIL 2021, AND DISPAT CHED 
AFTER 20 APRIL 2021 BY AN EMBRYO COLLECT ION OR PRODUCTION TEAM 
BY WHICH THE OOCYTES  OR EMBRYOS WERE COLL ECTED OR PRODUCED  
(MODEL ‘ EQUI -OOCYTES -EMB-B-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 306  EN  Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 307  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-B-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)either  [II.1.  the in vivo  derived embryos/ in vivo  derived ova(1) described above were collected, processed and 
stored by an embryo collection  team(2) approved and supervised in accordance with 
Chapter  I(III)(1) of Annex D to Directive 92/65/EEC(3);] 
(1)or [II.1.  the in vitro  produced embryos/micromanipulated embryos(1) described above were produced, 
processed and stored by an embryo production  team(2), approved and supervised in accordance 
with Chapter I(III) (1) and (2) of Annex D to Directive 92/65/EEC;]  
(1)either  [II.2.  the in vivo  derived embryos described above mee t the requirements of Chapter III(II)(1) of 
Annex  D to Directive 92/65/EEC;]  
(1)or [II.2.  the in vivo  derived ova described above meet the requirements of Chapter III(II)(2) of Annex D 
to Directive 92/65/EEC;]  
(1)or [II.2.  the in vitro  produced embryos des cribed above meet the requirements of Chapter III(II)(3) of 
Annex D to Directive 92/65/EEC;]  
(1)or [II.2.  the micromanipulated embryos described above meet the requirements of Chapter III(II)(4) of 
Annex D to Directive 92/65/EEC;]  
II.3. the ova or embryos described above come from donor mares which:  
II.3.1.  come from holdings fulfilling the conditions laid down in Article 4(5) of Directive 
2009/156/EC(4) onto which only equidae satisfying the conditions laid down in Articles 
4 and 5 or Articles 12 to 16 of Directive 2009/156/EC were admitted;  
II.3.2.  meet the requirements of Chapter IV(4) of Annex D to Directive 92/65/EEC;  
II.3.3.  were not used for natural breeding during a period of at least 30 days prior to the date of 
collection of the ova or embryos and between the date of the first sample referred to in 
points II.3.4.1 and II.3.4.2. and the date of the  collection of the ova or embryos;  
II.3.4.  underwent the tests, which meet at least the requirements of the relevant Chapter of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out 
in a laboratory which is recognised by the competent authority and has the tests referred 
to hereinafter included in its accreditation in accordance with Article 12 of Regulation  
(EC) No 882/2004(5), as follows:  
II.3.4.1.  for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test (AGID 
or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with a 
negative result carried out on a blood samples taken on ……………….(6), being 
not less than 14 days following the date of commencement of the period 
referred to in point II.3.3, and the test was last carried out on a sample of blood 
taken on …………………….(6); being not more than 90  days prior to the date 
of the collection of the ova or embryos intended for trade;  
II.3.4.2.  for contagious equine metritis (CEM), an agent identification test carried out 
with a negative result on at least two specimens (swabs) taken during the period 
referred to in point II.3.3 from at least the m ucosal surfaces of the clitoral fossa 
and the clitoral sinuses of the donor mare;  
(1)either  [II.3.4.2.1.  on two occasions with an interval of not less than 7 days 
on…………(6) and on………………..(6), in the case of isolation of 
Taylorella equigenitalis  after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 308  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-B-INTRA  
after taking the specimens from the donor animal, or 48 hours 
where the specimens are kept cool during transport;]  
(1)and/or  [II.3.4.2.2.  on one occ asion on………………..(6), in the case of the detection 
of genome of Taylorella equigenitalis  by a polymerase chain 
reaction (PCR) or real -time PCR test, carried out within 48 hours 
after taking the specimens from the donor animal.]  
The samples referred to in po ints II.3.4.2.1. and II.3.4.2.2. were in 
no case taken earlier than 7 days (systemic treatment) or 21 days 
(local treatment) after antimicrobial treatment of the donor stallion 
and were placed in transport medium with activated charcoal, such 
as Amies medi um, before dispatch to the laboratory;  
(1)either  [II.4.  the embryos described above were conceived as a result of artificial insemination of the donor 
mares with semen which was collected, processed, stored and transported under conditions which 
comply wit h the requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 
92/65/EEC; ] 
(1)or [II.4.  the embryos described above were conceived as a result of in vitro  fertilisation of ova complying 
with the conditions set out in point 2 of Chapter III(II) of Annex D to Directive 92/65/EEC with 
semen which was collected, processed, stored and transported under conditions which comply 
with the requirements of Chapters I( I), II(I) and III(I) of Annex D to Directive 92/65/EEC;]  
(1)or [II.4.  the ova have not been in contact with semen of the equine species ;] 
II.5. the ova or embryos described above were sent to the place of loading in a sealed container in 
accordance with po int 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the 
number detailed in Box I.19.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the embryo collection team or embryo production team 
of oocytes/embryos collection/production.  
Box I.12:  The place of destination shall correspond to the embryo collection team, embryo production team 
or to the holding of oocytes/embryos destination.  
Box I.19:  The identification of container and Seal number shall be indicated.  
Box I.30:  “Type” : specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 The donor identity shall correspond to the official identification of the animal.  
 The date of collection shall be indicated in the following format: dd/mm/yyyy.  
 
Part II:  
(1) Delete as appropriate.  
(2) Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Directive 92/65/EEC.  
(3) OJ L 268, 14.9.1992, p. 54.  
(4) OJ L 192, 23.7.2010, p. 1.  
(5) OJ L 165, 30.4.2004, p. 1.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 309  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-B-INTRA  
(6) Insert date.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 310  EN CHAPTER 51: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOCKS OF OOCYTES 
AND EMBRYOS OF EQUIN E ANIMALS COLLECTED,  PROCESSED AND 
STORED IN ACCORDANCE  WITH DIRECTIVE 92/65 /EEC AFTER 31  AUGUST 
2010 AND BEFORE 1 OC TOBER 2014, AND DISP ATCHED AFTER 20 APRI L 2021 
BY AN EMBRYO COLLECT ION OR PRODUCTION TE AM BY WHICH TH E 
OOCYTES OR EMBRYOS W ERE COLLECTED OR PRO DUCED  (MODEL ‘ EQUI -
OOCYTES -EMB-C-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 311  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 312  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-C-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
(1)either  [II.1.  the in vivo  derived embryos/ in vivo  derived ova(1) described above were collected, processed and 
stored by an embryo collection  team(2) approved and supervised in accordance with 
Chapter  I(III)(1) of Annex D to Directive 92/65/EEC;]  
(1)or [II.1.  the in vitro  produced embryos/micromanipulated embryos(1) described above were produced, 
processed and stored by an embryo production  team(2), approved and supervised in accordance 
with Chapter I(III) (1) and (2) of Annex D to Directive 92/65/EEC;]  
(1)either  [II.2.  the in vivo  derived embryos described above meet the requirements of Chapter III(II)(1) of 
Annex  D to Directive 92/65/EEC;]  
(1)or [II.2.  the in vivo  derived ova described above meet the requirements of Chapter III(II)(2) of Annex D to 
Directive 92/65/EEC;]  
(1)or [II.2.  the in vitro  produced embryos described above meet the requirements of Chapter III(II)(3) of 
Annex D to Directive 92/65/EE C;] 
(1)or [II.2.  the micromanipulated embryos described above meet the requirements of Chapter III(II)(4) of 
Annex D to Directive 92/65/EEC;]  
II.3. the ova or embryos described above come from donor mares which:  
II.3.1.  coming from holdings fulfilling the conditions laid down in Article 4(5) of Directive 
2009/156/EC(4) onto which only equidae satisfying the conditions laid down in Articles 4 
and 5 or Articles 12 to 16 of Directive 2009/156/EC have been admitted;  
II.3.2.  meet the additional requirements of C hapter IV(4) of Annex D to Directive 92/65/EEC;  
II.3.3.  have not been used for natural breeding during at least 30 days prior to the date of 
collection of ova or embryos and between the date of the first sample referred to in points 
II.3.4. and II.3.5. and the date of the  collection of ova and embryos;  
II.3.4.  have been subjected with negative result to an agar -gel immuno -diffusion test (Coggins 
test) or an ELISA for equine infectious anaemia carried out  on a blood samples taken on 
……………….(3), being during the past 30 days prior to the date of the first collection of 
ova or embryos and the last test was carried out on a sample of blood taken on 
…………………….(3); being not more than 90  days before the ova and embryos were 
collected;  
II.3.5.  have been subjected to an agent identification test for contagious equine metritis by 
isolation of Taylorella equigenitalis  after a cultivation of 7 to 14  days carried out with 
negative results in each case on samples taken during the past 30 days prior to the date of 
the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and 
clitoral sinuses on two consecutives oestrus periods on…………(3) and 
on………………..(3), and on an additional culture specimen take n during one of the 
oestrus periods from the endometrial cervix on……………….(3); 
(1)either  [II.4.  the embryos described above were conceived as a result of artificial insemination of the donor 
mares with semen which was collected, processed, stored and transp orted under conditions which 
comply with the requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 
92/65/EEC; ] 
(1) or [II.4.  the embryos described above were conceived as a result of in vitro  fertilisation of ova complying 
with the condit ions in point 2 of Chapter III(II) of Annex D to Directive 92/65/EEC with semen 
which was collected, processed, stored and transported under conditions which comply with the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 313  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB-C-INTRA  
requirements of Chapters I(I), II(I) and III(I) of Annex D to Directive 92/65/EEC; ] 
(1) or [II.4.  the ova have not been in contact with semen of the equine species ;] 
 II.5. the ova or embryos described above were sent to the place of loading in a sealed container in 
accordance with point 6 of Chapter III(II) of Annex D to Directive 92/65/EEC and bearing the 
number detailed in Box I. 19. 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch shall correspond to the embryo collection team or embryo production team of 
oocytes/embryos collection/production.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team or to 
the holding of oocytes/e mbryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  “Type ”: Specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Donor identity shall corre spond to the official identification of the animal.  
 Date of collection shall be indicated in the following format: dd/mm/yyyy.  
 Approval number of the team shall correspond to the embryo collection team or embryo 
production team of oocytes/embryos collect ion/production.  
 
Part II:  
(1) Delete as appropriate.  
(2) Only embryo collection or production teams approved by the competent authority and listed in accordance 
with Article 11(4) of Council Directive 92/65/EEC.  
(3) Insert date.  
(4) OJ L 192, 23.7.2010, p.  1. 
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 314  EN CHAPTER 52: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGNMENTS OF STOC KS OF OOCYTES 
AND EMBRYOS OF EQUIN E ANIMALS COLLECTED,  PROCESSED AND 
STORED IN ACCORDANCE  WITH DIRECTIVE 92/65 /EEC BEFORE 1 
SEPTEMBER 2010 AND D ISPATCHED AFTER 20 A PRIL 2021 BY AN EMBR YO 
COLLECTION OR PRODUC TION TEAM BY WHICH T HE OOCYTE S OR 
EMBRYOS WERE COLLECT ED OR PRODUCED (MODEL ‘ EQUI -OOCYTES -
EMB -D-INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 315  EN  Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 316  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB -D-INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. Ova/embryos(1) described above were collected by a collection team(2) approved by the competent 
authority and processed in an appropriate laboratory;  
II.2. Ova/embryos(1) were collected from donor mares which:  
II.2.1.  on the day of collection have been located in premises situated on the territory or in the case of 
regionalisation  in a part of the territory of a Member State which is not considered to b e infected 
with African horse sickness in accordance with Article 5(2)(a) and (b) of Directive 
2009/156/EC(3), 
II.2.2.  have been located in holdings under veterinary supervision which on the day of collection 
fulfilled the conditions of Article 4 of Direct ive 2009/156/EC,  
II.2.3.  have been kept prior to the collection in holdings free from clinical signs of contagious equine 
metritis for 60 days,  
II.2.4.  have not been used for natural breeding during the period of 30 days prior to the collection of 
ova/embr yos(1), 
II.2.5.  to the best of my knowledge and as far as I could ascertain, have not been in contact with equidae 
suffering from an infectious or contagious disease during the 15 days immediately preceding the 
collection of ova/embryos(1), 
II.2.6.  have on  the day of collection not shown clinical signs of an infectious or contagious disease;  
II.3. Ova/embryos(1) were collected, processed, stored and transported under conditions which comply with the 
requirements of Annex D of Directive 92/65/EEC;  
II.4. The semen used for the artificial insemination of the donor mares complies with the requirements of 
Directive 92/65/EEC(4)(1); 
II.5. The ova used for the in vitro  production of embryos comply with the requirements of Directive 
92/65/EEC(1). 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  Place of dispatch shall correspond to the embryo collection team of oocytes/em bryos collection.  
Box I.12:  Place of destination shall correspond to the embryo collection team, embryo production team or to 
the holding of oocytes/embryos destination.  
Box I.19:  Identification of container and Seal number shall be indicated.  
Box I.30:  “Type” : Specify if: in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 Donor identity shall correspond to the official identification of the animal.  
 Date of collection shall be indicated in the follow ing format: dd/mm/yyyy.  
 Approval number of the team shall correspond to the embryo collection team of oocytes/embryos 
collection.  
Part II:  
(1) Delete as appropriate.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 317  EN EUROPEAN UNION  Certificate model EQUI -OOCYTES -EMB -D-INTRA  
(2) Only embryo collection teams approved by the competent authority and listed in accordance with Article 
11(4) of Council Directive 92/65/EEC.  
(3) OJ L 192, 23.7.2010, p. 1.  
(4) Does not apply to oocytes.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 318  EN CHAPTER 53: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGMENTS OF:  
- semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 686 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in ac cordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collec ted or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 686 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or produced, processed and stored in 
accordance with Dir ective 92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 1 October 2014;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
PROCESSING ESTABLISH MENT  (MODEL ‘ EQUI -GP-PROCESSING -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 319  EN   Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 320  EN EUROPEAN UNION  Certificate model EQUI -GP-PROCESSING -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were 
processed and stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated 
embryos(2) described in Part I is/are intended for artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, 
and was/were moved to the germinal product processing establishment indicated in Box I.11. 
situated in the Member State of its/their collection or production under animal health certification 
requirements at least as  strict as those provided for  in: 
(2)either  [Model EQUI -SEM -A-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -B-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -C-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -D-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  EQUI -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -C-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -D-INTR A(4);] 
 (2)and/or  [Model EQUI -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, 
and was/were moved to the germinal product processing establishment indicated in Box I.11. 
situated in another Member State accompanied by certificate(s) in accordance with:  
(2)either  [Model EQUI -SEM -A-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -B-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -C-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -D-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model  EQUI -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -C-INTRA(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 321  EN EUROPEAN UNION  Certificate model EQUI -GP-PROCESSING -INTRA  
(2)and/or  [Model EQUI -OOCTYES -EMB -D-INTRA(4);] 
 (2)and/or  [Model EQUI -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -INTRA(4);]] 
(2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in a third country, territory or zone thereof listed in Annex X to Commission 
Implementing Regulation (EU) 2020/xx [SANTE/7140/20 20] and complying with requirements 
as regards responsibilities, operational procedures, facilities and equipment set out in Part 
1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, and  
entered the Union accompani ed by certificate(s) in accordance with:   
(2)either  [Model EQUI -SEM -A-ENTRY(4);] 
(2)and/or  [Model EQUI -SEM -B-ENTRY(4);] 
(2)and/or  [Model EQUI -SEM -C-ENTRY(4);]  
(2)and/or  [Model EQUI -SEM -D-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -B-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -C-ENTRY(4);] 
(2)and/or  [Model EQUI -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -ENTRY(4);] 
has been  collected, processed and stored in accordance with animal health requirements set out in Annex 
III to Delegated Regulation (EU) 2020/ 686; 
II.2.3. are placed  in straws or other packages on which the mark is applied in accordance with 
requirements  provided for in Article 10 of Delegated Regulation (EU) 2020/ 686 and/or Article 
83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4. are transported in a container which:  
II.2.4.1.  was sealed and numbered prior to the dispatch  by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.4.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
  (2)(5  )[II.2. 5. are placed in straws or other packages which are securely and hermetically sealed;  
II.2.6. are transpo rted in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.3. This certificate  is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 322  EN EUROPEAN UNION  Certificate model EQUI -GP-PROCESSING -INTRA  
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes, and/or embryos. Only germinal product processing establishment s 
approved by the competent autho rity and included in the register referred to in Article 
101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/ 686. 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s ) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were colle cted 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
process ing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embr yo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product processing establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/ 686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/ 686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially end orsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or pro duced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product processing establi shment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 323  EN EUROPEAN UNION  Certificate model EQUI -GP-PROCESSING -INTRA  
(5) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulat ed embryos of equine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 324  EN CHAPTER 54: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF CONSIGMENTS OF:  
- semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 686 after 20 April 2021;  
- stocks of  semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after  31 August 2010 and before 1 October 2014;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 686 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or produced,  processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and b efore 1 October 2014;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC before 1 September 2010,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
STORAGE CENTRE  (MODEL ‘ EQUI -GP-STORAGE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17 Accompanying documents  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 325  EN   Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled  Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 326  EN EUROPEAN UNION  Certificate model EQUI -GP-STORAGE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) was/were stored:  
II.1.1.  is approved and kept in a register by the competent authority;  
II.1.2.  complies with requirements as regards responsibilities, operational proced ures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated 
embryos(2) described in Part I is/are intended fo r artificial reproduction and  
(2)either  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or production and complying with 
requirements as regards responsibilities, operational procedures , facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, 
and was/were moved to the germinal product storage centre indicated in Box I.11. situated in the 
Member State of its/t heir collection or production under animal health certification requirements 
at least as strict as those provided for in:  
(2)either  [Model EQUI -SEM -A-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -B-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -C-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -D-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -C-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -D-INTRA(4);] 
 (2)and/or  [Model EQUI -GP-PROCESSING -INTRA(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -INTRA(4);]] 
(2)and/or  [Model  IA in Part A of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  IB in Part B of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  IC in Part C of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  ID in Part D of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Commission  Decision 95/307/EC(4);] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) situated in the Member State of its/their collection or pr oduction and complying with 
requirements as regards responsibilities, operational procedures, facilities and equipment set out 
in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, 
and was/were moved to the germinal product storage centre indicated in Box I.11. situated in 
another Member State accompanied by certificate(s) in accordance with:  
(2)either  [Model EQUI -SEM -A-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -B-INTRA(4);] 
(2)and/or  [Model EQUI -SEM -C-INTRA(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 327  EN EUROPEAN UNION  Certificate model EQUI -GP-STORAGE -INTRA  
(2)and/or  [Model EQUI -SEM -D-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -A-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -B-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -C-INTRA(4);] 
(2)and/or  [Model EQUI -OOCTYES -EMB -D-INTRA(4);] 
 (2)and/or  [Model EQUI -GP-PRO CESSING -INTRA(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -INTRA(4);]] 
(2)and/or  [Model  IA in Part A of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  IB in Part B of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  IC in Part C of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model  ID in Part D of Annex I to Decision 2010/470/EU(4);] 
(2)and/or  [Model in Annex to Commission  Decision 95/307/EC(4);] 
 (2)and/or  [II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3 ) situated in a third country, territory or zone thereof listed in Annex X to Commission 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] and complying with requirements 
as regards responsibilities, operational procedures, facilities and equipment se t out in Part 
1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to Delegated Regulation (EU) 2020/ 686, and  
entered the Union accompanied by certificate(s) in accordance with:  
(2)either  [Model EQUI -SEM -A-ENTRY(4);] 
(2)and/or  [Model EQUI -SEM -B-ENTRY(4);] 
(2)and/or  [Model EQUI -SEM -C-ENTRY(4);]  
(2)and/or  [Model EQUI -SEM -D-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -B-ENTRY(4);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -C-ENTRY(4);] 
(2)and/or  [Model EQUI -GP-PROCESSI NG-ENTRY(4);] 
(2)and/or  [Model EQUI -GP-STORAGE -ENTRY(4);] 
 (2)and/or  [Model  1 in Section A of Part 1 of Annex III to Regulation (EU) 2018/659(4);] 
(2)and/or  [Model  2 in Section B of Part 1 of Annex III to Regulation (EU) 2018/659(4);] 
(2)and/or  [Model  3 in Section C of Part 1 of Annex III to Regulation (EU) 2018/659(4);] 
(2)and/or  [Model  4 in Section D of Part 1 of Annex III to Regulation (EU) 2018/659(4);] 
(2)and/or  [Model  1 in Section A of Part 2 of Annex II to Decision 2010/471/EU(4);] 
(2)and/or  [Model  2 in Section B of Part 2 of Annex II to Decision 2010/471/EU(4);] 
(2)and/or  [Model  3 in Section C of Part 2 of Annex II to Decision 2010/471/EU(4);] 
(2)and/or  [Model in Annex to Commission  Decision 96/539/EC(4);] 
II.2.2. has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.3. are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 10 of Delegated Regulation (EU) 2020/ 686 and/or Article 
83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in Box I.30;  
II.2.4. are transported  in a container which:  
II.2.4.1. was sealed and numbered prior to the dispatch  by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 328  EN EUROPEAN UNION  Certificate model EQUI -GP-STORAGE -INTRA  
seal bears the number as indicated in Box I.19;  
II.2.4.2. has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.4.3. has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(5)[II.2. 5. are placed  in straws or other packag es which are securely and hermetically sealed;  
II.2.6. are transported  in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.3. This certificate  is valid  for 10 days from the d ate of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes, 
and/or embryos. Only germinal product storage centres approved by the competent 
authority and included in  the register referred to in Article 101(1)(b) of Regulation 
(EU) 2016/429 and Article 7 of Delegated Regulation (EU) 2020/ 686. 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes, 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/ or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the seme n, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.26:  Total number of packages shall correspond to the number of containers.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 329  EN EUROPEAN UNION  Certificate model EQUI -GP-STORAGE -INTRA  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres approved by the competent authority and included in the register 
referred to in Article 101(1)(b) of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation (EU) 
2020/ 686.  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments approved by the competent authority and included in the 
register referred to in Article 101(1)(b)  of Regulation (EU) 2016/429 and Article 7 of Delegated Regulation 
(EU) 2020/ 686. 
(4) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described abov e from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(5) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of equine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 330  EN CHAPTER 55: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF HONEY BEES (MODEL ‘ HBEE -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  
 Products for h uman   Live a quatic animals  Other  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 331  EN consumption  for human consumption  
I.21  For transit  through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 332  EN EUROPEAN UNION   Certificate model HBEE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. The animals in the consignment described in Part I meet the following requirements in any stage 
of their lifecycle, including honeybee brood:  
II.1.1.  The animals have not shown signs of occurrence of American foulbrood, Aethina 
tumida (Small hive beetle) and Tropilaelaps spp . during the visual examination 
carried out within 48 hours prior to departure.  
II.1.2.  Their packaging and any accompanying feed or other material have not shown signs 
of presence of American foulbrood, Aethina tumida  (Small hive beetle) and 
Tropilaelaps spp . during the visual examination carried out within 48 hours prior to 
departure.  
II.2. According to official information, the animals meet the following animal health requirements:  
II.2.1.  The animals come from an apiary situated in the centre of a circle of at least 3 km 
radius where American foulbrood has not been reported during the last 30 days prior 
to departure and which is not restricted due to an outbreak of American foulbrood;  
II.2.2.  The animals come from an apiary situated in the centre of a circle of at least 100 km 
radius, where infestation with Aethina tumida  (Small hive beetle) and Tropilaelaps 
spp. has not been reported and which is not restricted due to a suspected case or the 
confirmed occurrence of infestation with Aethina tumida  (Small hive beetle) or 
Tropilaelaps spp.  
(1)II.2.3.  [The animals come from a Member State or zone thereof with the status free from 
infestation with Varroa spp.  and a rrangements  have been made to ensure that they 
are protected from infestation with Varroa spp . during transport .] 
II.3. To the best of my knowledge and as declared by the operator, the animals in the consignment come 
from an establishment where there are no abnormal mortalities with an undetermined cause and 
they have  not been in contact with honeybees, which did not comply with the requirements 
referred to in point II.2.  
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the 
duration of the journey by waterway/sea.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch”:  Indicate a registered establishment.  
Box reference I. 12: “Place of destination”:  Indicate a registered establishment.  
Box reference I.30: “Nature of commodity ”: indicate: queen honeybee s with maximum 20 attendants, 
colonies with brood or other.  
 
Part II:  
(1) Delete if not applicable.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 333  EN EUROPEAN UNION   Certificate model HBEE -INTRA  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 334  EN CHAPTER 56: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF QUEEN HONEY BEE S UNDER DEROGATION 
(MODEL ‘QUE -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country  of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aquaculture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 335  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit  through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 336  EN EUROPEAN UNION   Certificate model QUE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. The animals(1) in the consignment described in Part I meet the following requirements:  
II.1.1.  The animals have not shown signs of occurrence of American foulbrood, Aethina 
tumida (Small hive beetle) and Tropilaelaps spp . during the visual examination 
carried out within  24 hours prior to departure.  
II.1.2.  Their packaging and any accompanying feed or other material have not shown signs 
of presence of American foulbrood, Aethina tumida  (Small hive beetle) and 
Tropilaelaps spp . during the visual examination carried out within 24 hours prior to 
departure.  
II.1.3.  The documentary check verified that the establishment of origin has been  inspected 
every month during the production season by the competent authority with negative 
results to provide a confidence level of at lea st 95% of detecting infestation with 
small hive beetle if at least 2% of the hives were infested . 
II.1.4.  The animals are caged individually with a maximum of 20 accompanying attendants.  
II.1.5.  Arrangements have been made to ensure that the cages, contain ers or the entire 
consignment are covered with fine mesh of not more than 2 mm in pore size 
immediately after the visual examination for the health certifica tion. 
II.2. According to official information, the animals meet the following animal health require ments:  
II.2.1.  The animals come from an apiary situated in the centre of a circle of at least 3 km 
radius where American foulbrood has not been reported during the last 30 days prior 
to departure and which is not restricted due to an  outbreak of American foulbrood.  
II.2.2.  The animals come from an apiary situated in the centre of a circle of at least 100 km 
radius, where infestation with Tropilaelaps spp. has not been reported and which is 
not restricted due to a suspected case or the  confirmed occurrence of infestation with 
Tropilaelaps spp.  
II.2.3.  In the apiary infestation with small hive beetle has not been reported and  the apiary is 
situated at a distance of at least 30 km from the limits of a protection zone of at  least 
20 km in radius established by the competent authority around a confirmed occurence 
of infestation with small hive beetle . 
II.2.4.  the apiary  is not located in a zone restricted by protective measures established by the 
Union due to the confirmed occurence of infestation with small hive beetle ; 
II.2.5.  the apiary  of origin is situated in an area where annual surveillance for the detection 
of infestation with small hive beetle by the competent authority is ongoing to provide 
a confidence level of at least 95% of  detecting infestation with small hive beetle if at 
least 2% of the apiaries were infested;  
(2)II.2.6.  [The animals come from a Member State or zone thereof with the status free from 
infestation with Varroa spp.  and a rrangements  have been made to ensure th at they 
are protected from infestation with Varroa spp . during transport .] 
II.3. To the best of my knowledge and as declared by the operator, the animals in the consignment come 
from an establishment where there were no abnormal mortalities with an undetermined cause and 
they have  not been in contact with honeybees which did not comply with the requirements 
referred to in point II.2.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 337  EN EUROPEAN UNION   Certificate model QUE -INTRA  
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of anim als, the period of 10 days for the validity of the certificate may be extended by the 
duration of the journey by waterway/sea.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing R egulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a registered establishment . 
Box reference I. 12: “Place of destination ”: Indicate a registered establishment . 
Box reference I.30: “Nature of commodity ”: indicate: queen honeybee s with maximum 20 attendants . 
 
Part II:  
(1) Animals can only be queen honeybee s with maximum 20 attendants . 
(2) Delete if not applicable.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local  Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 338  EN CHAPTER 57: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF BUMBLE BEES (MODEL ‘ BBEE -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  
 Products for h uman   Live a quatic animals  Other  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 339  EN consumption  for human consumption  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 340  EN EUROPEAN UNION   Certificate model BBEE -INTRA  art II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. The animals in the consignment described in Part I meet the following requirements:  
II.1.1.  The animals have not shown signs of occurrence of Aethina tumida  (Small hive 
beetle) during the visual examination carried out within 48 hours prior to departure.  
II.1.2.  Their packaging and any accompanying feed or other material hav e not shown signs 
of presence of small hive beetle during the visual examination carried out within 48 
hours prior to departure.  
II.2. According to official information, the animals come from an establishment situated in the centre of a 
circle of at least 100 km radius, where infestation with s mall hive beetle has not been reported and 
which is not restricted due to a suspected case or the confirmed occurrence of infestation with small 
hive beetle . 
II.3. To the best of my knowledge and as declared by the operator, the animals in the consignment come 
from an establishment where there are no abnormal mortalities with an undetermined cause and they  
have  not been in contact with bumble bees which did not comply with the requirements referred to in 
point II.2.  
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the duration of 
the journey by waterway/sea.  
 
Notes:  
Guidance on the comple tion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a registered establishment . 
Box reference I. 12: “Place of destination ”: Indicate a registered or approved establishment . 
Box reference I.30: “Nature of commodity ”: indicate either of the following: queens with maximum 20 
attendants, colonies with brood or other . 
 
Part II:  
(1) Delete  if not applicable.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 341  EN CHAPTER 58: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF TERRESTRIAL ANIMALS BETWEEN 
CONFINED ESTABLISHME NTS (MODEL ‘CONFINED -LIVE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 342  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 343  EN EUROPEAN UNION   Certificate model CONFINED -LIVE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. Animals(1) in the consignment described in Part I meet the following requirements:  
II.1.1.  Their confined establishment of dispatch is approved in accordance with Articles 97 and 99 of 
Regulation (EU) 2019/429.  
II.1.2.  They have not shown clinical signs or symptoms of diseases, in particular of those listed for 
their species, during the clinical  examination, or where this is not possible, a clinical 
inspection carried out within 48 hours prior to departure on ………………. ( insert date  
dd/mm/yyyy ). 
II.2. According to official i nformation, animals in the consignment described in Part I meet the following 
health requirements:  
II.2.1.  They come from a  confined establishment that is not subject to movement restrictions 
affecting the animals to be moved.  
(2)(3)either [II.2.2.  They originate from a Member State or a zone free from infection with bluet ongue virus 
(serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or Article 3 2(2) of Delegated Regulation 
(EU) 2020/688 are fulfilled .] 
(2)and/or [II.2.2.  They originate from a Member State or a zone covered by the eradication programme for 
infection with bluetongue virus (serotype 1 -24) and the requirements laid down in Article 
32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and 
they 
(2)either  [II.2.2.1.  have been kept in a Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24) in accordance with Article 40(3) of Regulation 
(EU) 2020/ 689 
(2)either  [II.2.2.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)or [II.2.2.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
animal into the Member State or zone seasonally free f rom infection 
with bluetongue virus (serotype 1 -24).]]]  
(2)or [II.2.2.1.3.  for at least 14 days prior to the date of mov ement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1-24).]]]  
(2)and/or [II.2.2.2.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.2.2.1.  for at le ast 60 days prior to the date of movement.]]]  
(2)or [II.2.2.3.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date o f the 
commencement of the period of protection against attacks by This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 344  EN EUROPEAN UNION   Certificate model CONFINED -LIVE -INTRA  
vectors.]]]  
(2)or [II.2.2.3.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 d ays following the date of the commencement of 
the period of protection against attacks by vectors.]]]  
(2)and/or [II.2.2.3.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 ye ars in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and  
(2)either  [II.2.2.3.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.2.2.3.2.  have been vaccinat ed with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of the 
vaccine.]]]  
(2)and/or [II.2.2.4.  have been subjected with positive resu lts to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zone and  
(2)either  [II.2.2.4.1.  the serological test has been carried out on  samples collected at least 
60 days before the date of movement.]]]  
(2)or [II.2.2.4.2.  the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with neg ative results, carried out on samples 
collected not earlier than 14 days before the date of movement.]]]  
(2)and/or [II.2.2.  They originate from a Member State or a zone neither free from infection with bluetongue 
virus (serotype 1 -24) nor covered by the era dication programme for infection with bluetongue 
virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688 are fulfilled, and they 
(2)either  [II.2.2.1.  have been protected against attacks by the vectors during transportation to the 
place of destination and have been kept protected against attacks by vectors in a 
vector protected establishment  
(2)either  [II.2.2.1.1.  for at least 60 days prior to the date of movement.]]]  
(2)or [II.2.2.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the date of the 
commencement of the period of protection agai nst attacks by 
vectors.]]]  
(2)or [II.2.2.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of the commencement of 
the p eriod of protection against attacks by vectors.]]]  
(2)or [II.2.2.1.  have been kept at least for the last 60 days prior to departure in an establishment 
situated in a Member State or in an area of at least 150 km radius centred on the 
establishment, where s urveillance in compliance with the requirements laid down 
in Sections 1 and 2 of Chapter 1 of Part II of Annex V to Regulation (EU) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 345  EN EUROPEAN UNION   Certificate model CONFINED -LIVE -INTRA  
2020/ 689 has been  carried out during that period  and 
(2)either  [II.2.2.1.1.  the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept  and are within the immunity period 
guaranteed in the s pecifications of the vaccine and  
(2)either  [II.2.2.1.1.1.  have been vaccinated more than 60 days before the 
date of movement.]]]]  
(2)and/or  [II.2.2.1.1.2.  have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine.]]]]  
(2)or [II.2.2.1.2.  the animals have been immunised against those serotypes from 1 to 
24 of infection with bluetongue virus which were report ed during the 
past 2 years in an area of at least 150 km radius centred on the place 
where the animals were kept, and   
(2)either  [II.2.2.1.2.1.  the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 60 days before the date of movement.]]]]  
(2)or [II.2.2.1.2.2.  the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 30 days before the date of the movement and to a 
PCR test, with negati ve results, carried out on samples 
collected not earlier than 14 days before the date of 
movement.]]]]  
(2)and/or [II.2.2.  They do not fulfil the requirements laid down in points 1 to 3 of Section 1 of Chapter 2 of 
Part II of Annex V to  Regulation (EU) 2020/ 689 and the competent authority of the Member 
State of origin authorised movement of those animals to another Member State or zone 
thereof  
(2)either  [II.2.2.1.  with the status free from infection with bluetongue virus (serotype 1 -24) and the 
Member State o f destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred to 
in Article 43(2)(a), (b) and (c) of Regulation  (EU) 2020/ 689 and 
(2)either  [II.2.2.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Artic le 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.2.1.  with an approved eradication program for infection with bluetongue virus This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 346  EN EUROPEAN UNION   Certificate model CONFINED -LIVE -INTRA  
(serotype 1 -24) and the Member State of destination has informed the 
Commission and the other Member States that  such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Regulation  
(EU) 2020/ 689 and 
(2)either  [II.2.2.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.2.2.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex  V to that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.2.9.1.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered by 
the eradication programme for infection with bluetongue virus (serotype 1 -24) 
and the Member State of destination has informed the Commission and the other 
Member States that such movement is authorised  
(2)either  [II.2.2.1.1.  without any conditions , and  
(2)and/or  [II.2.2.1.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of Annex V to  Regulation (EU) 2020/ 689, and  
(2)and/or  [II.2.2.1.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 2020/ 689, and  
(2)and/or  [II.2.2.1.4.  under the conditions referred to in point 7 of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 202 0/689, and  
(2)and/or  [II.2.2.1.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 2020/ 689, and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688  
and the requirements laid down in Article 33  of that Delegated Regulation  are fulfilled .]]]II.3. To the 
best of my knowledge and as declared by the operator:  
II.3.1.  In the confined establishment of dispatch there are no abnormal m ortalities with an 
undetermined cause affecting the animals to be moved . 
II.3.2.  The animals have not been in contact with animals which are subject to movement restrictions 
referred to in Point II.2.1., or with animals of a lower health status.  
II.3.3.  Based on the results of the surveillance plan of the confined establishment, the animals do not 
pose a significant risk at the confined establishment of destination for the spread of diseases 
for which they are listed.  
II.4. Arrangements  are made to transpor t the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2019/ 688. 
II.5. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of 10 days for the validity of the c ertificate may be extended by the duration of the 
journey by waterway/sea.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 347  EN EUROPEAN UNION   Certificate model CONFINED -LIVE -INTRA  
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined 
today and found fit for the intended journey and  all necessary arrangements were made to comply before 
and during the journey with the requirements of EU legislation on the protection of animals during 
transport, and especially as regards the means of transport, the loading and unloading facilities, the  
competence of the personnel, the space allowances, as well as watering, feeding intervals, journey times 
and resting periods , and IATA requirements and/or CITES guidelines for transport, where applicable.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a confined establishment approved in accordance with 
Articles 97 and 99 of Regulation (EU) 2019/429.  
Box reference I. 12: “Place of destination ”: Indicate a confined establishment approved in accordance with 
Articles 97 and 99 of Regulation (EU) 2 019/429.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete as applicable.  
(3) Only in case of animals belonging to the families Antilocapridae , Bovidae , Camelidae , Cervidae , 
Giraffidae , Moschidae  or Tragulidae.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 348  EN CHAPTER 59: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF PRIMATES INTO A  CONFINED 
ESTABLISHMENT (MODEL  ‘CONFINED -PRIMATE -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relayin g 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 349  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 350  EN EUROPEAN UNION   Certificate model CONFINED -PRIMATE -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. Animals(1) in the consignment described in Part I meet the following requirements:  
II.1.1.  They have shown no clinical signs or symptoms of diseases listed for primates during 
the clinical examination or where this is not possible, a clinical inspec tion carried out 
within 48 hours prior to departure on ………………. ( insert date  dd/mm/yyyy ). 
II.1.2.  Their movement has been authorised by an agreement of the competent authority of 
Member State of origin and the competent authority of Member State of destination 
pursuant to, and in compliance with, Article 63(2)(b) of Delegated Regulation 
2020/ 688. 
II.2. To the best of my knowledge and as declared by the operator:  
II.2.1.  The animals come  from an establishment where there are no abnormal mortalities 
with an undetermined cause . 
II.2.2. The animals are consigned directly to the confined establishment of destination.  
II.3. Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/ 688. 
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of 10 days for the validity of the certificate may be extended by the 
duration of the journey by waterway/sea.  
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before 
and during the journey with the requirements of  EU legislation on the protection of animals during 
transport, and especially as regards the means of transport, the loading and unloading facilities, the 
competence of the personnel, the space allowances, as well as watering, feeding intervals, journey ti mes 
and resting periods , and IATA requirements and/or CITES guidelines for transport, where applicable.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate an establishment.  
Box reference I. 12: “Place of destination ”: Indicate a confined establishment appr oved in accordance with 
Articles 97 and 99 of Regulation (EU) 2019/429.  
 
Part II:  
(1) There can be one or more animals in the consignment . 
Official veterinarian  
Name (in capital letters)   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 351  EN EUROPEAN UNION   Certificate model CONFINED -PRIMATE -INTRA  
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 352  EN CHAPTER 60: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF SEMEN, OOCYTES AND EMBRYOS  OF 
TERRESTRIAL ANIMALS KEPT AT CONFINED EST ABLISHMENT WHICH 
WERE COLLECTED OR PR ODUCED, PROCESSED AN D STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020/ 686 (MODEL ‘ GP-CONFINED -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vesse l  
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 353  EN  Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 354  EN EUROPEAN UNION  Certificate model GP-CONFINED -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that: 
II.1. The semen(1)/ in vivo  derived embryos(1)/ oocytes(1)/ in vitro  produced embryos(1)/ 
micromanipulated embryos(1) described in Part I have been collected or produced, processed and 
stored, and dispatched from the confined establishment(2) which  
II.1.1.  is approved,  assigned with a unique approval number and kept in a register by the 
competent authority;  
II.1.2.  complies with requirements  as regards quarantine, isolation and other biosecurity 
measures, surveillance and control measures, facilities  and equipment referred to in 
Article 16 of Delegated Regulation (EU) 2019/2035.  
II.2. The semen(1)/ oocytes(1)/ embryos(1) described in Part I is(1)/are(1) intended for artificial 
reproduction and were obtained from the donor animals which  
II.2.1.  have be en born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.2.2.  have remained in a single confined establishment of origin for a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1); 
(1)[II.2.3.  are bovine animals and they are identified as provided for in Article 38 of Delegated 
Regulation (EU) 2019/2035.]  
(1)[II.2.3.  are porcine animals and they are identified as provided for in Article 52(1) or 54(2) 
of Delegated Regulation (EU) 2019/2035.]  
(1)[II.2.3.  are ovine or caprine animals and they are identified as provided for in Article 45(2) 
or (4), or Article 46(1), (2) or (3) of Delegated Regulation (EU) 2019/2035.]  
(1)[II.2.3.  are equine animals and they are identified as provided for in Article 58(1) or 59(1) or 
62(1) of Delegated Regulation (EU) 2019/2035.]  
 (1)[II.2.3.  are terrestrial animals other than bovine, porcine, ovine, caprine and equine animals 
and they are identified an d registered in accordance with the rules of the confined 
establishment.]  
II.3. The semen(1)/ oocytes(1)/ embryos(1) described in Part I come from the confined establishment 
indicated in Box I.11. and are destined to another confined establishment.  
II.4. According to official information, the semen(1)/ oocytes(1)/ embryos(1) described in Part I were 
obtained from the donor animals which  
II.4.1.  do not come from a confined establishment, nor have been in contact with animals 
from a confined establishment, s ituated in a restricted zone established due to the 
occurrence of a category A disease, referred to in the Annex to Implementing 
Regulation (EU) 2018/1882, or of an emerging disease relevant for the species in 
those donor animals;  
II.4.2.  come from a confi ned establishment where no category D disease relevant for that 
species as referred to in the Annex to Implementing Regulation (EU) 2018/1882 has 
been reported for a period of at least 30 days prior to the date of collection of the 
semen(1)/ oocytes(1)/ embryos(1). 
II.5. To the best of my knowledge and as declared by the operator, the semen(1)/ oocytes(1)/ embryos(1) 
described in Part I were obtained from the donor animals which  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 355  EN EUROPEAN UNION  Certificate model GP-CONFINED -INTRA  
II.5.1.  have been clinically examined by the establishment veterinarian respons ible for the 
activities carried out at the confined establishment and showed no diseases symptoms 
on the day of collection of the semen(1)/ oocytes(1)/ embryos(1); 
II.5.2.  as much as possible, were not used for natural breeding during a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1) and during 
the collection period.  
 II.6. To the best of my knowledge  and based on the documentary check of the data submitted by the 
establishment veterinarian responsible for the activities carried out at the confined establishment, 
the semen(1)/ oocytes(1)/ embryos(1) described in Part I are placed in straws or other packages on 
which the mark is applied in accordance with requirements provided for in  
(1)(2)[Article 10  of Dele gated Regulation (EU) 2020/ 686 and that mark is indicated in Box I.30.]  
(1)(3)[Article 11  of Delegated Regulation (EU) 2020/ 686 and that mark is indicated in Box I.30.]  
II.7. The oocytes(1)/ embryos(1) described in Part I  
II.7.3.  are transported in a container which:  
II.7.3.1.  was sealed and numbered prior to the dispatch by the establishment 
veterinarian responsible for the activities carried out at the confined 
establishment, or by an official veterinarian, and the seal bears the 
number as indicated in Box I.19;  
II.7.3.2.  has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.7.3.3.  has been filled in with the cryogenic agent which not have been 
previously used for other products;  
(1)(2)(4)[II.7.4.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.7.5.  are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.8. This certificate  is valid for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the address and the unique approval number of the 
confined establishment of dispatch of the consignment of semen, oocytes or embryos.  
Box reference I.12:  “Place of destination ”: Indicate the address and the unique approval number of the 
confine d establishment of destination of the consignment of semen, oocytes or 
embryos.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 356  EN EUROPEAN UNION  Certificate model GP-CONFINED -INTRA  
“Approval or registration number of plant/establishment ”: Indicate the unique 
approval number of the confined establishment of the collection or production of 
semen, oocytes or embryos of th e consignment.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Applicable for the consignment of semen, oocytes or embryos  of bovine, porcine, ovine, caprine or equine  
animals.  
(3) Applicable for the consignment of semen, oocytes or embryos of terrestrial animals other than bovine, 
porcine, ovine, caprine or equine animals . 
(4) Applicable for the consignment where in one container  oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of bovine, porcine, ovine, caprine or equine animals are placed and 
transported.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 357  EN CHAPTER 61: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF DOGS, CATS AND FERRE TS (MODEL ‘ CANIS -
FELIS -FERRETS -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of  
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 358  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 359  EN EUROPEAN UNION   Certificate model CANIS -FELIS -FERRETS -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. The dogs, cats and ferrets(1) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are individually identified:  
(2)either  [in accordance with Article 70 of Commission Delegated Regulation (EU) 2019/2035 .] 
(2)and/or  [by a clearly readable tattoo applied before 3 July 2011.]  
II.1.2.  They are accompanied by their individual identification document as provided for in Article 
71 of Commission Delegated Regulation (EU) 2019/2035.  
II.1.3.  They have undergone a clinical examination or a clinical inspection on ………………. 
(insert date  dd/mm/yyyy ) within the last 48 hours prior to departure and have not shown 
symptoms or clinical signs of diseases.  
(3)[II.1.4.  They come from registered or approved establishments in which according to official 
information, infection with rabies virus in kept terre strial animals has not been reported 
during the last 30 days prior to departure and in which to the best of my knowledge and as 
declared by the operator, there were no abnormal mortalities with an undetermined cause.]  
II.2. The dogs, cats and ferrets(1) of the consignment described in Part I meet the following requirements:  
(2)either  [II.2.1.  The animals  were at least 12 weeks old at the time of vaccination against rabies 
and at least 21 days have elapsed since the completion of the primary anti -rabies 
vaccination carried out in accordance with the validity requirements set out in Part I of 
Annex VII to R egulation 2020/ ),688, and any subsequent revaccination was carried out 
within the period of validity of the preceding vaccination.]  
(2)or [II.2.1.  The animals are intended  for direct transport in accordance with Article 54(2) of Regulation 
(EU) 2020/ 688 to the confined establishment indicated in Box  I.12 of Part I.]  
(2)or [II.2.1.  The animals are less than 12 weeks old and have not received an anti -rabies vaccination, or 
are between 12 and 16 weeks old and have received a complete primary course of anti -
rabies vaccination in accordance with the validity requirements set out in Part I of Annex 
VII to Regulation 2020/ 688 less than 21 days prior to departure, and the Member State of 
destination has informed the public in accordance with Article 57 of Regulation 2020/ 688 
that it authorises the movement of such animals into its territory; and  
(2)either [they are accompanied by a declaration of the operator or the pet keeper(4), attached to this 
certificate, stating that from birth until the time of dispatch the animals have had no contact 
with kept terrestrial animals under suspicion of infection wit h rabies virus or wild animals 
of listed species for infection with rabies virus;]  
(2)or [the female on whom they still depend is their mother, and from the individual identification 
document of this female, it can be established that it received before th eir birth an anti -
rabies vaccination which complied with the validity requirements set out in Part I of Annex 
VII to Regulation (EU) 2020 /688;] 
[II.2.2.  The dogs, due to their intended destination(5) indicated in Box I.10, or in Box I.11 where 
regionalisation is applied:  
(2)either  [have been treated against Echinococcus multilocularis  in accordance with Article 6 of 
Commission Delegated Regulation (EU) 2018/772.]  
(2)or [have not been treated against(6) Echinococcus multilocularis .]] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 360  EN EUROPEAN UNION   Certificate model CANIS -FELIS -FERRETS -INTRA  
(2)or [II.2.2.  The animals are intended  for direct transport in accordance with Article 54(2) of Regulation 
(EU) 2020/ 688 to the confined establishment indicated in Box  I.12 of Part I.]  
(3)[II.3.  Arrangements  are made to transport the consignment in accordance with Article 4 of Delegated 
Regulation (EU) 2020/ 688. 
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea 
of animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
 
(3)Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify , that the animals described above were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before 
and during the journey with the requirements of EU legislation on t he protection of animals during 
transport, and especially as regards the means of transport, the loading and unloading faci lities, the 
competence of the personnel, the space allowances, as well as watering, feeding intervals, journey times 
and resting periods . 
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a registered establishment of dispatch, a n approved  
shelter of dogs, cats and ferrets, an establishment approved for assembly operations or 
a household (in case of movements of dogs, cats or ferrets other than non -commercial 
movements carried out in accordance with Article 55, and where applicable Article 56, 
of Regulation (EU) 2020/ 688 
Box reference I. 12: “Place of destination ”: Indicate a registered establishment of destination, a n approved 
shelter of dogs, cats and ferrets, an establishment approved for assembly operations, a 
household (in case of movements of dogs, cats or ferrets other than non -commercial 
movements carried out in accordance with Article 55, and where applicable Article 56,  
of Regulation (EU) 2020/ 688 or a confined establishment.  
Box reference I. 30: “Identification number” : Indicate for each animal of the consignment their 
alphanumeric code.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not  applicable.  
(3) Not applicable in case of movements of dogs, cats or ferrets other than non -commercial movements 
carried out in accordance with Article 55, and where applicable Article 56, of Regulation (EU) 2020/ 688. 
(4) The declaration referred to in point II.2.1.  to be attached to the certificate is laid down in Chapter NthisN  
of Annex I to Implementing Regulation 2020/… [this Regulation]  (after the model official certificate).  
(5) Member States or parts thereof listed i n the Annex to Commission Implementing Regulation (EU) 
2018/878.  
(6) Treatments  against Echinococcus multilocularis , if administered after the date this certificate was signed 
must be completed and documented in accordance with Article 6 of Commission Dele gated Regulation 
(EU) 2018/772 . This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 361  EN EUROPEAN UNION   Certificate model CANIS -FELIS -FERRETS -INTRA  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 362  EN Model of the declaration referred to in, and to be attached to the certificate pursuant to 
point (i)(b) of Article 54(1) or point (i)(b) of Article 56 of Regulation 2020/ 688 
 
I, the undersigned,  
…………………………………………………………………………………………………………...1 
[operator or pet keeper making movement of dogs, cats or ferrets other than non -commercial movements as 
provided for to in Article 55 of Regulation (EU) 2020/ 688] 
 
declare that from birth until the time of departure the animals have had no contact with kept 
terrestrial animals under suspicion of infection with rabies virus or wild an imals of listed 
species for infection with rabies virus.  
 
Transponder/tattoo2 Passport/animal health certificate2 number  
  
  
  
  
  
  
                                                 
1 To be completed in block letters  
2 Delete as appropriate  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 363  EN CHAPTER 62: MODEL CERTIFICATE FOR THE MOVEMENT WIT HIN THE 
UNION OF SEMEN, OOCYTES AND EMBRYOS OF DOGS AND CATS WHI CH 
WERE COLLECTED OR PR ODUCED, PROCESSED AN D STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020/ 686 (MODEL ‘ GP-CANIS -FELIS -INTRA ’) 
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal  number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 364  EN I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 365  EN EUROPEAN UNION  Certificate model GP-CANIS -FELIS -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that : 
II.1. The semen(1)/ oocytes(1)/ embryos(1) of dogs(1)/ cats(1) described in Part I are intended for artificial 
reproduction and were obtained from the donor animals which  
II.1.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.1.2.  are  
(1)either  [marked by the implantation of a transponder  in accordance with Article 17(1) of 
Regulation (EU) No 576/2013;]  
(1)or [marked by a clearly readable tattoo in accordance with Article 17(1) of Regu lation 
(EU) No 576/2013;]  
(1)or [identified in accordance with Article 70 of Delegated Regulation (EU) 2019/2035;]  
II.1.3.  have received an anti -rabies vaccination that complies with the validity requirements 
set out in Part 1 of Annex VII to Delegated Regulation (EU) 2020/ 688. 
II.2. The semen(1)/ oocytes(1)/ embryos(1) described in Part I come from a registered establishment 
assigned by the competent authority with a unique registration number as indicated in Box I.11.  
II.3. According to official informati on, the semen(1)/ oocytes(1)/ embryos(1) described in Part I were 
obtained from the donor animals which  
II.3.1.  come  from establishments i n which infection with rabies virus has not been 
confirmed for a period of at least 30 days prior to the date of colle ction of the 
semen(1)/ oocytes(1)/ embryos(1); 
II.3.2.  comply with any preventive health measure for diseases or infections other than 
rabies set out in Part 2 of Annex VII to Delegated Regulation (EU) 2020/ 688. 
II.4. To the best of my knowledge and as dec lared by the operator, the semen(1)/ oocytes(1)/ embryos(1) 
were obtained from the donor animals which  
II.4.1.  showed no diseases symptoms on the day of collection of the semen(1)/ oocytes(1)/ 
embryos(1); 
II.4.2.  were not used for natural breeding during a  period of at least 30 days prior to the date 
of collection of the semen(1)/ oocytes(1)/ embryos(1) and during the collection period.  
II.5. The semen(1)/ oocytes(1)/ embryos(1) described in Part I are placed in a sealed transport container 
and the seal bea rs the number as indicated in Box I.19.  
II.6. To the best of my knowledge and based on the documentary check of the data submitted by the 
operator, the semen(1)/ oocytes(1)/ embryos(1) described in Part I are placed in straws or other 
packages on which the mark is applied in accordance with requirements provided for in Article 
11 of Delegated Regulation (EU) 2020/ 686 and that mark is indicated in Box I.30.  
II.7. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 366  EN EUROPEAN UNION  Certificate model GP-CANIS -FELIS -INTRA  
Part I:  
Box reference I.11:  “Place of dispatch”:  indicate the address and the unique registration number of the 
establishment of dispatch of the consignment of semen, oocytes or embryos.  
Box reference I.12:  “Place of destination”:  Indicate the address and the unique registration number, if 
assigned by the competent authority, of the establishment of destination of the 
consignment of semen, oocytes or embryos.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species ”: Indicate “Canis lupus familiaris ” or “ Felis silvestris catus ” as appropriate . 
  “Identification number” : Indicate individual identification number of each donor 
animal.  
“Identification mark” : Indicate mark on the straw or other packages where semen, 
oocytes or embryos of the consignment are placed.  
“Date of  collection/production”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.  
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
registration number of the establishment of the collection or production of semen, 
oocytes or embryos of the consignment.  
“Quantity” : Indicate number of straws or other pa ckages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 367  EN CHAPTER 63: MODEL OFFICIAL CERTIFICATE FOR THE MOVEMENT 
BETWEEN MEMBER STATE S OF OTHER CARNIVORE S (MODEL ‘OTHCARN -
INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent  Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Release into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
impro vers  Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 368  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit thro ugh Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 369  EN EUROPEAN UNION   Certificate model OTHCARN -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify:  
II.1. The other carnivores(1)(2) of the consignment described in Part I meet the following requirements:  
II.1.1.  They are identified:  
(3)either  [individually ] 
(3)and/or  [as a group of animals of the same species kept together during the movement to 
destination]  
II.1.2.  They have undergone a clinical examination or a clinical inspection on ………………. 
(insert date  dd/mm/yyyy ) within the last 48 hours prior to departure and have not shown 
symptoms or clinical signs of diseases.  
II.1.3.  They come from a registered or approved establishment in which infection with rabies virus 
in kept terrestrial animals has not been reported during the last 30 days prior to departure 
and in wh ich to the best of my knowledge and as declared by the operator, there were no 
abnormal mortalities with an undetermined cause.  
II.2. The other carnivores(1) of the consignment described in Part I meet the following requirements:  
(3)either  [II.2.1.  They ha ve received a complete primary course of anti -rabies vaccination and at 
least 21 days have elapsed since the completion of the primary anti -rabies vaccination 
carried out in accordance with the validity requirements set out in Part I of Annex VII to 
Regula tion (EU) 2020/ 688, and any subs equent revaccination was carried out within the 
period of validity of the preceding vaccination.]  
(3)or [II.2.1.  They are intended  for direct transport in accordance with Article 58(2) of Regulation (EU) 
2020/ 688 to: 
(3)either  [the confined establishment indicated in Box I.20 of Part I.]  
(3) or [the establishment indicated in Box I.20 of Part I where these animals are kept as fur 
animals as defined in point 1 of Annex I to Regulation (EU) No 142/2011]]  
[II.2.2.  The canidae, other than dogs, due to their scheduled destination(4) indicated in Box I.10, or 
in Box I.11 where regionalisation is applied:  
(3)either  [have been treated against Echinococcus multilocularis  in accordance with Part 2(2) of 
Annex VII to Regulation  (EU) 2020/ 688]]; 
(3)or [have no t been treated against(5) Echinococcus multilocularis ]] 
Identification  Anti-echinococcus treatment  Administering veterinarian  
Name and 
manufacturer of the 
product  Date [dd/mm/yyyy] 
and time [00:00]of 
treatment  Name in capitals, stamp 
and signature  
    
    
    
    
(3)or [are intended for direct transport in accordance with Article 58(2) of Regulation (EU) 2020/ 688 to: This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 370  EN EUROPEAN UNION   Certificate model OTHCARN -INTRA  
 (3)either  [the confined establishment indicated in Box I.20 of Part I.]]]  
 (3)or [the establishment indicated in Box I.20 of Part I.]where these animals are kept as fur animals 
as defined in point (1) of Annex I to Regulation (EU) No 142/2011]]]  
II.3. Arrangements  are made to transport the consignment in accordance with Article 4 of Del egated 
Regulation (EU) 2020/ 688. 
II.4. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway /sea.  
 
Animal welfare attestation  
I, the undersigned official veterinari an, hereby certify, that the animals described above were examined 
today and found fit for the intended journey and all necessary arrangements were made to comply before 
and during the journey with the requirements of EU legislation on the protection of animals during 
transport, and especially as regards the means of transport, the loading and unloading facilities, the 
competence of the personnel, the space allowances, as well as wat ering, feeding intervals, journey time s 
and resting periods.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate a registered or an approved establishment of dispatch.  
Box reference I.12:  “Place of destination”:  Indicate a registered or an approved establishment of 
destination.  
Box reference I.30:  “Identification number” : Indicate for each animal of the consignment its identification.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Other carnivores means animals of the species belonging to the order Carnivora other than dogs, cats and 
ferrets as defined in Article 3(32) of Delegated Regulation (EU) 2020/ 688 
(3) Delete if not applicable.  
(4) Member States or parts thereof listed in th e Annex to Commission Implementing Regulation (EU) 
2018/878.  
(5) The table referred to in point II.2.2. must be used to document the details of the treatment against 
Echinococcus multilocularis, in accordance with Part 2(2) of Annex VII to Regulation (EU) 2020/ 688, if 
administered after the date the certificate was signed and prior to the scheduled entry into Member States 
or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 371  EN EUROPEAN UNION   Certificate model OTHCARN -INTRA  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 372  EN CHAPTER 64: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF WILD TERRESTRIAL ANIMALS (MODEL 
WILD -ANIMALS -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 Transporter  
 
 Aircraft   Vessel   Name  Registration/Authorisation No  
 Address   
 Country  ISO country code  
I.17 Accompanying documents  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document 
reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Further keeping   Slaughter   Confined 
establishment   Germinal products  
 Registered equi ne animal   Travelling circus/animal act   Exhibition   Event or activity near borders  
 Releas e into the wild   Dispatch centre   Relaying 
area/purification centre   Ornamental aqua culture 
establishment  
 Further process ing  Organic  fertilizers and soil 
improvers   Technical use   Quarantine  or similar 
establishment  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 373  EN  Products for h uman 
consumption    Live a quatic animals 
for human consumption   Other  
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  
I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24 Estimated journey time  I.25 Journey log   yes  no 
I.26 Total number of packages  I.27 Total quantity  
I.28 Total net weight/gross weight  (kg) I.29 Total space foreseen for the consignment  
I.30 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
Region of 
origin   Cold store   Identification 
mark  Type of packaging   Net weight  
        
Slaughterhouse   Treatment type   Nature of 
commodity  Number of packages   Batch No  
        
  Date of 
collection/production   Manufacturing 
plant  Approval or registration 
number of 
plant/establishment/centre  Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 374  EN EUROPEAN UNION   Certificate model WILD -ANIMALS -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The animals(1) of the consignment described in Part I  are wild terrestrial animals and meet the following 
requirements:  
II.1.1.  The majority of the animals of the consignment, for at least the last 30 days prior to the 
departure of the consignment, or since birth, if th ey are younger than 30 days of age,  
II.1.1.1.  have been resident in the habitat of origin;  
II.1.1.2.  have not been in contact with kept animals of a lower health status or subject to 
movement restrictions for animal health reasons;  
II.1.1.3.  have not bee n in direct or indirect contact with kept animals that have entered the 
Union from a third country or territory during the last 30 days prior to the 
departure of the animal . 
II.1.2.  They have not shown clinical signs or symptoms of listed diseases or emerg ing diseases for 
animals of the species concerned during the clinical examination, or where this is not 
possible, the clinical inspection, carried out within 24 hours prior to departure on 
………………. ( insert date  dd/mm/yyyy ). 
II.2. According to official infor mation, the wild terrestrial animals described in Part I do not come from a 
habitat subject to movement restrictions or situated in a restricted zone  established for reasons of listed 
diseases for animals of the species concerned.  
(2)[II.3. According to official information, the wild terrestrial animals described in Part I are ungulates and meet 
the following health requirements:  
(2)[II.3.1.  They come from a habitat in which infection with Brucella abortus, B. melitensis  and B. suis  
in wild terrestrial an imals of listed species for that disease has not been reported during the 
last 42 days prior to departure.]  
(2)[II.3.2.  They come from a habitat in which infection with  Mycobacterium tuberculosis complex  (M. 
bovis, M. caprae and M. tuberculosis) in wild te rrestrial animals of listed species for that 
disease has not been reported during the last 42 days prior to departure.]  
(2)[II.3.3.  They come from a habitat in which infection with rabies virus has not been reported during 
the last 30 days prior to departu re.] 
(2)[II.3.4.  They come from a habitat in which infection with epizootic haemorrhagic disease virus within 
a radius of 150 km has not been reported in wild terrestrial animals of listed species of that 
disease during the last 2 years prior to departure. ] 
(2)[II.3.5.  They come from a habitat  in which anthrax in ungulates has not been reported during the last 
15 days prior to departure.]  
(2)[II.3.6.  They come from a habitat  in which surra ( Trypanosoma evansi ) has not been reported during 
the last 30 days p rior to departure.]  
 (2)[II.4. According to official information the wild terrestrial animals described in Part I belong to the families 
Antilocapridae , Bovidae , Camelidae , Cervidae , Giraffidae , Moschidae  or Tragulidae  and meet the 
following health requirements:  
(2) either [II.4.1.  They originate from habitat in a Member State or a zone free from infection with bluetongue 
virus (serotype 1 -24) and have not been vaccinated with a live vaccine against infection with 
bluetongue virus (serotype 1 -24) in the last 60 days before the date of movement  and the 
requirements laid down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 375  EN EUROPEAN UNION   Certificate model WILD -ANIMALS -INTRA  
(EU) 2020/688 are fulfilled .] 
(2)and/or [II.4.2.  They originate from a h abitat in a Member State or a zone covered by the eradication 
programme for infection with bluetongue virus (serotype 1 -24) and the requirements laid 
down in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 2020/688 
are fulfilled,  and they 
(2)either  [II.4.2.1.  have been resident in a Member State or zone seasonally free from infection with 
bluetongue virus (serotype 1 -24) in accordance with Article 40(3) of Regulation 
(EU) 2020/ 689 
 (2)either  [II.4.2.1.1.  for at least 60 days prior  to the date of movement.]]]  
(2)or [II.4.2.1.2.  for at least 28 days prior to the date of movement and have been 
subjected to a serological test, with negative results, carried out on 
samples collected at least 28 days following the entry date of the 
anima l into the Member State or zone seasonally free from infection 
with bluetongue virus (serotype 1 -24).]]]  
(2)or [II.4.2.1.3.  for at least 14 days prior to the date of movement and have been 
subjected to a PCR test, with negative results, carried out on samp les 
collected at least 14 days following the entry date of the animal into 
the Member State or zone seasonally free f rom infection with 
bluetongue virus (serotype 1 -24).]]]  
 (2)and/or [II.4.2.2.  have been vaccinated against those serotypes from 1 to 24 of infection with 
bluetongue virus which were reported during the past 2 years in that Member 
State or zone and are within the immunity period guaranteed in the specifications 
of the vaccine and  
(2)either  [II.4.2.2.1.  have been vaccinated more than 60 days before the date of 
movement.]]]  
(2)and/or  [II.4.2.2.2.  have been vaccinated with an inactivated vaccine and subjected to a 
PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity set in the specifications of th e 
vaccine.]]]  
(2)and/or [II.4.2.3.  have been subjected with positive results to a serological test able to detect 
specific antibodies against all serotypes 1 -24 of infection with bluetongue virus 
reported during the past 2 years in that Member State or zon e and  
(2)either  [II.4.2.3.1.  the serological test has been carried out on samples collected at least 
60 days before the date of movement.]]]  
(2)or [II.4.2.3.2.  the serological test has been carried out on samples collected at least 
30 days before the date of the movement and the animal has been 
subjected to a PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of movement.]]]  
(2)and/or [II.4.3.  They originate from a habitat in a Member State or a zone ne ither free from infection with 
bluetongue virus (serotype 1 -24) nor covered by the eradication programme for infection with 
bluetongue virus (serotype 1 -24) and the requirements laid down in Article 32(1)(a), (b) or (c) 
or Article 32(2) of Delegated Regula tion (EU) 2020/688 are fulfilled, and they 
 [II.4.3.1.  have been resident at least for the last 60 days prior to departure in a habitat 
situated in a Member State or in an area of at least 150 km radius centred on the 
habitat, where surveillance in complia nce with the requirements laid down in 
Sections 1 and 2 of Chapter 1 of Part II of Annex V to Regulation (EU) 2020/ 689 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 376  EN EUROPEAN UNION   Certificate model WILD -ANIMALS -INTRA  
has been  carried out during that period  and 
(2)either  [II.4.3.1.1.  the animals have been vaccinated against those serotypes from 1 to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the 
habitat where the animals were resident  and are within the immunity 
period guaranteed in the specifications of the vaccine and  
(2)either  [II.4.3.1.1.1.  have been vaccinated more than 60 days before the 
date of movement.]]]]  
(2)and/or  [II.4.3.1.1.2.  have been vaccinated with an inactivated vaccine and 
subjected to a PCR test, with negative results on 
samples collected at least 14 days after the onset of the 
immunity set in the specifications of the vaccine.]]]]  
(2)or [II.4.3.1.2.  the animals have been immunised against those serotypes from 1  to 
24 of infection with bluetongue virus which were reported during the 
past 2 years in an area of at least 150 km radius centred on the 
habitat where the animals were resident, and   
(2)either  [II.4.3.1.2.1.  the animals have been subjected with positive r esults 
to a serological test carried out on samples collected at 
least 60 days before the date of movement.]]]]  
(2)or [II.4.3.1.2.2.  the animals have been subjected with positive results 
to a serological test carried out on samples collected at 
least 30 da ys before the date of the movement and to a 
PCR test, with negative results, carried out on samples 
collected not earlier than 14 days before the date of 
movement.]]]]  
(2)and/or [II.4.4.  They do not fulfil the requirements laid down in points 1 to 3 of Sect ion 1 of Chapter 2 of 
Part II of Annex V to  Regulation (EU) 2020/ 689 and the competent authority of the Member 
State of origin authorised movement of those animals to another Member State or zone 
thereof  
(2)either  [II.4.4.1.  with the status free from infec tion with bluetongue virus (serotype 1 -24) and the 
Member State of destination has informed the Commission and the other 
Member States that such movement is authorised under the conditions referred to 
in Article 43(2)(a), (b) and (c) of Regulation  (EU) 202 0/689 and 
(2)either  [II.4.4.1.1.  point 5 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.1.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.1.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.1.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Article 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.4.4.2.  with an approved eradication programme for infection with bluetongue virus This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 377  EN EUROPEAN UNION   Certificate model WILD -ANIMALS -INTRA  
(serotype 1 -24) and the Member State  of destination has informed the 
Commission and the other Member States that such movement is authorised 
under the conditions referred to in Article 43(2)(a), (b) and (c) of Regulation  
(EU) 2020/ 689 and 
(2)either  [II.4.4.2.1.  point 5 of Section 1 of Chapte r 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.2.2.  point 6 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.2.3.  point 7 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
(2)and/or  [II.4.4.2.4.  point 8 of Section 1 of Chapter 2 of Part II of Annex V to  that 
Regulation , and  
the requirements laid down in Article 32(1)(a), (b) or (c) or Article 
32(2) of Delegated Regulation (EU) 2020/688  and the requirements 
laid down in Artic le 33  of that Delegated Regulation  are fulfilled .]]] 
 (2)or [II.4.4.3.  neither free from infection with bluetongue virus (serotype 1 -24) nor covered by 
the eradication programme for infection with bluetongue virus (serotype 1 -24) 
and the Member State of de stination has informed the Commission and the other 
Member States that such movement is authorised  
(2)either  [II.4.4.3.1.  without any conditions , and  
(2)and/or  [II.4.4.3.2.  under the conditions referred to in point 5 of Section 1 of Chapter 2 
of Part II of  Annex V to  Regulation (EU) 2020/ 689, and  
(2)and/or  [II.4.4.3.3.  under the conditions referred to in point 6 of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 2020/ 689, and  
(2)and/or  [II.4.4.3.4.  under the conditions referred to in point 7  of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 2020/ 689, and  
(2)and/or  [II.4.4.3.5.  under the conditions referred to in point 8 of Section 1 of Chapter 2 
of Part II of Annex V to Regulation (EU) 2020/ 689, and  
the requirements laid down  in Article 32(1)(a), (b) or (c) or Article 32(2) of Delegated Regulation (EU) 
2020/688  and the requirements laid down in Article 33  of that Delegated Regulation  are fulfilled .]]]II.5.
 To the best of my knowledge and as declared by the operator, the wild t errestrial animals come 
from a habitat where there were no abnormal mortalities with an undetermined cause . 
II.6. Arrangements  are made to transport the consignment in accordance with Article 101(1), (2) and (3) of 
Delegated Regulation (EU) 2020/ 688. 
II.7. This certificate is valid  for 10 days from the date of issuing. In the case of transport by waterway/sea of 
animals, the period of validity of the certificate may be extended by the duration of the journey by 
waterway/sea.  
 
Animal welfare attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above were examined today and 
found fit for the intended journey and all necessary arrang ements were made to comply before and during the 
journey with the requirements of EU legislation on the protection of animals during transport, and especially as 
regards the means of transport, the loading and unloading facilities, the competence of the personnel, the space This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 378  EN EUROPEAN UNION   Certificate model WILD -ANIMALS -INTRA  
allowances, as well as watering, feeding intervals, journey tim es and resting periods . 
 
Notes:  
Guidance on the completion of th  this e official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) [IA FOOD] . 
 
Part I:  
Box reference I. 11: “Place of dispatch ”: Indicate a habitat of the origin of the animals in the consignment.  
Box reference I. 12: “Place of destination ”: Indicate a habitat or an establishment of the final destination of 
the consignment.  
Box reference I. 30: “Identification number” : Indicate ident ification codes of the animals in the 
consignment.  
 
Part II:  
(1) There can be one or more animals in the consignment.  
(2) Delete if not applicable.  
Official veterinarian  
Name (in capital letters)   Qualification and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 379  EN CHAPTER 65: MODEL OFFICIAL CER TIFICATE FOR THE MOV EMENT 
BETWEEN MEMBER STATE S OF SEMEN, OOCYTES AND EMBRYOS OF 
ANIMALS OF THE FAMIL IES CAMELIDAE AND CE RVIDAE WHICH WERE 
COLLECTED OR PRODUCE D, PROCESSED AND STO RED IN ACCORDANCE 
WITH REGULATION (EU)  2016/429 AND DELEG ATED REGULATION (EU) 
2020/ 686 (MODEL ‘GP -CAM -CER -INTRA’)  
EUROPEAN UNION  INTRA  Part I: Description of consignment  I.1 Consignor    I.2 IMSOC reference    
 Name   I.2a Local reference    
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country 
code  I.4 Local Competent Authority    
I.5 Consignee   I.6 Operator conducting assembly operations independently 
of an establishment  
 Name    Name  Registration No  
 Address    Address   
 Country  ISO country 
code   Country  ISO country code  
I.7 Country of origin  ISO country 
code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval 
No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of 
transport    I.16 
  
 Aircraft   Vessel   
 
 
I.17  
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
  Germinal products    
I.21  For transit through a third country  
 Third country  ISO country code  
 Exit point  BCP code  
 Entry point  BCP code  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 380  EN I.22  For transit through Member State(s)  I.23  For export  
 Member State  ISO country code   Third country  ISO country code  
 Member State  ISO country code   Exit point  BCP code  
 Member State  ISO country code     
I.24  I.25  
I.26 Total number of packages  I.27 Total quantity  
I.28  I.29  
I.30 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
Type   Date of 
collection/production   Identification 
mark  Approval or registration 
number of 
plant/establishment/centre  Test  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 381  EN EUROPEAN UNION  Certificate model GP-CAMELID -CERVID -INTRA  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that : 
II.1. The semen(1)/ oocytes(1)/ embryos(1) described in Part I are intended for artificial reproduction and 
were obtained from the donor animals which  
II.1.1.  have been born and remained since birth in the Union, or have entered the Union in 
accordance with the requirements for entry into the Union;  
II.1.2.  have remained in a single establishment of origin for a period of at least 30 days prior 
to the date of c ollection of the semen(1)/ oocytes(1)/ embryos(1); 
(1)[II.1.3.  are animals of the family Camelidae  and are identified in accordance with Article 
73(1) of Delegated Regulation (EU) 2019/2035.]  
(1)[II.1.3.  are animals of the family Cervidae  and are identifi ed in accordance with Article 73 
(2) or Article 74 of Delegated Regulation (EU) 2019/2035.]  
II.2. The semen(1)/ oocytes(1)/ embryos(1) described in Part I come from a registered establishment 
assigned by the competent authority with a unique registration number as indicated in Box I.11.  
II.3. According to official information, the semen(1)/ oocytes(1)/ embryos(1) were obtained from the 
donor animals which  
II.3.1.  do not come from an establishment, nor have been in contact with animals from an 
establishment , situated in a restricted zone established due to the occurrence of foot -
and-mouth disease, infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus or of an emerging disease 
relevant for the  species in those kept terrestrial animals;  
II.3.2.  come from an establishment where during a period of at least the preceding 12 
months prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1) 
II.3.2.1.  a surveillance programme to detect in fection with Mycobacterium 
tuberculosis complex ( M. bovis, M. caprae and M. tuberculosis ) has 
been carried out  in accordance with Part 2 or 3 of Annex II to Delegated 
Regulation (EU) 2020/ 688; 
II.3.2.2.  no animals of the family Camelidae  or Cervidae  which do not fulfil the 
requirements referred to in point II.3.2.1.  has been introduced;  
II.3.2.3.  in case of suspicion of infection with Mycobacterium tuberculosis 
complex ( M. bovis, M. caprae and M. tuberculosis ), investigations were 
carried out and the disease was ruled out;  
II.3.3.  come from an establishment where infection with Brucella abortus, Brucella 
melitensis  and Brucella suis  has not been reported during the period of at least the 
preceding 42 days prior to the date of collection of the semen(1)/ oocytes(1)/ 
embryos(1); 
(1)[II.3.4.  are animals of the family Camelidae  and come from an establishment where all 
animals present have been subjected to a test for infection with Brucella abortus, 
Brucella melitens is and Brucella suis  as referred to in Part 1 of Annex I to Delegated 
Regulation (EU) 2020/ 688 with negative results carried out on samples taken during 
the period of the preceding 30 days prior to the date of collection of the semen(1)/ 
oocytes(1)/ embryo s(1);] 
II.3.5.  come from an establishment where infectious bovine rhinotracheitis/ infectious This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 382  EN EUROPEAN UNION  Certificate model GP-CAMELID -CERVID -INTRA  
pustular vulvovaginitis has not been reported during the period of at least the 
preceding 30 days prior to the date of collection of the semen(1)/ oocytes(1)/ 
embryos(1); 
II.3.6.  come from an establishment where infection with epizootic haemorrhagic disease 
virus has not been reported during a period of at least the preceding 2 years prior to 
the date of collection of the semen(1)/ oocytes(1)/ embryos(1) within a radius of 150 km 
around the establishment ; 
II.3.7.  come from an establishment where infection with rabies virus has not been confirmed 
during the period of at least the preceding 30 days prior to the date of collection of 
the semen(1)/ oocytes(1)/ embryos(1); 
II.3.8.  come from an establishment where anthrax has not been reported during the period of 
at least the preceding 15 days prior to the date of collection of the semen(1)/ 
oocytes(1)/ embryos(1); 
II.3.9.  come from an establishment where surra ( Trypanos oma evansi ) has not been reported 
during a period of at least the preceding 30 days prior to the date of collection of the 
semen(1)/ oocytes(1)/ embryos(1), and  
(1)either  [surra has not been  confirmed during the preceding 2 years ;] 
 (1)or [surra has been confirmed during the preceding 2 years  and following the last 
outbreak of that disease the establishment has remained under movement restrictions 
until 
– the infected animals were removed from the establishment; and  
– the remaining animals on the establishmen t were subjected to a test for surra 
(Trypanosoma evansi ) referred to in Part 3 of Annex I to Delegated Regulation 
(EU) 2020/ 688, with negative result, carried out on samples taken at least 6 
months after the infected animals were removed from the establishment;]  
II.3.10.  comply with at least one of the following conditions as regards infection with 
bluetongue virus (serotypes 1 -24): 
(1)either  [II.3.10.1.  they have been kept in a Member State or zone thereof free from infection 
with bluetongue virus (serotypes 1 -24) for a period of at least 60 days 
prior to and during collection of the semen(1)/ oocytes(1)/ embryos(1);] 
(1)and/or  [II.3.10.2.  they have been kept in a seasonally disease -free zone, during the 
seasonally disease -free period, for a period of at least 60 days prior to and 
during collection of the semen(1)/ oocytes(1)/ embryos(1), in a Memebr State 
or zone thereof with an approved eradication progr amme against infection 
with bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.3.10.3.  they have been kept in a seasonally disease -free zone, during the 
seasonally disease -free period, for a period of at least 60 days prior to and 
during collection of the semen(1)/ oocytes(1)/ embryos(1), in a Memebr State 
or zone thereof where the competent authority of the place of origin of the 
consignment of semen(1)/ oocytes(1)/ embryos(1) has obtained the prior 
written consent of the competent authority of the Member St ate of 
destination to the conditions for establishment of that seasonally disease -
free zone and to accept the consignment of semen(1)/ oocytes(1)/ 
embryos(1);] 
(1)and/or  [II.3.10.4.  they have been kept in a vector -protected establishment for a period of at 
least 60 days prior to and during collection of the semen(1)/ oocytes(1)/ This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 383  EN EUROPEAN UNION  Certificate model GP-CAMELID -CERVID -INTRA  
embryos(1);] 
(1)and/or  [II.3.10.5.  they have been subjected to a serological test to detect antibodies to t he 
bluetongue virus serogroup 1 -24, with negative results, between 28 and 60 
days from the date of each collection of the semen(1)/ oocytes(1)/ 
embryos(1);] 
(1)and/or  [II.3.10.6.  they have been subjected to an agent identification test for bluetongue 
virus  (serotypes 1 -24), with negative results, on blood samples taken at 
commencement and final collection of the semen and during collection of 
the semen at intervals of  at least every 7 days, in the case of the virus 
isolation test, or of at least every 28 da ys, in the case of PCR;]  
(1)and/or  [II.3.10.7.  they have been subjected to an agent identification test for bluetongue 
virus (serotypes 1 -24), with negative results, on blood sample taken on the 
date of collection of the oocytes(1)/ embryos(1).] 
II.4. To the best of my knowledge and as declared by the operator, the semen(1)/ oocytes(1)/ embryos(1) 
described in Part I were obtained from the donor animals which  
II.4.1.  have been clinically examined by a veterinarian and showed no diseases symptoms 
on the day of collection of the semen(1)/ oocytes(1)/ embryos(1); 
II.4.2.  have  not been in contact with animals which did not comply with the requirements 
set out in point II.1.1. and in points II.3.1. to II.3.10. during the residency period of at 
least 30 days set out in point II.1.2.;  
II.4.3.  were  not used for natural breeding dur ing a period of at least 30 days prior to the date 
of collection of the semen(1)/ oocytes(1)/ embryos(1) and during the collection period.  
II.5. The semen(1)/ oocytes(1)/ embryos(1) described in Part I are placed in a sealed transport container 
and the sea l bears the number as indicated in Box I.19.  
II.6. To the best of my knowledge and based on the documentary check of the data submitted by the 
operator, the semen(1)/ oocytes(1)/ embryos(1) described in Part I are placed in straws or other 
packages on whic h the mark is applied in accordance with requirements provided for in Article 
11 of Delegated Regulation (EU) 2020/ 686 and that mark is indicated in Box I.30.  
II.7. This certificate is valid  for 10 days from the date of issuing.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch”:  Indicate the address and the unique registration number of the 
establishment of dispatch of the consignment of semen, oocytes or embryos.  
Box reference I.12:  “Place of destination”:  Indicate the address and the unique registration number of the 
establishm ent of destination of the consignment of semen, oocytes or embryos.  
Box reference I.30:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species” : Indicate “Camelidae ” or “Cervidae ” as appropriate . 
  “Identification number” : Indicate individual identification number of each donor 
animal.  
“Identification mark” : Indicate mark on the straw or other packages where semen, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 384  EN EUROPEAN UNION  Certificate model GP-CAMELID -CERVID -INTRA  
oocytes or embryos of the consignment are placed.  
“Date of collection/production: Indicate the date on which semen, oocytes or embryos 
of the consignment were collected or produced.  
“Approval or registration number of plant/establishment/centre”: Indicate the unique 
registration number of the establishment of t he collection or production of semen, 
oocytes or embryos of the consignment.  
“Quantity” : Indicate number of straws or other packages with the same mark.  
Part II:  
(1) Delete if not applicable.  
Official veterinarian  
Name (in capital letters)   Qualification  and title   
Local Control Unit name   Local Control Unit code   
Date     
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 385  EN ANNEX II  
Annex II contains the following model official certificate s for the entry into the Union:  
Model   
ungulates  
BOV -X Chapter 1: Model official certificate for the entry into the Union of bovine 
animals  
BOV -Y Chapter 2: Model official certificate for the entry into the Union of bovine 
animals intended for slaughter  
BOV -X-TRANSIT -RU Chapter 3: Model official certificate for the entry into the Union of domestic 
bovine animals (including Bubalus and Bison species and their cross -breeds) 
intended for transit from the region of Kaliningrad to other regions of Russia 
via the territory of Lithuania  
OV/CAP -X Chapter 4: Model official certificate for the entry into the Union of ovine and 
caprine animals  
OV/CAP -Y Chapter 5: Model official certificate for the entry into the Union of ovine and 
caprine animals intended for slaughter  
SUI-X Chapter 6: Model official certificate for the entry into the Union of porcine 
animals and animals of the famil y of Tayassuidae  
SUI-Y Chapter 7: Model official certificate for the entry into the Union of porcine 
animals intended for slaughter  
RUM  Chapter 8: Model official certificate for the entry into the Union of animals of 
the families Antilocapridae, Bovidae  (other than  bovine, ovine and caprine 
animals) , Giraffidae, Moschidae and Tragulidae  
RHINO  Chapter 9: Model official certificate for the entry into the Union of animals of 
the families Tapiridae, Rhinocerotidae and Elephantidae  
HIPPO  Chapter 10: Model official certificate for the entry into the Union of animals of 
the family Hippopotamidae  
CAM -CER  Chapter 11: Model official certificate for the entry into the Union of camelid 
and cervid animals  
equine animals  
EQUI -X Chapter 12: Model official certificate for the entry into the Union of 
consignments of domestic equidae not intended for slaughter  
EQUI -Y Chapter 13: Model official certificate for the entry into the Union of 
consignments of domestic equidae intended for slaughter  
EQUI -TRANSIT -X Chapter 14: Model health certificate and model declaration for transit through 
the Union of equine animals  not intended for slaughter  
EQUI -TRANSIT -Y Chapter 15: Model health certificate and model declaration for transit through 
the Union of equine animals intended for slaughter  
EQUI -RE-ENTRY -30 Chapter 16: Model health certificate and model declaration for the re -entry into 
the Union of registered horses for racing, competition and cultural events after 
temporary export for a period of not more than 30 days  
EQUI -RE-ENTRY -90-COM P Chapter 17: Model health certificate and model declaration applicable to re -
entry into the Union of registered horses for competition after temporary export 
for a period of not more than 90 days to participate in equestrian events 
organised under the auspices of the Fédération Equestre Internationale (FEI)  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 386  EN EQUI - RE-ENTRY -90-
RACE  Chapter 18: Model health certificate and model declaration applicable to re -
entry into the Union of registered horses for racing after temporary export for a 
period of not more than 90 days to participate in specific race events in 
Australia, Canada, the Unit ed States of America, Hong Kong, Japan, Singapore, 
the United Arab Emirates or Qatar  
ungulates intended for a confined establishment  
CONFINED -RUM  Chapter 19: Model official certificate for the entry into the Union of animals 
listed in Section 1 of Chapter N of Annex II that are originating from and 
intended for a confined establishment  
CONFINED -SUI Chapter 20: Model official certificate for the entry into the Union of animals 
listed in Section 1 of Chapter N of Annex II that are originating from and 
intended for a confined establishment  
CONFINED -TRE  Chapter 21: Model official certificate for the entry into the Union of animals 
listed in Section 1 of Chapter N of Annex II that are originating from and 
intended for a confined establishment  
CONFINED -HIPPO  Chapter 22: Model official certificate for the entry into the Union of animals of 
the family Hippopotamidae that are originating from and intended for a 
confined establishment  
Birds  
BPP Chapter 23: Model official certificate for the entry into the Union of breeding 
poultry other than ratites and productive poultry other than ratites  
BPR  Chapter 24: Model official certificate for the entry into the Union of breeding 
ratites and productive ratites  
DOC  Chapter 25: Model official certificate for the entry into the Union of day-old 
chicks other than of ratites  
DOR  Chapter 26: Model official certificate for the entry into the Union of day-old 
chicks of ratites  
HEP  Chapter 27: Model official certificate for the entry into the Union of hatching 
eggs of poultry other than ratites  
HER  Chapter 28: Model official certificate for the entry into the Union of hatching 
eggs of ratites  
SPF Chapter 29: Model official certificate for the entry into the Union of specified 
pathogen -free eggs  
SP Chapter 30: Model official certificate for the entry into the  Union of poultry 
intended for slaughter  other than ratites  
SR Chapter 31: Model official certificate for the entry into the Union of ratites 
intended for slaughter  
POU -LT20  Chapter 32: Model official certificate for the entry into the Union of less than  
20 heads of poultry other than ratites  
HE-LT20  Chapter 33: Model official certificate for the entry into the Union of  less than 
20 hatching eggs of poultry other than ratites  
CAPTIVE - BIRDS  Chapter 34: Model official certificate for the entry into the Union of captive 
birds  
HE-CAPTIVE -BIRDS  Chapter 35: Model official certificate for the entry into the Union of hatching 
eggs of captive birds  
bees This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 387  EN QUE  Chapter 36: Model official certificate for the entry into the Union of queen 
honeybees  
BBEE  Chapter 37: Model official certificate for the entry into the Union of bumble 
bees 
dogs, cats and ferrets  
CANIS -FELIS -FERRETS  Chapter 38: Model official certificate for the entry into the Union of dogs, cats 
and ferrets  
germinal products of bovine animals  
BOV -SEM -A-ENTRY  Chapter 39: Model official certificate for the entry into the Union of semen of 
bovine animals collected, processed and stored in accordance with Regulation 
(EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 , 
and dispatched from a semen collection centre where the semen was collected  
BOV -SEM -B-ENTRY  Chapter 40: Model official certificate for the entry into the Union of stocks of 
semen of bovine animals collected, processed and stored in accordance with 
Council Directive 88/407/EEC , as amended by Council Directive 2003/43/EC,  
after 31 December 2004 and before 21 April 2021, and entered into the Union 
after 20 April 2021, and dis patched from a semen collection centre where the 
semen was collected  
BOV -SEM -C-ENTRY  Chapter 41: Model official certificate for the entry into the Union of stocks of 
semen of bovine animals collected, processed and stored before 1 January 2005 
in accordan ce with Council Directive 88/407/EEC applying until 1  July 2004 , 
and entered into the Union after 20 April 2021, and dispatched from a semen 
collection centre where the semen was collected  
BOV -OOCYTES -EMB -A-
ENTRY  Chapter 42: Model official certificate  for the entry into the Union of oocytes 
and embryos of bovine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20  April 2021 , and dispatched by an embryo collection or  
production team by which the oocytes or embryos were collected or produced  
BOV -in-vivo-EMB -B-
ENTRY  Chapter 43: Model official certificate  for the entry into the Union of stocks of 
in vivo  derived embryos of bovine animals collected, processed and stored 
before 21 April 2021 in accordance with Council Directive 89/556/EEC , and 
entered into the Union after 20 April 2021, and dispatched by an embryo 
collection team by which the embryos were collected  
BOV -in-vitro -EMB -C-
ENTRY  Chapter 44: Model official certificate for the entry into the Union of stocks of 
in vitro  produced embryos of bovine animals produced, processed and stored 
before 21 April 2021 in accordance with Council Directive 89/556/EEC , 
conceived using semen complying with req uirments of Council Directive 
88/407/EEC, and entered into the Union after 20 April 2021, and dispatched by 
an embryo production team by which the embryos were produced  
BOV -in-vitro -EMB -D-
ENTRY  Chapter 45: Model official certificate  for the entry into the  Union of stocks of 
in vitro  produced embryos of bovine animals produced, processed and stored 
before 21 April 2021 in accordance with Council Directive 89/556/EEC , 
conceived using semen coming from semen collection or storage centres 
approved by the compe tent authority of the exporting country, and entered into 
the Union after 20 April 2021, and dispatched by an embryo production team 
by which the embryos were produced  
BOV -GP-PROCESSING -
ENTRY  Chapter 46: Model official certificate  for the entry into the Union of 
consignments of:  
- semen of bovine animals collected, processed and stored in accordance This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 388  EN with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed and stored 
before 1 January 2005 in accordance with Council Dir ective 
88/407/EEC applying until 1 July 2004;  
- oocytes  and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of in vivo  derived embryos of bovine animals collected, 
processed and stored in accordance with Directive 89/556/EEC  before 
21 April 2021;  
- stocks of in vitro  produced embryos of bovine animals produced, 
processed and stored in accordance with Directive 89/556/EEC  before 
21 April 2021,  conceived using semen complying with requirements 
of Council Directive 88/407/EEC;  
- stocks of in vitro  produced embryos of bovine animals collected, 
processed and stored in accordance with Directive 89/556/EEC before 
21 April 2021,  conceived using semen coming from semen collection 
or storage centres approved by the competent authority of the 
exporting country,  
and entered into the Union after 20 April 2021, and dispatched from a germinal 
product processing establishment  
BOV -GP-STOR AGE -
ENTRY  Chapter 47: Model official certificate  for the entry into the Union of 
consignments of:  
- semen of bovine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in 
accordance with Council Directive 88/407/EEC, as amended by 
Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collecte d, processed and stored 
before 1 January 2005 in accordance with Council Directive 
88/407/EEC applying until 1 July 2004;  
- oocytes  and embryos of bovine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of in vivo  derived embryos of bovine animals collected, 
processed and stored in accordance with Directive 89/556/EEC  before 
21 April 2021;  
- stocks of in vitro  produc ed embryos of bovine animals produced, 
processed and stored in accordance with Directive 89/556/EEC  before 
21 April 2021,  conceived using semen complying with requirements 
of Council Directive 88/407/EEC;  
- stocks of in vitro  produced embryos of bovine anima ls collected, 
processed and stored in accordance with Directive 89/556/EEC before 
21 April 2021,  conceived using semen coming from semen collection 
or storage centres approved by the competent authority of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 389  EN exporting country,  
and entered into the Union after 20 April 2021, and dispatched from a germinal 
product storage centre  
germinal products of ovine and caprine animals  
OV/CAP -SEM -A-ENTRY  Chapter 48: Model official certificate for the entry into the Union of semen of 
ovine and caprine animals collected , processed and stored  in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20  
April 2021 , and dispatched from a semen collection centre where the semen 
was collected  
OV/CAP -SEM -B-ENTRY  Chapter 49: Model official certificate for the entry into the Union of stocks of 
semen of ovine and caprine animals collected , processed and stored  in 
accordance with Directive 92/65/EEC before 21 April 2021, and dispatched 
after 20 April 2021 from a semen collectio n centre where the semen was 
collected  
OV/CAP -OOCYTES -EMB -
A-ENTRY  Chapter 50: Model official certificate for the entry into the Union of oocytes 
and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Regula tion (EU) 2016/429 and Delegated Regulation 
(EU) 2020/ 692 after 20 April 2021 and dispatched by an embryo collection or 
production team  by which the oocytes or embryos were collected or produced  
OV/CAP -OOCYTES -EMB -
B-ENTRY  Chapter 51: Model official certif icate for the entry into the Union of oocytes 
and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Directive 92/65/EEC before 21 April 2021 and 
dispatched by an embryo collection or production team  by which the oocytes or 
embryos were collected or produced  
OV/CAP -GP-PROCESSING -
ENTRY  Chapter 52: Model official certificate for the entry into the Union of 
consigments of:  
- semen of ovine and caprine animals collected, processed and stored in 
accordance with  Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 
April 2021;  
- oocytes  and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 
2021  
- stocks of oocytes  and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 21 April 2021,  
and entered into the Union after 20 April 2021, and dispatched from a germinal 
product processing establishment  
OV/CAP -GP-STORAGE -
ENTRY  Chapter 53: Model official certificate for the entry into the Union of 
consigments of:  
- semen of ovine and caprine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 
April 2021;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 390  EN - oocytes  and embryos of ovine and caprine animals collected or 
produced, processed and stored in accordance with Regulation (EU ) 
2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 
2021  
- stocks of oocytes  and embryos of ovine and caprine animals collected 
or produced, processed and stored in accordance with Council 
Directive 92/65/EEC before 21 April 2021,  
and entered into the Union after 20 April 2021, and dispatched from a germinal 
product storage centre  
germinal products of porcine animals  
POR -SEM -A-ENTRY  Chapter 54: Model official certificate for the entry into the Union of 
consignments of semen of porcine animals  collected , processed and stored  in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20  April 2021 , and dispatched from a semen collection centre 
where the semen was collected  
POR -SEM -B-ENTRY  Chapter 55: Model official certificate for the entry into the Union of 
consignments of stocks of semen of porcine animals collected , processed and 
stored  in accordance with Directive 90/429/EEC before 21 April 2021, and 
dispatched after 20 April 2021 from a semen co llection centre where the semen 
was collected  
POR -OOCYTES -EMB -
ENTRY  Chapter 56: Model official certificate for the entry into the Union of 
consignments of oocytes and embryos of porcine animals collected or 
produced, processed and stored in accordance wit h Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 and dispatched 
by an embryo collection or production team  by which the oocytes or embryos 
were collected or produced  
POR -GP-PROCESSING -
ENTRY  Chapter 57: Model official c ertificate for the entry into the Union of 
consigments of:  
- semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of porcine animals collected, processed and stored in 
accordance with Council Directive 90/429/EEC before 21 April 2021;  
- oocytes  and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 , 
and entered into the Union after 20 April 2021, and dispatched from a germinal 
product processing establishment  
POR -GP-STORAGE -ENTRY  Chapter 58: Model official certificate for the entry into the Union of 
consigments of:  
- semen of porcine animals collected, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation 
(EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of porcine animals collected, processed and stored in 
accordance with Council D irective 90/429/EEC before 21 April 2021;  
- oocytes  and embryos of porcine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 , 
and entered into the Union after 20 April 2021, and dispatched from a germinal This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 391  EN product storage centre  
germinal products of equine animals  
EQUI -SEM -A-ENTRY  Chapter 59: Model official certificate for the entry into the Union of 
consignments of semen of equine animals collected , processed and stored  in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20 April 2021 , and dispatched from a semen collection centre 
where the semen was collected  
EQUI -SEM -B-ENTRY  Chapter 60: Model official certificate for the entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and 
stored in accordance with Directive 92/65/EEC after 30  September 2014 and 
before 21 April 2021, and dispatched after 20 April 2021 from a semen 
collection centre where the semen was collected  
EQUI -SEM -C-ENTRY  Chapter 61: Model official certificate for the entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and 
stored in accordance  with Directive 92/65/EEC after 31 August 2010 and 
before 1 October 2014, and dispatched after 20 April 2021 from a semen 
collection centre where the semen was collected  
EQUI -SEM -D-ENTRY  Chapter 62: Model official certificate for the entry into the Union of 
consignments of stocks of semen of equine animals collected, processed and 
stored in accordance with Directive 92/65/EEC before 1 September 2010 and 
dispatched after 20 April 2021 from an approved semen collection centre where 
the semen was collected  
EQUI-OOCYTES -EMB -A-
ENTRY  Chapter 63: Model official certificate for the entry into the Union of 
consignments of oocytes and embryos of equine animals collected or produced , 
processed and stored  in accordance with Regulation (EU) 2016/429 and 
Delegated Regulation (EU) 2020/ 692 after 20 April 2021 , and dispatched by an 
embryo collection or production team  by which the oocytes or embryos were 
collected or produced  
EQUI -OOCYTES -EMB -B-
ENTRY  Chapter 64: Model official certificate for the entry into the Union of 
consignments of stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 92/65/EEC after 
30 September 2014 and before 21 April 2021 , and dispatched after 20 April 
2021 by an embryo collection or production team  by which the oocytes or 
embryos were collected or produced  
EQUI -OOCYTES -EMB -C-
ENTRY  Chapter 65: Model official certificate for the entry into the Union of 
consignments of stoc ks of oocytes and embryos of equine animals collected, 
processed and stored in accordance with Directive 92/65/EEC after 31  August 
2010 and before 1 October 2014, and dispatched after 20 April 2021 by an 
embryo collection or production team  by which the oo cytes or embryos were 
collected or produced  
EQUI -GP-PROCESSING -
ENTRY  Chapter 66: Model official certificate for the entry into the Union of 
consigments of:  
- semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429  and Delegated Regulation (EU) 
2020/ 692 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 392  EN before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
- oocytes  and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or 
produced, proces sed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1  October 2014,  
and dispatched after 20 April 2021 from a germinal product processing 
establishment  
EQUI -GP-STORAGE -
ENTRY  Chapter 67: Model official certificate for the entry into the Union of 
consigments of  
- semen of equine animals collected, processed and stored in accordance 
with Regulation (EU) 2016/429 and Delegated Regulation (EU) 
2020/ 692 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 9 2/65/EEC after 30 September 2014 and 
before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in 
accordance with Directive 92/65/EEC after 31 August 2010 and before 
1 October 2014;  
- stocks of semen of equine animals collected,  processed and stored in 
accordance with Directive 92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, 
processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or 
produced, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed 
and stored in accordance with Directive 92/65/EEC after 31 August 
2010 and before 1 October 2014,  
and dispatched after 20 April 2021 from a germinal product storage centre  
germinal products of certain categories of terrestrial animals  
GP-CONFINED -ENTRY  Chapter 68: Model official certificate for the entry into the Union of semen, 
oocytes and embryos of terrestrial animals kept at confined establishment 
which were collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated R egulation (EU) 2020/ 692 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 393  EN CHAPTER 1: MODEL OFF ICIAL CERTIFICATE FO R THE ENTRY INTO THE  
UNION OF BOVINE ANIMALS (MODEL ‘BOV -X’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circu s/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third  country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 394  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 395  EN COUNTRY  Certificate model BOV -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  [*to delete when the Union is not the final destination of the animals]  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Directive 96/22/EC);  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue  plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the 
concerned animals are listed in Decision 2011/163/E U for the concerned country of origin ; 
II.1.3.  with regard to bovine spongiform encephalopathy (BSE):  
 (a) the animals are identified by a permanent identification system enabling them to be traced 
back to the dam and herd of origin, and they are not:  
(i) BSE cases;  
(ii) bovine animals which, during their first year of life, were reared with BSE cases 
durin g their first year of life, and which an investigation has shown that they have 
consumed the same potentially contaminated feed during that period, or  
(iii) if the results of the investigation referred to in indent (ii) are inconclusive, bovine 
animals whi ch, during their first year of life, were reared with BSE cases during 
their first year of life, or were born in the same herd as, and within 12 months 
preceding or following the date of the birth of, the BSE cases;  
and 
(1) either  [(b) (i) the animals were  born and continuously reared in a country or region or countries or 
regions classified in accordance with Commission Decision 2007/453/EC as 
countries or regions posing a negligible BSE risk;  
  (ii) if there have been BSE indigenous cases in the country c oncerned, the animals were 
born after the date from which the ban on the feeding of ruminants with meat -and-
bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal 
Health Code of the World Organisation for Animal Health, was effe ctively 
enforced, or they were born after the date of birth of the last BSE indigenous case if 
born after the date of the feed ban.]  
(1) or [(b) (i) the country or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a c ountry or region posing a controlled BSE risk;  
  (ii) the animals were born after the date from which the ban on the feeding of ruminants 
with meat -and-bone meal and greaves derived from ruminants, as defined in the 
Terrestrial Animal Health Code of the Wo rld Organisation for Animal Health, was 
effectively enforced, or they were born after the date of birth of the last BSE 
indigenous case if born after the date of the feed ban.]  
(1) or [(b) (i) the country or region of origin of the animals is classified in  accordance with 
Decision 2007/453/EC as a country or region posing an undetermined BSE risk;  
  (ii) the feeding of ruminants with meat -and-bone meal and greaves from ruminants, as 
defined in the Terrestrial Animal Health Code of the World Organisation for  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 396  EN COUNTRY  Certificate model BOV -X 
Animal Health, has been banned and the ban has been effectively enforced in the 
country or region of origin;  
  (iii) the animals were born at least two years after the date from which the ban on the 
feeding of ruminants with meat -and-bone meal and greaves  derived from ruminants, 
as defined in the Terrestrial Animal Health Code of the World Organisation for 
Animal Health, was effectively enforced, or they were born after the date of birth of 
the last BSE indigenous case if born after the date of the feed ba n.] 
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I: 
II.2.1.  come from the zone  with code: __ __ - __(2) which, at the date of issue of this certificate is 
authorised for entry into the Union of bovine animals  and listed in Part 1 of Annex I to 
Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 months prior to 
the date of their dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to the date 
of their di spatch to the Union, in which period no animals have been introduced thereof.  
II.2.3.  had no contact with animals of a lower health status since birth or at least for 30 days prior to the 
date of their dispatch to the Union.  
II.2.4.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
and emerging diseases.  
(1) either  [II.2.5.  have been dispatched directly from their establishment of origin to the Union without passing 
through any other establishment].  
(1) or [II.2.5.  have undergone one single assembly operation in the zone of origin fulfilling the following 
requirements:  
(a)  the assembly operation took place in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in accordance with Article 5 of Commission Delegated 
Regulation (EU) 2019/2035;  
(ii) which has an unique approval number assigned by the competent authority of the third 
country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Commis sion Delegated Regulation 
(EU) 2019/2035;  
(iv) fulfilling the requirements provided for in Article 8 of Commission Delegated 
Regulation (EU) 2020/ 692. 
(b)  the assembly operation in the assembly centre took no longer than 6 days.]  
II.2.6.  have not been unloaded in any place that does not comply with the requirements laid down in 
point II.2.11. since they were dispatched from their establishment of origin until they are loaded 
for dispatch to the Union and during that period they have not been in contact with animals  of a 
lower health status.   
II.2.7.  are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 397  EN COUNTRY  Certificate model BOV -X 
competent authority of the third count ry or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.8.  have  been subjecte d to a clinical inspection within the 24 hours prior to loading for dispatch to 
the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the occurrence of diseases, including the  relevant listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging 
diseases.   
II.2.9.  have not been vaccinated against:  
(i) foot and mouth disease, infection with Rift Valley fever virus, infection with 
Mycoplasma mycoides  subsp. Mycoides SC  (Contagious bovine pleuropneumonia), 
Mycobacterium tuberculosis complex  (M.bovis, M.caprae and M.tuberculosis ) and 
infection with Brucella abortus, B. melitensis and B. suis , and  
(ii) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during 60 days 
prior to their dispatch to the Union.  
II.2.10.  come from a zone:  
II.2.10.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch of the animals to the 
Union](1)  
or  [since __/__/____ (dd/mm/yyyy)](1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth dis ease have been introduced during that period.  
II.2.10.2.  in which  infection with lumpy skin disease virus has not been reported for at least 12 
months prior to the date of dispatch of the animals to the Union.  
II.2.10.3.  in which infection with rinderpest virus, infection with Rift Valley fever virus and 
infection with Mycoplasma mycoides subsp. mycoides SC  (Contagious bovine 
pleuropneumonia) has not been reported for at least 12 months prior to the date of 
dispatch of the animals to the Union and during th at period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.  
either  [II.2.10.4.  which is free from infection with bluetongue virus (Serotypes 1 -24)](1)(5)  
or [II.2.10.4.  which is seasonally free from infection with bluetongue virus (Serotypes 1 -24):  
either [II.2.10.4.1.  for at least 60 days prior to the date of dispatch of the animals to the 
Union.] (1)(6)  
 or [II.2.10.4.1.  for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in 
accordance with Article 9(1)(b) of Commission Delegated Regulation 
(EU) 2020/ 692, with negative results, carried out on samples collected at 
least 28 days fol lowing the date of entry of the animal into the 
seasonally free zone.](1)(6)  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 398  EN COUNTRY  Certificate model BOV -X 
 or [II.2.10.4.1.  for at least 14 days prior to the date of dispatch of the animals to the 
Union and have been subjected to a PCR test, with negative results, 
carried out on sampl es collected at  least 14 days following the date of 
entry of the animal in the seasonally free zone.] (1)(6) 
or [II.2.10.4.  is not free from infection with bluetongue virus (Serotypes 1 -24) and the 
animals have been vaccinated against all the serotypes (1 to 24) of bluetongue virus reported 
during the past 2 years in that zone and are still within the immunity period of time guaranteed 
in the specifications of the vaccine and  
either [II.2.10.4.1.  have been vaccinated more than 60 days prior to the date of dispatch of 
the animals to the Union.]](1) 
or [II.2.10.4.1.  have been vaccinated with an inactivated vaccine and were subjected to 
a PCR test, with negative results on samples collected at least 14 days 
after the onset of the immunity protection set in the  specifications of the 
vaccine.]] (1) 
or [II.2.10.4. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals 
have been subjected with positive results to a serological test able to detect specific 
antibodies against all serotypes (1 to 24) of bluetongue virus reported during the past 
2 years in that zone and:  
either [II.2.10.4.1.   the serological test has been carried out on samples collected at least 60 
days prior to the date of dispatch of the animals to the Union.]](1)  
or [II.2.10.4.1.  the serological test has been carried out on samples collected at least 30 
days prior to the date of dispatch of the animals to the Union and the 
animals were subjected to a PCR test, with negative results, carried out on 
samples collected not ear lier than 14 days prior to the date of dispatch of 
the animals to the Union. ]] (1) 
either [II.2.10.5.  is free from enzootic bovine leukosis](1)(7)  
or [II.2.10.5.  is not free from enzootic bovine leukosis and the disease has not been reported 
in the establishment of origin of the animals during at least the 24 months prior to the date of 
dispatch of the animals to the Union, and  
[II.2.10.5.1.  the animals of the con signment over 24 months:  
either [II.2.10.5.1.1. have been kept in isolation from the other bovine 
animals kept in the same establishment prior to dispatch to the 
Union and during the period of isolation have been subjected to a 
laboratory examination for e nzootic bovine leukosis using one of the 
diagnostic methods referred to in Article 9(b)(i) of Commission 
Delegated Regulation (EU) 2020/ 692, with negative results, carried 
out on samples taken on two occasions at an interval of at least 4 
months.]](1)  
or [II.2.10.5.1.1. have been subjected to a laboratory examination for 
enzootic bovine leukosis using one of the diagnostic methods 
referred to in Article 9(b)(i) of Commission Delegated Regulation 
(EU) 2020/ 692, with negative results, carried out on a sample  taken 
during the last 30 days prior to the date of their dispatch to the 
Union and all bovine animals over 24 months kept in the 
establishment of origin have been subjected to a laboratory 
examination for enzootic bovine leukosis with one of the diagnosti c 
methods referred to in Article 9(b)(i) of Commission Delegated This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 399  EN COUNTRY  Certificate model BOV -X 
Regulation (EU) 2020/ 692, carried out, with negative results, on 
samples taken on two occasions at an interval of not less than 4 
months during the last 12 months prior to the date of dispatc h of the 
animals to the Union.]](1)  
[II.2.10.5.2.  the animals of the consignment younger than 24 months of age were born 
to dams which have been subjected to a laboratory examination for 
enzootic bovine leukosis with one of the diagnostic methods referred  to in 
Article 9(b)(i) of Commission Delegated Regulation (EU) 2020/ 692, with 
negative results, carried out on samples taken on two occasions at an 
interval of not less than 4 months during the last 12 months prior to the 
date of dispatch of the animals to  the Union.]](1) 
II.2.11.  come from an establishment : 
II.2.11.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 
years up -to-date records containing information regarding:  
(i) the species, categories, number and identification of animals on the 
establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.11.2.  which receives regular animal h ealth visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a 
frequency that is proportional to the ri sk posed by the establishment.  
II.2.11.3.  which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU) 2020/ 692 and emerging disease s, at the time of dispatch 
of the animals to the Union.  
II.2.11.4.  in and around which, in an area of 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has 
been reported for at least 3 0 days prior to the date of dispatch of the animals to 
the Union: foot and mouth disease, infection with rinderpest virus, infection with 
Rift valley fever virus, infection with Mycoplasma mycoides  subsp. mycoides  SC 
(Contagious bovine pleuropneumonia) and  infection with lumpy skin disease 
virus.  
either  [II.2.11.5.  in and around which, in an area with a 150 km radius, including where 
appropriate the territory of a neighbouring country, epizootic haemorrhagic 
disease has not been reported for at least 2 years before the date of dispatch of 
the animals to the Union.] (1)  
or [II.2.11.5.  which is located in a zone seasonally free of epizootic haemorrhagic 
disease.](1)(8) 
II.2.11.6.  free from infection with Mycobacterium tuberculosis complex  (M. bovis , M. 
caprae and M. tuberculosis ) as regards bovine animals (9), and  
 either [II.2.11.6.1.  in a zone free from the disease where vaccination against that 
disease is not practiced.](1)(10)  
 or     [II.2.11.6.1.  have been tested with one of the diagnostic methods provided for in 
Article 9(b)(i) of Commission Delegated Regulation (EU) 2020/ 692 
for infection with Mycobacterium tuberculosis complex (M. bovis, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 400  EN COUNTRY  Certificate model BOV -X 
M. caprae  and M. tuberculosis) , with negative results, during the 
last 30 days prior to the date of dispatch o f the animals to the 
Union;](1) 
or    [II.2.11.6.1.  are less than six weeks old.] (1) 
II.2.11.7 . free from infection with Brucella abortus, B. melitensis and B. suis  as regards 
bovine animals(9), and   
either [II.2.11.7.1.  in a zone free from the disease wh ere vaccination against that 
disease is not practiced.] (1)(11)  
or [II.2.11.7.1 . have been tested with one of the diagnostic methods provided for 
in Article 9(b)(i) of Commission Delegated Regulation (EU) 
2020/ 692 for infection with Brucella abortus, B. m elitensis and B. 
suis, with negative results, on a sample taken during the last 30 
days prior to the date of dispatch of the animals to the Union, and 
in the case of post -parturient females, the test is carried out on a 
sample taken at least 30 days after parturition.] (1) 
or [II.2.11.7.1.  are less than 12 months old.] (1) 
or [II.2.11.7.1.  are castrated.] (1) 
II.2.11.8.  in which infection with rabies virus has not been reported for at least 30 days prior 
to dispatch of the animals to the Union.  
II.2.11.9.  in which anthrax has not been reported for at least 15 days prior to the date of 
dispatch of the animals to the Union.  
either [II.2.11.10.  in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior 
to the date of dispatch of the an imals to the Union.](1) 
or [II.2.11.10.  in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was 
reported in the establishment of origin during the 2 y ears prior to the date of dispatch 
of the animals to the Union, the establishment remained under restriction until the 
infected animals were removed from the establishment and the remaining animals on 
the establishment were subjected with negative result t o a test for surra 
(Trypanosoma evansi ) as described in Article 9(b)(i) of Commission Delegated 
Regulation (EU) 2020/ 692 carried out on samples taken at least 6 months after the 
infected animals were removed from the establishment.] (1) 
(1)(12)[[II.2.12.  the animals  have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis, and 
either [II.2.12.1.  originate from a third country or territory or zone thereof free from Infectious 
bovine rhinotracheitis/ infectious pustular vulvovaginitis.]](1)(13)  
or [II.2.12.1.  have been kept in quarantine  for at least 30 days prior to the date of dispatch of the 
animals to the Union and have undergone a serological test for the detection of 
antibodies against whole bovine herpes virus -1 (BoHV -1) with one of the diagnostic 
methods referred to in Article 9(b)(i) of Commission Delegated Regulation (EU) 
2020/ 692, with negative results, on a sample taken within 15 days prior to the date 
of dispatch of the animals to the Union.]](1) 
(1)(12) [II.2.13.  the animals have not been vaccinated against bovine viral diarrhoea, and:  
either [II.2.13.1.  originate from a third country or territory or zone thereof free from bovine viral 
diarrhoea.]](1)(14)  
or [II.2.13.1.  have been tested for bovine v iral diarrhoea virus antigen or genome using one of the 
diagnostic methods provided for in Part 6 of Annex I to Commission Delegated This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 401  EN COUNTRY  Certificate model BOV -X 
Regulation (EU) 2020/ 688 with negative results, and  
either [II.2.13.1.1.  have been kept in a quarantine establishment for a period of at least 
21 days prior to their dispatch to the Union.]]  
or [II.2.13.1.1.  the animals are pregnant dams and have been kept in a quarantine 
establishment for a period of at least 21 days prior to their dispatch to 
the Union and have been subjected to a serological test for the 
detection of antibodies against bovine viral diarrhoea virus using one 
of the diagnostic methods provided for in Part 6 of Annex I to 
Commission Delegated Regulation (EU) 2020/ 688 with negative 
results carried out on  samples taken not less than 21 days after the 
commencement of the quarantine.]]  
or [II.2.13.1.1.  have been subjected to serological test for the detection of antibodies 
against bovine viral diarrhoea virus using one of the diagnostic 
methods provided for in Part 6 of Annex I to Commission Delegated 
Regulation (EU) 2020/ 688, with positive results, carried out on 
samples taken prior to their dispatch to the Union.]]  
or [II.2.13.1.1.  the animals are pregnant dams that have been subjected to 
serological test f or the detection of antibodies against bovine viral 
diarrhoea virus using one of the diagnostic methods provided for in 
Part 6 of Annex I to Commission Delegated Regulation (EU) 
2020/ 688 with positive results, carried out on samples taken before 
inseminati on preceding the current gestation.]]  
 
Notes:  
This certificate is intended for entry into the Union of bovine animals, including when the Union is not the final 
destination of the animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc ., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/ … [SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.  
(4) Only for zones with opening date in accordance with column 8 in part 1 of An nex I to Commission 
Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
(5) For zones with entry BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ]. 
(6) For zones with entry SF -BTV in column 7 of Part 1 of A nnex I to Commission Implementing Regulation 
(EU) 2020/ … [SANTE/7140/2020 ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 402  EN COUNTRY  Certificate model BOV -X 
(7) For zones with entry EBL in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ]. 
(8) For zones with entry SF -EHD in column 7 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/ … [SANTE/7140/2020 ]. 
(9) In accordance with Article 10 of Commission Delegated Regulation (EU) 2020/ 692. 
(10) For zones with entry TB -Bov in column 7 of Part 1 of Annex I to Regulation (EU) 2020/ … 
[SANTE/7140/ 2020 ]. 
(11) For zones with entry BRU -Bov in column 7 of Part 1 of Annex I to Regulation  (EU)  2020/ … 
[SANTE/7140/2020 ]. 
(12) Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement 
between the Union and the Swiss Confeder ation on trade in agricultural products (OJ L 114, 30.4.2002), either 
have disease -free status for the relevant C disease or an approved eradication programme.  
(13) For zones with entry IBR in column 7 of Part 1 of Annex I to Regulation (EU) 2020/ … [SANTE/7140/ 2020 ]. 
(14) For zones with entry BVD in column 7 of Part 1 of Annex I to Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 403  EN CHAPTER 2: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF BOVINE ANIMALS INTEN DED FOR SLAUGHTER (MODEL ‘BOV -Y’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 404  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 405  EN COUNTRY  Certificate  model BOV -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described above:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Directive 96/22/EC);  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the 
concerned animals are listed in Decision 2011/163/E U for the concerned country of origin ; 
II.1.3.  with regard to bovine spongiform encephalopathy (BSE):  
(a) the animals are identified by a permanent identification system enabling them to be traced 
back to the dam and herd of origin, and they are not:  
(i) BSE cases;  
(ii) bovine animals which, during their f irst year of life, were reared with BSE cases 
during their first year of life, and which  an investigation has shown that they have 
consumed the same potentially contaminated feed during that period, or  
(iii) if the results of the investigation referred to in indent (ii) are inconclusive, bovine 
animals which, during their first year of life, were reared with BSE cases during 
their first year of life, or were born in the same herd as, and within 12 months 
preceding or following the date of the birth of, the BSE cases;  
and 
(1) either  [(b) (i) the animals were born and continuously reared in a country or region or countries or 
regions classified in accordance with Commission Decision 2007/453/EC as 
countries or regions posing a negligible BSE risk;  
  (ii) if there have been BSE indigenous cases in the country concerned, the animals were 
born after the date from which the ban on the feeding of ruminants with meat -and-
bone meal and greaves derived from ruminants, as defined in the Terrestrial Animal 
Health Code of the World Organisation for Animal Health, was effectively 
enforced, or they were born after the date of birth of the last BSE indigenous case if 
born after the date of the feed ban.]  
(1) or [(b) (i) the country or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a country or region posing a controlled BSE risk;  
  (ii) the animals were born after the date from which the ban on the feeding of ruminants 
with meat -and-bone meal and greaves derived from ruminants, a s defined in the 
Terrestrial Animal Health Code of the World Organisation for Animal Health, was 
effectively enforced, or they were born after the date of birth of the last BSE 
indigenous case if born after the date of the feed ban.]  
(1) or [(b) (i) the co untry or region of origin of the animals is classified in accordance with 
Decision 2007/453/EC as a country or region posing an undetermined BSE risk;  
  (ii) the feeding of ruminants with meat -and-bone meal and greaves from ruminants, as 
defined in the Ter restrial Animal Health Code of the World Organisation for This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 406  EN COUNTRY  Certificate  model BOV -Y 
Animal Health, has been banned and the ban has been effectively enforced in the 
country or region of origin;  
  (iii) the animals were born at least two years after the date from which the ban on the  
feeding of ruminants with meat -and-bone meal and greaves derived from ruminants, 
as defined in the Terrestrial Animal Health Code of the World Organisation for 
Animal Health, was effectively enforced, or they were born after the date of birth of 
the last BSE indigenous case if born after the date of the feed ban.]  
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.2.1.  come from the zone with code: __ __ - __(2) which, at the date of issue of this certificate is 
authorised for entry into the Union of bovine animals intended for slaughter  and is listed in 
Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/XX [ SANTE/7140/2020 ]. 
II.2.2.  are intended for slaughter in the Union.  
II.2.3.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 3 months prior 
to the date of their dispatch to the Union, and  
(ii) in the establishment of origin since bi rth or for a period of time of at least 40 days prior to the 
date of their dispatch to the Union, in which period no animals have been introduced thereof.  
II.2.4.  had no contact with animals of a lower health status since birth or at least for 30 days prio r to the 
date of their dispatch to the Union.  
II.2.5.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 and emerg ing diseases.  
(1) either [II.2.6.  have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment].  
(1) or [II.2.6.  have undergone one single assembly operation in the zone of origin fulfilling th e following 
requirements:  
(a) the assembly operation took place in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in accordance with Article 5 of Commission Delegated 
Regulation (EU) 2019/2035;  
(ii) which has an unique approval number assigned by the compe tent authority of the third 
country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Commission Delegated Regulation 
(EU) 2019/2035;  
(iv) fulfilling the requirements provided for in Article 8 of Commission Delegated Regulation 
(EU) 2020/ 692. 
(b) the assembly operation in the assembly centre took no longer than 6 days.]  
II.2.7.  have not been unloaded in any place that does not comply with the requirements laid down in 
point II.2.12. since they were dispatched from their establishment of origin until they are loaded 
for dispatch to the Union and during that period they have not been in contact with animals of a 
lower health status.  
II.2.8.  are loaded for dispatc h to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 407  EN COUNTRY  Certificate  model BOV -Y 
competent authority of the third country or territory and constructed in such a way that:  
(i)  anim als cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.9.  have been subjected to a clinical inspection within the 24 hours prior to l oading for dispatch to 
the Union, carried out by an official veterinarian in the third country or territory of origin, who 
did not detect signs indicative of the occurrence of diseases, including the relevant listed diseases 
referred to in Annex I to Commi ssion Delegated Regulation (EU) 2020/ 692 and emerging 
diseases.  
II.2.10.  have not been vaccinated against:  
(i) foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma 
mycoides subsp. Mycoides  SC (Contagious bovine pleuropneum onia), Mycobacterium 
tuberculosis complex  (M.bovis, M.caprae  and M.tuberculosis ) and infection with Brucella 
abortus, B. melitensis  and B. suis , and  
(ii) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during 60 days prior to their 
dispatch to the Union.  
II.2.11.  come from a zone : 
II.2.11.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch of the animals to the Union](1) 
or [since __/__/____ (dd/mm/yyyy)](1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth disease have been introduced during that period.  
II.2.11.2.  in which infection with lumpy skin disease virus has not been reported for at least 12 
months prior to the date of dispatch of the animals to the Union.  
II.2.11.3.  in which infection with rinderpest virus, infection with Rift Valley fever virus and 
infection with Mycoplasma mycoides  subsp. mycoides SC (Contagious bovine 
pleuropneumonia) has not been reported for at least 12 months prior to the date of dispatch 
of the  animals to the Union and during that period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.  
either [II.2.11.4. which is free from infection with bluetongue virus (Serotypes 1 -24).](1)(5)  
or [II.2.11.4. which is seasonally free from infection with bluetongue virus (Serotypes 1 -24):  
either [II.2.11.4.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)  
or [II.2.11.4.1. for at lea st 28 days prior to the date of dispatch of the animals to the Union 
and the animals have been subjected to a serological test in accordance with Article 
9(1)(b) of Commission Delegated Regulation (EU) 2020/ 692, with negative results, 
carried out on sample s collected at least 28 days following the date of entry of the 
animal into the seasonally free zone.](1)(6)  
or [II.2.11.4.1. for at least 14 days prior to the date of dispatch of the animals to the Union 
and have been subjected to a PCR test, with negativ e results, carried out on samples 
collected at least 14 days following the date of entry of the animal in the seasonally free 
zone.](1)(6)  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 408  EN COUNTRY  Certificate  model BOV -Y 
or [II.2.11.4. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have been 
vaccinated  against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years in 
that zone and are still within the immunity period of time guaranteed in the specifications of the 
vaccine, and  
either [II.2.11.4.1. have been vaccinated more tha n 60 days prior to the date of dispatch of the 
animals to the Union.]](1) 
or [II.2.11.4.1. have been vaccinated with an inactivated vaccine and were subjected to a 
PCR test, with negative results on samples collected at least 14 days after the onset of 
the immunity protection set in the specifications of the vaccine.]](1) 
or [II.2.11.4. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have been 
subjected with positive results to a serological test able to detect specific ant ibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone, and  
either [II.2.11.4.1 the serological test has been carried out on samples collected at least 60 
days prior to the date of dispatch of the animals to the Union.]](1) 
or [II.2.11.4.1. the serological test has been carried out on samples collected at least 30 
days prior to the date of dispatch of the animals to the Union and the animals were 
subjected to a PCR test, with negative results, carried out o n samples collected not 
earlier than 14 days prior to the date of dispatch of the animals to the Union.]](1) 
either [II.2.11.5. is free from enzootic bovine leukosis.](1)(7)  
or [II.2.11.5. is not free from enzootic bovine leukosis and the disease has not b een reported in the 
establishment of origin of the animals during at least the 24 months prior to the date of dispatch of the 
animals to the Union, and  
[II.2.11.5.1. the animals of the consignment over 24 months:  
either [II.2.11.5.1.1. have been kept in isolation from the other bovine animals kept in the 
same establishment prior to dispatch to the Union and during the period of isolation 
have been subjected to a laboratory examination for enzootic bovine leukosis using one 
of the diagnostic methods referr ed to in Article 9(b)(i) of Commission Delegated 
Regulation (EU) 2020/ 692, with negative results, carried out on samples taken on two 
occasions at an interval of at least 4 months.]](1) 
or [II.2.11.5.1.1. have been subjected to a laboratory examination for  enzootic bovine 
leukosis using one of the diagnostic methods referred to in Article 9(b)(i) of 
Commission Delegated Regulation (EU) 2020/ 692, with negative results, carried out on 
a sample taken during the last 30 days prior to the date of their dispatch to the Union 
and all bovine animals over 24 months kept in the establishment of origin have been 
subjected to a laboratory examination for enzootic bovine leukosis with one of the 
diagnostic methods referred to in Article 9(b)(i) of Commission Delegated Re gulation 
(EU) 2020/ 692, carried out, with negative results, on samples taken on two occasions at 
an interval of not less than 4 months during the last 12 months prior to the date of 
dispatch of the animals to the Union.]](1) 
[II.2.11.5.2. the animals of th e consignment younger than 24 months of age were born to dams 
which have been subjected to a laboratory examination for enzootic bovine leukosis with one of 
the diagnostic methods referred to in Article 9(b)(i) of Commission Delegated Regulation (EU) 
2020/ 692, with negative results, carried out on samples taken on two occasions at an interval of 
not less than 4 months during the last 12 months prior to the date of  dispatch of the animals to 
the Union.]](1) 
II.2.12. come from an establishment :  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 409  EN COUNTRY  Certificate  model BOV -Y 
II.2.12.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years up -
to-date records containing information regarding:  
(i) the species, categories, num ber and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.12.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases referred to 
in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a frequency that is 
proportional to the risk posed by the establishment.  
II.2.12.3.  which was not subject to nat ional restriction measures for animal health reasons, including 
the relevant listed diseases referred to in Annex I to Commission Delegated Regulation 
(EU) 2020/ 692 and emerging diseases, at the time of dispatch of the animals to the Union.  
II.2.12.4.  in and around which, in an area of 10 km radius, including where appropriate the territory 
of a neighbouring country, none of the following listed diseases has been reported for at 
least 30 days prior to the date of dispatch of the animals to the Union: foot a nd mouth 
disease, infection with rinderpest virus, infection with Rift valley fever virus, infection 
with Mycoplasma mycoides subsp.  mycoides  SC (Contagious bovine pleuropneumonia) 
and infection with lumpy skin disease virus.  
either [II.2.12.5. in and around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, epizootic haemorrhagic disease has not been reported for at least 2 
years before the date of dispatch of the animals to the Union.](1) 
or [II.2.12.5. which is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(8)  
[II.2.12.6. free from infection with Mycobacterium tuberculosis complex  (M. bovis, M. caprae and M. 
tuberculosis ) as regards bovine animals.](1)(9) 
[II.2.12.7. f ree from infection with Brucella abortus, B. melitensis  and B. suis  as regards bovine 
animals.](1)(9) 
II.2.12.8. in which infection with rabies virus has not been reported for at least 30 days prior to 
dispatch of the animals to the Union.  
II.2.12.9. in wh ich anthrax has not been reported for at least 15 days prior to the date of dispatch of the 
animals to the Union.  
either [II.2.12.10. in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior to the 
date of dispatch of the animal s to the Union.](1) 
or [II.2.12.10. in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days prior to the 
date of dispatch of the animals to the Union and when the disease was reported in the establishment of 
origin during the 2 years  prior to the date of dispatch of the animals to the Union, the establishment 
remained under restriction until the infected animals were removed from the establishment and the 
remaining animals on the establishment were subjected with negative result to a test for surra 
(Trypanosoma evansi ) as described in Article 9(b)(i) of Commission Delegated Regulation (EU) 
2020/ 692 carried out on samples taken at least 6 months after the infected animals were removed from 
the establishment.](1) 
(1)(10)[II.2.13. the ani mals have not been vaccinated against infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis, and  
either [II.2.13.1.  originate from a third country or territory or zone thereof free from Infectious bovine 
rhinotracheitis/ infectious pustular  vulvovaginitis.]](1)(11)  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 410  EN COUNTRY  Certificate  model BOV -Y 
or [II.2.13.1.  have been kept in quarantine  for at least 30 days prior to the date of dispatch of the 
animals to the Union and have undergone a serological test for the detection of antibodies against 
whole bovine herpes virus -1 (BoHV -1) with one of the diagnostic methods referred to in Article 
9(b)(i) of Commission Delegated Regulation (EU) 2020/ 692, with negative results, on a sample 
taken within 15 days prior to the date of  dispatch of the animals to the Union.]](1) 
(1)(10)[II.2.14. the animals have not been vaccinated against bovine viral diarrhoea, and:  
either [II.2.14.1. originate from a third country or territory or zone thereof free from bovine viral 
diarrhoea.]](1)(12)  
or [II.2.14.1. have been tested for bovine viral d iarrhoea virus antigen or genome using one of the 
diagnostic methods provided for in Part 6 of Annex I to Commission Delegated Regulation (EU) 
2020/ 688 with negative results, and  
either [II.2.14.1.1. have been kept in a quarantine establishment for a peri od of at least 21 
days prior to their dispatch to the Union.]  
or [II.2.14.1.1. the animals are pregnant dams and have been kept in a quarantine 
establishment for a period of at least 21 days prior to their dispatch to the Union and 
have been subjected to a  serological test for the detection of antibodies against bovine 
viral diarrhoea virus using one of the diagnostic methods provided for in Part 6 of 
Annex I to Commission Delegated Regulation (EU) 2020/ 688 with negative results 
carried out on samples taken  not less than 21 days after the commencement of the 
quarantine.]  
or [II.2.14.1.1. have been subjected to serological test for the detection of antibodies 
against bovine viral diarrhoea virus using one of the diagnostic methods provided for in 
Part 6 of An nex I to Commission Delegated Regulation (EU) 2020/ 688, with positive 
results, carried out on samples taken prior to their dispatch to the Union.]]  
or [II.2.14.1.1. the animals are pregnant dams that have been subjected to serological test 
for the detectio n of antibodies against bovine viral diarrhoea virus using one of the 
diagnostic methods provided for in Part 6 of Annex I to Commission Delegated 
Regulation (EU) 2020/ 688, with positive results, carried out on samples taken before 
insemination preceding t he current gestation.]]  
 
Notes:  
This certificate is intended for entry of bovine animals that will be slaughtered in the Union.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU)  2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 411  EN COUNTRY  Certificate  model BOV -Y 
from this zone.  
(4) Only for zones with opening date in accordance with column 8 in part 1 of An nex I to Commission 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
(5) For zones with entry BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 
2020/xx [ SANTE/7140/2020 ]. 
(6) For zones with entry SF -BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(7) For zones with entry EBL in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 
2020/xx [ SANTE/7140/2020 ]. 
(8) For zones with entry SF -EHD in column 7 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(9) In accordance with Article 10 of Commission Delegated Regulation (EU) 2020/ 692. 
(10) Only applicable when the Member State of d estination or Switzerland, in accordance with the Agreement 
between the Union and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002), either 
have disease -free status for the relevant C disease or an approved eradication program me. 
(11) For zones with entry IBR in column 7 of Part 1 of Annex I to Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
(12) For zones with entry BVD in column 7 of Part 1 of Annex I to Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 412  EN CHAPTER 3: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF BOVINE ANIMALS INTEN DED FOR TRANSIT FROM  THE REGION 
OF KALININGRAD TO OT HER REGIONS OF RUSSI A VIA THE TERRITORY OF 
LITHUANIA  (MODEL ‘ BOV -X-TRANSIT -RU’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
     
     
     
I.21  For transit  I.22  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 413  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 414  EN COUNTRY  Certificate model BOV -X-TRANSIT -RU Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.1.1. come from the zone  with code RU -2(2) which, at the date of issuing this certificate is listed in Part 1 of 
Annex XX to Commission Implementing Regulation (EU) 2020/… [SANTE/7140/2020 ] for transit of 
bovine animals through the Union under specific conditions .  
(1) either [II.1.2.  they originate from the Union and they were introduced from the Union into the zone with code 
RU-2 on ………. (dd/mm/yyyy) and, since that date, they have been kept in facilities where 
only animals that originate from the Union are kept.]  
(1) or [II.1.2.  they have remained in the territory with code RU -2. since birth, or for at least the last six  
months before the date of dispatch to Russia via the Union and without contact with imported 
animals for the last 30 days.]  
II.1.3.  had no contact with animals not complying with the animal health requirements as described in this 
certificate.  
II.1.4.  are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging 
diseases.  
II.1.5.  have not been unloaded in any place that does not comply with the requirements laid down in point 
II.1.10. since they were dispatched from their establishment of origin until their dispatch to Russia via 
the Union and during that period they have not been in contact with animals of a lower h ealth status.  
II.1.6.  have been loaded for dispatch to Russia via the Union on ___/___/____  (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority of the third co untry or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.7.  have  been subjec ted to a clinical inspection within the 24 hours prior to loading for dispatch to Russia 
via the Union, carried out by an official veterinarian , who did not detect signs indicative of the 
occurrence of diseases, including the relevant listed diseases refe rred to in Annex I to Commission 
Delegated Regulation (EU) 2020/ 692 and emerging diseases.   
II.1.8.  have not been vaccinated against:  
(i) foot and mouth disease, infection with Rift Valley fever virus, infection with Mycoplasma 
mycoides  subsp. Mycoides  SC (Contagious bovine pleuropneumonia) s, and  
(ii) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during 60 days prior to 
their dispatch to Russia via the Union.  
II.1.9.  come from the zone described in point II.1.1.:  
II.1.9.1.  in which:  
(iii) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch to Russia via the Union](1) 
or [since __/__/____  (dd/mm/yyyy)](1)(4) 
(iv) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 415  EN COUNTRY  Certificate model BOV -X-TRANSIT -RU 
vaccinated against foot and mouth disease have been introduced during that period.  
II.1.9.2.  in which  infection with lumpy skin disease virus has not been reported for at l east 12 months 
prior to the date of dispatch to Russia via the Union.  
II.1.9.3.  in which infection with rinderpest virus, infection with Rift Valley fever virus and infection 
with Mycoplasma mycoides subsp. mycoides SC  (Contagious bovine pleuropneumonia) h as not 
been reported for at least 12 months prior to the date of dispatch to Russia via the Union and 
during that period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.  
either [II.1.9.4.  which is free from infection with bluetongue virus (Serotypes 1 -24)](1)(5)  
or [II.1.9.4.  is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have 
been vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years 
in that zone and are still within the immunity period of time guaranteed in the specifications of the 
vaccine and have been vaccinated more than 60 days prior to the date of dispatch of the animals to 
Russi a via the Union.]](1) 
II.1.10.  come from the establishment described under box reference I.11 [ where they have 
remained since birth or at least 40 days before the date of dispatch to Russia via the Union 
and](6): 
II.1.10.1.  which was not subject to nationa l restriction measures for animal health reasons, including 
the relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 and emerging diseases, at the time of dispatch of the animals to the Union.  
II.1.10.2.  in and around which, in an area of 10 km radius none of the following listed diseases has 
been reported for at least 30 days prior to the date of dispatch of the animals to the Union: 
foot and mouth disease, infection with rinderpest virus, infection with Rift va lley fever 
virus, infection with Mycoplasma mycoides  subsp. mycoides  SC (Contagious bovine 
pleuropneumonia) and infection with lumpy skin disease virus.  
II.1.10.3.  in and around which, in an area with a 150 km radius, including where appropriate the 
territ ory of a neighbouring country, epizootic haemorrhagic disease has not been reported 
for at least 60 days before the date of dispatch of the animals to Russia via the Union.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex XX to Commission Implementing Regulation 
(EU) 2020/... [ SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation for transit to Russia via the Union of the 
zone referred to in point II.1.1., or a date in a period when restriction measures have been adopted by the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 416  EN COUNTRY  Certificate model BOV -X-TRANSIT -RU 
Union against transit of these animals from this zone.  
(4) Only for zones with opening date in accordance with column 8 in part 1 of Annex XX to Commission 
Implementing Regulation (EU) 2020/... [ SANTE/7140/2020 ]. 
(5) For zones with entry BTV in column 7 of Part 1 of Annex XX to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ]. 
(6) Delete the  text in square brackets if the second option for point II.1.2. is deleted.   
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 417  EN CHAPTER 4: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF OVINE AND CAPRINE AN IMALS (MODEL ‘OV /CAP -X’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circu s/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 418  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
 
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 419  EN COUNTRY  Certificate model OV /CAP -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  [*to delete when the Union is not the final destination of the animals]  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist subs tances for purposes other than 
therapeutic or  zootechnical treatment (as defined in Directive 96/22/EC);  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and th e 
concerned animals are listed in Decision 2011/163/E U for the concerned country of origin . 
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.2.1.  come from the zone with code: __ __ - __(2) which, at the date of issue of this certificate is authorised 
for entry into the Union of ovine and caprine animals and listed in Part 1 of Annex I to Commission 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  have remai ned continuously:  
(i) in the zone referred to in point II.1 since birth or for a period of time of at least 6 months prior 
to the date of their dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days p rior to the 
date of their dispatch to the Union, in which period no animals have been introduced.  
II.2.3.  had no contact with animals of a lower health status since birth or at least for 30 days prior to the date 
of their dispatch to the Union.  
II.2.4.are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex 1 of Commission Delegated Regulation (EU) 2020/ 692 and 
emerging diseases.  
(1) either [II.2.5.  have been dispatched dire ctly from the establishment of origin to the Union without passing 
through any other establishment].  
(1) or [II.2.5.  have undergone one single assembly operation in the zone of origin fulfilling the following 
requirements:  
(a) the assembly operation took place  in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent authority in the 
third country or territory in accordance with Article 5 of Commission Delegated Regulation 
(EU) 2019/2035;  
(ii) which has an unique approval number  assigned by the competent authority of the third 
country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Commission Delegated Regulation 
(EU) 2019 /2035;  
(iv)  fulfilling the requirements provided for in Article 8 of Commission Delegated Regulation 
(EU) 2020/ 692. 
(b) the assembly operation in the assembly centre took no longer than 6 days.]  
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 420  EN COUNTRY  Certificate model OV /CAP -X 
II.2.6.  have not been unloaded in any place that does not comply with the requirements laid down in point 
II.2.11. since they were dispatched from their establishment of origin until they are loaded for 
dispatch to the Union and during that period have not been in contact with animals of a lower health 
status.   
II.2.7.  are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport which 
was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority 
in the third country or territory and constructed in s uch a way that:  
(iv) animals cannot escape or fall out;  
(v) visual inspection of the space where animals are kept is possible;  
(vi) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.8.  been subjected to a clinical inspection within the 24 h ours prior to loading for dispatch to the Union, 
carried out by an official veterinarian in the third country or territory of origin, who did not detect 
signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in 
Annex 1 to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.2.9.  have not been vaccinated against:  
(iii) foot and mouth disease, infection with Rift Valley fever virus, peste des petits 
ruminants, sheep pox and goat pox, conta gious caprine pleuropneumonia, Mycobacterium 
tuberculosis complex  (M.bovis , M.caprae  and M.tuberculosis ) and infection with Brucella 
abortus , B. melitensis  and B. suis , and  
(iv) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during the 60 days 
prior to  their dispatch to the Union.  
II.2.10.  come from a zone : 
II.2.10.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch to the Union](1)  
or [since __/__/____ (dd/mm/yyyy)] (1)(4) 
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 months 
prior to the date of dispatch of the animals to the Union, and no animals vaccinated against 
foot and mouth disease have been introduced during that period.  
II.2.10. 2. in which infection with rinderpest, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia has not been reported for at least 12 months prior to the date of dispatch 
of the animals to the Union and during that period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.   
either  [II.2.10.3.  is free from infection with bluetongue v irus (Serotypes 1 -24)](1)(5)  
 or [II.2.10.3.  is seasonally free from infection with bluetongue virus (Serotypes 1 -24): 
either [II.2.10.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6) 
or [II.2.10.3.1. for at least  28 days prior to the date of dispatch of the animals to the Union and 
the animals have been subjected to a serological test in accordance with Article 9(1)(b) of 
Commission Delegated Regulation (EU) 2020/ 692, with negative results, carried out on 
samples collected at least 28 days following the date of entry of the animal into the 
seasonally free zone.] (1)(6) 
or [II.2.10.3.1. for at least 14 days prior to the date of dispatch of the animals to the Union and 
have been subjected to a PCR test, with negative  results, carried out on samples collected at This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 421  EN COUNTRY  Certificate model OV /CAP -X 
least 14 days following the date of entry of the animal in the seasonally free zone.] (1)(6) 
 or [II.2.10.3.  is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have 
been vaccinate d against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years 
in that zone and are still within the immunity period of time guaranteed in the specifications of the 
vaccine and  
either [II.2.10.3.1. have been vaccinated more tha n 60 days prior to the date of dispatch of the 
animals to the Union.]](1) 
or [II.2.10.3.1. have been vaccinated with an inactivated vaccine and were subjected to a PCR 
test, with negative results on samples collected at least 14 days after the onset of the  
immunity protection set in the specifications of the vaccine.]](1) 
or [II.2.10.3.  is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have 
been subjected with positive results to a serological test able to detect specific ant ibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:  
either [II.2.10.3.1. the serological test has been carried out on samples collected at least 60 days 
prior to the date of dispatch of the animals  to the Union.]](1)  
 or [II.2.10.3.1. the serological test has been carried out on samples collected at least 30 days 
prior to the date of dispatch of the animals to the Union and the animals were subjected to a 
PCR test, with negative results, carried ou t on samples collected not earlier than 14 days 
prior to the date of dispatch of the animals to the Union.]](1) 
II.2.11.  come from an establishment :  
II.2.11.1.  which is registered by and under the control of the competent authority of the third country 
or territory of origin and has a system in place to maintain for at least 3 years up -to-date 
records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
 
II.2.11.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the occurrence of the relevant listed 
diseases refer red to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a 
frequency that is proportional to the risk posed by the establishment.  
II.2.11.3.  which was not subject to national restriction measures for animal health reasons, including 
the releva nt listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 and emerging diseases, at the time of dispatch to the Union.  
II.2.11.4.  in and around which, in an area with a 10 km radius, including where appropriate the 
territor y of a neighbouring country, none of the following listed diseases has been reported 
for at least 30 days prior to the date of dispatch of the animals to the Union: foot and mouth 
disease, infection with rinderpest virus, infection with Rift valley fever v irus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia.  
either [II.2.11.5.  in and around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring count ry, epizootic haemorrhagic disease has not been reported for at least 2 
years prior to the date of dispatch of the animals to the Union] (1) 
or [II.2.11.5 . which is located in a zone seasonally free of epizootic haemorrhagic disease.](1)(7)  
either [II.2.11.6. in which infection with Mycobacterium tuberculosis complex (M.bovis, M.caprae and This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 422  EN COUNTRY  Certificate model OV /CAP -X 
M.tuberculosis ) has not been reported during 42 days prior to the date of dispatch of the animals to the 
Union](1)(8)  
or [II.2.11.6. subjected to surveillance to detect infection with Mycobacterium tuberculosis complex 
(M.bovis, M.caprae and M.tuberculosis ) in accordance with the procedures in points (1) and (2) of part 
1 of Annex II to Commission Delegated Regulation (EU) 2020/ 688 during at least 12 months prior t o 
the date of dispatch to the Union and during this period:  
(i) only caprine animals from establishments applying the measures provided in the paragraph above 
have been introduced in the establishment;  
(ii) in case infection with Mycobacterium tuberculosis complex  (M.bovis , M.caprae  and 
M.tuberculosis ) has been reported in caprine animals kept on the establishment, measures were 
taken in accordance with point (3) of part 1 of Annex II to Commission Delegated Regulation 
(EU) 2020/ 688].(1)(9) 
II.2.11.7.  free from infection with Brucella abortus, B. melitensis and B. suis  as regards ovine and caprine 
animals(10); and   
either  [II.2.11.7.1. in a zone free from the disease as regards ovine and caprine animals where 
vaccination against that disease is not pra cticed] (1)(11);  
or [II.2.11.7.1. have been tested with one of the diagnostic methods provided for in Article 9(b)(i) 
of Commission Delegated Regulation (EU) 2020/ 692 for infection with Brucella abortus, B. 
melitensis and B. suis , with negative results, o n a sample taken during the last 30 days prior to 
the date of dispatch to the Union, and in the case of post -parturient females, the test is carried 
out on a sample taken at least 30 days after parturition](1) 
or [II.2.11.7.1. are less than 6 months old;](1) 
or [II.2.11.7.1. are castrated](1). 
II.2.11.8.  in which rabies has not been reported for at least 30 days prior to dispatch of the animals to the 
Union;  
II.2.11.9.  in which anthrax has not been reported for at least 15 days prior to the date of dispatc h of the 
animals to the Union;  
either [II.2.11.9. in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior 
to the date of dispatch of the animals to the Union.] (1) 
or [II.2.11.9. in which surra ( Trypanosoma evansi ) has not been  reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was reported in the 
establishment of origin during the 2 years prior to the date of dispatch of the animals to the 
Union, the establishment remain ed under restriction until the infected animals were removed 
from the establishment and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi ) as described in Article 9(b)(i) of 
Regulation (E U) 2019/ 692 carried out on samples taken at least 6 months after the infected 
animals were removed from the establishment.] (1) 
[II.2.11.10.  in which Burholderia mallei  (Glanders) has not been reported for at least 6 months prior 
to the date of dispatch of  the animals to the Union.](9) 
[II.2.12.  include uncastrated males of ovine animals, which have remained for a continuous period of at 
least 60 days prior to their dispatch to the Union in an establishment where infection with 
Brucella ovis  (contagious epididymitis) has not been reported during the period of 12 months 
prior to the date of their dispatch to the Union and have been subjected to a serological test for 
the detection of Brucella ovis , with negative results, during the 30 days pri or to the date of their 
dispatch to the Union.] (1) 
II.2.13.  comply with the following conditions as regards classical scrapie:  
II.2.13.1.  they have been kept continuously since birth in a country where the following This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 423  EN COUNTRY  Certificate model OV /CAP -X 
conditions are fulfilled:  
(a) classical scrapie is compulsorily notifiable;  
(b) an awareness, surveillance and monitoring system is in place;  
(c) ovine and caprine animals affected with classical scrapie are killed and 
completely destroyed;  
(d) the feeding to ovine and caprine animals of meat -and-bone meal or greaves 
of ruminant origin, as defined  in the Terrestrial Animal Health Code of the 
World Organisation for Animal Health,  has been banned and effectively 
enforced in the whole country for a period of at least the last seven years, 
and 
(1)either [II.2. 13.2. they are animals intended for production and they are destined for a Member 
State other than those with a negligible risk status for classical scrapie approved in accordance 
with point 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 9 99/2001, or 
other than those which are listed in point 3.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having an approved national scrapie control programme;]  
(1)or [II.2. 13.2. they are animals intended for breeding and they a re destined for a Member 
State other than those with a negligible risk status for classical scrapie approved in accordance 
with point 2.2 of Section A of Chapter A of Annex VIII to Regulation (EC) No 999/2001, or 
other than those which are listed in point 3.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001 as having an approved national scrapie control programme and:  
(1)either [they come from a holding or holdings that have complied with the 
requirements laid down in point 1.3 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]  
(1)or [they are ovine animals of the ARR/ARR prion protein genotype and they come 
from a holding or holdings where no official movement restriction has been 
imposed due to BSE or classical s crapie during the last two years;]]  
(1)or [II.2. 13.2. they are destined for a Member State with a negligible risk status for classical 
scrapie approved in accordance with point 2.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001, or for a Member State listed in point 3.2 of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001 as having an approved national scrapie control 
programme and:  
(1)either [they come from a holding or holdings that have complied with the 
requirements laid down in point 1.2 of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]  
(1)or [they are ovine animals of the ARR/ARR prion protein genotype and they come  
from a holding or holdings where no official movement restriction has been 
imposed due to BSE or classical scrapie during the last two years;]]  
 
Notes:  
This certificate is intended for entry into the Union of ovine animals other than ovine animals, including when the 
Union is not the final destination of the animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 424  EN COUNTRY  Certificate model OV /CAP -X 
Box ref erence I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/ … 
[SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union , or a date in a 
period when restriction measures have been adopted by the Union against entries of these animals from this zone.  
(4) For zones with opening date in accordance with column 8 in part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/…  (SANTE/7140/2020 ) 
(5) For zones with entry BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/ … 
(SANTE/7140/2020 ). 
(6) For zones with entry SF -BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/ … 
(SANTE/7140/2020 ). 
(7) For zones with entry SF -EHD in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/ … 
(SANTE/7140/2020 ). 
(8) Only for ovine animals.  
(9) Only for caprine animals.  
(10) In accordance with Article 10 of Commission Delegated Regulation (EU) 2020/ 692. 
(11) Zones with entry BRU -Ovi in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/XX 
(SANTE/7140/2020 ). 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 425  EN CHAPTER 5: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF OVINE AND CAPRINE AN IMALS INTENDED FOR S LAUGHTER 
(MODEL ‘OV /CAP -Y’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 426  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 427  EN COUNTRY  Certificate model OV /CAP -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechn ical treatment (as  defined in Directive 96/22/EC).  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the 
concern ed animals are listed in Decision 2011/163/E U for the concerned country of origin . 
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that  the animals  described in Part I : 
II.2.1.  come from the zone with code: __ __ - __(2) which, at the date of issuing this certificate is authorised for 
entry into the Union of ovine and caprine animals  and is listed in Part 1 of Annex I to Commission 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  are intended for slau ghter in the Union.  
II.2.3.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 3 months prior to the 
date of their dispatch to the Union, and  
(ii) in the establishment of origin since birth or fo r a period of time of at least 40 days prior to the date of 
their dispatch to the Union, in which period no animals have been introduced.  
II.2.4.  had no contact with animals of a lower health status since birth or at least for 30 days prior to the date of 
their dispatch to the Union.  
II.2.5.  are not to be killed under a national programme for the eradication of diseases, including the relevant listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
(1) either  [II.2.6.  have been dispatched directly from the establishment of origin to the Union without 
passing through any other establishment].  
(1) or [II.2.6.  have undergone one single assembly operation in the zone of origin fulfilling the 
following requi rements:  
(a) the assembly operation took place in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent authority in 
the third country or territory in accordance with Article 5 of Commission Delegated 
Regulation (EU) 2019/2035;  
(ii) which has an unique approval number assigned by the compe tent authority of the third 
country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Commission Delegated Regulation 
(EU) 2019/2035;  
(iv)  fulfilling the  requirements provided for in Article 8 of Commission Delegated 
Regulation (EU) 2020/ 692. 
(b) the assembly operation in the assembly centre took no longer than 6 days.]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 428  EN COUNTRY  Certificate model OV /CAP -Y 
II.2.7.  have not been unloaded in any place that does not comply with the requirements laid down in point II.2.12. 
since they were dispatched from their establishment of origin until their dispatch to the Union and during 
that period have not been in contact with animals of a lower health status.  
II.2.8.  have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport which 
was cleaned and disinfected prior to loading with a disinfectant authorised by the competent authority in the 
third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.9.  been subjected to a clinical inspection within the 24 hours prior to loading for dispa tch to the Union, carried 
out by an official veterinarian in the third country or territory of origin, who did not detect signs indicative 
of the occurrence of diseases, including the relevant listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.2.10.  have not been vaccinated against:  
(i) foot and mouth disease, infection with Rift Valley fever virus, peste des petits ruminants, sheep pox 
and goat pox, cont agious caprine pleuropneumonia,  Mycobacterium  tuberculosis complex  (M.bovis , 
M.caprae  and M.tuberculosis ) and infection with Brucella abortus , B. melitensis  and B. suis , and  
(ii) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during the 60 days prior to their 
dispatch to the Union.  
II.2.11.  come from a zone : 
II.2.11.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch to the Union](1)  
or  [since __/__/____  (dd/mm/yyyy)] (1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 months prior to 
the date of dispatch of the animals to the Union, and no animals vaccinated against foot and mouth 
disease have been introduced during that period.  
II.2.11.2.  in which infection with rinderpe st, infection with Rift Valley fever virus, infection with peste des 
petits ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia has not been 
reported for at least 12 months prior to the date of dispatch of the animals to the Unio n and during that 
period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.   
either  [II.2.11.3. is free from infection with bluetongue virus (Serotypes 1 -24)](1)(5)  
 or [II.2.11.3. is seasonally free from infection with bluetongue virus (Serotypes 1 -24): 
either [II.2.11.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.](1)(6)  
or [II.2.11.3.1. for at least 28 days prior to the date of dispatch of the animals to the Union 
and the animals have been subjected to a serological test in accordance with Article 
9(1)(b) of Commission Delegated Regulation (EU) 2020/ 692, with negative results, 
carried out on samples collected at least 28 days fol lowing the date of entry of the 
animal into the seasonally free zone.](1)(6)  
or [II.2.11.3.1. for at least 14 days prior to the date of dispatch of the animals to the Union 
and have been subjected to a PCR test, with negative results, carried out on sample s This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 429  EN COUNTRY  Certificate model OV /CAP -Y 
collected at least 14 days following the date of entry of the animal in the seasonally 
free zone.](1)(6) 
or [II.2.11.3.  is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have been 
vaccinated against all the serotypes (1 to  24) of bluetongue virus reported during the past 2 years in that 
zone and are still within the immunity period of time guaranteed in the specifications of the vaccine and  
either  [II.2.11.3.1.  have been vaccinated more than 60 days prior to the date of di spatch of the animals to 
the Union.]](1) 
or [II.2.11.3.1.  have been vaccinated with an inactivated vaccine and were subjected to a PCR test, with 
negative results on samples collected at least 14 days after the onset of the immunity protection set 
in the s pecifications of the vaccine.]] (1) 
or [II.2.11.3. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have been 
subjected with positive results to a serological test able to detect specific antibodies against all serotypes (1  to 
24) of bluetongue virus reported during the past 2 years in that zone and:  
either [II.2.11.3.1. the serological test has been carried out on samples collected at least 60 days 
prior to the date of dispatch of the animals to the Union.]] (1) 
 or [II.2.1 1.3.1. the serological test has been carried out on samples collected at least 30 days prior 
to the date of dispatch of the animals to the Union and the animals were subjected to a PCR 
test, with negative results, carried out on samples collected not earli er than 14 days prior to 
the date of dispatch of the animals to the Union.]] (1) 
II.2.12. come from an establishment : 
II.2.12.1.  which is registered by and under the control of the competent authority of the third country or 
territory of origin and has a s ystem in place to maintain for at least 3 years up -to-date records 
containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.12.2.  which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the occurrence of the relevant listed diseases referred 
to in Annex I to Commission D elegated Regulation (EU) 2020/ 692 at a frequency that is 
proportional to the risk posed by the establishment.  
II.2.12.3.  which was not subject to national restriction measures for animal health reasons, including the 
relevant listed diseases referred to in  Annex I to Commission Delegated Regulation (EU) 
2020/ 692 and emerging diseases, at the time of dispatch to the Union.  
II.2.12.4.  in and around which, in an area with a 10 km radius, including where appropriate the territory 
of a neighbouring country, none  of the following listed diseases has been reported for at least 30 
days prior to the date of dispatch of the animals to the Union: foot and mouth disease, infection 
with rinderpest virus, infection with Rift valley fever virus, infection with peste des pe tits 
ruminants virus, sheep pox and goat pox and contagious caprine pleuropneumonia.  
either [II.2.12.5.  in and around which, in an area with a 150 km radius, including where appropriate the territory of 
a neighbouring country, epizootic haemorrhagic diseas e has not been reported for at least 2 years 
prior to the date of dispatch of the animals to the Union] (1)  
or  [II.2.12.5. which is located in a zone seasonally free of epizootic haemorrhagic disease.] (1)(7) 
either [II.2.12.6.  in which infection with Mycobacterium tuberculosis complex (M. bovis, M. caprae and M. 
tuberculosis ) has not been reported during 42 days prior to the date of dispatch of the animals to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 430  EN COUNTRY  Certificate model OV /CAP -Y 
the Union] (1)(8)  
or [II.2.12.6.  subjected to surveillance to detect infection with Mycobacterium tuberculosis complex (M. bovis, 
M. caprae and M. tuberculosis ) in accordance with the procedures in points (1) and (2) of part 1 of 
Annex II to Commission Delegated Regulation (EU) 2020/ 688 during at least 12 months prior to 
the date of dispa tch to the Union and during this period:  
(iii) only caprine animals from establishments applying the measures provided in the paragraph 
above have been introduced in the establishment;  
(iv) in case infection with Mycobacterium tuberculosis complex  (M. bovis , M. caprae  and M. 
tuberculosis ) has been reported in caprine animals kept on the establishment, measures were 
taken in accordance with point (3) of part 1 of Annex II to Commission Delegated Regulation 
(EU) 2020/ 688]. (1)(9) 
II.2.12.7.  free from infection with  Brucella abortus, B. melitensis and B. suis  as regards ovine and caprine 
animals(10). 
II.2.12.8.  in which rabies has not been reported for at least 30 days prior to dispatch of the animals to the 
Union.  
II.2.12.9.  in which anthrax has not been reported fo r at least 15 days prior to the date of dispatch of the 
animals to the Union.  
either [II.2.12.10. in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior to 
the date of dispatch of the animals to the Union.] (1) 
or  [II.2.12.10 . in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days prior to 
the date of dispatch of the animals to the Union and when the disease was reported in the 
establishment of origin during the 2 years prior to the date of dispatch of the animals to the Union, 
the establishment remained under restriction until the infected animals were removed from the 
establishment and the remaining animals on the establishment were subjected with negative result 
to a test for surra ( Trypanosoma evansi ) as described in Article 9(b)(i) of Regulation (EU) 
2020/692  carried out on samples taken at least 6 months after the infected animals were removed 
from the establishment.] (1) 
[II.2.12.11.  in which Burholderia mallei  (Glanders) has not been reported for at least 6 months prior to 
the date of dispatch of the animals to the Union.](9) 
[II.2.13.  include uncastrated males of ovine animals, which have remained for a continuous period of 
at least 60 days prior to their dispatch to the Union in an establishment where infection with 
Brucella ovis  (contagious epididymitis) has not been reported during t he period of 12 months 
prior to the date of their dispatch to the Union and have been subjected to a serological test 
for the detection of Brucella ovis , with negative results, during the 30 days prior to the date of 
their dispatch to the Union.](1) 
II.2.14. have been kept continuously since birth in a country where the following conditions  as 
regards classical scrapie  are fulfilled: 
(a) classical scrapie is compulsorily notifiable;  
(b) an awareness, surveillance and monitoring system is in place;  
(c) ovine and caprine  animals affected with classical scrapie are killed and completely 
destroyed;  
(d) the feeding to ovine and caprine animals of meat -and-bone meal or greaves of ruminant 
origin, as defined  in the Terrestrial Animal Health Code of the World Organisation for 
Anima l Health,  has been banned and effectively enforced in the whole country for a 
period of at least the last seven years, and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 431  EN COUNTRY  Certificate model OV /CAP -Y 
 
Notes:  
This certificate is intended for entry of ovine animals that will be slaughtered in the Union.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union , or a date in a 
period when restriction measures have been adopted by the Union against entries of these animals from this zone.  
(4) For zones with opening date in accordance with column 8 in part 1 of Annex I to Commission Implementing Regulation 
2020/xx ( SANTE/7140/2020 ). 
(5) For zones with entry BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
(SANTE/7140/2020 ). 
(6) For zones with entry SF -BTV in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
(SANTE/7140/2020 ). 
(7) For zones with entry SF -EHD in column 7 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
(SANTE/7140/2020 ). 
(8) Only for ovine animals.  
(9) Only for caprine animals.  
(10) In ac cordance with Article 10 of Commission Delegated Regulation (EU) 2020/ 692. 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 432  EN CHAPTER 6: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF PORCINE ANIMALS AND ANIMALS OF THE FAMIL Y OF 
TAYASSUIDAE (MODEL ‘ SUI-X’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circus/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 433  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 434  EN COUNTRY  Certificate model SUI -X Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  [*to delete when the Union is not the final destination of the animals]  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as  defined in Directive 96/22/EC).  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 the reof, and the 
concerned animals are listed in Decision 2011/163/E U for the concerned country of origin . 
(1)(2)(10)[II.1.3.  are domestic porcine animals either coming from a holding officially recognised as 
applying controlled housing conditions in accordance with Article 8 of Implementing 
Regulation (EU) 2015/1375 or are not weaned and less than 5 weeks of age.]  
 
II.2. Animal health a ttestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.2.1.  come from the zone  with code: __ __ - __(2) which, at the date of issue of this certificate is 
authorised for entry into the Union of animals of the families Suidae  and Tayassuidae  and listed 
in Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 
months immediately prior to the date of their dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to 
the date of their dispatch to the Union, in which period no animals have been introduced.  
II.2.3.  had no contact with animals of a lower health status since b irth or at least for 30 days prior to the 
date of their dispatch to the Union.  
II.2.4.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated R egulation (EU) 2020/ 692 
and emerging diseases.  
(1) either [II.2.5.  have been dispatched directly from the establishment of origin to the Union 
without passing through any other establishment].  
 (1)(3) or [II.2.5.  have undergone one single assembly operatio n in the zone of origin fulfilling 
the following requirements:  
(a) the assembly operation took place in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent 
authority in the third country or territory in accordance with Article 5 of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 435  EN COUNTRY  Certificate model SUI -X 
Commission Delegated Regulation (EU) 2019/2035;  
(ii) which has an unique approval number assigned by the compe tent authority of the 
third country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory of 
dispatch with the information set out in Article 21 of Commission Delegated 
Regulation (EU) 2019/2035;  
(iv)  fulfilling the  requirements provided for in Article 8 of Commission Delegated 
Regulation (EU) 2020/ 692. 
(b) the assembly operation in the assembly centre took no longer than 6 days.]  
II.2.6.  have not been unloaded in any place that does not comply with the requirements laid  down in 
point II.2.11. since they were dispatched from their establishment of origin until their dispatch to 
the Union and during that period they have not been in contact with animals of a lower health 
status.  
II.2.7.  are loaded for dispatch to the Union  on ___/___/____ (dd/mm/yyyy)(4) in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escap e or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.8.  have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred 
to in Annex I to Commission Deleg ated Regulation (EU) 2020/ 692 and emerging diseases.  
II.2.9.  have not been vaccinated against foot and mouth disease and classical swine fever.  
II.2.10.  come from a zone  in which:  
II.2.10.1.  foot and mouth disease has not been reported for:  
either [at leas t 24 months prior to the date of dispatch of the animals to the Union.](1) 
or [since …………… (dd/mm/yyyy).](1)(5) 
and in which vaccination against foot and mouth disease has not been carried out for at 
least 12 months prior to the date of dispatch of the ani mals to the Union and no animals 
vaccinated against the disease have been introduced during that period.  
II.2.10.2.  infection with rinderpest virus has not been reported for at least 12 months prior to the 
date of dispatch of the animals to the Union and i n which vaccination against this 
disease has not been carried out for at least the last 12 months and no animals 
vaccinated against the disease have been introduced during that period.  
II.2.10.3.  classical swine fever has not been reported for:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 436  EN COUNTRY  Certificate model SUI -X 
either [at least 24 months prior to the date of dispatch of the animals to the Union.](1) 
or   [since …………… (dd/mm/yyyy), the disease has not been reported 
and the animals of the consignment have been subjected to a test for the detection of 
classical swine fever, with a negative result, carried out within a period of 30 days prior 
to the date of dispatch of the animals to the Union;] (1)(6) 
and in which vaccination against classical swine fever has not been carried out for at least 
12 months prior to the date of di spatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.  
[II.2.10.4.  African swine fever has not been reported for the last 12 months prior to the date of 
dispatch of the animals to the Union ] (1)(7). 
II.2.11.  come from an establishment : 
II.2.11.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.11.2.  which receives regular animal health vi sits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a 
frequency that is proportional to the risk posed  by the establishment.  
II.2.11.3.  which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases, at the  time of dispatch to the Union.  
II.2.11.4.  in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispa tch of the animals to the Union: foot and 
mouth disease, infection with rinderpest virus, classical swine fever and African swine 
fever.  
II.2.11.5.  [in which infection with Brucella abortus , B. melitensis  and B. suis  has not been 
reported during the last 4 2 days prior to dispatch to the Union and in which during the 
last 12 months prior to dispatch to the Union  
either [biosecurity and risk mitigating measures, including housing conditions and 
feeding systems, have been applied as necessary to prevent trans mission of infection 
with Brucella abortus , B. melitensis  and B. suis from wild animals of listed species to 
porcine animals kept on the establishment and only porcine animals from 
establishments applying equivalent biosecurity measures have been introduce d;]](1) 
or [surveillance for infection with Brucella abortus , B. melitensis  and B. suis  has been 
carried out on the porcine animals kept on the establishment in accordance with Annex 
III to Regulation (EU) 2019/ 688 during the last 12 months prior to dispat ch to the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 437  EN COUNTRY  Certificate model SUI -X 
Union, and during this period:  
- only porcine animals from establishments applying the biosecurity 
measures or the surveillance measures provided for above have been 
introduced in the establishment, and  
- in case infection with Brucella abortus , B. melitensis  and B. suis  has 
been reported in porcine animals kept on the establishment, measures 
were taken in accordance with [Part 1(3) of Annex II to Regulation (EU) 
2019/ 688]].(1) 
II.2.11.6.  in which infection with Aujeszky’s disease virus has not been reported for at least the 
30 days prior to dispatch of the animals to the Union;  
[II.2.11.7.  in which rabies has not been reported for at least the 30 days prior to dispatch of the 
animals to the Union](1)(7); 
II.2.11.8.  in which anthrax has not been repor ted for at least the 15 days prior to dispatch of the 
animals to the Union;  
either [II.12.1.9.  in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years 
prior to the date of dispatch of the animals to the Union.] (1) 
or  [II.2.11.9.  in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days 
prior to the date of dispatch of the animals to the Union and when the disease was reported in the 
establishment of origin during the 2 years prior to the date of dispatch of the animals to the 
Union, the establishment remained under restriction until the infected animals were removed 
from the establishment and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi ) as described in Article 9(b)(i) of 
Commission Implementing Regulation (EU) 2020/ 692 carried out on samples taken at least 6 
months after the infected animals were removed from the establishment.] (1) 
II.12.  Additional guarantees as regards category C disease s(1)(8) 
[II.12.1.  the animals   
either [II.12.1.1  originate from a third country or territory or zone thereof free from 
infection with Aujeszky’s disease virus](1)(9);  
or [II.12.1.1.  have undergone a serological test for the detection of antibodies 
against  whole Aujeszky’s disease virus or antibodies against ADV -gE 
protein, if necessary, using one of the diagnostic methods provided for 
in Part 7 of Annex 1 to Regulation (EU) 20 20/688, with a negative 
result on a sample taken during the period of 15 days prior to the date 
of their dispatch to the Union.]](1)(7) 
 
Notes:  
This certificate is intended for entry into the Union of porcine animals and animals of the family Tayassuidae , 
including when the Union is not the final destination of those animals.  
Guidan ce on the completion of this official certificate is available in Chapter 4 of Annex I to Commission This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 438  EN COUNTRY  Certificate model SUI -X 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Only possible for porcine animals.  
(4) Date of loading: it cannot be  a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.  
(5) Only for countries with the opening date in col umn 8 in Part 1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ). 
(6) For countries with entry CSF in column 6 of Part 1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ) 
(7) Only applicable to ungulates of the family Suidae.  
(8) When required by the Member State of destination.  
(9) For countries with entry ADV in column 6 of Part 1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ) recognised free from infection with Aujeszky’s disease virus or with an approved 
eradication programme and fulfilling th e requirements in Regulation (EU) 20 20/688 . 
(10) Only for third countries listed in Article 13.2 of implementing Regulation (EU) 2015/1375.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 439  EN CHAPTER 7: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF PORCINE ANIMALS INTE NDED FOR SLAUGHTER (MODEL ‘SUI -Y’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 440  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 441  EN COUNTRY  Certificate  model SUI -Y Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
- any stilbene or thyrostatic substances,  
- oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other  than 
therapeutic or zootechnic al treatment (as defined in Directive 96/22/EC).  
II.1.2.  fulfil the guar antees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and in 
particular Article 29 thereof and the concerned animals are listed in Decision 201 1/163/E U for 
the concerned country of origin . 
(1)(2)( 10)[II.1.3.  are domestic porcine animals either coming from a holding officially recognised as 
applying controlled ho using conditions in accordance with Article 8 of Implementing 
Regulation (EU) 2015/1375 or are not weaned and less than 5 weeks of age.]  
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.2.1.  come from the zone  with code: __ __ - __(2) which, at the date of issue of this certificate is 
authorised for the entry into the Union of porcine animals intended for slaughter  and listed in Part 1 of 
Annex I to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  are intended for slaughter in the Union.  
II.2.3.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 3 months prior to 
the date of their dispatch to the Union, and  
(ii) in the establishment of origin since bir th or for a period of time of at least 40 days prior to the date 
of their dispatch to the Union, in which period no animals have been introduced.  
II.2.4.  had no contact with animals of a lower health status since birth or at least for 30 days prior to the  
date of their dispatch to the Union.  
II.2.5.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and 
emerging disea ses. 
(1) either [II.2.6.  have been dispatched directly from the establishment of origin to the Union without 
passing through any other establishment].  
(1)(3) or [II.2.6.  have undergone one single assembly operation in the zone of origin fulfilling the 
following requirements:  
(a) the assembly operation took place in an establishment:  
(i) approved for conducting assembly operations of ungulates by the competent 
authority in the third country or territory in accordance with Article 5 of 
Commission Delegated Regul ation (EU) 2019/2035;  
(ii) which has an unique approval number assigned by the competent authority of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 442  EN COUNTRY  Certificate  model SUI -Y 
third country or territory;  
(iii) listed for that purpose by the competent authority of the third country or territory 
of dispatch with the information set out in Article 21 of Commission Delegated 
Regulation (EU) 2019/2035;  
(iv)  fulfilling the requirements provided for in Article 8 of Commission Delegated 
Regulation (EU) 2020/ 692. 
(b) the assembly operation in the assembly centre took no longer than 6 days.]  
II.2.7.  have not been unloaded in any place that does not comply with the requirements laid down in point 
II.2.12. since they were dispatched from their establishment of origin until their dispatch to the 
Union and during that period they have not been in contact wit h animals of a lower health status.  
II.2.8.  have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(4) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
 
II.2.9.  have been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of disease s, including the relevant listed diseases referred 
to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.2.10.  have not been vaccinated against foot and mouth disease and classical swine fever.  
II.2.11.  come from a zone  in which:  
II.2.11.1.  foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch of the animals to the Union.](1) 
or [since …………… (dd/mm/yyyy).](1)(5) 
and in which vaccination against foot and mouth disease has not been carried out for at least 
12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.  
II.2.11.2.  infection with rinderpest virus has not been reporte d for at least 12 months prior to the 
date of dispatch of the animals to the Union and in which vaccination against this disease 
has not been carried out for at least the last 12 months and no animals vaccinated against 
the disease have been introduced dur ing that period.  
II.2.11.3.  classical swine fever has not been reported for:  
either [at least 24 months prior to the date of dispatch of the animals to the Union.](1) 
or [since …………… (dd/mm/yyyy), the disease has not been reported and the animals of 
the c onsignment have been subjected to a test for the detection of classical swine fever, with 
a negative result, carried out within a period of 30 days prior to the date of dispatch of the 
animals to the Union;] (1)(6) 
and in which vaccination against classica l swine fever has not been carried out for at least 
12 months prior to the date of dispatch of the animals to the Union and no animals 
vaccinated against the disease have been introduced during that period.  
[II.2.11.4.  African swine fever has not been repo rted for the last 12 months prior to the date of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 443  EN COUNTRY  Certificate  model SUI -Y 
dispatch of the animals to the Union] (1)(7). 
II.2.12.  come from an establishment : 
II.2.12.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years up -
to-date records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishmen t; 
(iii) mortality in the establishment.  
 
II.2.12.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases referred 
to in Annex I to Commission De legated Regulation (EU) 2020/ 692 at a frequency that is 
proportional to the risk posed by the establishment.  
II.2.12.3.  which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases, at the time of dispatch to the Union.  
II.2.12.4.  in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch of the animals to the Union: foot and mouth 
disease, infection with rinderpest virus, classical swine fever and African swine fever.  
II.2.12.5.  [in which infection wi th Brucella abortus , B. melitensis  and B. suis  has not been reported 
during the last 42 days prior to dispatch to the Union and in which during the last 12 
months prior to dispatch to the Union  
either [biosecurity and risk mitigating measures, including housing conditions and 
feeding systems, have been applied as necessary to prevent  transmission of 
infection with  Brucella abortus , B. melitensis  and B. suis from wild animals of 
listed species to porcine animals kept on the establishment and only porcine 
animals from establishments applying equivalent biosecurity measures have been 
introduced;]](1) 
or  [surveillance for infection with Brucella abortus , B. melitensis  and B. suis  has 
been carried out on the porcine animals kept on the establishment in accorda nce 
with Annex III to Regulation (EU) 2019/ 688 during the last 12 months prior to 
dispatch to the Union, and during this period:  
- only porcine animals from establishments applying the biosecurity measures 
or the surveillance measures provided for above have  been introduced in the 
establishment, and  
- in case infection with  Brucella abortus , B. melitensis  and B. suis  has been 
reported in porcine animals kept on the establishment, measures were taken 
in accordance with [Part 1(3) of Annex II to Regulation (EU) 2019/ 688]].(1) 
II.2.12.6.  in which infection with Aujeszky’s disease virus has not been reported for at least the 30 
days prior to dispatch of the animals to the Union;  
[II.2.12.7.  in which rabies has not been reported for at least the 30 days prior to dispatch of the 
animals to the Union](1)(7); 
II.2.12.8.  in which anthrax has not been reported for at least the 1 5 days prior to dispatch of the 
animals to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 444  EN COUNTRY  Certificate  model SUI -Y 
either [II.2.12.9.  in which surra ( Trypanosoma evansi ) has not been reported for at least 
2 years prior to the date of dispatch of the animals to the Union.] (1) 
or  [II.2.12.9.  in which surra ( Trypanos oma evansi ) has not been reported for at least 
30 days prior to the date of dispatch of the animals to the Union and when the 
disease was reported in the establishment of origin during the 2 years prior to the 
date of dispatch of the animals to the Union, the establishment remained under 
restriction until the infected animals were removed from the establishment and the 
remaining animals on the establishment were subjected with negative result to a test 
for surra ( Trypanosoma evansi ) as described in Article 9(b)(i) of Commission 
Delegated Regulation (EU) 2020/ 692 carried out on samples taken at least 6 months 
after the infected animals were removed from the establishment.] (1) 
[either [II.2.13.  originate from a third country or territory or zone thereof free from infection with 
Aujeszky’s disease virus](1)(9);  
or [II.2.13.  have undergone a serological test for the detection of antibodies against whole Aujeszky’s 
disease virus or antibodies against ADV -gE protein, if necessary, using one of the 
diagnostic meth ods provided for in Part 7 of Annex I to Regulation (EU) 20 20/688 , with a 
negative result on a sample taken during the period of 15 days prior to the date of their 
dispatch to the Union.]](1)(7)](1)(8) 
 
Notes:  
This certificate is intended for porcine animals and animals of the family Tayassuidae  that will be slaughtered in 
the Union.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex I II to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ] 
(3) Only possible for porcine animals  
(4) Date of loading: it cannot be a date prior to the date of authorisation of the zone for e ntry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone  
(5) Only for countries with the opening date in column 8 in Part 1 of Annex I to Commission Implementing 
Regulation (EU) 2020/xx ( SANTE/7140/2020 ) 
(6) For countries with entry CSF in column 6 of Part 1 of Annex I to Commission Implementing Regulation (EU) 
2020/xx ( SANTE/7140/2020 ) 
(7) Only applicable to ungulates of the family Suidae  
(8) Only applicable when the Member S tate of destination or Switzerland, in accordance with the Agreement 
between the Union and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002), either 
have disease -free status for the relevant C disease or an approved eradicatio n programme  
(9) For countries with entry ADV in column 6 of Part 1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ) recognised free from infection with Aujeszky’s disease virus or with an approved This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 445  EN COUNTRY  Certificate  model SUI -Y 
eradication programme and fulfilling the requirements i n Commission Delegated Regulation (EU) 2020/ 688. 
(10) Only for third countries listed in Article 13.2 of implementing Regulation (EU) 2015/1375.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 446  EN CHAPTER 8: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF ANIMALS OF THE FAMIL IES ANTILOCAPRIDAE, BOVIDAE  
(OTHER THAN  BOVINE, OVINE AND CA PRINE ANIMALS) , GIRAFFIDAE, 
MOSCHIDAE AND TRAGUL IDAE (MODEL ‘RUM’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circus/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 447  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 448  EN COUNTRY  Certificate model RUM  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1 Public health attestation  [*to delete when the Union is not the final destination of the animals]   
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1.  have not received:  
 any stilbene or thyrostatic substances,  
 oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as  defined in Directive 96/22/EC).  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the 
concerned animals are listed in Decision 2011/163/E U for the concerned countr y of origin . 
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.2.1.  come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for the entry into the Union of ungulates of the families Antilocapridae, Bovidae, 
Giraffidae, Moschidae, Tragulidae  and listed in Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
II.2.2.  have remained continuously:  
(i) in the zone referred to in point II.2.1. since birth or for a period of time of at least 6 months 
prior to the date o f dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of dispatch to the Union, in which period no animals have been introduced.  
II.2.3.  had no contact with animals of a lower  health status since birth or at least for 6 months prior to the 
date of dispatch to the Union.  
II.2.4.  are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex I to Commi ssion Delegated Regulation (EU) 2020/ 692 and 
emerging diseases.  
II.2.5.  have been dispatched directly from the establishment of origin to the Union without passing through 
any other establishment.  
II.2.6.  have not been unloaded in any place that does not c omply with the requirements laid down in point 
II.2.11 since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in contact with animals of a lower health status.  
II.2.7.  have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent 
authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.8.  have  been subjected to a clinical inspection within t he 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred to 
in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 449  EN COUNTRY  Certificate model RUM  
II.2.9.  have not been vaccinated against:  
(i) foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever virus, 
infection with Mycoplasma mycoides  subsp . Mycoides SC (contagious bovine pleuropneumonia), 
contagious caprine pleuropneumonia, Mycobacterium tuberculosis complex (M.bovis, M.caprae 
and M.tuberculosis) , infection with  Brucella abortus, B. melitensis and B. suis, and 
(ii) infection with b luetongue virus (Serotypes 1 -24) with a live vaccine during the 60 days prior to 
their dispatch to the Union.  
II.2.10.  come from a zone:  
II.2.10.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of  dispatch to the Union](1)  
or [since __/__/____  (dd/mm/yyyy)] (1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated against 
foot and mouth d isease have been introduced during that period.  
II.2.10.2.  infection with rinderpest virus, [infection with Rift Valley fever virus](1)(5), [infection 
with Mycoplasma mycoides subsp.  Mycoides SC  (contagious bovine pleuropneumonia)](1)(6) 
[and contagious ca prine pleuropneumonia](1)(7) has not been reported for the last 12 months 
prior to dispatch to the Union and during that period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been intro duced.  
either [II.2.10.3.  which is free from infection with bluetongue virus (Serotypes 1 -24)](1)(8)  
 or [II.2.10.3.  which is seasonally free from infection with bluetongue virus (Serotypes 1 -24):  
either  [II.2.10.3.1. for at least 60 days prior to the date of dispatch of the animals to the 
Union.] (1)(9)  
 or [II.2.10.3.1. for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in accordance with 
Article 9(1)(b) of Commissio n Delegated Regulation (EU) 2020/ 692, with negative 
results, carried out on samples collected at least 28 days following the date of entry of 
the animal into the seasonally free zone.] (1)(9)  
 or [II.10.3.1. for at least 14 days prior to the date of dispat ch of the animals to the Union 
and have been subjected to a PCR test, with negative results, carried out on samples 
collected at least 14 days following the date of entry of the animal in the seasonally 
free zone.] (1)(9) 
or [II.2.10.3.   is not free from i nfection with bluetongue virus (Serotypes 1 -24) and the animals have been 
vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 years 
in that zone and are still within the immunity period of time guaranteed in the sp ecifications of 
the vaccine and  
either  [II.2.10.3.1.have been vaccinated more than 60 days prior to the date of dispatch of the animals 
to the Union.]](1) 
or [II.2.10.3.1. have been vaccinated with an inactivated vaccine and were subjected to a PCR 
test, with negative results on samples collected at least 14 days after the onset of the immunity 
protection set in the specifications of the vaccine.]] (1) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 450  EN COUNTRY  Certificate model RUM  
or [II.2.10.3. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have been 
subjected with positive results to a serological test able to detect specific antibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:  
either [II.2.10.3.1. the serological test has been carried out on samples collected at least 60 days 
prior to the date of dispatch of the animals to the Union.]](1)  
or [II.2.10.3.1. the serological test has been carried out on samples collected at least 30 days 
prior to the date of dispatch of the animals to the Union and the animals were subjected to a 
PCR test, with negative results, carried out on samples collected not earlier than 14 days 
prior to the date of dispatch to the Union. ]](1) 
II.2.11.  come from an  establishment : 
II.2.11.1.  which is registered by and under the control of the competent authority of the third country 
or territory of origin and has a system in place to maintain for at least 3 years up -to-date 
records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.11.2  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, sign s indicative of the relevant listed diseases referred to 
in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a frequency that is 
proportional to the risk posed by the establishment.  
II.2.11.3.  which was not subject to national restriction measur es for animal health reasons, including 
the relevant listed diseases referred to in Annex I to Commission Delegated Regulation 
(EU) 2020/ 692 and emerging diseases, at the time of dispatch to the Union.  
II.2.11.4.  in and around which, in an area with a 10 k m radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been reported 
for at least 30 days prior to dispatch to the Union:  
 foot and mouth disease,  
 infection with rinderpest virus,  
 [infectio n with Rift Valley fever virus](1)(5),  
 [infection with Mycoplasma mycoides  subsp . Mycoides SC (contagious bovine 
pleuropneumonia)](1)(6)  
 [contagious caprine pleuropneumonia](1)(7)  
either [II.2.11.5. in and around which, including where appropriate the territory of a neighbouring country, 
epizootic haemorrhagic disease has not been reported for at least 2 years before the date of dispatch to 
the Union in an area with a 150 km radius](1) 
or [II.2.11.5. which is located in a zone seasonally free of epizoot ic haemorrhagic disease.] (1)(10) 
II.2.11.6.  in which infection with Mycobacterium tuberculosis complex  (M. bovis , M. caprae  and 
M. tuberculosis ) has not been reported in kept animals of listed species during the 42 days 
prior to dispatch to the Union  
II.2.11.7.  in which infection with Brucella abortus, B. melitensis and B. suis  has not been reported 
in kept animals of listed species during the 42 days prior to dispatch to the Union.  
[II.2.11.8.  in which rabies has not been reported for at least the 30 days prior to dispatch to the 
Union].(1)(11) 
II.2.11.9.  in which anthrax has not been reported for at least the 15 days prior to dispatch to the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 451  EN COUNTRY  Certificate model RUM  
Union.  
II.2.11.10.  in which surra ( Trypanosoma evansi ) has not been reported for at least the 30 days prior 
to dispatch to the Union and if the disease was reported in the establishment of origin 
during the last 2 years prior to dispatch to the Union, the affected establishment 
remained under restriction until the infected animals were removed from the 
establishmen t and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi ) as described in Part 3 of Annex 
I to Commission Delegated Regulation (EU) 2020/ 688 carried out on samples taken at 
least 6 months after the infected animals were removed from the establishment.  
 
Notes:  
This certificate is intended for entry into the Union of animals of the families Antilocapridae, Bovidae (other than  
bovine, ovine and caprine animals),  Giraffidae, Moschidae and Tragu lidae , including when the Union is not the 
final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I: 
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification cod es of the animals in accordance 
with Article 21.1 of Commission Delegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to the Union 
either prior to the date of authorisation for entry into the Union of the third country, territory or zone thereof ref erred to in 
boxes reference II.1, or during a period where restriction measures have been adopted by the Union against entries of these 
animals from this third country, territory or zone thereof.  
(4) Only for countries with the opening date in column 8 in Part  1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ). 
(5) Not applicable to ungulates of the family  Tragulidae . 
(6) Only applicable to ungulates of the species  Syncerus cafer.  
(7) Only applicable to ungulates of the species  Gazzella spp.  
(8) For countries with entr y BTV in Part 1 of Annex I to Regulation (EU) 2020/xx ( SANTE/7140/2020 ) 
(9) For countries with entry SF -BTV in Part 1 of Annex I to Regulation (EU) 2020/xx ( SANTE/7140/2020 ). 
(10) For countries with entry SF -EHD in Part 1 of Annex I to Regulation (EU) 2020/xx ( SANT E/7140/2020 ). 
(11) Only applicable to  ungulates of the family  Bovidae.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 452  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 453  EN CHAPTER 9: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF ANIMALS OF THE FAMILIES TAPIRID AE, RHINOCEROTIDAE A ND 
ELEPHANTIDAE  (MODEL ‘RHINO ’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central  Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circus/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 454  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 455  EN COUNTRY  Certificate model RHINO  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
 
I, the undersigned official veterinarian, hereby certify, that the animals  described in Part I : 
II.1.1. come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for entry into the Union of animals of the  families Tapiridae , 
Rinocerothidae and Elephantidae  and listed in Part 1 of Annex I to Commission Implementing 
Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.1.2. have remained continuously:  
(i) in the zone referred to in point II. 1.1. since birth or for a period of time of at least 6 months prior 
to the date of dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to the 
date of dispatch to the Union, in which no animals have been introduced during that period of 
time.  
II.1.3. had no contact with animals of  a lower health status since birth or at least for 6 months prior to the 
date of dispatch to the Union.  
II.1.4. are not to be killed under a national programme for the eradication of diseases, including listed 
diseases and emerging diseases.  
II.1.5. have b een dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.  
II.1.6. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection  of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.7. have  been subjected with negative result  to a clinical inspection, carried out by an official 
veterinarian in the third cou ntry or territory of origin or zone thereof within the 24 hours prior to 
loading for dispatch to the Union for the purpose of detection of signs indicative of the occurrence 
of diseases, including the relevant listed diseases referred to in Annex 1 to Comm ission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases.  
II.1.8. have not been vaccinated against [foot and mouth disease and](1)(4) infection with Rift Valley fever 
virus.  
II.1.9. come from a zone:  
[II.1.9.1. in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch to the Union](1)  
or [since __/__/____  (dd/mm/yyyy)] (1)(5)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated against 
foot and mouth disease have been introduced during that period.](1)(4) 
II.1.9.2. infection with Rift Valley fever virus has not been reported for the last 12 months prior to 
dispatch to the Union and  during that period:  
(i) vaccination against the disease has not been carried out, and  
(ii) animals vaccinated against the disease have not been introduced.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 456  EN COUNTRY  Certificate model RHINO  
II.1.10. come from an  establishment :  
II.1.10.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.1.10.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of t he relevant listed diseases referred 
to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a frequency that 
is proportional to the risk posed by the establishment.  
II.1.10.3.  which was not subject to national restriction measures for animal hea lth reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.  
II.1.10.4. in and around which, including where appropriate the territory of a neighbouring 
country, none of the following listed diseases has been reported  for at least 30 days 
prior to dispatch to the Union in an area with a 10 km radius: [foot and mouth disease 
and](1)(4) infection with Rift Valley fever virus.  
II.1.10.5.  in which anthrax has not been reported for at least the 15 days prior to dispatch to the 
Union.  
 
Notes:  
This certificate is intended for entry into the Union of animals of the families Tapiridae, Rhinocerotidae  and 
Elephantidae , including when the Union is not the final destination of those animals.  
Guidance on the completion of this offic ial certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction measures hav e been 
adopted by the Union against entries of these animals from this third country, territory or zone thereof.   
(4) Only applicable to ungulates of the family  Elephantidae.  
(5) Only for countries with the opening date in column 8 in Part 1 of Annex I to Regulati on (EU) 2020/xx 
(SANTE/7140/2020 ). 
Official veterinarian  
Name (in capital letters)     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 457  EN COUNTRY  Certificate model RHINO  
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 458  EN CHAPTER 10: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF ANIMALS OF THE FAMILY HIPPOPOTA MIDAE  (MODEL ‘HIPPO ’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circus/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 459  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 460  EN COUNTRY  Certificate model HIPPO  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
 
I, the undersigned official veterinarian, hereby certify, that the  animals  described in Part I : 
II.1.1. come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for entry into the Union of animals of the family Hipopotamidae  and 
listed in Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ]. 
II.1.2. have remained continuously:  
(i) in the zone referred to in point II. 1.1. since birth or for a period of time of at least 6 months 
prior to the date of dispatch of the animals to the Union, and  
(ii) in the establishment of origin since birth or for a perio d of time of at least 40 days prior to the 
date of dispatch of the animals to the Union, in which period no animals have been 
introduced.  
II.1.3. had no contact with animals of a lower health status since birth or at least for 6 months prior to the 
date of  dispatch of the animals to the Union.  
II.1.4. are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
and emerging dise ases.  
II.1.5. have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.  
II.1.6. have not been unloaded in any place that does not comply with the requirements laid down in point 
II.1.11. si nce they were dispatched from their establishment of origin until their dispatch to the 
Union and during that period they have not been in contact with animals of a lower health status.  
II.1.7. have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
 
II.1.8. have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred 
to in Annex I to Commission Delegated Regulation (EU ) 2020/ 692 and emerging diseases.  
II.1.9. have not been vaccinated against foot and mouth disease, infection with rinderpest virus, infection 
with Rift Valley fever virus, Mycobacterium tuberculosis complex (M.bovis, M.caprae and 
M.tuberculosis) and infect ion with  Brucella abortus, B. melitensis and B. suis.  
II.1.10. come from a zone:  
II.1.10.1.in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch of the animals to the Union](1) 
or [since __/__/____  (dd/mm/yyyy)] (1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch of the animals to the Union, and no animals 
vaccinated against foot and mouth disease have been introduced during that 
period.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 461  EN COUNTRY  Certificate model HIPPO  
II.1.10.2.  infection with rinderpest virus and infection with Rift Valley fever virus has not been 
reported for the last 12 months prior to dispatch of the animals to the Union and 
during that period:  
(i) vaccination against the se diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced.  
II.1.11. come from an  establishment :  
II.1.11.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:  
(i) the species, categories, number and identification of animals on the establishment;  
(ii) movements of animals into and out of the  establishment;  
(iii) mortality in the establishment.  
II.1.11.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the relevant listed diseases 
referred to in Annex I to C ommission Delegated Regulation (EU) 2020/ 692 at a 
frequency that is proportional to the risk posed by the establishment.  
II.1.11.3.  which was not subject to national restriction measures for animal health reasons, 
including the relevant listed diseases ref erred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases, at the time of dispatch of the 
animals to the Union.  
II.1.11.4.  in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch of the animals to the Union: foot and 
mouth disease, infection with rinderpest virus and infection with Rift Valley fever 
virus.  
II.1.11.5.  in which infection with Mycobacterium tuberculosis complex  (M. bovis , M. caprae  and 
M. tuberculosis ) has not been reported in kept animals of listed species during the 42 
days prior to dispatch of the animals to the Union.  
II.1.11.6.  in which infection wi th Brucella abortus, B. melitensis and B. suis  has not been 
reported in kept animals of listed species during the 42 days prior to dispatch of the 
animals to the Union.  
II.1.11.7.  in which anthrax has not been reported for at least the 15 days prior to dis patch of the 
animals to the Union.  
either [II.1.11.8.  in which surra ( Trypanosoma evansi ) has not been reported for at least 2 years prior 
to the date of dispatch of the animals to the Union.] (1) 
or [II.1.11.8.  in which surra ( Trypanosoma evansi ) has not been reported for at least 30 days prior 
to the date of dispatch of the animals to the Union and when the disease was 
reported in the establishment of origin during the 2 years prior to the date of dispatch 
of the animals to the Union, the establishment re mained under restriction until the 
infected animals were removed from the establishment and the remaining animals on 
the establishment were subjected with negative result to a test for surra 
(Trypanosoma evansi ) as described in Article 9(b)(i) of Regulatio n (EU) 2020/ 692 
carried out on samples taken at least 6 months after the infected animals were 
removed from the establishment.] (1) 
 
Notes:  
This certificate is intended for entry into the Union of animals of the family Hippopotamidae , including when the 
Union is not the final destination of those animals.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 462  EN COUNTRY  Certificate model HIPPO  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in acc ordance 
with Article 21.1 of Commission Delegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to the Union 
either prior to the date of authorisation for entry into the Union of the third country, territory or zone thereof referred t o in 
boxes referenc e II.1, or during a period where restriction measures have been adopted by the Union against entries of these 
animals from this third country, territory or zone thereof.  
(4) Only for countries with the opening date in column 8 in Part 1 of Annex I to Regulatio n (EU) 2020/xx 
(SANTE/7140/2020 ). 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 463  EN CHAPTER 11: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CAMELID AND  CERVID ANIMALS (MODE L ‘CAM -CER’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     Travelling circus/animal acts  
   Quarantine establishment   Exhibition   
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 464  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 465  EN COUNTRY  Certificate model CAM -CER  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  [*to delete when the Union is not the final destination of the animals]  
I, the undersigned official veterinarian, hereby certify, that the animals described in this certificate:  
II.1.1. have not received:  
- any stilbene or thyrostatic substances,  
- oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other  than 
therapeutic or zootechnic al treatment (as defined in Directive 96/ 22/EC).  
II.1.2.  fulfil the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Council Directive 96/23/EC, and in particular Article 29 thereof , 
and the concerned animals are listed in Decision 2011/163/E U for the concerned country of 
origin . 
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify, that the animals  described in Part I : 
II.2.1.  come from the come from the zone  with code: __ __ - __(2) which, at th e date of issuing this 
certificate is authorised for entry into the Union of  camelid and cervid animals  and listed in 
Part 1 of Annex I to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ].  
II.2 .2.  have remained continuously:  
(i) in the zone  referred to in point II.2.1. since birth or for a period of time of at least 6 months 
prior to the date of their dispatch to the Union, and  
(ii) in the establishment of origin since birth or for a period of time of at least 40 days prior to 
the date of their d ispatch to the Union, in which no animals have been introduced during that 
period of time.  
II.2.3.  had no contact with animals of a lower health status since birth or at least for 6 months prior to the 
date of their dispatch to the Union.  
II.2.4.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
and emerging diseases.  
II.2.5.  have been dispatched directly from the es tablishment of origin to the Union without passing 
through any other establishment.  
II.2.6.  have not been unloaded in any place that does not comply with the requirements laid down in point 
II.11 since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in contact with animals of a lower health status.  
II.2.7.  have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleane d and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is p ossible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.2.8.  have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third co untry or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 466  EN COUNTRY  Certificate model CAM -CER  
to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.2.9.  have not been vac cinated against:  
(i) foot and mouth disease, infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus, Mycobacterium tuberculosis 
complex (M.bovis, M.caprae and M.tuberculosis) , infection with  Brucella abortus, B. 
melitensis and B. suis, and  
(ii) infection with bluetongue virus (Serotypes 1 -24) with a live vaccine during the 60 days 
prior to their dispatch to the Union.  
II.2.10.  come from a zone:  
II.2.10.1.  in which:  
(i) foot and mouth disease has not been reported for:  
either [at least 24 months prior to the date of dispatch to the Union](1)  
or [since __/__/____ (dd/mm/yyyy)] (1)(4)  
(ii) vaccination against foot and mouth disease has not been carried out for at least 12 
months prior to the date of dispatch to the Union, and no animals vaccinated 
against foot and mouth disease have been introduced during that period.  
II.2.10.2.  infection with rinderpest virus, infection with Rift Valley fever virus , infection with 
peste des petits ruminants virus has not been reported for the last 12 months prior to 
dispatch to the Union and during that period:  
(i) vaccination against these diseases has not been carried out, and  
(ii) animals vaccinated against these diseases have not been introduced . 
 either [II.2.10.3. which is free from infection with bluetongue virus (Serotypes 1 -24)](1)(5)  
 or [II.2.10.3. which is seasonally free from infection with bluetongue virus (Serotypes 1 -24): 
either [II.2.10.3.1.  for at least 60 days prior to the date of dispatch of the animals to the 
Union.] (1)(6)  
or [II.2.10.3.1.  for at least 28 days prior to the date of dispatch of the animals to the 
Union and the animals have been subjected to a serological test in 
accordance with Article 9(1)(b) of Commission Delegat ed Regulation 
(EU) 2020/ 692, with negative results, carried out on samples collected 
at least 28 days following the date of entry of the animal into the 
seasonally free zone.] (1)(6)  
 or [II.2.10.3.1.  for at least 14 days prior to the date of dispatch of t he animals to the 
Union and have been subjected to a PCR test, with negative results, 
carried out on samples collected at least 14 days following the date of 
entry of the animal in the seasonally free zone.] (1)(6) 
 or [II.2.10.3.is not free from infection  with bluetongue virus (Serotypes 1 -24) and the animals have 
been vaccinated against all the serotypes (1 to 24) of bluetongue virus reported during the past 2 
years in that zone and are still within the immunity period of time guaranteed in the 
specificat ions of the vaccine and  
either [II.2.10.3.1.  have been vaccinated more than 60 days prior to the date of dispatch 
to the Union.]](1) 
or [II.2.10.3.1.  have been vaccinated with an inactivated vaccine and were subjected 
to a PCR test, with negative results on samples collected at least 14 days after the onset of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 467  EN COUNTRY  Certificate model CAM -CER  
the immunity protection set in the specifications of the vaccine.]] (1) 
 or [II.2.10.3. is not free from infection with bluetongue virus (Serotypes 1 -24) and the animals have 
been subjected with posi tive results to a serological test able to detect specific antibodies against all 
serotypes (1 to 24) of bluetongue virus reported during the past 2 years in that zone and:  
either [II.2.10.3.1.  the serological test has been carried out on samples collected  at least 
60 days prior to the date of dispatch of the animals to the Union.]](1) 
or [II.2.10.3.1.  the serological test has been carried out on samples collected at least 
30 days prior to the date of dispatch of the animals to the Union and the animals wer e 
subjected to a PCR test, with negative results, carried out on samples collected not earlier 
than 14 days prior to the date of dispatch of the animals to the Union. ]](1) 
II.2.11. come from an  establishment :  
II.2.11.1.  which is registered by and under the control of the competent authority of the third 
country or territory of origin and has a system in place to maintain for at least 3 years 
up-to-date records containing information regarding:  
(i) the species, categories, number and identification of animals  on the establishment;  
(ii) movements of animals into and out of the establishment;  
(iii) mortality in the establishment.  
II.2.11.2.  which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicat ive of the relevant listed diseases referred 
to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 at a frequency that 
is proportional to the r isk posed by the establishment.  
II.2.11.3.  which was not subject to national restriction measures for an imal health reasons, 
including listed diseases and emerging diseases, at the  time of dispatch to the Union.  
II.2.11.4.  in and around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the fol lowing listed diseases has been 
reported for at least 30 days prior to dispatch to the Union: foot and mouth disease, 
infection with Rift Valley fever virus and infection with peste des petits ruminants 
virus . 
either [II.2.11.5.  in and around which, in an area with a 150 km radius, including where 
appropriate the territory of a neighbouring country, epizootic haemorrhagic disease has not 
been reported for at least 2 years before the date of dispatch to the Union.](1) 
or [II.2.11.5 . which is located in a zon e seasonally free of epizootic haemorrhagic 
disease.](1)(7) 
II.2.11.6.  subjected to surveillance to detect infection with Mycobacterium tuberculosis complex 
(M.bovis, M.caprae and M.tuberculosis ) in animals of the same species of animals as 
the animals of the consignment in accordance with the procedures in points (1) and (2) 
of part 2 of Annex II to Regulation (EU) 20 20/688  during at least the last 12 months 
prior to dispatch to the Union and during this period:  
(i) only animals from establishments applying the measures provided in the paragraph 
above have been i ntroduced in the establishment;  
(ii) [Mycobacterium tuberculosis complex (M.bovis, M.caprae and M.tuberculosis ) has 
been reported in animals of the same species of animals as the animals of the 
consignment  kept on the establishment and measures were taken in accordance 
with point (3) of part 2 of Annex II to Regulation (EU) 2019/ 688]].(1) 
II.2.11.7.  in which infection with Brucella abortus, B. melitensis  and B. sui s in animals of the 
same species of animals  as the animals of the consignment has not been reported during This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 468  EN COUNTRY  Certificate model CAM -CER  
the last 42 days prior to dispatch to the Union, and the animals of the consignment have 
been subjected to a test for the detection of infection with  Brucella abortus, B. 
melitensis  and B. sui s with one of the diagnostic methods provided for in Part 1 of 
Annex I to Regulation (EU) 2019/ 688, with negative results, carried out on a sample 
taken during the last 30 days prior to dispatch to the Union, and in the case of post -
parturient females, tak en at least 30 days after parturition . 
II.2.11.8.  in which rabies has not been reported for at least the 30 days prior to dispatch to the 
Union.  
II.2.11.9.  in which anthrax has not been reported for at least the 15 days prior to dispatch to the 
Union.  
II.2.11.10.  in which surra ( Trypanosoma evansi ) has not been reported for at least the 30 days prior 
to dispatch to the Union and if the disease was reported in the establishment of origin 
during the last 2 years prior to dispatch to the Union, the affected es tablishment 
remained under restriction until the infected animals were removed from the 
establishment and the remaining animals on the establishment were subjected with 
negative result to a test for surra ( Trypanosoma evansi ) as described in Part 3 of Anne x I 
to Commission Delegated Regulation (EU) 2020/xx [ DA trade ] carried out on samples 
taken at least 6 months after the infected animals were removed from the establishment.  
[II.2.11.11.  in which, if an infection with Burkholderia mallei  (Glanders) has bee n reported during 
the period of 3 years prior to the date of dispatch to the Union, following the last 
outbreak the establishment remained under movement restrictions by  the competent 
authority until:  
(i) the infected animals have been killed and destroyed; an d 
(ii) the remaining animals were subjected to a test carried out as described in point 1 
of Annex XI of Delegated Regulation (EU) 2020/688  with negative results on 
samples taken at least 6 months after the date on which the infected animals were 
killed and des troyed and the establishment cleaned and disinfected](1)(8) 
[II.2.12.  originate from an establishment in which infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis has not been reported on camelid animals in the last 30 days 
prior to dispatch to the Union.](1)(9) 
 
Notes:  
This certificate is intended for entry into the Union of camelid and cervid animals, including when the Union is not 
the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 of Commission Delegated  Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 469  EN COUNTRY  Certificate model CAM -CER  
(3) Date of loading: entries of these animals shall not be permitted  when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction measures ha ve been 
adopted by the Union against entries of these animals from this third country, territory or zone thereof.  
(4) Only for countries with the opening date in column 8 in Part 1 of Annex I to Regulation (EU) 2020/xx 
(SANTE/7140/2020 ) 
(5) For countries with entry BTV in Part 1 of Annex I to Regulation (EU) 2020/xx ( SANTE/7140/2020 ). 
(6) For countries with entry SF -BTV in Part 1 of Annex I to Regulation (EU) 2020/xx ( SANTE/7140/2020 ). 
(7) For countries with entry SF -EHD in Part 1 of Annex I to Regul ation (EU) 2020/xx ( SANTE/7140/2020 ). 
(8) Only applicable for ungulates of the family Camelidae.  
(9) Only applicable when the Member State of destination or Switzerland, in accordance with the Agreement 
between the Union and the Swiss Confederation on trade in agricultural products (OJ L 114, 30.4.2002), either 
have disease -free status for infectious bovine rhinotracheitis /infectious pustular vulvovaginitis in bovine 
animals or an approved eradication programme.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 470  EN CHAPTER 12: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
FOR ENTRY INTO THE U NION OF EQUINE ANIMA LS NOT INTENDED FOR 
SLAUGHTER (MODEL EQU I-X) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     Registered  horse   
       
     
      
I.21  I.22  For internal market  
   I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 471  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 472  EN  
 COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animal described in Part I:  
II.1.1.  is not intended for slaughter for human consumption and not intended for slaughter in the 
framework of the eradication of a disease communicable to equine animals, and  
(1)either  [is a registered equine  animal, as defined in Article 2(30) of Delegated Regulation (EU) 
2019/2035.]  
(1)or [is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035.]  
(1)or [is an equine animal other than a registered equine animal or a registered  horse.]  
II.1.2.  has not shown clinical signs or symptoms of diseases listed for equine animals in 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date  dd/mm/yyyy )(2), this being within 48 hours, or in the case of a 
registered horse on the last working day, prior to departure from the registered 
establishment.  
II.1.3.  meets  the requirements  attested in points II.2. to II. 5. of this certificate;  
II.1.4.  is accompanied  by a written  declaration, signed by t he operator of the animal, which forms 
part of this certificate.  
II.2. Attestation  on third country, territory or zone thereof and on establishment of dispatch  
II.2.1.  The equine  animal described in Part I  is dispatched from …………………...  (insert name 
of country, territory or zone thereof ), a country, territory or zone thereof, which on the date 
of issuing this certificate has the Code: ………..…(3) and is assigned to Sanitary Group 
……(3). 
II.2.2.  In the country or territory of dispatch the following diseases  are compulsorily notifiable: 
African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia 
mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine 
infectious anaemia, rabies and anthrax.  
II.2.3.  The equine animal described in Part I comes from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidemiological evidence of African horse sickness during the period of 24 months prio r to 
the date of departure of the animal and there have been no systematic vaccinatio ns against 
African horse sickness during the period of 12 months prior to the date of departure.  
II.2.4.  The equine animal described  in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(1)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 
months prior to the date of departure of the animal.]  
(1)or [a surveillance and eradication programme for infection with Burkholderia mallei  
(glanders ) recognised by the European Union(2) has been carried out during the last 36 
months prior to the date of departure, and  
(1)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of dispatch during the last 36 months prior to the date of departure 
of the animal.]  
(1)or [infection with Burkholderia mallei  (glanders ) has been reported in the 
establishment during the last 36 months prior to the date of departure of the animal This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 473  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
and following the last outbreak, the establishment has remained under movement 
restriction  
(1)either  [until the remaining equine  animals in the establishment have been 
subjected to a complement fixation test for infection with Burkholderia 
mallei  (glanders )(4), carried out, with negative results at a serum dilution 
of 1 in 5, on samples taken at least 6 months after the infected animals 
have been killed and destroyed.]]]  
(1)or [for at least 30 days from the date of cleaning and disinfection, after the 
last animal of listed species on the establishment was killed and destroyed 
cted.]]]  
II.2.5.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(1)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(1)or [a surveillance and eradication programme for surra recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the animal, 
and  
(1)either  [surra has not  been  reported in the establishment during the last 24 months prior to 
the date of departure of the animal.]  
(1)or [surra has  been reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and  following the last outbreak the establishment 
has remained under movement restriction  
(1)either  [until the remaining animals in the establishmen t have been subjected to 
an enzyme -linked immunosorbent assay (ELISA) for trypanosomosis  or 
card agglutination test for trypanosomosis  (CATT) at a serum dilution of 
1 in 4(4) carried out, with negative results, on samples taken at least 6 
months after the last infected animal has been removed from the 
establishment.]]]  
(1)or  [for at least 30 days from the date of cleaning and disinfection, after the 
last animal of listed spec ies on the establishment was either killed and 
destroyed or slaughtered .]]] 
II.2.6.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(1)either  [dourine has not been reported  during the last 24 months prior to the date of departure of 
the animal.]  
(1)or [a surveillance and eradication  programme for surra recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the animal, 
and 
(1)either  [dourine  has not been reported in the establishment during the last 24 months prior 
to the date of departure of the animal .] 
(1)or [dourine has been  reported in the establishment during the last 24 months prior to 
the date of departure of the animal, and following the last outbreak, the 
establishment has remained under movement restriction  
(1)either  [until the remaining equine  animals in the establishment, except castrated 
male  equine animals , have been subjected to a complement fixation test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(4) on 
samples taken at least 6 months after the infected ani mals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 474  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
(1)or [for at least 30 days from the date of cleaning and disinfection, after the last 
animal of listed species on the establishment was e ither killed and destroyed 
or slaughtered .]] 
II.2.7.  The equine animal described in Part I comes from an establishment  in which  
(1)either  [equine infectious anaemia has not been reported during the last 12 months prior to the date 
of departure of the animal.]  
(1)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animal and following  the last outbreak the establishment has remained 
under movement restriction  
(1)either  [until the remaining equine animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(4) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a 
minimum interval of 90 days following cl eaning and disinfection of the 
establishment after the infected animals have been killed and destroyed, or 
slaughtered .]] 
(1)or [for at least 30 days from the date of cleaning and disinfection, after the last 
animal of listed species on the establishment w as either killed and destroyed or 
slaughtered .]] 
II.2.8.  The equine animal described in Part I comes from an establishment  in which  
II.2.8.1.  infection with rabies virus in kept terrestrial animals has not been reported during 
the last 30 days prior to th e date of departure of the animal;  
II.2.8.2.  anthrax in ungulates has not been reported during the last 15 days prior to the date 
of departure of the animal.  
II.2.9.  To the best of my knowledge and as declared by the operator, the equine animal described 
in Part I has not been in contact with kept animals  of listed species which did not comply 
with the requirements  referred to in Points II.2.3. to II.2.8.1 during the l ast 30 days prior to 
the date of departure of the animal, and with the requirement referred to in point II.2.8.2. 
during the last 15 days prior to the date of departure of the animal.  
II.3. Attestation  of residence and pre -export isolation  
(1)either  [II.3.1.  The equine animal described in Part I has been resident in the country, territory or zone 
thereof of dispatch during a period of at least 40 days prior to the date of its departure, or 
since its entry from a Member State of the European Union , Nor way or the United 
Kingdom in respect of Northern  Ireland , or since birth if it is less than 40 days of age.]  
(1)or [II.3.1.  During a period of at least 40 days prior to the date of its departure, the registered horse 
described in Part I has been resident in the country, territory or zone thereof of dispatch;  
(1)either  [and in a Member  State of the European Union , Norway  or the United Kingdom in respect 
of Northern  Ireland ;] 
(1)and/or  [and in a country , territory or zone thereof with Code: …………………(3) that i s authorised 
for entry into the Union of registered horses, and from which it was imported into the 
country, territory or zone thereof of dispatch under conditions at least as strict as those 
required in accordance with Union legislation for the entry of r egistered horses from this 
country, territory or zone thereof directly to the Union, and which is:  
(1)either  [assigned  to the same Sanitary Group ……….. (3) as the country, territory or zone 
thereof of dispatch;]]  
(1)and/or [assigned to Sanitary  Group A, B or C;]]  
(1)and/or [China(5)(6), Hong Kong, Japan, Korea  Republic , Macao, Malaysia (Peninsula), 
Singapore, or the United Arab Emirates.]]]  
(1)either  [II.3.2.  The equine animal described in Part I is dispatched from a country, territory or zone thereof This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 475  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
assig ned to Sanitary Group A, B, C, D, or G, and  
(1)either  [during the last 30 days prior to the date of its departure, or since entry from a Member  
State of the Union , Norway or the United Kingdom in respect of Northern Ireland , or since 
birth if it is less t han 30 days of age,  
(1)either  [it has been kept apart from other equine animals, except in case of a foal at foot of 
his mother, in an establishment situated in a country, territory or zone thereof 
assigned to Sanitary Group A.]]]  
(1)or [it has been kept in pre -export isolation from other equine animals, except in case 
of a foal at foot of his mother, in an establishment situated in a country, territory or 
zone thereof assigned to Sanitary Group B, C, D or G.]]]  
(1)or [it is a registered horse which has be en kept in establishments under veterinary supervision 
during the last 30 days prior to the date of its departure, or since entry in accordance with 
point II.3.1 from a Member State of the Union, Norway , Norway or the United Kingdom in 
respect of Northern Ireland,  or a country, territory or zone thereof which is assigned to 
Sanitary Group A, B, C, D, E or G.]]  
(1)(7)or [II.3.2.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, and  
(1)either  [during the last 40 days prior to the date of its departure, or since birth if it is less than 40 
days of age, or since entry in accordance with point II.3.1 from a Member State of the 
Union, Norway , the United Kingdom in respect of Northern Irel and or a country, territory 
or zone thereof which is assigned to Sanitary Group A, B, C, D, E or G, it has been kept  
(1)either  [in isolation in an establishment  protected from vector insects.]]]  
(1)or [in an establishment under veterinary supervision, and  the country, territory or 
zone thereof of dispatch is recognised  by the World Organisation for Animal 
Health (OIE) as officially free of African horse sickness.]]]  
(1)or [is a registered horses which has been kept during the last 30 days prior to the date  of its 
departure, or since entry in accordance with point II.3.1 from a Member State of the Union, 
Norway , the United Kingdom in respect of Northern Ireland  or a country, territory or zone 
thereof which is assigned to Sanitary Group A, B, C, D, E or G, in  establishments under 
veter inary supervision, and the country, territory or zone thereof of dispatch is recognised 
by the OIE as officially free of African horse sickness.]]  
(1)(7)or [II.3.2.  The registered horse described in Part I is dispatched from a c ountry, territory or zone 
thereof assigned to Sanitary Group F, and:  
(1)either  [during at least the last 40 days prior to the date of departure it has been kept in the 
approved quarantine station of …………………………. ( insert name of quarantine 
station ), confine d to the vector -protected premises at least from two hours prior to sunset 
until two hours after sunrise and exercise was provided under official veterinary 
supervision, following the application of insect repellents in combination with an 
insecticide effe ctive against Culicoides  prior to the removal from the quarantine stables, 
and in strict isolation from equidae not being prepared for export under conditions at least 
as strict as required for entry into the Union.]]  
(1)or [during the period of at least 1 4 days prior to the date of its departure has been permanently 
confined in the approved vector -proof quarantine station of …………………………. 
(insert name of quarantine station ) and constant monitoring of the vector protection has 
proven absence of vectors inside  the vector -proof part of the quarantine station.]]  
II.4. Attestation  of vaccination and health tests  
(1)either  [II.4.1.  The equine animal described in Part I was not vaccinated against African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information suggesting This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 476  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
previous vaccination.]  
(1)or [II.4.1.  The equine animal described in Part I was vaccinated against African horse sickness more 
than 12 months prior to the date of its departure.]  
(1)(7)or [II.4.1.  The registe red horse described in Part I was vaccinated against African horse sickness not 
more than 24 months and at least 40 days prior to the date of entry in the vector -protected 
or vector –proof quarantine situated in a country, territory or zone thereof assigned  to 
Sanitary Group F, and this vaccination consisted of a complete primary course of 
vaccination against African horse sickness, or a booster within the period of validity of the 
previous vaccination, by administration according to manufacturer's instructi ons of a 
registered vaccine which is protective against the circulating serotypes of the African horse 
sickness virus, and the last vaccination was applied on …………….. (insert date) .] 
II.4.2.  The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the last 60 days prior to the date of its departure, and  
(1)either  [it comes from an establishment  situated in a country or territory in which Venezuelan 
equine encephalomyelitis has not been reported during the last 24 months prior to the date 
of its departure.]  
(1)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not  
been reported during the last 6 months prior to the date of its departure and which is 
situated in a country, territory or zone  thereof in which a surveillance and eradication 
programme for Venezuelan equine encephalomyelitis recognised by the European Un ion(2) 
has been carried out during the last 24 months prior to the date of its departure, and during 
the period of at least 21 days prior to the date of departure of the animal described in Part I, 
all equine animals in the establishment have remained clin ically healthy, and  
(1)either  [the equine animal described in Part I has been kept protected from attacks by 
insect vectors in a quaran tine, in which any equine animal that showed a rise in 
daily taken body temperature has been subjected with negative res ult to a virus 
isolation test for Venezuelan equine encephalomyelitis(4); and the equine animal 
described in Part I  
(1)either  [was vaccinated against Venezuelan equine encephalomyelitis with a 
complete primary course and revaccinated according to manufact urer's 
recommendations not less than 60 days and not more than 12 months 
prior to the date of departure;]]]  
(1)or [was subjected to a haemagglutination inhibition test for Venezuelan 
equine encephalomyelitis(4), carried out, with negative result, on a sample 
taken not less than 14 days after the date of its entry into quarantine.]]]  
(1)or [the body temperature of the equine animal described in Part I has been taken 
daily, either without  a rise or the animal has been subjected to a virus isolation test 
for Venezuelan equine encephalomyelitis with negative result, and the equine 
animal described in Part I has been subjected to   
 a haemagglutination inhibition test for Venezuelan equine 
encephalomyelitis(4), without an increase in antibody titre, carried out  on 
paired samples taken on two occasions with an interval of 21 days, the 
second of which was taken during a period of 10 days prior to the date of its 
departure, and  
 a reverse transcription -polymerase chain reaction (RT -PCR) for the 
detection of Venezuel an equine encephalomyelitis virus genome(4), with 
negative result, carried out on a sample taken within 48 hours prior to its 
departure, and  
 protection from vector attacks during the period after sampling until This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 477  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
loading for dispatch, by combined use of approved insect repellents and 
insecticides on the animal and disinsectization of the stable and the means 
in which it is transported.]]]  
(1)(7)either  [II.4.3.  The equine animal described in Part I is dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where it was continuously resident since 
birth, and did not come into contact with equidae which have entered Iceland from other 
countries.]  
(1)or [II.4.3.  The equine animal described in Part I was subjected with negative result to an agar gel 
immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infectious 
anaemia(4) carried out on a blood sample taken on …………… (insert date), this being  
within  
(1)either  [a period of 30 days prior to the date o f its departure.]]  
(1)(7)or [a period of 90 days prior to the date of its departure from a country, territory or zone 
thereof assigned to Sanitary Group A.]] 
(1)[II.4.4.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group B, D or E, or from China, or from a country or territory in 
which infection with Burkholderia mallei  (glanders ) has been reported during a period of 
36 months prior to the date of departure, and was subjected to a complement fixation test 
for infection with Burkholderia mallei  (glanders )(4) carried out with negative result at a 
serum dilution of 1 in 5 on a blood s ample taken on ……………………. ( insert  date), 
within a period of 30 days prior to the date of departure.]  
(1)[II.4.5.  The equine animal described in Part I is an uncastrated male or female equine animal older 
than 270 days dispatched from a country, territory or  zone thereof assigned to Sanitary 
Group B, D, E or F, or from China, or from a country in which dourine has been reported 
during a period of 24 months prior to the date of departure, and was subjected to a 
complement fixation test for dourine(4) carried o ut with negative result at a serum dilution 
of 1 in 5 on a blood sample taken on ……………………. ( insert  date), within a period of 
30 days prior to the date of departure, and the equine animal described in Part I has not 
been used for breeding during the period of at least 30 days prior to and after the date the 
sample was taken.]  
(1)[II.4.6.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay, Malaysia (Peninsul a) or from 
a country or territory in which surra was reported during the last 24 months prior to the date 
of departure, and was subjected to a card agglutination test for trypanosomosis  (CATT)(4), 
carried out with negative result at a serum dilution of 1 i n 4 on a blood sample taken on 
……………………. ( insert date ), within a period of 30 days prior to the date of departure.] 
(1)(7)[II.4.7.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
which is assigned to Sanitary G roup E, and  
(3)either  [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8), 
which was carried out by the same laboratory on the same day on blood samples taken on 
two occasions with an interval of between 21 and 30 days, on …………………… (insert 
date) and on ………………… (insert date) , the second of which was taken within a period 
of 10 d ays prior to the date of departure,  
(3)either  [with negative  results in each case.]]]  
(3)or [with a positive result in the first sample, and  
(3)either  [the second  sample was subsequently tested with negative result in a 
Real-time RT -PCR(8).]]]] 
(3)or [the two samples  were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 478  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]  
(1)or [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8) 
with negative result on a blood sample taken on ……………… (insert date), within a 
period of 21 days prior to the date of departure, and the country or territory of dispatch is 
recognised by t he OIE as officially free of African horse sickness.]]  
(1)or [it is a registered horse not vaccinated against African horse sickness and dispatched from a 
country, territory or zone thereof which is recognised by the OIE as officially free of 
African horse  sickness.]]  
(1)(7)[II.4.8.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group F, and  
(1)either  [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8) 
carried out by the same laboratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date) 
and on ………………… (insert date) , the first sample not taken less than 7 days after 
introduction in to the vector -protected quarantine, the second sample taken within a period 
of 10 days prior to the date of departure,  
(1)either  [with negative results  in each case.]]]  
(1)or [with a positive result  in the first sample, and  
(1)either  [the second  sample was subsequently tested with negative result in a 
Real-time RT -PCR(8).]]]] 
(1)or [the two samples  were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]  
(1)or [it was subjected to an indirect ELISA or a blocking ELISA and a Real -time RT -PCR for 
African horse sickness(8) carried out with negative result in each case on a blood sample 
taken on ……… ………… ( insert date ) not less than 28 days after the date of introduction 
into the vector -protected quarantine and within a period of 10 days prior to the date of 
departure.]]  
(1)or [it was subjected to a Real -time RT -PCR for African horse sickness(8), carri ed out with 
negative result on a blood sample taken on ………………… ( insert date ) not less than 14 
days after the date of introduction into the vector -proof quarantine and not more than 72 
hours before departure.]]  
II.5. Attestation of the transport conditions  
(1)(7)either  [II.5.1.  The equine animal described in Part I is dispatched from a country, territory of zone thereof 
assigned to Sanitary Group A, B, C, D, E or G and arrangements have been made to 
transport it directly to the Union, without subjecting the animal to any assembly operation 
and without coming into contact with other equine animals not complying with at least the 
same health requirem ents as described in this health certificate.]  
(1)(7)or [II.5.1.  The animal is dispatched from a country, territo ry or zone thereof which is assigned to 
Sanitary Group F and arrangements have been made to transport it directly from the vector -
protected or vector –proof quarantine station without coming into contact with other equine 
animals not complying with at least  the same health requirements as described in this health 
certificate  
(1)either  [to the airport under vector -protected conditions and arrangements have been made for the 
aircraft to be cleansed and disinfected in advance with a disinfectant officially recognised  in 
the third country of dispatch, and sprayed against vector insects just prior to take off.]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 479  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
(1)or [to a sea port in that country, territory or zone thereof under vector -protected conditions and 
arrangements have been made to transport it on a  vessel which is scheduled directly to a 
port in the Union without calling into a port situated in a country, territory  or zone thereof 
not approved for the entry into the Union of equine animals, in stalls which were cleansed 
and disinfected in advance wi th a disinfectant officially recognised in the third country of 
dispatch and sprayed against vector insects just prior to departure.]]  
II.5.2.  Arrangements have been made and verified to prevent any contact with other equine 
animals not complying with at l east the same health requirements as described in this health 
certificate during the period from certification until dispatch to the Union.  
II.5.3.  The transport vehicles or containers in which the animal is going to be loaded were cleaned 
and disinfected before loading with a disinfectant officially recognised in the country or the 
territory of dispatch and they are so constructed that faeces, urine, litter or fodder cannot 
escape during transportation.  
 
(1)(9)II.6. Attestation of public health  
I, the unde rsigned  official veterinarian, hereby certify, that the equine animal described in this certificate:  
II.6.1.  in the country or territory of dispatch has not received:  
- any stilbene or thyrostatic substances;  
- oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical treatment (as defined in Directive 96/22/EC);  
II.6.2.  fulfils the guarantees covering live equine animals provided by the residue plan submitted 
and approved in accordance with Dir ective 96/23/EC, and in particular Article 29 thereof 
and it has been dispatched from a country or territory listed for equine animals in the Annex 
to Decision 2011/163/EU.]  
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I : 
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column  2 of Annex III to Commission Implementing Regulation (EU) 2020/…[IA on lists 
of TCs ]. 
Box reference I.27:  “Identification system ”: The animal must bear an individual identifier as defined in point 
(a), (c), (e), or (g) of Annex III to Delegated Regulation  (EU) 2019/2035 which permits to 
link the animal to the identification document or be identified by an alternative method in 
accordance with Article 62 of that Regulation provided it is recorded in its identification 
document (passport). Specify the identi fication system (such as ear tag, tattoo, brand, 
transponder etc.) and the anatomic place used on the animal.  If a passport accompanies the 
animal, its number should be stated and the name of the competent authority which 
validated it.  
“Age”: Date of birth  (dd/mm/yyyy).  
“Sex”: M = male, F = female, C = castrated.  
Part II:  
(1) Delete as appropriate.  
(2) The certificate must be issued on the day of loading or on the last working day before loading of the animal This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 480  EN  COUNTRY  EQUI -X 
Entry – equine animal not intended for slaughter  
for dispatch to the Member State of destination in the Union.  
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a perio d where restrictive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof. Check against columns 8 and 9 of Part  1 of 
Annex III to Implementing Regulation (EU) 2020/…. [IA list ]. 
(3)  Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex III to Implementing Regulation ( EU) 2020/…. [IA list] . 
(4) Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop  
(5) Zone of country or territory authorised for entry into the Union as appearing in columns 2 and 5 
respectively of Part  1 of Annex III to Implementing Regulation (EU) 202 0/…. [IA list] . 
(6) Only authorised if country of dispatch is assigned to Sanitary Group G.  
(7) Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatc h is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.  
(8) Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx  
(9) By deleting this point the equine animal will be excluded from slaughter for human consumption in the 
identification document issued in accordance with Union animal health rules following its release for free 
circulation in accordance with Union customs rules . 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and  title  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 481  EN Declaration by the operator responsible for the entry into the European Union of the equine 
animal not intended for slaughter  
Identification of the animal(1)  
Species (Scientific name)  
 
 Identification system  
 
……………………….  Identification number  
 
……………………….  Age 
 
……………….  Sex 
 
…………  
I, the undersigned operator  of the equine animal  described above , hereby declare, that : 
- the equine animal  
 (2)either  [has remained in …………………... ( insert name of country , territory or zone thereof  of dispatch ) during a period 
of at least 40 days prior to the date of dispatch , or since birth, or since entry from the European Union, 
Norway or the United Kingdom in respect of Northern Ireland ;] 
(2)or [entered …………………... ( insert name of country , territory or zone thereof  of dispatch ) during the required 
residence period of at least 40 days prior to the date of dispatch:  
(a) on……….( insert date ) from………….………. ( insert name of country or territory from where horse 
entered country, territory or zone th ereof of dispatch ) 
(b) on……….(insert date) from………….………. ( insert  name of country or territory from where horse 
entered country, territory or zone thereof of dispatch ) 
(c) on……….( insert date ) from………….………. ( insert name of country or territory from where horse 
entered country, territory or zone thereof of dispatch );] 
- during the period of 15 days prior to the date of departure the equine animal has not been in contact with animals 
suffering from infectious or contagious diseases transmissible to equine an imals;  
- the conditions for residence and pre -export isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;  
- the conditions for the transport as a pplicable in accordance with point II.4. of the accompanying health certificate for the 
country or part of the territory of the country of dispatch are fulfilled;  
- I am aware of the animal health and veterinary certification requirements for the movement of equine animals from one 
EU Member State to another laid down in Delegated Regulation (EU) 2020/ 688; 
- the equine animal  is scheduled to leave  the Union on ………………………….…… ( date) at the border post of 
……………………………… ( insert name and place of border post of e xit) or otherwise will be subject to the 
identification and registration rules applicable in accordance with Delegated Regulat ion (EU) 2019/ 2035 . 
 
Name  and address of the operator : ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier which permits to link the animal to the identification document. Specify the 
identification system (such as ear tag, tattoo,  brand, transponder) and the anatomic place used on the animal.  
 If a passport accompanies the animal, its number should be stated and the name of the competent authority which validated it.  
 Age: Date of birth (dd/mm/yyyy).  
 Sex (M = male, F = female, C =  castrated).  
(2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 482  EN CHAPTER 13: MODEL HEALTH CERTIFI CATE AND MODEL DECLA RATION 
FOR ENTRY INTO THE U NION OF EQUINE ANIMA LS INTENDED FOR 
SLAUGHTER  (MODEL ‘EQUI -Y’) 
 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  I.22  For internal market  
   I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 483  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
Slaughterhouse         
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 484  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  Part II: Certification  II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that : 
II.1. The equine animals(1) of the consignment described in Part I:  
II.1.1.  are intended for slaughter for human consumption and are not intended for slaughter in 
the framework of the eradication of a disease communicable to equine animals;  
II.1.2.  have not shown clinical signs or symptoms of diseases listed for equine animals in 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date  dd/mm/yyyy )(2), this being within 48 hours prior to departure  
(3)either  [from the registered establishment of origin in the country , territory  or zone thereof  of 
dispatch;]  
(3)or [from the establishment approved for conducting assembly operations of equine animals 
by the competent authority in the country or territory of dispatch in accordance with 
requirements at least as stringent as those laid down in Articl e 5 of Commission 
Delegated Regulation (EU) 2019/2035;  
II.1.3.  meet  the requirements  attested in points II.2. to II. 6. of this certificate,  including in case 
of dispatch from an establishment approved for assembly operations;  
II.1.4.  are accompanied  by a written  declaration, signed by the operator of the consignment of 
animals, which forms part of this certificate.  
II.2. Attestation  on third country, territory or zone thereof and on establishment of dispatch  
II.2.1.  The equine  animals described in Part I  are dispatched from …………………...  (insert 
name of country, territory or zone thereof ), a country, territory or zone thereof, which on 
the date of issuing this certificate has the Code: ………..…(4) and is assigned to Sanitary 
Group ……(4). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: 
African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma 
equiper dum), equine infectious anaemia, infection with rabies virus and anthrax.  
II.2.3.  The equine animals described in Part I are dispatched from a country, territory or zone 
thereof in which there has been no clinical, serological (in unvaccinated equine anima ls) 
or epidemiological evidence of African horse sickness during the period of 24 months 
prior to the date of departure of the animal s, and there have been no systematic 
vaccinations against African horse sickness during the period of 12 months prior to th e 
date of departure.  
II.2.4.  The equine animals described  in Part I come from an establishment  of origin situated in a 
country, territory or zone thereof  in which  
(3)either [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 
months prior to the date of departure of the animals.]  
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei  
(glanders ) recognised by the European Union(2) has been carried out during the last 36 
months prior to the date of departure, and  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of origin during the last 36 months prior to the date of departure 
of the animals.]  
(3)or [infection with Burkholderia mallei  (glanders ) has been reported in the  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 485  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  
 establishment of origin during the last 36 months prior to the date of departure 
of the animal and following the last outbreak, the establishment has remained 
under movement restriction  
(3)either  [until the remai ning equine  animals in the establishment have been 
subjected to a complement fixation test for infection with 
Burkholderia mallei  (glanders )(5), carried out, with negative results at 
a serum dilution of 1 in 5, on samples taken at least 6 months after the 
infected animals have been killed and destroyed.]]]  
(3)or [for at least 30 day s from the date of cleaning and disinfection after 
the last equine animal on the establishment was killed and 
destroyed.]]]  
II.2.5.  The equine animals described in Part I come from an establishment  of origin situated in a 
country, territory or zone thereof in which  
(3)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(3)or [a surveillance and eradication programme for surra recognised  by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the 
animals, and  
(4)either  [surra has not been  reported in the establishment of origin during the last 24 
months prior to the date of departure of th e animals.]  
(3)or [surra has been reported in the establishment of origin during the last 24 
months prior to the date of departure of the animals, and  following the last 
outbreak the establishment has remained under movement restriction  
(3)either  [until th e remaining animals in the es tablishment have been subjected 
to an enzyme -linked immunosorbent assay (ELISA) for 
trypanosomosis  or card agglutination test for trypanosomosis  (CATT) 
at a serum dilution of 1 in 4(5) carried out, with negative results, on 
samples taken at least 6 months after the last infected animal has been 
removed from the establishment.]]]  
(3)or  [for at least 30 days from the date of cleaning and disinfection after 
the last animal of listed speci es on the establishment was either killed 
and destroyed or slaughtered .]]] 
II.2.6.  The equine animals described in Part I come from an establishment  of origin situated in a 
country, territory or zone thereof in which  
(3)either  [dourine has not been reporte d during the last 24 months prior to the date of departure of 
the animals.]  
(3)or [a surveillance and eradication  programme for surra recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the 
animals, and  
(3)either  [dourine  has not been reported in the establishment of origin during the last 24 
months prior to the date of departure of the animals .] 
(3)or [dourine has been  reported in the establishment of origin during the last 24 
months prior t o the date of departure of the animals, and following the last 
outbreak, the establishment has remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment, except 
castrated male  equine animals , have been subjected to a complement 
fixation test for dourine , carried out with negative results at a serum  
 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 486  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  
dilution of 1 in 5(5) on samples taken at least 6 months after the 
infected animals have been killed and destroyed or slaughtered, or the 
infected entire male  equine animals have been castrated.]]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after 
the last equine animal on the establishment was either killed and 
destroyed or slaughtered.]]]  
II.2.7.  The equine animals described in Part  I come from an establishment  of origin in which  
(3)either  [equine infectious anaemia has not been reported during the last 12 months prior to the 
date of departure of the animals.]  
(3)or [equine infectious anaemia has been reported during the last 12 mon ths prior to the date 
of departure of the animals and following  the last outbreak the establishment has 
remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected to 
an agar gel immuno -diffus ion test (AGID) or ELISA(5) for equine infectious 
anaemia carried out, with negative results, on samples taken on two occasions 
with a minimum interval of 90 days following cleaning and disinfection of the 
establishment after the infected animals have been  killed and destroyed or 
slaughtered .]] 
(3)or [for at least 30 days  from the date of cleaning and disinfection, after the last 
equine animal on the establishment was either killed and destroyed  or 
slaughtered. ]] 
II.2.8.  The equine animals described in Part  I come from an establishment  of origin in which  
II.2.8.1.  infection with rabies virus in kept terrestrial animals has not been reported 
during the last 30 days prior to the date of departure of the animals;  
II.2.8.2.  anthrax in ungulates has not been rep orted during the last 15 days prior to the 
date of departure of the animals.  
II.2.9.  To the best of my knowledge and as declared by the operator of the consignment, the 
equine animals described in Part I have not been in contact with kept animals  of listed 
species which did not comply with the requirements  referred to in Points II.2.3. to II.2.8.1 
during the last 30 days prior to the date of departure of the animals, and with the 
requirement referred to in point II.2.8.2. during the last 15 days p rior to the date of 
departure of the animals.  
II.3. Attestation of residence and pre -export isolation  
II.3.1.  The equine animals described in Part I have been resident in the country, territory or zone 
thereof of dispatch during a period of at least 90 day s prior to the date of departure.  
(3)either  [II.3.2.  The equine animals described in Part I are dispatched from a country, territory or zone 
thereof assigned to Sanitary Group A, B, C, D, or G, and during the last 30 days prior to 
the date of departure from the establishment of origin have been kept in pre -export 
isolation.]  
(3)(6)or [II.3.2.  The equine animals described in Part I are dispatched from a country, territory or zone 
thereof assigned to Sanitary Gr oup E, and during the last 40 days prior to the date of 
departure from the establishment of origin, have been kept  
(3)either  [in isolation in an establishment of origin protected from vector insects.]]  
(3)or [in an establishment of origin under veterinary supervision, and the country, territory or 
zone thereof of dispatch is recognised by the World Organisation for Animal Health 
(OIE) as officially free of African horse sickness.]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 487  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  
(3)[II.3.3.  Immediately prior to their dispatch from the country or territor y of dispatch, the equine 
animals of the consignment described in Part I have been kept in the establishment 
approved for assembly operations referred to in point II.1.2. for a period of not more than 
6 days after leaving their respective establishments of  origin. In the approved 
establishment, which complies with the requirements for establishments in point II.2., the 
animals have been kept under conditions that effectively protect their health status and 
without coming into contact with equine animals not  complying with the requirements in 
points II.2., II.3.1., II.3.2. and II.4. of this certificate.]  
II.4. Attestation of vaccination and health tests  
II.4.1.  The equine animals described in Part I were not vaccinated against African horse 
sickness in the country, territory or zone thereof of dispatch and there is no information 
suggesting previous vaccination.  
II.4.2.  The equine animals  described in Part I have not been vaccinated against Venezuelan 
equine encephalomyelitis during the last 60 days prior to the date of departure, and come 
from an establishment  situated in a country or territory or zone thereof in which 
Venezuelan equine encephalomyelitis has not been reported during the last 24 months 
prior to the date of departure.  
(3)either  [II.4.3.  The equine animals described in Part I are dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, wh ere they have been continuously 
resident since birth, and did not come into contact with equidae which have entered 
Iceland from other countries.]  
(3)or [II.4.3.  The equine animals described in Part I were subjected with negative result in each case 
to an agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine 
infectious anaemia(5) carried out on a blood sample taken on …………… (insert date), 
within a period of 30 days prior to the date of departure. 
(3)[II.4.4.  The equine animals described in Part I are dispatched from a country, territory or zone 
thereof assigned to Sanitary Group B, D or E, or from a country or territory in which 
infection with Burkholderia mallei  (glanders ) has been reported during a period of  36 
months prior to the date of departure, and were subjected to a complement fixation test 
for infection with Burkholderia mallei  (glanders )(5) carried out with negative result in 
each case at a serum dilution of 1 in 5 on a blood sample taken on …………………… . 
(insert  date), within a period of 30 days prior to the date of departure.  
(3)[II.4.5.  The equine animals described in Part I are uncastrated male or female equine animals 
older than 270 days dispatched from a country, territory or zone thereof assigned t o 
Sanitary Group B, D or E, or from a country in which dourine has been reported during 
a period of 24 months prior to the date of departure, and were subjected to a complement 
fixation test for dourine(5) carried out with negative result in each case at a  serum 
dilution of 1 in 5 on a blood sample taken on ……………………. ( insert  date), within a 
period of 30 days prior to the date of departure.  
(3)[II.4.6.  The equine animals described in Part I are dispatched from a country, territory or zone 
thereof which is as signed to Sanitary Group E, from Brazil, Bolivia, Uruguay, or from a 
country or territory in which surra was reported during the last 24 months prior to the 
date of departure, and were subjected to a card agglutination test for trypanosomosis  
(CATT)(5), carried out with negative result in each case at a serum dilution of 1 in 4 on a 
blood sample taken on ……………………. ( insert date ), within a period of 30 days 
prior to the date of departure. 
(3)(6)[II.4.7.  The equine animals described in Part I are dispatched fr om a country, territory or zone This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 488  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  
thereof which is assigned to Sanitary Group E, and  
(3)either  [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7), 
which was carried out with negative  results in each case by the same laboratory on the 
same day on blood samples taken on two occasions with an interval of between 21 and 
30 days, on …………………… (insert date) and on ………………… (insert date) , the 
second of which was taken within a period of 10 days prior to the date of departure.]  
(3)or [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7) 
with negative result on a blood sample taken on ……………… (insert date), within a 
period of 21 days prior to the date of departu re, and the country or territory of dispatch is 
recognised by the OIE as officially free of African horse sickness.]]  
II.5. Attestation of the transport conditions  
II.5.1.  Arrangements have been made to transport this consignment of animals directly to the  
Union, without subjecting the animals after certification to any further assembly 
operation outside the Europea n Union and without co ming into contact with other 
equine animals not complying with at least the same health requirements as described in 
this health certificate.  
II.5.2.  Arrangements have been made and verified to prevent any contact with other equine 
animals not complying with at least the same health requirements as described in this 
health certificate during the period from certification unti l dispatch to the European 
Union.  
II.5.3.  The transport vehicles or containers in which the animals are going to be loaded were 
cleaned and disinfected before loading with a disinfectant officially recognised in the 
country or territory of dispatch and the y are so constructed that faeces, urine, litter or 
fodder cannot escape during transportation.  
II.6. Public health attestation  
I, the undersigned  official veterinarian, hereby certify, that the equine animal s described in this certificate:  
II.6.1.  in the country  or territory of dispatch ha ve not received:  
- any stilbene or thyrostatic substances;  
- oestrogenic, androgenic, gestagenic or beta -agonist substances for purposes other 
than therapeutic or zootechnical treatment (as defined in Directive 96/22/EC);  
II.6.2.  fulfil the guarantees covering  live equine animals provided by the residue plan 
submitted and approved in accordance with Directive 96/23/EC, and in particular Article 
29 thereof and ha ve been dispatched from a country or territory listed for equi ne animals 
in the Annex to Decision 2011/163/EU.  
EU 
Notes : 
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as 
appearing in column 2 of Annex III to Commission Implementing Regulation 
(EU) 2020/…[IA on lists of TCs ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 489  EN  COUNTRY  EQUI -Y 
Entry – equine animals intended for slaughter  
  II.a Certificate reference  II.b. IMSOC reference  
Box reference I.27:  “Identification system ”: The animal must bear an indivi dual identifier as 
defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 
2019/2035 which permits to link the animal to the identification document. 
Specify the identification system (such as ear tag, tattoo, brand, transponder 
etc.) and the anatomic place used on the animal.  
Part II:  
(1) There can be one or more equine animals in the consignment.  
(2) The certificate must be issued on the day of loading of the animals for dispatch to the Member State 
of destination in the Union.  
The entry into the Union shall not be allowed when the animals were loaded either prior to the date 
of authorisation for entry into the Union from the respective country, territory or zone thereof 
referred to in point II.1.1., or during a period where rest rictive measures have been adopted by the 
Union against the entry of equidae from this country, territory or zone thereof. Check against 
columns 8 and 9 of Part  1 of Annex III to Implementing Regulation ( EU) 2020/…. [IA list] . 
(3) Delete as appropriate.  
(4) Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 
3 respectively in Part 1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list ]. 
(5) Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine 
encephalomyelitis described by the European Union Reference Laboratory for Equine Diseases 
other than African horse sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop  
(6) Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group 
to which the country, territory or zone thereof of dispatch is ass igned, may be left out, provided that 
the numbering of the subsequent statements is maintained.  
(7) Tests for African horse sickness described by the European Union Reference Laboratory for African 
horse sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -
diagnostico.aspx  
 
 Official veterinarian  
 Name (in capital letters):  Qualification and title:  
 Date:  Signature:  
 Stamp:  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 490  EN  
Declaration by the operator of the consignment of equine animals intended for slaughter  
Identification of the animals(1)  
Total number  
 
 Species (Scientific 
name)  
……………………….  Identification system  
 
……………………….  Identification number(s)  
 
……………….  Quantity  
 
…………  
I, the undersigned operator of the consignment of equine animals intended for slaughter described above , hereby declare, that : 
 
- the animals have remained in the country, territory or zone thereof of dispatch for at least 90 days prior to the date of 
dispatch;  
- during the period of 15 days prior to the date of dispatch the animals have not been in contact with animals suffering 
from infectious or contagious diseases transmissible to equine animals;  
- the conditions f or residence and pre -export isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;  
- the conditions for the transport as applicable in accordance w ith point II.4. of the accompanying health certificate for the 
country, territory or zone thereof of dispatch are fulfilled;  
- the transportation will be effected in such a way that health and well -being of the animals can be protected effectively at 
all stages of the journey;  
- the animals will be sent  
 (2)either  [directly from the establishment of origin to the slaughterhouse of destination without coming into contact 
with other equine animals not of the same health status;]  
 (2)or [from the establishmen t approved for assembly operations on equine animals to the slaughterhouse of 
destination without coming into contact with other equine animals not of the same health status;]  
 
Name  and address of the operator: ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier which permits to link the animal to the identification document. Specify the 
identification system (such as ear tag, tattoo, brand, transponder) and the anatomic place used on the animal.  
 (2) Delete as appropriate. 
 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 491  EN CHAPTER 14: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
FOR TRANSIT THROUGH THE UNION OF EQUINE ANIMALS NOT INTENDED  
FOR SLAUGHTER (MODEL  EQUI -TRANSIT -X) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
    Registered horse   
     
     
     
I.21  For transit  I.22  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 492  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 493  EN  
 COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that all:  
II.1. The equine animal described in Part I:  
II.1.1.  is not intended for slaughter for human consumption and not intended for slaughter in the 
framework of the eradication of a disease communicable to equine animals, and  
(1)either  [is a registered equine animal, as defined in Article 2(30) of Delegated Regulation (EU) 
2019/2035.]  
(1)or [is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035.]  
(1)or [is an equine animal other t han a registered equine animal or a registered horse.]  
II.1.2.  has not shown clinical signs or symptoms of diseases listed for equine animals in 
Implementing Regulation (EU) 2018/1882 during the clinical examination carried out on 
………………. ( insert date  dd/mm/yyyy )(2), this being within 48 hours, or in the case of a 
registered horse on the last working day, prior to departure from the registered 
establishment.  
II.1.3.  meets  the requirements  attested in points II.2. to II. 5. of this certificate;  
II.1.4.  is accompanied  by a written  declaration, signed by the operator of the animal, which forms 
part of this certificate.  
II.2. Attestation  on third country, territory or zone thereof and on establishment of dispatch  
II.2.1.  The equine  animal described in Part I  is dispatched from …………………...  (insert name 
of country, territory or zone thereof ), a country, territory or zone thereof, which on the date 
of issuing this certificate has the Code: ………..…(3) and is assigned to Sanitary Group 
……(3). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: 
African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia 
mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine 
infectious anaemia, infection with rabies  virus  and anthrax.  
II.2.3.  The equine animal described in Part I comes from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidem iological evidence of African horse sickness during the period of 24 months prior to 
the date of departure of the animal and there have been no systematic vaccinations against 
African horse sickness during the period of 12 months prior to the da te of depar ture. 
II.2.4.  The equine animal described  in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(1)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 
months prior to the date of departure of the animal.]  
(1)or [a surveillance and eradication  programme for infection with Burkholderia mallei  
(glanders ) recognised by the European Union(2) has been carried out during the last 36 
months p rior to the date of departure, and  
(1)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of dispatch during the last 36 months prior to the date of departure 
of the animal.]  
(1)or [infection with Burkholderia m allei (glanders ) has been reported in the 
establishment during the last 36 months prior to the date of departure of the animal This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 494  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
and following the last outbreak, the establishment has remained under movement 
restriction  
(1)either  [until the remaining equine  animals in the establishment have been 
subjected to a complement fixation test for infection with Burkholderia 
mallei  (glanders )(4), carried out, with negative results at a serum dilution of 
1 in 5, on samples taken at least 6 months after the infected an imals have 
been killed and destroyed.]]]  
(1)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was killed and destroyed.]]]  
II.2.5.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(1)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(1)or [a surveillance and eradication programme for surra recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the animal, 
and 
(1)either  [surra has not  been  reported in the establishment during the last 24 months prior to 
the date of departure of the animal.]  
(1)or [surra has been reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and  following the last outbreak the establishment 
has remained under movement restriction  
(1)either  [until the remaining animals in the establishment  have been subjected to an 
enzyme -linked immunosorbent assay (ELISA) for trypanosomosis  or card 
agglutination test for trypanosomosis  (CATT) at a serum dilution of 1 in 
4(4) carried out, with negative results, on samples taken at least 6 months 
after the l ast infected animal has been removed from the establishment.]]]  
(1)or  [for at least 30 days  from  the date of cleaning and disinfection,  after the 
last animal of listed species on the establishment was either killed and 
destroyed or slaughtered .]]] 
II.2.6.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(1)either  [dourine has not been reported  during the last 24 months prior to the date of departure of 
the animal.]  
(1)or [a surveill ance and eradication  programme for surra recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of departure of the animal, 
and 
(1)either  [dourine  has not been reported in the establishment during the last 24 m onths prior 
to the date of departure of the animal .] 
(1)or [dourine has been  reported in the establishment during the last 24 months prior to 
the date of departure of the animal, and following the last outbreak, the 
establishment has remained under movemen t restriction  
(1)either  [until the remaining equine  animals in the establishment, except castrated 
male  equine animals , have been subjected to a complement fixation test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(4) on 
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals 
have been castrated.]]  
(1)or [for at least 30 days from the date of cleaning and disinfection after the  last 
equine animal on the establishment was either killed and destroyed or This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 495  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
slaughtered.]]  
II.2.7.  The equine animal described in Part I comes from an establishment  in which  
(1)either  [equine infectious anaemia has not been reported during the last 12 mon ths prior to the date 
of departure of the animal.]  
(1)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animal and following  the last outbreak the establishment has remained 
under movement restr iction  
(1)either  [until the remaining  equine  animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(4) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a 
minimum interval of 90 days following cleaning and disinfection of the 
establishment after the infected animals have been killed and destroyed or 
slaughtered.]]  
(1)or [for at least 30 days from the date of cleaning and di sinfection after the last equine 
animal on the establishment was either killed and destroyed or slaughtered.]]  
II.2.8.  The equine animal described  in Part I comes from an establishmen t in which  
II.2.8.1.  infection with rabies virus in kept terrestrial animals has not been reported during 
the last 30 days prior to the date of departure of the animal;  
II.2.8.2.  anthrax in ungulates has not been reported during the last 15 days prior to the date 
of departure of the animal.  
II.2.9.  To the best of my knowledge and as declared by the operator, the equine animal described 
in Part I has not been in contact with kept animals  of listed species which did not comply 
with the requirements  referred to in Points II.2.3. to II.2.8.1 during the last 30 days prior to 
the date of departure of the animal, and with the requirement referred to in point II.2.8.2. 
during the last 15 days prior to the date of departure of the animal.  
II.3. Attestation  of residence and pre -export isolation  
(1)either  [II.3.1.  The equine animal described in Part I has been resident in the country, territory or zone 
thereof of dispatch during a period of at least 40 days prior to the date of its departure, or 
since birth i f it is less than 40 days of age.]  
(1)or [II.3.1.  During a period of at least the last 40 days prior to the date of its departure, the equine 
animal described in Part I has been resident in the country, territory or zone thereof of 
dispatch;  
(1)either  [and in a Member  State of the European Union , Norway  or the United Kingdom in respect 
of Northern Ireland ;] 
(1)and/or  [and in a country , territory or zone thereof with Code: …………………(3) that is authorised 
for entry into the Union  of registered horses or other equine animals not intended for 
slaughter and from which it was imported into the country, territory or zone thereof of 
dispatch under conditions at least as strict as those required in accordance with Union 
legislation for t he entry of registered horses from this country, territory or zone thereof 
directly to the Union, and which is:  
(1)either  [assigned  to the same Sanitary Group ……….. (3) as the country, territory or zone 
thereof of dispatch;]]]  
(1)and/or [assigned to Sanita ry Group A, B or C;]]]  
(1)and/or [assigned to Sanitary  Group D, E or G, and the animal is a registered horse.]]]  
(1)either  [II.3.2.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group A, B, C, D, or G, and  
(1)either  [during the last 30 days prior to the date of its departure, or since entry from a Member This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 496  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
State of the Union, Norway, the United Kingdom in respect of Northern Ireland , or since 
birth if it is less than 30 days of age,  
(1)either  [it has been kept apart from other equine animals, except in case of a foal at foot of 
his mother, in an establishment situated in a country, territory or zone thereof 
assigned to Sanitary Group A.]]]  
(1)or [it has been kept in pre -export isolation from other equine animals, except in case 
of a foal at foot of his mother, in an establishment situated in a country, territory or 
zone thereof assigned to Sanitary Group B, C, D or G.]]]  
(1)or [it is a registered horse which has been kept in establishment s under veterinary supervision 
during the last 30 days prior to the date of its departure, or since entry in accordance with 
point II.3.1 from a Member State of the Union, Norway , the United Kingdom in respect of 
Northern Ireland,  or a country, territory o r zone thereof which is assigned to Sanitary Group 
A, B, C, D, E or G.]]  
(1)(7)or [II.3.2.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, and  
(1)either  [during the last 40 days prior to the date of its departure, or since birth if it is less than 40 
days of age, or since entry in accordance with point II.3.1 from a Member State of the 
Union, Norway , the United Kingdom in respect of Northern Ireland,  or a country, territory 
or zone  thereof which is assigned to Sanitary Group A, B, C, D, E or G, it has been kept  
(1)either  [in isolation in an establishment protected from vector insects.]]]  
(1)or [in an establishment under veterinary supervision, and the country, territory or 
zone thereof of dispatch is recognised by the World Organisation for Animal 
Health (OIE) as officially free of African horse sickness.]]]  
(1)or [is a registered horses which has been kept during the last 30 days prior to the date of its 
departure, or since entr y in accordance with point II.3.1 from a Member State of the Union, 
Norway , the Unitd Kingdom in respct of Northern Ireland  or a country, territory or zone 
thereof which is assigned to Sanitary Group A, B, C, D, E or G, in establishments under 
veter inary s upervision, and the country, territory or zone thereof of dispatch is recognised 
by the OIE as officially free of African horse sickness.]]  
(1)(7)or [II.3.2.  The registered horse described in Part I is dispatched from a country, territory or zone 
thereof assigned to Sanitary Group F, and:  
(1)either  [during at least the last 40 days prior to the date of departure it has been kept in the 
approved quarantine station of …………………………. ( insert name of quarantine 
station ), confined to the vector -protected premises  at least from two hours prior to sunset 
until two hours after sunrise and exercise was provided under official veterinary 
supervision, following the application of insect repellents in combination with an 
insecticide effective against Culicoides  prior to the removal from the quarantine stables, 
and in strict isolation from equidae not being prepared for export under conditions at least 
as strict as required for entry into the Union.]]  
(1)or [during the period of at least 14 days prior to the date of its de parture has been permanently 
confined in the approved vector -proof quarantine station of …………………………. 
(insert name of quarantine station ) and constant monitoring of the vector protection has 
proven absence of vectors inside the vector -proof part of the quar antine station.]]  
II.4. Attestation of vaccination and health tests  
(1)either  [II.4.1.  The equine animal described in Part I was not vaccinated against African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information  suggesting 
previous vaccination.]  
(1)or [II.4.1.  The equine animal described in Part I was vaccinated against African horse sickness more This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 497  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
than 12 months prior to the date of its departure.]  
(1)(7)or [II.4.1.  The registered horse described in Part I was vaccinated against African horse sickness not 
more than 24 months and at least 40 days prior to the date of entry in the vector -protected 
or vector –proof quarantine situated in a country, territory or zone there of assigned to 
Sanitary Group F, and this vaccination consisted of a complete primary course of 
vaccination against African horse sickness, or a booster within the period of validity of the 
previous vaccination, by administration according to manufacturer' s instructions of a 
registered vaccine which is protective against the circulating serotypes of the African horse 
sickness virus, and the last vaccination was applied on …………….. (insert date) .] 
II.4.2.  The equine animal described  in Part I has not been vac cinated against Venezuelan equine 
encephalomyelitis during the last 60 days prior to the date of its departure, and  
(1)either  [it comes from an establishment  situated in a country or territory in which Venezuelan 
equine encephalomyelitis has not been repo rted during the last 24 months prior to the date 
of its departure.]  
(1)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not 
been reported during the last 6 months prior to the date of its departure and which is 
situated in a country, territory or zone thereof in which a surveillance and eradication 
programme for Venezuelan equine encephalomyelitis recognised by the European Union(2) 
has been carried out during the last 24 months prior to the date of its departure, and dur ing 
the period of at least 21 days prior to the date of departure of the animal described in Part I, 
all equine animals in the establishment have remained clinically healthy, and  
(1)either  [the equine animal  described in Part I has been kept protected fro m attacks by 
insect vectors in a quarantine , in which any equine animal that showed a rise in 
daily taken body temperature has been subjected with negative result to a virus 
isolation test for Venezuelan equine encephalomyelitis(4); and the equine animal 
described in Part I  
(1)either  [was vaccinated against Venezuelan equine encephalomyelitis with a 
complete primary course and revaccinated according to manufacturer's 
recommendations not less than 60 days and not more than 12 months prior 
to the date of dep arture;]]]  
(1)or [was subjected to a haemagglutination inhibition test for Venezuelan 
equine encephalomyelitis(4), carried out, with negative result, on a sample 
taken not less than 14 days after the date of its entry into quarantine.]]]  
(1)or [the body temperature of the equine animal described in Part I has been taken 
daily, either without  a rise or the animal has been subjected to a virus isolation test 
for Venezuelan equine encephalomyelitis with negative result, and the equine 
animal describ ed in Part I has been subjected to  
 a haemagglutination inhibition test for Venezuelan equine 
encephalomyelitis(4), without an increase in antibody titre, carried out on 
paired samples taken on two occasions with an interval of 21 days, the 
second of which was taken during a period of 10 days prior to the date of its 
departure, and  
 a reverse transcription -polymerase chain reaction (RT -PCR) for the 
detection of Venezuelan equine encephalomyelitis virus genome(4), with 
negative result, carried out on a sample taken within 48 hours prior to its 
departure, and  
 protection from vector attacks during the period after sampling until 
loading for dispatch, by combined use of approved insect repellents and 
insecticides on the animal and disinsectization of the stable an d the means This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 498  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
in which it is transported.]]]  
(1)(7)either  [II.4.3.  The equine animal described in Part I is dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where it was continuously resident since 
birth, and did  not come into contact with equidae which have entered Iceland from other 
countries.]  
(1)or [II.4.3.  The equine animal described in Part I was subjected with negative result to an agar gel 
immunodiffusion test (AGID or Coggins test) or to an ELISA for equi ne infectious 
anaemia(4) carried out on a blood sample taken on …………… (insert date), this being  
within  
(1)either  [a period of 30 days prior  to the date of its departure.]]  
(1)(7)or [a period of 90 days prior to the date of its departure from a country, territory or zone 
thereof assigned to Sanitary Group A.]] 
(1)[II.4.4.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group B, D or E, or from China, or from a country or territory in 
which  infection with Burkholderia mallei  (glanders ) has been reported during a period of 
36 months prior to the date of departure, and was subjected to a complement fixation test 
for infection with Burkholderia mallei  (glanders )(4) carried out with negative res ult at a 
serum dilution of 1 in 5 on a blood sample taken on ……………………. ( insert  date), 
within a period of 30 days prior to the date of departure.] 
(1)[II.4.5.  The equine animal described in Part I is an uncastrated male or female equine animal older 
than 27 0 days dispatched from a country, territory or zone thereof assigned to Sanitary 
Group B, D, E or F, or from China, or from a country in which dourine has been reported 
during a period of 24 months prior to the date of departure, and was subjected to a 
complement fixation test for dourine(4) carried out with negative result at a serum dilution 
of 1 in 5 on a blood sample taken on ……………………. ( insert  date), within a period of 
30 days prior to the date of departure, and the equine animal described in Part I has  not 
been used for breeding during the period of at least 30 days prior to and after the date the 
sample was taken.]  
(1)[II.4.6.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group E, fro m Brazil, Bolivia, Uruguay, Malaysia (Peninsula) or from 
a country or territory in which surra was reported during the last 24 months prior to the date 
of departure, and was subjected to a card agglutination test for trypanosomosis  (CATT)(4), 
carried out w ith negative result at a serum dilution of 1 in 4 on a blood sample taken on 
……………………. ( insert date ), within a period of 30 days prior to the date of departure.] 
(1)(7)[II.4.7.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E, and  
(3)either  [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8) 
carried out by the same laboratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date) 
and on ………………… (insert date) , the second of which was taken within a period of 10 
days prior to the date of depart ure, 
(3)either  [with negative  results in each case.]]]  
(3)or [with a positive  result in the first sample, and  
(3)either  [the second  sample was subsequently tested with negative result in a 
Real-time RT -PCR(8).]]]] 
(3)or [the two samples  were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 499  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
(1)or [it was subjected to an indirect ELIS A or a blocking ELISA for African horse sickness(8) 
with negative result on a blood sample taken on ……………… (insert date), within a 
period of 21 days prior to the date of departure, and the country or territory of dispatch is 
recognised by the OIE as offici ally free of African horse sickness.]]  
(1)or [it is a registered horse not vaccinated against African horse sickness and dispatched from a 
country, territory or zone thereof which is recognised by the OIE as officially free of 
African horse sickness.]]  
(1)(7)[II.4.8.  The equine animal described in Part I is dispatched from a country, territory or zone thereof 
assigned to Sanitary Group F, and  
(1)either  [it was subjected to an indirect ELISA or a blocking ELISA for African horse sickness(8) 
carried out by t he same laboratory on the same day on blood samples taken on two 
occasions with an interval of between 21 and 30 days, on …………………… (insert date) 
and on ………………… (insert date) , the first sample not taken less than 7 days after 
introduction into the vector -protected quarantine, the second sample taken within a period 
of 10 days prior to the date of departure,  
(1)either  [with negative results  in each case.]]]  
(1)or [with a positive result  in the first sample, and  
(1)either  [the second sample was subsequently te sted with negative result in a 
Real-time RT -PCR(8).]]]] 
(1)or [the two samples were tested without more than a two -fold increase in 
antibody titre in a virus neutralisation test as described in point 2.4 of 
Chapter 2.5.1. of the OIE Terrestrial Manual for Diagnostic Tests and 
Vaccines.]]]]  
(1)or [it was subjected to an indirect ELISA or a blocking ELISA and a Real -time RT -PCR for 
African horse sickness(8) carried out with negative result in each case on a blood sample 
taken on ………………… ( insert date ) not less  than 28 days after the date of introduction 
into the vector -protected quarantine and within a period of 10 days prior to the date of 
departure.]]  
(1)or [it was subjected to a Real -time RT -PCR for African horse sickness(8), carried out with 
negative result  on a blood sample taken on ………………… ( insert date ) not less than 14 
days after the date of introduction into the vector -proof quarantine and not more than 72 
hours before departure.]]  
II.5. Attestation of the transport conditions  
(1)(7)either  [II.5.1.  The e quine animal described in Part I is dispatched from a country, territory of zone thereof 
assigned to Sanitary Group A, B, C, D, E or G and arrangements have been made to 
transport it directly to the Union, without subjecting the animal to any assembly oper ation 
and without coming into contac t with other equine animals not complying with at least the 
same health requirements as described in this health certificate.]  
(1)(7)or [II.5.1.  The animal is dispatched from a country, territory or zone thereof which is  assigned to 
Sanitary Group F and arrangements have been made to transport it directly from the vector -
protected or vector –proof quarantine station without coming into contact with other equine 
animals not complying with at least the same health requiremen ts as described in this health 
certificate  
(1)either  [to the airport under vector -protected conditions and arrangements have been made for the 
aircraft to be cleansed and disinfected in advance with a disinfectant officially recognised  in 
the third country  of dispatch, and sprayed against vector insects just prior to take off.]]  
(1)or [to a sea port in that country, territory or zone thereof under vector -protected conditions and 
arrangements have been made to transport it on a vessel which is scheduled dire ctly to a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 500  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
port in the Union without calling into a port situated in a country, territory,  or zone thereof 
not approved for the entry into the Union of equine animals, in stalls which were cleansed 
and disinfected in advance with a disinfectant officially r ecognised in the third country of 
dispatch and sprayed against vector insects just prior to departure.]]  
II.5.2.  Arrangements have been made and verified to prevent any contact with other equine 
animals not complying with at least the same health requireme nts as described in this health 
certificate during the period from certification until dispatch to the Union.  
II.5.3.  The transport vehicles or containers in which the animal is going to be loaded were cleaned 
and disinfected before  loading with a disinfec tant officially recognised in the third country 
of dispatch and they are so constructed that faeces, urine, litter or fodder cannot escape 
during transportation.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex III to Commission Implementing Regu lation (EU) 2020/…[IA on 
lists of TCs ]. 
Box reference  I.27:  “Identification system ”: The animal must bear an individual identifier as defined in 
point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035 which 
permits to link the animal to the identification document or be identified by an 
alternative method in accordance with Article 62 of that Regulation provided it is 
recorded in its identification document (passport). Specify the identification system 
(such as ear tag, tattoo, brand, transponder etc.) and the anatomic place used on the 
animal.  If a passport accompanies the animal, its number should be stated and the 
name of the competent authority which validated it.  
“Age”: Date of birth (dd/mm/yyyy).  
“Sex”: M = male, F = female , C = castrated.  
Part II:  
(1) Delete as appropriate.  
(2) The certificate must be issued within 48 hours  of loading or on the last working day before loading of the 
animal for dispatch to the Member State of destination in the Union.  
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restri ctive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof. Check against columns 8 and 9 of Part  1 of 
Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(3)  Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(4) Tests for glanders, surra, dourine, equine infectious anaemia a nd Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisite /equine -diseases/sop  
(5) Zone of country or territory authorised for entry into the Union as appearing in columns 2 and 5 
respectively of Part  1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list] . This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 501  EN  COUNTRY  EQUI -TRANSIT -X 
Transit – equine animal s not intended for slaughter  
(6) Only authorised if country of dispatch is a ssigned to Sanitary Group G.  
(7) Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.  
(8) Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 502  EN Declaration by the operator responsible for the transit through the Union of the equine animal  
Identification of the animal(1)  
Species (Scientific name)  
 
 Identification system  
 
……………………….  Identification number  
 
……………………….  Age 
 
……………….  Sex 
 
…………  
I, the undersigned operator  of the equine animal described above , hereby declare, that : 
- the equine animal  
 (2)either  [has remained in …………………... ( insert name of country, territory or zone thereof of dispatch ) during a period 
of at least 40 days prior to the date of dispatch;]  
(2)or [entered …………………... ( insert name of country, territory or zone thereof of dispatch ) during the required 
residence period of at least 40 days prior to the date of dispatch:  
(a) on……….( insert date ) from………….………. ( insert name of country or territory from where horse 
entered country, territory or zone thereof of dispatch ) 
(b) on……….(insert date) from………….………. ( insert  name of country or territory from where horse 
entered country, territory or zone thereof of dispatch ) 
(c) on……….( insert date ) from………….………. ( insert name of country or territory from where horse 
entered country, territory or zone thereof of dispatch );] 
- during the period of 15 days prior to the date of departure the equine animal has not been in contact with animals 
suffering from infectious or contagious diseases transmissible to equine animals;  
- the transportation will be effected in such a way that health and well -being of the equine animal can be protected 
effectively at all stages of the journey;  
- the conditions for residence and pre -expor t isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, terriroty or zone thereof of dispatch are fulfilled;  
- the conditions for the transport as applicable in accordance with point II.5. of the acc ompanying health certificate for the 
country or part of the territory of the country of dispatch are fulfilled;  
- the equine animal is scheduled to leave  the Union on ………………………….…… ( date) at the border post of 
……………………………… ( insert name and place of border post of exit ); 
 
Name  and address of the operator: ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier which permits to link the animal to the identification document. Specify the 
identification system (such as ear tag, tattoo, brand, transponder) and the anatomic place used on the animal.  
 If a passport accompanies the animal, its number should be stated and the name of the com petent authority which validated it.  
 Age: Date of birth (dd/mm/yyyy).  
 Sex (M = male, F = female, C = castrated).  
(2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 503  EN CHAPTER 15: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
FOR TRANSIT THROUGH THE UNION OF EQUINE ANIMALS INTENDED FOR 
SLAUGHTER (MODEL EQU I-TRANSIT -Y) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 504  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 505  EN  
 COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animals(1) of the consignment described in Part I:  
II.1.1.  are intended for slaughter for human consumption and are not intended for slaughter in the 
framework of the eradication of a  disease communicable to equine animals;  
II.1.2.  have not shown clinical signs or symptoms of diseases listed for equine animals in Implementing 
Regulation (EU) 2018/1882 during the clinical examination carried out on ………………. 
(insert date  dd/mm/yyyy )(2), this being within 48 hours prior to departure  
(3)either  [from the registered establishment of origin in the country or territory of dispatch;]  
(3)or [from the establishment approved for conducting assembly operations of equine animals by the 
competent auth ority in the country or territory of dispatch in accordance with requirements at 
least as stringent as those laid down in Article 5 of Commission Delegated Regulation (EU) 
2019/2035;  
II.1.3.  meet  the requirements  attested in points II.2. to II. 5. of this certificate, including in case of 
dispatch from an establishment approved for assembly operations;  
II.1.4.  are accompanied  by a written  declaration, signed by the operator of the consignment of animals, 
which forms part of this certificate.  
II.2. Attestation  on third country, territory or zone thereof and on establishment of dispatch  
II.2.1.  The equine  animals described in Part I  are dispatched from …………………...  (insert name of 
country, territory or zone thereof ), a country, territory or zone thereo f, which on the date of 
issuing this certificate has the Code: ………..…(4) and is assigned to Sanitary Group ……(4). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei  
(glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection with rabies virus and anthrax.  
II.2.3.  The equine animals described in Part I are dispatched from a country, territory or zone thereof in 
which there has been no clinical, serological (in unvaccinated equine animals) or 
epidemiological evidence of African horse sickness during the period of 24 months prior to the 
date of departure of the animal and there have been no systematic vaccinations against Afric an 
horse sickness during the period of 12 months prior to the date of departure.  
II.2.4.  The equine animals described  in Part I come from an est ablishment  of origin situated in a 
country, territory or zone thereof  in which  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 months 
prior to the date of departure of the animals.]  
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei  (glanders ) 
recognised by the European Union(2) has been carried out during the last 36 months prior to the 
date of departure, and  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of origin during the last 36 months prior to the date of departure of the 
animals.]  
(3)or [infection with Burkholderia mallei  (glanders ) has been reported in the establishment 
of origin during the last  36 months prior to the date of departure of the animal and 
following the last outbreak, the establishment has remained under movement This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 506  EN  COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  
restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected 
to a complement fixat ion test for infection with Burkholderia mallei  
(glanders )(5), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at least 6 months after the infected animals have been killed 
and destroyed.]]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was killed and destroyed.]]]  
II.2.5.  The equine animals described in Part I come from an establishment  of origin situated in a 
country, territory or zone thereof i n which  
(3)either [surra has not been reported during the last 24 months prior to the date of departure.]  
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the animals, and  
(4)either  [surra has has not been  reported in the establishment of origin during the last 24 
months prior to the date of departure of the animals.]  
(3)or [surra has been reported in the establishment of origin duri ng the last 24 months prior 
to the date of departure of the animals, and  following the last outbreak the 
establishment has remained under movement restriction  
(3)either  [until the remaining animals in the establishment have been subj ected to an 
enzyme -linked immunosorbent assay (ELISA) for trypanosomosis  or card 
agglutination test for trypanosomosis  (CATT) at a serum dilution of 1 in 4(5) 
carried out, with negative results, on samples taken at least 6 months after the 
last infected an imal has been removed from the establishment.]]]  
(3)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either killed and destroyed 
or slaughtered .]]] 
II.2.6.  The equine animals described in Part I come from an establishment  of origin situated in a 
country, territory or zone thereof in which  
(3)either  [dourine has not been reported  during the last 24 months prior to the date of departure of the 
animals.]  
(3)or [a surveilla nce and eradication  programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the animals, and  
(3)either  [dourine  has not been reported in the establishment of origin during the  last 24 months 
prior to the date of departure of the animals .] 
(3)or [dourine has been  reported in the establishment of origin during the last 24 months 
prior to the date of departure of the animals, and following the last outbreak, the 
establishment has remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment, except castrated 
male  equine animals , have been subjected to a complement fix ation test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(5) on 
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been cas trated.]]]  
(3)or [for a t least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]]  
II.2.7.  The equine animals described in Part I come from an establishment  or origin in which  
(3)either  [equine infectious anaemia has not been reported during the last 12 months prior to the date of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 507  EN  COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  
departure of the animals.]  
(3)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animals an d following  the last outbreak the establishment has remained under 
movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(5) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a minimum 
interval of 90 days following cleaning and disinfection of the establishment after the 
infected animals have been killed and destroyed or sl aughtered.]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last equine 
animal on the establishment was either killed and destroyed or slaughtered.]]  
II.2.8.  The equine animals described in Part I come from an establishment  of origin in which  
II.2.8.1.  infection with rabies virus in kept terrestrial animals has not been reported during the 
last 30 days prior to the date of departure of the animals;  
II.2.8.2.  anthrax in ungulates has not been reported during the  last 15 days prior to the date of 
departure of the animals.  
II.2.9.  To the best of my knowledge and as declared by the operator of the consignment, the equine 
animals described in Part I have not been in contact with kept animals  of listed species which d id 
not comply with the requirements  referred to in Points II.2.3. to II.2.8.1 during the last 30 days 
prior to the date of departure of the animals, and with the requirement referred to in point 
II.2.8.2. during the last 15 days prior to the date of depart ure of the animals.  
II.3. Attestation of residence and pre -export isolation  
II.3.1.  The equine animals described in Part I have been resident in the country, territory or zone thereof 
of dispatch during a period of at least 90 days prior to the date of departure.  
(3)either  [II.3.2.  The equine animals described in Part I are dispatched from a country, territory or zone thereof 
assigned to Sanitary Group A, B, C, D, or G, and during the last 30 days prior to the date of 
departure from the establishment of origin have been kept in pre -export isolation.]  
(3)(6)or [II.3.2.  The equine animals described in Part I are dispatche d from a country, territory or zone thereof 
assigned to Sanitary Group E, and during the last 40 days prior to the date of departure from the 
establishment of origin, have been kept  
(3)either  [in isolation in an establishment of origin protected from vector insects.]]  
(3)or [in an establishment of origin under veterinary supervision, and the country, territory or zone 
thereof of dispatch is recognised by the OIE as officially free of African horse sickness.]]  
(3)[II.3.3.  Immediately prior to their disp atch from the country or territory of dispatch, the equine animals 
of the consignment described in Part I have been kept in the establishment approved for 
assembly operations referred to in point II.1.2. for a period of not more than 6 days after leaving 
their respective establishments of origin. In the approved establishment, which complies with the 
requirements for establishments in point II.2., the animals have been kept under conditions that 
effectively protect their health status and without coming int o contact with equine animals not 
complying with the requirements in points II.2., II.3.1., II.3.2. and II.4. of this certificate.]  
II.4. Attestation of vaccination and health tests  
II.4.1.  The equine animals described in Part I were not vaccinated against  African horse sickness in 
the country, territory or zone thereof of dispatch and there is no information suggesting 
previous vaccination.  
II.4.2.  The equine animals  described in Part I have not been vaccinated against Venezuelan equine 
encephalomyelitis d uring the last 60 days prior to the date of departure, and come from an 
establishment  situated in a country or territory or zone thereof in which Venezuelan equine This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 508  EN  COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  
encephalomyelitis has not been reported during the last 24 months prior to the date of 
departure.  
(3)either  [II.4.3.  The equine animals described in Part I are dispatched from Iceland, which is certified as 
officially free from equine infectious anaemia, where they have been continuously resident 
since birth, and did not come into contact wi th equidae which have entered Iceland from other 
countries.]  
(3)or [II.4.3.  The equine animals described in Part I were subjected with negative result in each case to an 
agar gel immunodiffusion test (AGID or Coggins test) or to an ELISA for equine infecti ous 
anaemia(5) carried out on a blood sample taken on …………… (insert date), within a period of 
30 days prior to the date of departure. 
(3)[II.4.4.  The equine animals described in Part I are dispatched from a country, territory or zone thereof 
assigned to Sanitary Group B, D or E, or from a country or territory in which infection with 
Burkholderia mallei  (glanders ) has been reported during a period of 36 months prior to the date 
of departure, and were subjected to a complement fixation test for infection with Burkholderia 
mallei  (glanders )(5) carried out with negative result in each case at a serum dilution of 1 in 5 on 
a blood sample taken on ……………………. ( insert  date), within a period of 30 days prior to 
the date of departure. 
(3)[II.4.5.  The equine animals described in Part I are uncastrated male or female equine animals older than 
270 days dispatched from a country,  territory or zone thereof assigned to Sanitary Group B, D 
or E, or from a country in which dourine has been reported during a period of 24 months prior 
to the date of departure, and were subjected to a complement fixation test for dourine(5) carried 
out w ith negative result in each case at a serum dilution of 1 in 5 on a blood sample taken on 
……………………. ( insert  date), within a period of 30 days prior to the date of departure.  
(3)[II.4.6.  The equine animals described in Part I are dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E, from Brazil, Bolivia, Uruguay, or from a country or 
territory in which surra was reported during the last 24 months prior to the date of departure, 
and were subjected to a card agglutination test for trypanosomosis  (CATT)(5), carried out with 
negative result in each case at a serum dilution of 1 in 4 on a blood sample taken on 
……………………. ( insert date ), within a period of 30 days prior to the date of departure. 
(3)(6)[II.4.7.  The equine animals described in Part I are dispatched from a country, territory or zone thereof 
which is assigned to Sanitary Group E, and  
(3)either  [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7) carried 
out with negative  results in e ach case by the same laboratory on the same day on blood samples 
taken on two occasions with an interval of between 21 and 30 days, on …………………… 
(insert date) and on ………………… (insert date) , the second of which was taken within a 
period of 10 days prior to the date of departure.]  
 (3)or [were subjected to an indirect ELISA or a blocking ELISA for African horse sickness(7) with 
negative result on a blood sample taken on ……………… (insert date), within a period of 21 
days prior to the date of departure, and the c ountry or territory of dispatch is recognised by the 
World Organisation for Animal Health (OIE) as officially free of African horse sickness.]]  
II.5. Attestation of the transport conditions  
II.5.1.  Arrangements have been made to transport this consignment of animals directly to the Union, 
without subjecting the animals after certification to any further assembly operation outside the 
Europea n Union and without coming into contact with other equine ani mals not complying with 
at least the same health requirem ents as described in this health certificate.  
II.5.2.  Arrangements have been made and verified to prevent any contact with other equine animals 
not complying with at least the same health requirements as described in this health certificate 
during the period from certification until dispatch to the Union.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 509  EN  COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  
II.5.3.  The transport vehicles or containers in which the animals are going to be loaded were cleaned 
and disinfected before loading with a disinfectant officially recognised in the third country of 
dispatch and they are so constructed that faeces, urine, litter or fodder cannot escape during 
transportation.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex III to Commission Implementing Regulation (EU) 2020/…[IA on 
lists of TCs ]. 
Box reference I.27:  “Identification system ”: The animal must bear an individual identifier as defined in 
point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035 which 
permits to link the animal to the identification document. Specify the identification 
system (such as ear tag, tattoo, brand, transponder etc.) and the anatomic place used on 
the animal.  
Part II:  
(1) There can be one or more equine animals in the consignment.  
(2) The certificate must be issued within 48 hours of loading of the animals for dispatch to the Member State of 
destination in the Union.  
The entry into the Union shall not be allowed when the animals were loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restrictive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof . Check against columns 8 and 9 of Part  1 of 
Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(3) Delete as appropriate.  
(4) Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in P art 1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list ]. 
(5) Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other t han African horse 
sickness: https://sitesv2.anses.fr/en/minisite/equine -diseases/sop  
(6) Statements that relate entirely and exclusively to a Sanitary Group different from the Sanitary Group to 
which the country, territory or zone thereof of dispatch is assigned, may be left out, provided that the 
numbering of the subsequent statements is maintained.  
(7) Tests for African horse sickness described by the European Union Reference Laboratory for African horse 
sickness: https://www.mapa.gob.es/en/ganaderia/temas/laboratorios/lcv/directrices -diagnostico.aspx  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 510  EN  COUNTRY  EQUI -TRANSIT -Y 
Transit – equine animal s intended for slaughter  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 511  EN Declaration by the operator of the consignment of equine animals intended for slaughter  
Identification of the animals(1)  
Total number  
 Species (Scientific 
name)  
……………………….  Identification system  
……………………….  Identification number  
 
……………….  Quantity  
 
…………  
I, the undersigned operator of the consignment of equine animals intended for slaughter described above , hereby declare, that : 
 
- the animals have remained in the country, territory or zone thereof of dispatch for at least 90 days prior to the date of 
dispatch;  
- during the period of 15 days prior to the date of dispatch the animals have not been in contact with animals suffering 
from infectious or contagious diseas es transmissible to equine animals;  
- the conditions for residence and pre -export isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled;  
- the cond itions for the transport as applicable in accordance with point II.4. of the accompanying health certificate for the 
country, territory or zone thereof of dispatch are fulfilled;  
- the transportation will be effected in such a way that health and well -being of the animals can be protected effectively at 
all stages of the journey to the European Union;  
- the animals will be sent  
 (2)either  [directly from the establishment of origin to the slaughterhouse of destination without coming into contact 
with other equine animals not of the same health status;]  
 (2)or [from the establishment approved for assembly operations on equine animals to the slaughterhouse of 
destination without coming into contact with other equine animals not of the same health status;]  
- arrangements have  been made to transport the animals on the territory of the European Union in accordance with 
Regulat ion (EC) No 1/2005;  
- the animals are scheduled to leave the Union on ………………….. ( insert date dd/mm/yyyy ) at the border control post of 
…………… …………………. ( insert name and place of the border control post of exit ). 
 
 
Name  and address of the operator: ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier which permits to link the animal to the identification document. Specify the 
identification system (such as ear tag, tattoo, brand, transponder) and the anatomic place used on the animal.  
 (2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 512  EN CHAPTER 16: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
FOR THE RE -ENTRY INTO THE UNION  OF REGISTERED HORSES  FOR 
RACING, COMPETITION AND CULTURAL EVENTS AFTER TEMPORARY 
EXPORT FOR A PERIOD OF NOT MORE THAN 30 DAYS (MODEL EQUI -RE-
ENTRY -30) 
COUNTRY  Offic ial certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent  Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country  code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
    Registered horse   
     
     
     
I.21  I.22  
   I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 513  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 514  EN  
 COUNTRY  EQUI -RE-ENTRY -30 
Re-entry after temporary export of not more than 30 days  
Registered horse  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that :: 
II.1. The equine animal described in Part I:  
II.1.1.  is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035, not 
intended for slaughter in the framework of the eradication of a disease communicable to equine 
animals;  
II.1.2. has not shown clinical signs or symptoms of diseases listed for equine animals in Implementing 
Regulation (EU) 2018/1882 during the clinical examination carried out on ………………. 
(insert date  dd/mm/yyyy )(1), this being within 48 hours or on the last workin g day prior to 
departure from the registered establishment;  
II.1.3.  meets  the requirements  attested in points II.2. to  II.3. of this certificate;  
II.1.4.  is accompanied  by a written declaration, signed by the operator of the animal, which forms part 
of thi s certificate.  
II.2. Attestation  on third country, territory or zone thereof an don establishment of dispatch  
II.2.1.  The animal  is dispatched from …………… ( insert name of co untry, territory or zone thereof ), a 
country, territory or zone thereof which on the  date of issuing this certificate has the Code: 
……………(2) and is assigned to Sanitary Group ………..…(2). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomye litis, infection with Burkholderia mallei  
(glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infectin with rabies  infection  and anthrax.  
II.2.3.  The equine animal described in Part I comes from a country, t erritory or zone thereof in which 
there has been no clinical, serological (in unvaccinated equine animals) or epidemiological 
evidence of African horse sickness during the period of 24 months prior to the date of departure 
of the animal and there have been  no systematic vaccinations against African horse sickness 
during the period of 12 months prior to the date of departure.  
II.2.4.  The equine animal described  in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 months 
prior to the date of departure of the animal.]  
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei  (glanders ) 
recognised by the European Union(2) has been carried out during the last 36 months prior to the 
date of departure, and  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of dispatch during the last 36 month s prior to the date of departure of 
the animal.]  
(3)or [infection with Burkholderia mallei  (glanders ) has been reported in the establishment 
during the last 36 months prior to the date of departure of the animal and following the 
last outbreak, the establishment has remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected 
to a complement fixation test for infection with Burkholderia mallei  
(glanders )(4), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at least 6 months after the infected animals have been killed This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 515  EN  COUNTRY  EQUI -RE-ENTRY -30 
Re-entry after temporary export of not more than 30 days  
Registered horse  
and destroyed.]]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was killed and destroyed.]]]  
II.2.5.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(3)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(3)or [a surveillance and eradication programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the animal, and  
(3)either  [surra has not  been  reported in the establishment during the last 24 months prior to the 
date of departure of the animal.]  
(3)or [surra has been reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and  following the last outbreak the establishment has 
remained under movement restriction  
(3)either  [until the remaining animals in the establishment have been sub jected to an 
enzyme -linked immunosorbent assay (ELISA) for trypanosomosis  or card 
agglutination test for trypanosomosis  (CATT) at a serum dilution of 1 in 4(4) 
carried out, with negative results, on samples taken at least 6 months after the 
last infected animal has been removed from the establishment.]]]  
(3)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed speci es on the establishment was either killed and destroyed 
or slaughtered .]]] 
II.2.6.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(3)either  [dourine has not been reported  during the last 24 months prior to the date of departure of the 
animal.]  
(3)or [a surveillance and eradication  programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the ani mal, and  
(3)either  [dourine  has not been reported in the establishment during the last 24 months prior to 
the date of departure of the animal .] 
(3)or [dourine has been  reported in the establishment during the last 24 months prior to the 
date of departure o f the animal, and following the last outbreak, the establishment has 
remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment, except castrated 
male  equine animals , have been subjected to a complement fixation  test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(4) on 
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrate d.]] 
(3)or [for at least 30 days  from the date of cleaning and disinfection  after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]  
II.2.7.  The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the last 60 days prior to the date of its departure, and  
(3)either  [it comes from an establishment  situated in a country or territory in which  Venezuelan equine 
encephalomyelitis has not been reported during the last 24 months prior to the date of its 
departure.]  
(3)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 516  EN  COUNTRY  EQUI -RE-ENTRY -30 
Re-entry after temporary export of not more than 30 days  
Registered horse  
reported during the last 6 months prio r to the date of its departure and which is situated in a 
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2) has been carried out 
during the last 24 months prior to the date of its departure.  
II.2.8.  The equine animal described in Part I comes from an establishment  in which  
(3)either  [equine infectious anaemia has not been reported during the last 12 months prior to the date of 
departure of the animal.]  
(3)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animal and following  the last outbreak the establishment has remained under 
movement restriction  
(3)either  [until the re maining equine  animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(4) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a minimum 
interval of 90 days following cleaning and disinfection after the infected animals have 
been killed and destroyed or slaughtered.]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last equine 
animal on the establishment was either killed and d estroyed or slaughtered.]]  
II.2.9.  The equine animal described in Part I comes from an establishment  in which  
II.2.9.1.  infection with rabies virus in kept terrestrial animals has not been reported during the 
last 30 days prior to the date of departure of  the animal;  
II.2.9.2.  anthrax in ungulates has not been reported during the last 15 days prior to the date of 
departure of the animal.  
II.2.10.  To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been  in contact with kept animals of listed species which did not comply with the 
requirements referred to in Points II.2.3. to II.2.9.1 during the last 30 days prior to the date of 
departure of the animal, and with the requirement referred to in point II.2.9. 2. during the last 15 
days prior to the date of departure of the animal.  
II.3. Attestation  of residence and pre -export isolation  
II.3.1.  The animal  described in Part I was imported into the country, territory or zone thereof of 
dispatch on ………………………………… (insert date)  
(3)either  [directly  from the EU Member State ……………………..… ( insert name of EU Member 
State ).] 
(3)or [from a country, territory or zone thereof …………………… ( insert name of country, territory 
or zone thereof )  authorised for entry of equine animals into the Union, under conditions at least 
as strict as those set out in this certificate.]  
II.3.2.  The animal described in Part I exited from the Union less than 30 days ago, and since exit from 
the Union it was never in a country, territory or zone thereo f(2) other than those of the same 
Sanitary Group, and resident in establishments under veterinary supervision, accommodated in 
separated stables without coming into contact with equine animals of lower health status, except 
during racing, competition or the cu ltural event.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 517  EN  COUNTRY  EQUI -RE-ENTRY -30 
Re-entry after temporary export of not more than 30 days  
Registered horse  
Part I:  
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex III to Commission Implementing Regulation (EU) 2020/…[IA on 
lists of TCs ]. 
Box reference I.27:  “Identification system ”: The animal must bear an individual identifier as defined in 
point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035 which 
permits to link the animal to the identification document  or be identified by an 
alternative method in accor dance with Article 62 of that Regulation provided it is 
recorded in its identification document (passport).  Specify the identification system 
(such as tattoo, brand, transponder etc.) and the anatomic place used on the animal.  
The number of the accompanyin g passport or the Unique Code, if no passport number 
is available, should be stated and the name of the competent authority which validated 
it. 
“Age”: Date of birth ( dd/mm/yyyy ). 
“Sex”: M = male, F = female, C = castrated.  
Part II:  
(1) The certificate must be issued within 48 hours of loading or on the last working day before loading of the 
animal for dispatch to the Member State of destination in the Union.  
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restri ctive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof. Check against columns 8 and 9 of Part  1 of 
Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(2) Code of the country, territ ory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(3) Delete as appropriate.  
(4)  Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisit e/equine -diseases/sop  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 518  EN Declaration by the operator responsible for the re -entry after temporary export of a  
registered horse for racing, competition  and cultural events  
Identification of the animal(1)  
Species (Scientific name)  
Equus caballus  Identification system  
 
……………………….  Identification number  
 
……………………….  Age 
 
……………….  Sex 
 
…………  
I, the undersigned operator  of the registered horse described above , hereby declare, that : 
- the registered horse  
 (2)either  [was temporarily exported from the Union to the country of dispatch on…………………... ( insert  date) less 
than 30 days prior to this declaration;]  
 (2)or [entered the country of dispatch on ……………….. ( insert  date) from………….……….( insert  name of 
country from where horse entered country of dispatch );] 
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases t ransmissible to equine animals;  
- the transportation will be effected in such a way that health and well -being of the horse can be protected effectively at all 
stages of the journey;  
- the conditions for residence and pre -export isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.  
Name  and address of the operator: ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier as defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulatio n (EU) 2019/2035 
which permits to link the anim al to the identification document or be identified by an alternative method in accordance with Article 62 of that Regulation 
provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transp onder etc.) and the anatomic 
place used on the animal.  
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name  of the competent authority 
which validated  the passport.  
 Age: Date of birt h (dd/mm/yyyy).  
 Sex (M = male, F = female, C = castrated).  
(2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 519  EN CHAPTER 17: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
APPLICABLE TO RE -ENTRY INTO THE UNION  OF REGISTERED HORSES  FOR 
COMPETITION AFTER TE MPORARY EXPORT FOR A  PERIOD OF NOT MORE 
THAN 90 DAYS TO PART ICIPATE IN EQUESTRIA N EVENTS ORGANISED 
UNDER THE AUSPICES O F THE FÉDÉRATION EQU ESTRE INTERNATIONALE  
(FEI) (MODEL EQUI -RE-ENTRY -90-COMP ) 
(Test event in preparation of the Olympic Games, Olympic Games, Paralympics, Worl d Equestrian 
Games/World Championship, Asian Equestrian Games, American Equestrian Games (including the 
PanAmerican Games, South American Games, Central American and Caribbean Games), Endurance World Cup 
in United Arab Emirates, LG Global Champions Tour, U nited Arab Emirates International Show Jumping 
League)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval  No 
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping   Germinal products   Registe red horse   
     
     
     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 520  EN I.21  I.22  
   I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 521  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 522  EN  
 COUNTRY  EQUI -RE-ENTRY -90-COMP  
Re-entry after temporary export of not more than 90 days  
Specific competitions - Registered horse  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animal described in Part I:  
II.1.1.  is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035, not 
intended for slaughter in the framework of the eradication of a disease communicable to equine 
animals;  
II.1.2.  has not shown clinical signs or symptoms of diseases listed for equine animals in Implementing 
Regulation (EU) 20 18/1882 during the clinical examination carried out on ………………. 
(insert date  dd/mm/yyyy )(1), this being within 48 hours or on the last working day prior to 
departure from the registered establishment;  
II.1.3.  meets  the requirements  attested in points II.2. to II. 3. of this certificate;  
II.1.4.  is accompanied  by a written declaration, signed by the operator of the animal, which forms part 
of this certificate.  
II.2. Attestation  on third country, territory or zone thereof an don establishment of dispatch  
II.2.1.  The animal  is dispatched from …………… ( insert name of country, territory or zone thereof ), a 
country, territory or zone thereof which on the date of issuing this certificate has the Code: 
……………(2) and is assigned to Sanitary Group ………..…(2). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei  
(glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiper dum), equine infectious 
anaemia, infection of rabies virus and anthrax.  
II.2.3.  The equine animal described in Part I comes from a country, territory or zone thereof in which 
there has been no clinical, serological (in unvaccinated equine animals) or epidemiological 
evidence of African horse sickness during the period of 24 months prior to the date of departure 
of the animal and there have been no systematic vaccinations against African horse sickness 
during the period of 12 months prior to the date of  departure.  
II.2.4.  The equine animal described  in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 months 
prior to the date of departure of the animal.]  
(3)or [a surveillance and eradication programme for infection with Burkholderia mallei  (glanders ) 
recognised by the European Union(2) has been carried out during the last 36 months p rior to the 
date of departure, and  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of dispatch during the last 36 months prior to the date of departure of 
the animal.]  
(3)or [infection with Burkholderia mallei  (glanders ) has been reported in the establishment 
during the last 36 months prior to the date of departure of the animal and following the 
last outbreak, the establishment has remained under movement restriction  
(3)either  [until the remaining equin e animals in the establishment have been subjected 
to a complement fixation test for infection with Burkholderia mallei  
(glanders )(4), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at least 6 months after the infected a nimals have been killed This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 523  EN  COUNTRY  EQUI -RE-ENTRY -90-COMP  
Re-entry after temporary export of not more than 90 days  
Specific competitions - Registered horse  
and destroyed.]]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was killed and destroyed.]]]  
II.2.5.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(3)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(3)or [a surveillance and eradication programme for surra recognised by the European U nion(2) has 
been carried out during the last 24 months prior to the date of departure of the animal, and  
(3)either  [surra has not  been  reported in the establishment during the last 24 months prior to the 
date of departure of the animal.]  
(3)or [surra has been reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and  following the last outbreak the establishment has 
remained under movement restriction  
(3)either  [until the remaining animals in the establishment  have been subjected to an 
enzyme -linked immunosorbent assay (ELISA ) for trypanosomosis  or card 
agglutination test for trypanosomosis  (CATT) at a serum dilution of 1 in 4(4) 
carried out, with negative results, on samples taken at least 6 months after the 
last infected animal has been removed from the establishment.]]]  
(3)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either killed and destroyed 
or slaughtered .]]] 
II.2.6.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(3)either  [dourine has not been reported  during the last 24 months prior to the date of departure of the 
animal.]  
(3)or [a surveillance and eradication  programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the animal, and  
(3)either  [dourine  has not been reported in the establishment during the last 24 months prior to 
the date of departure of the animal .] 
(3)or [dourine has been  reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and following the last outbreak, the establishment has 
remained under movement restriction  
(3)either  [until the remaining equine  animals in the establis hment, except castrated 
male  equine animals , have been subjected to a complement fixation test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(4) on 
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrated.]]  
(3)or [for at least 30 days following cleaning and disinfection after the last equine 
animal on the establishment was either killed and destroyed or slaughtered.]]  
II.2.7.  The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the last 60 days prior to the date of its departure, and  
(3)either  [it comes from an establishment  situated in a countr y or territory in which Venezuelan equine 
encephalomyelitis has not been reported during the last 24 months prior to the date of its 
departure.]  
(3)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been 
reported during  the last 6 months prior to the date of its departure and which is situated in a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 524  EN  COUNTRY  EQUI -RE-ENTRY -90-COMP  
Re-entry after temporary export of not more than 90 days  
Specific competitions - Registered horse  
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2) has been carri ed out 
during the last 24 months prior to the date of its departure.  
II.2.8.  The equine animal described in Part I comes from an establishment  in which  
(3)either  [equine infectious anaemia has not been reported during the last 12 months prior to the date of 
departure of the animal.]  
(3)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animal and following  the last outbreak the establishment has remained under 
movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(4) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a minimum 
interval  of 90 days following cleaning and disinfection after the infected animals have 
been killed and destroyed or slaughtered.]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last equine 
animal on the establishment was either killed and destroyed or slaughtered.]]  
II.2.9.  The equine animal described in Part I comes from an establishment  in which  
II.2.9.1.  infection with rabies virus in kept terrestrial animals has not been reported during the 
last 30 days prior to the date of departure of the animal;  
II.2.9.2.  anthrax in ungulates has not been reported during the last 15 days prior to the date of 
departure of the animal.  
II.2.10.  To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been in contact with kept animals of listed species which did not comply with the 
requirements referred to in Points II.2.3. to II.2.9.1 during the last 30 days prior to the date of 
departure of the animal, and with the requirement referred to in p oint II.2.9.2. during the last 15 
days prior to the date of departure of the animal.  
II.3. Attestation  of residence and pre -export isolation  
II.3.1.  The animal  described in Part I was imported into the country, territory or zone thereof of 
dispatch on ………………………………… (insert date)  
(3)either  [directly  from the EU Member State ……………………..… ( insert name of EU Member 
State ).] 
(3)or [from a country, territory or zone th ereof …………………… ( insert name of country, territory 
or zone thereof )  authorised for entry of equine animals into the Union, under conditions at least 
as strict as those set out in this certificate.]  
II.2.2.  the animal exited from the Union  
(3)either  [less than 30 days ago, and since exit from the Union was never in a country territory or zone 
thereof (1) other than those of the same Sanitary Group, and resident in establishments under 
veterinary supervision, accommodated in separated stables without c oming into contact with 
equine animals of lower health status except during competition and has taken part in or was 
stabled together with horses participating in the LG Global Champions Tour  
(3)either  [in the Metropolitan  area of Mexico City, Mexico;]  
(3)and/or [in Miami, Unites States of America;]  
(3)or [in Shanghai, China;]]  
(3)or [less than 60 days ago, and since exit from the Union was never in a country, territory or zone 
thereof(1) other than those of the same Sanitary Group, and resident in establis hments under 
veterinary supervision, accommodated in separated stables without coming into contact with 
equine animals of lower health status except during competition and has taken part in or was This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 525  EN  COUNTRY  EQUI -RE-ENTRY -90-COMP  
Re-entry after temporary export of not more than 90 days  
Specific competitions - Registered horse  
stabled together with horses participating in  
(3)either  [the Asian Games in ………………………….………...………..(insert place).]]  
(3)or [the American Games(5) in ………………..…………….….............(insert place).]]  
(3)or [the Endurance World Cup in United Arab Emirates.]]  
(3)or [less than 90 days ago, and since exit from the Union was  never in a country, territory or zone 
thereof(1) other than those of the same Sanitary Group, and resident in establishments under 
veterinary supervision, accommodated in separated stables without coming into contact with 
equine animals of lower health st atus except during competition and has taken part in or was 
stabled together with horses participating in  
(3)either  [the Test event for the Olympic Games in ……….…….…………( insert place ).]] 
(3)or [the Olympic Games in ……………………..…………………..( insert place ).]] 
(3)or [the Paralympics in ………………………………………………..( insert place ).]] 
(3)or [the World Equestrian Games/World Championships in ……………..( insert place ).]] 
(3)or [the United Arab Emirates International Show Jumping League.]]  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column  2 of Annex III to Commission Implementing Regulation (EU) 2020/…[IA on 
lists of TCs] . 
Box reference I.27:  “Identification system ”: The animal must bear an individual identifier as defined in 
point (a), (c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035 which 
permits to link the animal to the identification document  or be identified by an 
alternative method in accordance with Article 62 of that Regulation provide d it is 
recorded in its identification document (passport).  Specify the identification system 
(such as tattoo, brand, transponder etc.) and the anatomic place used on the animal.  
The number of the accompanying passport or the Unique Code, if no passport nu mber 
is available, should be stated and the name of the competent authority which validated 
it. 
“Age”: Date of birth ( dd/mm/yyyy ). 
“Sex”:  (M = male, F = female, C = castrated.  
 
Part II:  
(1) The certificate must be issued within 48 hours  of loading or on the last working day before loading of the 
animal for dispatch to the Member State of destination in the Union.  
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restri ctive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof. Check against columns 8 and 9 of Part  1 of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 526  EN  COUNTRY  EQUI -RE-ENTRY -90-COMP  
Re-entry after temporary export of not more than 90 days  
Specific competitions - Registered horse  
Annex III to Implementing Regulation (EU) 2020/…. [IA list ]. 
(2) Code of the country, territ ory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex III to Implementing Regulation (EU ) 2020/…. [IA list ]. 
(3) Delete as appropriate.  
(4)  Tests for glanders, surra, dourine, equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https://sitesv2.anses.fr/en/minisit e/equine -diseases/sop   
(5) Including the PanAmerican Games, South American Games, Central American and Caribbean Games.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 527  EN Declaration by the operator responsible for the re -entry after temporary export of a  
registered horse for racing, competition and cultural events  
Identification of the animal(1)  
Species (Scientific name)  
Equus caballus  Identification system  
 
……………………….  Identification number  
 
……………………….  Age 
 
……………….  Sex 
 
…………  
I, the undersigned operator  of the registered horse described above , hereby declare, that : 
- the registered horse  
(2)either  [was temporarily  exported from the Union to the country, territory or zone thereof of dispatch 
on…………………... ( insert  date) less than 90 days prior to this declaration;]  
(2)or [entered the country or territory or zone thereof of dispatch on ……………….. ( insert  date) 
from………….… …….( insert  name of country, territory or zone thereof from where horse entered country, 
territory or zone thereof of dispatch );] 
- the registered horse has been temporarily exported from the Union to take part in  
(2)either  [the Asian Games in ………………………….…… …...………..( insert place );] 
(2)or [the American  Games in ………………..…………….….............( insert place );] 
(2)or [the Endurance  World Cup in United Arab Emirates;]  
(2)or [the Test event for the Olympic Games in ……….…….…………( insert place );] 
(2)or [the Olympic Games  in ……………………..……………………..( insert place );] 
(2)or [the Paralympics in ………………………………………………..( insert place );] 
(2)or [the World Equestrian Games in …………………………………..( insert place); ] 
(2)or [the LG Global Champions Tour in  
(2)either  [the Metropolitan area of Mexico City, Mexico;]  
(2)and/or [Miami, Unites States of America;]  
(2)or [Shanghai, China;]  
(2)or [the United Arab Emirates International Show Jumping League]  
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases transmissible to equine animals;  
- the transportation will be effected in such a way that health and well -being of the horse can be protected effectively at all 
stages of the journey;  
- the condition s for residence and pre -export isolation as applicable in accordance with point II.2. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.  
Name  and address of the operator: ……………………………………………………..  
Date : …………………………( dd/mm/yyyy ) 
 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier as defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulatio n (EU) 2019/2035 
which permits to link the animal to the identification document or be identified by an alternative method in accordance with Article 62 of that Regulation 
provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transponder etc.) and the anatomic 
place used on the animal.  
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name  of the competent authority 
which validated  the passport.  
 Age: Date of birth (dd/mm/yyyy).  
 Sex (M = male, F = female, C = castrated).  
(2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 528  EN CHAPTER 18: MODEL HEALTH CERTI FICATE AND MODEL DEC LARATION 
APPLICABLE TO RE -ENTRY INTO THE UNION  OF REGISTERED HORSES  FOR 
RACING AFTER TEMPORARY EXPORT FOR  A PERIOD OF NOT MORE  THAN 
90 DAYS TO PARTICIPA TE IN SPECIFIC RACE EVENTS IN AUSTRALIA,  
CANADA, THE UNITED S TATES OF AMERICA, HO NG KONG, JAPAN, 
SINGAPORE, THE UNITE D ARAB EMIRATES OR Q ATAR (MODEL EQUI -RE-
ENTRY -90-RACE ) 
 (International G roup/Grade meetings, the Japan Cup, the Melbourne Cup, the Dubai Racing World -Cup, the 
Hong Kong International Races)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions     
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping   Germinal products   Registered horse   
     
     
     
I.21  I.22  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 529  EN    I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 530  EN I.24  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 531  EN  
 COUNTRY  EQUI -RE-ENTRY -90-RACE  
Re-entry after temporary export of not more than 90 days  
Specific races - Registered horse  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The equine animal described in Part I:  
II.1.1.  is a registered horse as defined in Article 2(30) of Delegated Regulation (EU) 2019/2035, not 
intended for slaughter in the framework of the eradication of a disease communicable to equine 
animals;  
II.1.2.  has not shown clinical signs or symptoms of diseases l isted for equine animals in Implementing 
Regulation (EU) 2018/1882 during the clinical examination carried out on ………………. 
(insert date  dd/mm/yyyy )(1), this being within 48 hours or on the last working day prior to 
departure from the registered establishment;  
II.1.3.  meets  the requirements  attested in points II.2. to  II.3. of this certificate;  
II.1.4.  is accompanied  by a written declaration, signed by the operator of the animal, which forms part 
of this certificate.  
II.2. Attestation  on third cou ntry, territory or zone thereof an don establishment of dispatch  
II.2.1.  The animal  is dispatched from …………… ( insert name of country, territory or zone thereof ), a 
country, territory or zone thereof which on the date of issuing this certificate has the Cod e: 
……………(2) and is assigned to Sanitary Group ………..…(2). 
II.2.2.  In the country or territory of dispatch the following diseases are compulsorily notifiable: African 
horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia mallei  
(glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine infectious 
anaemia, infection with rabies virus and anthrax.  
II.2.3.  The equine animal described in Part I comes from a country, territory or zone thereof in which 
there has been no clinical, serological (in unvaccinated equine animals) or epidemiological 
evidence of African horse sickness during the period of 24 months prior to the date of departure 
of the animal and there have been no systematic vaccinations against African horse sickness 
during the period of 12 months prior to the date of departure.  
II.2.4.  The equine animal described  in Part I comes from an establishment  situated in a country, 
territory or zone thereof  in which  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported  during the last 36 months 
prior to the date of departure of the animal.]  
(3)or [a surveillance and eradication programme for  infection with Burkholderia mallei  (glanders ) 
recognised by the European Union(2) has been carrie d out during the last 36 months prior to the 
date of departure, and  
(3)either  [infection with Burkholderia mallei  (glanders ) has not been reported in the 
establishment of dispatch during the last 36 months prior to the date of departure of 
the animal.]  
(3)or [infection with Burkholderia mallei  (glanders ) has been reported in the establishment 
during the last 36 months prior to the date of departure of the animal and following the 
last outbreak, the establishment has remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected 
to a complement fixation test for infection with Burkholderia mallei  
(glanders )(4), carried out, with negative results at a serum dilution of 1 in 5, 
on samples taken at lea st 6 months after the infected animals have been killed This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 532  EN  COUNTRY  EQUI -RE-ENTRY -90-RACE  
Re-entry after temporary export of not more than 90 days  
Specific races - Registered horse  
and destroyed.]]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was killed and destroyed.]]]  
II.2.5.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which   
(3)either  [surra has not been reported during the last 24 months prior to the date of departure.]  
(3)or [a surveillance and eradication programme for  surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the animal, and  
(3)either  [surra has not  been  reported in the establishment during the last 24 months prior to the 
date of departure  of the animal.]  
(3)or [surra has been reported in the establishment during the last 24 months prior to the 
date of departure of the animal, and  following the last outbreak the establishment has 
remained under movement restriction  
(3)either  [until the remaining animals in the establishment have been subjected to an 
enzyme -linked immunosorbent assay (ELISA) for trypanosomosis  or card 
agglutination test for trypanosomosis  (CATT) at a serum dilution of 1 in 4(4) 
carried out, with negative result s, on samples taken at least 6 months after the 
last infected animal has been removed from the establishment.]]]  
(3)or  [for at least 30 days from the date of cleaning and disinfection after the last 
animal of listed species on the establishment was either  killed and destroyed 
or slaughtered .]]] 
II.2.6.  The equine animal described in Part I comes from an establishment  situated in a country, 
territory or zone thereof in which  
(3)either  [dourine has not been reported  during the last 24 months prior to the date of departure of the 
animal.]  
(3)or [a surveillance and eradication  programme for surra recognised by the European Union(2) has 
been carried out during the last 24 months prior to the date of departure of the ani mal, and  
(3)either  [dourine  has not been reported in the establishment during the last 24 months prior to 
the date of departure of the animal .] 
(3)or [dourine has been  reported in the establishment during the last 24 months prior to the 
date of departure o f the animal, and following the last outbreak, the establishment has 
remained under movement restriction  
(3)either  [until the remaining equine  animals in the establishment, except castrated 
male  equine animals , have been subjected to a complement fixation  test for 
dourine , carried out with negative results at a serum dilution of 1 in 5(4) on 
samples taken at least 6 months after the infected animals have been killed 
and destroyed or slaughtered, or the infected entire male equine animals have 
been castrate d.]] 
(3)or [for at least 30 days from the date of cleaning and disinfection after the last 
equine animal on the establishment was either killed and destroyed or 
slaughtered.]]  
II.2.7.  The equine animal described in Part I has not been vaccinated against Venezuelan equine 
encephalomyelitis during the last 60 days prior to the date of its departure, and  
(3)either  [it comes from an establishment  situated in a country or territory in which  Venezuelan equine 
encephalomyelitis has not been reported during the last 24 months prior to the date of its 
departure.]  
(3)or [it comes from an establishment in which Venezuelan equine encephalomyelitis has not been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 533  EN  COUNTRY  EQUI -RE-ENTRY -90-RACE  
Re-entry after temporary export of not more than 90 days  
Specific races - Registered horse  
reported during the last 6 months prio r to the date of its departure and which is situated in a 
country, territory or zone thereof in which a surveillance and eradication programme for 
Venezuelan equine encephalomyelitis recognised by the European Union(2) has been carried out 
during the last 24 months prior to the date of its departure.  
II.2.8.  The equine animal described in Part I comes from an establishment  in which  
(3)either  [equine infectious anaemia has not been reported during the last 12 months prior to the date of 
departure of the animal.]  
(3)or [equine infectious anaemia has been reported during the last 12 months prior to the date of 
departure of the animal and following  the last outbreak the establishment has remained under 
movement restriction  
(3)either  [until the remaining equine  animals in the establishment have been subjected to an 
agar gel immuno -diffusion test (AGID) or ELISA(4) for equine infectious anaemia 
carried out, with negative results, on samples taken on two occasions with a minimum 
interval of 90 days following cleaning and disinfection after the infected animals have 
been killed and destroyed or slaughtered.]]  
(3)or [for at least 30 days from the date of cleaning and disinfection after the last equine 
animal on the establishment was either killed and d estroyed or slaughtered.]]  
II.2.9.  The equine animal described in Part I comes from an establishment  in which  
II.2.9.1.  infection with rabies virus in kept terrestrial animals has not been reported during the 
last 30 days prior to the date of departure of  the animal;  
II.2.9.2.  anthrax in ungulates has not been reported during the last 15 days prior to the date of 
departure of the animal.  
II.2.10.  To the best of my knowledge and as declared by the operator, the equine animal described in 
Part I has not been  in contact with kept animals of listed species which did not comply with the 
requirements referred to in Points II.2.3. to II.2.9.1 during the last 30 days prior to the date of 
departure of the animal, and with the requirement referred to in point II.2.9. 2. during the last 15 
days prior to the date of departure of the animal.  
II.3. Attestation  of residence and pre -export isolation  
II.3.1.  The animal  described in Part I was imported into the country, territory or zone thereof of 
dispatch on ………………………………… (insert date)  
(3)either  [directly  from the EU Member State ……………………..… ( insert name of EU Member 
State ).] for the participation in  
(3)either  [The Japan  Cup;]  
(3)or [The Melbourne  Cup;]  
(3)or [The Dubai Racing  World -Cup;]  
(3)or [The Hong Kong International  Races;]  
(3)or [from Australia(3), Canada(3), the United States of America(3), Hong Kong(3), Japan(3), 
Singapore(3), United Arab Emirates(3) or Qatar(3) for the participation in International 
Group/Grade meetings in the country of dispatch;]  
II.3.2.  as far as can be ascertained  and based on the declaration of the operator of the horse 
accompanying this certificate, the animal was:  
- not continuously outside the Union for more than 90 days, the date of scheduled return in 
accordance with this certifica te included;  
- not outside the country of dispatch or in case of International Gr oup/Grade meetings 
outside Australia, Canada, the United States of America, Hong Kong, Japan, Singapore, the 
United Arab Emirates or Qatar;  
- resident in establishments under veterinary supervision, accommodated in separated stables This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 534  EN  COUNTRY  EQUI -RE-ENTRY -90-RACE  
Re-entry after temporary export of not more than 90 days  
Specific races - Registered horse  
without coming into contact with equine animals of lower health status except during 
racing.  
II.3.3.  the animal entered the country of dispatch under animal health conditions at least as strict as 
those laid down in this health certificate.  
 
Notes:  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the country, territory or zone thereof of dispatch as appearing in 
column 2 of Annex III to Commission Implementing Regulation (EU) 2020/…[IA on 
lists of TCs ]. 
Box reference I.27:  Identification system ”: The animal must bear an individual identifier as defined in point (a), 
(c), (e), or (g) of Annex III to Delegated Regulation (EU) 2019/2035 which permits to link 
the animal to the identification document  or be identified by an alternative method in 
accor dance with Article 62 of that Regulation provided it is recorded in its identification 
document (passport).  Specify the identification system (such as tattoo, brand, transponder 
etc.) and the anatomic place used on the animal.  The number of the accompanyin g passport 
or the Unique Code, if no passport number is available, should be stated and the name of the 
competent authority which validated it.  
“Age”: Date of birth ( dd/mm/yyyy ). 
“Sex”: M = male, F = female, C = castrated.  
 
Part II:  
(1) The certificate mus t be issued within 48 hours  of loading or on the last working day before loading of the 
animal for dispatch to the Member State of destination in the Union.  
The entry into the Union shall not be allowed when the animal was loaded either prior to the date of 
authorisation for entry into the Union from the respective country, territory or zone thereof referred to in 
point II.1.1., or during a period where restri ctive measures have been adopted by the Union against the 
entry of equidae from this country, territory or zone thereof. Check against columns 8 and 9 of Part  1 of 
Annex III to Implementing Regulation (EU) 2020/…. [IA list ]. 
(2) Code of the country, territory or zone thereof and the Sanitary Group as appearing in columns 2 and 3 
respectively in Part 1 of Annex III to Implementing Regulation (EU) 2020/…. [IA list] . 
(3) Delete as appropriate.  
(4)  Tests for glanders, surra, dourine,  equine infectious anaemia and Venezuelan equine encephalomyelitis 
described by the European Union Reference Laboratory for Equine Diseases other than African horse 
sickness: https:// sitesv2.anses.fr/en/minisite/equine -diseases/sop  
 
Official veterinarian  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 535  EN  COUNTRY  EQUI -RE-ENTRY -90-RACE  
Re-entry after temporary export of not more than 90 days  
Specific races - Registered horse  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 536  EN Declaration by the operator responsible for the re -entry after temporary export of a  
registered horse for racing  
Identification of the animal(1)  
Species (Scientific name)  
Equus caballus  Identification system  
 
……………………….  Identification number  
 
……………………….  Age 
 
……………….  Sex 
 
…………  
I, the undersigned operator  of the registered horse described above , hereby declare, that : 
- the registered horse  
(2)either  [was temporarily  exported from the Union to the country, territory or zone thereof of dispatch 
on…………………... ( insert  date) less than 90 days prior to this declaration;]  
(2)or [entered the country or territory or zone thereof of dispatch on ……………….. ( insert  date) 
from………….……….( insert  name of country, territory or zone thereof from where horse entered country, 
territory or zone thereof of dispatch );] 
- the registered horse has been temporarily exported from the Union to take part in  
 (2)either  [The Japan Cup;]  
(2)or [The Melbourne Cup;]  
(2)or [The Dubai Racing World -Cup;]  
(2)or [The Hong Kong International Races;]  
(2)or [International Group/Grade meetings in Australia(2), Canada(2), the United States of America(2), Hong 
Kong(2), Japan(2), Singapore(2), United Arab  Emirates(2) or Qatar(2);] 
- during the period of 15 days prior to the date of dispatch the horse has not been in contact with animals suffering from 
infectious or contagious diseases transmissib le to equine animals;  
- the transportation will be effected in such a way that health and well -being of the horse can be protected effectively at all 
stages of the journey;  
- the conditions for residence and pre -export isolation as applicable in accordance  with point II.3. of the accompanying 
health certificate for the country, territory or zone thereof of dispatch are fulfilled.  
Name  and address of the operator: ……………………………………………………..  
Date: …………………………( dd/mm/yyyy ) 
 
…………………………………………………………………………………………………………………..  
(Signature ) 
 
(1) Identification system : The animal must bear an individual identifier as defined in point (a), (c), (e), or (g) of Annex III to Delegated Regulatio n (EU) 2019/2035 
which permits to link the anim al to the identification document or be identified by an alternative method in accordance with Article 62 of that Regulation 
provided it is recorded in its identification document (passport). Specify the identification system (such as tattoo, brand, transp onder etc.) and the anatomic 
place used on the animal.  
The number of the accompanying passport or the Unique Code, if no passport number is available, should be stated and the name  of the competent authority 
which validated  the passport.  
 Age: Date of birt h (dd/mm/yyyy).  
 Sex (M = male, F = female, C = castrated).  
(2) Delete as appropriate. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 537  EN CHAPTER 19 (‘MODEL CONFINED -RUM’)  
 
Section 1  
List of animals originating from and intended for a confined establishment  covered by model 
official certificate model ‘ CONFINED -RUM’ set out in section 2 of this Chapter  
 
Order  Family  Genera/species  
Artiodactyla  Antilocapridae  Antilocapra ssp. 
Bovidae  Addax ssp., Aepyceros ssp., Alcelaphus ssp., Ammodorcas 
ssp., Ammotragus ssp., Antidorcas ssp., Antilope ssp., Bison 
ssp., Bos ssp. (including Bibos, Novibos, Poephagus), 
Boselaphus ssp., Bubalus ssp. (including anoa), Budorcas 
ssp., Capra ssp., Cephalophus ssp., Connochaetes ssp., 
Damaliscus ssp. (including Beatragus), Dorcatragus ssp., 
Gazella ssp., Hemitragus ssp., Hippotragus ssp., Kobus ssp., 
Litocranius ssp., Madoqua ssp., Naemorhedus ssp. 
(including Nemorhaedus and Capricornis), Neotragus ssp., 
Oreamnos ssp., Oreotragus ssp., Oryx ssp., Ourebia ssp., 
Ovibos ssp., Ovis ssp., Patholops ssp., Pelea ssp., Procapra 
ssp., Pseudois ssp., Pseudoryx ssp., Raphicerus ssp., 
Redunca ssp., Rupicapra ssp., Saiga ssp., Sigmoceros -
Alecelaphus ssp., Sylvicapra ssp., Syncerus ssp., 
Taurotragus ssp., Tetracerus ssp., Tragelaphus ssp. 
(including Boocerus ).  
Camelidae  Camelus ssp., Lama ssp., Vicugna ssp.  
Cervidae  Alces ssp., Axis-Hyelaphus ssp., Blastocerus ssp., Capreolus 
ssp., Cervus -Rucervus ssp., Dama ssp., Elaphurus ssp., 
Hippocamelus ssp., Hydropotes ssp., Mazama ssp., 
Megamuntiacus ssp., Muntiacus ssp., Odocoileus ssp., 
Ozotoceros ssp., Pudu ssp., Rangifer ssp.  
Giraffidae  Giraffa ssp., Okapia ssp.  
Moschidae  Moschus ssp.  
Tragulidae  Hyemoschus ssp., Tragulus -Moschiola ssp.  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 538  EN  
Section 2  
MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE UNION OF 
ANIMALS LISTED IN SE CTION 1 OF THIS CHAP TER THAT ARE ORIGINA TING 
FROM AND INTENDED FO R A CONFINED ESTABLISH MENT  (MODEL 
‘CONFINED -RUM’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
   Confined establishment    
     
     
I.21  For transit  I.22  For internal market  
 Third  country  ISO country code  I.23  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 539  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 540  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
     Approval or registration 
number of 
plant/establishment/centre    
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 541  EN COUNTRY  Certificate model CONFINED -RUM  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.1.1.  come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for the entry into the Union of animals of the families Antilocapridae, 
Bovidae, Camelidae, Cervidae, Giraffidae, Moschidae, Tragulidae  intended for confined 
establishments and listed in Part 1 of Annex III to Commission Implementing Regulation (EU) 
2020/xx [ SANTE/7140/2020 ]. 
II.1.2.  have remained continuously in the establishment of origin since birth or for a period of time of at 
least 6 months prior to the date of dispatch to the Union, in which period n o animals have been 
introduced.  
II.1.3.  had no contact with animals of a lower heal th status since birth or at least for 30 days prior to the  
date of dispatch to the Union.  
II.1.4.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission D elegated Regulation (EU) 
2020/ 692 and emerging diseases.  
II.1.5.  have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.  
II.1.6.  have not been unloaded in any place that does not comply w ith the requirements laid down in 
point II.1.9. since they were dispatched from their establishment of origin until their dispatch to 
the Union and during that period they have not been in contact with animals of a lower health 
status.  
II.1.7.  have been lo aded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.8.  have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred 
to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.1.9.  have not been vaccinated against foot and mouth disease and infection with rinderpest virus.  
(1)[II.1.10.  have been vaccinated against:  
– (1) [anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],  
– (1) [rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].  
II.1.11.  come from a confined establishment : 
II.1.11.1.  which  is approved by the competent authority in accordance with the conditions set 
out in Article 30 of Commission delegated Regulation (EU) 2020/ 692. 
II.1.11.2.  which was not subject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the time of dispatch to the Union.  
II.1.11.3.  in which at the date of issue of this certificate the following diseases have not been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 542  EN COUNTRY  Certificate model CONFINED -RUM  
reported for the last 6 months:  
– foot and mouth disease,  
– infection with rinderpest virus ,  
– [infection with Rift Valley fever virus,](1)(4) 
– [infection with Mycoplasma Mycoides subsp. Mycoides  SC (Contagious bovine 
pleuropneumonia),](1)(5)  
– [infection with peste des petits ruminants virus,](1)(6) 
– [sheep pox and goat pox,](1)(7) 
– [contagious caprine pleuropneumonia,](1)(8) 
– [infection with lumpy skin disease virus,](1)(9) 
– [infection with  Burkholderia mallei  (Glanders),](1)(10) 
– infection with  Brucella abortus, B. melitensis and B. suis,  
– infection with Mycobacterium tuberculosis complex  (M. bovis , M.capare, 
M.Tuberculosis ),  
– [rabies,](1)11) 
– infection with bluetongue virus (Serotypes 1 -24). 
II.1.11.3.  in which at the date of issue of this certificate s urra ( Trypanosoma evansi ) and anthrax 
have not been reported for the last [30 days](1)(12)[180 days](1)13). 
II.1.11.4.   around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior to dispatch to the Union:  
– foot and mouth disease,  
– infection with rinderpest virus,  
– [infection with Mycoplasma Mycoides subsp. Mycoides  SC (Contagious bovine 
pleuropneumonia),](1)(5)  
– [infection with peste des petits ruminants virus,](1)(6) 
– [sheep pox and goat pox,](1)(7) 
– [contagious c aprine pleuropneumonia,](1)(8) 
– [infection with lumpy skin disease virus,](1)(9) 
– [infection with  Burkholderia mallei  (Glanders),](1)(10) 
– infection with  Brucella abortus, B. melitensis and B. suis,  
– infection with Mycobacterium tuberculosis complex  (M. bovis,  M.capare, 
M.Tuberculosis ), 
– [rabies](1)(11)
. 
II.1.11.5.  around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, none of the following listed diseases has been 
reported for at least 30 days prior t o dispatch to the Union:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 543  EN COUNTRY  Certificate model CONFINED -RUM  
– [infection with Rift Valley fever virus,](1)(4) 
– infection with bluetongue virus (Serotypes 1 -24), 
– infection with epizootic haemorrhagic disease virus.  
either (1)[II.1.12.  come from a zone which at the date of issue of this certifi cate foot and mouth disease 
has not been reported for the last 12 months.]  
or (1)  [II.1.12.  have been subjected to a virological and serological test for evidence of foot -and-
mouth disease virus infection carried out in accordance with one of the prescribe d 
tests for international trade laid down in the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals (OIE Terrestrial Manual), with negative results, 
taken in the 10 days prior to dispatch to the Union; and]  
either (1)  [II.1.13.  come from a zone which at the date of issue of this certificate infection with Rift 
Valley fever virus has not been reported for the last 48 months.]  
or (1)  [II.1.13.  have:  
(i) been kept in quarantine in a vector -protected facility in the approved confined 
establishment for a period of at least 30 days prior to the date of dispatch to the Union;  
(ii) showed no disease symptoms of infection with Rift valley fever virus for a period of  at 
least 30 days prior to the date of dispatch to the Union;  
(iii) been protected from vectors when transported between the vector -protected facility referred 
to in point (i) and loading for dispatch to the Union; and  
(iv) undergone a virus neutralisation test with  negative results for evidence of infection with 
Rift valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly  on 
samples taken  at the date of commencement of the quarantine period and secondly on 
samples taken  at least 42 days  from that that date and during a period of 10 days prior to 
the dispatch to the Union.  
either (1) [II.1.14.  have not been vaccinated against  infection with  Brucella (abortus, B. melitensis and 
B. suis ) and come from a zone which at the date of issue of th is certificate  this 
disease  has not been reported for the last 12 months.]  
or (1) [II.1.14.  have undergone a test as laid down and prescribed for international trade by the OIE 
Terrestrial Manual, on samples taken during the period of the 30 days prior to the 
date of dispatch to the Union.]  
 or (1) [II.1.14.  they are castrated males of any age.]  
either (1) [II.1.15.  come from a zone which at the date of issue of this certificate  infection with  
bluetongue virus  (Serotypes 1 -24) has not been reported for the last 24 months.]  
or (1)  [II.1.15.   they have been kept in quarantine in a vector -protected facility in the confined 
establishment for a period of at least 30 days prior to the date of dispatch to the 
Union and have undergone a serology test for infection w ith bluetongue virus (1 -24) 
and infection with epizootic haemorrhagic disease virus carried out in accordance 
with the OIE Terrestrial Manual with negative results, carried out at least 28 days 
after the introduction of the animals i nto the confined establ ishment;  
or (1) [II.1.15.  they have been kept in quarantine in a vector -protected facility in the approved 
confined establishment for a period of at least 30 days prior to the date of dispatch to 
the Union and have undergone a PCR test for infection with bluetongue virus (1 -24) 
and infection with epizootic haemorrhagic disease virus in accordance with the OIE 
Terrestrial Manual, with negative results, carried out at least 14 days after the 
introduction i nto the confined establishment;  
or (1)  [II.1.15.  they come from a seasonally disease -free area and have undergone during that This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 544  EN COUNTRY  Certificate model CONFINED -RUM  
disease -free period a serology test for infection with bluetongue virus (1 -24) and 
infection with epizootic haemorrhagic disease virus according to the OIE Terrestrial 
Manual, with ne gative results, carried out on samples taken at least 28 days after 
introduction of the animals i nto the confined establishment;  
or (1)  [II.1.15.  they come from a seasonally free area and have undergone during that period a PCR 
test for infection with bluetongue virus (1 -24) and infection with epizootic 
haemorrhagic disease virus in accordance with the OIE Terrestrial Manual, with 
negative results, carried out on samples taken at least 14 days after the introduction 
of the animals into the approved confined establishment.  
II.1.16. they have been treated at least twice during the period of 40 days prior to dispatch to 
the Union against internal and ex ternal parasites with the following 
product(s)………………………….. Specify the active ingredients and the doses of 
the products used ……………………………….............  
 
Notes:  
This certificate is intended for entry into the Union of animals listed in Section 1 of this Chapter that are 
originating from and intended for a confined establishment . 
 
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex I II to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 or 21.3 of Commission Delegate d Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex III to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction measures have been 
adopted by the Union against entries of these an imals from this third country, territory or zone thereof.  
(4) Not applicable to animals of the family Tragulidae.  
(5) Only applicable to bovine animals and Syncerus caffer.  
(6) Only applicable to ovine animals, caprine animals, camelid animals and cervid animals.  
(7) Only  applicable to ovine and caprine animals.  
(8) Only applicable to caprine animals and Gazzella spp . 
(9) Only applicable to bovine animals.  
(10) Only applicable to caprine animals and camelid animals.  
(11) Only applicable to animals of the family Bovidae , camelid animals and cervid animals.  
(12) Not applicable to camelid animals.  
(13) Only applicable to camelid animals.  
 
Official veterinarian  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 545  EN COUNTRY  Certificate model CONFINED -RUM  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 546  EN  
CHAPTER 20 (MODEL ‘ CONFINED -SUI’)  
 
Section 1  
List of animals originating from and intended for a confined establishment  covered by model 
official certificate model ‘ CONFINED -SUI’ set out in section 2 of this Chapter  
 
Order  Family  Genera/species  
Artiodactyla  Suidae  Babyrousa ssp., Hylochoerus ssp., Phacochoerus ssp., 
Potamochoerus ssp., Sus ssp.  
Tayassuidae  Catagonus ssp., Pecari -Tayassu ssp. 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 547  EN Section 2  
MODEL OFFICIAL CERTI FICATE OF ANIMALS LI STED IN SECTION 1 OF  THIS 
CHAPTER THAT ARE ORI GINATING FROM AND IN TENDED FOR A 
CONFINED ESTABLISHME NT (MODEL ‘ CONFINED -SUI’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country  code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
   Confined establishment    
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 548  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
     Approval or registration 
number of 
plant/establishment/centre    
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 549  EN COUNTRY  Certificate model CONFINED -SUI Part  II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.1.1.  come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of 
this certificate is authorised for the entry into the Union of animals of the families Suidae 
and Tayassuidae  intended for confined establishments and listed in Part 1 of Annex III to 
Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.1.2.  have remained continuously in the establishment of origin since birth or for a period of 
time of at least 6 months prior to the date of dispatch to the Union, in which period n o 
animals have been introduced.  
II.1.3.  had n o contact with animals of a lower health status since birth or at least for 30 days prior 
to the  date of dispatch to the Union.  
II.1.4.  are not to be killed under a national programme for the eradication of diseases, including 
the relevant listed diseases referred to in Annex I to Commission Delegated Regulation 
(EU) 2020/ 692 and emerging diseases.  
II.1.5.  have been dispatched directly from the establishment of origin to the Union without 
passing through any other establishment.  
II.1.6.  have not been unload ed in any place that does not comply with the requirements laid down 
in point II.1.9. since they were dispatched from their establishment of origin until their 
dispatch to the Union and during that period they have not been in contact with animals of 
a low er health status.  
II.1.7.  have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means 
of transport which was cleaned and disinfected prior to loading with a disinfectant 
authorised by the competent authority in the third country o r territory and constructed in 
such a way that:  
(iv) animals cannot escape or fall out;  
(v) visual inspection of the space where animals are kept is possible;  
(vi) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.8.   have  been subjected to  a clinical inspection within the 24 hours prior to loading for 
dispatch to the Union, carried out by an official veterinarian in the third country or 
territory of origin, who did not detect signs indicative of the occurrence of diseases, 
including the rel evant listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases.  
II.1.9.  have not been vaccinated against foot and mouth disease and infection with rinderpest 
virus.  
(1 [II.1.10.  have been vaccinated agai nst: 
–  (1) [anthrax on the ……………… (dd/mm/yyyy) with the following 
vaccine(s) …………………………… (name of vaccine (s) used)],  
– (1) [rabies on the ……………… (dd/mm/yyyy) with the following 
vaccine(s) …………………………… (name of vaccine (s) used)]].  
II.1.11.  come from a confined establishment : 
II.1.11.1.  which is approved by the competent authority in accordance with the 
conditions set out in Article 30 of Commission delegated Regulation (EU) 
2020/ 692. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 550  EN COUNTRY  Certificate model CONFINED -SUI 
II.1.11.2.   which was not subject to national restriction measures for  animal health 
reasons, including listed diseases and emerging diseases, at the time of 
dispatch to the Union.  
II.1.11.3.  in which at the date of issue of this certificate the following diseases have not 
been reported for the last 6 months:  
– foot and mouth disease,  
– infection with rinderpest virus,  
– classical swine fever;  
– [African swine fever](1)(4) 
– infection with  Brucella abortus, B. melitensis and B. suis,  
– rabies.  
II.1.11.3.  in which at the date of issue of this certificate s urra ( Trypanosoma 
evansi ) and anthrax have not been reported for the last 30 days.  
II.1.11.4.   around which, in an area with a 10 km radius, including where 
appropriate the territory of a neighbouring country, none of the following listed 
diseases has been reported for at least 1 2 months prior to dispatch to the Union:  
– foot and mouth disease,  
– infection with rinderpest virus,  
– classical swine fever,  
– [African swine fever,](1)(4) 
– rabies.  
either (1)  [II.1.12.  come from a zone which at the date of issue of this certificate foot and mouth 
disease has not been reported for the last 12 months.]  
or (1)  [II.1.12.  have been subjected to a virological and serological test for evidence of foot -
and-mouth disease virus infection carried out in accordance with one of the 
prescribed tests for in ternational trade laid down in the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals (OIE Terrestrial 
Manual), with negative results, taken in the 10 days prior  to dispatch to the 
Union; and]  
either (1)  [II.1.13.  come from a zone which at  the date of issue of this certificate classical swine 
fever has not been reported for the last 12 months.]  
or (1)  [II.1.13.  have undergone a virology and serology test for the detection of classical 
swine fever  in accordance with the test prescribed for international trade in the 
OIE Terrestrial Manual, carried out on samples taken  during the period of 30 
days prior to the  date of dispatch to the Union.  
(1)(4)[either (1)  [II.1.14.  come from a zone which at the d ate of issue of this certificate classical 
swine fever has not been reported for the last 12 months.]]  
or (1)  [II.1.14.  have undergone a virology and serology test for the detection of African 
swine fever  and in accordance with the test prescribed for inte rnational 
trade in the OIE Terrestrial Manual, carried out on samples taken  during 
the period of 30 days prior to the date of dispatch to the Union.]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 551  EN COUNTRY  Certificate model CONFINED -SUI 
either (1)  [II.1.15.  have not been vaccinated against  infection with  Brucella (abortus, B. 
melitensis and  B. suis ) and come from a zone which at the date of issue 
of this certificate  this disease  has not been reported for the last 12 
months.]  
or (1)  [II.1.15.  have undergone a test as laid down and prescribed for international 
trade by the OIE Terrestrial Manual, on samples taken during the period 
of the 30 days prior to the date of dispatch to the Union.]  
or (1)  [II.1.15.  they are castrated males of any age.]  
II.1.16.  they have been treated at least twice during the period of 40 days prior 
to dispatch to the Union against internal and external parasites with the 
following product(s)………………………….. Specify the active 
ingredients and the doses of the products used 
…… ………………………….............  
 
Notes:  
This certificate is intended for entry into the Union of animals listed in Section 1 of this Chapter that are 
originating from and intended for a confined establishment . 
 
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 or 21.3 of Commission D elegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex III to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be  permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction m easures have been 
adopted by the Union against entries of these animals from this third country, territory or zone thereof.  
(4) Not applicable to animals of the family Tayassuidae.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title  
Stamp   Signature   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 552  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 553  EN  
CHAPTER 21 (MODEL ‘ CONFINED -TRE’)  
 
Section 1  
List of animals originating from and intended for a confined establishment  covered by model 
official certificate model ‘ CONFINED -TRE’ set out in section 2 of this Chapter  
 
Order  Family  Genera/species  
Perissodactyla  Tapiridae  Tapirus ssp.  
Perissodactyla  Rhinocerotidae  Ceratotherium ssp., Dicerorhinus ssp., Diceros ssp., 
Rhinoceros ssp.  
Proboscidea  Elephantidae  Elephas ssp., Loxodonta ssp.  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 554  EN Section 2  
MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE UNION OF 
ANIMALS LISTED IN SE CTION 1 OF THIS CHAP TER THAT ARE ORIGINA TING 
FROM AND INTENDED FO R A CONFINED ESTABLISH MENT (MODEL 
‘CONFINED -TRE’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
   Confined establishment    
     
     
I.21  For transit  I.22  For internal market  
 Third  country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 555  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  
(kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
     Approval or registration 
number of 
plant/establishment/centre    
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 556  EN COUNTRY  Certificate model CONFINED -TRE  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.1.1.  come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for the entry into the Union of animals of the families Tapiridae , 
Rhinocerotidae and Elephantidae  intended for confined establishments and listed in Part 1 of 
Annex III to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.1.2.  have remained continuously in the establ ishment of origin since birth or for a period of time of at 
least 6 months prior to the date of dispatch to the Union, in which period n o animals have been 
introduced.  
II.1.3.  had no contact with animals of a lower health status since birth or at least for  30 days prior to the  
date of dispatch to the Union.  
II.1.4.  are not to be killed under a national programme for the eradication of diseases, including the 
relevant listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 and emerging diseases.  
II.1.5.  have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment.  
II.1.6.  have not been unloaded in any place that does not comply with the requirements laid down in 
point II.1.9. since they were dispatched from their establishment of origin until their dispatch to 
the Union and during that period they have not been in contact with animals of a lower health 
status.  
II.1.7.  have been loaded for dispatch to the Union on ___ /___/____ (dd/mm/yyyy)(3) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
(i) animals cannot escape or f all out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.8.  have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch t o the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred 
to in Annex I to Commission Delegated Regul ation (EU) 2020/ 692 and emerging diseases.  
II.1.9. have not been vaccinated against foot and mouth disease and infection with rinderpest virus.  
(1) [II.1.10.  have been vaccinated against:  
– (1) [anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],  
– (1) [rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].  
II.1.11.  come from a confined establishment : 
II.1.11.1.  which is approved by the competent au thority in accordance with the conditions set 
out in Article 30 of Commission delegated Regulation (EU) 2020/ 692. 
II.1.11.2.  which was not subject to national restriction measures for animal health reasons, 
including listed diseases and emerging diseases, at the  time of dispatch to the Union.  
II.1.11.3.  in which at the date of issue of this certificate the following diseases have not been This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 557  EN COUNTRY  Certificate model CONFINED -TRE  
reported for the last 6 months:  
– [foot and mouth disease,](1)(4)  
– infection with rinderpest virus,  
– infection with Rift V alley fever virus,  
II.1.11.4.  in which at the date of issue of this certificate anthrax has not been reported for the 
last 30 days.  
[II.1.11.5.  around which, in an area with a 10 km radius, including where appropriate the 
territory of a neighbouring countr y, foot and mouth disease has not been reported for 
at least 30 days prior to dispatch to the Union] (1)(4)  
II.1.11.6.  around which, in an area with a 150 km radius, including where appropriate the 
territory of a neighbouring country, infection with Rift V alley fever virus has not 
been reported for at least 30 days prior to dispatch to the Union.  
(1)(4)[either (1)  [II.1.12.  come from a zone which at the date of issue of this certificate foot and mouth 
disease has not been reported for the last 12 months.]]  
or (1)  [II.1.12.  have been subjected to a virological and serological test for evidence of foot -
and-mouth disease virus infection carried out in accordance with one of the 
prescribed tests for international trade laid down in the OIE Manual of 
Diagnostic T ests and Vaccines for Terrestrial Animals (OIE Terrestrial 
Manual), with negative results, taken in the 10 days prior to dispatch to the 
Union; and]]  
either (1)  [II.1.13.  come from a zone which at the date of issue of this certificate infection with 
Rift V alley fever virus has not been reported for the last 48 months.]  
or (1) [II.1.13.  have:  
(i) been kept in quarantine in a vector -protected facility in the approved confined establishment 
for a period of at least 30 days prior to the date of dispatch to the Unio n;  
(ii) showed no disease symptoms of infection with Rift valley fever virus for a period of at least 
30 days prior to the date of dispatch to the Union;  
(iii) been protected from vectors when transported between the vector -protected facility referred 
to in point ( i) and loading for dispatch to the Union; and  
(iv) undergone a virus neutralisation test with negative results for evidence of infection with Rift 
valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly  on 
samples taken  at the date  of commencement of the quarantine period and secondly on 
samples taken  at least 42 days from that that date and during a period of 10 days prior to the 
dispatch to the Union.  
II.1.14.  they have been treated at least twice during the period of 40 days prio r to dispatch to the Union 
against internal and external parasites with the following product(s)………………………….. 
Specify the active ingredients and the doses of the products used 
……………………………….............  
 
Notes:  
This certificate is intended for entry into the Union of animals listed in Section 1 of this Chapter that are 
originating from and intended for a confined establishment . 
 
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 558  EN COUNTRY  Certificate model CONFINED -TRE  
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 or 21.3 of Commission D elegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex III to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be  permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction m easures have been 
adopted by the Union against entries of these animals from this third country, territory or zone thereof.  
(4) Only applicable to animals of the family Elephantidae.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 559  EN CHAPTER 22: MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE 
UNION OF ANIMALS OF THE FAMILY OF HIPPOP OTAMIDAE THAT ARE 
ORIGINATING FROM AND  INTENDED FOR A CONFI NED ESTABLISHMENT 
(MODEL ‘ CONFINED -HIPPO’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
   Confined establishment    
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 560  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
        
        
     Approval or registration 
number of 
plant/establishment/centre    
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 561  EN  
COUNTRY  Certificate model CONFINED -HIPPO  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the animals  described in Part I : 
II.1.1.  come from the come from the zone  with code: __ __ - __(2) which, at the date of issue of this 
certificate is authorised for the entry into the Union of animals of the families Hippopotamidae  
intended for confined establishments and listed in Part 1 of Annex III to Commission Implementing 
Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
II.1.2.  have remained continuously in the establishment of origin since birth or for a period of time of at least 
6 months prior to the date of dispatch to the Union, in which period n o animals have been introduced.  
II.1.3.  had no contact with animals of a lower health status since birth or at least for 30 days prior to the  date 
of dispatch to the Union.  
II.1.4.  are not to be killed under a national programme for the eradication of diseases, including the relevant 
listed diseases referred t o in Annex I to Commission Delegated Regulation (EU) 2020/ 692 and 
emerging diseases.  
II.1.5.  have been dispatched directly from the establishment of origin to the Union without passing through 
any other establishment.  
II.1.6.  have not been unloaded in any place that does not comply with the requirements laid down in point 
II.1.9. since they were dispatched from their establishment of origin until their dispatch to the Union 
and during that period they have not been in contact with animals of a lower health status.   
II.1.7.   have been loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(3) in a means of transport 
which was cleaned and disinfected prior to loading with a disinfectant authorised by the competent 
authority in the third country or terri tory and constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter or feed is prevented or minimized.  
II.1.8.  have  been subjected to a clini cal inspection within the 24 hours prior to loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant li sted diseases referred to in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.1.9.   have not been vaccinated against foot and mouth disease and infection with rinderpest virus.  
(1) [II.1.10.  have been vaccinated against:  
– (1) [anthrax on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)],  
– (1) [rabies on the ……………… (dd/mm/yyyy) with the following vaccine(s) 
…………………………… (name of vaccine (s) used)]].  
II.1.11.  come from a confined establishment : 
II.1.11.1.  which is approved by the competent authority in accordance with the conditions set out in 
Article 30 of Commission delegated Regulation (EU) 2020/ 692. 
II.1.11.2.   which was not subject to national restriction measures for animal h ealth reasons, including 
listed diseases and emerging diseases, at the  time of dispatch to the Union.  
II.1.11.3.  in which at the date of issue of this certificate the following diseases have not been reported 
for the last 6 months:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 562  EN COUNTRY  Certificate model CONFINED -HIPPO  
– foot and mouth disease,  
– infection with rinderpest virus,  
– [infection with Rift Valley fever virus,](1)(4) 
– infection with  Brucella abortus, B. melitensis and B. suis,  
– infection with Mycobacterium tuberculosis complex  (M. bovis, M.capare, 
M.Tuberculosis ), 
II.1.11.3.  in which at the date of issue of this certificate s urra ( Trypanosoma evansi ) and anthrax 
have not been reported for the last 30 days.  
II.1.11.4.  around which, in an area with a 10 km radius, including where appropriate the territory of 
a neighbouring country, none of the following listed diseases has been reported for at least 
30 days prior to dispatch to the Union:  
– foot and mouth disease,  
– infectio n with rinderpest virus,  
– infection with  Brucella abortus, B. melitensis and B. suis,  
– infection with Mycobacterium tuberculosis complex  (M. bovis, M.capare, 
M.Tuberculosis ). 
II.1.11.5.  around which, in an area with a 150 km radius, including where appropria te the territory of 
a neighbouring country, infection with Rift Valley fever virus has not been reported for at 
least 30 days prior to dispatch to the Union:  
either (1)  [II.1.12.  come from a zone which at the date of issue of this certificate foot and mouth disease has 
not been reported for the last 12 months.]  
or (1)  [II.1.12.  have been subjected to a virological and serological test for evidence of foot -and-mouth 
disease virus infection carried out in accordance with one of the prescribed tests for 
international trade laid down in the OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals (OIE Terrestrial Manual), with negative results, taken in the 10 days 
prior  to dispatch to the Union; and]  
either (1)  [II.1.13.  come from a zone which at  the date of issue of this certificate infection with Rift Valley 
fever virus has not been reported for the last 48 months.]  
or (1)  [II.1.13.  have:  
(i) been kept in quarantine in a vector -protected facility in the approved confined 
establishment for a period of at least 30 days prior to the date of dispatch to the Union;  
(ii) showed no disease symptoms of infection with Rift valley fever virus for a period of  at 
least 30 days prior to the date of dispatch to the Union;  
(iii) been protected from vectors when transported between the vector -protected facility 
referred to in point (i) and loading for dispatch to the Union; and  
(iv) undergone a virus neutralisation test with  negative results for evidence of infection with 
Rift valley fever virus in accordance with the OIE Terrestrial Manual, carried out firstly  
on samples taken  at the date of commencement of the quarantine period and secondly on 
samples taken  at least 42 days  from that that date and during a period of 10 days prior to 
the dispatch to the Union.  
either (1)  [II.1.14.  have not been vaccinated against  infection with  Brucella (abortus, B. melitensis and B. 
suis) and come from a zone which at the date of issue of th is certificate  this disease  has not 
been reported for the last 12 months.]  
or (1) [II.1.14.  have undergone a test as laid down and prescribed for international trade by the OIE This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 563  EN COUNTRY  Certificate model CONFINED -HIPPO  
Terrestrial Manual, on samples taken during the period of the 30 days prior to the date of 
dispatch to the Union.]  
or (1) [II.1.14.  they are castrated males of any age .] 
or (1) [II.1.14.  they are castrated males of any age.]  
[II.1.15.  they have been treated at least twice during the period of 40 days prior to dispatch to the 
Union ag ainst internal and external parasites with the following 
product(s)………………………….. Specify the active ingredients and the doses of the 
products used ……………………………….............  
 
Notes:  
This certificate is intended for entry into the Union of animals listed in Section 1 of this Chapter that are 
originating from and intended for a confined establishment . 
 
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.27:  “Identification system and identification number ”: Specify the identification system (such 
as ear tag, tattoo, transponder etc., from the list in Annex III to Delegated Regulation 
(EU) 2019/2035) and the individual identification codes of the animals in accordance 
with Article 21.1 or 21.3 of Commission D elegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) Keep as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex III to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: entries of these animals shall not be  permitted when the animals were loaded for dispatch to 
the Union either prior to the date of authorisation for entry into the Union of the third country, territory or 
zone thereof referred to in boxes reference II.1, or during a period where restriction m easures have been 
adopted by the Union against entries of these animals from this third country, territory or zone thereof.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 564  EN CHAPTER 23: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF BREEDING POULTRY OTHER THAN R ATITES AND  PRODUCTIVE 
POULTRY OTHER THAN R ATITES (MODEL BPP)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
    Release into the wild   
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 565  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 566  EN COUNTRY  Certificate model BPP  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
(1)[II.1.1. The Salmonella  control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No 
1177/2006, have been applied to the flock of origin and the flock has been tested fo r Salmonella  
serotypes of public health significance:  
Identification of the 
flock  Age of the 
birds  Date of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]  Result of all testing in 
the flock(2) 
positive  negative  
     
For reasons other than the  Salmonella control programme, within the last three weeks prior to entry into 
the Union:  
(3)either  [antimicrobials were not administered to the breeding and productive poultry other than 
ratites;]  
(3)(4)or [the following antimicrobi als were administered to the breeding and productive poultry other 
than ratites: ……………………………………;]]  
(1)[II.1.2. If breeding poultry, neither Salmonella  Enteritidis nor Salmonella  Typhimurium were detected within 
the control programme referred to in point II .1.1.] 
(5)[II.1.3. If the Member States of Destination is Finland or Sweden:  
(3) either  [the breeding poultry has tested negative for Salmonella in accordance with the rules laid down in 
Decision 2003/644/EC;]  
(3) or  [the laying hens (productive poultry reared in view to producing eggs for consumption)have tested 
negative in accordance with the rules laid down in Decision 2004/235/EC.]]  
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the [breeding poultry(6) other than ratites](3) [productive 
poultry(7) other than ratites](3) described in this certificate:  
II.2.1. come from the zone with code _ _ - _ (8) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] for entry into the Union of breeding poultry other than ratites and 
productive poultry other than ratites;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in ac cordance with 
Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(d) is considered free from infectio n with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;  
II.2.2. come from the zone referred to in point II. 2.1, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not c arried out;]  
(3)(9 )or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Commission Delegated Regulation This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 567  EN COUNTRY  Certificate model BPP  
(EU) 2020/ 692 is prohibited;]  
(3)(10 )or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the animals:  
(i) have not been vaccinated with such vaccines for a peri od of at least the 12 months prior to 
the date of loading of the consign ment for dispatch to the Union;  
(ii) come from a flock or flocks which underwent a virus isolation test(11) for infection with 
Newcastle disease virus carried out on a random sample of cloa cal swabs from at least 60 
birds in each flock , taken not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avian paramyxoviruses with an 
ICPI of more than 0,4 were found;  
(iii) were kept in isolation  under official surveillance on the establishment of origin during the 
2 weeks mentioned in ( ii); 
(iv) during the period of 60 days prior to the date of loading of the consignment for dispatch 
to the Union, were not in contact with poultry which do not fulfil t he conditions in ( i) and 
(ii);] 
II.2.3. have remained in the zone referred to in point II. 2.1 for a continuous period of at least:  
(3)(12 )either  [3 months immediately prior to the date of loading for dispatch to the Union or since hatching where 
they are less than 3 months of age ;] 
(3)(13 )or [6 weeks immediately prior to the date of loading for dispatch to the Union or since hatching where they 
are less than 6 weeks of age;]  
and where they were imported into the zone referred to in point II. 2.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant requirements of 
Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/ 692 and the zone from 
where the animals were imported, is listed in Part 1 of Annex IV to Commission Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] for entry into the Union of breeding poultry other than  
ratites and productive poultry other than ratites;  
II.2.4. come from the establishment, indicated in Box I.11, approved by the competent authority of the country 
or territory of origin in accordance with requirements which are at least as stringent as tho se laid down 
in Article 8 of Commission Delegated Regulation (EU) 2019/2035 and:  
(a) the approval of which has not been suspended or withdrawn;  
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, in accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for t he purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the estab lishment;  
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases, at the tim e of dispatch of the animals to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
(f) in which no confirmed case of infection with low pathogenic avian influenza viruses has been 
reported for at least 21 days prior to the date of loading for dispatch to the Union;  
(g) in which:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 568  EN COUNTRY  Certificate model BPP  
(3)either  [infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae was not confirmed during the 
last 12 months prior to date of loading of the consignment for dispatch to the Union;]  
(3)or [infection with Salmonella  Pullorum, S. Gallinarum o r S. arizonae was confirmed during the last 
12 months prior to date of loading of the consignment for dispatch to the Union and the measures 
provided for in Article 44(d) of Commission Delegated Regulation (EU) 2020/ 692 have been 
applied;]  
(h) in which:  
(3)either  [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not confirmed 
during the last 12 months prior to date of loading of the consignment for dispatch to the Union;]  
(3)or [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleag ridis) was confirmed during 
the last 12 months prior to date of loading of the consignment for dispatch to the Union and the 
measures provided for in Article 44(e) of Commission Delegated Regulation (EU) 2020/ 692 
have been applied;]  
II.2.5. come from a flock which:  
(a) has not been vaccinated against highly pathogenic avian influenza;  
(3)either  [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]  
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(14) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
(c) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Commission Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed 
any grounds for suspecting any infection, by the following agents:  
(3)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  (in case of Gallus 
gallus );] 
(3)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  Gallinarum, 
Mycoplasma meleagridis  and Mycoplasma  gallisepticum  (in case of Meleagris gallopavo );]  
(3)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]  
(d) has been subjected to a clinical inspection(15) within the 24  hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for the species a nd emerging diseases;  
II.2.6. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least:  
(3)(12 )either  [6 weeks immediately prior to the date of loading for dispatch to the Union;]  
(3)(13 )or [30 days imm ediately prior to the date of loading for dispatch to the Union ;] 
II.2.7. had no contact with animals of a lower health status since hatching or for a continuous period of at least:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 569  EN COUNTRY  Certificate model BPP  
(3)(12 )either  [6 weeks immediately prior to the date of loading for dispatch to the Union;]  
(3)(13 )or [30 days immediately prior to the date of loading for dispatch to the Union ;] 
II.2.8. are not to be killed under a national programme for the eradication of diseases, including the liste d 
diseases referred to in Annex  I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
II.2.9. have  been subjected to a clinical inspection(15) on ___/___/____ (dd/mm/yyyy) within the 24 hours prior 
to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases;  
II.2.10. are loaded for dispatch to the Union in contai ners which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape  of animal excrements, litter, feed or feathers is prevented or minimized;  
(b) contain only poultry of the same species and category coming from the same establishment;  
(c) are: 
(3)either  [unused and purpose -designed disposable containers to be destroyed after first use;]  
(3)or [cleaned and disinfected and dried or allowed to dry  prior to loading of the animals;]  
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) bear the  information set out in Annex XVI to  Commission Delegated Regulation (EU) 2020/ 692 
relevant for breeding poultry and productive poultry;  
II.2.11. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(16) in a means of transport which is 
constructed in accordance with II. 2.10(a) a nd was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;  
(17)[II.2.12. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) were kept in isolation for at least 14 days prior to th e date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the 
supervision of an official veterinarian, where:  
(i) no poultry was vaccinated against infection with Newcastle disease virus  during the 
period of at least 21 days prior to the date of loading of the consignment;  
(ii) no other birds have entered into the establishment during that time;  
(iii) no vaccination has been carried out;  
(c) have tested(11) negative to serological tests to detect antibodies against Newcastle disease virus, 
performed on blood samples at a level which gives 95% confidence of detecting infection at 5% 
prevalence and which were taken during the period of at least 14 days prior to the date of loading 
for dispa tch to the Union;]  
 
 
Notes:  
This certificate is intended for entry into the Union of breeding poultry other than ratites and productive poultry, 
other than ratites including when the Union is not the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I of to Commission This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 570  EN COUNTRY  Certificate model BPP  
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IV to Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
Box reference I.27:  Description of consignment:  
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.05 or 01.06.39.  
“Category” : select one of the following: Pure line/grandparents/parents/laying 
pullets/others.  
 
Part II:  
(1) This guarantee applies only for poultry belonging to the species of Gallus gallus  and turkeys .  
(2) If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:  
- flocks of breeding poultry: Salmonella  Hadar, Salmonella  Virchow and Salmonella Infantis;  
- flocks of productive poultry: Salmonella  Enteritidis and Salmonella  Typhimurium.  
(3) Keep as appropriate.  
(4) Complete if appropriate: indicate the name and active substance of antimicrobials used.  
(5) Delete if consignment is not intended for Finland or Sweden.  
(6) ‘Breeding poultry’ means poultry 72 hours old or more , intended for the production of hatching eggs, as 
defined in Article 2 of Commission Delegated Regulation (EU) 2020/ 692. 
(7) ‘Productive poultry’ means poultry 72 hours old or more , reared for the production of meat, eggs  for 
consumption or other products or for restocking supplies of game birds, as defined in Article 2 of 
Commission Delegated Regulation (EU) 2020/ 692. 
(8) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implement ing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
(9) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(10) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/ … 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(11) Tests should be carried out on samples taken by or under the control of the competent aut hority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(12) Applicable for breeding poultry and productive poultry for the production of  meat and eggs for 
consumption.  
(13) Applicable for productive poultry for restocking supplies of game birds. 
(14) To be completed when animals were vaccinated against infection with Newcastle disease virus.  
(15) The clinical inspection must have been carr ied out by an official veterinarian of the country or territory 
of origin.  
(16) The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 571  EN COUNTRY  Certificate model BPP  
entry of these animals from that zone.  
(17) This guarantee is required only for  consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 572  EN CHAPTER 24: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF BREEDING RATITES AND  PRODUCTIVE RATITES ( MODEL BPR)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 573  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 574  EN COUNTRY  Certificate model BPR  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the [breeding ratites(1)](2) [productive ratites(3)](2) 
described in this certificate:  
II.1.1. come from the zone with code _ _ - _ (4) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ] for entry into the Union of breeding ratites an d productive ratites;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in accordance with 
Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accorda nce with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
II.1.2. come from the zone referred to in point II. 1.1, which at the date of issue of this certificate:  
(2)either  [is considered free from infection with Newcastle disease virus in accor dance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;] 
(2)(5)or [is not considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692 and the animals:  
(a) have been placed under official surveillance for a period of at least 21 days prior to the date of 
loading of the consignment for dispatch to the Union;  
(b) have been kept in complete isolation during the period referred to in point (a), away from direct 
or ind irect contact with other birds, in facilities approved by the competent authority of the 
country or territory of origin for this purpose;  
(c) have undergone a virus detection test(6) for infection with Newcastle disease virus:  
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under official surveillance referred 
to in point (a);  
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicit y 
Index (ICPI) of more than 0.4 have been found;  
(iii) with favourable results being available for all birds in the consignment before they left the 
facilities referred to in point (b) for dispatch to the Union;  
(d) come from flocks in which surveillance f or infection with Newcastle disease virus was carried 
out under a statistically -based sampling plan which produced negative results for a period of at 
least 6 months immediately prior to the date of dispatch of the consignment for entry into the 
Union;]  
II.1.3. come from the zone referred to in point II. 1.1, in which:  
(2)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(2)(7)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with  a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692 is carried out;]  
(2)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply  
with both the general and specific criteria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  
(2)(8)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the animals:  
(i) have not been vaccinated with such vaccines for a period of at least the 12 months prior to 
the date of loading of the consignment for dispatch to the Union;  
(ii) come from a flock or flocks which underwent a virus isolation test(6) for infection with 
Newcastle disease virus carried out on a random sample of cloacal swabs from at least 60 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 575  EN COUNTRY  Certificate model BPR  
birds in each flock , taken not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avian paramyxoviruses with an 
ICPI of more than 0,4 were found;  
(iii) were kept in isolation under official surveillance on the establishment of origin during the 
2 weeks mentioned in ( i); 
(iv) during the period of 60 days prior to the date of loading of the consignment for dispatch to 
the Union, were not in contact with poultry which do not fulfil the conditions in ( i) and 
(ii);] 
II.1.4. have remained in the zone referred to in point II. 1.1. for a continuous period of at least 3 months 
immediately prior to the date of loading for dispatch to the Union or since hatching where they are less 
than 3 months of age ;  
and where they were imported into the zone referred to in point II. 1.1, the import  took place in 
accordance with animal health requirements that are at least as stringent as the relevant requirements of 
Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/ 692 and the zone from 
where the animals were imported, is listed  in Part 1 of Annex IV to Commission Implementing 
Regulation (EU) 2020/ … [SANTE/7140/2020 ] for entry into the Union of breeding ratites and 
productive ratites;  
II.1.5. come from the establishment, indicated in Box I.11, approved by the competent authority of the country 
or territory of origin in accordance with requirements which are at least as stringent as those laid down 
in Article 8 of Commission Delegated Regulation (EU) 2019/2035 and:  
(a) the approval of which has not been suspended or withdrawn;  
(b) which is  under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, in accordance with Article 8 of Commission D elegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulation (E U) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including the 
listed diseases referred to in Annex I to Comm ission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases, at the time of dispatch of the animals to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
(f) in which no confirmed case of infection with low pathogenic avian influenza viruses  has been 
reported for at least 21 days prior to the date of loading for dispatch to the Union;  
II.1.6. come from a flock which:  
(a) has not been vaccinated against highly pathogenic avian influenza;  
(2)either  [(b) has not been vaccinated against infection wit h Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]  
(2)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(9) 
Identificati
on of the Age of 
the Date of 
vaccinatioName and 
type of virus Batch 
number Name of 
the Manufacture
r of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 576  EN COUNTRY  Certificate model BPR  
flock  birds  n strain used  of the 
vaccine  vaccine  vaccine  
 
       
] 
(c) has been subjected to a clinical inspection(10) within the 24 hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for  the species and emerging diseases;  
II.1.7. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least 6 weeks immediately prior to the date of loading for dispatch to the Union;  
II.1.8. had no contact with animals of a lower health status since hatching or for a continuous period of at least 
6 weeks immediately prior to the date of loading for dispatch to the Union;  
II.1.9. are not to be killed under a national programme for the eradication of diseases,  including the listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
II.1.10. have  been subjected to a clinical inspection(10) on ___/___/____ (dd/mm/yyyy), within the 24 hou rs 
prior to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases;  
II.1.11. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept i s possible;  
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minimized ; 
(b) contain only poultry of the same species and category coming from the same establishment;  
(c) are: 
(2)either  [unused and purpose -designed disposable containers to be destroyed after first use;]  
(2)or  [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]  
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin t o avoid any possibility of substitution of the content;  
(e) bear the  information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant for breeding poultry and productive poultry;  
II.1.12. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(11) in a means of transport which is 
constructed in accordance with II. 1.11(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;  
 (12)[II.1.13. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated again st infection with Newcastle disease virus;  
(b) were kept in isolation for at least 14 days prior to the date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the 
supervision of an offi cial veterinarian, where:  
(i) no poultry was vaccinated against infection with Newcastle disease virus during the 
period of at least 21 days prior to the date of loading of the consignment;  
(ii) no other birds have entered into the establishment during tha t time;  
(iii) no vaccination has been carried out;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 577  EN COUNTRY  Certificate model BPR  
(c) have tested(6) negative to serological tests to detect antibodies against Newcastle disease virus, 
performed on blood samples at a level which gives 95% confidence of detecting infection at 5% 
prevale nce and which were taken during the period of at least 14 days prior to the date of loading 
for dispatch to the Union;]  
 
Notes:  
This certificate is intended for entry into the Union of breeding ratites or productive ratites, including when the 
Union is not  the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IV to Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box reference I.27:  Description of consignment:  
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.  
“Identification system”:  The animal must be individually identified by neck -tags or an 
injectable transponder in accordance with Article 43 of Commission Delegated 
Regulation (EU) 2020/ 692. 
“Category” : select one of th e following: Pure line/grandparents/parents/others.  
“Identification number” : Indicate the identification number, which must include the 
code of the country or territory of origin conforming with ISO standards in accordance 
with Article 43 of Commission Del egated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) ‘Breeding ratites’ means ratites 72 hours old or more , intended for the production of hatching eggs, as 
defined in Commission Delegated Regulation (EU) 2020/ 692. 
(2) Keep as appropriate.  
(3) ‘Productive ratites’ means ratites 72 hours old or more , reared for the production of meat, eggs for 
consumption or other products, as defined in Commission Delegated Regulation (EU) 2020/ 692. 
(4) Code of the zone as it appears in column 2 of the table in Part 1 of An nex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(5) This guarantee is required only for consignments from zones which are not considered free from 
infection with Newcastle disease virus in accordance with Article 39 of Commission Delegated 
Regulation (EU) 2020/ 692 and are listed in Part 1 of Annex IV to Commission Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “C” in column “---” of the table.  
(6) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(7) This applies only to zones in which vac cination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to  
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in 
column “ ---” of the table.  
(8) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus  which comply only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 578  EN COUNTRY  Certificate model BPR  
thereof, and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/ … 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(9) To be completed when animals were vaccinated against infection with Newcastle disease virus.  
(10) The clinical inspection must have been carried out by an official veterinarian of th e country or territory 
of origin.  
(11) The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.  
(12) This guarantee is required only for  consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated R egulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 579  EN CHAPTER 25: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF DAY -OLD CHICKS OTHER THA N OF RATITES (MODEL DOC)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 580  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 581  EN COUNTRY  Certificate model DOC  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
(1)[II.1.1. The Salmonella  control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and 
the specific requirements for the use of antimicrobials and vaccines in Regulation (EC) 
No 1177/2006, have been applied to the parent flock of origin an d this parent flock has been tested 
for Salmonella  serotypes of public health significance:  
Identification of 
the flock  Age of the 
birds  Date of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]  Result of all testing in the 
flock(2) 
positive  negative  
     
 
The specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No  1177/2006 
have been applied to the day -old chicks.  
For reasons other than the  Salmonella control programme:  
(3)either  [antimicrobials were not administered to the day -old chicks (including in -ovo 
injection);]  
(3)(4)or [the following antimicrobials were administered to the day -old chicks (including in -ovo 
injection)…………………………………………………………..;]]  
(1)[II.1.2. If the day -old chicks are intended for breeding, neither Salmonella  Enteritidis nor Salmonella  
Typhimurium were detected within the control programme referred to in point II. 1.1.] 
(5)[II.1.3. If the Member States of destination is Finland or Sweden, the day-old chicks for introduction into 
flocks of breeding poultry or flocks of productive poultry come from flocks which have tested 
negative for Salmonella in accordance with the rules laid down in Decision 2003/644/EC;]  
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the day -old chicks(6) other than ratites described in this 
certificate:  
II.2.1. have been hatched on the zone with code _ _ - _ (7) which, at the date of issue of this certificate:  
(a) is authorise d and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] for entry into the Union of day -old chicks other than ratites;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in accordan ce with 
Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(d) is considered free from infection with  Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692; 
II.2.2. come from the zone referred to in point II. 2.1, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(3)(8)or [(a)  vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b)  vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 582  EN COUNTRY  Certificate model DOC  
(3)(9)or [(b) vaccination against infect ion with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the animals:  
(i) have not been vaccinated with such vaccines;  
(ii) come from flocks which:  
- have not been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Union;  
- underwent a virus isolation test(10) for infection with Newcastle disease virus carried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an ICPI of more than 0,4 
were found;  
- were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for dispatch to the 
Union;  
- during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second intend above;  
(iii) come from hatching eggs which have not been in contact in the hatchery or during 
transport with poultry or hatching eggs not meetin g the requirements set out in (ii);]  
II.2.3. come from a hatchery, indicated in Box I.11, approved by the competent authority of the country or 
territory of origin in accordance with requirements which are at least as stringent as those laid down in 
Article 7 of Commission Delegated Regulation (EU) 2019/2035 and:  
(a) the approval of which ha s not been suspended or withdrawn;  
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, i n accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in An nex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases, at the time of dispatch of the animals to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
II.2.4. come from a flock which:  
(a) has remained in zone referred to in point II. 2.1 for a continuous period of at least 3 months 
immediately prior to the date of loading of the day -old chicks for dispatch to the Union;  
and where the flock was imported into the zone referred to in point II. 2.1, the import took place 
in accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 
2020/ 692 and the zone from where the animals were imported , is listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for entry into the 
Union of breeding poultry other than ratites and productive poultry other than ratites;  
(b) has been kept for a continuous period of at lea st 6 weeks immediately prior to the date of loading This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 583  EN COUNTRY  Certificate model DOC  
of the day -old chicks for dispatch to the Union in an establishment:  
(i) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringe nt as those laid down in Article 8 of 
Commission Delegated Regulation (EU) 2019/2035;  
(11) 
Name of establishment  Address  Approval number  
 
   
(ii)  the approval of which has not been suspended or withdrawn at the time the hatching eggs, 
from which the day-old chicks were hatched, were sent to the hatchery;  
(iii)  in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs, from 
which the d ay-old chicks were hatched;  
(iv) in which;  
(3)either   [infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae was not confirmed 
during the last 12 months prior to date of loading of the consignment for dispatch to the 
Union;]  
(3)or  [infection wi th Salmonella  Pullorum, S. Gallinarum or S. arizonae was confirmed during 
the last 12 months prior to date of loading of the consignment for dispatch to the Union 
and the measures provided for in Article 46(d) of Commission Delegated Regulation 
(EU) 2020/ 692 have been applied;]  
(v) in which:  
(3)either  [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months prior to date of loading of the consignment for 
dispatch to the Union;]  
(3)or  [avian mycoplasmosi s (Mycoplasma gallisepticum and M. meleagridis) was confirmed 
during the last 12 months prior to date of loading of the consignment for dispatch to the 
Union and the measures provided for in Article 46(e) of Commission Delegated 
Regulation (EU) 2020/ 692 have been applied;]  
(3)either  [(c) has not been vaccinated against highly pathogenic avian influenza;]  
(3)(8 )or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements  set out in Annex XIII to Commission 
Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union; ] 
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(12) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
       This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 584  EN COUNTRY  Certificate model DOC  
 
] 
(e) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Commission Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed 
any grounds for suspecting any infection, by the following agents:  
(3)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  (in case of Gallus 
gallus );] 
(3)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  Gallinarum, 
Mycoplasma meleagridis  and Mycoplasma  gallisepticum  (in case of Meleagris gallopavo );]  
(3)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , Coturnix 
coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]  
II.2.5. come from hatching eggs which:  
(a) comply with the requirement s for entry into the Uni on laid down in Title 2 of Part  III of 
Commission Delegated Regulation (EU) 2020/ 692; 
(b) prior to their dispatch  to the hatchery, have been marked in accordance with the instructions of 
the competent authority of the country or territory of origin;  
(c) have been disinfected in accordance with the instructions of the competent authority of the 
country or territory of origin;  
(d) have had no contact with poultry or hatching eggs of lower health status, captive birds or wild 
birds, either d uring transport to the hatchery or in the hatchery;  
II.2.6. have remained:  
(a) in the country or territory or zone thereof referred to in point II. 2.1 since hatching;  
(b) in the establishment indicated in Box I.11 since hatching ; 
II.2.7. have not been vacc inated against highly pathogenic avian influenza;  
II.2.8. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for th e 
species and emerging diseases;  
II.2.9. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii)  visual inspection of the space where animals are kept is possible;  
(iii the escape of animal excrements, litter, feed or feathers is prevented or minimized;  
(b) contain only poultry of the same species and category coming from the same establishment;  
(c) are disposable, clean and used for the first time;  
(d) are closed in acc ordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant for day -old chicks;  
II.2.10. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(13) in a means of transport which is 
constructed in accordance with II. 2.9(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;  
 (14)[II.2.11. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) come from hatching eggs coming from flocks which:  
(3)either  [have not been vaccinated against infection with Newcastle disease virus;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 585  EN COUNTRY  Certificate model DOC  
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collec ted;] 
(c) come from a hatchery where working practices ensure that the hatching eggs from which the 
day-old chicks have hatched, were incubated at completely separate times and locations from 
eggs not satisfying the requirements of point (b);]  
 
Notes:  
This certificate is intended for entry into the Union of day -old chicks other than ratites, including when the Union 
is not the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IV to Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
Box reference I.27:  Description of consignment:  
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.05 or 01.06.39.  
“Category” : select one of the following: Pure line/grandparents/parents/layin g 
stock/broilers/others.  
 
Part II:  
(1) This guarantee applies only for day -old chicks belonging to the species of Gallus gallus and turkeys.  
(2) If any of the results were positive for the serotypes below during the life of the flock, indicate as 
positive:  
- flocks of breeding poultry: Salmonella  hadar , Salmonella  Virchow and Salmonella  infantis ; 
- flocks of productive poultry: Salmonella  enteritidis  and Salmonella  typhimurium . 
(3) Keep as appropriate.  
(4) Keep if appropriate: indicate the name and active substance of antimicrobials used.  
(5) Delete if consignment is not intended f or Finland or Sweden.  
(6) ‘Day -old chicks’ means poultry less than 72 hours old , as defined in Article 2 of Commission Delegated 
Regulation (EU) 2020/ 692.  
(7) Code of the zone as  it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation 2020/… [ SANTE/7140/2020 ]. 
(8) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/ ... [SANTE/7140/2020 ] with the entry “ A” in column 
“---” of the table.  
(9) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commission Delegated Regu lation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(10) Tests shoul d be carried out on samples taken by or under the control of the competent authority of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 586  EN COUNTRY  Certificate model DOC  
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(11) Indicate the name, address and approval number of the establishment were the flock of origin of the 
day-old chicks was kept during the 6 weeks immediately prior to the date of loading of the day -old 
chicks for dispatch to the Union.  
(12) To be completed when animals were vaccinated against infection with Newcastle disease virus.  
 (13) The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopt ed by the Union in relation to the 
entry of these animals from that zone.  
(14) This guarantee is required only for  consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccinati on in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
(15)III. Supplementary health information concerning certificate reference number  (Box I.2.) 
…………………………………………………………………………………………………………….  
I, the undersigned official veterinarian, hereby certify t hat: 
(a)       the health conditions of Part II of this certificates continue to be met;  
(b)       the day -old chicks described in this certificate:  
(i) have been hatched on ………………. (dd/mm/yyyy);  
(ii) have been subjected to a clinical inspection(16) on __/__/__ (dd/mm/yyyy_, within the 24 
hours prior to loading for dispatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU) 2020/692 relevant for the species and emerging diseases;  
(iii) had no contact with animals of a lower health status since hatching.  
 
 
(15) This section can be on a separate sheet provided it is attached to Part II of the health certificate.  
(16) The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 587  EN COUNTRY  Certificate model DOC  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 588  EN CHAPTER 26: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF DAY -OLD CHICKS OF RATITE S (MODEL DOR)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompany ing documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 589  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 590  EN COUNTRY  Certificate model DOR  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the day -old chicks(1) of ratites described in this 
certificate:  
II.1.1. have been hatched on the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/202 0] for entry into the Union of day -old chicks of ratites;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in accordance with 
Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly p athogenic avian influenza in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
II.1.2. come from th e zone referred to in point II.1 .1, which at the date of issue of this certificate:  
(3)either  [is considered free from infection w ith Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692 and the day -old chicks come from flocks:  
(a) which have been placed in isolation under official surveillance for a period of at least 30 days 
prior to the date of laying of the hatching eggs from which the day -old chicks of this 
consignment are de rived;  
(b) which have undergone a virus detection test(5) for infection with Newcastle disease virus:  
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under official surveillance referred 
to in point (a);  
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0.4 have been found;  
(iii) with favourable results being available for all birds before the d ay-old chicks left the 
hatchery for dispatch to the Union;  
(c) in which surveillance for infection with Newcastle disease virus was carried out under a 
statistically -based sampling plan which produced negative results for a period of at least 6 
months imme diately prior to the date of dispatch of the consignment for entry into the Union;  
(d) have not been kept with poultry which do not fulfil the guarantees under points (a), (b) and (c) 
during the period of 30 days prior to the date of laying and during the  laying of the hatching eggs 
from which the day -old chicks of this consignment are derived;]  
II.1.3. come from th e zone referred to in point II.1 .1, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  
(3)(7)or [(b) vaccination against infection with Newca stle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the animals:  
(i) have not been vaccinated with such vaccines;  
(ii) come from flocks which:  
- have not been  vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 591  EN COUNTRY  Certificate model DOR  
- underwent a virus isolation test(5) for infection with Newcastle disease virus carried 
out on a random sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avia n paramyxoviruses with an ICPI of more than 0,4 
were found;  
- were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for dispatch to the 
Union;  
- during the period of  60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second intend above;  
(iii) come from hatching eggs which have not been in contact in the hatchery  or during 
transport with poultry or hatching eggs not meeting the requirements set out in (ii);]  
II.1.4. come from a hatchery, indicated in Box I.11, approved by the competent authority of the country or 
territory of origin in accordance with requirements  which are at least as stringent as those laid down in 
Article 7 of Commission Delegated Regulation (EU) 2019/2035 and:  
(a) the approval of which has not been suspended or withdrawn;  
(b) which is under the control of the competent authority of the country or terri tory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, in accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal heal th visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a frequency that is 
proporti onal to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the specie s and emerging diseases, at the time of dispatch of the animals to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
II.1.5. come from a flock which:  
(a) has remained in th e zone referred to in point II.1 .1 for a continuous period of at least 3 months 
immediate ly prior to the date of loading of the day -old chicks for dispatch to the Union;  
and where the flock was imported into the zone tereof referred to in point II.1 .1, the import took 
place in accordance with animal health requirements that are at least as str ingent as the relevant 
requirements of Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 
2020/ 692 and the country or territory or zone thereof from where the animals were imported, is 
listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/… 
[SANTE/7140/2020 ] for entry into the Union of breeding ratites and productive ratites;  
(b) has been kept for a continuous period of at least 6 weeks immediately prior to the date of loading 
of the day -old chicks for dispatch to the Union  in establishments:  
(i) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of 
Commission Delegated Regulation (EU) 2019/2035;  
(8) 
Name of establishment  Address  Approval number  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 592  EN COUNTRY  Certificate model DOR  
 
   
(ii) the approval of which has not been suspended or withdrawn at the time the hatching eggs, 
from which the day -old chicks were hatched, were sent to the hatchery;  
(iii) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs, from 
which the day -old chicks were hatched;  
(3)either  [(c) has not been vaccinated against highly pathogenic avian infl uenza;]  
(3)(6)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Commission 
Delegated Regulation (EU) 2020/ 692: 
(3)either  [(d) has n ot been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]  
(3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12  months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(9) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
II.1.6. come from hatching eggs which:  
(a) comply with the requirements for entry into the Union laid down in Title 2 of Part III of 
Commission Delegated Regulation (EU) 2020/ 692; 
(b) prior to their dispatch  to the hatchery, have been marked in accordance with the instructions of 
the competent authority of the country or territory of origin;  
(c) have been disinfected in accordance with the instructions of the competent authority of the 
country or territory of origin;  
(d) have had no contact with poultry or hatching eggs of lower health status, captive birds or wild 
birds, either during transport to the hatchery  or in the hatchery;  
II.1.7. have remained:  
(a) in the country or territory or zone t hereof referred to in point II.1 .2 since hatching;  
(b) in the establishment indicated in Box I.11 since hatching ; 
II.1.8. had no contact with animals of a lower health status since hatching ; 
II.1.9. have not been vaccinated against highly pathogenic avian influenza;  
II.1.10. are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
II.1.11. have  been subjected to a clinical inspection(10) on ___/___/____ (dd/mm/yyyy), within the 24 hours 
prior to loading for dispatch to the Union, and showed no signs i ndicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 593  EN COUNTRY  Certificate model DOR  
relevant for the species and emerging diseases;  
II.1.12. are loaded for dispatch to the Union in containers which : 
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter, feed or feathers is prevented or minimized;  
(b) contain  only poultry of the same species and category coming from the same establishment;  
(c) are disposable, clean and used for the first time;  
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to  avoid any possibility of substitution of the content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant for day -old chicks;  
II.1.13. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(11) in a means of transport which is 
constructed in accordance with II.1 .12(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;  
 (12)[II.1.14. are intended for a  Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle d isease virus;  
(b) come from hatching eggs coming from flocks which:  
(3)either   [have not been vaccinated against infection with Newcastle disease virus;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]  
(3)or  [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collected;]  
(c) come from a hatchery where working practices ensure that the hatching eggs from which the 
day-old chicks have hatched, were incubated at completely separate times and locations from 
eggs not satisfying the requirements of point (b);]  
 
 
 
Notes:  
This certificate is intended for entry into the Union of day -old chicks of ratites, includin g when the Union is not 
the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.8: Provide the code of the country or territory or zone thereof as it appears in column 2 of 
the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ]. 
Box reference  I.27:  “CN code” : use the appropriate  Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.  
“Category” : select one of the following: Pure line/grandparents/parents/others.  
 
Part II:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 594  EN COUNTRY  Certificate model DOR  
(1) ‘Day -old chicks’ means poultry less than 72 hours old , as defined in Article 2 of Commission Delegated 
Regulation (EU) 2020/ 692. 
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) This guarantee is required only for consignments from zones which are not considered free from infection 
with Newcastle disease virus in accordance with Article 39 of Commission Delegated Regulation (EU) 
2020/ 692 and are listed in Part 1 of Annex IV to Commission Implementing Regula tion (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “C” in column “---” of the table.  
(5) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(6) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out in 
accordance with a vaccination programme that com plies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in column “---” of the 
table.  
(7) This guarantee is required only for day -old chicks coming from zones in which the use of vaccines 
against infection with Newcastle disease virus which comply only with the general criteria of Annex XV 
to Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 
37(e)(ii) thereof, and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(8) Indicate the name, address and approv al number of the establishment were the flock of origin of the day -
old chicks was kept during the 6 weeks immediately prior to the date of loading of the day -old chicks for 
dispatch to the Union.  
(9) To be completed when animals were vaccinated against inf ection with Newcastle disease virus.  
(10) The clinical inspection must have been carried out by an official veterinarian of the country or territory of 
origin.  
(11) The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone 
thereof for entry into the Union, or a date in a period when restriction measures have been adopted by the 
Union in relation to the entry of these animals from that country or territory or zone thereof.  
(12) This guarantee is required onl y for consignments intended for a Member State which has been granted the 
status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 595  EN CHAPTER 27: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF HATCHING EGGS OF POU LTRY OTHER THAN RATI TES (MODEL 
HEP)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
   Germinal products    
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 596  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 597  EN COUNTRY  Certificate model HEP  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1) of poultry other than ratites 
described in this certificate:  
II.1.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ] for entry into the Union of hatching eggs of poultry  other than 
ratites ; 
(b) carries out a surveillance programme for highly pathogenic a vian influenza in accordance with 
Article 105(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(d) is consider ed free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;  
II.1.2. come from the zone referred to in point II. 2.1, in which:  
(3)either  [(a) vaccination against highly pathogenic avi an influenza is not carried out;]  
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the hatching eggs:  
(i) come from flocks which:  
- have no t been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consignment for dispatch to the Uni on; 
- underwent a virus isolation test(6) for infection with Newcastle disease virus carried 
out on a random sa mple of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an IC PI of more than 0,4 
were found;  
- were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consignment for di spatch to the 
Union;  
- during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second intend above;  
(ii) have not been in contact in the hatchery or during transport with poultry or hatching eggs 
not meeting the requirements set out in (i);]  
II.1.3. come from the establishment, indicated in Box I.11:  
(3)(7)either  [(a) which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 7 of  Commission 
Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or 
withdrawn at the time the hatching eggs were collected;]  
(3)(8)or [(a) which is approved by the competent authority of the country or territory of origin in  accordance This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 598  EN COUNTRY  Certificate model HEP  
with requirements which are at least as stringent as those laid down in Article 8 of Commission 
Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or 
withdrawn at the time the hatching eggs were collected;]  
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, in accordance with Article 8 of Commiss ion Delegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulati on (EU) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases, at the time of dispatch of the hatching eggs to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
coun try, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
II.1.4. come from a flock which:  
(a) has remained in zone referred to in  point II. 2.1 for a continuous period of at least 3 months 
immediately prior to the date of loading of the hatching eggs for dispatch to the Union;  
and where the flock was imported into the zone referred to in point II. 2.1, the import took place 
in accorda nce with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 
2020/ 692 and the zone from where the animals were imported, is listed in Part 1 of Annex IV  to 
Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ] for entry into the 
Union of breeding poultry other than ratites and productive poultry other than ratites;  
(b) has been kept for a continuous period of at least 6 weeks immediately prior to t he date of loading 
of the hatching eggs for dispatch to the Union in an establishment:  
(i) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs;  
(ii) in which:  
(3)either  [infection with Salmonella  Pullorum, S. Gallinarum or S. arizonae was not confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to 
the Union;]  
(3)or [infection with Salmone lla Pullorum, S. Gallinarum or S. arizonae was confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to 
the Union and the measures provided for in Article 107(d) of Commission Delegated 
Regulation (EU) 2020/ 692 have been applied;]  
(iii) in which;  
(3)either  [avian mycoplasmosis (Mycoplasma gallisepticum and M. meleagridis) was not 
confirmed during the last 12 months prior to date of collection of the hatching eggs for 
dispatch to the Union;]  
(3)or [avian mycoplasmo sis (Mycoplasma gallisepticum and M. meleagridis) was confirmed 
during the last 12 months prior to date of collection of the hatching eggs for dispatch to 
the Union and the measures provided for in Article 107(e) of Commission Delegated 
Regulation (EU) 202 0/692 have been applied;]  
(7) [(iv) approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 599  EN COUNTRY  Certificate model HEP  
Commission Delegated Regulation (EU) 2019/2035;  
(9) 
Name of establishment  Address  Approval number  
 
   
(v) the approval of which has not been suspended or withdrawn at the time the hatching 
eggs were collected;  
(vi) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading 
for dispatch to the Union;  
(vii) which is under the control of the competent a uthority of the country or territory of 
origin and has a system in place to maintain for at least 3 years up -to-date information 
on animals, movements and production records, in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(viii) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the s pecies, 
at a frequency that is proportional to the risk posed by the establishment;  
(ix) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated 
Regulatio n (EU) 2020/ 692 relevant for the species and emerging diseases, at the time of 
dispatch of the hatching eggs to the Union;]  
 (3)either  [(c) has not been vaccinated against highly pathogenic avian influenza;]  
 (3)(4)or [(c) has been vaccinated against highl y pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Commission 
Delegated Regulation (EU) 2020/ 692;] 
 (3)either  [(d) has not been vaccinated against infection with Newcastle d isease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]  
 (3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignm ent for dispatch to the Union, with vaccines that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(10) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
(e) underwent a disease surveillance programme that meets the requirements set out in Annex II to 
Commission Delegated Regulation (EU) 2019/2035 and was found not to be infected or showed 
any grounds for suspecting any infection, by the following agents:  
(3)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  (in case of Gallus This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 600  EN COUNTRY  Certificate model HEP  
gallus );] 
(3)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  Gallinarum, 
Mycoplasma meleagridis  and Mycoplasma  gallisepticum  (in case of Meleagris gallopavo );]  
(3)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , Coturnix 
coturni x, Phasianus colchicus , Perdix perdix and Anas spp );]  
(f) had no contact with poultry or hatching eggs of a lower health status, or with captive or wild 
birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the 
hatching eggs for dispatch to the Union;  
(g) did not show symptoms of transmissible diseases at the time of collection of the hatching eggs;  
(h) has been subjected to a clinical inspection(11) within the 24 hours prior to loading of the hatching 
eggs for dispa tch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for the species and emerging diseases;  
II.1.5. were:  
(3)either  [(a) not vaccinated against highly pathogenic avian influenza;]  
(3)(4)or [(a) vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Commission 
Delegated  Regulation (EU) 2020/ 692; 
(3)either  [(b) not vaccinated against infection with Newcastle disease virus;]  
(3)or [(b) vaccinated against infection with Newcastle disease virus with vaccines that comply with the 
general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692; 
(c) marked using colour ink, with a stamp indicating the unique approval number of the establishment 
of origin;  
(d) disinfected in accordance with the instructions of the competent authority of the country or 
territor y of origin;  
II.1.6. were collected [on ___/___/____ (dd/mm/yyyy)](3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ 
(dd/mm/yyyy)] (3); (12)  
II.1.7. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that the hatching eggs cannot fall out;  
(b) are designed to allow cleaning and disinfection;  
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;  
(d) are closed in accordance with the instructions of the compete nt authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) are: 
(3)either  [disposable, clean and used for the first time;]  
(3)or [cleaned and disinfected before loading of the hatching eggs in accordance  with the instructions 
of the competent authority of the country or territory of origin;]  
(f) bear t he information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant for hatching eggs of poultry;  
II.1.8. are loaded for dispatch to the Union in a means of transport which is constructed in accordance with 
II.2.7(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent 
authority of the country or territory of origin and dried or allowed to dry immed iately before loading of 
the hatching eggs for dispatch to the Union;  
(13)[II.1.9. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegate d Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 601  EN COUNTRY  Certificate model HEP  
(b) come from flocks which:  
(3)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days prior to the date the eggs were collected;]  
II.2. Public health attestation  
(14)[II.2.1. The Salmonella  control programme referred to in Article 10 of Regulation (EC) No 2160/2003 and the 
specific requirements for the use of antimicrobials and vaccines in Regulation (EC) No  1177/2006, have 
been applied to the pa rent flock of origin and this parent flock has been tested for Salmonella  serotypes 
of public health significance:  
Identification of 
the flock  Age of the 
birds  Date of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]  Result of all testing in the 
flock(15) 
Positive  Negative  
     
 
(14)[II.2.2. Neither Salmonella  Enteritidis nor Salmonella  Typhimurium were detected within the control 
programme referred to in point II.1.1.]  
(16)[II.2.3. If the Member States of destination is Finland or Sweden, the hatching eggs come from flocks which 
have tested negative for Salmonella  in accordance with the rules laid down in Decision 2003/644/EC;]  
 
 
Notes:  
This certificate is intended for entry into the  Union hatching eggs of poultry other than ratites, including when the 
Union is not the final destination of those germinal products.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Re gulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IX to Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box reference I.27:  “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 04.07.  
“Category” : select one of the following: Pure line/grandparents/parents/laying 
pullets/others.  
Part II:  
(1) Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) This applies only to zones in which vaccination ag ainst highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IX to 
Commission  Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 602  EN COUNTRY  Certificate model HEP  
column “---” of the table.  
(5) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comp ly only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 2020/… 
[SANTE/71 40/2020 ] with the entry “B” in column “---” of the table.  
(6) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(7) Keep in case the hatching eggs are dispatched from a hatchery.  
(8) keep in case the hatching eggs are dispatched from the establishment of the flock of origin.  
(9) Indicate the name,  address and approval number of the establishment were the flock of origin of the 
hatching eggs was kept during the 6 weeks immediately prior to the date of loading of the hatching eggs 
for dispatch to the Union.  
(10) To be completed when animals were vacc inated against infection with Newcastle disease virus.  
(11)  The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(12) The date(s) of collection cannot be a date prior to the date of authoris ation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these hatching eggs from that zone.  
(13) This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 692. 
(14) This guarantee applies only for hatching eggs belonging to the species of Gallus gallus  and turkeys.  
(15) If any of the results were positive for the following serotypes during the life of the parent flock, indicate 
as positive: below during the life of th e flock, indicate as positive: Salmonella hadar, Salmonella 
virchow and Salmonella infantis .. 
 (16) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 603  EN CHAPTER 28: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF HATCHING EGGS OF RAT ITES (MODEL HER)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen 
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
   Germinal products    
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 604  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 605  EN COUNTRY  Certificate model HER  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1) of ratites  described in this 
certificate:  
II.1.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ] for entr y into the Union of hatching eggs of ratites ; 
(b) carries out a surveillance programme for highly pathogenic avian influenza in accordance with 
Article 105(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic a vian influenza in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
II.1.2. come from th e zone referred to in point II.1 .1, which at the date of issue of this certificate:  
(3)either  [is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020 /692 and the hatching eggs come from flocks:  
(a) which have been placed in isolation under official surveillance for a period of at least 30 days 
prior to the date of laying of the hatching eggs from which the day -old chicks of this 
consignment are derived;  
(b) which have undergone a virus detection test(5) for infection with Newcastle disease virus:  
(i) which was carried out on cloacal swabs or faeces samples collected from each ratite 
within 7 to 10 days of the date the ratites were placed under of ficial surveillance referred 
to in point (a);  
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral Pathogenicity 
Index (ICPI) of more than 0.4 have been found;  
(iii) with favourable results being available for all birds before the day -old chicks left the 
hatchery for dispatch to the Union;  
(c) in which surveillance for infection with Newcastle disease virus was carried out under a 
statistically -based sampling plan which produced negative results for a period of at least 6 
months immedi ately prior to the date of dispatch of the consig nment for entry into the Union;  
(d) have not been kept with poultry which do not fulfil the guarantees under points (a), (b) and (c) 
during the period of 30 days prior to the date of laying and during the la ying of the hatching eggs 
from which the day -old chicks of this consignment are derive d;] 
II.1.3. come from th e zone referred to in point II.1 .1, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination agai nst infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific criteria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  
(3)(7)or [(b) vaccination against infection with Newcastle  disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692 is 
not prohibited, and the hatching eggs:  
(i) come from flocks which:  
- have not been vaccinated with such vaccines for a period of at least the 12 months 
prior to the date of loading of the consign ment for dispatch to the Union;  
- underwent a virus isolation test(5) for infection with Newcastle disease virus carried This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 606  EN COUNTRY  Certificate model HER  
out on a ra ndom sample of cloacal swabs taken from at least 60 birds in each flock, 
not earlier than 2 weeks prior to the date of loading of the consignment for dispatch 
to the Union, and in which no avian paramyxoviruses with an IC PI of more than 0,4 
were found;  
- were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks prior to the date of loading of the consign ment for dispatch to the 
Union;  
- during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in first and second intend above;  
(ii) have not been in contact in the hatchery or during transport with poultry or hatching 
eggs not meeting the requirements set out in (i );] 
II.1.4. come from the establishment, indicated in Box I.11:  
(3)(8)either  [(a  which is approved by the competent authority of the country or territory of origin in accordance 
with requirements which are at least as stringent as those laid down in Artic le 7 of Commission 
Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or 
withdrawn at the time the hatching eggs were collected;]  
(3)(9)or [(a) which is approved by the competent authority of the country or territory of or igin in accordance 
with requirements which are at least as stringent as those laid down in Article 8 of Commission 
Delegated Regulation (EU) 2019/2035 and the approval of which has not been suspended or 
withdrawn at the time the hatching eggs were collecte d;] 
(b) which is under the control of the competent authority of the country or territory of origin and has 
a system in place to maintain for at least 3 years up -to-date information on animals, movements 
and production records, in accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the detection of, 
and information on, signs indicative of the listed diseases referred to in Annex I to Commission 
Delegated R egulation (EU) 2020/ 692 relevant for the species, at a frequency that is proportional 
to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in  Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases, at the time of dispatch of the hatching eggs to the 
Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a neighbouri ng 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
II.1.5. come from a flock which:  
(a) has remained i n zone referre d to in point II.1 .1 for a continuous period of at least 3 months 
immediately prior to the date of loading of the hatching eggs for dispatch to the Union;  
and where the flock was imported into the zone referred to in point II.1 .1, the import took place 
in accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 
2020/ 692 and the zone from where the animals were imported, is listed in Part 1 of A nnex IV to 
Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ] for entry into the 
Union of breeding ratites and productive ratites;  
(b) has been kept for a continuous period of at least 6 weeks immediately prior to the date of loading 
of the hatching eggs for dispatch to the Union in an establishment:  
(i) in which no confirmed case of infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of collection of the hatching eggs;  
(8)[(ii) approved by the competent authority of the country or territory of origin in accordance This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 607  EN COUNTRY  Certificate model HER  
with requirements which are at least as stringent as those laid down in Article 8 of 
Commission Delegated Regulation (EU) 2019/2035;  
(10) 
Name of establishment  Address  Approval number  
 
   
(iii) the approval of which has not been suspended or withdrawn at the time the hatching 
eggs were collected;  
(iv) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading 
for dispatch to the Union;  
(v) which is under the control of the competent authority of the country or territory of 
origin and has a system in place to maintain for at least 3 years up -to-date information 
on animals, movements and production records, in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(vi) which receives regular animal health vi sits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, 
at a frequency that is proportional to the risk posed by the establishment;  
(vii) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and  emerging diseases, at the time of 
dispatch of the hatching eggs to the Union;]  
 (3)either  [(c) has not been vaccinated against highly pathogenic avian influenza;]  
 (3)(5)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Commission 
Delegated Regulation (EU) 2020/ 692;] 
 (3)either  [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to  the date of loading of the consignment for dispatch to the Union;]  
 (3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccine s that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(11) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Nam e of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
(e) had no contact with poultry or hatching eggs of a lower health status, or with captive or wild 
birds for a continuous period of at least 6 weeks immediately prior to the date of loading of the 
hatching eggs for dispatch to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 608  EN COUNTRY  Certificate model HER  
(f) did not show symptoms of transmissible diseases at the time of collection of the hatching eggs;  
(g) has been subjected to a clinical inspection(12) within the 24 hours prior to loading of the hatching 
eggs for d ispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for the species and emerging diseases;  
II.1.6. were:  
(3)either  [(a) not vaccinated against highly pathogenic avian influenza;]  
(3)(5)or [(a) vaccinated against highly pathogenic avian influenza in accordance with a vaccination 
programme which complies with the requirements set out in Annex XIII to Commission 
Delegated Regulation (EU) 2020/ 692: 
(3)either  [(b) not vaccinated against infection with Newcastle disease virus;]  
(3)or [(b) vaccinated against infection with Newcastle disease virus with vaccines that comply with the 
general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 2020/ 692: 
(c) marked using colour ink, with a stamp indicating the ISO code of the country or territory of 
origin and the unique approval number of the establishment of origin;  
(d) disinfected in accordance with the instructions of the competent authority of the country or 
territory of origin;  
II.1.7. were collected [on ___/___/____ (dd/mm/yyyy)](3) [from ___/___/____ (dd/mm/yyyy) to ___/___/____ 
(dd/mm/yyyy)] (3); (13)  
II.1.8. are loaded for dispatch to the Union in  containers which:  
(a) are constructed in such a way that the hatching eggs cannot fall out;  
(b) are designed to a llow cleaning and disinfection;  
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;  
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) are: 
(3)either  [disposable, clean and used for the first time;]  
(3)or [cleaned and disinfected before loading of the hatching eggs in accordance with the instructions 
of the competent authority of the country or territory of origin;]  
(f) bear the  information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant f or hatching eggs of poultry;  
II.1.9. are loaded for dispatch to the Union in a means of transport which is con structed in accordance with 
II.1.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the competent 
authority of the cou ntry or territory of origin and dried or allowed to dry immediately before loading of 
the hatching eggs for dispatch to the Union;  
 (14)[II.1.10. are intended for a Member State which has been granted the status free from infection with Newcastle 
disease v irus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) come from flocks which:  
(3)either  [have not been vaccinated against infect ion with Newcastle disease virus;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]  
(3)or [have been vaccinated against infection with Newcastle disease virus with a live vaccine at the 
latest 60 days  prior to the date the eggs were collected;]  
 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 609  EN COUNTRY  Certificate model HER  
Notes:  
This certificate is intended for entry into the Union hatching eggs of ratites, including when the Union is not the 
final destination of those germinal products.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IX to Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box reference I.27:  Description of consignment:  
“CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 04.07.  
“Category” : select one of the following: Pure line/grandparents/parents/others.  
 
Part II:  
(1) Hatching eggs as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) This guarantee is required only for consignments from zones which are not considered free from 
infection with Newcastle disease virus in accordance with Article 39 of Commission Delegated 
Regulati on (EU) 2020/ 689 and are listed in Part 1 of Annex IX to Commission Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “C” in column “---” of the table.  
(5) Tests should be carried out on samples taken by or under the control of the comp etent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(6) This applies only to zones in which vaccination against highly patho genic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 689, and are listed in Part 1 of Annex IX to 
Commission Implementing Regu lation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(7) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the g eneral criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 689 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(8) Keep in case the hatching eggs are dispatched from a hatchery.  
(9) keep in case the hatching eggs are dispatched from the establishment of the flock of origin.  
(10) Indicate the name, address and approval number of the establishment were the flock of origin of the 
hatching eggs was kept during the 6 weeks immediately prior to the date of loading of the hatching eggs 
for dispatch to the Union.  
(11) To be completed when animals were vaccinated against infection with  Newcastle disease virus.  
(12) The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(13) The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry in to the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these hatching eggs from that zone.  
(14) This guarantee is required only for consignments intended for a Member State which has been gr anted 
the status free from infection with Newcastle disease virus without vaccination in accordance with This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 610  EN COUNTRY  Certificate model HER  
Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 611  EN CHAPTER 29: MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE 
UNION OF SPECIFIED PATHOGEN -FREE EGGS  (MODEL ‘ SPF’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
   Germinal products    
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 612  EN I.24 Total number of packages  I.25 Total  quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 613  EN COUNTRY  Certificate model SPF  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the specified pathogen -free eggs (1) described in 
this certificate:  
II.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate is 
authorised and listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] for entry into  the Union of specified pathogen -free eggs;  
II.2. come from the establishment, indicated in Box I.11, which;  
(a) is under the control of the competent authority of the country or territory of origin and 
has a system in place to maintain for at least 3 years up -to-date information on animals, 
movements and production records, in accordance with Article 8 of Commission 
Delegated Regulation (EU) 2020/ 692; 
(b) comply with the conditions described in the European Pharmacopoeia;  
(c) receives regular animal health visits from  a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a 
frequency that is proportional to the ri sk posed by the establishment;  
(d) was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for the species and emerging disea ses, at the time of dispatch of the 
eggs to the Union;  
II.3. come from a flock which:  
(a) has been kept for a continuous period of at least 6 weeks prior to the date of collection 
of the eggs for dispatch to the Union in the establishment referred to in point II.1.2;  
(b) is free from specified pathogens as described in the European Pharmacopoeia and 
clinical examinations required for this specific status have been favourable, including 
negative testing results for highly pathogenic avian influenza, infection with N ewcastle 
disease virus and infection with low pathogenic avian influenza viruses carried out 
within the period of 30 days prior to the date of the collection of the eggs for dispatch to 
the Union;  
(c) has been clinically examined at least one week as described  in the European 
Pharmacopoeia and no disease symptoms or ground for suspecting the presence of any 
disease were detected;  
(d) has had no contact with poultry of a lower health status , or with birds for a period of at 
least 6 weeks prior to the date of collec tion of the eggs;  
(e) did not show symptoms of transmissible diseases at the time of collection of the eggs;  
II.4. were:  
(b) marked using colour ink, with a stamp indicating the ISO code of the zone referred to 
in point II.1. 1 and  the unique approval number of the establishment of origin;  
(c) disinfected in accordance with the instructions of the competent authority of the 
country or territory of origin;  
II.5. were collected [on ___/___/____ (dd/mm/yyyy)](3) [from ___/___/____ (dd/mm/y yyy) to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 614  EN COUNTRY  Certificate model SPF  
___/___/____ (dd/mm/yyyy)] (3); (4)  
II.6. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that the eggs cannot fall out;  
(b) are designed to allow cleaning and disinfection;  
(c) contain only eggs of the same species, category and type coming from the same 
establishment;  
(d) are closed in accordance with the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the content;  
(e) are: 
(3)either  [disposable, clean and used for the first time;]  
(3)or [cleaned and disinfected before loading of the eggs in accordance with the instructions 
of the competent authority of the country or territory of origin;]  
(f) bear the information set out in Ann ex XVI to Commission Delegated Regulation (EU) 
2020/ 692 relevant for specified pathogen -free eggs;  
II.7. are loaded for dispatch to the Union in a means of transport which is constructed in accordance 
with II.1.6(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the 
competent authority of the country or territory of origin and dried or allowed to dry 
immediately before loading of the eggs for dispatch to the Union.  
 
Notes:  
This certificate is intended for entry into the specified pathogen -free eggs, including when the Union is not the 
final destination of those products.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/ 2020 ]. 
 
Part I:  
Box I.8.:  Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box I.27:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.  
 
Part II:  
(1) Specified pathogen -free eggs as defined in Article 2 of Commission Delegated Regulation (EU) 
2020/ 692.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) The date(s) of collection cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when r estriction measures have been adopted by the Union in relation to the 
entry of these products from that zone.  
 
Official veterinarian  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 615  EN COUNTRY  Certificate model SPF  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 616  EN CHAPTER 30: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF POULTRY INTENDED FOR  SLAUGHTER  OTHER THAN RATITES  
(MODEL SP)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 617  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species       Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 618  EN COUNTRY  Certificate model SP  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 
 
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the poultry intended for slaughter(1) other than ratites 
described in this certificate:  
II.1.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] for entry into the Union of poultry intended f or slaughter other 
than ratites;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in accordance with 
Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza  in accordance with Article 38 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(d) is considered free from infection with Newcastle disease virus in accordance with Article 39 of 
Commission Delegated Regulation (EU) 2020/ 692;  
II.1.2. come from the zone referred to in point II. 2.1, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme t hat complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not comply 
with both the general and specific crite ria of Annex XV to Commission Delegated Regulation 
(EU) 2020/ 692 is prohibited;]  
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply only 
with the general criteria of Annex XV to Commission Delegated Regulati on (EU) 2020/ 692 is 
not prohibited and the animals:  
(i) have not been vaccinated with such vaccines for a period of at least the 12 months prior to 
the date of loading of the consignment for dispatch to the Union;  
(ii) come from a flock or flocks which underwent a virus isolation test(6) for infection with 
Newcastle disease virus not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, carried out on a random sample of cloacal swabs 
taken from at least 60 birds in each floc k and in which no avian paramyxoviruses with an 
ICPI of more than 0,4 were found;  
(iii) were kept in isolation under official surveillance on the establishment of origin during the 
2 weeks mentioned in (ii);  
(iv) during the period of 60 days prior to the date of load ing of the consignment for dispatch to 
the Union, were not in contact with poultry which do not fulfil the conditions in (i) and 
(ii);] 
II.1.3. have remained in the zone referred to in point II. 2.1 for a continuous period of at least 6 weeks 
immediately pr ior to the date of loading for dispatch to the Union or since hatching where they are less 
than 6 weeks of age;  
and where they were imported into the zone referred to in point II. 2.1, the import took place in 
accordance with animal health requirements that  are at least as stringent as the relevant requirements of 
Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 2020/ 692 and the zone from 
where the animals were imported, is listed in Part 1 of Annex IV to Commission Implementing 
Regulation ( EU) 2020/… [ SANTE/7140/2020 ] for entry into the Union of poultry intended for 
slaughter other than ratites;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 619  EN COUNTRY  Certificate model SP  
II.1.4 come from the establishment, indicated in Box I.11:  
(a) which is registered by and is under the control of the competent authority of the country  or 
territory of origin and has a system in place to maintain for at least 3 years up -to-date 
information on animals, movements and production records, in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(b) which receives regular animal health visits from a veterinarian for the purpose of the detection 
of, and information on, signs indicative of the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the establishment;  
(c) which was not subject to national restriction measures for animal health reasons, including for 
the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for  the species and emerging diseases, at the time of dispatch of the animals to the 
Union;  
(d) within a 10 km radius of which, including, where appropriate, the territory of a neighbouring 
country, there has been no outbreak of highly pathogenic avian influenza or infection with 
Newcastle disease virus for at least 30 days prior to the date of loading for dispatch to the Union;  
(e) in which no confirmed case of infection with low pathogenic avian influenza viruses has been 
reported for at least 21 days prior to the d ate of loading for dispatch to the Union;  
II.1.5. come from a flock which:  
(a) has not been vaccinated against highly pathogenic avian influenza;  
(3)either  [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union;]  
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months prior to 
the date of loading of the consignment for dispatch to the Union, with vaccin es that comply with 
both the general and specific criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692; 
(7) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
(c) has been subjected to a clinical inspection(8) within the 24 hours prior to loading of the animals 
for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/ 692 relevant for  the species and emerging diseases;  
II.1.6. have remained in the establishment indicated in Box I.11 since hatching or for a continuous period of at 
least 30 days immediately prior to the date of loading for dispatch to the Union ; 
II.1.7. had no contact with animals of a lower health status since hatching or for a continuous period of at least 
30 days immediately prior to the date of loading for dispatch to the Union ; 
II.1.8 are not to be killed under a national programme for the eradication of diseases, including the listed 
diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
II.1.9. have  been subjected to a clinical inspection(8) on ___/___/____ (dd/mm/yyyy), within the 24 hours prior 
to loading for dispatch to the Union, and showed no signs indicative of the occurrence of diseases, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 620  EN COUNTRY  Certificate model SP  
including the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases;  
II.1.10. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escap e of animal excrements,  litter,  feed or feathers is prevented or minimized;  
(b) contain only poultry of the same species and category coming from the same establishment;  
(c)  are: 
(3)either  [unused and purpose -designed disposable containers to be destroyed after first use;]  
(3)or [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]  
(d)  are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation (EU) 2020/ 692 
relevant for poultry intended for slaughter;  
II.1.11. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(9) in a means of transport which  is 
constructed in accordance with II. 2.10(a) and was cleaned and disinfected prior to loading with a 
disinfectant authorised by the competent authority of the country or territory of origin;  
 (10)[II.1.12. are intended for a Member State which has been gr anted the status free from infection with Newcastle 
disease virus without vaccination in accordance with Commission Delegated Regulation (EU) 
2020/ 689, and they:  
(3)either  [have not been vaccinated against infection with Newcastle disease virus and have te sted(6) negative to 
serological tests to detect antibodies against Newcastle disease virus, performed on blood samples at a 
level which gives 95% confidence of detecting infection at 5% prevalence and which were taken during 
the period of at least 14 days prior to the date of loading for dispatch to the Union;]  
(3)or [have been vaccinated against infection with Newcastle disease virus but not with a live vaccine during 
the period of the last 30 days prior to the date of loading for dispatch to the Union and  tested negative to 
a virus isolation test(6) for infection with Newcastle disease virus, performed on a random sample of 
cloacal swabs or faeces samples taken from at least 60 bird within the 14 days prior to the date of 
loading for dispatch to the Union; ] 
 
II.2. Public health attestation  
II.2.1. I, the undersigned official veterinarian, hereby certify, that the animals described above have not 
received:  
- any stilbene or thyrostatic substances,  
- oestrogenic, androgenic, gestagenic or beta -agonist substances  for purposes other than 
therapeutic or zootechnical treatment (as defined in Directive 96/22/EC).  
II.2.2. I, the undersigned official veterinarian, hereby certify, that the animals described above fulfil the 
guarantees covering live animals and products t hereof provided by the residue plans submitted in 
accordance with Directive 96/23/EC, and in particular Article 29 thereof, and the concerned 
animals are listed in Decision 2011/163/E U for the concerned country of origin.  
(11)[II.2.3. The Salmonella  contro l programme referred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Regulation (EC) No  1177/2006, have been applied to the flock of origin and this parent 
flock has been tested f or Salmonella  serotypes of public health significance:  
Identification of Age of the Date of last sampling of Result of all testing in the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 621  EN COUNTRY  Certificate model SP  
the flock  birds  the flock from which the 
testing result is 
known[dd/mm/yyyy]  flock(12) 
positive  negative  
     
For reasons other than the  Salmonella control programme:  
(3)either  [antimicrobials were not administered to the slaughter poultry;]  
(3)(13)or [the following antimicrobials were administered to the slaughter poultry: 
…………………………………………………………..;]]  
(14)[II.2.4. If the Member States of destination is Finland or Sweden, the poultry underwent a 
microbiological test by sampling on the holding of origin and tested Salmonella  negative in 
accordance with Decision 95/410/EC.]  
 
Notes:  
This certificate is intended for ent ry into the Union of poultry intended for slaughter other than ratites, including 
when the Union is not the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Imple menting Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex 
IV to Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
Box reference  I.27:  “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.05 or 01.06.39.  
 
Part II:  
(1) ‘Poultry intended for slaughter’ means poultry to be transported directly to a slaughterhouse , as defined 
in Article 2 of Commission Delegated Regulation (EU) 2020/ 692. 
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) This applies onl y to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed i n Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(5) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IV to Commission Implementin g Regulation (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(6) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carr ied out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(7) To be completed when animals were vaccinated against infection with Newcastle disease virus.  
(8) The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(9) The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 622  EN COUNTRY  Certificate model SP  
thereof for entry into the Union, or a date in a period when restriction meas ures have been adopted by 
the Union in relation to the entry of these animals from that country or territory or zone thereof.  
(10) This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infe ction with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
(11) This guarantee applies only to poultry belonging to the species of Gallus gallus and turkeys.  
(12) If any of the results were positive for the following serotypes during the life of the flock, indicate as 
positive: Salmonella  enteritidis  and Salmonella  typhimurium . 
(13) Complete if appropriate: indicate the name and active substance of antimicrobials us ed. 
(14) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 623  EN  
CHAPTER 31: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF RATITES INTENDED FOR  SLAUGHTER (MODEL SR)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 624  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species       Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 625  EN COUNTRY  Certificate model SR  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
II.1.1.  I, the undersigned official veterinarian, hereby certify, that the animals described above have not 
received:  
- any stilbene or thyrostatic substances,  
- oestrogenic, androgenic, gestagenic or beta-agonis t substances for purposes other than 
therapeuti c or zootechnical treatment (as defined in Directive 96/22/EC).  
II.1.2.  I, the undersigned official veterinarian, hereby certify, that the animals described above fulfil the 
guarantees covering live animals and products thereof provided by the residue plan s submitted in 
accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the concerned 
animals are listed in Decision 2011/163/E U for the concerned country of origin . 
] 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the ratites intended for slaughter(1) described in 
this certificate:  
II.2.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to C ommission Implementing Regulation 
(EU) 2020/… [ SANTE/7140/2020 ] for entry into the Union of ratites intended for 
slaughter;  
(b) carries out a surveillance programme for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delega ted Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 
of Commission Delegated Regulation (EU) 2020/ 692; 
II.2.2. come from the zone referred to in point II. 2.1, which at the date of issue of this certificate:  
(3)either   [is considered free from infection with Newcastle disease virus in accordance with Article 39 
of Commission Delegated Regulation (EU) 2020/ 692;] 
(3)(4)or [is not considered free from infection with Newcastle disease virus in accordance with Article 
39 of Commission Delegated Regulation (EU) 2020/ 692 and the animals;  
(a) have been placed under official surveillance for a period of at least 21 days prior to the 
date of loading of the consignment for dispatch to the Union;  
(b) have been kept in complete isolation during the period referred to in point (a), away 
from direct or indirect contact with other birds, in facilities approved by the competent 
authority of the country or territory of origin for this purpose;  
(c) have under gone a virus detection test(5) for infection with Newcastle disease virus:  
(i) which was carried out within 7 to 10 days of the date the ratites were placed 
under official surveillance referred to in point (a) on cloacal swabs or faeces 
samples collected f rom each ratite;  
(ii) in which no avian paramyxovirus type 1 isolates with an Intracerebral 
Pathogenicity Index (ICPI) of more than 0.4 have been found;  
(iii) with favourable results being available for all birds in the consignment before 
they left the fac ilities referred to in point (b) for dispatch to the Union;  
(d) come from flocks in which surveillance for infection with Newcastle disease virus was 
carried out under a statistically -based sampling plan which produced negative results for 
a period of at l east 6 months immediately prior to the date of dispatch of the 
consignment for entry into the Union;]  
II.2.3. come from the zone referred to in point II. 2.1, in which:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 626  EN COUNTRY  Certificate model SR  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out; ] 
(3)(6)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with 
a vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either   [(b) vaccination against infection with Newcastle disease virus with vaccines which do not 
comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/ 692 is prohibited;]  
(3)(7)or  [(b) vaccination against infection with Newcastle disease virus with vaccines which comply 
only with the general criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692 is not prohibited and the animals:  
(i) have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consignment for dispatch to the Union;  
(ii) come from a flock or flocks which underwent a virus isolation test(5) for infection 
with Newcastle disease virus not earlier than 2 weeks prior to the date of loading 
of the consignment for dispatch to the Union, carried out on a random sample of 
cloacal swabs taken from at least 60 birds in each flock and in which no avian 
paramyxoviruses with an ICPI of more than 0,4 were found;  
(iii) were kept in isolation under official surve illance on the establishment of origin 
during the 2 weeks mentioned in (ii);  
(iv) during the period of 60 days prior to the date of loading of the consignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in (i) and (ii);]  
II.2.4. have remained in the zone referred to in point II. 2.1 for a continuous period of at least 6 weeks 
immediately prior to the date of loading for dispatch to the Union or since hatching where they 
are less than 6 weeks of age;  
and where the y were imported into the zone referred to in point II. 2.1, the import took place in 
accordance with animal health requirements that are at least as stringent as the relevant 
requirements of Regulation (EU) 2016/429 and Commission Delegated Regulation (EU) 
2020/ 692 and zone from where the animals were imported, is listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for entry into the 
Union of ratites intended for slaughter;  
II.2.5. come from the establishment, ind icated in Box I.11:  
(a) which is registered by and is under the control of the competent authority of the country 
or territory of origin and has a system in place to maintain for at least 3 years up -to-date 
information on animals, movements and production reco rds, in accordance with Article 
8 of Commission Delegated Regulation (EU) 2020/ 692; 
(b) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to  in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, 
at a frequency that is proportional to the risk posed by the establishment;  
(c) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases, at the time of 
dispatch of the animals to the Union;  
(d) within a 10 km radius of which, including, where appropriat e, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days prior to the date of loading 
for dispatch to the Union;  
(e) in which no confirmed case of  infection with low pathogenic avian influenza viruses has 
been reported for at least 21 days prior to the date of loading for dispatch to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 627  EN COUNTRY  Certificate model SR  
II.2.6. come from a flock which:  
(a) has not been vaccinated against highly pathogenic avian influenza;  
(3)either [(b) has not been vaccinated against infection with Newcastle disease virus in the last 12 
months prior to the date of loading of the consignment for dispatch to the Union;]  
(3)or [(b) has been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to the date of loading of the consignment for dispatch to the Union, with vaccines 
that comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/ 692; 
(8) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] 
(c) has been subjected to a clinical inspection(9) within the 24 hours prior to loading of the 
animals for dispatch to the Union, and showed no signs indicative of the occurrence of 
diseases, including the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for  the species and emerging diseases;  
II.2.7. have remained in the establishment indicated in Box I.11 since hatching or for a continuous 
period of at least 30 days immediately prior to the date of loading for dispatch to the Union ; 
II.2.8. had no contact wi th animals of a lower health status since hatching or for a continuous period 
of at least 30 days immediately prior to the date of loading for dispatch to the Union ; 
II.2.9 are not to be killed under a national programme for the eradication of diseases, in cluding the 
listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases;  
II.2.10. have  been subjected to a clinical inspection(9) on ___/___/____ (dd/mm/yyyy), within the 24 
hours p rior to loading for dispatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU) 2020/ 692 relevant for the species and emerging diseases;  
II.2.11. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escap e of animal excrements,  litter,  feed or feathers is prevented or 
minimized;  
(b) contain only poultry of the same species and category coming from the same 
establishment;  
(c) are: 
(3)either   [unused and purpose -designed disposable containers to be destroyed after first use;]  
(3)or  [cleaned and disinfected and dried or allowed to dry prior to loading of the animals;]  
(d) are closed in accordance with the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the c ontent;  
(e) bear the  information set out in Annex XVI to Commission Delegated Regulation (EU) 
2020/ 692 relevant for poultry intended for slaughter;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 628  EN COUNTRY  Certificate model SR  
II.2.12. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(10) in a means of transport 
which  is constructed in accordance with II. 2.11(a) and was cleaned and disinfected prior to 
loading with a disinfectant authorised by the competent authority of the country or territory of 
origin;  
 (11)[II.2.13. are intended for a Member State which has been g ranted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Commission Delegated 
Regulation (EU) 2020/ 689, and they:  
(3)either  [have not been vaccinated against infection with Newcastle disease virus and have t ested(5) 
negative to serological tests to detect antibodies against Newcastle disease virus, performed on 
blood samples at a level which gives 95% confidence of detecting infection at 5% prevalence 
and which were taken during the period of at least 14 days  prior to the date of loading for 
dispatch to the Union;]  
(3)or [have been vaccinated against infection with Newcastle disease virus but not with a live vaccine 
during the period of the last 30 days prior to the date of loading for dispatch to the Union an d 
tested negative to a virus isolation test(5) for infection with Newcastle disease virus, performed 
on a random sample of cloacal swabs or faeces samples taken from at least 60 bird within the 
14 days prior to the date of loading for dispatch to the Union ;] 
 
 
 
Notes:  
This certificate is intended for entry into the Union of ratites intended for slaughter, including when the Union is 
not the final destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference  I.8: Provide the code of the country or territory or zone thereof as it appears in column 2 of 
the table in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/ … [SANTE/7140/2020 ]. 
Box reference I.27:  “CN code” : use the appropriate Harmonised System (HS) code of the World Customs 
Organisation: 01.06.39.  
 
Part II:  
(1) ‘Ratites intended for slaughter’ means ratites to be transported directly to a slaughterhouse , as defined 
in Article 2 of Commission Delegated Regulation (EU) 2020/ 692. 
(2) Code of  the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(3) Keep as appropriate.  
(4) This guarantee is required only for consignments from zones which are not considered fr ee from 
infection with Newcastle disease virus in accordance with Article 39 of Commission Delegated 
Regulation (EU) 2020/ 692 and are listed in Part 1 of Annex IV to Commission Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “C” in column “---” of the table.  
(5) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance wi th Article 37 of Regulation (EU) 2017/625.  
(6) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 629  EN COUNTRY  Certificate model SR  
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(7) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof,  and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “B” in column “----” of the table.  
(8) To be completed when animals were vaccinated against infection with Newcastle disease virus.  
(9) The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(10) The date of loading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.  
(11) This guarantee is required only for consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 630  EN CHAPTER 32 MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE 
UNION OF OF LESS THA N 20 HEADS OF POULTRY OTHER THA N RATITES 
(MODEL ‘ POU -LT20’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border  Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
  Slaughter     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 631  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 632  EN COUNTRY  Certificate model POU -LT20  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
II.1.1. I, the undersigned official veterinarian, hereby certify, that the animals described above have not 
received:  
- any stilbene or thyrostatic substances,  
- oestrogenic, androgenic, gestagenic or beta-agonist substances for purposes other than 
therapeutic or zootechnical tre atment (as defined in Directive 96/22/EC).  
II.1.2. I, the undersigned official veterinarian, here by certify, that the animals described above fulfil 
the guarantees covering live animals and products thereof provided by the residue plans 
submitted in accordance with Directive 96/23/EC, and in particular Article 29 thereof , and the 
concerned animals and  products are listed in Decision 2011/163/E U for the concerned country 
of origin . 
II.1.3.  I, the undersigned official veterinarian, hereby certify that the [breeding poultry other than 
ratites](2) [productive poultry  other than ratites](2) [poultry intended for slaughter other than 
ratites](2) [day-old chicks other than ratites](2) described in this certificate:  
(16)[II.1.3.1.  The Salmonella  control programme referred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requireme nts for the use of antimicrobials and vaccines in 
Regulation (EC) No 1177/2006, have been applied to the flock of origin and the flock 
has been tested for Salmonella  serotypes of public health significance:  
Identification of the 
flock  Age of the 
birds  Date  of last sampling of the 
flock from which the testing 
result is known 
[dd/mm/yyyy]  Result of all testing in 
the flock(17) 
positive  negative  
     
For reasons other than the  Salmonella control programme, within the last three weeks 
prior to entry into the Union:  
(2)either  [antimicrobials were not administered to the breeding and productive 
poultry other than ratites;]  
(2)(18)or [the following antimicrobials were administered to the breeding and 
productive poultry other than ratites: ……………………………………;]]  
(16)[II.1.3.2.  If breeding poultry, neither Salmonella  Enteritidis nor Salmonella  Typhimurium 
were detected within the control programme referred to in point II.1.3.1.]  
(19)[II.1.3.3.  If the Member States of Destination is Finland or Sweden:  
(2) either  [the breeding poultry has tested negative for Salmonella in accordance 
with the rules laid down in Decision 2003/644/EC;]  
(2) or [the laying hens (productive poultry reared in view to producing eggs for 
consumption) have tested negative in accordance with t he rules laid down 
in Decision 2004/235/EC.]]  
 
II.2. Animal health attestation  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 633  EN COUNTRY  Certificate model POU -LT20  
I, the undersigned official veterinarian, hereby certify that the [breeding poultry(1) other than ratites](2) 
[productive poultry(3) other than ratites](2) [poultry intended for  slaughter(4) other than ratites](2) [day-old 
chicks(5) other than ratites](2) described in this certificate:  
II.2.1. form a single consignment of less than 20 heads of poultry;  
II.2.2. come from the zone with code _ _ - _ (6) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation 
(EU) 2020/ … [SANTE/7140/2020 ] for entry into the Union of less than 20 heads of 
poultry other than ratites;  
(b) carries out a surveillance programm e for highly pathogenic avian influenza in 
accordance with Article 37(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 
of Commission Delegated Regulation (EU) 2 020/692; 
(d) is considered free from infection with Newcastle disease virus in accordance with 
Article 39 of Commission Delegated Regulation (EU) 2020/ 692; 
II.2.3. come from the zone referre d to in point II.2.2, in which:  
(2)either  [vaccination against highly pathogenic avian influenza is not carried out;]  
(2)(7)or [vaccination against highly pathogenic avian influenza is carried out in accordance with a 
vaccination programme that complies with the requirements set out in Annex XIII to 
Commission Delegat ed Regulation (EU) 2020/ 692;] 
(2)either  [II.2.4. the [breeding poultry other than ratites](2) [productive poultry  other than ratites](2) [poultry 
intended for slaughter other than ratites](2): 
II.2.4.1. come from th e zone referred to in point II.2 .2, in which:  
 (2)either  [vaccination against infection with Newcastle disease virus with vaccines which do 
not comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/ 692 is prohibited;]  
(2)(8)or [vacci nation against infection with Newcastle disease virus with vaccines which 
comply only with the general criteria of Annex XV to Commission Delegated 
Regulation (EU) 2020/ 692 is not prohibited, and the animals:  
(a) have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consign ment for dispatch to the 
Union;  
(b) come from a flock or flocks which underwent a virus isolation test(11) for 
infection with Newcastle disease virus carried out on a random sample of 
cloacal swabs from at least 60 birds in each flock , taken not earlier than 2 
weeks prior to the date of loading of the consignment for dispatch to the Union, 
and in which no avia n paramyxoviruses with an ICPI of more than 0,4 were 
found;  
(c) were kept in isolation under official surveillance on the establishment of origin 
during the 2 weeks mentioned in point (b); 
(d) during the period of 60 days prior to the date of loading of the co nsignment for 
dispatch to the Union, were not in contact with poultry which do not fulfil the 
conditions in points (a) and ( b);] 
II.2.4.2. have remained:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 634  EN COUNTRY  Certificate model POU -LT20  
(a) in the zone referred to in poi nt II.2 .2 for a continuous period of at least 3 
months immediately p rior to the date of loading for dispatch to the Union or 
since hatching where they are less than 3 months of age ; 
 and where they were imported into th e zone referred to in point II.2 .2, the 
import took place in accordance with animal health requirements t hat are at 
least as stringent as the relevant requirements of Regulation (EU) 2016/429 and 
Commission Delegated Regulation (EU) 2020/ 692 and the zone from where 
the animals were imported, is listed in Part 1 of Annex IV to Commission 
Implementing Regulatio n (EU) 2020/ … [SANTE/7140/2020 ] for entry into the 
Union of less than 20 heads of poultry other than ratites;  
(b) in the establishment indicated in Box I.11 for a continuous period of at least 3 
weeks immediately prior to the date of loading for dispatch t o the Union or 
since hatching where they are less than 3 weeks of age ; 
(c) without contact with animals of a lower health status for a continuous period of 
at least 3 weeks immediately prior to the date of loading for dispatch to the 
Union or since hatchin g where they are less than 3 weeks of age ; 
II.2.4.3. come from the establishment, indicated in Box I.11: 
(a) which is registered by and is under the control of the competent authority of the 
country or territory of origin and has a system in place to maintain for at least 3 
years up -to-date information on animals, movements and production records, 
in accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(b) which receives regular animal health visits from a veterinarian for the purpose 
of the detection of, and information on, signs indicative of the listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species, at a frequency that is proportional to the risk posed by 
the establishment;  
(c) which wa s not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU) 2020/ 692 relevant for the species and emerging 
diseases, at the time of dispatch of t he animals to the Union;  
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian 
influenza or infection with Newcastle disease virus for at least 30 days p rior to 
the date of loading for dispatch to the Union;  
(e) in which no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of loading for 
dispatch to the Union;  
II.2.4.4. come from a flock which:  
(a) has not been vaccinated against hig hly pathogenic avian influenza;  
(2)either  [(b) has not been vaccinated against infection with Newcastle disease virus 
in the last 12 months prior to the date of loading of the consignment for 
dispatch to the Union;]  
(2)or [(b) has been vaccinated against infection with Newcastle disease virus in 
the last 12 months prior to the date of loading of the consignment for dispatch 
to the Union, with vaccines that comply with both the general and specific This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 635  EN COUNTRY  Certificate model POU -LT20  
criteria  of Annex XV to Commission Delegated Regulation (EU) 2020/ 692; 
(9) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
(c) has been subjected to a clinical inspection(10) within the 24 hours prior to loading 
of the animals for dispatch to the Union, and showed no signs indicative of the 
occurrence of diseases, including the listed diseases referred to in Annex I to 
Commission  Delegated Regulation (EU) 2020/ 692 relevant for the species and 
emerging diseases;  
II.2.4.5. the animals:  
(a) have not been vaccinated against highly pathogenic avian influenza;  
(b) are not to be killed under a national programme for the eradication of diseases, 
including the liste d diseases referred to in Annex  I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases;  
(c) have  been subjected to a clinical inspection(10) on ___/___/____ (dd/mm/yyyy) 
within the 24 hours prior to loading for dispatch to the Union, and show no signs 
indicative of the occurrence of diseases, including the listed  diseases referred to 
in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
(d)  tested negative in serological and/or bacteriological tests(11) within the period of 
30 days prior to the date of loading of the animals for dispatch to the Union and 
were found not to be infected or sho wed any grounds for suspecting any 
infection, by the following agents:  
(2)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  
(in case of Gallus gallus );] 
(2)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  
Gallinarum, Mycoplasma meleagridis  and Mycoplasma  gallisepticum  (in case of 
Meleagris gallopavo );]  
(2)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp);] 
II.2.4.6. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape  of animal excrements, litter, feed or feathers is prevented or 
minimized;  
(b) contain only poultry of the same species and category coming from the same 
establishment;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 636  EN COUNTRY  Certificate model POU -LT20  
(c) are: 
(2)either   [unused and purpose -designed disposable containers to be destroyed after first 
use;]  
(2)or  [cleaned and disinfected and dried or allowed to dry prior to loading of the 
animals;]  
(d) are closed in accordance with the instructions of the competent authority of the 
country or territory of origin to avoid any possibility of substitution of the 
content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation 
(EU) 2020/ 692 relevant for [breeding poultry and productive poultry ](2) [poultry 
intended for slaughter](2); 
II.2.4.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(12) in a means of 
transport which is constructed in accordance with II. 2.4.6(a) and was cleaned and 
disinfected prior to loading with a disinfectant authorised by the competent authority of 
the country or territory of  origin;  
 (13) II.2.4.8. are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without vaccination in accordance with Commission 
Delegated Regulation (EU) 2020/ 689, 
(2)(14)either  [and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) were kept in isolation for at least 14 days prior to the date of loading of the 
consignment for dispatch to the Union in the establishment of origin or 
quarantine establishment un der the supervision of an official veterinarian, where:  
(i) no poultry was vaccinated against infection with Newcastle disease virus 
during the period of at least 21 days prior to the date of loading of the 
consignment;  
(ii) no other birds have entered into the establishment during that time;  
(iii) no vaccination has been carried out;  
(c) have tested(11) negative to serological tests to detect antibodies against Newcastle 
disease virus, performed on blood samples at a level w hich gives 95% confidence 
of detecting infection at 5% prevalence and which were taken during the period 
of at least 14 days prior to the date of loading for dispatch to the Union;]  
 (2)(15)or [and they: 
(2)either  [have not been vaccinated against infectio n with Newcastle disease virus and have 
tested(11) negative to serological tests to detect antibodies against Newcastle disease 
virus, performed on blood samples at a level which gives 95% confidence of detecting 
infection at 5% prevalence and which were t aken during the period of at least 14 days 
prior to the date of loading for dispatch to the Union;]  
(2)or [have been vaccinated against infection with Newcastle disease virus but not with a 
live vaccine during the period of the last 30 days prior to the da te of loading for 
dispatch to the Union and tested negative to a virus isolation test(11) for infection with 
Newcastle disease virus, performed on a random sample of cloacal swabs or faeces 
samples taken from at least 60 bird within the 14 days prior to th e date of loading for 
dispatch to the Union;]]]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 637  EN COUNTRY  Certificate model POU -LT20  
(2)or [II.2.4. the day -old chicks other than ratites:  
II.2.4.1. come from the zone referre d to in point II.2.2, in which:  
(2)either   [vaccination against infection with Newcastle disease virus with vaccines w hich do not 
comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/ 692 is prohibited;]  
 (2)(8)or  [vaccination against infection with Newcastle disease virus with vaccines which comply 
only with the gene ral criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692 is not prohibited, and the animals:  
(a) have not been vaccinated with such vaccines;  
(b) come from flocks which:  
(i) have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consign ment for dispatch to the 
Union;  
(ii) underwent a virus isolation test(11) for infection with Newcastle disease 
virus carried out o n a random sample of cloacal swabs taken from at least 
60 birds in each flock, not earlier than 2 weeks prior to the date of loading 
of the consignment for dispatch to the Union, and in which no avian 
paramyxoviruses with an IC PI of more than 0,4 were foun d; 
(iii) were kept in isolation under official surveillance on the establishment of 
origin during the 2 weeks prior to the date of loading of the consign ment 
for dispatch to the Union;  
(iv) during the period of 60 days prior to the date of loading of the 
consignment for dispatch to the Union, were not in contact with poultry 
which do not fulfil the conditions in (i) and (ii);  
(c) come from hatching eggs which have not been in contact in the hatchery or 
during transport with poultry or hatching eggs not meet ing the requirements set 
out in point (b);]  
II.2.4.2. have remained:  
(a) in the zone referred to in point II.2 .2 since hatching;  
(b) in the establishment indicated in Box I.11 since hatching ; 
(c) without contact with animals of a lower health status since hatching ; 
II.2.4.3. come from the establishment, indicated in Box I.11: 
(a) which is registered by and is under the control of the competent authority of the 
country or territory of origin and has a system in place to maintain for at least 3 
years up -to-date information on animals, movements and production records, in 
accordance with Article 8 of Commission Delegated Regulation (EU) 2020/ 692; 
(b) which receives regular animal health visits from a veterinarian for the purpose of 
the detection of, and information on , signs indicative of the listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species, at a frequency that is proportional to the risk posed by 
the establishment;  
(c) which was not subject to national restri ction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 638  EN COUNTRY  Certificate model POU -LT20  
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases, at the 
time of dispatch of the animals to the Union;  
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian 
influenza or infection with Newcastle disease virus for at least 30 days prior to 
the date of loading for dispatch to the Union;  
(e) in which no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of loading for 
dispatch to the Union;]  
II.2.4.4. come from a flock which:  
(a) has remained in the zone referred to in point II. 2.2 for a continuous period of at 
least 3 months immediately prior to the date of loading of the day -old chicks for 
dispatch to the Union;  
and where the flock was imported into the zone referred to in point II. 2.2, the 
import took place in accordance with animal health requirements that are at least 
as stringent as the relevant requirements of Regulation (EU) 2016/429 and 
Commission Delegated Regulation (EU) 2020/ 692 and the zone from where the 
animals were imported, is l isted in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ] for entry into the 
Union of breeding poultry other than ratites and productive poultry other than 
ratites;  
(b) has remained for a continuous period of at least 3 we eks immediately prior to the 
date of loading of the day -old chicks for dispatch to the Union in an 
establishment:  
(i) which is registered by and is under the control of the competent authority 
of the country or territory of origin and has a system in place  to maintain 
for at least 3 years up -to-date information on animals, movements and 
production records, in accordance with Article 8 of Commission 
Delegated Regulation (EU) 2020/ 692; 
(ii) which receives regular animal health visits from a veterinarian for t he 
purpose of the detection of, and information on, signs indicative of the 
listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species, at a frequency that is 
proportional to the risk posed by the estab lishment;  
(iii) which was not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species 
and emerging diseases, at the time of dispatch of the animals to the 
Union;  
(iv) in which no confirmed case of infection with low pathogenic avian 
influenza viruses has been reported for at least 21 days prior to the date of 
collection of the hatching eggs, from which the day -old chicks were 
hatched;  
(v) within a 10 km radius of which, including, where appropriate, the territory 
of a neighbouring country, there has been no outbreak of highly 
pathogenic avian influenza or infection  with Newcastle disease virus for 
at least 30 days prior to the date of loading for dispatch to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 639  EN COUNTRY  Certificate model POU -LT20  
(2)either  [(c) has not been vaccinated against highly pathogenic avian influenza;]  
(2)(7)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with 
a vaccination programme which complies with the requirements set out in Annex 
XIII to Commission Delegated Regulation (EU) 2020/ 692;] 
(2)either  [(d) has not been vaccinated against infection with Newcastle disease virus in the last 
12 months prior to the date of loading of the consignment for dispatch to the 
Union;]  
(2)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 
months prior to the date of loading of the consignment for dispatch to t he Union, 
with vaccines that comply with both the general and specific criteria of Annex 
XV to Commission Delegated Regulation (EU) 2020/ 692; 
(9) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
numb er 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
(e) underwent serological and/or bacteriological tests(11) within the period of 90 days 
prior to the date of loading of the day -old chicks for dispatch to the Union at a 
level which gives 95% confidence of detecting infection at 5% prevelance and 
was found not to be infected or showed any grounds for suspecting a ny infection, 
by the following agents:  
(2)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  
(in case of Gallus gallus );] 
(2)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  
Gallinarum, Mycoplasma  meleagridis  and Mycoplasma  gallisepticum  (in case of 
Meleagris gallopavo );] 
(2)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]  
(f) had no contact with a nimals of a lower health status for a continuous period of at 
least 3 weeks immediately prior to the date of collection of the eggs from which 
the day -old chicks have been hatched;  
(g) has been subjected to a clinical inspection(10) within the 24 hours pri or to loading 
of the day -old chicks for dispatch to the Union, and showed no signs indicative of 
the occurrence of diseases, including the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species and 
emerging diseases;]  
II.2.4.5 the animals:  
(a) have not been vaccinated against highly pathogenic avian influenza;  
(b) are not to be killed under a national programme for the eradication of diseases, 
including the listed diseases referred to in Annex I to Commissio n Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 640  EN COUNTRY  Certificate model POU -LT20  
(c) have  been subjected to a clinical inspection(10) on ___/___/____ (dd/mm/yyyy) 
within the 24 hours prior to loading for dispatch to the Union, and show no signs 
indicative of the occurrence of diseases, including the listed diseases referred to 
in Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the 
species and emerging diseases;  
(d) come from hatching eggs which prior to incubation , have been disinfected in 
accordance with the instructions of the competent authority of the country or 
territory of origin;  
II.2.4.6. are loaded for disp atch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escap e of animal excrements, litter,  feed or feathers is prevented or 
minimized;  
(b) contain only poultry of the same species and category coming from the same 
establishment;  
(c) are unused and purpose -designed disposable containers to be destroyed after first 
use; 
(d) are closed in accordan ce with the instructions of the competent authority of the 
country or territory of origin to avoid any possibility of substitution of the 
content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation 
(EU) 2020/ 692 relevant for d ay-old chicks;  
II.2.4.7. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(12) in a means of 
transport which is constructed in accordance with II. 2.4.6(a) and was cleaned and 
disinfected prior to loading with a disinfectant authorised by th e competent authority of 
the country or territory of origin;  
 (13) II.2.4.8. are intended for a Member State which has been granted the status free from infection 
with Newcastle disease virus without vaccination in accordance with Commission 
Delegated Regu lation (EU) 2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) come from hatching eggs coming from flocks which:  
(2)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(2)or  [have been vaccinated against infection with Newcastle disease virus with an 
inactivated vaccine;]  
(2)or  [have been vaccinated against infection with Newcastle disease virus with a live 
vaccine at the latest 60 days prior to the date the eggs were collected;]  
(c) come from a hatchery where working practices ensure that the hatching eggs 
from which the day -old chicks have hatched, were incubated at completely 
separate times and locations from eggs not satisfying the requirements of point 
(b);] 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 641  EN COUNTRY  Certificate model POU -LT20  
Notes:  
This certificate is intended for entry into the Union of less than 20 heads of poultry other than ratites, including 
when the Union is not the final destination of those animals.  
Guidance on the completion of this official certificate is available i n Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.8.:  Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box I.27:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
01.05 or 01.06.39.  
 
Part II:  
(1) ‘Breeding poultry’ means poultry 72 hours old or more , intended for the production of hatching eggs, as 
defined in Article 2 of Commission Delegated Regulation (EU) 2020/ 692. 
(2) Keep as appropriate.  
(3) ‘Productive poultry’ means poultry 72 hours old or more , reared for the production of meat, eggs for 
consumption or other products or for restocking supplies of game birds, as defined in Article 2 of 
Commission Delegated Regulation (EU) 2020/ 692. 
(4) ‘Poultry intended for slaughter’ means poultry to be transported directly to a slaughterhouse , as defined 
in Article 2 of Commission Delegated Regulation (EU) 2020/ 692. 
(5) ‘Day -old chicks’ means poultry less than 72 hours old , as defined in Article 2 of Commission Delegated 
Regulation (EU) 2020/ 692.  
(6) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
(7) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regulation (EU) 2020/ 692, and are listed in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(8) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commis sion Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/… 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the tabl e. 
(9)  To be completed when animals were vaccinated against infection with Newcastle disease virus.  
(10)  The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(11) Tests should be carried ou t on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(12) The date of l oading cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the 
entry of these animals from that zone.  
(13) This guarantee is  required only for  consignments intended for a Member State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 642  EN COUNTRY  Certificate model POU -LT20  
(14) Applicable for breeding poultry and productive poultry.  
(15) Applicable for poultry intended for slaughter.  
(16) This guarantee applies only for poultry belonging to the species of Gallus gallus  and turkeys . 
(17) If any of the results were positive for the serotypes belo w during the life of the flock, indicate as 
positive:  
- flocks of breeding poultry: Salmonella  Hadar, Salmonella  Virchow and Salmonella Infantis;  
- flocks of productive poultry: Salmonella  Enteritidis and Salmonella  Typhimurium.  
(18) Complete if appropriat e: indicate the name and active substance of antimicrobials used.  
(19) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 643  EN CHAPTER 33: MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE 
UNION OF LESS THAN 2 0 HATCHING EGGS OF P OULTRY OTHER THAN 
RATITES (MODEL ‘HE -LT20’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border  Control Post  
  Airplane   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
   Germinal products    
     
     
     
I.21  For transit to  I.22  For internal market  
 Third country  ISO country code  I.23  Re-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 644  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Breed/Category   Identification 
system  Identification number   Quantity  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 645  EN COUNTRY  Certificate model HE-LT20  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Public health attestation  
I, the undersigned official veterinarian, hereby certify, that the hatching eggs described above:  
(12)[II.1. 1. The Salmonella  control programme referred to in Article 10 of Regulation (EC) No 
2160/2003 and the specific requirements for the use of antimicrobials and vaccines in 
Regulation (EC) No  1177/2006, have been applied to the parent flock of origin and this 
parent flock has been tested for Salmonella  serotypes of public health significance:  
Identification of 
the flock  Age of the 
birds  Date of last sampling of 
the flock from which the 
testing result is 
known[dd/mm/yyyy]  Result of all testing in the 
flock(13) 
Positive  Negative  
     
(12)[II.1.2 . Neither Salmonella  Enteritidis nor Salmonella  Typhimurium were detected within the control 
progr amme referred to in point II.1.1 .] 
(14)[II.1.3 . If the Member States of destination is Finland or Sweden, the hatching eggs come from flocks 
which have tested negative for Salmonella  in accordance with the rules laid down in Decision 
2003/644/EC.]  
 
II.2. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the hatching eggs(1) of poultry other than ratites 
described in this certificate:  
II.2.1. form a single consignment of less than 20 hatching eggs;  
II.2.2. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate:  
(a) is authorised and listed in Part 1 of Annex IX to Commission Implementing Regulation 
(EU) 2020/ … [SANTE/7140/2020 ] for entry into the Union of hatching eggs of poultry;  
(b) carries out a surveillance  programme for highly pathogenic avian influenza in 
accordance with Article 105(a) of Commission Delegated Regulation (EU) 2020/ 692; 
(c) is considered free from highly pathogenic avian influenza in accordance with Article 38 
of Commission Delegated Regulat ion (EU) 2020/ 692; 
(d) is considered free from infection with Newcastle disease virus in accordance with 
Article 39 of Commission Delegated Regulation (EU) 2020/ 692;  
II.2.3. come from the zone referred to in point II.2 .2, in which:  
(3)either  [(a) vaccination against highly pathogenic avian influenza is not carried out;]  
(3)(4)or [(a) vaccination against highly pathogenic avian influenza is carried out in accordance with 
a vaccination programme that complies with the requirements set out in Annex XI II to 
Commission Delegated Regulation (EU) 2020/ 692;] 
(3)either  [(b) vaccination against infection with Newcastle disease virus with vaccines which do not 
comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU ) 2020/ 692 is prohibited;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 646  EN COUNTRY  Certificate model HE-LT20  
(3)(5)or [(b) vaccination against infection with Newcastle disease virus with vaccines which comply 
only with the general criteria of Annex XV to Commission Delegated Regulation (EU) 
2020/ 692 is not prohibited, and the hatching e ggs: 
(i) come from flocks which:  
- have not been vaccinated with such vaccines for a period of at least the 12 
months prior to the date of loading of the consignment for dispatch to the 
Union;  
- underwent a virus isolation test(6) for infection with Newcastle disease virus 
carried out on a random sample of cloacal swabs taken from at least 60 birds 
in each flock, not earlier than 2 weeks prior to the date of loading of the 
consignment for dispatch to the Union, and in which no avia n 
paramyxoviruses with an ICPI of more than 0,4 were found;  
- were kept in isolation under official surveillance on the establishment of 
origin during the 2 weeks prior to the date of loading of the consignment for 
dispatch to the Union;  
- during the period of 60 days prior to the date of loading of the consignment 
for dispatch to the Union, were not in contact with poultry which do not 
fulfil the conditions in first and second intend above;  
(ii) have not been in contact in the hatchery or during transport with po ultry or 
hatching eggs not meeting the requirements set out in (i);]  
II.2.4. come from the establishment, indicated in Box I.11:  
(a) which is registered by and is under the control of the competent authority of the country 
or territory of origin and has a syst em in place to maintain for at least 3 years up -to-date 
information on animals, movements and production records, in accordance with Article 
8 of Commission Delegated Regulation (EU) 2020/ 692; 
(b) which receives regular animal health visits from a veterinarian  for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, 
at a frequency that is proportional to the risk posed by the  establishment;  
(c) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases, at t he time of 
dispatch of the hatching eggs to the Union;  
(d) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle diseas e virus for at least 30 days prior to the date of loading 
for dispatch to the Union;  
II.2.5. come from a flock which:  
(a) has remained in zone referred to in point II. 2.2 for a continuous period of at least 3 
months immediately prior to the date of loading of the hatching eggs for dispatch to the 
Union;  
and where the flock was imported into the zone referred to in point II. 2.2, the import 
took place in accordance with animal health requirements that are at least as stringent as 
the relevant requirements of Regulation (EU) 2016/429 and Commission Delegated 
Regulation (EU) 2020/ 692 and the zone from where the animals were imported, is listed This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 647  EN COUNTRY  Certificate model HE-LT20  
in Part 1 of Annex IV to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ] for entry into the Union of breeding poultry other than ratites and 
productive poultry other than ratites;  
(b) has been kept for a continuous period of at least 3 weeks immediately prior to the date 
of loading of the hatching eggs for dispatch to the Union in an establishment:  
(i) in whi ch no confirmed case of infection with low pathogenic avian influenza 
viruses has been reported for at least 21 days prior to the date of collection of 
the hatching eggs;  
(7) [(ii) which is registered by and is under the control of the competent authority of the 
country or territory of origin and has a system in place to maintain for at least 3 
years up -to-date information on animals, movements and production records, 
in accordance with Article 8 of Commission Delegated Regulation (EU) 
2020/ 692; 
(iii) which  receives regular animal health visits from a veterinarian for the purpose 
of the detection of, and information on, signs indicative of the listed diseases 
referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species, at  a frequency that is proportional to the risk posed by 
the establishment;  
(iv) which was not subject to national restriction measures for animal health 
reasons, including for the listed diseases referred to in Annex I to Commission 
Delegated Regulation (EU ) 2020/ 692 relevant for the species and emerging 
diseases, at the time of dispatch of the hatching eggs to the Union;  
(v) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of h ighly pathogenic avian 
influenza or infection with Newcastle disease virus for at least 30 days prior to 
the date of loading for dispatch to the Union;]  
 (3)either  [(c) has not been vaccinated against highly pathogenic avian influenza;]  
 (3)(4)or [(c) has been vaccinated against highly pathogenic avian influenza in accordance with a 
vaccination programme which complies with the requirements set out in Annex XIII to 
Commission Delegated Regulation (EU) 2020/ 692;] 
 (3)either  [(d) has not been vaccinated against infection with Newcastle disease virus in the last 12 
months prior to the date of loading of the consignment for dispatch to the Union;]  
 (3)or [(d) has been vaccinated against infection with Newcastle disease virus in the last 12 months 
prior to t he date of loading of the consignment for dispatch to the Union, with vaccines 
that comply with both the general and specific criteria of Annex XV to Commission 
Delegated Regulation (EU) 2020/ 692; 
(8) 
Identification 
of the flock  Age of 
the 
birds  Date of 
vaccination  Name and 
type of 
virus strain 
used Batch 
number 
of the 
vaccine  Name of 
the 
vaccine  Manufacturer 
of the 
vaccine  
 
       
] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 648  EN COUNTRY  Certificate model HE-LT20  
(e) underwent serological and/or bacteriological tests(6) within the period of 90 days prior to 
the date of loading of the day -old chicks for dispatch to the Union at a level which gives 
95% confidence of detecting infection at 5% prevelance and was found not to be infected 
or showed any grounds for suspecting a ny infection, by the following agents:  
(3)either  [Salmonella  Pullorum, Salmonella  Gallinarum and Mycoplasma  gallisepticum  (in case 
of Gallus gallus );] 
(3)or [Salmonella  arizonae  (serogroup O:18(k)), Salmonella  Pullorum and Salmonella  
Gallinarum, Mycoplasma  meleagridis  and Mycoplasma  gallisepticum  (in case of 
Meleagris gallopavo );]  
(3)or [Salmonella  Pullorum and Salmonella  Gallinarum (in case of Numida meleagris , 
Coturnix coturnix , Phasianus colchicus , Perdix perdix and Anas spp );]  
(f) has been isolated on  the establishment of origin for a period of at least 21 days prior to the 
collection of the eggs;  
(g) had no contact with poultry or hatching eggs of a lower health status, or with captive or 
wild birds for a continuous period of at least 3 weeks immediat ely prior to the date of 
loading of the hatching eggs for dispatch to the Union;  
(h) did not show symptoms of transmissible diseases at the time of collection of the hatching 
eggs;  
(i) has been subjected to a clinical inspection(9) within the 24 hours prio r to loading of the 
hatching eggs for dispatch to the Union, and showed no signs indicative of the occurrence 
of diseases, including the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and em erging diseases;  
II.2.6. were:  
(a) not vaccinated against highly pathogenic avian influenza;  
(b) not vaccinated against infection with Newcastle disease virus;  
(c) disinfected in accordance with the instructions of the competent authority of the country 
or ter ritory of origin;  
II.2.7. were collected [on ___/___/____ (dd/mm/yyyy)](3) [from ___/___/____ (dd/mm/yyyy) to 
___/___/____ (dd/mm/yyyy)] (3); (10)  
II.2.8. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that the  hatching eggs cannot fall out;  
(b) are designed to allow cleaning and disinfection;  
(c) contain only hatching eggs of the same species, category and type coming from the same 
establishment;  
(d) are closed in accordance with the instructions of the compet ent authority of the country or 
territory of origin to avoid any possibility of substitution of the content;  
(e) are: 
(3)either   [disposable, clean and used for the first time;]  
(3)or  [cleaned and disinfected before loading of the hatching eggs in accorda nce with the 
instructions of the competent authority of the country or territory of origin;]  
(f) bear the information set out in Annex XVI to Commission Delegated Regulation (EU) 
2020/ 692 relevant for hatching eggs of poultry;  
II.2.9. are loaded for dispatch to the Union in a means of transport which is constructed in accordance 
with II. 2.8(a) and (b) and was cleaned and disinfected with a disinfectant authorised by the 
competent authority of the country or territory of origin and dried or allowed to dry immediately 
before loading of the hatching eggs for dispatch to the Union;  
 (11)[II.2.10. are intended for a Member State which has been granted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Commissi on Delegated This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 649  EN COUNTRY  Certificate model HE-LT20  
Regulation (EU) 2020/ 689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) come from flocks which:  
(3)either  [have not been vaccinated against infection with Newcastle disease virus;]  
(3)or  [have bee n vaccinated against infection with Newcastle disease virus with an inactivated 
vaccine;]  
(3)or  [have been vaccinated against infection with Newcastle disease virus with a live vaccine 
at the latest 60 days prior to the date the eggs were collected;]  
 
Notes: 
This certificate is intended for entry into the Union less than 20 hatching eggs of poultry other than ratites, 
including when the Union is not the final destination of those germinal products.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) [IA FOOD] . 
 
Part I:  
Box I.8.:  Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to 
Commission Implementing Regulati on (EU) 2020/ … [SANTE/7140/2020 ]. 
Box I.27:  Description of consignment  
 “CN code ”: use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.  
 “Category ”: select one of the following: Pure line/grandparents/parents/laying pullets/others.  
 
Part II:  
(1) Hatching eggs as defined in Article  4 of Regulation (EU) 2016/429.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to Commission 
Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
(3) Keep  as appropriate.  
(4) This applies only to zones in which vaccination against highly pathogenic avian influenza is carried out 
in accordance with a vaccination programme that complies with the requirements set out in Annex XIII 
to Commission Delegated Regul ation (EU) 2020/ 692, and are listed in Part 1 of Annex IX to 
Commission Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ] with the entry “A” in 
column “---” of the table.  
(5) This guarantee is required only for poultry coming from zones in which the use of vaccines against 
infection with Newcastle disease virus which comply only with the general criteria of Annex XV to 
Commission Delegated Regulation (EU) 2020/ 692 is not prohibited, in accordance with Article 37(e)(ii) 
thereof, and are listed in Part 1 of Annex IX to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ] with the entry “B” in column “---” of the table.  
(6) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territ ory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(7) Keep in case the hatching eggs are dispatched from a hatchery.  
(8)  To be completed when animals were vaccin ated against infection with Newcastle disease virus.  
(9)  The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(10) The date(s) of collection cannot be a date prior to the date of authorisati on of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union in relation to the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 650  EN COUNTRY  Certificate model HE-LT20  
entry of these hatching eggs from that zone.  
(11) This guarantee is required only for  consignments intended for a Mem ber State which has been granted 
the status free from infection with Newcastle disease virus without vaccination in accordance with 
Commission Delegated Regulation (EU) 2020/ 689. 
(12) This guarantee applies only for hatching eggs belonging to the species o f Gallus gallus  and turkeys.  
(13) If any of the results were positive for the following serotypes during the life of the parent flock, indicate 
as positive: below during the life of the flock, indicate as positive: Salmonella hadar, Salmonella 
virchow and Salmonella infantis . 
(14) Delete if consignment is not intended for Finland or Sweden.  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 651  EN CHAPTER 34: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CAPTIVE BIRDS  (MODEL ‘CAPTIVE - BIRDS’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying d ocuments  
  
  Railway   Road veh icle  Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
     
     
   Quarantine establishment    
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 652  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category   Identification 
system  Identification number   Quantity  
        
        
        
        
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 653  EN COUNTRY  Certificate model CAPTIVE -BIRDS  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the captive birds(1) described in this 
certificate:  
II.1.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate, is 
authorised and listed in Part 1 of Annex IV to Commission Implementing Regulation (EU) 
2020/… [ SANTE/7140/2020 ] for entry i nto the Union of captive birds;  
II.1.2. come from the establishment(3), indicated in Box I.11 approved by the competent authority of 
the country or territory of origin in accordance with requirements which are at least as 
stringent as those laid down in Article 56 of Commission Delegated Regulation (EU) 
2020/ 692 and: 
(a) the approval of which has not been suspended or withdrawn;  
(b) which is under the control of the competent authority of the country or territory of 
origin and has a system in place to maintain fo r at least 3 years up -to-date information 
on animals, movements and production records, in accordance with Article 8 of 
Commission Delegated Regulation (EU) 2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to in 
Annex I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, 
at a frequency that is proportional to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, 
including for the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases, at the time 
of dispatch of the  animals to the Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathogenic avian influenza 
or infection with Newcastle disease virus for at least 30 days pri or to the date of 
loading for dispatch to the Union;  
(4)[(f) in which  
(5)either  [avian chlamydiosis has not been confirmed for a period of at least 6 months prior to 
the date of loading of the captive birds for dispatch to the Union;]  
(5)or [avian chlamydiosis has been confirmed during the last 6 months prior to the date of 
loading of the captive birds for dispatch to the Union, but not during the last 60 days, 
and the measures provided for in Article 55(e)(i) of Commission Delegated Regulation 
(EU)  2020/ 692 have been applied;]  
(5)or [the animals have been kept under veterinary supervision for the 45 days prior to the 
date of loading for dispatch to the Union and were treated against avian chlamydiosis;]  
II.1.3. come from a flock which has  been subje cted to a clinical inspection(6) within the 24 hours 
prior to loading of the animals for dispatch to the Union, and showed no signs indicative of 
the occurrence of diseases, including the listed diseases referred to in Annex I to Commission 
Delegated Regul ation (EU) 2020/ 692 relevant for the species and emerging diseases;  
II.1.4. the animals:  
(a) have remained in the establishment indicated in Box I.11 since hatching or for a This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 654  EN COUNTRY  Certificate model CAPTIVE -BIRDS  
continuous period of at least 3 weeks  immediately prior to the date of loading for 
dispatch to the Union ; 
(b) have not been vaccinated against highly pathogenic avian influenza;  
(c) have been vaccinated against infection with Newcastle disease virus with vaccines that 
comply with both the general and specific criteria of Annex XV to Commission 
Dele gated Regulation (EU) 2020/ 692; 
(d) have been subjected to a virus detection test(7) for highly pathogenic avian influenza 
and infection with Newcastle disease virus with negative results within the period of 7 
to 14 days prior to the date of loading for dispa tch to the Union;  
(e) had no contact with animals of a lower health status since hatching or for a continuous 
period of at least 3 weeks immediately prior to the date of loading for dispatch to the 
Union ; 
(f) are not to be killed under a national programme for the  eradication of diseases, 
including the listed diseases referred to in Annex I to Commission Delegated 
Regulation (EU) 2020/ 692 relevant for the species and emerging diseases;  
(g) have  been subjected to a clinical inspection(6) on ___/___/____ (dd/mm/yyyy), within 
the 24 hours prior to loading for dispatch to the Union, and showed no signs indicative 
of the occurrence of diseases, including the listed diseases referred to in Annex I to 
Commission Delegated Regulation (EU) 2020/ 692 relevant for the species and 
emerging diseases;  
II.1.5. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that:  
(i) animals cannot escape or fall out;  
(ii) visual inspection of the space where animals are kept is possible;  
(iii) the escape of animal excrements, litter, feed or feathers is prevented or 
minimized;  
(b) contain only captive birds of the same species coming from the same establishment;  
(c) are used for the first thime;  
(d) are closed in accordance wi th the instructions of the competent authority of the country 
or territory of origin to avoid any possibility of substitution of the content;  
(e) bear the in formation set out in Annex XVI to Commission Delegated Regulation (EU) 
2020/ 692 relevant for captiv e birds;  
II.1.6. are loaded for dispatch to the Union on ___/___/____ (dd/mm/yyyy)(8) in a means of transport 
which is con structed in accordance with II.1 .5(a) and was cleaned and disinfected prior to 
loading with a disinfectant authorised by the competent  authority of the country or territory of 
origin;  
(9)[II.1.7. are intended for a Member State which has been granted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Commission Delegated 
Regulation (EU) 20 20/689, and they:  
(a) have not been vaccinated against infection with Newcastle disease virus;  
(b) were kept in isolation for at least 14 days prior to the date of loading of the 
consignment for dispatch to the Union in the establishment of origin or quara ntine This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 655  EN COUNTRY  Certificate model CAPTIVE -BIRDS  
establishment under the supervision of an official veterinarian, where:  
(i) no poultry was vaccinated against infection with Newcastle disease virus during 
the period of at least 21 days prior to the date of loading of the consignment;  
(ii) no other birds have entered into the establishment during that time;  
(iii) no vaccination has been carried out;  
(c) have tested(7) negative to serological tests to detect antibodies against Newcastle 
disease virus, performed on blood samples at a level which gives 95% confidence of 
detecting infection at 5% prevalence and which were taken during the period of at 
least 14 days prior to the date of loading for dispatch to the Union.]  
 
Notes:  
This certificate is intended for entry into the Union of captive birds, inclu ding when the Union is not the final 
destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.8.:  Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to 
Commission Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]. 
Box I.12:  Provide the information on the quarantine establishment, approved in accordance with Ar ticle 13 of 
Commission Delegated Regulation (EU) 2019/2035, where the captive birds must be transported 
without delay following entry into the Union  
Box I.27:  Description of consignment  
 “CN code” : use the appropriate Harmonised System (HS) code of the Wor ld Customs 
Organisation: 01.36.31, 01.06.32 or 01.06.39.  
 “Identification system”:  The animal must be individually identified by means of a unique marked 
closed leg -ring or an injectable transponder in accordance with Article 53 of Commission 
Delegated Regulation (EU) 2020/ 692. 
 
Part II:  
(1) ‘Captive birds’  as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IV to Commission 
Implementing Regulation (EU) 2020/… [ SANTE/7140/202 0]. 
(3) The name and unique approval number of the establishment must appear on the list of establishments 
drawn up and published by the Commission. 
(4)  This guarantee is required only for  consignments of psittacidae.  
(5) Keep as appropriate.  
(6) The clin ical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(7) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and test ing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU) 2017/625.  
(8) The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone 
thereof for entry into  the Union, or a date in a period when restriction measures have been adopted by 
the Union in relation to the entry of these animals from that country or territory or zone thereof.  
(9) This guarantee is required only for  consignments of captive birds of th e galliformes species intended This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 656  EN COUNTRY  Certificate model CAPTIVE -BIRDS  
for a Member State which has been granted the status free from infection with Newcastle disease virus 
without vaccination in accordance with Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 657  EN CHAPTER 35: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF HATCHING EG GS OF CAPTIVE BIRDS (MODEL ‘HE -CAPTIVE -
BIRDS) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Airplane   Vessel I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
   Germinal products    
     
     
     
I.21  For transit to  I.22  For internal market  
 Third country  ISO country code  I.23  Re-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 658  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Breed/Category   Identification 
system  Identification number   Quantity  
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 659  EN COUNTRY  Certificate model HE -CAPTIVE -BIRDS  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
II.1. Animal health attestation  
I, the undersigned official veterinarian, hereby certify that the hatching eggs of captive birds(1) described in 
this certificate:  
II.1.1. come from the zone with code _ _ - _ (2) which, at the date of issue of this certificate, is authorised 
and listed in Part 1 of Annex IX to Commi ssion Implementing Regulation (EU) 2020/ … 
[SANTE/7140/2020 ] for entry into the Union of hatching eggs of captive birds;  
II.1.2. come from the establishment(3) indicated in Box I.11, approved by the competent authority of the 
country or territory of origin in accordance with requirements which are at least as stringent as 
those laid down in Article 56 of Commission Delegated Regulation (EU) 2020/ 692 and: 
(a) the approval of which has not been suspended or withdrawn;  
(b) which is under the control of the competent au thority of the country or territory of origin 
and has a system in place to maintain for at least 3 years up -to-date information on animals, 
movements and production records, in accordance with Article 8 of Commission Delegated 
Regulation (EU) 2020/ 692; 
(c) which receives regular animal health visits from a veterinarian for the purpose of the 
detection of, and information on, signs indicative of the listed diseases referred to in Annex 
I to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species, at a 
frequency that is proportional to the risk posed by the establishment;  
(d) which was not subject to national restriction measures for animal health reasons, including 
for the listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 
2020/692 relevant for the species and emerging diseases, at the time of dispatch of the 
animals to the Union;  
(e) within a 10 km radius of which, including, where appropriate, the territory of a 
neighbouring country, there has been no outbreak of highly pathoge nic avian influenza or 
infection with Newcastle disease virus for at least 30 days prior to the date of loading for 
dispatch to the Union;  
(4)[(f) in which;  
(5)either   [avian chlamydiosis has not been confirmed for a period of at least 6 months prior to the 
date of loading of the hatching eggs of captive birds for dispatch to the Union;]  
(5)or  [avian chlamydiosis has been confirmed during the last 6 months prior to the date of 
loading of the hatching eggs of captive birds for dispatch to the Union, but n ot during the 
last 60 days, and the measures provided for in Article 55(e)(i) of Commission Delegated 
Regulation (EU) 2020/ 692 have been applied;]  
(5)or  [the animals from which the hatching eggs have been obtained, have been kept under 
veterinary supervis ion for the 45 days prior to the date of collection of the hatching eggs 
and were treated against avian chlamydiosis;]  
II.1.3. come from animals which:  
(a) have remained in the establishment indicated in Box I.11 since hatching or for a continuous 
period of at  least 3 weeks  immediately prior to the date of loading of the hatching eggs for 
dispatch to the Union ; 
(b) have not been vaccinated against highly pathogenic avian influenza;  
(c) have been vaccinated against infection with Newcastle disease virus with vaccines th at This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 660  EN COUNTRY  Certificate model HE -CAPTIVE -BIRDS  
comply with both the general and specific criteria of Annex XV to Commission Delegated 
Regulation (EU) 2020/ 692; 
(d) have been subjected to a virus detection test(7) for highly pathogenic avian influenza and 
infection with Newcastle disease virus with negat ive results within the period of 7 to 14 
days prior to the date of collection of the hatching eggs;  
(e) had no contact with animals of a lower health status since hatching or for a continuous 
period of at least 3 weeks immediately prior to the date of collecti on of the eggs ; 
(f) are not to be killed under a national programme for the eradication of diseases, including the 
listed diseases referred to in Annex I to Commission Delegated Regulation (EU) 2020/ 692 
relevant for the species and emerging diseases;  
(g) have  been  subjected to a clinical inspection(6) on ___/___/____ (dd/mm/yyyy), within the 24 
hours prior to loading of the hatching eggs for dispatch to the Union, and showed no signs 
indicative of the occurrence of diseases, including the listed diseases referred t o in Annex I 
to Commission Delegated Regulation (EU) 2020/ 692 relevant for the species and emerging 
diseases;  
II.1.4. are loaded for dispatch to the Union in containers which:  
(a) are constructed in such a way that hatching eggs cannot fall out;  
(b) contain only hatching eggs of captive birds of the same species coming from the same 
establishment;  
(c) are used for the first thime;  
(d) are closed in accordance with the instructions of the competent authority of the country or 
territory of origin to avo id any possibility of substitution of the content;  
(e) bear the information set out in Annex XVI to Commission Delegated Regulation (EU) 
2020/ 692 relevant for hatching eggs of captive birds;  
II.1.5. are loaded for dispatch to the Union on ___/___/____ (dd/ mm/yyyy)(8) in a means of transport 
which is const ructed in accordance with II.1 .4(a) and was cleaned and disinfected prior to loading 
with a disinfectant authorised by the competent authority of the country or territory of origin;  
(9)[II.1.6. are intended  for a Member State which has been granted the status free from infection with 
Newcastle disease virus without vaccination in accordance with Commission Delegated 
Regulation (EU) 2020/ 689, and they come from animals which:  
(a) have not been vaccinated agai nst infection with Newcastle disease virus;  
(b) were kept in isolation for at least 14 days prior to the date of loading of the consignment for 
dispatch to the Union in the establishment of origin or quarantine establishment under the 
supervision of an off icial veterinarian, where:  
(i) no poultry was vaccinated against infection with Newcastle disease virus during the 
period of at least 21 days prior to the date of loading of the consignment;  
(ii) no other birds have entered into the establishment during th at time;  
(iii) no vaccination has been carried out;  
(c) have tested(7) negative to serological tests to detect antibodies against Newcastle disease 
virus, performed on blood samples at a level which gives 95% confidence of detecting 
infection at 5% prevalence and which were taken during the period of at least 14 days prior 
to the date of lo ading for dispatch to the Union. ] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 661  EN COUNTRY  Certificate model HE -CAPTIVE -BIRDS  
 
Notes:  
This certificate is intended for entry into the Union of hatching eggs of captive birds, including when the Union is 
not the final destination of those products.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) [IA FOOD] . 
 
Part I:  
Box I.8.:  Provide the code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to 
Commission Implementing Regulati on (EU) 2020/ … [SANTE/7140/2020 ]. 
Box I.27:  Description of consignment  
 “CN code ”: use the appropriate Harmonised System (HS) code of the World Customs Organisation: 
04.07.  
 
Part II:  
(1) ‘Captive birds’  as defined in Article 4 of Regulation (EU) 2016/429.  
(2) Code of the zone as it appears in column 2 of the table in Part 1 of Annex IX to Commission 
Implementing Regulation (EU) 2020/ … [SANTE/7140/2020 ]. 
(3) The name and unique approval number of the establishment must appear on the list of establishments 
drawn up and published by the Commission. 
(4) This guarantee is required only for  consignments of psittacidae.  
(5) Keep as appropriate.  
(6) The clinical inspection must have been carried out by an official veterinarian of the country or territory 
of origin.  
(7) Tests should be carried out on samples taken by or under the control of the competent authority of the 
country or territory of origin and testing should be carried out in an official laboratory designated in 
accordance with Article 37 of Regulation (EU ) 2017/625.  
(8) The date of loading cannot be a date prior to the date of authorisation of the country or territory or zone 
thereof for entry into the Union, or a date in a period when restriction measures have been adopted by 
the Union in relation to the entry of these animals from that country or territory or zone thereof.  
(9) This guarantee is required only for  consignments of captive birds of the galliformes species intended for 
a Member State which has been granted the status free from infection with N ewcastle disease virus 
without vaccination in accordance with Commission Delegated Regulation (EU) 2020/ 689. 
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 662  EN CHAPTER 36: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF QUEEN HONEYBEE S (MODEL ‘QUE’)  
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No  Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 663  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net  weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
       Net weight  
        
    Nature of 
commodity  Number of packages    
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 664  EN COUNTRY  Certificate model QUE  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the honeybee queens described in Part I : 
II.1. come from the come from the zone with code: __ __ - __(2) which, at the date of issuing this certificate is 
listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] 
for entry into the Union of queen honeybees.  
II.2. have remained continuously:  
(i) in the zone referred to in  point II.1 since hatching, and  
(ii) in the establishment of origin since hatching, in which period no animals have been introduced.  
II.3. had no contact with honeybees of a lower health status since hatching.  
II.4. are not to be killed under a national progr amme for the eradication of diseases, including the relevant 
listed diseases referred to in Annex 1 of Commission Delegated Regulation (EU) 2020/ 692 and emerging 
diseases.  
II.5. have been dispatched in closed cages each containing one single queen honeybee  with a maximum 20 
accompanying attendants:  
II.5.1 . in packaging material which, before packing the queen honeybees of the consignment:  
(i) was new;  
(ii) had not been in contact with any bees and brood combs;  
(iii) has been subject to all precautions to prevent its contamination with pathogens causing 
diseases of honeybees.  
II.5.2 . accompanied by feedingstuff free from pathogens causing their diseases;  
II.5.3 . in packaging material and with accompanying products which have undergone a visual 
examination before dispatch to the Union to ensure that they do not pose an animal health risk and 
do not contain Aethina tumida  (Small hive beetle) and Tropilaelaps  mite in any of their life stages.  
II.5.4 . directly from the establishment of origin to the Union without passing through any other 
establishment without being unloaded in any place that does not comply with the requirements laid 
down in point II.7 since t hey were dispatched from their establishment of origin until dispatch to 
the Union and have not been in contact with animals of a lower health status.  
II.6. have  been subjected to a clinical inspection within the 24 hours prior to loading for dispatch to t he 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not detect 
signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in Annex 
1 of Commission Delegated Regulati on (EU) 2020/ 692 and emerging diseases.  
II.7. originate from an apiary:  
II.7.1. in and around which, in an area of 100 km radius, including where appropriate the territory of 
a neighbouring country  
(i) infestation with Aethina tumida  (Small hive beetle) or infestation with Tropilaelaps  spp. has 
not been reported;  
(ii) there are no restrictions in place due to a suspicion, case or outbreak of the diseases referred 
to (i).  
II.7.2 . in and around which, in an area of 3 km radius, including where appropriate  the territory of a 
neighbouring country;  
(i) American foulbrood has not been reported for at least 30 days prior to the date of dispatch 
to the Union;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 665  EN COUNTRY  Certificate model QUE  
(ii) there are no restrictions in place due to a suspicion or a confirmed case of American 
foulbrood du ring the period referred to in point (i);  
[(iii) there had been a previous confirmed case of American foulbrood before the period referred 
to in point (i) and all hives were subsequently checked by the competent authority in the 
third country or territory of origin and all infected hives were treated and subsequently 
inspected with favourable results within a period of 30 days from the date of last recorded 
case of that disease.] (1) 
II.8. originate from hives from which samples of the comb have been tested  for American foulbrood with 
negative results within the period of 30 days prior to the date of their dispatch to the Union.  
[II.9. Additional guarantees regarding category C diseases: (1)(4) 
[II.9.1 . the queen honeybees:  
(i) originate from a third country or territory or zone thereof free from infestation with 
Varroa spp   
(ii) in the third country or territory of origin or zone thereof, infestation with Varroa spp . has 
not been reported for a period of 30 days prior to the date of loading for dispatch to the 
Union;  
(iii) every precaution has been taken to avoid contamination of the consignment with Varroa 
spp. during loading and dispatch to the Union.] (1)(5) 
 
Notes:  
This certificate is intended for entry into the Union of honeybee queen s, including when the Union is not the final 
destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.27:  “Nature of commodity ”: indicate queens with maximum 20 attendants.  
 
Part II:  
(1) Delete as appropriate  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing Regulation 
(EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the Union, or a 
date in a period when restriction measures have been adopted by the Union against entries of these animals 
from this zone.  
(4) Only applicable when the M ember State of destination either has disease -free status for the relevant C disease 
or has an approved eradication programme.  
(5) For countries with entry VAR in Annex IV to Regulation (EU) 2020/xx ( SANTE/7140/2020 ) recognised free 
of infestation with Varroa spp. (Varroasis).  
 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 666  EN COUNTRY  Certificate model QUE  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 667  EN CHAPTER 37: MODEL OFFICIAL CERTI FICATE FOR THE ENTRY  INTO THE 
UNION OF BUMBLE BEES  (MODEL ‘BBEE’)  
COUNTRY  Official certificate to  the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region  of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of  loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
     
     
     
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For re-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 668  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category      Quantity  
        
       Net weight  
        
    Nature of 
commodity  Number of packages    
        
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 669  EN COUNTRY  Certificate model BBEE  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that the bumble bees described in Part I : 
II.1. come from the come from the zone with code: __ __ - __(2) which, at the date of issuing this certificate is 
listed in Part 1 of Annex II to Commission Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] 
for entry into the Union of  bumble bees.  
II.2. have remained continuously:  
(i) in the zone referred to in point II.1 since hatching, and  
(ii) in the establishment of origin since hatching, in which no animals  have been introduced into their 
epidemiological unit of origin during that period of time.  
II.3. had no contact with animals of a lower health status since hatching.  
II.4. are not to be killed under a national programme for the eradication of diseases, including listed diseases 
and emerging diseases.  
II.5. have been dispatched in closed containers each containing a colony of maximum 200 adult bumble bees, 
with or without a queen:  
II.5.1 . in packaging material which, before packing the bumble bees of the consignment:  
(i) was new;  
(ii) had not been in contact with any bees and brood combs;  
(iii) has been subject to all precautions to prevent its contamination with pathogens causing 
diseases of bumble bees.  
II.5.2 . accompanied by feedingstuff free from pat hogens causing their diseases;  
II.5.3 . in packaging material and with accompanying products which have undergone a visual 
examination before dispatch to the Union to ensure that they do not pose an animal health risk 
and do not contain Aethina tumida  (Small hive beetle), in any of their life stages.  
II.5.4 . directly from the establishment of origin to the Union without passing through any other 
establishment and without being unloaded in any place that does not comply with the 
requirements laid down i n points II.7, II.8 since they were dispatched from their 
establishment of origin until dispatch to the Union and have not been in contact with animals 
of a lower health status.  
II.6. have  been subjected to a clinical inspection within the 24 hours prior t o loading for dispatch to the 
Union, carried out by an official veterinarian in the third country or territory of origin, who did not 
detect signs indicative of the occurrence of diseases, including the relevant listed diseases referred to in 
Annex 1 of Co mmission Delegated Regulation (EU) 2020/ 692 and emerging diseases.  
II.7. have been bred and kept in an environmentally isolated bumble bee production establishment which:  
II.7.1 . has facilities which ensure that the production of bumble bees is carried o ut inside of a flying 
insect -proof building;  
II.7.2 . has facilities and equipment which ensure that the bumble bees are further isolated in separate 
epidemiological units and each colony in closed containers within the building throughout the 
whole product ion;  
II.7.3 . the storage and handling of pollen within the facilities is isolated from the bumble bees 
throughout the whole production of bumble bees until it is fed to them;  
II.7.4 . has standard operating procedures to prevent the entry of small hive bee tle into the 
establishment and to regularly survey for the presence of small hive beetle within the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 670  EN COUNTRY  Certificate model BBEE  
establishment.  
II.8. within the establishment come from an epidemiological unit in which infestation with Aethina tumida  
(Small hive beetle) has not been de tected.  
 
Notes:  
This certificate is intended for entry into the Union of bumble bees, including when the Union is not the final 
destination of those animals.  
Guidance on the completion of this official certificate is available in Chapter 2 of Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
 
Part II:  
(1) Delete as appropriate.  
(2) Code of the zone as it appears in Column 2 of Part 1 of Annex I to Commission Implementing 
Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
(3) Date of loading: it cannot be a date prior to the date of authorisation of the zone for entry into the 
Union, or a date in a period when restriction measures have been adopted by the Union against entries 
of these animals from this zone.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 671  EN CHAPTER 38: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF DOGS, CATS AND FERRETS (MODEL ‘ CANIS -FELIS -FERRETS’ ) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
     
     
  Further keeping     
   Confined establishment    
   Quarantine establishment    
    Other   
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  For r e-entry  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 672  EN I.24 Total number of packages  I.25 Total quantity  I.26 Total net weight/gross weight  (kg) 
I.27 Description of consignment  
CN code  Species  Subspecies/Category  Sex Identification 
system  Identification number  Age Quantity  
        
        
        
    Nature of 
commodity     
        
      Test  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 673  EN COUNTRY  Certificate model CANIS -FELIS -FERRETS  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian of ………………………………………….. ( insert name of third country ) 
certify that the animals described in Part I : 
II.1. come from a country, territory or zone  thereof with code: __ __ - __(1) which, on the date of issue 
of this certificate is authorised for the entry into the Union of dogs, cats and ferrets and is listed in 
Part 1 of Annex VI to Commission Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020 ].; 
(2)(3)either  [II.2.  have been dispatched directly from the establishment of origin to the Union without passing 
through any other establishment];  
(2)(3)or [II.2.  have undergone one single assembly operation in the country, territory or zone thereof of o rigin 
which took place for not more than 6 days in an establishment fulfilling the following 
requirements:  
- it is approved for conducting assembly operations of dogs, cats and ferrets by the competent 
authority in the third country or territory in accordanc e with Article 10 of Commission 
Delegated Regulation (EU) 2019/2035;  
- it has a unique approval number assigned by the competent authority of the third country or 
territory;  
- it is listed for that purpose by the competent authority of the third country or te rritory of 
dispatch with the information set out in Article 21 of Commission Delegated Regulation (EU) 
2019/2035;  
- it complies with the record keeping requirements provided for in point (a)(iv) of Article 73(2) 
of Commission Delegated Regulation (EU) 2020/ 692. 
(3)[II.3.  have been loaded for dispatch to the Union on ___/___/____(dd/mm/yyyy)(4) in a means of 
transport which was cleaned and disinfected prior to loading with a disinfectant authorised by the 
competent authority in the third country or territory and constructed in such a way that:  
- animals cannot escape or fall out;  
- visual inspection of the space where animals are kept is possible;  
- the escape of animal excrements, litter or feed is prevented or minimized.]  
II.4 have been subjected with negative res ult to a clinical inspection, carried out by an official 
veterinarian in the third country, territory or zone thereof of origin within 48 hours prior to 
loading for dispatch to the Union for the detection of signs indicative of the occurrence of 
diseases, including the relevant listed diseases referred to in Annex 1 of Commission Delegated 
Regulation (EU) 2020/ 692 and emerging diseases . 
(2)either  [II.5.  are destined for direct entry into the Member State of destination to be isolated in:  
(2)either  [a confin ed establishment;]]  
(2)or [an approved quarantine establishment;]]  
(2)or [II.5.  were at least 12 weeks old at the time of vaccination against rabies and at least 21 days have 
elapsed since the completion of the primary anti -rabies vaccination(5) carried out in accordance 
with the validity requirements set out in Annex III to Regulation (EU) No 576/2013 of the 
European Parliament and of the Council, and any subsequent revaccination was carried out within 
the period of validity of the preceding vac cination(6), and  
(2)either  [they come from, and in case of transit are scheduled to transit through, a territory or third This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 674  EN COUNTRY  Certificate model CANIS -FELIS -FERRETS  
country listed in Annex II to Commission Implementing Regulation (EU) No 577/2013 and 
details of the current anti -rabies vaccination a re provided in columns 1 to 7 in the table 
below;]]  
(2)or [they come from or are scheduled to transit through a territory or third country not listed in 
Annex II to Commission Implementing Regulation (EU) No 577/2013 , and  
details of the current anti -rabie s vaccination are provided in columns 1 to 7 in the table 
below, and  
- a rabies antibody titration test(7), carried out on a blood sample taken by the veterinarian 
authorised by the competent authority not less than 30 days after the preceding 
vaccination and at least three months prior to the date of issue of this certificate, proved 
an antibody titre equal to or greater than 0,5 IU/ml(8) and any subsequent revaccination 
was carried out within the period of validity of the preceding vaccination, and the da te 
of sampling for testing the immune response are provided in column 8 in the table 
below:]]  
Transponder  
Date of 
vaccination 
[dd/mm/yyyy]  Name and 
manufacturer 
of vaccine  Batch 
number  Validity of 
vaccination  
Date of blood 
sampling  
[dd/mm/yyyy]  Alphanumeric 
code of the 
animal  Date of 
implantation 
and/or 
reading (9) 
[dd/mm/yyyy
] 
From  
[dd/mm/yyyy]  
to 
[dd/mm/yyyy]  
1 2 3 4 5 6 7 8 
        
        
        
        
        
(2)either  [II.6.  the consignment includes dogs destined for a Member State listed in the Annex to Commission 
Implementing Regulation (EU) 2018/878 and those dogs have been treated against infestation 
with Echinococcus multilocularis , and the details of the treatment carrie d out by the administering 
veterinarian in accordance with point 2 of Annex XXI to Commission Delegated Regulation (EU) 
2020/ 692(10) (11) are provided in the table below  
Transponder or tattoo. 
Alphanumeric code of 
the dog  Anti -Echinococcus treatment  Administering veterinarian  
Name and 
manufacturer of 
the product  Date 
[dd/mm/yyyy] and 
time of treatment 
[00:00]  Name in capitals, stamp and 
signature  
    
    
    This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 675  EN COUNTRY  Certificate model CANIS -FELIS -FERRETS  
    
    
   ] 
(2)or [II.6.  the dogs have not been treated against infestation with Echinococcus multilocularis. ] 
(2)or [II.6.  the dogs are destined for direct entry into the Member State of destination to be isolated in :  
(1)either  [a confined establishment.]]  
(1)or [an approved quarantine establishment.]]  
 
Notes:  
This certificate is intended for commercial entries into the Union of dogs, cats and ferrets, including when they are 
destined to a confined establishment or to an approved quarantine establishment and when the Union is not the final 
destination of the ani mals and entry into the Union of dogs, cats and ferrets moved in accordance with Article 5(4) 
of Regulation (EU) No 576/2013 of the European Parliament and of the Council . 
Guidance on the completion of this official certificate is available in Chapter 2 of  Annex I to Commission 
Implementing Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.20:   Certified for : indicate  
- “Further keeping” where dogs, cats or ferrets are moved in accordance with Title V of Part II of 
Commission Delegated Regulat ion (EU) 2020/ 692; 
- Confined establishment: as defined in Article 4(48) of Regulation (EU) 2016/429 of the European 
Parliament and of the Council;  
- Quarantine establishment: as defined in Article 3(9) of Commission Delegated Regulation (EU) 
2020/ 688 
- "others"  where dogs ( Canis lupus familiaris ), cats ( Felis silvestris catus ) or ferrets ( Mustela 
putorius furo ) are moved in accordance with Article 5(4) of Regulation (EU) No 576/2013 of the 
European Parliament and of the Council.  
 
Part II:  
(1) Code of the zone as it appears in Column 2 of Part 1 of Annex VI to Commission Implementing 
Regulation (EU) 2020/xx [ SANTE/7140/2020 ]. 
(2) Keep as appropriate.  
(3) Not applicable to the movement of dogs, cats and ferrets other than non -commercial movements  kept as 
pet animals in households that cannot be carried out in accordance with the conditions laid down in 
Article 245(2) or Article 246(1) and (2) of Regulation (EU) 2016/429.  
(4) Date of loading: it cannot be a date prior to the date of authorisation o f the zone for entry into the Union, 
or a date in a period when restriction measures have been adopted by the Union against entries of these 
animals from the zone.  
(5) Any revaccination must be considered a primary vaccination if it was not carried out within the period of 
validity of a previous vaccination.  
(6) A certified copy of the identification and vaccination details of the animals concerned shall be attached to 
the certificate.  
(7) The rabies antibody titration test referred to in point II.5:  
- must be carried out on a sample collected by a veterinarian authorised by the competent authority, at 
least 30 days after the date of vaccination and three months before the date of import ; This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 676  EN COUNTRY  Certificate model CANIS -FELIS -FERRETS  
- must measure a level of neutralising antibody to rabies virus in serum equal to or greater than 
0,5 IU/ml;  
- must be performed by an approved laboratory (list of approved laboratories available at 
http://ec.europa.eu/food/animals/pet -movement /approved -labs_en );  
- does not have to be renewed on an animal, which following that test with satisfactory results, has 
been revaccinated against rabies within the period of validity of a previous vaccina tion. 
 A certified copy of the official report from the approved laboratory on the result of the rabies antibody 
test referred to in point II.5. shall be attached to the certificate.  
(8) By certifying this result, the official veterinarian confirms that he has verified, to the best of his ability 
and w here necessary with contacts with the laboratory indicated in the report, the authenticity of the 
laboratory report on the results of the antibody titration test referred to in point II.5.  
(9) In conjunction with footnote (6), the marking of the animals co ncerned by the implantation of a 
transponder must be verified before any entry is made in this certificate and must always precede any 
vaccination, or where applicable, testing carried out on those animals.  
(10) The treatment against infestation with Echin ococcus multilocularis  referred to in point II.6 must:  
- be administered by a veterinarian within a period of not more than 48 hours and ending not less than 
24 hours before the time of the scheduled entry of the dogs into one of the Member States or parts  
thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878;  
- consist of an approved medicinal product which contains the appropriate dose of praziquantel or 
pharmacologically active substances, which alone or in combination, have bee n proven to reduce the 
burden of mature and immature intestinal forms of Echinococcus multilocularis  in the host species 
concerned.  
(11) The table referred to in point II.6 must be used to document the details of a further treatment if 
administered after t he date the certificate was signed and prior to the scheduled entry into one of the Member States 
or parts thereof listed in the Annex to Commission Implementing Regulation (EU) 2018/878.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 677  EN CHAPTER 39: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF SEMEN OF BOVINE ANIMALS COLLE CTED, PROCESSED AND 
STORED IN ACCORDANCE  WITH REGULATION (EU)  2016/429 AND 
DELEGATED REGULATION  (EU) 2020/ 692 AFTER 20 APRIL 2021 , AND 
DISPATCHED FROM A SE MEN COLLECTION CENTR E WHERE THE SEMEN 
WAS COLLECTED  (MODEL ‘BOV -SEM -A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal  produc ts   
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 678  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 679  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of semen of bovine animals and listed in Annex VII to 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection of the semen and for a period of 30 days after its collection;]  
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the semen and for a period of 30 
days after its collection;]  
II.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia  and lumpy skin disease  were not reported for a period of at least 12 
months immediately prior to collection of the semen and for a period of 30 days after its 
collection;  
II.1.4.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever  virus and contagious bovine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection of the semen and 
for a period of 30 days after its collection, and no vaccinated animals entered into the third 
country, te rritory or zone  during that period.  
II.2. The semen described in Part I was obtained from the donor animals which, before the commencement of 
the quarantine referred to in point II.4.8., originate from establishments   
II.2.1.  situated in an area where foot -and-mouth disease has not been reported within a 10 -km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3 months, and  
 (1)either  [they were  not vaccinated against foot -and-mouth disease;]  
(1)or [they were vaccinated against foot -and-mouth disease during the period of 12 months prior to 
the date of collection of the semen bu t not during the period of the last 30 days immediately 
prior to the date of collection  of the semen, and 5 % (with a minimum of five straws) of each 
quantity of semen taken from a donor animal at any time is submitted to a virus isolation test 
for foot -and-mouth disease with negative results;]  
II.2.2. free from infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae  and M. 
tuberculosis ) and they have never been kept previously in any establishment of a lower health 
status;  
II.2.3.  free from infection with Brucella abortus, B. melitensis  and B. suis  and they have never been 
kept previously in any establishment of a lower health status;  
(1)either  [II.2.4.  free from enzootic bovine leukosis  and they have never been kept previously in any 
establishment of a lower health status;]  
(1)or [II.2.4.  not free from enzootic bovine leukosis and the donor animals are younger than 2 years of age 
and have been produced by dams which have been subjected, with negative results, to a 
serological test for enzootic bovine leukosis after removal of the animal from the dam;]  
(1)or [II.2.4.  not free from enzootic bovine leukosis and the donor animals have reached the age of 2 years 
and have been subjected, with a negative result, to a serological test for enzootic bovine 
leukosis;]  
(1)either  [II.2.5.  free from infectious  bovine rhinotracheitis/infectious pustular vulvovaginitis  and they have 
never been kept previously in any establishment of a lower health status; ] 
(1)or [II.2.5.  not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and the 
donor animals have been subjected, with a negative result, to a serological test (whole virus) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 680  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
on a blood sample;]  
II.2.6.  in which  surra ( Trypanosoma evansi ) has not been reported during the last 30 days, a nd 
(1)either  [surra has no t been  reported in the establishments during the last 2 years;]  
(1)or [surra has been reported in the establishments during the last 2 years and  following the last 
outbreak the establishments have remained under movement restrictions until  
 the infected animals hav e been removed from the establishment, and  
 the remaining animals on the establishment have been subjected to a test for surra  
(Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of 
Annex I  to Delegated Regulation (EU) 2020/ 688, carried out, with negative results, on 
samples taken at least 6 months after the infected animals have been removed from the 
establishment. ] 
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the sem en 
collection centre(3) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of  Annex I to Delegated Regulation (EU) 2020/ 686. 
II.4. The semen described in Part I was obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, contagious bovine ple uropneumonia and lumpy skin disease;  
II.4.2.  remained for a period of at least 6 months prior to the date of collection of the semen in a 
third country or territory or zone thereof referred to in Box I.7.;  
II.4.3.  did not show symptoms or clinical signs of  transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.4.4.  are individually identified as provided for in Article 21(1 ) of Delegated Regulation (EU) 
2020/ 692; 
II.4.5.  for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period  
II.4.5.1.  were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with ri nderpest virus, 
infection with Rift Valley fever virus, contagious bovine pleuropneumonia and 
lumpy skin disease or of an emerging disease relevant for the bovine animals;  
II.4.5.2.  were kept on a single establishment where infection with  Brucella abortus,  B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax,  surra (Trypanosoma 
evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic 
haemorrhagic disease virus, infection with bluetongue virus (serotype 1 -24), 
bovine genital campylobacteriosis and trichomonosis have not been reported;  
II.4.5.3.  were not in contact with ani mals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from 
establishments which do not meet the conditions referred to in point II.4.5.2.;  
II.4.5.4.  were not used for natural breeding;  
II.4.6. have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were present, which on the day of their admission to the semen collection ce ntre complied 
with the following conditions:  
II.4.6.1.  it was not situated in a restricted zone established due to diseases referred to in 
point II.4.5.1.;  
II.4.6.2.  none of the diseases referred to in point II.4.5.2. has been reported for a period of This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 681  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
at least 30 days;  
II.4.6.3.  it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;  
II.4.6.4.  has had no outbreak of foot -and-mouth disease r eported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;  
II.4.7.  were kept in the semen collection centre  
II.4.7.1.  which was not situated in a restricted zone established due to diseases  referred to 
in point II.4.5.1.;  
II.4.7.2.  where none of the diseases referred to in point II.4.5.2. has been reported for a 
period of at least 30 days prior to the date of collection of the semen, and  
(1)(4)[at least 30 days following the date of the coll ection;]  
(1)(5)[until the date of dispatch of the consignment of semen to another Member 
State;]  
II.4.7.3.  situated in an area where foot -and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of a t least 30 
days; and  
(1)(4)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30 days from the date of collection;]  
(1)(5)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to another Member State and the donor animals has been kept at that 
semen collection centre for a continuous period of at least 30 days immediately 
prior to the date of collection of the semen;]  
II.4.8.  comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24): 
(1)either  [II.4.8.1.  they have been kept in a third country, territory or zone thereof free  from infection 
with bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and 
during collection of the semen;]  
(1)and/or  [II.4.8.2.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for  a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof with an approved eradication 
programme against infection with bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.4.8.3.  they have been ke pt in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof where the competent authority of 
the place of origi n of the consignment of semen has obtained the prior written 
consent of the competent authority of the Member State of destination to the 
conditions for establishment of that seasonally disease -free zone and to accept the 
consignment of semen;]  
(1)and/or  [II.4.8.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.4.8.5.  they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1 -24, with negative results, between 28 and 60 days from the date of 
each collection of the semen;]  
(1)and/or  [II.4.8.6.  they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of  at This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 682  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
least every 7 days, in the case of the virus isolation test, or of at least every 28 days, 
in the case of PCR;]  
II.4.9.  comply wi th at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.4.9.1.  they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 150 km of 
the establishment;]  
(1)and/or  [II.4.9.2.  they have been kept in a vector -protected establishment for  a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.4.9.3.  were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with n egative results in each case to  the following tests carried out in an 
official laboratory:  
(1)either  [II.4.9.3.1.  a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]  
(1)and/or  [II.4.9.3.2.  an agent identification test for EHDV 1 -7, with negative results, on 
blood samples taken at the commencement and final collection of the 
semen and during th e collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PCR.]]  
II.4.10.  have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.4.6., 
with negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.4.10.5.2., required in accordance with point 1(b) of Chapter I of Pa rt 1 of Annex II to 
Delegated Regulation (EU) 2020/ 686: 
II.4.10.1.  for infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regu lation (EU) 2020/ 688; 
II.4.10.2.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(6)[II.4.10.3.  for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4 of 
Annex I to Delegated Regulation (EU) 2020/ 688;] 
II.4.10.4.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample if the animals do  not come from 
an establishment free from infectious bovine rhinotracheitis/infectious pustular 
vulvovaginitis;  
II.4.10.5.  for bovine  viral diarrhoea:  
II.4.10.5.1.  a virus isolation test, a test for virus genome or a test for virus 
antigen, and  
II.4.10.5 .2. a serological test to determine the presence or absence of antibodies;  
II.4.11.  have been subjected to the following tests, carried out on blood samples taken within a period 
of at least 21 days,  or 7 days in the case of the tests referred to in points  II.4.11.4. and 
II.4.11.5., prior to the commencement of the quarantine referred to in point II.4.6., with 
negative results, except for the bovine viral diarrhoea antibody test referred to in point 
II.4.11.3.2., required in accordance with point 1(c) of Ch apter I of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/ 686: This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 683  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
II.4.11.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
II.4.11.2.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;  
II.4.11.3.  for bovine  viral diarrhoea:  
II.4.11.3.1.  a virus isolation test, a test for virus genome or a test for virus 
antigen,  and  
II.4.11.3.2.  a serological test to determine the presence or absence of antibodies;  
II.4.11.4.  for bovine genital campylobacteriosis ( Campylobacter fetus ssp. venerealis ):  
(1)either  [II.4.11.4.1.  a single test carried out on a sample of artificial vagina washings or 
preputial specimen , in the case of animals less than 6 months old or 
kept since that age in a single sex group without contact with 
females prior to the quarantine referred to in point II.4.6.;]  
(1)or [II.4.11.4.2.  tests carried out on s amples of artificial vagina washings or preputial 
specimens taken on three occasions at intervals of at least 7 days;]  
II.4.11.5.  for trichomonosis ( Trichomonas foetus ):  
(1)either  [II.4.11.5.1.  a single test carried out on a sample of preputial specimen , in the 
case of animals less than 6 months old or kept since that age in a 
single sex group without contact with females prior to the quarantine 
referred to in point II.4.6.;]  
(1)or [II.4.11.5.2.  tests carried out on preputial specimens taken on three occas ions at 
intervals of at least 7 days;]  
II.4.12.  have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 1 of Annex 
II to Delegated Regulation (EU) 2020/ 686: 
II.4.12.1.  for infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae 
and M. tuberculosis ), an intradermal tuberculin test referred to in point 1 of Part 
2 of Annex I to Delegated Regulation (EU) 2020/ 688; 
II.4.12.2.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
II.4.12.3.  for enzootic bovine leukosis, a serological test referred to in point (a) of Part 4  of 
Annex I to Delegated Regulation (EU) 2020/ 688; 
II.4.12.4.  for infectious bovine rhinotracheitis/infectious pustular vulvovaginitis, a 
serological test (whole virus) on a blood sample;  
(1)(7)[II.4.12.5.  for bovine  viral diarrhoea, a serological test for  detection of an antibody;]  
(1)(8)[II.4.12.6.  for bovine genital campylobacteriosis ( Campylobacter fetus ssp. venerealis ), a 
test on a sample of preputial specimen;]  
(1)(8)[II.4.12.7.  for trichomonosis  (Trichomonas foetus ), a test on a sample of preputial 
specimen;]  
II.5. The semen described in Part I  
II.5.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in Annex III to Delegated Regulation (EU) 2020/ 686; 
II.5.2.  is placed in straws or other packages on which  the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  is transported in a container which:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 684  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
II.5.3.1.  was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, o r is single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for other products.  
II.6. The semen is preserved by the addition of antibiotics as follows:  
II.6.1.  The following  antibiotic or mixture of antibiotics,  effective in particular against campylobacters, 
leptospires and mycoplasmas, has been added to the semen after final dilution, or is contained in 
the used semen diluents, to reach the indicated concentration per ml of  semen:  
(1)either  [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (1)or [a mixture  of amikacin (75 μg ) and divekacin (25 μg);]  
(1)or [an antibiotic  or a mixture of antibiotics(9) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.6.2.  Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature regime with a documented equivalent bactericidal activity.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission websi te: 
  http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.24:  Total number of packages shall correspond to the numbe r of containers.  
Box reference I.27:  “Type ”: Indicate semen.  
  “Species ”: Select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: indicate mark on the straw or other packages where semen of 
the consignment is placed.  
“Date of  collection/production ”: Indicate the date on which semen of the 
consignment was collected.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 685  EN COUNTRY  Certificate model BOV -SEM -A-ENTRY  
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or  zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ind ex_en.htm  . 
(4) Applicable for frozen semen . 
(5) Applicable for fresh and chilled semen.  
(6) Not applicable to animals which come from an establishment not free from enzootic bovine leukosis and 
which are less that 2 years of age as referred to in Article 20(2)(a) of Delegated Regulation (EU) 2020/ 686. 
(7) Applicable only to seronegative animals. 
(8) Applicable only to bulls in semen production or having contact with bulls in semen production. Bulls 
returning to collection after a lay -off period of more tha n 6 months shall be tested during a period of 30 days 
prior to resuming production. 
(9) Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 686  EN CHAPTER 40: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF STOCKS OF SEMEN OF B OVINE ANIMALS COLLEC TED, 
PROCESSED AND STORED  IN ACCORDANCE WITH C OUNCIL DIRECTIVE 
88/407/EEC, AS AMEND ED BY COUNCIL DIRECT IVE 2003/43/EC, AFTE R 31 
DECEMBER 2004 AND BE FORE 21 APRIL 2021, AND ENTE RED INTO THE 
UNION AFTER 20 APRIL  2021, AND DISPATCHED FROM A SEMEN 
COLLECTION CENTRE WH ERE THE SEMEN WAS CO LLECTED  (MODEL 
‘BOV -SEM -B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 687  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 688  EN COUNTRY  Certificate model BOV -SEM -B-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 I, the undersigned official veterinarian, hereby certify that :  
II.1. ……………………………………………………………………………………………………………  
(name of exporting country  or part thereof)(1) 
 was free from rinderpest and foot -and-mouth disease during the 12 months immediately prior to collection 
of the semen for export and until its date of dispatch to the Union and no vaccination against these 
diseases has taken place during the same period.  
II.2. The centre(2) described in Box I.11. at which the semen to be  exported was collected:  
II.2.1.  met the conditions laid down in Chapter I(1) of Annex A to Directive 88/407/EEC;  
II.2.2.  was operated and supervised in accordance with the conditions laid down in Chapter II(1) of 
Annex  A to Directive 88/407/EEC.  
II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, 
brucellosis, anthrax and contagious bovine pleuropneumonia during 30 days prior to the date of collection 
of the semen to be exported and the 30 days after collecti on (in the case of fresh semen until the day of 
dispatch to the Union).  
II.4. The bovine animals standing at the semen collection centre:  
(3)II.4.1.  come from herds which satisfy the conditions of paragraph 1(b) of Chapter I of Annex B to 
Directive 88/407/ EEC;  
II.4.2.  come from herds or were born to dams which comply with the conditions of paragraph 1(c) of 
Chapter I of Annex B to Directive 88/407/EEC, or were tested at the age of at least 24 months in 
accordance with paragraph 1(c) of Chapter II of Annex B  to that Directive;  
II.4.3.  underwent the tests required in accordance with paragraph 1(d) of Chapter I of Annex B to 
Directive 88/407/EEC in the 28 days preceding the quarantine isolation period;  
II.4.4.  have satisfied the quarantine isolation period and testing requirements laid down in paragraph 1(e) 
of Chapter I of Annex B to Directive 88/407/EEC;  
II.4.5.  have undergone, at least once a year, the routine tests referred to in Chapter II of Annex B to 
Directive 88/407/EEC.  
II.5. The semen to be exported was obtained from donor bulls which:  
II.5.1.  satisfy the conditions laid down in Annex C of Directive 88/407/EEC;  
(4)either  [II.5.2.  have remained in the exporting country for at least the last six months prior to collection of the 
semen to be exported;  
(4)or [II.5.2.  have remained in the exporting country for at least 30 days prior to the collection of the semen 
since entry and they were imported from ………………………….(1) during the period of less than 
six months prior to the collection of the semen and satisfie d the animal health conditions applying 
to donors of the semen which is intended for export to the European Union;]  
II.5.3.  comply with at least one of the following conditions as regards bluetongue, as detailed in the table 
in point I.27.:  
(4)either  [II.5.3.1. were kept in a bluetongue virus -free country or zone for at least 60 days prior to, and 
during, collection of the semen;]  
(4)and/or  [II.5.3.2.  were kept during a bluetongue virus seasonally free period in a seasonally free zone for 
at least 60 days p rior to, and during, collection of the semen;]  
(4)and/or  [II.5.3.3.  were kept in a vector -protected establishment for at least 60 days prior to, and during, 
collection of the semen;]  
(4)and/or  [II.5.3.4.  were subjected to a serological test for the detecti on of antibody to the bluetongue virus 
serogroup, carried out in accordance with the OIE Manual of Diagnostic Tests and 
Vaccines for Terrestrial Animals, with negative results, at least every 60  days 
throughout the collection period and between 21 and 60 d ays after the final collection This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 689  EN COUNTRY  Certificate model BOV -SEM -B-ENTRY  
for this consignment of semen;]  
(4)and/or  [II.5.3.5.  were subjected to an agent identification test for bluetongue virus, carried out in 
accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals,  with negative results, on blood samples taken at commencement and final 
collection for this consignment of semen and at least every 7 days (virus isolation test) 
or at least every 28 days, if carried out as polymerase chain reaction (PCR), during 
collecti on for this consignment of semen;]  
II.5.4.  comply with at least one of the following conditions as regards epizootic haemorrhagic disease 
(EHD), as detailed in the table in point I.27.:  
(4)either  [II.5.4.1.  were resident in the exporting country which acco rding to official findings is free from 
epizootic haemorrhagic disease (EHD);]  
(4)(5)and/or  [II.5.4.2.  were resident in the exporting country in which according to official findings the 
following serotypes of epizootic haemorrhagic disease (EHD) exist: 
………………………… and were subjected with negative results in each case to  the 
following tests carried out in an approved laboratory:  
(4)either  [II.5.4.2.1.  a serological test(6) for the detection of antibody to the EHD virus 
serogroup,  carried out on samples of blood taken on two occasions not 
more than 12 months apart prior to and not less than 21  days following 
collection for this consignment of semen;]]  
(4)and/or  [II.5.4.2.2.  a serological  test(6) for the detection of antibody to the EHD virus 
serogroup, carri ed out on samples taken at intervals of not more than 
60 days throughout the collection period and between  21 and 60  days after 
the final collection for this consignment of semen.]]  
(4)and/or  [II.5.4.2.3.  an agent  identification  test(6) carried out on bloo d samples collected at 
commencement and conclusion of, and at least every 7  days (virus isolation 
test) or at least every 28  days, if carried out as PCR, during collection for 
this consignment of semen.]]  
II.6. The semen to be exported was collected after the date on which the centre was approved by the competent 
national authorities of the exporting country.  
II.7. The semen to be exported was processed, stored and transported under conditions which satisfy the terms 
of Directive 88/407/EEC.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment ”: this box is to be filled in only if  it is a certificate for 
transit commodity.  
Box I.11:  “Place of dispatch ” shall correspond to the semen collection centre listed in accordance with Article 
9(2) of Directive 88/407/EEC  on the Commission website:  
 http://ec.euro pa.eu/food/animal/semen_ova/bovine/index_en.htm  and where the semen was collected.  
Box I.19:  Identification of container and seal number shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I.24:  Total number of packages  shall correspond to the number of containers.  
Box I.27:  “Species ”: Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.  
 Identification number  shall correspond to the official identification of the animal.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 690  EN COUNTRY  Certificate model BOV -SEM -B-ENTRY  
 “Date of collection/production ” shall be indicated in the following format: dd/mm/yyyy.  
 “Quantity ” shall correspond to the number of straws of semen collected on a particular date from an 
identified donor bull complying with particular conditions for bluetongue and EHD.  
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for semen of bovine animals . 
(2) Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the 
Commi ssion website: http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm . 
(3) For New Zealand, appearing with the entry “XII” in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p.1), officially tuberculosis -free bovine herds shall be 
considered equivalent to officially tuberculosis -free bovine herds in the Member States recognised based on 
the conditions laid down in paragraphs 1 an d 2 of Annex A.I to Council Directive 64/432/EEC.  
(4) Delete as necessary.  
(5) Compulsory for Australia, Canada and the United States.  
(6) Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter (2.1.3) of the Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 691  EN CHAPTER 41: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF STOCKS OF SEMEN OF B OVINE ANIMALS COLLECTED, 
PROCESSED AND STORED  BEFORE 1 JANUARY 200 5 IN ACCORDANCE WITH  
COUNCIL DIRECTIVE 88 /407/EEC APPLYING UN TIL 1  JULY 2004, AND 
ENTERED INTO THE UNI ON AFTER 20 APRIL 20 21, AND DISPATCHED F ROM 
A SEMEN COLLECTION C ENTRE WHERE THE SEME N WAS COLLECTED  
(MODEL ‘BOV -SEM -C-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country  code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 692  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 693  EN COUNTRY  Certificate model BOV -SEMEN -C Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that :  
II.1. ……………………………………………………………………………………………….  
(name of exporting country)(1) 
 has been free from rinderpest and foot -and-mouth disease during the 12 months immediately prior to 
collection of the semen for export and until its date of dispatch and no vaccination against these diseases 
has taken place during the same period.  
II.2. The semen described above was collected before 31 December 2004 at the semen collection centre(2) 
which:  
II.2.1.  met the conditions laid down in Chapter I of Annex A to Direct ive 88/407/EEC;  
II.2.2.  was operated and supervised in accordance with the conditions laid down in Chapter II of Annex A to 
Directive 88/407/EEC.  
II.3. The centre at which the semen to be exported was collected was free from rabies, tuberculosis, 
brucellos is, anthrax and contagious bovine pleuropneumonia during the period commencing 30 days 
prior to the date of collection of the semen to be exported and the 30 days after collection.  
II.4. At the time semen described above was collected, all bovine animals s tanding at the semen collection 
centre:  
II.4.1.  came from herds and/or were born to dams which satisfy the conditions of paragraph 1(b) and (c) of 
Chapter I of Annex B to Directive 88/407/EEC;  
II.4.2.  had tested negative, within the 30 days preceding the q uarantine isolation period, to:  
– the tests referred to in points 1(d)(i), (ii) and (iii) of Chapter I of Annex B to Directive 
88/407/EEC, and  
– a serum neutralization  test or an ELISA test for infectious bovine rhinotracheitis/infectious 
pustular vulvo -vagini tis, and  
– a virus isolation test (fluorescent antibody test or immunoperoxidase test) for bovine viral 
diarrhoea, deferred until the animal reached the age of six months in the case of younger 
animals;  
II.4.3.  had undergone the 30 -day quarantine isolation period and had tested negative to the following health 
tests:  
– a serological test for brucellosis carried out in accordance with the procedure described in Annex 
C to Directive 64/432/EEC;  
– either an immunofluorescent antibody test or a culture test for Camp ylobacter fetus  infection on 
a sample of preputial  material or artificial vagina washings, or, in the case of a female animal, a 
vaginal mucus agglutination test;  
– a microscopic  examination and culture test for Trichomonas foetus  on a sample of preputial 
material or artificial vagina washings, or in the case of a female animal a vaginal mucus 
agglutination test;  
II.4.4.  had tested negative, at least once a year, to the routine tests referred to in points 1(a), (b) and (c) of 
Chapt er II of Annex B to Directive 88/407/EEC . 
II.5. At the time the semen described above was collected,  
II.5.1.  all female bovine animals in the centre had tested negative at least once a year to a vaginal mucus 
agglutination test for Campylobacter fetus  infection, and  
II.5.2.  all bulls used for semen production had tested negative either to an immunofluorescent antibody test or 
to a culture test for Campylobacter fetus  infection on a sample of preputial material or artificial vagina 
washings carried out in 12  months prior to collection.  
II.6. The semen to be exported was obtained from donor bulls which  
II.6.1.  satisfy the conditions laid down in Annex C of Directive 88/407/EEC;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 694  EN COUNTRY  Certificate model BOV -SEMEN -C 
(3)either  [II.6.2.  were resident in the exporting country during the six months imm ediately prior to collection of 
the semen for export;]  
(3)or [II.6.2.  were  imported from ………………………….(1) after spending less than six months in the 
exporting country and at the time of import satisfied the animal health conditions applying to 
donors of the semen which is intended for export to the European Union;]  
II.6.3.  stand in a semen collection centre a t which:  
(3)either  [all bovine animals were not vaccinated against infectious bovine rhinotracheitis and tested negative at 
least once a year to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/ 
infectious pustular vulvo -vaginitis ;] 
(3)or [bovine  animals not vaccinated  against infectious bovine rhinotracheitis tested negative, at least once a 
year, to a serum neutralisation test or an ELISA test for infectious bovine rhinotracheitis/ infectious 
pustular vulvo -vaginitis, at which testing for infectious bovine rhinotrache itis was not carried out on 
bulls which had received their first vaccination against infectious bov ine rhinotracheitis at the 
insemination centre after they had tested negative to a serum neutralisation test or an ELISA test for 
infectious bovine rhinotrac heitis/ infectious pustular vulvo -vaginitis and which had been regularly re -
vaccinated at intervals of not more than six months since the first vaccination;]  
(3)either  [II.6.4.  have not been vaccinated against infectious bovine rhinotracheitis,]  
(3)or [II.6.4. have been vaccinated against infectious bovine rhinotracheitis in accordance with point II.6.3.,]  
II.6.5.  fulfil the import conditions for bovine semen laid down in the Bluetongue Chapter of the Terrestrial 
Animal Health Code of the OIE, depending on the status of the country or zone of residence;****  
II.6.6.  were resident in the country of export in which the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: ……………………………..: and tested negative on two occasions not more than 
12 months a part to an agar -gel immuno -diffusion test(4) and to a virus neutralization test for all above -
listed serotypes of EHD, carried out in approved laboratory on samples of blood taken prior to and not 
less than 21 days following collection of the semen;***  
II.6.7. were resident in the country of export in which the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: ……………………………..: and tested negative, prior to entry and at six -monthly 
intervals, to an agar -gel immuno -diffusion test(4) and a virus  neutralization test for all above -listed 
serotypes of EHD, carried out in approved laboratory;**  
II.6.8.  tested negative on two occasions not more than 12 months apart to a serum neutralization test for 
Akabane virus carried out in approved laboratory on samples of blood taken prior to and not less than 
21 days following collection of the semen.*  
II.7. The semen to be exported was collected after the date on which the centre was approved by the 
competent national authorities of the exporting country.  
II.8. The semen to be exported was processed, stored and transported under conditions which satisfy the 
terms of Directive 88/407/EEC prior to its amendment by Directive 2003/43/EC.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment ”: This box is to be filled in only if it is a certificate for 
transit commodity.  
Box I.11:  “Place of dispatch ” shall correspond to the semen collection centre where the semen was collected.  
Box I.12:  “Place of destination ”: This box is to be filled in only if it is a certificate for transit commodity.  
Box I.19:  Identification of container and seal number shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 695  EN COUNTRY  Certificate model BOV -SEMEN -C 
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I.24:  Total number of pack agesshall correspond to the number of containers.  
Box I.27:  Identification number  shall correspond to the official identification of the animal.  
 “Date of collection/production ” shall be prior to 31 December 2004 and indicated in the following 
format: dd/m m/yyyy.  
 “Approval or registration number of plant/establishment/centre ” shall correspond to the approval 
number of the approved semen collection centre where the semen was collected.  
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/xx 
[SANTE/7140/2020 ] for semen of bovine animals . 
(2) Only semen collection centres listed in accordance with Article 9(2) of Directive 88/407/EEC on the 
Comm ission website:  
 http://ec.europa.eu/food/animal/semen_ova/bovine/index_en.htm . 
(3) Delete as necessary.  
(4) Standards for EHD virus diagnostic tests are described in the Bluetongue Chapter of the Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals.  
****  To be used only by Australia, Canada and the USA.  
*** To be used only by Australia and the USA.  
** To be used only by Canada.  
* To be used only by Australia.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 696  EN CHAPTER 42: MODEL OFFICIAL CER TIFICATE  FOR THE ENTRY INTO T HE 
UNION OF OOCYTES AND  EMBRYOS OF BOVINE AN IMALS COLLECTED OR 
PRODUCED, PROCESSED AND STORED IN ACCORD ANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED R EGULATION (EU) 2020/ 692 
AFTER 20 APRIL 2021 , AND DISPATCHED BY AN EMBRYO COLLECTION  OR 
PRODUCTION TEAM BY W HICH THE OOCYTES OR EMBRYOS WERE 
COLLECTED OR PRODUCE D (MODEL ‘BOV -OOCYTES -EMB -A-ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 697  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
 
COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The oocytes(1)/ in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I are intended for artificial reproduction and were obtained from the donor animals 
which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of oocytes(1)/ embryos(1) of bovine animals and liste d in 
Annex VII to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period 
of 30 days after their collection(1)/ production(1);] 
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1) and for 
a period of 30 days after their collection(1)/ production(1);] 
II.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease  were not reported for a period of at least 12 
months immediately prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a 
period of 30 days after their collection(1)/ production(1); 
II.1.4.  where no vaccination against foot -and-mouth disease, infection with rinderpest vir us, 
infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection(1)/ production(1) 
of the oocytes(1)/ embryos(1), and for a period of 30 days after thei r collection(1)/ production(1), 
and no vaccinated animals entered into the third country, territory or zone  during that period.  
(1)[II.2.  The in vivo  derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(3) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with require ments as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
(1)[II.2.  The oocytes(1)/ in vitro  produced embryos(1) described in Part I have been collected or produ ced, 
processed and stored, and dispatched by the embryo production team(3) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational proced ures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.3. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which originate from 
establishments   
II.3.1.  free from  infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae  and M. 
tuberculosis ), and they have never been kept previously in any establishment of a lower This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 698  EN COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  
health status;  
II.3.2.  free from infection with Brucella abortus, B. melitensis  and B. suis and they have never been 
kept previously in any establishment of a lower health status ; 
(1)either  [II.3.3.  free from enzootic bovine leukosis  and they have never been kept previously in any 
establishment of a lower health status;]  
(1)or [II.3.3.  not free from enzootic bovine leukosis and the donor animals are younger than 2 years of age 
and the official veterinarian responsible for the establishment of origin has certified that there 
has been no clinical case of enzootic bovine leukosis during a period  of at least the preceding 
3 years;]  
 (1)either  [II.3.4.  free from infectious  bovine rhinotracheitis/infectious pustular vulvovaginitis  and they have 
never been kept previously in any establishment of a lower health status;]  
(1)or [II.3.4.  not free from infectious bovine rhinotracheitis/infectious pustular vulvovaginitis and the 
official veterinarian responsible for the establishment of origin has certified that there has 
been no clinical case of infectious bovine rhinotracheitis/infectious pustular vulvo vaginitis 
during a period of at least the preceding 12 months;]  
II.3.5.  in which surra ( Trypanosoma evansi ) has not been reported during the last 30 days prior to  
collection(1)/ production(1) of the oocytes(1)/ embryos(1), and  
(1)either  [surra has not been  reported in the establishments during the last 2 years prior to  
collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [surra has been reported in the establishments during the last 2 years prior to to  
collection(1)/ production(1) of the oocytes(1)/ embryos(1) and following the last 
outbreak the establishments have remained under movement restrictions until  
 the infected animals have been removed from the establishment, and  
 the remaining animals on the establishment have been subjected to a test for 
surra  (Trypanosoma evansi ) with one of the diagnostic methods provided for 
in Part 3 of Annex I  to Delegated Regulation (EU) 2020/ 688, carried out, 
with negative results, on samples taken at least 6 months after the infected 
animals  have been removed from the establishment; ] 
II.4. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, contagi ous bovine pleuropneumonia and lumpy skin disease;  
II.4.2.  remained for a period of at least 6 months prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1) in a third country or territory or zone thereof referred to in Box I.7.;  
II.4.3.  for a period of at least 30 days prior to the date of collection(1)/ product ion(1) of the oocytes(1)/ 
embryos(1) and during the collection period  
II.4.3.1.  were kept on establishments not situated in a restricted zone established due to 
the occurr ence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, contagiou s bovine pleuropneumonia and 
lumpy skin disease or of an emerging disease relevant for the bovine animals;  
II.4.3.2.  were kept on a single est ablishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax,  surra (Trypanosoma 
evansi), enzootic bovine leukosis, infectious bovine rhinotracheitis/infectious 
pustular vulvovaginitis, bovine viral diarrhoea, infection with epizootic 
haemorrhagic disease virus and infection with bluetongue virus (serotype 1 -24) 
have not been reported;  
II.4.3.3.  were not in contact with animals fr om establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.3.1. or from 
establishments which do not meet the conditions referred to in point II.4.3.2.;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 699  EN COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  
II.4.3.4.  were not used for natural breeding;  
II.4.4.  were examined by the team veterinarian or its team member and did not show symptoms or 
clinical signs of transmissible animal diseases on the day of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1);  
II.4.5.  are individually identified as provided  for in Article 21(1)  of Delegated Regulation (EU) 
2020/ 692; 
II.4.6.  comply with the following conditions as regards foot -and-mouth disease  
II.4.6.1.  they come from establishments  
 situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a period of at least 30 
days immediately prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1) of 
the oocytes(1)/ embryos(1); 
 (1)either  [II.4.6.2.  they were  not vaccinated against foot -and-mouth disease;]  
(1)(4)or [II.4.6.2.  they were vaccinated  against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and 
II.4.6.2.1.  have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of col lection 
of the embryos;  
II.4.6.2.2.  the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) or the semen 
complies with the conditions set out in point 2  of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/ 686; 
II.4.6.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the recommendations of the 
IETS Manual(5); 
II.4.6.2.4.  the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of foot -and-mouth disease;]  
(1)(6)[II.4.7.  comply with at least one of the following conditions as regards infection with bluetongue 
virus (s erotypes 1 -24): 
(1)either  [II.4.7.1.  they have been kept in a third country, territory or zone thereof free from infection 
with bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and 
during collection of the oocytes;]  
(1)and/or  [II.4.7.2.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
oocytes, in a third country, territory or zone thereof with an approved eradica tion 
programme against infection with bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.4.7.3.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
oocytes, in a third country, territory or zone thereof where the competent authority 
of the place of origin of the consignment of oocytes(1)/ in vitro  produced embryos(1) 
has obtained the prior written consent of the competent authority of the Member 
State of destination to the conditions for establishment of that seasonally disease -
free zone and to accept the consignment of oocytes(1)/ in vitro  produced embryos(1);] 
(1)and/or [II.4.7.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the oocytes;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 700  EN COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  
(1)and/or  [II.4.7.5.  they have been subjected to a serological test to detect antibodies to the blueton gue 
virus serogroup 1 -24, with negative results, between 28 and 60 days from the date of 
each collection of the oocytes;]  
(1)and/or  [II.4.7.6.  they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative res ults, on blood sample taken on the date of 
collection of the oocytes;]]  
(1)(6)[II.4.8.  comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.4.8.1.  they have been kept for a period of at least 60 days prior to and during collection of 
the oocytes in a third country, territory or zone thereof where EHDV 1 -7 has not 
been reported for a period of at least the preceding 2 years within a radius of 150 km 
of the establishment;]  
(1)and/or  [II.4.8.2.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the oocytes;]  
(1)and/or  [II.4.8.3.  were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to  the following tests carried out in an 
official laboratory:  
(1)either  [II.4.8.3.1.  a serological test to detect antibodies t o EHDV 1 -7, with negative 
results, on blood sample taken between 28 and 60 days from the date of 
the collection of the oocytes;]]  
(1)and/or  [II.4.8.3.2.  an agent identification test for EHDV 1 -7, with negative results, on 
blood sample taken on the date of collection of the oocytes.]]]  
(1)(6)[II.4.9.  comply with animal health requirements laid down in Chapter III of Part 1 of Annex II to 
Delegated Regulation (EU) 2020/ 686;] 
II.5. The oocytes(1)/ embryos(1) described in Part I  
II.5.1.  has been collected, proc essed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to Delegated Regulation (EU) 
2020/ 686; 
II.5.2.  are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  are transported in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch by the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for other products;  
(1)(7)[II.5.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.5.5.  are transported in a conta iner where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
(1)(8)[II.6.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in 
Part I were conceived by artificial insemination using semen coming from a semen collection centre, 
germinal product processing establishment or germinal product storage centre approved for the collection, 
processing and/or storage of semen b y the competent authority of a third country, territory or zone thereof 
listed in Annex VII to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for semen of bovine 
animals or by the competent authority of a Member State.]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 701  EN COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  
(1)(9)[II.7. The following  antibiotic or mixture of antibiotics(10) has been added to the collection, processing, washing 
or storage media: …………………………………………………………………………]  
 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
Box reference I.12:  “Place of destination ”: Indicate the a ddress and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.24:  Total number of packages shall correspond to the number of containers.  
Box reference I.27:  “Species ”: Select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
  “Type ”: Specify if oocytes, in vivo  derived  embryos, in vitro  produced embryos or 
micromanipulated embryos.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which oocytes o r embryos of the 
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
(4) Option available only for  the consignment of  in vivo  derived embryos.  
(5) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society 1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).  
(6) Applicable for the consignment o f oocytes and in vitro  produced embryos.  
(7) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of bovine animals are placed and transported.  
(8) Does  not apply to oocytes.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 702  EN COUNTRY  Certificate model BOV -OOCYTES -EMB -A-ENTRY  
(9) Mandatory attestation in case antibiotics were added.  
(10) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 703  EN CHAPTER 43: MODEL OFFICIAL CER TIFICATE  FOR THE ENTRY INTO T HE 
UNION OF STOCKS OF IN VIVO  DERIVED EMBRYOS OF B OVINE ANIMALS 
COLLECTED, PROCESSED  AND STORED BEFORE 21  APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89 /556/EEC , AND ENTERED INTO 
THE UNION AFTER 20 A PRIL 2021, AND DISPA TCHED BY AN EMBRYO 
COLLECTION TEAM BY W HICH THE EMBRYOS WER E COLLECTED  (MODEL 
‘BOV -in-vivo-EMB-B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 704  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 705  EN COUNTRY  Certificate model BOV -in-vivo-EMB-B-ENTRY  Part  II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 I, the undersigned, official veterinarian of the ……….…………..........……………….… certify that:  
(exporting country)(1) 
II.1. The embryos to be exported:  
II.1.1.  were collected in the exporting country, which according to official findings:  
II.1.1.1.  was free from rinderpest during the 12 months immediately prior to their collection;  
(2)either  [II.1.1.2.  was free from foot -and-mouth disease and lumpy skin disease during  the 12 months immediately 
prior to their collection and did not carry out vaccination against foot -and-mouth disease or 
lumpy skin disease during that period.]  
(2)or [II.1.1.2.  was not free from foot -and-mouth disease or lumpy skin disease during the 12 months 
immediately prior to their collection or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and:  
 the embryos were not subjected to penetration of the zona pellucida,  
 the embryos were stored under approve d conditions for at least 30 days immediately after 
their collection,  
 the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of 
a susc eptible species showed clinical signs of foot -and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at least the 30 days after, the embryos were collected.]  
II.1.2.  were collected by the embryo collection team(3) which :  
 had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;  
 which carried out the collection, processing, storing and transport of the embryos in accordance with 
Chapter II of Annex A to Directive 89/556/EEC;  
 was subject to inspection by an o fficial veterinarian at least twice a year.  
II.1.3.  were collected and processed on premises situated in an area of at least 10 km radius centred on them, on 
which according to official findings there was no occurrence of foot -and-mouth disease, epizootic 
haemorrhagic disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or 
lumpy skin disease in the 30 days immediately prior to their collection and until dispatch to the Union, in 
the case of fresh embryos, or during the 30 days  after collection, in the case of embryos subject to a 
mandatory storage for at least 30 days in accordance with point II.1.1.2.  
II.1.4.  from the time of collection until 30 days thereafter or, in the case of fresh embryos until the day of their 
dispatch t o the Union, they were stored on premises situated in an area of at least 10 km radius centred on 
them, on which according to official findings there was no occurrence of foot -and-mouth disease, 
vesicular stomatitis, Rift Valley fever, contagious bovine pl europneumonia or lumpy skin disease.  
II.1.5.  were collected from the donor females, which:  
II.1.5.1.  were located, during the 30 days immediately prior to collection, on premises situated in an area 
of at least 10 km radius centred on them, on which, accor ding to official findings, there was no 
occurrence of foot -and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular 
stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;  
II.1.5.2.  showed no clinical signs o f disease on the day of collection;  
II.1.5.3.  spent the six months immediately prior to collection within the territory of the exporting country 
in no more than two herds:  
 which, according to official findings, were free from tuberculosis during that time,  
 which, according to official findings, were free from brucellosis during that time,  
 which were free from enzootic bovine leukosis or in which no bovine animal showed 
clinical signs of enzootic bovine leukosis during the previous three years,  
 in which no b ovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 706  EN COUNTRY  Certificate model BOV -in-vivo-EMB-B-ENTRY  
II.1.6.  The embryos to be exported were conceived by artificial insemination using semen coming from semen 
collection  or storage centres approved for the collection, processing and/or storage of semen by the 
competent authority of a third country or part thereof listed in Annex I to Implementing Decision 
2011/630/EU(4) or by the competent authority of a Member State.  
 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment ”: this box is to be filled in only if it is a certificate for 
transit commodity.  
Box I.11:  “Place of dispatch ” shall correspond to the embryo collection team from which the embryos are 
dispatched to the Union and which is listed in accordance with Article 8(2) of Directive 89/556/EEC 
on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.  
Box I.19:  Identification of container and seal number shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  
Box I .22: Fill in according to whether it is a transit or an import certificate.  
Box I.24:  Total number of packages  shall correspond to the number of containers.  
Box I.27:  “Species ”: Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate . 
 “Type ”: Select " in vivo  derived embryos".  
 Identification number  shall correspond to the official identification of the animal.  
 “Date of collection/production ” shall be indicated in the following format: dd.mm.yyyy  
 “Approval or registration number of plant/establishment/centre ” shall correspond to the embryo 
collection team by which the embryos were collected, processed and stored; and listed in accordance 
with Article 8(2) of Directive 89/556/EEC on the Commission website:  
 http://ec.europa.eu/food/an imal/semen_ova/bovine/ova_embryos_en.htm.  
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for embryos of bovine animals . 
(2) Delete as appropriate.  
(3) Only  embryo collection teams listed in accordance with Article 8(2) of Directive 89/556/EEC on 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.  
(4) OJ L 247, 24.9.2011, p. 32.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 707  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 708  EN CHAPTER 44: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF STOCKS OF IN VITRO  PRODUCED EMBRYOS OF BOVINE ANIMALS 
PRODUCED, PROCESSED AND STORED BEFORE 21  APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89 /556/EEC , CONCEIVED USING 
SEMEN COMPLYING WITH  REQUIRMENTS OF COUNC IL DIRECTIVE 
88/407/EEC, AND ENTE RED INTO THE UNION A FTER 20 A PRIL 2021, AND 
DISPATCHED BY AN EMB RYO PRODUCTION TEAM BY WHICH THE 
EMBRYOS WERE PRODUCE D (MODEL ‘BOV -in-vitro-EMB -C-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen 
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal  products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 709  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 710  EN COUNTRY  Certificate model BOV -in-vitro -EMB-C-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 I, the undersigned, official veterinarian of ……….…………..........……………….… certify that:  
(exporting country)(1) 
II.1. The embryos to be exported:  
II.1.1.  were produced in the exporting country, which according to official findings:  
II.1.1.1.  was free from rinderpest during the 12 months immediately prior to their production;  
(2)either  [II.1.1.2.  was free from foot -and-mouth disease and lumpy skin disease during the 12 months 
immediately prior to their production and did not carry out vaccination against foot -and-mouth 
disease or lumpy skin disease during that period.]  
(2)or [II.1.1.2.  was not free from foot -and-mouth disease or lumpy skin disease during the 12 months 
immediately prior to their productio n or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and  
 the embryos were produced without penetration of the zona pellucida,  
 the embryos were stored under approved conditions for at least 30 days immediatel y after 
their production,  
 the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days prior to collection and no animal of 
a susceptible species showed clinical signs of foo t-and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at least the 30 days after, the oocytes were collected.]  
II.1.2.  were produced by the embryo production team(3) which:  
 had been approved in accordance with Chapter I of Annex A to D irective 89/556/EEC,  
 carried out the production, processing, storing and transport in accordance with Chapter II 
of Annex A to Directive 89/556/EEC,  
 was subject to inspection by an official veterinarian at least twice a year.  
II.2. The oocytes used in the production of the embryos to be exported were collected on premises situated in 
an area of at least 10 km radius centred on them, on which according to official findings there was no 
occurrence of foot -and-mouth disease, epizootic haemorrhagic disease, ves icular stomatitis, Rift Valley 
fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their 
collection and until their dispatch to the Union, in the case of fresh embryos, or during the 30 days after 
collection, in the case of embryos subject to a mandatory storage for at least 30 days in accordance with 
point II.1.1.2.  
II.3. From the time of collection of the oocytes until 30 days thereafter or, in the case of fresh embryos, until 
the day of dispatch, the embryos  to be exported were stored on premises situated in an area of at least 10 
km radius centred on them, on which according to official findings there was no occurrence of foot -and-
mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleu ropneumonia or lumpy skin 
disease.  
II.4. The donors of oocytes used in the production of the embryos to be exported:  
II.4.1.  were located, during the 30 days immediately prior to collection of the oocytes, on premises 
situated in an area of at least 10 -km radius on which, according to official findings, there was 
no occurrence of foot -and-mouth disease, bluetongue, epizootic haemorrhagic disease, 
vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin 
disease;  
II.4.2.  showed  no clinical signs of disease on the day of collection;  
II.4.3.  spent the six months immediately prior to collection within the territory of the exporting 
country  in no more than two herds:  
 which, according to official findings, were free from tuberculosis  during that time,  
 which, according to official findings, were free from brucellosis during that time,  
 which were free from enzootic bovine leukosis or in which no bovine animal showed This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 711  EN COUNTRY  Certificate model BOV -in-vitro -EMB-C-ENTRY  
clinical signs of enzootic bovine leukosis during the previous three ye ars, 
 in which no bovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months;  
(2)either  [II.4.4.  were kept in a bluetongue virus -free country or zone for at least 60 days prior to, and during, 
collection of the oocytes.]  
(2)or [II.4.4.  were kept during a seasonally free period or protected from the vector for at least 60 days prior 
to, and during, the collection of the oocytes, and the embryos were produced without 
penetration of  the zona pellucida, except if the donors underwent a serological test to detect 
antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals between 21 and 60 days after c ollection 
and giving negative results and the embryos were stored for at least 30 days.]  
(2)or [II.4.4.  underwent a serological test to detect antibodies to the bluetongue virus group, carried out in 
accordance with the OIE Manual of Diagnostic Tests and V accines for Terrestrial Animals 
between 21 and 60 days after collection and giving negative results, and the embryos were 
stored for at least 30 days.]  
(2)or [II.4.4.  underwent an agent identification test, carried out in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of 
collection or the day of slaughtering and giving negative results – the embryos having been 
produced, in the latter case, without penetration of the zona pellucida .] 
II.5. The embryos to be exported were conceived by in vitro  fertilisation using semen coming from semen 
collection or storage centres(4): 
(2)either  [II.5.1.  approved in accordance with Article 5(1) of Directive 88/407/EEC and located in a Member 
State of  the European Union, and the semen complies with the requirements of Directive 
88/407/EEC.]  
(2)or [II.5.1.  approved in accordance with Article 9(1) of Directive 88/407/EEC and located in a third 
country or part thereof listed in Annex I to Implementing Decision 2011/630/EU, and the 
semen complies with the requirements set out in Section A of Part 1 of Annex II to that 
Decision.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment : this box is to be filled in only if it is a certificate for 
transit commodity.  
Box I.11:  “Place of dispatch ” shall correspond to the embryo production team from which the embryos are 
dispatch to the Union and listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website:  
 http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en. htm. 
Box I.19:  Identification of container and seal number shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I.24:  Total  number of packages  shall correspond to the number of containers.  
Box I.27:  “Species ”: Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.  
 “Type” : Select " in vitro  produced embryos".  
 “Identification number” : 
“Dam identity ” shall correspond to the official identification of the animal.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 712  EN COUNTRY  Certificate model BOV -in-vitro -EMB-C-ENTRY  
“Sire identity ” shall correspond to the official identification of the animal.  
 “Approval or registration number of plant/establishment/centre ” shall correspond to the embryo 
production team b y which the embryos were produced, processed and stored; and listed in accordance 
with Article 8(2) of Directive 89/556/EEC on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm  
 
Part II:  
(1) Only third country, ter ritory or zone thereof listed in Annex VII to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for embryos of bovine animals . 
(2) Delete as appropriate.  
(3) Only  embryo production teams listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.  
(4) Only semen collection centres approved  by the competent authority of a third country, territory or zone 
thereof listed in Annex VII to Implementing Regulation (EU)  2020/… [ SANTE/7140/2020 ] for semen of 
bovine animals or by the competent authority of a Member State . 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 713  EN CHAPTER 45: MODEL OFFICIAL CER TIFICATE  FOR THE ENTRY INTO T HE 
UNION OF STOCKS OF IN VITRO  PRODUCED EMBRYOS OF BOVINE ANIMALS 
PRODUCED, PROCESSED AND STORED BEFORE 21  APRIL 2021 IN 
ACCORDANCE WITH COUNCIL DIRECTIVE 89 /556/EEC , CONCEIVED USING 
SEMEN COMING FROM SE MEN COLLECTION OR ST ORAGE CENTRES  
APPROVED BY THE COMP ETENT AUTHORITY OF T HE EXPORTING 
COUNTRY, AND ENTERED  INTO THE UNION AFTER  20 APRIL 2021, AND 
DISPATCHED BY AN EMB RYO PRODUCTION TEAM BY WHICH THE 
EMBRYOS WERE PRODUCE D (MODEL ‘BOV -in-vitro -EMB -D-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen 
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 714  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 715  EN COUNTRY  Certificate model BOV -in-vitro -EMB -D-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 I, the undersigned, official veterinarian of ……….…………..........……………….… certify that:  
(exporting country)(1) 
II.1. The embryos to be exported  
II.1.1.  were produced in the exporting country, which according to official findings:  
II.1.1.1  was free from rinderpest during the 12 months immediately prior to their production;  
(2)either  [II.1.1.2.  was free from foot -and-mouth disease and lumpy skin disease during the 12 months 
immediately prior to their production and did not carry out vaccination against foot -and-mouth 
disease or lumpy skin disease during that period.]  
(2)or [II.1.1.2.  was not free from foot -and-mouth d isease or lumpy skin disease during the 12 months 
immediately prior to their production or carried out vaccination against foot -and-mouth disease 
or lumpy skin disease during that period, and  
 the embryos were produced without penetration of the zona pelluc ida, 
 the embryos were stored under approved conditions for at least 30 days immediately after 
their production,  
 the donor females come from holdings on which no animal was vaccinated against foot -and-
mouth disease or lumpy skin disease during the 30 days p rior to collection and no animal of 
a susceptible species showed clinical signs of foot -and-mouth disease or lumpy skin disease 
during the 30 days prior to, and at least the 30 days after, the oocytes were collected.]  
II.1.2.  were produced by the embryo pr oduction team(3) which:  
 had been approved in accordance with Chapter I of Annex A to Directive 89/556/EEC;  
 carried out the production, processing, storing and transport of the embryos in accordance 
with Chapter II of Annex A to Directive 89/556/EEC;  
 was subject to inspection by an official veterinarian at least twice a year.  
II.2. The oocytes used in the production of the embryos to be exported were collected on premises situated in 
an area of at least 10 km radius centred on them, on which according to official findings there was no 
occurrence of foot -and-mouth disease, epizootic haemorrhagic disease, vesicular stomatitis, Rift Valley 
fever, contagious bovine pleuropneumonia or lumpy skin disease in the 30 days immediately prior to their 
collection and u ntil their dispatch to the Union, in case of fresh embryos, or during the 30 days after 
collection, in case of embryos subject to a mandatory storage for at least 30 days in accordance with point 
II.2.2.  
II.3. From the time of collection of the oocytes unt il 30 days thereafter or, in the case of fresh embryos, until 
the day of dispatch, the embryos to be exported were stored on premises situated in an area of at least 10 
km radius centred on them, on which according to official findings there was no occurre nce of foot -and-
mouth disease, vesicular stomatitis, Rift Valley fever, contagious bovine pleuropneumonia or lumpy skin 
disease.  
II.4. The donors of oocytes used in the production of the embryos to be exported:  
II.4.1.  were located, during the 30 days imme diately prior to collection of the oocytes, on premises 
within a 10 -km radius of which, according to official findings, there was no occurrence of foot -
and-mouth disease, bluetongue, epizootic haemorrhagic disease, vesicular stomatitis, Rift 
Valley fever, contagious bovine pleuropneumonia or lumpy skin disease;  
II.4.2.  showed no clinical signs of disease on the day of collection;  
II.4.3.  spent the six months immediately prior to collection within the territory of the exporting 
country  in no more than two he rds: 
 which, according to official findings, were free from tuberculosis during that time,  
 which, according to official findings, were free from brucellosis during that time,  
 which were free from enzootic bovine leukosis or in which no animal showed clinica l signs 
of enzootic bovine leukosis during the previous three years,  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 716  EN COUNTRY  Certificate model BOV -in-vitro -EMB -D-ENTRY  
 in which no bovine animal showed clinical signs of infectious bovine 
rhinotracheitis/infectious pustular vulvo -vaginitis during the previous 12 months.  
(2)either  [II.4.4.  were kept in a b luetongue virus -free country or zone for at least 60 days prior to, and during, 
collection of the oocytes.]  
(2)or [II.4.4.  were kept during a seasonally free period or protected from the vector for at least 60 days prior 
to, and during, the collection of t he oocytes, and the embryos were produced without 
penetration of the zona pellucida, except if the donors underwent a serological test to detect 
antibodies to the bluetongue virus group, carried out in accordance with the OIE Manual of 
Diagnostic Tests and  Vaccines for Terrestrial Animals between 21 and 60 days after collection 
and giving negative results and the embryos were stored for at least 30 days.]  
(2)or [II.4.4.  underwent a serological test to detect antibodies to the bluetongue virus group, carried  out in 
accordance with the OIE Manual of Diagnostic Tests and Vaccines for Terrestrial Animals 
between 21 and 60 days after collection and giving negative results, and the embryos were 
stored for at least 30 days.]  
(2)or [II.4.4.  underwent an agent identi fication test, carried out in accordance with the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals on a blood sample taken on the day of 
collection or the day of slaughtering and giving negative results – the embryos having been 
produced , in the latter case, without penetration of the zona pellucida .] 
II.5. The embryos to be exported were conceived by in vitro  fertilisation using semen coming from semen 
collection or storage centres approved for the collection, processing and/or storage o f semen by the 
competent authority of a third country or a part thereof listed in Annex I to Implementing Decision 
2011/630/EU(4) or by the competent authority of a Member State.  
 
Notes  
In accordance with Article 3(a) of Directive 89/556/EEC, the in vitro  produced bovine embryos using semen from 
semen centres approved by the exporting country, imported under the conditions laid down in this certificate are 
excluded from intra -Union trade.  
Guidance on the completion of this official certificate is available  in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment ”: This box is to be filled in only if it is a certificate for 
transit commodity.  
Box I.11:  “Place of dispatch ” shall correspond to the embryo production team from which the embryos are 
dispatch to the Union and listed in accordance with Article 8(2) of Directive 89/556/EEC on the 
Commission website:  
 http://ec.europa.eu/food/animal/semen_ova/bovine/ova_em bryos_en.htm.  
Box I.19:  Identification of container and seal number shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I. 24: Total number of packages  shall correspond to the number of containers.  
Box I.27:  “Species ”: Select amongst “ Bos taurus ”, “Bison bison" or "Bubalus bubalis ” as appropriate.  
 “Type ”: Select " in vitro  produced embryos".  
 “Identification number” : 
“Dam identit ”y shall correspond to the official identification of the animal.  
“Sire identity ” shall correspond to the official identification of the animal.  
 “Approval or registration number of plant/establishment/centre ” shall correspond to the embryo 
producti on team by which the embryos were produced, processed and stored; and listed in accordance This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 717  EN COUNTRY  Certificate model BOV -in-vitro -EMB -D-ENTRY  
with Article 8(2) of Directive 89/556/EEC on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.  
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for embryos of bovine animals . 
(2) Delete as appropriate.  
(3) Only embryo production teams listed in accordance with Article 8(2) of Direc tive 89/556/EEC on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm.  
(4) Only third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for semen of bovine an imals . 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 718  EN CHAPTER 46: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF  CONSIGMENTS OF:  
- semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in accordance with Council Dir ective 
88/407/EEC, as amended by Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/407/EEC applying  until 1 July 2004;  
- oocytes  and embryos of bovine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of in vivo  derived embryos of bovine animal s collected, processed and stored in accordance with 
Directive 89/556/EEC  before 21 April 2021;  
- stocks of in vitro  produced embryos of bovine animals produced, processed and stored in accordance 
with Directive 89/556/EEC  before 21 April 2021,  conceived using semen complying with requirements 
of Council Directive 88/407/EEC;  
- stocks of in vitro  produced embryos of bovine animals produced , processed and stored in accordance 
with Directive 89/556/EEC before 21 April 2021,  conceived using semen coming from se men 
collection or storage centres approved by the competent authority of the exporting country,  
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT PROCESSING ESTAB LISHMENT  (MODEL 
‘BOV -GP-PROCESSING -ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 719  EN  Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 720  EN  
I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 721  EN COUNTRY  Certificate model BOV -GP-PROCESSING -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipulated embryos(2) to be exported to 
the European Union was/were processed and stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of bovine animals 
and listed in A nnex VII to Implementing Regulation (EU) 2020/xx 
[SANTE/7140/2020] ; 
(2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin  disease  were not reported for a period of at 
least 12 months immediately prior to collection(2)/ production(2) of the semen(2)/ 
oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2); 
II.1.1.4.  where no vaccination  against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection(2)/ 
production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after 
its/their collection(2)/ production(2), and no vaccinated animals entered into the third 
country, territory or zone  during that period;  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4), and/or processed and stored in a 
germinal product processing establishment(2)(4), and/or stored in a germinal product storage 
centre(2)(4) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(5), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of bovine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:  
(2)either  [Model BOV -SEM -A-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -B-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -C-ENTRY(4);] 
(2)and/or  [Model BOV -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model BOV -in-vivo-EMB -B-ENTRY(4);] 
(2)and/or  [Model BOV -in-vitro -EMB -C-ENTRY(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 722  EN COUNTRY  Certificate model BOV -GP-PROCESSING -ENTRY  
(2)and/or  [Model BOV -in-vitro -EMB -D-ENTRY(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model BOV -GP-STORAGE -ENTRY (4);]] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been f illed in with the cryogenic agent which not have been previously used for 
other products.  
(2)(7)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from  each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product processing establishments 
listed in accordance with Articl e 233(3) of Regulation (EU) 2016/429 on the 
Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
Box reference I.12:  “Place of destina tion”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall  
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection  and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the  semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 723  EN COUNTRY  Certificate model BOV -GP-PROCESSING -ENTRY  
produced embryos or micromanipulated embryos.  
  “Species ”: Select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark o n the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or p roduced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website:  
 http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(4) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/seme n_ova/bovine/in dex_en.htm . 
(5) Only a third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/…  
[SANTE/7140/2020 ] and the EU Member States.  
(6) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were co llected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product proc essing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(7) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of bovine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 724  EN CHAPTER 47: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGMENTS OF:  
- semen of bovine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of bovine animals collected, processed and stored in accordance with Council Directive 
88/407/EEC, as amended by Council Directive 2003/43/EC, before 21 April 2021 and after 31 
December 2004;  
- stocks of semen of bovine animals collected, processed and stored before 1 January 2005 in accordance 
with Council Directive 88/ 407/EEC applying until 1 July 2004;  
- oocytes  and embryos of bovine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of in vivo  derived embryos of bovine animals collected, processed and stored in accordance with 
Directive 89/556/EEC  before 21 April 2021;  
- stocks of in vitro  produced embryos of bovine animals produced, processed and stored in accordance 
with Directive 89/556/EEC  before 21 April 202 1, conceived using semen complying with requirements 
of Council Directive 88/407/EEC;  
- stocks of in vitro  produced embryos of bovine animals produced , processed and stored in accordance 
with Directive 89/556/EEC before 21 April 2021,  conceived using semen c oming from semen 
collection or storage centres approved by the competent authority of the exporting country,  
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT STORAGE CENTRE  (MODEL ‘BOV -GP-
STORAGE -ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railw ay  Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 725  EN  Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 726  EN  
I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 727  EN COUNTRY  Certificate model BOV -GP-STORAGE -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2/ micromanipulated embryos(2) to be exported to the 
European Union was/were stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of bovine animals 
and listed in Annex VII to Implementing Regula tion (EU) 2020/xx 
[SANTE/7140/2020 ]; 
(2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days  after its/their collection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, contagious 
bovine pleuropneumonia and lumpy skin disease  were not reported for a period of at 
least 12 months immediately prior to collection(2)/ production(2) of the semen(2)/ 
oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2); 
II.1.1.4.  where no vaccination against foot -and-mouth disease , infection with rinderpest virus, 
infection with Rift Valley fever virus and contagious bovine pleuropneumonia has been 
carried out for a period of at least 12 months immediately prior to collection(2)/ 
production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after 
its/their collection(2)/ production(2), and no vaccinated animals entered into the third 
country, territory or zone  during that period;  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4), and/or processed and stored in a 
germinal product processing establishment(2)(4), and/or stored in a germinal product storage 
centre(2)(4) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(5), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ in vivo  derived 
embryos(2)/ in vitro  produced embryos(2) of bovine animals in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product storage centre described in  Box I.11. under conditions at 
least as strict as described in:  
(2)either  [Model BOV -SEM -A-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -B-ENTRY(4);] 
(2)and/or  [Model BOV -SEM -C-ENTRY(4);] 
 (2)and/or  [Model 1 in Section A of Part 2 of Annex II to Decision 2011/630/EU(4);] 
(2)and/or  [Model 2 in Section B of Part 2 of Annex II to Decision 2011/630/EU(4);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 728  EN COUNTRY  Certificate model BOV -GP-STORAGE -ENTRY  
 (2)and/or  [Model 3 in Section C of Part 2 of Annex II to Decision 2011/630/EU(4);] 
(2)and/or  [Model BOV -OOCYTES -EMB -A-ENTRY(4);] 
(2)and/or  [Model BOV -in-vivo-EMB -B-ENTRY(4);] 
(2)and/or  [Model BOV -in-vitro -EMB -C-ENTRY(4);] 
(2)and/or  [Model BOV -in-vitro -EMB -D-ENTRY(4);] 
(2)and/or  [Model BOV -GP-PROCESSING -ENTRY(4);] 
(2)and/or  [Model BOV -GP-STORAGE -ENTRY(4);]] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been f illed in with the cryogenic agent which not have been previously used for 
other products.  
(2)(7)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from  each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centre liste d in accordance with 
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen  was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or t he germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 729  EN COUNTRY  Certificate model BOV -GP-STORAGE -ENTRY  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Species ”: Select amongst “ Bos taurus ”, “Bison bison " or " Bubalus bubalis ” as 
appropriate.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identificat ion mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or emb ryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/xx  [SANTE/7140/2020 ]. 
(4) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.e uropa.eu/food/animal/seme n_ova/bovine/index_en.htm . 
(5) Only a third country, territory or zone thereof listed in Annex VII to Implementing Regulation 2020/xx  
[SANTE/7140/2020 ] and the EU Member States.  
(6) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were co llected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product stor age centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(7) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanip ulated embryos of bovine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 730  EN CHAPTER 48: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF SEMEN OF OVINE AND CAPRINE AN IMALS COLLECTED, 
PROCESSED AND STORED  IN ACCORDANCE WITH R EGULATION (EU) 
2016/429 AND DELEGAT ED REGULATION (EU) 2020/ 692 AFTER 20 APRIL 2021,  
AND DISPATCHED FROM A SEMEN COLLECTION C ENTRE WHERE THE 
SEMEN WAS COLLECTED  (MODEL ‘OV /CAP -SEM -A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 731  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 732  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of semen of ovine(1)/caprine(1) animals and li sted in Annex 
VIII to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection of the semen and for a period of 30 days after  its collection;]  
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the semen and for a period of 30 
days after its collection;]  
II.1.3.  where  infection with rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia  were not reported for a period of at least 12 months immediately prior to 
collection of the semen and for a period of 30 days after its collection;  
II.1.4.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants vir us, sheep 
pox and goat pox and contagious caprine pleuropneumonia has been carried out for a period 
of at least 12 months immediately prior to collection of the semen and for a period of 30 days 
after its collection, and no vaccinated animals entered into the third country, territory or zone  
during that period.  
II.2. The semen described in Part I was obtained from the donor animals which originate, before the 
commencement of the quarantine  referred to in point II.4.6., from establishments   
II.2.1.  situated in an area where foot -and-mouth disease has not been reported within a 10 -km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3 months, and  
 (1)either  [they were  not vaccinated against foot -and-mouth disease;]  
(1)or [they were vaccinated against foot -and-mouth disease during the period of 12 months prior to 
the date of collection of the semen but not during the period of the last 30 days immediately 
prior to the date of collection  of the semen, and 5 % (with a minimu m of five straws) of each 
quantity of semen taken from a donor animal at any time is submitted to a virus isolation test 
for foot -and-mouth disease with negative results;]  
II.2.2.  free from infection with Brucella abortus, B. melitensis  and B. suis  and have never been kept 
previously in any establishment of a lower health status;  
(1)(3)[II.2.3.  in which infection with Mycobacterium tuberculosis  complex ( M. bovis, M. caprae and M. 
tuberculosis ) has not been reported during the last 42 days;]  
(1)(4)[II.2.3.  in which surveillance for infection with  Mycobacterium tuberculosis complex  (M. bovis, M. 
caprae and M. tuberculosis) has been  carried out on the caprine animals kept on the 
establishments during at least the last 12 months, as referred to in Articl e 15(3) of Delegated 
Regulation (EU) 2020/ 688, and in case, during this period, infection with  Mycobacterium 
tuberculosis complex  (M. bovis, M. caprae and M. tuberculosis) has been reported in caprine 
animals kept on the establishment, measures were taken in accordance with Part 1(3) of 
Annex II to that Delegated Regulation;]  
II.2.4.  in which  surra ( Trypanosoma evansi ) has not been reported during the last 30 days, a nd  
(1)either  [surra has not been  reported in the establishments during the last 2 years;]  
(1)or [surra has been reported in the establishments during the last 2 years and  following the last 
outbreak the establishments have remained under movement restrictions until  
 the infected animals have been removed from the  establishment, and  
 the remaining  animals on the establishment have been subjected to a test for surra  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 733  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
(Trypanosoma evansi ) with one of the diagnostic methods provided for in Part 3 of 
Annex I  to Delegated Regulation (EU) 2020/ 688, carried out, with negative results, on 
samples taken at l east 6 months after the infected animals have been removed from the 
establishment; ] 
 (1)(3)[II.2.5.  where they have remained for a continuous period of at least 60 days and where ovine 
epidydimitis ( Brucella ovis ) has not been reported during the period of  12 months;]  
(1)(4)[II.2.6.  where, during the period of 60 days prior to their stay in the quarantine accommodation, they 
have been subjected, with negative results, to a serological test for ovine epidydimitis 
(Brucella ovis ) or any other test with an equivalent documented sensitivity and specificity;]  
(1)(5)[II.2.7.  where infection with Burkholderia mallei  (glanders) was not reported during the period of 6 
months.]  
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(6) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipme nt set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/ 686. 
II.4. The semen described in Part I was obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus , infection with peste des petits ruminants virus, sheep pox and goat pox and contagious 
caprine pleuropneumonia;  
II.4.2.  remained for a period of at least 6 months prior to the date of collection of the semen in a 
third country or territory or zone thereo f referred to in Box I.7.;  
II.4.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.4.4.  are individually identified as provid ed for in Article 21(1)  of Delegated Regulation (EU) 
2020/ 692; 
II.4.5.  for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period  
II.4.5.1.  were kept on establishments not situated in a restricted zone e stablished due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants 
virus, sheep pox and goat pox and contagious caprine pleuropneumonia or of an 
emerging disease relevant for the ovine and caprine animals;  
II.4.5.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax,  surra (Trypanosoma 
evansi), infection with epizootic haemorrhagic disease virus, infection with 
bluetongue virus (serotype 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine anim als, ovine epidydimitis ( Brucella 
ovis) have not been reported;  
II.4.5.3.  were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from 
establishments which do no t meet the conditions referred to in point II.4.5.2.;  
II.4.5.4.  were not used for natural breeding;  
II.4.6.  have been subjected to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at lea st the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the following conditions:  
II.4.6.1.  it was not situated in a restricted zone established due to diseases referred to in This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 734  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
point II.4.5.1.;  
II.4.6.2.  none of the diseases referred to in point II.4.5.2. has been reported for a period of 
at least 30 days;  
II.4.6.3.  it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quaran tine accommodation for a period of 
at least 30 days;  
II.4.6.4.  has had no outbreak of foot -and-mouth disease reported during a period of at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;  
II.4.7.  were kept in  the semen collection centre  
II.4.7.1.  which was not situated in a restricted zone established due to diseases referred to 
in point II.4.5.1.;  
II.4.7.2.  where none of the diseases referred to in point II.4.5.2. has been reported for a 
period of at least 30  days prior to the date of collection of the semen, and  
(1)(7)[at least 30 days following the date of the collection;]  
(1)(8)[until the date of dispatch of the consignment of semen to another Member 
State;]  
II.4.7.3.  situated in an area where foot -and-mout h disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 
days; and  
(1)(7)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and 30  days from the date of collection;]  
(1)(8)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to another Member State and the donor anim als has been kept at that 
semen collection centre for a continuous period of at least 30 days immediately 
prior to the date of collection of the semen;]  
II.4.8.  comply with at least one of the following conditions as regards infection with bluetongue 
virus  (serotypes 1 -24): 
(1)either  [II.4.8.1.  they have been kept in a third country, territory or zone thereof free from infection 
with bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and 
during collection of the semen;]  
(1)and/or  [II.4.8.2.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection of the 
semen, in a third country, territory or zone thereof with an approved eradic ation 
programme against infection with bluetongue virus (serotype 1 -24);]  
(1)and/or  [II.4.8.3.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection  of the 
semen, in a third country, territory or zone thereof where the competent authority of 
the place of origin of the consignment of semen has obtained the prior written 
consent of the competent authority of the Member State of destination to the 
condit ions for establishment of that seasonally disease -free zone and to accept the 
consignment of semen;]  
(1)and/or  [II.4.8.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.4.8.5.  they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogroup 1 -24, with negative results, between 28 and 60 days from the date of 
each collection of the semen;]  
(1)and/or  [II.4.8.6.  they have been subjected to an agent identification test for bluetongue virus This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 735  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
(serotypes 1 -24), with negative results, on blood samples taken at commencement 
and final collection of the semen and during collection of the semen at intervals of  at 
least every 7 days, in the case of the virus isolation test, or of at least every 28 days, 
in the case of PCR;]  
II.4.9.  comply with at least one of the following conditions as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.4.9.1.  they have been kept for a period of at least 60 days prior to and during collection of 
the semen in a third country, territory or zone thereof where EHDV 1 -7 has not been 
reported for a period of at least the preceding 2 years within a radius of 1 50 km of 
the establishment;]  
(1)and/or  [II.4.9.2.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection of the semen;]  
(1)and/or  [II.4.9.3.  were resident in the exporting country in which ac cording to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to  the following tests carried out in an 
official laboratory:  
(1)either  [II.4.9.3.1.  a serological test to detect antibodies to EHDV 1 -7, with negative 
results, at least every 60 days throughout the collection period and 
between 28 and 60 days from the date of the final collection of the 
semen;]]  
(1)and/or  [II.4.9.3.2.  an agent identification test for EHDV 1 -7, with n egative results, on 
blood samples taken at the commencement and final collection of the 
semen and during the collection of the semen at intervals of at least 
every 7 days, in the case of virus isolation test, or of at least every 28 
days, in the case of PC R.]] 
II.4.10.  have been subjected to the following tests, carried out on blood samples taken within the 
period of 30 days prior to the commencement of the quarantine referred to in point II.4.6., 
with negative results, required in accordance with point 1(c ) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/ 686: 
II.4.10.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(9)[II.4.10.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an 
equivalent documented sensitivity and specificity;]  
II.4.11.  have been subjected to the following tests, carried out on blood samples taken within a peri od 
of at least 21 days prior to the commencement of the quarantine referred to in point II.4.6., 
with negative results, required in accordance with point 1(d) of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/ 686: 
II.4.11.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(9)[II.4.11.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test  with an 
equivalent documented sensitivity and specificity;]  
II.4.12.  have been subjected at semen collection centre, at least once a year, to the following 
compulsory routine tests, required in accordance with point 2 of Chapter I of Part 3 of Annex 
II to Delegated Regulation (EU) 2020/ 686: 
II.4.12.1.  for infection  with Brucella abortus, B. melitensis  and B. suis,  a serological test 
referred to in point 1 of Part 1 of Annex I to Delegated Regulation (EU) 
2020/ 688; 
(1)(9)[II.4.12.2.  for ovine epidydimitis ( Brucella ovis ), a serological test or any other test with an This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 736  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
equivalent documented sensitivity and specificity.]]  
II.4.13.  comply with the following conditions as regards classical scrapie:  
II.4.13.1. they have been kept continuously since birth in a country where the following 
conditions are fulfilled:  
II.4.13.1.1. classical scrapie is compulsorily notifiable;  
II.4.13.1.2. an awareness, surveillance and monitoring system is in place;  
II.4.13.1.3. ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;  
II.4.13.1.4. the feeding to ovine and caprine animals of meat -and-bone 
meal, or greaves of ruminant origin, as defined in the 
Terrestrial Animal Health Code of the World Organisation 
for Animal Health, has been banned and effectively enforced 
in the whole country for a period of at least the last seven 
years;  
And 
 (1)either  [II.4. 13.2. they have been kept continuously for  the last three years preceding the date of 
the collection of the semen to be exported in a h olding or holdings which has/have fulfilled 
during that period all the requirements  set out in points 1.3. (a) to (f) of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were 
kept at a semen collection  centre that complied during that period with the conditions set out 
in the four indents of point 1.3.(c)(iv) of that Section;]  
 (1)or [II.4. 13.2. they are ovine animals of the ARR/ARR prion protein genotype.]  
II.5. The semen described in Part I  
II.5.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/ 686; 
II.5.2.  is placed in straws or other packages on which the mark is applied in acc ordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  is transported in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for other products.  
(1)(10)[II.6. The semen is preserved by the additi on of antibiotics as follows:  
II.6.1.  The following  antibiotic or mixture of antibiotics has been added to the semen after final dilution, 
or is contained in the used semen diluents, to reach the indicated concentration per ml of semen:  
(1)either  [gentamic in (250 μg);]  
(1)or [a mixture  of penicillin (500 IU) and streptomycin (500 μg);]  
(1)or [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (1)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(1)or [an antibiotic  or a mixture of antibiotics(11) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:  
- gentamicin (250 μg);  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 737  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
- penicillin (500 IU) and streptomycin (500 μg);  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.6.2.  Immediately  after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or under a 
time-temperature r egime with a documented equivalent bactericidal activity.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission websi te: 
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Indicate semen.  
  “Species ”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen of 
the consignment is placed.  
“Date of  collection/production ”: Indicate the date on which semen of the 
consignment was collected.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Applicable for ovine animals.  
(4) Applicable for ovine animals and for those caprine animals which are kept together with ovine animals. 
(5) Applicable for caprine animals. 
(6) Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
(7) Applicable for frozen semen . 
(8) Applicable for fresh and chilled semen.  
(9) Applicable for ovine animals and for those caprine animals which are kept together with ovine animals. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 738  EN COUNTRY  Certificate model OV/CAP -SEM -A-ENTRY  
(10) Mandatory attestation in case antibiotics were added.  
(11) Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official v eterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 739  EN CHAPTER 49: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF STOCKS OF SEMEN OF O VINE AND CAPRINE ANI MALS 
COLLECTED, PROCESSED  AND STORED IN ACCORDANCE WITH DIRE CTIVE 
92/65/EEC BEFORE 21 APRIL 2021, AND DISP ATCHED AFTER 20 APRI L 2021 
FROM A SEMEN COLLECT ION CENTRE WHERE THE  SEMEN WAS 
COLLECTED  (MODEL ‘OV /CAP -SEM -B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 740  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 741  EN COUNTRY  Certificate model OV/CAP -SEM -B-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, hereby certify that:  
II.1. The exporting country ……………………………………………………………………  
(name of exporting  country )(1) 
II.1.1.  has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious 
caprine pleuropneumonia and Rift Valley fever during the 12 months immediately prior to 
collection of the semen to be exported and until its date  of dispatch to the Union and no 
vaccination against these diseases took place during that period;  
II.1.2.  has been free from foot -and-mouth disease during the 12 months immediately prior to 
collection of the semen to be exported and until its date of disp atch to the Union and no 
vaccination against this disease took place during that period.  
II.2. The semen collection centre(2) described in Box I.11. and at which the semen to be exported was 
collected and stored:  
II.2.1.  met the conditions for the approval  of semen collection centres laid down in Chapter I(I)(1) of 
Annex D to Directive 92/65/EEC;  
II.2.2.  was operated and supervised in accordance with the conditions applicable to semen collection 
centres and storage centres laid down in Chapter  I(II)(1) of A nnex D to Directive 92/65/EEC.  
II.3. The ovine(3)/caprine(3) animals standing at the semen collection centre:  
II.3.1.  prior to their stay in the quarantine accommodation described in point II.3.3.,  
(3)(4)either  [II.3.1.1.  originate from the territory described in Box I.8., which has been recognised as officially 
brucellosis ( B. melitensis )-free,]  
(3)or [II.3.1.1.  have belonged to a holding which has obtained and maintained its officially brucellosis ( B. 
melitensis )-free status in accordance with Directive 91/68/EEC,]  
(3)or [II.3.1.1.  originate from a holding, where in respect of brucellosis ( B. melitensis ) all susceptible animals 
have been free from clinical or any signs of this disease for the last 12 months, none of the 
ovine and caprine animals  have been vaccinated against this disease, save those vaccinated 
with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals over six 
months of age have been subjected to at least two tests(5), carried out with negative results on 
sampl es taken on ……………. ( date) and on …………. ( date) at least six months apart, the 
latter being within 30 days before entry into the quarantine accommodation,]  
and have not been kept previously in a holding of a lower status;  
II.3.1.2.  have been kept continuousl y for at least 60 days on a holding where no case of contagious 
epididymitis ( Brucella ovis ) has been diagnosed in the last 12 months,  
(3)and [they are animals of the ovine species and have undergone during the 60 days prior to their 
stay in the quarantine  accommodation described in point II.3.3. a complement fixation test, or 
any other test with an equivalent documented sensitivity and specificity, to detect contagious 
epididymitis with result of less than 50 ICFTU/ml;]  
II.3.1.3.  to the best of my knowledg e do not come from holdings and have not been in contact with 
animals of a holding, in which, based on the official notification system and according to the 
written declaration made by the owner, any of the following diseases has been clinically 
detected w ithin the periods referred to in points (a) to (d) prior to their stay in the quarantine 
accommodation described in point II.3.3.  
(a) contagious agalactia of sheep or goats ( Mycoplasma agalactiae, Mycoplasma 
capricolum, Mycoplasma mycoides var. mycoides " large colony"), within the last six 
months,  
(b) paratuberculosis and caseous lymphadenitis, within the last 12 months,  
(c) pulmonary adenomatosis, within the last three years;  
(3)either  [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 742  EN COUNTRY  Certificate model OV/CAP -SEM -B-ENTRY  
three years;]  
(3)or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
12 months, and all the infected animals were slaughtered and remaining animals 
subsequently reacted negatively to two t ests carried out at least six months apart;]  
II.3.2.  have undergone the following tests carried out on a blood sample collected within the 28 days 
preceding the commencement of the period of quarantine specified in point II.3.3. for:  
– brucellosis ( B. melitensis ), with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;  
– contagious  epididymitis ( Brucella. ovis ), in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other test with an equivalent documented sensitivity and specificity;  
– border disease in accordance with point 1.4(c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC;  
II.3.3.  have satisfied the quarantine isolation period of at least 28 days in  a quarantine 
accommodation specifically approved for the purpose by the competent authority and during 
that period:  
II.3.3.1.  only animals of at least the same health status were present in the quarantine accommodation;  
II.3.3.2.  the animals have undergon e the following tests, carried out by the laboratory approved by the 
competent authority of the exporting country on samples taken not earlier than 21 days after 
the animals were admitted to the quarantine accommodation, for:  
– brucellosis ( B. melitensis ) with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;  
– contagious  epididymitis ( Brucella ovis ), in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other t est with an equivalent documented sensitivity and specificity;  
– border disease in accordance with point 1.6 of Chapter II(II) of Annex D to Directive 
92/65/EEC;  
II.3.4.  have undergone at least once a year the routine tests for:  
– brucellosis ( B. melitensi s) with negative results in each case in accordance with 
Annex C to Directive 91/68/EEC;  
– contagious epididymitis ( Brucella ovis),  in the case of sheep only, with negative 
results in each case in accordance with Annex D to Directive 91/68/EEC, or any 
other test with an equivalent documented sensitivity and specificity;  
– border disease in accordance with point 5(c) of Chapter II(II) of Annex D to 
Directive 92/65/EEC.  
II.4. The semen to be exported was obtained from donor rams(3)/bucks(3) which:  
II.4.1.  were admitted to the approved semen collection centre with the express permission of the 
centre veterinarian.  
II.4.2.  show no clinical signs of disease on the day of admission to the approved semen collection 
centre and on the day the semen was collected;  
(3)either  [II.4.3.  have not been vaccinated against foot -and-mouth disease during the 12 months prior to 
collection of the semen;]  
(3)or [II.4.3.  have been vaccinated against foot -and-mouth disease at least 30 days prior to the collection, 
and 5 % (with a min imum of five straws) of each collection have been submitted to a virus 
isolation test for foot -and-mouth disease with negative results;]  
II.4.4.  have been kept at an approved semen collection centre for a continuous period of at least 
30 days immediately p rior to collection of the semen, in the case of collections of fresh 
semen;  
II.4.5.  have not served naturally after their entry to the quarantine accommodation described in point This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 743  EN COUNTRY  Certificate model OV/CAP -SEM -B-ENTRY  
II.3.3. and up to and including the day of semen collection;  
II.4.6.  have bee n kept at approved semen collection centres:  
II.4.6.1.  which have been free from foot -and-mouth disease for at least three months prior to collection 
of the semen and 30 days after collection or, in the case of fresh semen, until the date of 
dispatch, and  which are situated in the centre of an area of 10 kilometres radius in which there 
has been no case of foot -and-mouth disease for at least 30 days prior to collection of the 
semen;  
II.4.6.2.  which have been free, during the period commencing 30 days prior  to collection and ending 
30 days after collection of the semen or, in the case of fresh semen, until the date of dispatch, 
from brucellosis ( B. melitensis ), contagious epididymitis ( Brucella. ovis ), anthrax and rabies;  
(3)either  [II.4.7.  have remained in the exporting country for at least the past six months prior to collection of 
the semen to be exported;]  
(3)or [II.4.7.  during the last six months prior to collection of the semen they complied with the animal 
health conditions applying to donors of the se men which is intended for export to the Union 
and they have been imported into the exporting country at least 30 days prior to collection of 
the semen from ………………………….(1);] 
(3)either  [II.4.8.  were kept in a bluetongue virus -free country or zone for at leas t 60 days prior to, and during, 
collection of the semen;]  
(3)or [II.4.8.  were kept during a bluetongue virus seasonally free period in a seasonally free zone for at 
least 60 days prior to, and during collection of the semen;]  
(3)or [II.4.8.  were kept in a vector -protected establishment for at least 60 days prior to, and during 
collection of the semen;]  
(3)or [II.4.8.  were subjected to a serological test for the detection of antibody to the bluetongue virus 
group, carried out in accordance with the OIE Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals, with negative results, on blood samples taken at least every 60  days 
throughout the collection period and between 21 and 60 days after the final collection for this 
consignment of semen;]  
(3)or [II.4.8.  were subjected to an agent identification test for bluetongue virus, carried out in accordance 
with the Manual of Diagnostic Tests and Vaccines for Terrestrial Animals with negative 
results on blood samples taken at commencement and final colle ction for this consignment of 
semen and at least every 7 days (virus isolation test) or at least every 28 days (PCR test) 
during collection for this consignment of semen;]  
(3)(6)either  [II.4.9.  were resident in the exporting country which according to offi cial findings is free from 
epizootic haemorrhagic disease (EHD);]  
(3)or [II.4.9.  were resident in the exporting country in which according to official findings the following 
serotypes of epizootic haemorrhagic disease (EHD) exist: …………………… and were 
subject ed with negative results in each case to:  
(3)either  [a serological test(7) for the detection of antibody to the EHDV group carried out in an 
approved laboratory on samples of blood taken on two occasions not more than 12 months 
apart prior to and not less than 21 days after the final collection for this consignment of 
semen.]]  
(3)or [a serological test(7) for the detection of antibody to the EHDV group, carried out in an 
approved laboratory on samples of blood taken at intervals of not more than 60  days 
throughout the collection period and between  21 and 60  days after the final collection for this 
consignment of semen.]]  
(3)or [an agent identification test(7) carried out in an approved laboratory on samples of blood taken 
at commencement and conclusion of, and at least every 7  days (virus isolation test) or at least 
every 28  days (PCR test) during collection for this consignment of semen.]]  
II.4.10.  comply with the following conditions as regards classical scrapie:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 744  EN COUNTRY  Certificate model OV/CAP -SEM -B-ENTRY  
II.4.10.1.  they have been kept continuously since birth in a country where the following 
conditions are fulfilled:  
II.4.10.1.1.  classical scrapie is compulsorily notifiable;  
II.4.10.1.2.  an awaren ess, surveillance and monitoring system is in place;  
II.4.10.1.3.  ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;  
II.4.10.1.4.  the feeding to ovine and caprine animals of meat -and-bone meal, 
or greaves of rumi nant origin has been banned and effectively 
enforced in the whole country for a period of at least the last 
seven years;  
And 
 (3)either  [II.4.10.2.  they have been kept continuously for  the last three years preceding the date of 
the collection of the semen to be exported in a holding or holdings which has/have been 
complying for the last three years before the collection of the semen to be exported with  the 
requirements  set out in points 1.3. (a) to (f) of Section A of Chapter A of Annex VIII to 
Regulation (EC) No 999/2001;]  
 (3)or [II.4.10.2.  they are ovine animals of the ARR/ARR prion protein genotype.]  
II.5. The semen to be exported:  
II.5.1.  was collected after the date on which the semen collection centre was approved by the 
competent authority of the exporting country;  
II.5.2.  was collected, processed, preserved, stored and transported in accordance with the 
requirements applicable to semen laid down in Chapter III(I) of Annex D to Directive 
92/65/EEC;  
II.5.3.  was sent to the place of loading in a sealed container in accordance with the requirements for 
semen to be subject to trade laid down in point 1.4 of Chapter III(I) of Annex D to Directive 
92/65/EEC and bearing the number indic ated in Box I.19.  
(3)either  [II.6.  No antibiotics were added to the semen.]  
(3)or [II.6.  The following antibiotic or combination of antibiotics was added to produce a concentration 
in the final diluted semen of not less than(8): 
……………………………………………………………. .]  
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6 : “Operator responsible for the consignment ”: this box is to be filled in only if it is a certificate for transit 
commodity.  
Box I.11 : Place of dispatch  shall correspond to the semen collection centre in which the semen was collected and 
listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
Box I.19 : Identification of container and seal number shall be indicated.  
Box I.21: Fill in a ccording to whether it is a transit or an import certificate.  
Box I.22 : Fill in according to whether it is a transit or an import certificate.  
Box I.24 : “Number of packages ” shall correspond to the number of containers.  
Box I.27 : “Species ”: select amongst “Ovis aries ” or “ Capra hircus ” as appropriate.  
 Identification number  shall correspond to the official identification of the animal.  
 “Date of collection/production ” shall be indicated in the following format: dd.mm.yyyy.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 745  EN COUNTRY  Certificate model OV/CAP -SEM -B-ENTRY  
 “Approval or registration number  of plant/establishment/centre ” shall correspond to the approval 
number of the semen collection centre indicated in Box I.11.  
 
Part II:  
(1) Only third country , territory or zone thereof listed in Annex VIII to Implementing Regulation 2020/…  
[SANTE/7140/2020 ] for semen of ovine and caprine animals . 
(2) Only  semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
(3) Delete as necessary.  
(4) Only for the territory appearing with the entry "V" in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ L 73, 20.3.2010, p. 1.).  
(5) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.  
(6) See remarks for exporting country concerned in Annex I to Decision 2010/472/EU.  
(7) Standards for EHD virus diagnostic tests are described in Chapter 2.1.3. of the OIE Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals.  
(8) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 746  EN CHAPTER 50: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF OOCYTES AND EMBRYOS OF OVINE AND CAPRINE  ANIMALS 
COLLECTED OR PRODUCE D, PROCESSED AND STO RED IN ACCORDANCE 
WITH REGULATION (EU)  2016/429 AND DELEGAT ED REGULATION (EU) 
2020/ 692 AFTER 20 APRIL 2021 , AND DISPATCHED BY AN  EMBRYO 
COLLECTION OR PRODUC TION TEAM BY WHICH T HE OOCYTES OR 
EMBRYOS WERE COLLECT ED OR PRODUCED  (MODEL ‘ OV/CAP -OOCYTES -
EMB -A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 747  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 748  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The oocytes(1)/ in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I are intended for artificial reproduction and were obtained from the donor animals 
which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of oocytes(1)/ embryos(1) of ovine(1)/caprine(1) animals and 
listed in Annex VIII to Implementing Regulation (EU) 2020/… [SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period 
of 30 days after their collection(1)/ production(1);] 
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1) and for 
a period of 30 days after their collection(1)/ production(1);] 
II.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, infection with 
peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period of 30 days after their 
collection(1)/ production(1); 
II.1.4.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, sheep 
pox and goat pox and contagious caprine p leuropneumonia has been carried out for a period 
of at least 12 months immediately prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and for a period of 30 days after their collection(1)/ production(1), and no vaccinated 
animals entered i nto the third country, territory or zone  during that period.  
 (1)[II.2.  The in vivo  derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(3) which  
II.2.1.  is approved and listed by the competent authority of the third country or territory;  
II.2.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
(1)[II.2.  The oocyt es(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(3) which  
II.2.1.  is approved and listed by the competent authority of t he third country or territory;  
II.2.2.  complies with requirements  as regards responsibilities, operational procedures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.3. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which originate from 
establishments  free from infection with Brucella abortus, B. melitensis  and B. suis  and have never been 
kept previously in any establishment of a lower health status.  
II.4. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, infection with Rift Valley fever 
virus, infection with peste des petits ruminants virus, sheep pox an d goat pox and contagious 
caprine pleuropneumonia;  
II.4.2.  remained for a period of at least 6 months prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1) in a third country or territory or zone thereof referred to in Box I.7.;  
II.4.3.  for a period of at least 30 days prior to the date of collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and during the collection(1)/ production(1) period  
II.4.3.1.  were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 749  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -A-ENTRY  
virus, sheep pox and goat pox and contagious caprine pleuropneumonia or of an 
emerging disea se relevant for the ovine and caprine animals;  
II.4.3.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with Mycobacterium tuberculosis  complex ( M. 
bovis, M. caprae and M. tuberculosis ), rabies, anthrax,  surra (Trypanosoma 
evansi), infection with epizootic haemorrhagic disease virus, infection with 
bluetongue virus (serotype 1 -24) and, in case of ovine animals and those caprine 
animals which are kept together with ovine animals, ovine epid ydimitis ( Brucella 
ovis) have not been reported;  
II.4.3.3.  were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.4.1. or from 
establishments which do not meet the cond itions referred to in point II.4.4.2.;  
II.4.3.4.  were not used for natural breeding;  
II.4.4.  were examined by the team veterinarian or its team member and did not show symptoms or 
clinical signs of transmissible animal diseases on the day of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1);  
II.4.5.  are individually identified as provided for in Article 21(1)  of Delegated Regulation (EU) 
2020/ 692; 
II.4.6.  comply with the following conditions as regards foot -and-mouth disease  
II.4.6.1.  they come f rom establishments  
 situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a period of at least 30 
days immediately prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1) of 
the oocytes(1)/ embryos(1); 
 (1)either  [II.4.6.2.  they were  not vaccinated against foot -and-mouth disease;]  
(1)(4)or [II.4.6.2.  they were vaccinated  against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and 
II.4.6.2.1.  have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of collection 
of the embryos;  
II.4.6.2.2.  the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) or the sem en 
complies with the conditions set out in point 2  of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/ 686; 
II.4.6.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the recommendations of the 
IETS Manual(5); 
II.4.6.2.4.  the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of foot -and-mouth disease;]  
II.4.7.  comply with at least one of the following conditions as regards infection with bluetongue 
virus (serotypes 1 -24): 
(1)either  [II.4.7. 1. they have been kept in a third country, territory or zone thereof free from infection 
with bluetongue virus (serotypes 1 -24) for a period of at least 60 days prior to and 
during collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.4.7.2.  they have been kept in a seasonally disease -free zone, during the seasonally disease -This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 750  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -A-ENTRY  
free period, for a period of at least 60 days prior to and during collection(1)/ 
production(1) of the oocytes(1)/ embryos(1), in a third country, territory or zone thereof  
with an approved eradication programme against infection with bluetongue virus 
(serotype 1 -24);]  
(1)and/or  [II.4.7.3.  they have been kept in a seasonally disease -free zone, during the seasonally disease -
free period, for a period of at least 60 days prior to and during collection(1)/ 
production(1) of the oocytes(1)/ embryos(1), in a third country, territory or zone thereof 
where the competent authority of the place of origin of the consignment of the 
oocytes(1)/ embryos(1) has obtained the prior written con sent of the competent 
authority of the Member State of destination to the conditions for establishment of 
that seasonally disease -free zone and to accept the consignment of the oocytes(1)/ 
embryos(1);] 
(1)and/or  [II.4.7.4.  they have been kept in a vector -protected establishment for a period of at least 60 
days prior to and during collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.4.7.5.  they have been subjected to a serological test to detect antibodies to the bluetongue 
virus serogr oup 1 -24, with negative results, between 28 and 60 days from the date of 
each collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.4.7.6.  they have been subjected to an agent identification test for bluetongue virus 
(serotypes 1 -24), with negative results, on blood sample taken on the date of 
collection of the oocytes(1)/ embryos(1);] 
II.4.8.  comply with at least one of the following conditi ons as regards infection with epizootic 
haemorrhagic disease virus (serotypes 1 -7) (EHDV 1 -7): 
(1)either  [II.4.8.1.  they have been kept for a period of at least 60 days prior to and during collection(1)/ 
production(1) of the oocytes(1)/ embryos(1) in a third country, territory or zone thereof 
where EHDV 1 -7 has not been reported for a period of at least the preceding 2 years 
within a radius of 150 km of the establishment;]  
(1)and/or  [II.4.8.2.  they have been kept in a vector -protected establishment  for a period of at least 60 
days prior to and during collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)and/or  [II.4.8.3.  were resident in the exporting country in which according to official findings the 
following serotypes of EHDV exist: ………………………… and have been 
subjected with negative results in each case to  the following tests carried out in an 
official laboratory:  
(1)either  [II.4.8.3.1.  a serological test to detect antibodies to EHDV 1 -7, with negative 
results, on blood sample taken bet ween 28 and 60 days from the date of 
the collection(1)/ production(1) of the oocytes(1)/ embryos(1);]] 
(1)and/or  [II.4.8.3.2.  an agent identification test for EHDV 1 -7, with negative results, on 
blood sample taken on the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1).]] 
II.4.9.  comply with the following conditions as regards classical scrapie:  
II.4.9.1.  have been kept continuously since birth in a country where the following 
conditions are fulfilled:  
II.4.9.1.1.  classical scrapie is compulsorily notifiable;  
II.4.9.1.2.  an awareness, surveillance and monitoring system is in 
place;  
II.4.9.1.3.  ovine and caprine animals affected with classical scrapie are 
killed and completely destroyed;  
II.4.9.1.4. the feeding to ovine and caprine animals of meat -and-bone meal or 
greaves of ruminant origin, as defined in the Terrestrial 
Animal Health Code of the World Organisation for Animal 
Health, has been banned and effectively enforced in the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 751  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -A-ENTRY  
whole country for a period of at least the last seven  years;  
And 
(1)either  [II.4.9.2. have been kept continuously for the last three years preceding the date of the 
collection of the semen to be exported in a holding or holdings which has/have fulfilled 
during that period all the requirements set out in points 1.3. (a) to (f) of Section A of Chapter 
A of Annex VIII to Regulation (EC) No 999/2001, except during the period when they were 
kept at a semen collection centre that complied during that period with the conditions set out 
in the four indents of poi nt 1.3.(c)(iv) of that Section;]  
(1)or [II.4.9.2. they are ovine animals and the embryos   
(1)either  [are of the ARR/ARR prion protein genotype;]  
(1)or [carry at least one ARR allele.]]  
II.5. The oocytes(1)/ embryos(1) described in Part I   
II.5.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to Delegated Regulation (EU) 
2020/ 686; 
II.5.2.  are placed in straws or other packages on which the mark  is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  are transported in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch by  the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for other products;  
(1)(6)[II.5.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.5.5.  are transported in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
(1)(7)[II.6.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in 
Part I were conceived by artificial insemination using semen coming from a semen collection centre, 
germinal product processing establishment or germinal product storage centre approved for the collection, 
processing and/or storage of semen by the compe tent authority of a third country, territory or zone thereof 
listed in Annex VIII to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for semen of ovine 
and caprine animals or by the competent authority of a Member State.]  
(1)(8)[II.7. The following  antibiotic or mixture of antibiotics(9) has been added to the collection, processing, washing 
or storage media: …………………………………………………………………………]  
 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of ooc ytes or 
embryos. Only embryo collection or production teams listed in accordance with This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 752  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -A-ENTRY  
Article 233(3) of Regulation (EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number ” shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
  “Species ”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or oth er packages where oocytes or 
embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
(4) Option available only for  the consignment of  in vivo  derived embryos.  
(5) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transfer technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society 1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA (http://www.iets.org/).  
(6) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated e mbryos of ovine or caprine animals are placed and transported.  
(7) Does  not apply to oocytes.  
(8) Mandatory attestation in case antibiotics were added.  
(9) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 753  EN CHAPTER 51: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF OOCY TES AND EMBRYOS OF O VINE AND 
CAPRINE ANIMALS COLL ECTED OR PRODUCED, P ROCESSED AND STORED 
IN ACCORDANCE WITH D IRECTIVE 92/65/EEC B EFORE 21 APRIL 2021 AND 
DISPATCHED BY AN EMB RYO COLLECTION OR PR ODUCTION TEAM BY 
WHICH THE OOCYTES OR  EMBRY OS WERE COLLECTED OR  PRODUCED 
(MODEL ‘ OV/CAP -OOCYTES -EMB -B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country  code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 754  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 755  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -B-ENTRY - Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, hereby certify that:  
II.1. The exporting country ………………………………………………………………………..  
(name of exporting country )(1) 
II.1.1.  has been free from rinderpest, peste des petits ruminants, sheep and goat pox, contagious 
caprine pleuropneumonia, and Rift Valley fever during the 12 months immediately prior to 
collection of the ova(2)/embryos(2) to be exported and until their date of dispatch to the Union 
and no vaccination against these diseases took place d uring that period;  
(2)either  [II.1.2.  has been free from foot -and-mouth disease during the 12 months immediately prior to 
collection of the ova(2)/embryos(2) and did not carry out vaccination against foot -and-mouth 
disease during that period;]  
(2)or [II.1.2.  has not been free from foot -and-mouth disease during the 12 months immediately prior to 
collection of the ova(2)/embryos(2) and/or carried out vaccination against foot -and-mouth 
disease during that period and  the donor females come from holdings o n which no animal was 
vaccinated against foot -and-mouth disease during 30 days prior to collection and no animal of 
susceptible species showed clinical signs of foot -and-mouth disease during the 30  days prior 
to, and at least 30 days after, the ova(2)/embr yos(2) were collected and the ova(2)/embryos(2) 
were not subjected to penetration of zona pellucida ;] 
II.2. The ova(2)/embryos(2) to be exported:  
II.2.1.  were collected(2)/produced(2) and processed on premises within a 10 -km radius of which there 
was no incidence of foot -and-mouth disease, vesicular stomatitis, Rift Valley fever in the 
30 days immediately prior to their collection;  
II.2.2.  were stored at all times on approved premises within a 10 -km radius of which there was no 
incidence of foot -and-mouth disease, vesicular stomatitis or Rift Valley fever from the time of 
their collection until 30 days thereafter;  
II.2.3.  were collected(2)/produced(2) by the team described in Box I.11.,  which had been approved and 
supervised in accordance with the conditions for the approval and supervision of embryo 
collection teams and embryo production teams(3) laid down in Chapter I(III) of Annex D to 
Directive 92/65/EEC;  
II.2.4.  meet the conditions for ova and embryos laid down in Chapter III(II) of Annex D to Directive 
92/65/EEC;  
II.2.5.  come from the donor females of ovine(2)/caprine(2) species which:  
(2)either  [II.2.5.1.  were kept in a bluetongue virus -free country or zone for at least 60 days pri or to, and during 
collection of the ova(2)/embryos(2);] 
(2)or [II.2.5.1.  were kept during a bluetongue virus seasonally free period in a seasonally free zone;]  
(2)or [II.2.5.1.  were kept protected from the vector for at least 60  days prior to, and during the collection of 
the ova(2)/embryos(2);] 
(2)or [II.2.5.1.  underwent a serological test for the detection of antibody to the bluetongue virus serogroup, 
carried out in accordance with the Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals betw een 21 and 60 days after collection of the ova(2)/embryos(2) and giving negative 
results;]  
(2)or [II.2.5.1.  underwent an agent identification test for bluetongue virus, carried out in accordance with the 
Manual of Diagnostic Tests and Vaccines for Terrestr ial Animals on a blood sample taken on 
the day of the ova(2)/embryos(2) collection or the day of slaughtering and giving negative 
results;]  
II.2.5.2.  to the best of my knowledge do not come from holdings and have not been in contact with 
animals of a holdi ng, in which, based on the official notification system and according to the 
written declaration made by the owner, any of the following diseases has been clinically 
detected within the periods referred to in points (a) to (d) prior to collection of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 756  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -B-ENTRY - 
ova(2)/embryos(2) to be exported:  
(a) contagious agalactia of sheep or goats ( Mycoplasma agalactiae, Mycoplasma 
capricolum, Mycoplasma mycoides var. mycoides "large colony"), within the last six 
months;  
(b) paratuberculosis and caseous lymphadenitis, within the last 12 months;  
(c) pulmonary adenomatosis, within the last three years;  
(2)either  [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
three years;]  
(2)or [(d) Maedi/Visna for sheep or caprine viral arthritis/encephalitis for goats, within the last 
12 months, and all the infected animals were slaughtered and remaining animals 
subsequently reacted negatively to two tests carried out at least six months apart;]  
II.2.5.3.  showed no clinical signs of dise ase on the day of the ova(2)/embryos(2) collection;  
(2)(4)either  [II.2.5.4.  originate from the region described in Box I.8., which has been recognised as officially 
brucellosis (B. melitensis) -free, and]  
(2)or [II.2.5.4.  have belonged to a holding which ha s obtained and maintained its officially brucellosis 
(B. melitensis) -free status in accordance with Directive 91/68/EEC, and]  
(2)or [II.2.5.4.  originate from a holding, where in respect of brucellosis ( B. melitensis ) all susceptible animals 
have been free from any clinical or any signs of this disease for the last 12 months, none of 
the ovine and caprine animals have been vaccinated against this disease, save those vaccinated 
with Rev. 1 vaccine more than two years ago, and all ovine and caprine animals ove r six 
months of age have been subjected to at least two tests(5), carried out with negative results on 
samples taken on ……………. ( date) and on …………. ( date) at least six months apart, the 
latter being within 30 days prior to collection of the ova(2)/embryos(2),] 
and have not been kept previously in a holding of a lower status;  
(2)either  [II.2.5.5.  have remained in the exporting country for at least the past six months prior to collection of 
the ova(2)/embryos(2) to be exported;]  
(2)or [II.2.5.5.  during the pas t six months prior to collection of the ova(2)/embryos(2) they complied with the 
animal health conditions applying to donors of the ova/embryos(2) which are intended for 
export to the Union and they have been imported into the exporting country at least 30  days 
prior to collection of the ova(2)/embryos(2) from ………………………….(1);] 
II.2.5.6.  comply with the following conditions as regards classical scrapie:  
II.2.5.6.1  they have been kept continuously since birth in a country where the following 
conditions are fulfilled:  
II.2.5.6.1.1.  classical scrapie is compulsorily notifiable;  
II.2.5.6.1.2.  an awareness, surveillance and monitoring system is in place;  
II.2.5.6.1.3.  ovine and caprine animals affected with classical scrapie are killed and 
completely destroyed;  
II.2.5.6.1.4.  the feeding to ovine and caprine animals of meat -and-bone meal or 
greaves of ruminant origin has been banned and effectively enforced in 
the whole country for a period of at least the last seven years;  
And 
(2)either  [II.2.5.6.2  they have been  kept continuously for  the last three years before the collection of the 
embryos to be exported in a holding or holdings which has/have been complying for 
the last three years before the collection of the embryos to be exported with the 
requirements laid d own in points (a) to (f) of point 1.3. of Section A of Chapter A of 
Annex VIII to Regulation (EC) No 999/2001 ;] 
(2)or [II.2.5.6.2  they are ovine animals and the embryos  
(2)either  [are of the ARR/ARR prion protein genotype;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 757  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -B-ENTRY - 
(2)or [carry at least one ARR allele and were collected after the date of 1 January 2015 .]] 
[II.2.6.  were collected(2)/produced(2) in the exporting country,  
(2)either  [II.2.6.1.  which according to official findings is free from epizootic haemorrhagic disease (EHD);]]  
(2)(6)or [II.2.6.1 . in which according to official findings the following serotypes of epizootic haemorrhagic 
disease (EHD) exist: …………………… and the donor females of ovine(2)/caprine(2) species 
were subjected with negative results in each case to  the following tests carried out in an 
approved laboratory:  
(2)either  [a serological test(7) for the detection of antibody to the EHD virus serogroup, carried out on 
samples of blood taken on two occasions not more than 12 months apart prior to and not less 
than 21 days following coll ection for this consignment of ova(2)/embryos(2);]] 
(2)or [a serological test(7) for the detection of antibody to the EHD virus serogroup, carried out on 
samples of blood taken at intervals of not more than 60  days throughout the collection period 
and betw een 21 and 60  days after the final collection for this consignment of 
ova(2)/embryos(2);]] 
(2)or [an agent identification test(7), carried out on samples of blood collected at commencement 
and conclusion of, and at least every 7  days, if carried out as vir us isolation test, or at least 
every 28  days, if carried out as polymerase chain reaction, during collection for this 
consignment of ova(2)/embryos(2);]] 
II.2.7.  were collected(2)/produced(2) after the date on which the embryo collection team was approved 
by the competent authority of the exporting country;  
II.2.8.  were processed and stored under approved conditions for at least 30 days immediately after 
their collection(2)/production(2) and transported under conditions for ova and embryos laid 
down in Chapter  III(II) of Annex D to Directive 92/65/EEC;  
II.2.9.  were sent to the place of loading in a sealed container in accordance with the requirements for 
the transport of embryos laid down  in point 6 of Chapter  III(II) of Annex D to Directive 
92/65/EEC and bearing the number detailed in Box  I.19. 
(2)[II.2.10.  the consignment consists of embryos of the ovine or caprine species which were conceived by 
artificial insemination(2)/as a result of  in vitro  fertilisation(2) using semen coming from semen 
collection centres approved(8) in accordance with:  
(2)either  [II.2.10.1.  Article 11(2) of Directive 92/65/EEC and located in a Member State of the European Union; 
and the semen complies with the requ irements of Directive 92/65/EEC.]]  
(2)or [II.2.10.1.  Article 17(3)(b) of Directive 92/65/EEC and located in a third country or part thereof listed in 
Annex I to Decision 2010/472/EU, and the semen complies with the requirements set out in 
Part 2 of Annex I I to that Decision.]]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consignment ”: This box is to be filled in only if it is a certificate 
for transit commodity.  
Box I.11:  Place of dispatch  shall correspond to the embryo collection team or embryo production team by 
which the oocytes/embryos were collected/produced, processed and stored; and listed in 
accordance with Article 233(3) of Regulation (EU) 2016/429 on the Commission website: 
http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
Box I.19:  “Identification of container ” and Seal number ” shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 758  EN COUNTRY  Certificate model OV/CAP -OOCYTES -EMB -B-ENTRY - 
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I.24:  “Number of packages ” shall correspond to the number of containers.  
Box I.27:  “Species ”: Select amongst “ Ovis aries ” or “ Capra hircus ” as appropriate.  
 “Type ”: Specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos 
or micromanipulated embryos.  
 Identification number  shall correspond to the official identification of the animal.  
 “Date of collection/ production ” shall be indicated for in vivo  derived embryos and in the 
following format: dd.mm.yyyy.  
 “Approval or registration number of plant/establishment/centre ” shall correspond to the 
embryo collection team or embryo production team by which the oocytes/embryos were 
collected/produced, processed and stored; and listed in accordance with Article 233(3) of 
Regulation (EU) 2016/429 on the Commission website:  
 http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex VIII to Implementing Regulation 2020/ … 
[SANTE/7140/2020 ] for oocytes/embryos of ovine and caprine animals . 
(2) Delete as appropriate.  
(3) Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm . 
(4) Only for the territory appearing with the entry "V" in column 6 of Part 1 of Annex I to Commission 
Regulation (EU) No 206/2010 (OJ  L 73, 20.3.2010, p. 1).  
(5) Tests shall be carried out in accordance with Annex C to Directive 91/68/EEC.  
(6) See remarks for exporting country or part thereof concerned in Annex III to Decision 2010/472/EU.  
(7) Standards for EHD virus diagnostic tests ar e described in Chapter 2.1.3. of the OIE Manual of Diagnostic 
Tests and Vaccines for Terrestrial Animals.  
(8) Only semen collection centres approved  by the competent authority of a third country, territory or zone 
thereof listed in Annex VIII to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for semen of 
ovine and caprine animals or by the competent authority of a Member State . 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 759  EN CHAPTER 52: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENT S OF:  
- semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 202 1; 
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021;  
- oocytes  and embryos of ovine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 
2021  
- stocks of oocytes and embryos of ovine and caprine animals collected or produced, processed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2021,  
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT PROCESSING ESTAB LISHMENT  (MODEL 
‘OV/CAP -GP-PROCESSING -ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 760  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 761  EN  
I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 762  EN COUNTRY  Certificate model OV/CAP -GP-PROCESSING -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipulated embryos(2) to be exported to 
the European Union was/were processed and stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of 
ovine(2)/caprine(2) animals and listed in Annex VIII to Implementing Regulation (EU) 
2020/xx [ SANTE/7140/2020 ]; 
 (2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, infection 
with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not report ed for a period of at least 12 months immediately prior 
to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 
30 days after its/their collection(2)/ production(2); 
II.1.1.4.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, 
sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out 
for a period of at least 12 months immedia tely prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2), and no vaccinated animals entered into the third country, territory or zone  
during that period;  
II.1.2. is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artific ial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4), and/or processed and stored in a 
germinal product processing  establishment(2)(4), and/or stored in a germinal product storage 
centre(2)(4) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(5), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of 
ovine(2)/caprine(2) animals in accordance with Regulation (EU) 2016/429 and Delegated 
Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:  
(2)either  [Model OV/CAP -SEM -A-ENTRY(6);] 
(2)and/or  [Model OV/CAP -SEM -B-ENTRY(6);] 
 (2)and/or  [Model OV/CAP -OOCYTES -EMB -A-ENTRY(6);] 
(2)and/or  [Model OV/CAP -OOCYTES -EMB -B-ENTRY(6);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 763  EN COUNTRY  Certificate model OV/CAP -GP-PROCESSING -ENTRY  
 (2)and/or  [Model OV/CAP -GP-PROCESSING -ENTRY(6);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -ENTRY(6);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been clean ed and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(7)[II.2.6.  are placed  in straws or other packages which are s ecurely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product processing establishments 
listed in accordance with Articl e 233(3) of Regulation (EU) 2016/429 on the 
Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes and/or embryos were processed and stored, and/or the germinal product 
storage centre where the semen, oocytes and/or embryos were stored to the germinal 
product processing establishment described in Box I.11. The original(s) of those 
document(s) or those certificate(s) or the officially endorsed copies thereof must be 
attached to this certificat e. 
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type” : Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 764  EN COUNTRY  Certificate model OV/CAP -GP-PROCESSING -ENTRY  
  “Species ”: Indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes and/or embryos 
were  collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date i n accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/xx  [SANTE/7140/2020 ]. 
(4) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
(5) Only a third country, territory or zone thereof listed in Annex VIII to Implementing Regulation 2020/…  
[SANTE/7140 /2020 ] and the EU Member States.  
(6) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes and/or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
and/or embryos were processed and stored, and /or the germinal product storage centre where the semen, 
oocytes and/or embryos were stored to the germinal product processing establishment of the semen, oocytes 
and/or embryos dispatch described in Box I.11 must be attached to this certificate.  
(7) Appli cable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 765  EN CHAPTER 53: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENT S OF:  
- semen of ovine and caprine animals collected, processed and stored in accordance with Regulation (EU) 
2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of ovine and caprine animals collected, processed and stored in accordance with 
Council Directive 92/65/EEC before 21 April 2021;  
- oocy tes and embryos of ov ine and caprine animals collected or produced, processed and stored in 
accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 
2021  
- stocks of oocytes and embryos of ovine and caprine animals collected or produced, pro cessed and 
stored in accordance with Council Directive 92/65/EEC before 21 April 2021,  
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT STORAGE CENTRE  (MODEL ‘ OV/CAP -GP-
STORAGE -ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 766  EN   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 767  EN  
I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 768  EN COUNTRY  Certificate model OV/CAP -GP-STORAGE -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2)/ micromanipulated embryos(2) to be exported to the 
European U nion was/were stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of 
ovine(2)/caprine(2) animals and listed in Annex VIII to Implementing Regulation (EU) 
2020/xx [ SANTE/7140/2020 ]; 
 (2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after it s/their collection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.3.  where infection with rinderpest virus, infection with Rift Valley fever virus, infection 
with peste des petits ruminants virus, sheep pox and goat pox and contagious caprine 
pleuropneumonia were not reported for a period of at least 12 months immediately prior 
to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 
30 days after its/their collection(2)/ production(2); 
II.1.1.4.  where  no vaccination against foot -and-mouth disease, infection with rinderpest virus, 
infection with Rift Valley fever virus, infection with peste des petits ruminants virus, 
sheep pox and goat pox and contagious caprine pleuropneumonia has been carried out 
for a period of at least 12 months immediately prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2), and no vaccinated animals entered into the third country, te rritory or zone  
during that period;  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artific ial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(4)/ by an 
embryo collection team(2)(4)/ by an embryo production team(2)(4), and/or processed and stored in a 
germinal product processing  establishment(2)(4), and/or stored in a germinal product storage 
centre(2)(4) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(5), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of 
ovine(2)/caprine(2) animals in accordance with Regulation (EU) 2016/429 and Delegated 
Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:  
(2)either  [Model OV/CAP -SEM -A-ENTRY(6);] 
(2)and/or  [Model OV/CAP -SEM -B-ENTRY(6);] 
(2)and/or  [Model 1 in Section A of Part 2 of Annex II to Decision 2010/472/EU (6);] 
(2)and/or  [Model 2 in Section B of Part 2 of Annex II to Decision 2010/472/EU (6);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 769  EN COUNTRY  Certificate model OV/CAP -GP-STORAGE -ENTRY  
(2)and/or  [Model OV/CAP -OOCYTES -EMB -A-ENTRY(6);] 
(2)and/o r [Model OV/CAP -OOCYTES -EMB -B-ENTRY(6);] 
 (2)and/or  [Model OV/CAP -GP-PROCESSING -ENTRY(6);] 
(2)and/or  [Model OV/CAP -GP-STORAGE -ENTRY(6);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(7)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centres listed in accordance with 
Article 233(3) of Regulati on (EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
Box reference I.12:  “Place of destination ”: Indicate the address and u nique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes and/or embryos were processed and stored, and/or the germinal product 
storage centre where the semen, oocytes and/or embryo s were stored to the germinal 
product storage centre described in Box I.11. The original(s) of those document(s) or 
those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number  shall b e indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 770  EN COUNTRY  Certificate model OV/CAP -GP-STORAGE -ENTRY  
produced embryos or micromanipulated embryos.  
  “Species ”: indicate “Ovis aries ” and/or “ Capra hircus ” as appropriate . 
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes, in vivo  derived 
embryos or  in vitro  produced embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/xx  [SANTE/7140/2020 ]. 
(4) Only approved germinal product establishments listed in accordance with Article  233(3) of Regulation (EU) 
2016/429 on the Commission website: http://ec.europa.eu/food/animal/semen_ova/ovine/index_en.htm  . 
(5) Only a third country, territory or zone thereof listed in Annex VIII to Implementing Regulation 2020/…  
[SANTE/7140/2020 ] and the EU Member States.  
(6) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of ther eof that 
accompanied the semen, oocytes and/or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or th e germinal product processing establishment where the semen, oocytes 
and/or embryos were processed and stored, and/or the germinal product storage centre where the semen, 
oocytes and/or embryos were stored to the germinal product storage centre of the seme n, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(7) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of ovine and/or caprine animals are placed and 
transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 771  EN CHAPTER 54: MODEL OFFICIAL CER TIFICATE FOR  THE ENTRY INTO THE 
UNION OF  CONSIGNMENTS OF SEME N OF PORCINE ANIMALS  COLLECTED, 
PROCESSED AND STORED  IN ACCORDANCE WITH R EGULATION (EU) 
2016/429 AND DELEGAT ED REGULATION (EU) 2020/ 692 AFTER 20 APRIL 2021,  
AND DISPATCHED FROM A SEMEN COLLECTION C ENTRE WHER E THE 
SEMEN WAS COLLECTED  (MODEL ‘POR -SEM -A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country  of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 772  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 773  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned  official veterinarian, hereby certify that:  
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from the donor 
animals which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of semen of porcine animals and listed in Annex IX to 
Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately  prior to collection of the semen and for a period of 30 days after its collection;]  
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the semen and for a period of 30 
days after its collection;]  
(1)either  [II.1.3.  where classical s wine fever was not reported for a period of at least 12 months immediately 
prior to collection of the semen and for a perio d of 30 days after its collection;]  
(1)or [II.1.3.  where classical swine fever was not reported for a period starting on the date(3) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the semen and for a period of 30 
days after its collectio n;] 
II.1.4.  where infection with rinderpest virus and African swine fever were not reported for a period 
of at least 12 months immediately prior to collection of the semen and for a period of 30 days 
after its collection;  
II.1.5.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus and 
classical swine fever has been carried out for a period of at least 12 months immediately prior 
to collection of the semen and for a period of 30 days after its collection, and no vaccinat ed 
animals entered into the third country, territory or zone  during that period.  
II.2. The semen described in Part I was obtained from the donor animals which originate,  before the 
commencement of the quarantin e referred to in point II.4.6.,  from establish ments  
II.2.1.  situated in an area where foot -and-mouth disease has not been reported within a 10 -km radius 
centred on the establishment for a period of at least 30 days and in which foot -and-mouth 
disease has not been reported during a period of at least 3  months, and  
 (1)either  [they were  not vaccinated against foot -and-mouth disease;]  
(1)or [they were vaccinated against foot -and-mouth dis ease during the period of 12 months prior to 
the date of collection of the semen but not during the period of the last  30 days immediately 
prior to the date of collection  of the semen, and 5 % (with a minimum of five straws) of each 
quantity of semen taken from a donor animal at any time is submitted to a virus isolation test 
for foot -and-mouth disease with negative resul ts;] 
II.2.2.  free from infection with Brucella abortus, B. melitensis  and B. suis  in accordance with the 
requirements laid down in Chapter IV of Part 5 of Annex II to Delegated Regulation (EU) 
2020/ 686; 
II.2.3.  where no clinical, serological, virological o r pathological evidence of infection with 
Aujeszky’s disease virus had been detected during the period of at least 12 months;  
II.2.4.  where, during the period of at least 3 months prior to the date of entry into the quarantine 
accommodation, no animal was vaccinated against infection with porcine reproductive and 
respiratory syndrome virus and no infection with porcine reproductive and respiratory 
syndrome virus was detected.  
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(4) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipme nt set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/ 686. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 774  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  
II.4. The semen described in Part I was obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, classical swine fever and infection 
with porcine reproductive and respiratory syndrome virus;  
II.4.2.  remained for a period of at least 3 months prior to the date of collection of the semen in a 
third country or territory or zone thereof referred to in Box I.7.;  
II.4.3.  did not show symptoms or clinical signs of transmissible animal diseases on the day of their 
admission to a semen collection centre and on the day of collection of the semen;  
II.4.4.  are individually identified as provided for in Article 21(1)  of Delegate d Regulation (EU) 
2020/ 692; 
II.4.5.  for a period of at least 30 days prior to the date of collection of the semen and during the 
collection period  
II.4.5.1.  were kept on establishments not situated in a restricted zone established due to 
the occurrence of  foot-and-mouth disease, infection with rinderpest virus, 
classical swine fever and African swine fever or of an emerging disease relevant 
for the porcine animals;  
II.4.5.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax,  infection with 
Aujeszky’s disease virus and infection with porcine reproductive and respiratory 
syndrome virus  have not been reported;  
II.4.5.3.  were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.5.1. or from 
establishments which do not meet the conditions referred to in point II.4.5.2.;  
II.4.5.4.  were not used for natural breeding;  
II.4.6.  have been subjected  to a quarantine for a period of at least 28 days in quarantine 
accommodation, where only other cloven -hoofed animals with at least the same health status 
were present, which on the day of their admission to the semen collection centre complied 
with the fo llowing conditions:  
II.4.6.1.  it was not situated in a restricted zone established due to diseases referred to in 
point II.4.5.1.;  
II.4.6.2.  none of the diseases referred to in point II.4.5.2. has been reported for a period of 
at least 30 days;  
II.4.6.3.  it was situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the quarantine accommodation for a period of 
at least 30 days;  
II.4.6.4.  has had no outbreak of foot -and-mouth disease reported during a period of  at 
least 3 months preceding the date of admission of the animals into the semen 
collection centre;  
II.4.6.5.  it was free from infection with Brucella abortus, Brucella melitensis and 
Brucella suis  for the period of at least the preceding 3 months ; 
II.4.7.  were kept in the semen collection centre  
II.4.7.1.  which was not situated in a restricted zone established due to diseases referred to 
in point II.4.5.1.;  
II.4.7.2.  where none of the diseases referred to in point II.4.5.2. has been reported for a 
period o f at least 30 days prior to the date of collection of the semen, and  
(1)(5)[at least 30 days following the date of the collection;]  
(1)(6)[until the date of dispatch of the consignment of semen to another Member 
State;]  
II.4.7.3.  situated in an area where foot-and-mouth disease has not been reported within a 
10-km radius centred on the semen collection centre for a period of at least 30 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 775  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  
days; and  
(1)(5)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the  semen and 30 days from the date of collection;]  
(1)(6)[free from foot -and-mouth disease for a period of at least 3 months prior to the 
date of collection of the semen and until the date of dispatch of the consignment 
of semen to another Member State and t he donor animals has been kept at that 
semen collection centre for a continuous period of at least 30 days immediately 
prior to the date of collection of the semen;]  
II.4.7.4.  where no clinical, serological, virological or pathological evidence of infectio n 
with Aujeszky’s disease virus had been reported for a period comprising at least 
30 days prior to the date of admission and at least 30 days immediately prior to 
the date of collection of the semen;  
II.4.8.  have been subjected to the following tests, car ried out within the period of 30 days prior to the 
commencement of the quarantine referred to in point II.4.6., with negative results, required in 
accordance with point 1(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 
2020/ 686: 
II.4.8.1.  as regards infection  with Brucella abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella  species;  
II.4.8.2.  as regards infection with Auj eszky’s disease virus  
(1)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]  
(1)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect 
antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
(1)[II.4.8.3.  as regards classical swine fever, an antibody ELISA or serum neutralisation test, 
in case o f animals coming from a Member State or zone thereof where classical 
swine fever has been reported or vaccination against this disease has been 
practiced for the period of the preceding 12 months;]  
II.2.8.4.  as regards infection with porcine reproductive a nd respiratory syndrome virus, a 
serological test (the immunoperoxidase monolayer assay (IPMA), 
immunofluorescence assay (IFA), or ELISA);  
II.4.9.  have been subjected to the following tests, carried out on samples taken within a period of at 
least 21 days from the date of commencement of the quarantine referred to in point II.4.6., 
with negative results, required in accordance with point 1(c) of Chapter I of Part 2 of Annex 
II to Delegated Regulation (EU) 2020/ 686: 
II.4.9.1.  as regards infection  with Brucel la abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test), a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella  species;  
II.4.9.2.  as regards infection with Aujeszk y’s disease virus  
(1)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Aujeszky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]  
(1)[in the case of animals vaccinated with  a gE deleted vaccine, an ELISA to detect 
antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
(1)[II.4.9.3.  as regards classical swine fever, an antibody ELISA or serum neutralisation test, 
in case of animals coming from a Member State or z one thereof where classical 
swine fever has not been reported and vaccination against this disease has not 
been practiced for the period of the preceding 12 months;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 776  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  
II.4.9.4.  as regards infection with porcine reproductive and respiratory syndrome virus, a  
serological test (IPMA, IFA, or ELISA) and a test for virus genome (reverse -
transcription polymerase chain reaction (RT -PCR), nested set RT -PCR, real -time 
RT-PCR);  
II.4.10.  have been subjected, at semen collection centre, to the following compulsory routi ne tests, 
required in accordance with point 2(a) of Chapter I of Part 2 of Annex II to Delegated 
Regulation (EU) 2020/ 686: 
II.4.10.1.  as regards infection  with Brucella abortus, B. melitensis  and B. suis,  a buffered 
Brucella antigen test (rose Bengal test) , a competitive ELISA or an indirect 
ELISA for the detection of antibodies to smooth Brucella  species;  
II.4.10.2.  as regards infection with Aujeszky’s disease virus  
(1)[in the case of non -vaccinated animals, an ELISA to detect antibodies to the 
whole Auje szky’s disease virus or to glycoprotein B (ADV -gB) or glycoprotein 
D (ADV -gD) of the virus or a serum neutralisation test;]  
(1)[in the case of animals vaccinated with a gE deleted vaccine, an ELISA to detect 
antibodies to glycoprotein E (ADV -gE) of Aujeszky’s disease virus;]  
II.4.10.3.  as regards classical swine fever, an antibody ELISA or serum neutralisation test;  
II.4.10.4.  as regards infection with porcine reproductive and respiratory syndrome virus, a 
serological test (IPMA, IFA, or ELISA);  
II.4.11.  have been subjected to the tests referred to in point II.4.10. carried out, in accordance with 
point 2(b) of Chapter I of Part 2 of Annex II to Delegated Regulation (EU) 2020/ 686, on 
samples taken from:  
 (1)either  [all animals immediately prior to  leaving the semen collection centre, or upon arrival at the 
slaughterhouse, and in no case later than 12 months from the date of admission to the semen 
collection centre.]  
(1)or [at least 25 % of the animals in the semen collection centre every 3 months t o test for 
infection with Brucella abortus, Brucella melitensis and Brucella suis , infection with 
Aujeszky’s disease virus and classical swine fever and from at least 10 % of the animals in 
the semen collection centre every month to test for infection with  porcine reproductive and 
respiratory syndrome virus.]  
(1)or [at least 10  % of the animals in the semen collection centre every month to test for infection 
with Brucella abortus, Brucella melitensis and Brucella suis , infection with Aujeszky’s 
disease viru s, classical swine fever and infection with porcine reproductive and respiratory 
syndrome virus.]  
II.5. The semen described in Part I  
II.5.1.  has been collected, processed and stored in accordance with animal health requirements set 
out in points 1 and 2 o f Part 1 of Annex III to Delegated Regulation (EU) 2020/ 686; 
II.5.2.  is placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  is transported in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch from the semen collection centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and 
the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for o ther products.  
II.6. The semen is preserved by the addition of antibiotics as follows:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 777  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  
II.6.1.  The following  antibiotic or mixture of antibiotics,  effective in p articular against leptospires, has 
been added to the semen after final dilution, or is containe d in the used semen diluents, to reach the 
indicated concentration per ml of semen:  
(1)either  [a mixture of gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicill in (500 IU) and streptomycin (500 
μg);]  
 (1)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(1)or [an antibiotic  or a mixture of antibiotics(7) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.6.2.  Immediately after the addition of the antibiotics, and before any possible freezing, the diluted 
semen was kept at a temperature  of at least 5°C or 15°C for a period of not less than 45 minutes, or 
under a time-temperature regime with a documented equivalent bactericidal activity.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only seme n 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:  
  https://ec.europa.eu/food/animals/semen/porcine_en   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: indicate semen.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen of 
the consignment is placed.  
“Date of  collection/production ”: Indicate the date on which semen of the 
consignment was collected.  
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Commission Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(4) Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 778  EN COUNTRY  Certificate model POR -SEM -A-ENTRY  
Commission website: https://ec.europa.eu/food/animals/semen/p orcine_en  . 
(5) Applicable for frozen semen . 
(6) Applicable for fresh and chilled semen.  
(7) Insert the name(s) of the antibiotic(s) added and its(their) concentration or the commercial name of the 
semen diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 779  EN CHAPTER 55: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOC KS OF SEMEN OF PORCI NE ANIMALS 
COLLECTED, PROCESSED  AND STORED IN ACCORDANCE WITH DIRE CTIVE 
90/429/EEC BEFORE 21  APRIL 2021, AND DISP ATCHED AFTER 20 APRI L 2021 
FROM A SEMEN COLLECT ION CENTRE WHERE THE  SEMEN WAS 
COLLECTED  (MODEL ‘POR -SEM -B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 780  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 781  EN COUNTRY  Certificate model POR -SEM -B-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
 I, the undersigned, official veterinarian, hereby certify that:  
II.1. the exporting country …………………………………………………………………………  
(name of exporting country)(1) 
(2)either  [II.1.1.  has during the past 12 months been free of foot -and-mouth disease, classical swine fever and 
African swine fever,  
and that no vaccinations have been carried out against any of these diseases during the past 12 
months;]  
(2)or [II.1.1.  is rec ognised as free of foot -and-mouth disease without vaccination by the World Organisation 
for Animal Health (OIE) and free of classical swine fever and African swine fever, in 
accordance with the recommendations laid down in the OIE Terrestrial Animal Health  Code;]  
II.2. the semen collection centre(3) in which the semen in this consignment was collected:  
II.2.1.  was approved for export to the Union by the veterinary services of ………………………. 
(name of third country(2)) and complied on date of collection with the conditions for approval 
and supervision set out in Chapter I and Chapter II of Annex A to Directive 90/429/EEC;  
II.2.2.  was, during the period commencing three months prior to the date of collection of the semen  in 
this consignment until the date of its dispatch, situated in an area not restricted due to an 
outbreak of foot -and-mouth disease, classical swine fever, African swine fever, swine vesicular 
disease, and vesicular stomatitis;  
II.2.3.  was, during the per iod commencing 30 days prior to the date of collection of the semen in this 
consignment until the date of its dispatch, free from brucellosis and Aujeszky's disease;  
(2)either  [II.2.4.  contained only animals that have not been vaccinated against Aujeszky's  disease and met the 
requirements of Annex B to Directive 90/429/EEC.]  
(2)(4)and/or  [II.2.4.  was a centre in which some or all of the animals have been vaccinated against Aujeszky's 
disease using a gE deleted vaccine and met the requirements of Annex B to Directive 
90/429/EEC.]  
Conditions for the admission of animals to the semen collection centre  
II.3. Prior to be admitted to the semen collection centre, all animals:  
II.3.1.  were subjected to a period of quarantine of at least 30 days in accommodation spec ifically 
approved for the purpose by the competent authority, and where only animals having at least 
the same health status were present (quarantine accommodation);  
II.3.2.  prior to entering the quarantine accommodation, were chosen from herds or holdings:  
II.3.2.1.  which were free of brucellosis in accordance with the Chapter on porcine brucellosis 
of the Terrestrial Animal Health Code of the World Organisation for Animal Health 
(OIE) ; 
II.3.2.2.  in which no animal vaccinated against foot and -mouth disease was present in the 
preceding 12 months;  
II.3.2.3.  which were not situated in a restricted area defined under the provisions of the 
national legislation due to an outbreak of foot -and-mouth disease, classical swine 
fever, African swine fever, swine vesicula r disease, vesicular stomatitis and 
Aujeszky's disease;  
II.3.2.4.  in which no clinical, serological, virological or pathological evidence of Aujeszky's 
disease was detected in the preceding 12 months;  
II.3.3.  prior to entering the quarantine accommodation,  were not previously kept in any herd of a 
lower health status than described in II.3.2.;  
II.3.4.  within 30 days prior to entering the quarantine accomodation referred to in point II.3.1., were 
subjected to the following tests, performed in accordance with  international standards, with This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 782  EN COUNTRY  Certificate model POR -SEM -B-ENTRY  
negative results:  
II.3.4.1.  as regards brucellosis, a buffered Brucella  antigen test (rose Bengal test), or a 
cELISA or an iELISA ; 
II.3.4.2.  as regards Aujeszky’s disease,  
(2)either  [II.3.4.2.1.  in the case of non -vaccinated animals, a serum neutralisation test or an 
ELISA for detecting antibodies to the whole Aujeszky’s disease virus or 
to its glycoprotein B (ADV -gB) or glycoprotein D (ADV -gD);]  
(2)or [II.3.4.2.1.  in the case of animals vaccinated with a gE deleted vaccine, a n ELISA 
for detecting antibodies to glycoprotein E (ADV -gE);]  
(2)either  [II.3.5.  were admitted to the centre after all of the animals had reacted with negative result to a buffered 
Brucella  antigen test (rose Bengal test), or a cELISA or an iELISA carried out on samples 
collected during the last 15 days of the period of quarantine specified in point II.3.1.;]  
(2)or [II.3.5.  were admitted to the centre after not all of the animals had reacted with negative result to a 
buffered Brucella  antigen test (rose Ben gal test), or a cELISA or an iELISA carried out on 
samples collected during the last 15 days of the period of quarantine specified in point II.3.1. 
and the suspicion of brucellosis was ruled out in accordance with point 1.5. of Chapter I of 
Annex B to Dire ctive 90/429/EEC;]  
II.3.6.  were  subjected to the following tests for Aujeszky's disease carried out on samples collected 
during the last 15 days of the period of quarantine specified in point II.3.1.:  
(2)either  [II.3.6.1.  in the case of non -vaccinated animals, a serum neutralisation test or an ELISA for 
detecting antibodies to the whole Aujeszky’s disease virus or to its glycoprotein B 
(ADV -gB) or glycoprotein D (ADV -gD);]  
(2)or [II.3.6.1.  in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting 
antibodies to glycoprotein E (ADV -gE);]  
(2)either  [II.3.6.2.  the tests referred to in point II.3.6.1. were carried out with negative result in each 
case;]  
(2)or [II.3.6.2.  the animals that proved positive in a test referred to in point II.3.6.1. were removed 
immediately from the quarantine accommodation and the competent authority took 
all necessary measures to ensure that the remaining animals had a satisfactory health 
status before being admitted to the collection centre in accordance with point II.3.;]  
II.3.7.  All tests were carried out in a laboratory approved by the competent authority;  
II.3.8.  Animals were only admitted to the semen collection centre with the express permission of the 
centre veterinarian and all animal movements, en tering and exiting the semen collection centre, 
are recorded;  
II.3.9.  No animal admitted to the semen collection centre showed any clinical sign of disease on the 
day of admission; all animals came directly from the quarantine accommodation which, on the 
day of consignment and during the period of residency of the animals, officially fulfilled the 
following conditions:  
II.3.9.1.  it was not situated in a restricted area defined under the provisions of national 
legislation due to an outbreak of foot -and-mouth  disease, classical swine fever, 
African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's 
disease;  
II.3.9.2.  no clinical, serological, virological or pathological evidence of foot -and-mouth 
disease, classical swine fever, African s wine fever, swine vesicular disease, vesicular 
stomatitis and Aujeszky's disease had been recorded for the past 30 days.  
Compulsory routine tests for animals kept at the semen collection centre  
II.4. All animals kept at the semen collection centre are subjected to the following routine tests carried out 
in a laboratory approved by the competent authority:  
II.4.1.  as regards brucellosis, a buffered Brucella  antigen test (rose Bengal test), or a cELISA or an This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 783  EN COUNTRY  Certificate model POR -SEM -B-ENTRY  
iELISA ; 
II.4.2.  as regards Aujeszky’s disease,  
(1)either  [II.4.2.1.  in the case of non -vaccinated animals, a serum neutralisation test or an ELISA for 
detecting antibodies to the whole Aujeszky’s disease virus or to its glycoprotein B 
(ADV -gB) or glycoprotein D (ADV -gD); 
(1)or [II.4.2.1.  in the case of animals vaccinated with a gE deleted vaccine, an ELISA for detecting 
antibodies to glycoprotein E (ADV -gE); 
II.4.3.  The routine tests referred to in points II.4.1. and II.4.2. are carried out on samples taken in 
accordance with point 1.2. of Chapter II of Annex B to Directive 90/429/EEC in order to ensure 
that all animals in the center have been tested at least once during their stay at that centre and at 
least every 12 months from the date of admission, if their stay exceeds 12 months;  
(2)either [II.4.4.  All of the animals have reacted with negative results in the routine tests referred to in points 
II.4.1. and II.4.2. carried out on samples referred to in point II.4.3 .] 
(2)or [II.4.4.  Not all of the animals have reacted with negative results in the tests referred to in points II.4.1. 
and II.4.2. carried out on samples referred to in point II.4.3 .: 
(a) the animals which proved positive were isolated,  
(b) the semen collected from each animal at the centre since the date of that animal's last 
negative test was held in separate storage from semen eligible for export to the 
European Union which was collected before the animal's last negative test or after the 
health status of the centre had been re -established under responsibility of the competent 
authority of the exporting coutry.  
Conditions for semen collected at a semen collection centre and intended for export to the Union  
II.5. The semen in this consignment was obtained from animals which:  
II.5.1.  have been resident in ……………………………… (name of third  country(1)) for a minimum 
period of three months immediately prior to collection;  
II.5.2.  showed no clinical signs of disease on the day the semen was collected;  
II.5.3.  had not been vaccinated against foot -and-mouth disease;  
II.5.4.  satisfy the requireme nts referred to in point II.3.;  
II.5.5.  have not been allowed to serve naturally;  
II.5.6.  were kept in semen collection centres which were not situated in a restricted area designated 
under the provisions of the national legislation relating to foot -and-mouth disease, classical 
swine fever, African swine fever, swine vesicular disease, vesicular stomatitis and Aujeszky's 
disease;  
II.5.7.  were kept in semen collection centres in which no clinical, serological, virological or 
pathological evidence of foot-and-mouth disease, classical swine fever, African swine fever, 
swine vesicular disease, vesicular stomatitis and Aujeszky's disease has been detected in the 30 -
day period immediately prior to collection . 
II.6. An effective combination of antibiotics, in parti cular against leptospires, was added to the semen in this 
consignment after final dilution or to the diluent. In the case of frozen semen, antibiotics were added 
before the semen was frozen.  
II.6.1.  The combination of antibiotics referred to in point II.6.  produced an effect at least equivalent to 
the following concentration in the final diluted semen : 
(a) not less than 500 μg streptomycin per ml final dilution,  
(b) not less than 500 IU penicillin per ml final dilution,  
(c) not less than 150 μg lincomycin p er ml final dilution,  
(d) not less than 300 μg spectinomycin per ml final dilution;  
II.6.2.  Immediately after the addition of the antibiotics the diluted semen was kept at a temperature of 
at least 15°C for a period of not less than 45 minutes.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 784  EN COUNTRY  Certificate model POR -SEM -B-ENTRY  
II.7. The semen in this consignment:  
II.7.1.  has been stored as laid down in point 2(d) of Chapter I and point 6(a), (b), (e) and (f) of Chapter 
II of Annex A to Directive 90/429/EEC prior to dispatch;  
II.7.2.  is being transported to the country of destination in flasks which were cleaned and disinfected 
or sterilised before use and which have been sealed prior to dispatch from the approved storage 
facilities.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.6:  “Operator responsible for the consigment ”: this box is to be filled in only if it is a certificate for 
transit commodity.  
Box I.7:  Provide the code of the third country.  
Box I.11: Place of dispatch  shall correspond to the semen collection centre of the semen dispatch listed in 
accordance with Article 8(2) of Directive 90/429/EEC:  
http://ec.europa.eu /food/animal/semen_ova/porcine/index_en.htm . 
Box I.12:  “Place of destination ”: This box is to be filled in only if it is a certificate for transit commodity.  
Box I.19:  Container number/Seal number : “Identification of container ” and Seal number  shall be indicated.  
Box I.21:  Fill in according to whether it is a transit or an import certificate.  
Box I.22:  Fill in according to whether it is a transit or an import certificate.  
Box I.24:  Total number of packages shall correspond to the number of containers.  
Box I.27:  Identification number  shall correspond to the official identification of the animal.  
“Date of collection/production ” shall be indicated in the following format: dd/mm/yyyy.  
 “Approval or registration number of plant/establishment/cent re” shall correspond to the 
approval number of the semen collection centre where the semen was collected.  
 
Part II:  
(1) Only third country, territory or zone thereof listed in Annex IX to Implementing Regulation 2020/… 
[SANTE/7140/2020 ] for semen of porcine animals . 
(2) Delete as necessary.  
(3) Only semen collection centres listed in accordance with Article 8(2) of Directive 90/429/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/porcine_en.  
(4) This option shall be  deleted in case the Member State, or a region thereof, of destination is free of 
Aujeszky’s disease in accordance with Article 10 of Directive 64/432/EEC, has informed the Commission 
in accordance with point 4 of Annex C to Directive 90/429/EEC and is lis ted on the following website: 
https://ec.europa.eu/food/animals/semen/porcine_en  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 785  EN COUNTRY  Certificate model POR -SEM -B-ENTRY  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 786  EN CHAPTER 56: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF OOCY TES AND EMBRYOS OF P ORCINE 
ANIMALS COLLECTED OR  PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020/ 692 AFTER 20 APRI L 2021 , AND DISPATCHED BY AN  
EMBRYO COLLECTION OR  PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED (MODEL ‘POR -OOCYTES -
EMB -ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 787  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 788  EN COUNTRY  Certificate model POR -OOCYTES -EMB -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The oocytes(1)/ in vivo  derived embryos(1)/ in vitro  produced embryos(1) described in Part I are intended for 
artificial reproduction and were obtained from the donor animals which originate from a third country, 
territory or zone  
II.1.1.  authorised for entry into the Union of oocytes(1)/ in vivo  derived embryos(1)/ in vitro  produced 
embryos(1)/ micromanipulated embryos(1) of porcine animals and listed in Annex IX to 
Implementing Regulation (EU) 2020/xx [SANTE/7140/2020 ]; 
(1)either  [II.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immedia tely prior to collection of the oocytes(1)/ embryos(1) and for a period of 30 days after 
their collection(1)/ production(1);] 
(1)or [II.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(2) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1) and for 
a period of 30 days after their collection(1)/ production(1);] 
(1)either  [II.1.3.  where classical swine fever was not reported for a period of at least 12 months immediately 
prior to collection of the oocytes(1)/ embryos(1) and for a period of 30 days after their 
collection(1)/ production(1);] 
(1)or [II.1.3.  where classical swine fever was not reported for a period starting on the date(3) …………. 
(insert date  dd/mm/yyyy ) immediately prior to collection of the oocytes(1)/ embryos(1) and for 
a period of 30 days after their collection(1)/ production(1);] 
II.1.4.  where infection with rinderpest virus and African swine fever  were not reported for a period 
of at least 12 months  immediately prior to collection of the oocytes(1)/ embryos(1) and for a 
period of 30 days after their collection(1)/ production(1); 
II.1.5.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus and 
classical swine fever has been carried out for a period of at least 12 months immediately prior 
to collection of the oocytes(1)/ embryos(1) and for a period of 30 days after their collection(1)/ 
production(1) and no vaccinated animals entered into the third country, territory or zo ne during 
that period.  
(1)(4)[II.1.6.  free from infection with Aujeszky’s disease virus or where an approved eradication 
programme for infection with Aujeszky’s disease virus is carried out.]  
II.2. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which originate from 
establishments   
II.2.1.  in which infection  with Brucella abortus, B. melitensis  and B. suis  in porcine animals has not 
been reported during the last 42 days prior to collection of the oocytes(1)/ embryos(1), and in 
which during at least the last 12 months prior to collection of the oocytes(1)/ embryos(1)  
(1)either  [II.2.2.1.  biosecurity  and risk mitigating measures, including housing conditions and feeding 
systems, have been app lied as necessary to prevent transmission of infection with 
Brucella abortus, B. melitensis  and B. suis  from wild animals of listed species to 
porcine animals kept on the establishment and only porcine animals from 
establishments applying equivalent biosecurity measures have been introduced;  
(1)and/or  [II.2.2.2.  surveillance  for infection with  Brucella abor tus, B. melitensis and B. suis has been  
carried out on the porcine animals kept on the establishments in accordance with 
Annex III to Delegated Regulation (EU) 2020/ 688, and during the same period  
– only porcine animals from establishments applying the biosecurity measures or 
the surveillance measures provided for in point II.2.2.1. or II.2.2.2. have been 
introduced in the establishment; and  
– in case infection with Brucella abortus, B. melitensis  and B. suis  has been 
reported in porcine animals kept on the establishment, measures were taken in 
accordance with Part 1(3) of Annex II to Delegated Regulation (EU) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 789  EN COUNTRY  Certificate model POR -OOCYTES -EMB -ENTRY  
2020/ 688;] 
II.2.2.  where no clinical, serological, virological or pathological evidence of infection with 
Aujeszky’s disease virus had been detecte d during the period of at least 12 months prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1). 
(1)[II.3.  The in vivo  derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(5) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Delegate d Regulation (EU) 2020/ 686.] 
(1)[II.3.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(5) which  
II.3.1.  is app roved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU)  2020/ 686.] 
II.4. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which  
II.4.1.  were not vaccinated against infection with rinderpest virus, classical swine fever and infection 
with porcine reproductive and respiratory s yndrome virus;  
II.4.2.  remained for a period of at least 3 months prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1) in a third country or territory or zone thereof referred to in Box I.7.;  
II.4.3.  for a period of at least 30 d ays prior to the date of collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and during the collection period  
II.4.3.1.  were kept on establishments not situated in a restricted zone established due to 
the occurrence of foot -and-mouth disease, infec tion with rinderpest virus, 
classical swine fever and African swine fever or of an emerging disease relevant 
for the porcine animals;  
II.4.3.2.  were kept on a single establishment where infection with  Brucella abortus, B. 
melitensis and B. suis , infection with rabies virus, anthrax,  infection with 
Aujeszky’s disease virus and infection with porcine reproductive and respiratory 
syndrome virus  have not been reported;  
II.4.3.3.  were not in contact with animals from establishments situated in a restricted zone 
due to the occurrence of diseases referred to in point II.4.3.1. or from 
establishments which do not meet the conditions referred to in point II.4.3.2.;  
II.4.3.4.  were not used for natural breeding;  
II.4.4.  have been clinically examined by the team veterin arian or a team member and did not show 
symptoms of transmissible diseases on the day of collection(1)/ production(1) of the oocytes(1)/ 
embryos(1);  
II.4.5.  are individually identified as provided for in Article 21(1)  of Delegated Regulation (EU) 
2020/ 692; 
II.4.6.  comply with the following conditions as regards foot -and-mouth disease  
II.4.6.1.  they come from establishments  
 situated in an area where foot -and-mouth disease has not been reported 
within a 10 -km radius centred on the establishment for a perio d of at least 30 
days immediately prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1); 
 in which foot -and-mouth disease has not been reported during a period of at 
least 3 months immediately prior to the date of collection(1)/ production(1) of 
the oocytes(1)/ embryos(1); 
 (1)either  [II.4.6.2.  they were  not vaccinated against foot -and-mouth disease;]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 790  EN COUNTRY  Certificate model POR -OOCYTES -EMB -ENTRY  
(1)(6)or [II.4.6.2.  they were vaccinated  against foot -and-mouth disease during the period of 12 
months prior to the date of collection of the embryos and 
II.4.6.2.1.  have not been vaccinated against foot -and-mouth disease within the 
period of at least 30 days immediately prior to the date of collection 
of the embryos;  
II.4.6.2.2.  the semen used for fertilisation was collected from a male donor that 
complies with the conditions set out in point 1(b) or the semen 
complies with the conditions set out in point 2  of Chapter I of Part 5 
of Annex II to Delegated Regulation (EU) 2020/ 686; 
II.4.6.2.3.  prior to freezing, the embryos have been subjected to trypsin 
washing carried out in accordance with the recommendations of the 
IETS Manual(7); 
II.4.6.2.4.  the embryos were stored deep frozen for a period of at least 30 days 
from the date of collection, and during this period the donor animal 
has not shown clinical signs of foot -and-mouth disease;]  
 (1)(8)[II.4.7.  were subjected to a serological test for infection with porcine reproductive and respiratory 
syndrome virus, with negative results, on two occasions, at an interval of not less than 21 
days, the second test being performed within a period of 15 days prior to embryo collection.]  
II.5. The oocytes(1)/ embryos(1) described in Part I  
II.5.1.  has been c ollected, processed and stored in accordance with animal health requirements set 
out in Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of Annex III to Delegated Regulation (EU) 
2020/ 686; 
II.5.2.  are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that 
mark is indicated in Box I.27;  
II.5.3.  are transported in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch by the embryo collection or 
production team under responsibility of the team veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or i s single -use 
container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used 
for other products;  
(1)(9)[II.5.4.  are placed in straws or other packages which are securely and hermetically sealed;  
II.5.5.  are transported  in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
(1)(10)[II.6.  The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I were conceived by artificial insemination using semen coming from a semen collection 
centre, germinal product processing establishment or germinal product storage centre approved for the 
collection, processing and/or storage of semen by the competent autho rity of a third country, territory or 
zone thereof listed in Annex IX to Implementing Regulation (EU) 2020/xx [SANTE/7140/2020 ] for 
semen of porcine animals or by the competent authority of a Member State.]  
(1)(11)[II.7. The following  antibiotic or mixture of antibiotics(12) has been added to the collection, processing, 
washing or storage media: …………………………………………………………………………]  
 
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 791  EN COUNTRY  Certificate model POR -OOCYTES -EMB -ENTRY  
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:  
  https://ec.europa.eu/food/animals/semen/porcine_en  . 
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or  approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall  be indicated.  
Box reference I.24:  Total number of packages shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where oocytes or 
embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which oocytes or embryos of the 
consignment was collected or produced.   
“Approval or registration num ber of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Commission Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Commission Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(4) Not applicable for in vivo  derived embryos subject to trypsin treatme nt. 
(5) Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en  . 
(6) Option available only for  the consignment of  in vivo  derived embryos.  
(7) Manual of the International Embryo Transfer Society — A procedural guide and general information for the 
use of embryo transf er technology emphasising sanitary procedures, published by the International Embryo 
Transfer Society 1 111 North Dunlap Avenue, Savoy, Illinois 61 874 USA ( http://www.iets.org/ ). 
(8) Applicable for in vivo  derived embryos.  
(9) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of porcine animals are placed and transported.  
(10) Does  not apply to oocytes.  
(11) Mandatory attestation in case antibiotics were added.  
(12) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 792  EN COUNTRY  Certificate model POR -OOCYTES -EMB -ENTRY  
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 793  EN CHAPTER 57: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGMENTS OF:  
- semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of  porcine animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;  
- oocytes  and embryos of porcine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delega ted Regulation (EU) 2020/ 692 after 20 April 2021 , 
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT PROCESSING ESTAB LISHMENT  (MODEL 
‘POR -GP-PROCESSING -ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description  of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 794  EN I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 795  EN COUNTRY  Certificate model POR -GP-PROCESSING -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipluated embryos(2) to be exported to 
the European Union was/were processed a nd stored:  
II.1.1.  is located  in a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in 
vitro  produced embryos(2)/ micromanipluated embryos(2) of porcine animals and listed 
in Annex IX to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
 (2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
(2)either  [II.1.1.3.  where classical swine fever was not reported for a period of at least  12 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ produc tion(2);] 
(2)or [II.1.1.3.  where classical swine fever was not reported for a period starting on the date(4) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.4.  where infection with rinde rpest virus and African swine fever were not reported for a 
period of at least 12 months immediately prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2); 
II.1.1.5.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus 
and classical swine fever has been carried out for a period of at least 12 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2) and no vaccinated 
animals entered into the third country, territory or zone  during that period;  
II.1.2.  is approved  and listed by the competent authority of the third count ry or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(5)/ by an 
embryo collection team(2)(5)/ by an embryo production team(2)(5), and/or proce ssed and stored in a 
germinal product processing establishment(2)(5), and/or stored in a germinal product storage 
centre(2)(5) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(6), and has/have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of porcine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:  
((2)either  [Model POR -SEM -A-ENTRY(7);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 796  EN COUNTRY  Certificate model POR -GP-PROCESSING -ENTRY  
(2)and/or  [Model POR -SEM -B-ENTRY(7);] 
 (2)and/or  [Model POR -OOCYTES -EMB -ENTRY(7);] 
 (2)and/or  [Model POR -GP-PROCESSING -ENTRY(7);] 
(2)and/or  [Model POR -GP-STORAGE -ENTRY(7);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been f illed in with the cryogenic agent which not have been previously used for 
other products.  
(2)(8)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from  each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes and/or embryos. Only germinal product processing  establishments 
listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embry os_en.htm .  
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the  semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, an d/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 797  EN COUNTRY  Certificate model POR -GP-PROCESSING -ENTRY  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos  of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product processing establishments listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en  . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 1 in part 8 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(4) Only for a third country, territory or zone thereof with opening date in accordance with column 1 in part 8 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(5) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porc ine_en . 
(6) Only a third country, territory or zone thereof listed in Annex IX to Implementing Regulation 2020 /… 
[SANTE/7140/2020 ] for semen of porcine animals and the EU Member States.  
(7) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal produ ct processing establishment of the semen, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(8) Applicable for the consignment where in one container semen, oocytes, in vivo derived embryos, in vitro 
produced embry os and micromanipulated embryos of porcine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 798  EN CHAPTER 58: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGMENTS OF:  
- semen of porcine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of  porcine animals collected, processed and stored in accordance with Council 
Directive 90/429/EEC before 21 April 2021;  
- oocytes  and embryos of porcine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delega ted Regulation (EU) 2020/ 692 after 20 April 2021 , 
AND ENTERED INTO THE  UNION AFTER 20 APRIL  2021, AND DISPATCHED  
FROM A GERMINAL PROD UCT STORAGE CENTRE  (MODEL ‘POR -GP-
STORAGE -ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 799  EN I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 800  EN COUNTRY  Certificate model POR -GP-STORAGE -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2) to be exported to the European Union was/were stored:  
II.1.1.  is located  in a third country, territory  or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ in vivo  derived embryos(2)/ in 
vitro  produced embryos(2)/ micromanipluated embryos(2) of porcine animals and listed 
in Annex IX to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ]; 
 (2)either  [II.1.1.2.  where foot -and-mouth disease was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their c ollection(2)/ production(2);] 
(2)or [II.1.1.2.  where foot -and-mouth disease was not reported for a period starting on the date(3) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
(2)either  [II.1.1.3.  where classical swine fever was not reported for a period of at least 12 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2);] 
(2)or [II.1.1.3.  where classical swine fever was not reported for a period starting on the date(4) 
…………. (insert date  dd/mm/yyyy ) immediately prior to collection(2)/ production(2) of 
the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their 
collection(2)/ production(2);] 
II.1.1.4.  where infection with rinderpest virus and African swine fever were not reported for a 
period of at least 12 months im mediately prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2); 
II.1.1.5.  where no vaccination against foot -and-mouth disease, infection with rinderpest virus  
and classical swine fever has been carried out for a period of at least 12 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) 
and for a period of 30 days after its/their collection(2)/ production(2) and no vac cinated 
animals entered into the third countr y, territory or zone  during that period;  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(5)/ by an 
embryo collection team(2)(5)/ by an embryo production team(2)(5), and/or proce ssed and stored in a 
germinal product processing establishment(2)(5), and/or stored in a germinal product storage 
centre(2)(5) complying with requirements set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of 
Annex I to Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(6), and has/have been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of por cine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:  
(2)either  [Model POR -SEM -A-ENTRY(7);] 
(2)and/or  [Model POR -SEM -B-ENTRY(7);] This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 801  EN COUNTRY  Certificate model POR -GP-STORAGE -ENTRY  
 (2)and/or  [Model POR -OOCYTES -EMB -ENTRY(7);] 
 (2)and/or  [Model POR -GP-PROCESSING -ENTRY(7);] 
(2)and/or  [Model POR -GP-STORAGE -ENTRY(7);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product storage centre 
under responsibility of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been f illed in with the cryogenic agent which not have been previously used for 
other products;  
(2)(8)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulati on (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centres listed in accordance with 
Article 233(3) of Regulati on (EU) 2016/429 on the Commission website:  
  http://ec.europa.eu/food/animal/semen_ova/bovine/ova_embryos_en.htm   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germinal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 802  EN COUNTRY  Certificate model POR -GP-STORAGE -ENTRY  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are pl aced.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the  semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en  . 
(2) Delete if not applicable.  
(3) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(4) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/…  [SANTE/7140/2020 ]. 
(5) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/porcine_en . 
(6) Only a third country, territory or zone thereof listed in Annex IX to Implementing Regulation 2020/…  
[SANTE/7140/2020 ] for semen of porcine animals and the EU Member States.  
(7) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or the germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocytes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(8) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of porcine animals are placed and transported.  
Official ve terinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 803  EN CHAPTER 59: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF SEMEN OF EQUINE ANIMALS COLLE CTED, PROCESSED AND 
STORED IN ACCORDANCE  WITH REGULATION (EU)  2016/429 AND 
DELEGATED REGULATION  (EU) 2020/ 692 AFTER 20 APRIL 2021,  AND 
DISPATCHED FROM A SE MEN COLLECTION CENTR E WHERE THE SEMEN 
WAS COLLECTED  (MODEL ‘EQUI -SEM -A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 804  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 805  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The semen described in Part I is intended for artificial reproduction and was obtained from the donor animals 
which originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of semen of equine animals and listed in Annex X to 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
II.1.2.  in which African horse sickness, Venezuelan equine encephalomyelitis, infection with Burkholderia 
mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), equine 
infectious anaemia, infection with rabies  virus , anthrax, infection with equine arteritis virus and 
contagious equine metritis ( Taylorella equigenitalis ) are notifiable diseases;  
II.1.3. free from African horse sickness for a period of at least 2 4 months immediately prior to collection of 
the semen and for a period of 30 days after its collection in accordance with Article 22(2)(a) of 
Delegated Regulation (EU) 2020/ 692, and where no systematic vaccination against African horse 
sickness has been ca rried out for a period of at least 12 months immediately prior to collection of the 
semen and for a period of 30 days after its collection in accordance with Article 22(4)(b) of that 
Regulation;  
II.1.4. where Venezuelan equine encephalomyelitis was not rep orted for a period of at least 24 months 
immediately prior to collection of the semen and for a period of 30 days after its collection;  
(1)either  [II.1. 5. where infection with Burkholderia mallei  (glanders) was not reported for a period of at least 36 
mont hs immediately prior to collection of the semen and for a period of 30 days after its collection;]  
(1)or [II.1. 5. from the establishment of origin where infection with Burkholderia mallei  (glanders) was not 
reported for a period of at least 6 months immediately prior to collection of the semen and for a 
period of 30 days after its collection, and the Commission has recognised the surveillance 
programme carried out in breeding equine animal s in the establishment of origin to demonstrate 
absence of infection during that period of 6 months;]  
 (1)either  [II.1. 6. where dourine was not reported for a period of at least 24 months immediately prior to collection 
of the semen and for a period of 30 days after its collection;]  
(1)or [II.1. 6. from the establishment of origin where dourine was not reported for a period of at least 6 months 
immediately prior to collection of the semen and for a period of 30 days after its collection, and the 
Commission h as recognised the surveillance programme carried out in breeding equine animals in 
the establishment of origin to demonstrate absence of infection during that period of 6 months;]  
(1)either  [II.1. 7. where surra ( Trypanosoma evansi ) was not reported for a p eriod of at least 24 months immediately 
prior to collection of the semen and for a period of 30 days after its collection.]  
(1)or [II.1. 7. from the establishment of origin where surra ( Trypanosoma evansi ) was not reported for a period of 
at least 6 months immediately prior to collection of the semen and for a period of 30 days after its 
collection, and the Commission has recognised the surveillance programme carried out in breeding 
equine animals in the establishment of origin to demonstrate absence of infe ction during that period 
of 6 months.]  
II.2. The semen described in Part I was obtained from the donor animals which originate, before entering the 
semen collection centre, from establishments   
II.2.1.  in which surra ( Trypanosoma evansi ) has not been repor ted during the period of the preceding 30 
days prior to collection of the semen, and  
(1)either  [surra has not been  reported in the establishment during the period of the preceding 2 years prior to 
collection of the semen;]  
(1)or [surra has been reported in the establishment during the period of the preceding 2 years prior to 
collection of the semen and  following the last outbreak the establishment has remained under 
movement restriction  
(1)either  [until the rem aining animals in the establishment have been  subjected to a test for surra with 
one of the diagnostic methods provided for in Part 3 of Annex I to  Delegated Regulation This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 806  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
(EU) 2020/ 688, carried out, with negative results, on samples taken at least 6 months after 
the last infected animal has been remove d from the establishment;]]  
(1)or  [for at least 30 days from the date of cleaning and disinfection after the last animal of listed 
species on the establishment was either killed and destroyed or slaughtered.]]  
II.2.2.  in which dourine has not been reporte d during the period of the preceding 6 months prior to 
collection of the semen, and  
(1)either  [dourine  has not been reported in the establishment during the period of the preceding 2 years prior 
to collection of the semen;]  
(1)or [dourine has been reported  in the establishment during the period of the preceding 2 years prior to 
collection of the semen and following the last outbreak, the establishment has remained under 
movement restriction until  
(1)either  [the remaining equine  animals in the establishment,  except castrated male  equine animals , 
have been subjected to a test for dourine with the diagnostic method provided for in Part 8 
of Annex I to  Delegated Regulation (EU) 2020/ 688, carried out, with negative results, on 
samples taken at least 6 months afte r the infected animals have been killed and destroyed or 
slaughtered, or the infected entire male equine animals have been castrated;]]  
(1)or  [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected;]]  
II.2.3.  in which equine infectious anaemia has not been reported during the period of the preceding 90 days 
prior to collection of the semen, and  
(1)either  [equine infectious anaemia has not bee n reported on the establishment during the period of the 
preceding 12 months prior to collection of the semen;]  
(1)or [equine infectious anaemia has been reported on the establishment during the period of the preceding 
12 months prior to collection of the semen and following  the last outbreak the establishment has 
remained under movement restriction until  
(1)either  [the remaining equine  animals in the establishment have been subjected to a test for equine 
infectious anaemia with the diagnostic method provided for in Part 9 of Annex I to 
Delegated Regulation (EU) 2020/ 688, carried out, with negative results, on samples taken 
on two occasi ons with a minimum interval of 3 months after the infected animals have been 
killed and destroyed or slaughtered and the establishment was cleaned and disinfected;]]  
(1)or  [for at least 30 days after the last equine animal on the establishment w as either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected;]]  
II.2.4.  in which during the period of 30 days prior  to the date of collection of the semen no equine animal 
has shown signs of infection with equine arteritis v irus and o f contagious equine metritis.  
II.3. The semen described in Part I has been collected, processed and stored, and dispatched from the semen 
collection centre(3) which  
II.3.1.  is approved  and listed by the competent authority of the third country or territory;  
II.3.2.  complies  with requirements as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 1 of Annex I to Delegated Regulation (EU) 2020/ 686. 
II.4. The semen described in Part I was obtained from the donor animals which  
II.4.1.  were not vaccinated against African horse sickness at least in the last 40 days prior to collection of 
the semen;  
II.4.2.  were not vaccinated against Venezuelan equine e ncephalomyelitis  at least in the last 60 days prior to 
collection of the semen;  
II.4.3.  remained for a period of at least 3 months prior to the date of collection of the semen in a third 
country or territory or zone thereof referred to in Box I.7.;  
II.4.4.  for a period of at least 30 days prior to the date of collection of the semen and during the collection 
period  
II.4.4.1.  were  kept on establishments not situated in a restricted zone established due to the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 807  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
occurrence of African horse sickness, infection with Burkholderia mallei  (glanders) or of an 
emerging disease relevant for the equine animals;  
II.4.4.2.  were  kept on a single establishment where Venezuelan equine encephalomyelitis, dourine, 
surra ( Trypanosoma evansi ), equine infections anaemia, infectio n with equine arteritis  virus , 
contagious equine metritis,  infection with rabies virus and anthrax have not been reported;  
II.4.4.3.  were not in contact with animals from establishments situated in a restricted zone due to the 
occurrence of diseases referred to in point II.4.4.1. or from establishments which do not 
meet the conditions referred to in point II.4.4.2.;  
II.4.5.  were not used for natural breeding during a period of at least 30 days prior to the date of first semen 
collection and between th e dates of the first sample referred to in points II.4.8.1., II.4.8.2. and/or 
II.4.8.3. and until the end of the collection period;  
II.4.6.  did not show symptoms of transmissible diseases on the day of admission to the semen collection 
centre and on the da y the semen was collected;  
II.4.7.  are individually identified as provided for in Article 21(2)  of Delegated Regulation (EU) 2020/ 692; 
II.4.8.  have  been subjected to the following tests, referred to in point 1(a) of Chapter I of Part 4 of Annex II 
to Deleg ated Regulation (EU) 2020/ 686, as follows:  
(4)[II.4.8.1.  for infection  with equine infectious anaemia (EIA), an agar -gel immuno -diffusion test 
(AGID or Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with a negative 
result;]  
II.4.8.2.  for infection with equine  arteritis virus (EVA),  
(1)either  [II.4.8.2.1. a serum neutralisation test with a negative result at a serum dilution of one in 
four;]  
(1)and/or  [II.4.8.2.2. a virus isolation test, polymerase chain reaction (PCR) or real -time PCR with a 
negative result on an aliquot of the entire semen of the donor stallion;]  
II.4.8.3.  for contagious  equine metritis (CEM), an agent identification test carried out on three 
specimens (swabs) taken from the donor stallion on two occasions with an inte rval of not 
less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;  
The samples were in no case taken earlier than 7 days (systemic treatment) or 21 days (local 
treatment) after antimicrobial treatment of the donor st allion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the laboratory 
where they were subjected with a negative result to a test for:  
(1)either  [II.4.8.3.1. the isolation of Taylorella equigenitalis  after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours after taking the 
specimens from the donor animal, or 48 hours where the specimens are kept cool 
during transport;]  
(1)and/or  [II.4.8.3.2. the detection of genome of Taylorella equigenitalis  by PCR or real -time PCR, 
carried out within 48 hours after taking the specimens from the donor animal;]  
II.4.9.  were subjected with the results specified in point II.4.8. in each case to at least one of the following 
testing programmes detailed respectively in points 1(b)(i), (ii) and (iii) of Chapter I of Part 4 of 
Annex II to Delegated Regulation (EU) 2020/ 686: 
(5)[II.4.9.1.  The donor  stallion was continuously resident at the semen collection centre for a period of 
at least 30 days prior to the date of the first collection and during the period of collection of 
the semen described above, and no equine animals in the semen collection centre came 
during that time into direct contact with equine animals of lower health st atus than the donor 
stallion.  
The tests described in point II.4.8. were carried out on samples taken(6) from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the first 
collection of semen intended for entry into t he Union of fresh, chilled or frozen semen and 
not less than 14 days following the date of the commencement of the residence period of at This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 808  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
least 30 days prior to the first semen collection.]  
(5)[II.4.9.2.  The donor stallion was resident on the semen collection centre for a period of at least 30 
days prior to the date of the first collection and during the period of collection of the semen 
described above, but left the semen collection centre under the responsibility of the centre 
veterinarian for a co ntinuous period of less than 14  days during the collection period, or 
other equine animals in the semen collection centre came into direct contact with equine 
animals of a lower health status.  
The tests described in point II.4.8. were carried out on sample s taken(6) from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the date of the 
first collection of semen intended for entry into the Union of fresh, chilled or frozen semen 
and not less than 14 days following th e date of the commencement of the residence period 
of at least 30 days  prior to the first semen collection, and during the period of collection of 
the semen intended for entry into the Union of fresh, chilled or frozen semen the donor 
stallion was subjecte d to the tests described in point II.4.8., as follows:  
(a) for equine infectious anaemia, one of the tests described in point II.4.8.1. was last 
carried out on a sample of blood taken(6) not more than 90 days prior to the collection 
of the semen described above;  
(b) for infection with equine arteritis  virus , one of the tests described  
(1)either  [in point II.4.8.2. was last carried out on a sample taken(6) not more than 30 days prior 
to the date of the collection of the semen described above;]  
(1)or [in point II.4.8.2.2., in case the non -shedder state of a donor stallion seropositive for 
infection with equine arteritis virus is confirmed, was carried out on an aliquot of the 
entire semen of  the donor stallion taken(6) not more than 6 months prior to the date of 
the collection of the semen described above and a blood sample taken(6) from the donor 
stallion during the 6 months period reacted with a positive result in a serum 
neutralisation tes t for infection with equine arteritis virus at a serum dilution of more 
than one in four;]   
(c) for contagious equine metritis, the test described in point II.4.8.3. was last carried out 
on three specimens (swabs) taken(6) not more than 60 days prior to th e date of the 
collection of semen described above  
(1)either  [on two occasions;]  
(1)or [on a single occasion and subjected to a PCR or real -time PCR.]]  
(5)[II.4.9.3.  The donor stallion does not meet the conditions set out in points 1(b)(i) and (ii) of Chapt er 
I of Part 4 of Annex II to Delegated Regulation (EU) 2020/ 686 and the semen is collected 
for entry into the Union as frozen semen.  
The tests described in points II.4.8.1, II.4.8.2 and II.4.8.3 were carried out on samples 
taken(6) from the donor stallion at least once a year at the beginning of the breeding season, 
and the tests described in points II.4.8.1 and II.4.8.3. were carried out on samples taken(6) 
from the donor stallion during the storage period of the semen of a minimum  period of 30 
days from the date of the collection of the semen and before the semen is removed from the 
semen collection centre, not less than 14 days and not more than 90 days after the collection 
of the semen described above, and  
(1)either  [the tests fo r infection with equine arteritis virus described in point II.4.8.2. were carried out 
on samples taken(6) during the storage period of the semen of a minimum period of 30 days 
from the date of the collection of the semen and before the semen is removed fro m the 
semen collection centre or used, not less than 14 days and not more than 90 days after the 
date of the collection of the semen described above.]  
(1)or [the non -shedder state of a donor stallion seropositive for infection with equine arteritis virus 
was confirmed by virus isolation test, PCR or real -time PCR carried out with a negative 
result on samples of an aliquot of the entire semen of the donor stallion taken(6) twice a year This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 809  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
at an interval of at least 4 months and the donor stallion has reacted wi th a positive result at a 
serum dilution of at least one in four in a serum neutralisation test for infection with equine 
arteritis  virus .] 
II.4.10.  underwent the testing provided for in point II.4.9. on samples taken on the following dates:  
 
Identification 
of semen  
Test 
programme  Start date(6) Date of sampling for health tests(6) 
Donor 
residence  Semen 
collection  EIA II.4.8.1.  EVA II.  
4.8.2.  CEM  
II.4.8.3.  
Blood 
sample  Semen 
sample  1.  
sample  2.  
sample  
          
      
          
      
          
      
II.5. The semen described in Part I  
II.5.1.  has been  collected, processed and stored in accordance with animal health requirements set out in 
points 1 and 2 of Part 1 of Annex III to Delegated Regulation (EU) 2020/ 686; 
II.5.2.  is placed in straws or other packages on which the mark is applied in accordance with requirements 
provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in 
Box I.27;  
II.5.3.  is transported in a container which:  
II.5.3.1.  was sealed  and numbered prior to the dispatch from the semen collection centre under 
responsibility of the centre veterinarian, or by an official veterinarian, and the seal bears the 
number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use container;  
II.5.3.3.  has been filled  in with the cryogenic agent which not have been previously used for other 
products.  
 (1)(7)[II.6. The semen is preserved by the addition o f antibiotics as follows:  
II.6.1.  The following  antibiotic or mixture of antibiotics has been added to the semen after final dilution, or 
is contained in the used semen diluents, to reach the indicated concentration per ml of semen:  
(1)either  [a mixture of  gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (150/300 μg);]  
(1)or [a mixture of lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 
μg);]  
 (1)or [a mixture  of amikacin (75 μg) and divekacin (25 μg);]  
(1)or [an antibiotic  or a mixture of antibiotics(8) …………………………………………………, with a 
bactericidal activity at least equivalent to one of the following mixtures:  
- gentamicin (250 μg), tylosin (50 μg) and lincomycin -spectinomycin (1 50/300 μg);  
- lincomycin -spectinomycin (150/300 μg), penicillin (500 IU) and streptomycin (500 μg);  
- amikacin (75 μg) and divekacin (25 μg).]  
II.6.2.  Immediately  after the addition of the antibiotics, and before any possible freezing, the diluted semen 
was kept at a temperature  of at least 5°C for a period of not less than 45 minutes, or under a time-
temperature regime with a documented equivalent bactericidal activity.]  
 
Notes  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 810  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the semen collection centre of dispatch of the consignment of semen. Only semen 
collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 
on the Commission websi te: 
  https://ec.europa.eu/food/animals/semen/equine_en   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval number 
of the establishment of d estination of the consignment of semen.  
Box reference I.19:  Seal number  shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type” : Indicate semen.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen of the 
consignment is placed.  
“Date of  collection/production ”: Indicate the date on which semen of the consignment 
was collected  in the following format: dd.mm.yyyy.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected.  
“Quantity ”: Indicate number of straws or othe r packages with the same mark.  
 
Part II:  
Guidance for the completion of the table in point II.4.10.  
Abbreviations:  
EIA-1 Equine infectious anaemia (EIA) testing first occasion  
EIA-2 EIA testing second occasion  
EVA -B1 Infection with equine arteritis virus (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metritis (CEM) testing first occas ion first sample  
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identified in  column A in correspondence with Box I.27, the test programme (points II.4.9.1., 
II.4.9.2. and/or II.4.9.3.) shall be specified in column B, and columns C and D shall be completed with the dates 
required.  
The dates when samples were taken for laboratory te sting prior to the first collection of the semen described 
above as required in points II.4.9.1., II.4.9.2. and II.4.9.3., shall be entered in the upper line of columns 5 to 9 of 
the table, this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the 
example below.  
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.9.2. 
or II.4.9.3. shall be entered in the lower line of columns 5 to 9 in table , this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM -22 in the example below.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 811  EN COUNTRY  Certificate model EQUI -SEM -A-ENTRY  
 
Identification 
of semen  
Test 
programme  Start date  Date of sampling for health tests  
Donor 
residence  Semen 
collection  EIA II.4.8.1.  EVA  
II.4.8.2.  CEM  
II.4.8.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Implementing Regulation 2020/xx  [SANTE/7140/2020 ]. 
(3) Only semen collection centres listed in accordance with Article 233(3) of Regulation (EU) 2016/429 on the 
Commission website: https: //ec.europa.eu/food/animals/semen/equine_en . 
(4) The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equidae which have continuously resided in Iceland since birth, provided that Ic eland has 
remained officially free of equine infectious anaemia and no equidae and their semen, oocyt es and embryos 
have been introduced into Iceland from outside prior to and during the period the semen was collected.  
(5) Cross out the programmes that do not apply to the consignment.  
(6) Insert date in table in point II.4.10 (follow Guidance in Part II of the Notes).  
(7) Mandatory attestation in case antibiotics were added. 
(8) Insert  the name(s) of the antibiotic(s) added and its(their) concentration or t he commercial name of the semen 
diluent containing antibiotics.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 812  EN CHAPTER 60: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOCKS OF SEMEN O F EQUINE ANIMALS 
COLLECTED, PROCESSED  AND STORED IN ACCORD ANCE WITH DIRECTIVE 
92/65/EEC AFTER 30  SEPTEMBER 2014 AND B EFORE 21 APRIL 2021,  AND 
DISPATCHED AFTER 20 APRIL 2021 FROM A SE MEN COLLECTION CENTR E 
WHERE THE SEMEN WAS COLLECTED  (MODEL ‘EQUI -SEM -B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country  code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 813  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 814  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, of the exporting country (1)………………………………….… hereby  
 (name of exporting country ) 
certify that:  
II.1. The semen collection centre(2), in which the semen described above was collected, processed and 
stored for export  to the Union was approved and supervised by the competent authority in 
accordance with the conditions of Chapters I(I)(1) and I(II)(1) of Annex D to Directive 
92/65/EEC(3); 
II.2. During the period commencing 30 days prior to the date of first collection o f the semen described 
above until the date the fresh or chilled semen was dispatched or until the 30 days storage period for 
frozen semen elapsed, the semen collection centre:  
II.2.1.  was situated in the exporting country or, in the case of regionalisation  according to Article 13 of 
Directive 2009/156/EC(4), in that part of the territory of the exporting country which was:  
‒ not considered to be infected with African horse sickness in accordance with Article 5(2)(a)and 
(b) of Directive 2009/156/EC,  
‒ free f rom Venezuelan equine encephalomyelitis for a period of at least 2 years,  
‒ free from glanders and dourine for a period of at least 6 months;  
II.2.2.  fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC and in 
particular:  
(5)either  [II.2.2.1.  following a case of a disease mentioned below not all the animals of species susceptible to 
that disease located in the holding were slaughtered or killed and the holding has been 
free: 
‒ from any type of equine encephalomy elitis for a period of at least 6 months, 
beginning on the day on which the equidae suffering from the disease are 
slaughtered,  
‒ from equine infectious anaemia (EIA) for at least the period required to obtain a 
negative result in an agar gel immunodiffusi on test (AGID or Coggins test) carried 
out on samples taken after the infected animals were slaughtered on two occasions 
three months apart from each of the remaining animals,  
‒ from vesicular stomatitis (VS) for a period of at least 6 months from the last  recorded 
case,  
‒ from rabies for a period of at least one month from the last recorded case,  
‒ from anthrax for a period of at least 15 days from the last recorded case,]  
(5)or [II.2.2.1.  following a case of a disease mentioned below all the animals of sp ecies susceptible to that 
disease located in the holding have been slaughtered or killed and the premises 
disinfected, and the holding was free for a period of at least 30 days from any type of 
equine encephalomyelitis, equine infectious anaemia, vesicular  stomatitis and rabies or 15 
days in the case of anthrax, beginning on the day on which following the destruction of the 
animals the disinfection of the premises was satisfactorily completed;]  
II.2.3.  contained only equidae which were free of clinical sign s of equine viral arteritis and contagious 
equine metritis,  
II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the 
centre:  
II.3.1.  were continuously resident for a period of three months (or since entry  if they were directly 
imported from a Member State of the Union during the three months period) in the exporting 
country or, in the case of regionalisation in accordance with Article 13 of Directive 2009/156/EC, in 
that part of the territory of the export ing country which was during that period:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 815  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  
‒ not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and 
(b) of Directive 2009/156/EC,  
‒ free from Venezuelan equine encephalomyelitis for a period of at least 2 years,  
‒ free from glanders and dourine for a period of at least 6 months;  
(5)either  [II.3.2.  originated from the country of export which was on the day of admission into the centre free from 
vesicular stomatitis (VS) for a period of at least 6 months,]  
(5)or [II.3.2.  were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a negative 
result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result in accordance 
with the relevant Chapter of the Manual of  Diagnostic Tests and Vaccines for Terrestrial Animals  of 
the OIE  on a blood sample taken(6) within 14 days prior to entering the centre;]  
II.3.3.  originated from holdings which on the day of admission onto the centre fulfilled the requirements of 
point II .2.2.;  
II.4. The semen described above was collected from donor stallions which:  
II.4.1.  did not show any clinical sign of an infectious or contagious disease at the time of admission onto 
the semen collection centre and on the day the semen was collected;  
II.4.2.  were kept for a period of at least 30 days prior to the date of semen collection in holdings where no 
equine animal has shown any clinical sign of equine viral arteritis or contagious equine metritis 
during that period;  
II.4.3.  were not used for n atural mating during a period of at least 30 days prior to the date of first semen 
collection and between the dates of the first sample referred to in points II.4.5.1., II.4.5.2. and/or 
II.4.5.3. and until the end of the collection period;  
II.4.4.  underwen t the following tests, which meet at least the requirements of the relevant Chapter of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE,  carried out in a 
laboratory which is recognised by the competent authority and has the te sts referred to hereinafter 
included in its accreditation equivalent to that provided for in Article 12 of Regulation (EC) No 
882/2004(7), as follows:  
(8)[II.4.4.1.  for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test (AGID or 
Coggins tes t) or an enzyme -linked immunosorbent assay (ELISA) for equine infectious 
anaemia with a negative result;]  
II.4.4.2.  for equine viral arteritis (EVA),  
(5)either  [II.4.4.2.1.  a serum neutralisation test with a negative result at a serum dilution of one in 
four;]  
(5)and/or  [II.4.4.2.2.  a virus isolation test, polymerase chain reaction (PCR) or real -time PCR with a 
negative result on an aliquot of the entire semen of the donor stallion;]  
II.4.4.3.  for contagious equine metritis (CEM), an agent identification test carried out on three 
specimens (swabs) taken from the donor stallion on two occasions with an interval of not 
less than 7 days at least from the penile sheath (prepuce), the urethra and the fossa glandis;  
The samples were in no case taken earlier than  7 days (systemic treatment) or 21 days (local 
treatment) after antimicrobial treatment of the donor stallion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the laboratory 
where they were subjected wit h a negative result to a test for:  
(5)either  [II.4.4.3.1.  the isolation of Taylorella equigenitalis  after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours after taking the 
specimens from the donor animal, or 48 hours where the specimens are kept 
cool during transport;]  
(5)and/or  [II.4.4.3.2.  the detect ion of genome of Taylorella equigenitalis  by PCR or real -time PCR, 
carried out within 48 hours after taking the specimens from the donor animal;]  
II.4.5.  were subjected with the results specified in point II.4.4. in each case to at least one of the test 
programmes detailed respectively in points 1.6(a), (b) and (c) of Chapter II of Annex D to Directive This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 816  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  
92/65/EEC as follows:  
(9)[II.4.5.1.  The donor stallion was continuously resident on the semen collection centre for a period of 
at least 30 days prior to the  date of the first collection and during the period of collection 
of the semen described above, and no equidae on the semen collection centre came during 
that time into direct contact with equidae of lower health status than the donor stallion.  
The tests described in point II.4.4. were carried out on samples taken(6) from the donor 
stallion at least once a year at the beginning of the breeding season or prior to the first 
collection of semen intended for imports into the Union of fresh, chilled or frozen s emen 
and not less than 14 days following the date of the commencement of the residence period 
of at least 30 days prior to the first semen collection.]  
(9)[II.4.5.2.  The donor stallion was resident on the semen collection centre for a period of at least 30  
days prior to the date of the first collection and during the period of collection of the 
semen described above, but left the semen collection centre under the responsibility of the 
centre veterinarian for a continuous period of less than 14  days, and/or other equidae on 
the semen collection centre came into direct contact with equidae of a lower health status.  
The tests described in point II.4.4. were carried out on samples taken(6) from the donor 
stallion at least once a year at the beginning of the bree ding season or prior to the date of 
the first collection of semen intended for imports into the Union of fresh, chilled or frozen 
semen and not less than 14 days following the date of the commencement of the residence 
period of at least 30 days  prior to th e first semen collection,  
and during the period of collection of the semen intended for imports into the Union of fresh, 
chilled or frozen semen the donor stallion was subjected to the tests described in point 
II.4.4., as follows:  
(a) for equine infectious  anaemia, one of the tests described in point II.4.4.1. was last 
carried out on a sample of blood taken(6) not more than 90 days prior to the 
collection of the semen described above;  
(b) for equine viral arteritis, one of the tests described  
(5)either  [in point II.4.4.2. was last carried out on a sample taken(6) not more than 30 days 
prior to the date of the collection of the semen described above;]  
(5)or [in point II.4.4.2.2 was carried out on an aliquot of the entire semen of the donor 
stallion taken(6) not more than 6 months prior to the date of the collection of the 
semen described above and a blood sample taken(6) from the donor stallion during 
the 6 months period reacted with a positive result in a serum neutralisation test for 
equine viral arteritis a t a serum dilution of more than one in four;]  
(c) for contagious equine metritis, the test described in point II.4.4.3. was last carried 
out on three specimens (swabs) taken(6) not more than 60 days prior to the date of 
the collection of semen described ab ove 
(5)either  [on two occasions;]  
(5)or [on a single occasion and subjected to a PCR or real -time PCR.]]  
(9)[II.4.5.3.  The donor stallion does not meet the conditions set out in points 1.6(a) and (b) of Chapter 
II of Annex D to Directive 92/65/EEC and the semen is collected for imports into the 
Union of frozen semen.  
The tests described in points II.4.4.1, II.4.4.2 and II.4.4.3 were carried out on samples 
taken(6) from the donor stallion at least once a year at the beginning of the breeding season,  
and the tests described in points II.4.4.1 and II.4.4.3. were carried out on samples taken(6) from 
the donor stallion during the storage period of the semen of a minimum period of 30 days 
from the date of the collection of the semen and before the semen is removed  from the 
semen collection centre, not less than 14 days and not more than 90 days after the 
collection of the semen described above,  
and (5)either  [the tests for equine viral arteritis described in point II.4.4.2. were carried out on This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 817  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  
samples taken(6) during the storage period of the semen of a minimum period of 
30 days from the date of the collection of the semen and before the semen is 
removed from the semen collection centre or used, not less than 14 days and not 
more than 90 days after the date of the c ollection of the semen described above.]  
(5)or [the non -shedder state of a donor stallion seropositive for equine viral arteritis 
was confirmed by virus isolation test, PCR or real -time PCR carried out with a 
negative result on samples of an aliquot of the  entire semen of the donor stallion 
taken(6) twice a year at an interval of at least four months and the donor stallion 
has reacted with a positive result at a serum dilution of at least one in four in a 
serum neutralisation test for equine viral arteritis .] 
II.4.6.  underwent the testing provided for in points II.3.2.(5) and II.4.5. on samples taken on the following dates:  
 
Identification 
of semen  
Test 
programme  Start date(6) Date of sampling for health tests(6) 
Donor 
residence  Semen 
collection  VS(5) 
II.3.2  EIA 
II.4.4.1.  EVA II.  
4.4.2.  CEM  
II.4.4.3.  
Blood 
sample  Semen 
sample  1.  
sample  2.  
sample  
          
     
          
     
          
     
(5)either  [II.5.  No antibiotics were added to the semen;]  
(5)or [II.5.  The following antibiotic or combination of antibiotics was added to produce a concentration in the 
final diluted semen of not less than(10): 
……………………………………………………………….....................................  
……………………………………………………….…………………………….. ;]  
II.6. The semen described above was:  
II.6.1.  collected, processed, stored and transported under conditions which comply with the requirements of 
Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;  
II.6.2.  sent to the place of loading in a sealed container in a ccordance with point 1.4 of Chapter III(I) of 
Annex  D to Directive 92/65/EEC and bearing the number indicated in Box I.19.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter  4 of Annex I to Implementing 
Regulation (EU) 2 020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the semen collection centre of the semen origin.  
Box I.19:  “The identification of container ” and Seal number  shall be indicated.  
Box I.24:  Total number of packages shall correspond to the number of containers.  
Box I.27:  “Identification number ”: The donor identity shall correspond to the official identification of the animal.  
 “Date of  collection/production ”: The date of collection shall be indicated in the following format: 
dd/mm/yyyy.  
 This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 818  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  
Part II:  
Guidance for the completion of the table in point II.4.6.  
Abbreviations:  
VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2  
EIA-1 Equine infectious anaemia (EIA) testing first occasion  
EIA-2 EIA testing second occasion  
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample  
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identified in column A in correspondence with Box I.27, the test programme (points II.4.5.1., 
II.4.5.2. and/or II.4.5.3.) shall be specified in column B, and columns C and D shall be completed with the  dates 
required.  
The dates when samples were taken for laboratory testing prior to the first collection of the semen described 
above as required in points II.4.5.1., II.4.5.2. and II.4.5.3., shall be entered in the upper line of columns 5 to 9 of 
the table , this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the 
example below.  
The dates when samples were taken for repeat laboratory testing as required in accordance with point II.4.5.2. 
or II.4.5.3. shall be entered in the lower  line of columns 5 to 9 in table , this being the boxes EIA -2, EVA -B2 or 
EVA -S2 and CEM -21 and CEM -22 in the example below.  
 
Identification 
of semen  
Test 
programme  Start date  Date of sampling for health tests  
Donor 
residence  Semen 
collection  VS 
II.3.2.  EIA 
II.4.4.1.  EVA  
II.4.4.2.  CEM  
II.4.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D VS EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
 
(1) Imports of equine semen are authorised from a third country listed in column 1 of Annex X to Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] provided that the semen was collected in the part of the 
territory of the third country detailed in column 2 of that Annex from a donor stallion of the category of 
equidae indicated in column 3 of that Annex.  
(2) Only semen collection centres listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the 
Commission website: https://ec.europa.eu/food/ani mals/semen/equine_en.  
(3) Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in and 
imports into the Community of animals, semen, ova and embryos not subject to animal health requirements 
laid down in specifi c Community rules referred to in Annex A (I) to Directive 90/425/EEC (OJ L 268, 
14.9.1992, p. 54) . 
(4) Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the movement 
and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).  
(5) Delete as necessary.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 819  EN COUNTRY  Certificate model EQUI -SEM -B-ENTRY  
(6) Insert date in table in point II.4.6 (follow Guidance in Part II of the Notes).  
(7) Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official 
controls perfor med to ensure the verification of compliance with feed and food law, animal health and animal 
welfare rules (OJ L 165, 30.4.2004, p. 1).  
(8) The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not require d for donor equidae which have continuously resided in Iceland since birth, provided that Iceland 
has remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos 
have been introduced into Iceland from outside prior  to and during the period the semen was collected.  
(9) Cross out the programmes that do not apply to the consignment.  
(10) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 820  EN CHAPTER 61: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOC KS OF SEMEN OF EQUIN E ANIMALS 
COLLECTED, PROCESSED  AND STORED IN ACCORD ANCE WITH DIRECTIVE 
92/65/EEC AFTER 31 A UGUST 2010 AND BEFOR E 1 OCTOBER 2014, AND 
DISPATCHED AFTER 20 APRIL 2021 FROM A SE MEN COLLECTION CENTR E 
WHERE THE SEMEN WAS COLLECTED  (MODEL ‘EQUI -SEM -C-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal  products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 821  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 822  EN COUNTRY  Certificate model EQUI -SEM -C-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, of the exporting country (1)………………………………….… hereby  
 (name of exporting country ) 
certify that :  
II.1. The semen collection centre(2), in which the semen described above was collected, processed and stored for 
export to the European Union was approved and supervised by the competent authority in accordance with 
the conditions of Chapter I(I)(1) and Chapter I(II)(1) of Annex D to Directive 92/65/EEC,  
II.2. during the period commencing 30 days prior to the date of first collection of the semen described above 
until the 30 days storage period for frozen semen elapsed, the semen collection centre:  
II.2.1.  was situated in the exporting country or, in the case of regionalis ation according to Article 13 of 
Directive 2009/156/EC(3), in that part of the territory of the exporting country which was:  
‒ not considered to be infected with African horse sickness in accordance with Article 5(2)(a) and 
(b) of Directive 2009/156/EC(3), 
‒ free from Venezuelan equine encephalomyelitis for 2 years,  
‒ free from glanders and dourine for 6 months;  
II.2.2.  fulfilled the conditions for a holding laid down in Article 4(5) of Directive 2009/156/EC(3) and in 
particular:  
(4)either  [II.2.2.1.  following a case of a disease mentioned below not all the animals of species susceptible to 
the disease located on the holding were slaughtered or killed and the holding has been free:  
‒ from any type of equine encephalomyelitis for at least 6 months, begi nning on the day 
on which the equidae suffering from the disease are slaughtered,  
‒ from equine infectious anaemia for at least the period required to obtain a negative result 
in an agar gel immunodiffusion test (Coggins test) carried out on samples taken after the 
infected animals were slaughtered on two occasions three months apart from each of the 
remaining animals,  
‒ from vesicular stomatitis for at least 6 months from the last recorded case,  
‒ from rabies for at least one month from the last recorded c ase, 
‒ from anthrax for at least 15 days from the last recorded case,]  
(4)or [II.2.2.1.  following a case of a disease mentioned below all the animals of species susceptible to the 
disease located on the holding have been slaughtered or killed and the premi ses disinfected, 
the holding has been free for at least 30 days from any type of equine encephalomyelitis, 
equine infectious anaemia, vesicular stomatitis and rabies or 15 days in the case of anthrax, 
beginning on the day on which following the destruction  of the animals the disinfection of 
the premises was satisfactorily completed;]  
II.2.3.  contained only equidae which were free of clinical signs of equine viral arteritis and contagious 
equine metritis,  
II.3. Prior to entering the semen collection centre the donor stallions and any other equidae located in the centre:  
II.3.1.  were continuously resident for three months (or since entry if they were directly imported from a 
Member State of the European Union during the three months period) in the exporting c ountry or, in 
the case of regionalisation according to Article 13 of Directive 2009/156/EC(3), in that part of the 
territory of the exporting country which was during that period  
‒ not considered to be infected with African horse sickness in accordance wit h Article 5(2)(a) and 
(b) of Directive 2009/156/EC(3), 
‒ free from Venezuelan equine encephalomyelitis for at least 2 years,  
‒ free from glanders and dourine for at least 6 months;  
(4)either  [II.3.2.  originated from the country of export which was on the d ay of admission into the centre free of 
vesicular stomatitis (VS) for at least 6 months,]  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 823  EN COUNTRY  Certificate model EQUI -SEM -C-ENTRY  
(4)or [II.3.2.  were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with negative 
result at a serum dilution of 1 in 12 on a blood sample taken(5) within 14 days prior to entering the 
centre;]  
II.3.3.  originated from holdings which on the day of admission onto the centre fulfilled the requirements of 
point II.2.2.;  
II.4. The semen described above was collected from donor stallions, wh ich: 
II.4.1.  have not shown any clinical sign of an infectious or contagious disease at the time of admission onto 
the centre and on the day the semen was collected;  
II.4.2.  have been kept for 30 days prior to the date of semen collection on holdings where  no equine animal 
has shown any clinical sign of equine viral arteritis or contagious equine metritis during that period;  
II.4.3.  have not been used for natural mating during at least 30 days prior to the date of first semen 
collection and between the date s of the first sample referred to in points II.4.5.1., II.4.5.2. and/or 
II.4.5.3. and until the end of the collection period;  
II.4.4.  have undergone the following tests, which meet at least the requirements of the relevant Chapter of 
the Manual of Diagnost ic Tests and Vaccines for Terrestrial Animals of the OIE,  carried out on 
samples taken in accordance with one of the programmes specified in point II.4.5. in a laboratory 
recognised by the competent authority:  
(4)(6)either  [II.4.4.1.  an agar -gel immuno -diffusion test (Coggins test) for equine infectious anaemia (EIA) with 
negative result; ]  
(4)(6)or [II.4.4.1.  an ELISA for equine infectious anaemia (EIA) with negative result;]  
and (4)either  [II.4.4.2.  a serum neutralisation test for equine viral a rteritis (EVA) with negative result at a serum 
dilution of one in four;]  
(4)or [II.4.4.2.  a virus isolation test for equine viral arteritis (EVA) carried out with negative result on an 
aliquot of the entire semen of the donor stallion;]  
and II.4.4.3.  an ag ent identification test for contagious equine metritis (CEM) carried out on two 
occasions on samples collected with an interval of seven days by isolation of Taylorella 
equigenitalis  after a cultivation of 7 to 14  days from pre -ejaculatory fluid or a semen  
sample and from genital swabs taken at least from the penile sheath, urethra and urethral 
fossa with negative result in each case;  
II.4.5.  have been subjected with the results specified in II.4.4. in each case to at least one of the test 
programmes(7) detailed in points II.4.5.1., II.4.5.2. and II.4.5.3. as follows:  
II.4.5.1.  The donor stallion was continuously resident on the semen collection centre for at least 30 
days prior to the date of the first collection and during the period of collection of the s emen 
described above, and no equidae on the semen collection centre came during that time into 
direct contact with equidae of lower health status than the donor stallion.  
The tests described in point II.4.4. have been carried out on samples taken(5) prior to the 
first semen collection and at least 14 days following the date of the commencement of the 
residence period of at least 30 days.  
II.4.5.2.  The donor stallion was resident on the semen collection centre for at least 30 days prior to 
the date of the fi rst collection and during the period of collection of the semen described 
above, but has left the centre under the responsibility of the centre veterinarian for a 
continuous period of less than 14  days, or other equidae on the collection centre came into 
direct contact with equidae of lower health status.  
The tests described in point II.4.4. have been carried out on samples taken(5) prior to the 
date of the first semen collection of the breeding season or collection period in the year the 
semen described ab ove was collected and at least 14 days following the date of the 
commencement of the residence period of at least 30 days,  
and the test described in point II.4.4.1. for equine infectious anaemia was last carried out on a 
sample of blood taken(5) not more than 90 days before the semen described above was This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 824  EN COUNTRY  Certificate model EQUI -SEM -C-ENTRY  
collected;  
and (4)either  [one of the tests described in point II.4.4.2. for equine viral arteritis was last carried out on 
a sample taken(5) not more than 30 days before the semen described above  was collected, ]  
(4)or [a virus isolation test for equine viral arteritis was carried out with negative result on an 
aliquot of the entire semen of the donor stallion taken(5) not more than 6 months before the 
semen described above was collected and a blo od sample taken on the same date(5) reacted 
positive in a serum neutralisation test for equine viral arteritis at a serum dilution of more 
than one in four,]  
and the test described in point II.4.4.3. for contagious equine metritis was last carried out on 
samples taken(5), not more than 60 days before the semen described above was collected.  
II.4.5.3.  The tests described in point II.4.4. have been carried out on samples taken(5) prior to the 
date of the first semen collection of the breeding season or collec tion period in the year the 
semen described above was collected,  
and the tests described in point II.4.4. have been carried out on samples taken(5) between 14 and 
90 days after the collection of the semen described above.  
II.4.6.  have undergone the testing  provided for in points II.3.2.(4) and II.4.5. on samples taken on the following 
dates:  
 
Identifica tion 
of semen  
Test 
programme  Start date(5) Date of sampling for health tests(5) 
Donor 
residence  Semen 
collection  VS(4) 
II.3.2  EIA 
II.4.4.1.  EVA II.  
4.4.2.  CEM  
II.4.4.3.  
Blood 
sample  Semen 
sample  1.  
sample  2.  
sample  
          
     
          
     
          
     
          
     
          
     
(4)either  [II.5.  No antibiotics were added to the semen;]  
(4)or [II.5.  The following antibiotic or combination of antibiotics was added to produce a concentration in the 
final diluted semen of not less than(8): 
……………………………………………………………….....................................  
……………………………………………………….…………………………….. ;]  
II.6. The semen described above was:  
II.6.1.  collected, processed, stored and transported under conditions which comply with the requirements of 
Chapters II(I)(1) and III(I) of Annex D to Directive 92/65/EEC;  
II.6.2.  sent to the place of loading in a seale d container in accordance with point 1.4 of Chapter III(I) of 
Annex  D to Directive 92/65/EEC and bearing the number indicated in Box I.19.  
 
Notes  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 825  EN COUNTRY  Certificate model EQUI -SEM -C-ENTRY  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the semen collection centre of the semen origin.  
Box I.19:  The identification of container and seal number shall be indicated.  
Box I.24: Total number of packages shall correspond to the number of containers.  
Box I.27:  “Identification number ”: The donor identity shall correspond to the official identification of the animal.  
 “Date of  collection/production ”: The date of collection shall  be indicated in the following format: 
dd/mm/yyyy.  
 
Part II:  
Guidance for the completion of the table in point II.4.6.  
Abbreviations:  
VS Vesicular stomatitis (VS) testing if required in accordance with point II.3.2  
EIA-1 Equine infectious anaemia (EIA) tes ting first occasion  
EIA-2 EIA testing second occasion  
EVA -B1 Equine viral arteritis (EVA) testing on blood sample first occasion  
EVA -B2 EVA testing on blood sample second occasion  
EVA -S1 EVA testing on semen sample first occasion  
EVA -S2 EVA testing on semen sample second occasion  
CEM -11 Contagious equine metritis (CEM) testing first occasion first sample  
CEM -12 CEM testing first occasion second sample taken 7 days after CEM -11 
CEM -21 CEM testing second occasion first sample  
CEM -22 CEM testing second occasion second sample taken 7 days after CEM -21 
Instructions:  
For each semen identified in column A in correspondence with Box I.2 7, the test programme (II.4.5.1., II.4.5.2. 
and/or II.4.5.3.) must be specified in column B, and columns C and D must be comp leted with the dates 
required.  
The dates when samples were taken for laboratory testing prior to the first collection of the semen described 
above as required in II.4.5.1., II.4.5.2. and II.4.5.3., are entered in the upper line of columns 5 to 9 of the tab le, 
this being the boxes marked with EIA -1, EVA -B1 or EVA -S1 and CEM -11 and CEM -12 in the example below.  
The dates when samples were taken for repeat laboratory testing as required in accordance with II.4.5.2. or 
II.4.5.3. are entered in the lower line of columns 5 to 9 in table , this being the boxes EIA -2, EVA -B2 or EVA -
S2 and CEM -21 and CEM -22 in the example below.  
 
Identifica tion 
of semen  
Test 
programme  Start date  Date of sampling for health tests  
Donor 
residence  Semen 
collection  VS 
II.3.2.  EIA 
II.4.4.1.  EVA  
II.4.4.2.  CEM  
II.4.4.3.  
Blood 
sample  Semen 
sample  1. 
sample  2. 
sample  
A B C D VS EIA-1 EVA -B1 EVA -S1 CEM -11 CEM -12 
EIA-2 EVA -B2 EVA -S2 CEM -21 CEM -22 
 
(1) Imports of equine semen are authorised from a third country listed in column 1 of Annex X to Implementing 
Regulation (EU) 2020/… [ SANTE/7140/2020 ] provided the semen was collected in the part of the territory This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 826  EN COUNTRY  Certificate model EQUI -SEM -C-ENTRY  
of the third country detailed in column 2 of that Annex from a donor stallion of the category of equidae 
indicated in column 3 of that Annex.  
(2) Only semen collection centres listed in accordance with Article 17(3)(b) of Directive 92/65/EEC on the 
Commission website: https://ec.europa.eu/food/ani mals/semen/equine_en.  
(3) OJ L 192, 23.7.2010, p. 1.  
(4) Delete as necessary.  
(5) Insert date in table in point II.4.6 (follow Guidance in Part II of the Notes)  
(6) The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia  are not 
required for donor equidae which have continuously resided in Iceland since birth, provided that Iceland has 
remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos have 
been introduced into Iceland fr om outside prior to and during the period the semen was collected.  
(7) Cross out the programmes that do not apply to the consignment.  
(8) Insert names and concentrations.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 827  EN CHAPTER 62: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOC KS OF SEMEN OF EQUIN E ANIMALS 
COLLECTED, PROCESSED  AND STORED IN ACCORD ANCE WITH DIRECTIVE 
92/65/EEC BEFORE 1 S EPTEMBER 2010 AND DI SPATCHED AFTER 20 APRIL 
2021 FROM AN APPROVE D SEMEN COLLECTION C ENTRE WHERE THE 
SEMEN WAS COLLECTED  (MODEL ‘EQUI -SEM -D-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 828  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 829  EN COUNTRY  Certificate model EQUI -SEM -D-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, of the exporting country(1) ………………………………….… hereby  
 (name of exporting country ) 
certify that:  
II.1. The semen collection centre(2) in which the semen described above was collected, processed and stored 
for export to the European Union:  
II.1.1.  was approved and supervised by the competent authority according to the conditions of Chapter I, 
Annex  D to Directive 92/65/EEC,  
II.1.2.  is si tuated in the territory or in the case of regionalisation according to Article 13 of Directive 
2009/156/EC(3) in a part of the territory of the country of export which was on the day the semen was 
collected until the date of dispatch free of:  
 African horse sickness, in accordance with EU legislation,  
 Venezuelan equine encephalomyelitis for 2 years,  
 glanders and dourine for 6 months;  
II.1.3.  was during the period commencing 30 days pri or to the date of collection of the semen until the day of its 
dispatch not subject to a prohibition order for animal health reasons which laid down one of the 
following conditions:  
II.1.3.1.  if not all the animals of species susceptible to the disease loc ated in the holding were slaughtered or 
killed, the prohibition l asted for:  
 6 months, beginning on the day on which the equidae suffering from the disease are slaughtered, in 
the case of equine encephalomyelitis,  
 a period required to carry out with negative result two Coggins tests three months apart in the 
animals remaining after the infected animals have been slaughtered, in the case of infectious 
equine anaemia,  
 6 months, in the case of vesicular stomatitis,  
 one month from the last recorded case, in the case of rabies,  
 15 days from the last recorded case, in  the case of anthrax.  
II.1.3.2.  if all the animals of species susceptible to the disease located in the holding have been slaughtered or 
killed and the premises disinfected, the prohibition l asted for 30 days, or 15 days in the case of anthrax, 
beginning o n the day on which following the destruction of the animals the disinfection of the premises 
was satisfactorily completed;  
II.1.4.  contained during the period commencing 30 days prior to seme n collection and lasting until the date of 
its dispatch only equi dae which were free of clinical signs of equine viral arteritis and contagious equine 
metritis,  
II.2. Prior to entering the semen collection centre the donor stallions and any other equidae located in the 
centre:  
II.2.1.  were continuously resident for thre e months (or since entry if they were directly imported from a 
Member State of the Union during the three months period) in the territory or in the case of 
regionalisation in a part of the territory(4) of the country of export which was during that period free of:  
 African horse sickness, in accordance with EU legislation,  
 Venezuelan equine encephalomyelitis for 2 years,  
 glanders for 6 months,  
 dourine for 6 months;  
(4)either  [II.2.2.  originated from the territory of the country of export which was on  the day of admission into 
the centre free of vesicular stomatitis for 6 months,]  
(4)or [II.2.2.  were tested by a virus neutralisation test for vesicular stomatitis in a blood sample taken on This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 830  EN COUNTRY  Certificate model EQUI -SEM -D-ENTRY  
.............................(5), this being within 14 days prio r to entering the centre, with negative result 
at a serum dilution of 1 in 12;]  
II.2.3.  originated from holdings which on the day of admission onto the centre fulfilled the requirements of 
point II.1.3.;  
II.3. The semen described above was collected from d onor stallions, which:  
II.3.1.  on the day the semen was collected have not shown clinical signs of an infectious or contagious disease,  
II.3.2.  during at least 30 days prior to collection of the semen have not been used for natural service,  
II.3.3.  during  the last 30 days prior to collection of the semen have been kept on holdings where no equine 
animal showed clinical signs of equine viral arteritis,  
II.3.4.  during the last 60 days prior to collection of the semen have been kept on holdings where no equi ne 
animal showed clinical signs of contagious equine metritis,  
II.3.5.  to the best of my knowledge and as far as I could ascertain have not been in contact with equidae 
suffering from an infectious or contagious disease the 15 days immediately preceding the collection of 
the semen;  
II.3.6.  have undergone the following animal health tests carried out in a laboratory recognised by the competent 
authority,  in accordance with a test programme as specified in point II.3.7.:  
II.3.6.1.  an agar -gel immuno -diffusion test (Coggins test) for equine infectious anaemia with negative result(6); 
(4)either  [II.3.6.2.  a serum neutralisation test for equine viral arteritis with negative result at a serum dilution of 1 
in 4;]  
(4)or [II.3.6.2.  a virus isolation test for equine viral arteritis carried out with negative result on an aliquot of the 
entire semen;]  
II.3.6.3.  a test for contagious equine metritis carried out on two occasions with an interval of seven days by 
isolation of Taylorella equigenitalis  from p re-ejaculatory fluid or a semen sample and from genital swabs 
taken at least from the penile sheath, urethra and from the urethral fossa with negative result in each case;  
II.3.7.  have been subjected to one of the following test programmes(7): 
II.3.7.1.  The donor stallion was continuously resident on the collection centre for at least 30 days prior to the 
semen collection, and during the collection period, and no equidae on the collection centre came during 
that time into direct contact with equidae of lowe r health status than the donor stallions.  
 The tests required in point II.3.6. have been carried out on samples taken on ………………………..(5) 
and on ………………………..(5) at least 14 days after the commencement of the above residence period 
and at least at the beginnin g of the breeding season;  
II.3.7.2.  The donor stallion was not continuously resident on the collection centre or other equidae on the 
collection centre came into direct contact with equidae of lower health status than the donor stallions.  
 The tests requir ed in point II.3.6. have been carried out on samples taken on ………………………..(5) 
and on ……………....(5), within the 14 days period before the first semen collection and at least at the 
beginning of breeding season.  
 The test required in point II.3.6.1. was last carried out on a sample of blood taken not more than 120 days 
before the semen was collected on ………………………..(5); 
(4)either [The test required in point II.3.6.2. was last carried out not more than 30 days before the semen was 
collected on …………………..(5);] 
(4)or [The non -shedder state of the seropositive stallion for equine viral arteritis was confirmed by a virus 
isolation test which was carried out not more than one year before the semen was collected on 
…………………………..(5);] 
II.3.7.3.  The tests required in point II.3.6. have been carried out during the 30 days mandatory storage period of 
frozen semen and not less than 14 days after the collection of the semen on samples taken on 
……………………(5) and on …………………….(5); 
II.4. The semen described above was collected, proces sed, stored and transported under conditions which 
comply with the requirements of Chapter II and III of Annex D of Directive 92/65/EEC.  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 831  EN COUNTRY  Certificate model EQUI -SEM -D-ENTRY  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the semen collection centre of the semen origin.  
Box I.19:  The identification of container and seal number shall be indicated.  
Box I.24: Total number of packages shall correspond to the number of containers.  
Box I.27:  “Identification number ”: The donor identity shall correspond to the official identification of the 
animal.  
 “Date of  collection/production ”: The date of collection shal l be indicate in the following format: 
dd/mm/yyyy.  
 
Part II:  
(1) Imports of equine semen are authorised from a third country listed in column 1 of Annex X to 
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] provided the semen was collected in the part 
of the territory of the third country detailed in column 2 of that Annex from a donor stallion of the category 
of equidae indicated in column 3 of that Annex.  
(2) Only semen collection centres listed in accordance with Article 17(3)(b) of Directive 92 /65/EEC on the 
Commission website: https://ec.europa.eu/food/animals/semen/equine_en.  
(3) OJ L 192, 23.7.2010, p. 1.  
(4) Delete as necessary.  
(5) Insert date.  
(6) The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equidae which have continuously resided in Iceland since birth, provided that Iceland 
has remained officially free of equine infectious anaemia and no equidae and their semen, ova and embryos 
have been introduced into Iceland fro m outside prior to and during the period the semen was collected.  
(7) Cross out the programmes that do not apply to the consignment.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 832  EN CHAPTER 63: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF OOCY TES AND EMBRYOS OF E QUINE 
ANIMALS COLLECTED OR  PRODUCED, PROCESSED AND STORED IN 
ACCORDANCE WITH REGU LATION (EU) 2016/429  AND DELEGATED 
REGULATION (EU) 2020/ 692 AFTER 20 APRIL  2021 , AND DISPATCHED BY AN  
EMBRYO COLLECTION OR  PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED  (MODEL ‘EQUI -OOCYTES -
EMB-A-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 833  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 834  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-A-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The oocytes(1)/ in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) 
described in Part I are intended for artificial reproduction and were obtained from the donor animals which 
originate from a third country, territory or zone  
II.1.1.  authorised for entry into the Union of oocytes(1)/ embryos(1) of equine animals and listed in Annex 
X to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
II.1.2.  in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma equiperdum ), 
equine infectious anaemia, infection with rabies  virus , anthrax, infection with equine arteritis virus 
and contagious equine metritis ( Taylorella equigenitalis ) are notifiable diseases;  
II.1.3 . free from African horse sick ness for a period of at least 24 months immediately prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period of 30 days after their 
collection(1)/ production(1) in accordance with Article 22(2)(a) of Delegated Regulation (EU) 
2020/692, and where no systematic vaccination against African horse sickness has been carried out 
for a period of at least 12 months immediately prior to collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and for a period of 30 days after their colle ction(1)/ production(1) in accordance with 
Article 22(4)(b) of that Regulation;  
II.1.4 . where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 months 
immediately prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period of 30 
days after their collection(1)/ production(1); 
(1)either  [II.1.5 . where infection with Burkholderia mallei  (glanders) was not reported for a period of at least 36 
months immediately prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a 
period of 30 days after their collection(1)/ production(1);] 
(1)or [II.1.5 . from the establishment of origin where infection with Burkholderia mallei  (glanders) was not 
reported for a period of at least 6 months immediately prior to collection(1)/ production(1) of the 
oocytes(1)/ embryos(1) and for a period of 30 days after their collection(1)/ production(1), and the 
Commission has recognised the surve illance programme carried out in breeding equine animals in 
the establishment of origin to demonstrate absence of infection during that period of 6 months;]  
 (1)either  [II.1.6 . where dourine not reported for a period of at least 24 months immediately prior  to collection(1)/ 
production(1) of the oocytes(1)/ embryos(1) and for a period of 30 days after their collection(1)/ 
production(1);] 
(1)or [II.1.6. from the establishment of origin where dourine was not reported for a period of at least 6 months 
immediate ly prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period of 30 
days after their collection(1)/ production(1), and the Commission has recognised the surveillance 
programme carried out in breeding equine animals in the establishment of origin to demonstrate 
absence of infection during that period of 6 months;]  
(1)either  [II.1.7 . where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months immediately 
prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and for a period of 30 days after 
their collection(1)/ production(1).] 
(1)or [II.1.7 . from the establishment of origin where surra ( Trypanosoma evansi ) was not reported for a period 
of at least 6 months immediately prior to c ollection(1)/ production(1) of the oocytes(1)/ embryos(1) and 
for a period of 30 days after their collection(1)/ production(1), and the Commission has recognised 
the surveillance programme carried out in breeding equine animals in the establishment of origin to 
demonstrate absence of infection during that period of 6 months.]  
II.2. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which originate from 
establishments   
II.2.1.  in which surra ( Trypanosoma evansi ) has not b een reported during the period of the preceding 30 
days prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1), and  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 835  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-A-ENTRY  
(1)either  [surra has not been  reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [surra has been reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1) and following the last outbreak the 
establishment has remained under movement restriction  
(1)either  [until the remaining animals in the establishment have been subjected to a test for surra 
with one of the diagnostic methods provided for in Part 3 of Annex I to Delegated 
Regulation (EU) 2020/ 688, carried out, with negative results, on samples taken at least 6 
months after the last infected animal has been removed from the establishment;]]  
(1)or  [for at least 30 days from the date of cleaning and disinfection after the last animal of 
listed species on the establishment was either killed and destroy ed or slaughtered .]] 
II.2.2.  in which dourine has not been reported during the period of the preceding 6 months prior to 
collection(1)/ production(1) of the oocytes(1)/ embryos(1), and  
(1)either  [dourine  has not been reported in the establishment during the period of the preceding 2 years prior 
to collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [dourine has been reported in the establishment during the period of the preceding 2 years prior to 
collection(1)/ produ ction(1) of the oocytes(1)/ embryos(1) and following the last outbreak, the 
establishment has remained under movement restriction until  
(1)either  [the remaining equine  animals in the establishment, except castrated male  equine animals , 
have been subjected to a test for dourine with the diagnostic method provided for in Part 8 
of Annex I to  Delegated Regulation (EU) 2020/ 688, carried out, w ith negative results, on 
samples taken at least 6 months after the infected animals have been killed and destroyed 
or slaughtered, or the infected entire male equine animals have been castrated;]]  
(1)or  [for at least 30 days after the last equine animal o n the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned a nd disinfected;]]  
II.2.3.  in which equine infectious anaemia has not been reported during the period of the preceding 90 
days prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1), and  
(1)either  [equine infectious anaemia has not been reported on the establishment during the period of the 
preceding 12 months prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1);] 
(1)or [equine infectious anaemia has been reported on the establishment during the period of the 
preceding 12 months prior to collection(1)/ production(1) of the oocytes(1)/ embryos(1) and following  
the last outbreak the establishment has remained under movement restriction until  
(1)either  [the remaining equine  animals in the establishment have been subjected to a test for equine 
infectious anaemia with the diagnostic method provided for in Part 9 of  Annex I to 
Delegated Regulation (EU) 2020/ 688, carried out, with negative results, on samples taken 
on two occasions with a minimum interval of 3 months after the infected animals have 
been killed and destroyed or slaughtered and the establishment was cle aned and 
disinfected.]]  
(1)or  [for at least 30 days after the last equine animal on the establishment was either killed and 
destroyed or slaughtered, and the premises were cleaned and disinfected.]]  
(1)[II.3.  The in vivo  derived embryos described in Part I have been collected, processed and stored, and dispatched 
by the embryo collection team(3) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with require ments as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 2 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
(1)[II.3.  The oocytes(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in Part I have been 
collected or produced, processed and stored, and dispatched by the embryo production team(3) which  
II.3.1.  is approved and listed by the competent authority of the third country or territory;  
II.3.2.  complies with requirement s as regards responsibilities, operational procedures, facilities and This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 836  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-A-ENTRY  
equipment set out in Parts 2 and 3 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.4. The oocytes(1)/ embryos(1) described in Part I were obtained from the donor animals which  
II.4.1.  were not vaccinated against African horse sickness at least in the last 40 days prior to collection(1)/ 
production(1) of the oocytes(1)/ embryos(1);  
II.4.2.  were not vaccinated against Venezuelan equine encephalomyelitis  at least in the last 60 days prior 
to collection(1)/ production(1) of the oocytes(1)/ embryos(1); 
II.4.3.  remained for a period of at least 3 months prior to the date of collection(1)/ production(1) of the 
oocytes(1)/ embryos(1) in a third country or territory or zone thereof ref erred to in Box I.7.;  
II.4.4.  for a period of at least 30 days prior to the date of collection(1)/ production(1) of the oocytes(1)/ 
embryos(1) and during the collection period  
II.4.4.1.  were  kept on establishments not situated in a restricted zone establi shed due to the 
occurrence of African horse sickness, infection with Burkholderia mallei  (glanders) or of 
an emerging disease relevant for the equine animals;  
II.4.4.2.  were  kept on a single establishment where Venezuelan equine encephalomyelitis, dourine,  
surra ( Trypanosoma evansi ), equine infections anae mia, contagious equine metritis , 
infection with rabies virus and anthrax have not been reported;  
II.4.4.3.  were not in contact with animals from establishments situated in a restricted zone due to 
the occu rrence of diseases referred to in point II.4.4.1. or from establishments which do 
not meet the conditions referred to in point II.4.4.2.;  
II.4.5.  were not used for natural breeding during a period of at least 30 days prior to the date of the 
collection of the oocytes(1)/ embryos(1) and between the date of the first samples referred to in 
points II.4.8.1. and II.4.8.2. and the date of the collection of the oocytes(1)/ embryos(1); 
II.4.6.  were examined by the team veterinarian or its team member and did not show symptoms or clinical 
signs of transmissible animal diseases on the day of collection(1)/ production(1) of the oocytes(1)/ 
embryos(1);  
II.4.7.  are individually identified as provided for in Article 21(2)  of Delegated Regulation (EU) 2020/ 692; 
II.4.8.  have  been subjected to the following tests, referred to in points 2(b) and (c) of Chapter II of Part 4 
of Annex II to Delegated Regulation (EU) 2020/ 686, as follows:  
(4)[II.4.8.1.  for equine  infectious anaemia (EIA), an agar -gel immuno -diffusion test (AGID  or Coggins 
test) or an enzyme -linked immunosorbent assay (ELISA) with a negative result carried out 
on a blood sample taken on ……………….(5), being not less than 14 days following the 
date of commencement of the period referred to in point II.4.5, and the te st was last 
carried out on a blood sample taken on …………………….(5); being not more than 
90 days prior to the date of the collection of the oocytes(1)/embryos(1) intended for entry 
into the Union;]  
II.4.8.2.  for contagious  equine metritis (CEM), an agent identification test carried out with a 
negative result on at least two specimens (swabs) taken during the period referred to in 
point II.4.5. from at least the mucosal surfaces of the clitoral fossa and the clitoral sinuses  
of the donor mare  
(1)either  [II.4.8.2.1.  on two occasions with an interval of not less than 7 days on…………(5) and 
on………………..(5), in the case of isolation of Taylorella equigenitalis  after 
cultivation under microaerophilic conditions for a period of at least 7 days, set 
up within 24 hours after taking the specimens from the donor animal, or 48 
hours where the specimens are kept cool during transport.]  
(1)and/or  [II.4.8.2.2.  on one occ asion on………………..(5), in the case of detection of genome of 
Taylorella equigenitalis  by a polymerase chain reaction (PCR) or real -time 
PCR , carried out within 48 hours after taking the specimens from the donor 
animal.]  
The samples referred to in points II. 4.8.2.1. and II.4.8.2.2. were in no case taken earlier than This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 837  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-A-ENTRY  
7 days (systemic treatment) or 21 days (local treatment) after antimicrobial treatment of the 
donor mare and were placed in transport medium with activated charcoal, such as Amies 
medium, before d ispatch to the laboratory.  
II.5. The oocytes(1)/ embryos(1) described in Part I  
II.5.1.  has been collected, processed and stored in accordance with animal health requirements set out in 
Part 2(1)/Part 3(1)/Part 4(1)/Part 5(1) and Part 6 of  Annex III to Delegated Regulation (EU) 2020/ 686; 
II.5.2.  are placed in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is 
indicated in Box I.27;  
II.5.3.  are transported  in a container which:  
II.5.3.1.  was sealed and numbered prior to the dispatch by the embryo collection or production 
team under responsibility of the team veterinarian, or by an official veterinarian, and the 
seal bears th e number as indicated in Box I.19;  
II.5.3.2.  has been cleaned and either disinfected or sterilised before use, or is single -use container;  
II.5.3.3.  has been filled in with the cryogenic agent which not have been previously used for other 
products.  
(1)(6)[II.5.4.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.5.5.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
(1)(7)[II.6. The in vivo  derived embryos(1)/ in vitro  produced embryos(1)/ micromanipulated embryos(1) described in 
Part I were conceived by artificial insemination using semen coming from a semen collection centre, 
germinal product processing establishment or germinal product storage centre approved for the collection, 
processing and/or storage of semen b y the competent authority of a third country, territory or zone thereof 
listed in Annex X to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] for semen of equine 
animals  or by the competent authority of a Member State(8).] 
(1)(9)[II.7. The following  antibiotic or mixture of antibiotics(10) has been added to the collection, processing, washing 
or storage media: …………………………………………………………………………]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the embryo collection or production team of dispatch of the consignment of oocytes or 
embryos. Only embryo collection or production teams listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:  
  https://ec.europa.eu/food/animals/semen/equine_en   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or approval 
number of the establishment of destination of the consignment of oocytes or embryos.  
Box reference I.19:  Seal number shall be indicated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced 
embryos or micromanipulated embryos.  
“Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where oocytes  or 
embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which oocytes or embryos of the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 838  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-A-ENTRY  
consignment was collected or pr oduced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the embryo collection or production team by which the oocytes or 
embryos were collected or produced.  
“Quantity ”: Indicate number of straws or o ther packages with the same mark.  
Part II:  
(1) Delete if not applicable.  
(2) Only for a third country, territory or zone thereof with opening date in accordance with column 8 in part 1 of 
Annex I to Commission Implementing Regulation 2020/xx  [SANTE/7140/2020 ]. 
(3) Only embryo collection or production teams listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/ani mals/semen/equine_en .  
(4) The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not required for donor equidae which have continuously resided in Iceland since birth, provided that Iceland 
has remained officially free of equine infectious a naemia and no equidae and their semen, ova and embryos 
have been introduced into Iceland from outside prior to and during the period the ova or embryos were 
collected and the semen was used for fertilisation.  
(5) Insert date in the following format: dd.mm. yyyy.  
(6) Applicable for the consignment where in one container oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of equine animals are placed and transported.  
(7) Does  not apply to oocytes.  
(8) Only a semen collection centre, germinal product processing establishment or germinal product storage 
centre listed on the Commission websites:  
- a third country, territory or zone thereof:  
https://ec.europa.eu/food/animals/live_animals/approved -establishments_en   
- of a Member State : https://ec.europa.eu/food/animals/semen/equine_en   
(9) Mandatory attestation in case antibiotics were added.  
(10) Insert the name(s) of the antibiotic(s) added and its(their) concentration.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 839  EN CHAPTER 64: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOC KS OF OOCYTES AND EM BRYOS OF 
EQUINE ANIMALS COLLE CTED OR PRODUCED, PR OCESSED AND STORED I N 
ACCORDANCE WITH DIRE CTIVE 92/65/EEC AFTE R 30 SEPTEMBER 2014 AND 
BEFORE 21 APRIL 2021 , AND DISPATCHED AFT ER 20 APRIL 2021 BY AN 
EMBRYO COLLECTION OR  PRODUCTION TEAM BY W HICH THE OOCYTES 
OR EMBRYOS WERE COLL ECTED OR PRODUCED  (MODEL ‘EQUI -OOCYTES -
EMB-B-ENTRY ’) 
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 840  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 841  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-B-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, of the exporting country(1) ………………………………….… hereby  
 (name of exporting country ) 
certify that:  
II.1. The ova(2)/embryos(2) described above:  
II.1.2.  were collected(2)/produced(2) by the team(3) described in Box I.11, which had been approved and 
supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC(4) and was subject to 
inspection by an offic ial veterinarian at least once every calendar year;  
II.1.3.  were collected(2)/produced(2), processed and stored in accordance with the requirements of Chapter III(II) 
of Annex D to Directive 92/65/EEC;  
II.1.4.  were collected at a place separated from other  parts of the premises or holding which is in good repair 
and was cleaned and disinfected prior to the collection;  
II.1.5.  were examined, processed and packed in laboratory facilities which are not situated in a zone subject to 
prohibition or quarantine me asures as set out in Box II.1.6., in a section which is separated from the 
section for storing equipment and materials used in contact with donor animals and from the area where 
the donor animals are handled;  
II.1.6.  come from donor mares which:  
II.1.6.1.  were continuously resident for a period of three months (or since entry if they were directly 
imported from a Member State of the Union during the three months period) in the exporting 
country or, in the case of regionalisation in accordance with Article 1 3 of Directive 
2009/156/EC(5), in that part of the territory of the exporting country which was during that 
period  
 not considered to be infected with African horse sickness in accordance with 
Article  5(2)(a) and (b) of Directive 2009/156/EC,  
 free from Vene zuelan equine encephalomyelitis for a period of at least 2 years,  
 free from glanders and dourine for a period of at least 6 months;  
(2)either  [II.1.6.2.  originated from a country of export which was on the day of collection free from vesicular 
stomatitis (VS) for a period of at least 6 months;]  
(2)or [II.1.6.2.  were subjected to a virus neutralisation test for vesicular stomatitis (VS) carried out with a 
negative result at a serum dilution of 1 in 32 or a VS ELISA carried out with a negative result 
in acco rdance with the relevant Chapter of the Manual of Diagnostic Tests and Vaccines for 
Terrestrial Animals  of the OIE  on a blood sample taken on …………………(6) within 30 days 
prior to the collection of the ova(2)/embryos(2);] 
(2)either  [II.1.6.3.  during a period of the past 30 days prior to the date of the collection were located in holdings 
under veterinary supervision which fulfilled from the day of the collection of the 
ova(2)/embryos(2) until the date of their dispatch the conditions for a holding laid down in  
Article 4(5) of Directive 2009/156/EC, and in particular:]  
(2)or [II.1.6.3.  in the case of frozen ova(2)/embryos(2), during a period of the past 30 days prior to the date of 
the collection were kept in holdings under veterinary supervision which fulfilled , from the 
day of the collection of the ova(2)/embryos(2) until the end of the period of 30 days mandatory 
storage at approved premises, the conditions for a holding laid down in Article 4(5) of 
Directive 2009/156/EC, and in particular:]  
(2)either  [II.1.6. 3.1. following a case of a disease mentioned below not all the animals of species 
susceptible to that disease located in the holding were slaughtered or killed and 
the holding has been free:  
 from any type of equine encephalomyelitis for a period of at leas t 6 
months, beginning on the day on which the equidae suffering from the This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 842  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-B-ENTRY  
disease are slaughtered,  
 from equine infectious anaemia for at least the period required to obtain a 
negative result in an agar gel immunodiffusion test (AGID or Coggins 
tests) carrie d out on samples taken after the infected animals were 
slaughtered on two occasions three months apart from each of the 
remaining equidae,  
 from vesicular stomatitis for a period of at least 6 months from the last 
recorded case,  
 from rabies for a period of at least one month from the last recorded case,  
 from anthrax for a period of at least 15 days from the last recorded case,]  
(2)or [II.1.6.3.1.  following a case of a disease mentioned below all the animals of species 
susceptible to that disease located in t he holding were slaughtered or killed and 
the premises disinfected, the holding was free for a period of at least 30 days 
from any type of equine encephalomyelitis, equine infectious anaemia, 
vesicular stomatitis and rabies or a period of at least 15 days in the case of 
anthrax, beginning on the day on which following the destruction of the 
animals the disinfection of the premises was satisfactorily completed;]  
II.1.6.4.  during a period of the past 30 days prior to the collection the ova(2)/embryos(2) were kept in 
holdings in which none of the equidae has shown clinical signs of contagious equine metritis 
for a period of at least 60 days;  
II.1.6.5.  were not used for natural breeding during a period of at least 30 days prior to the date of the 
collection of t he ova(2)/embryos(2) and between the date of the first samples referred to in 
points II.1.6.6.1. and II.1.6.6.2. and the date of the  collection of the ova(2)/embryos(2);  
II.1.6.6.  have undergone the tests, which meet at least the requirements of the relev ant Chapters of the 
Manual of Diagnostic Tests and Vaccines for Terrestrial Animals of the OIE, carried out in a 
laboratory which is recognised by the competent authority and has the tests referred to 
hereinafter included in its accreditation equivalent to  that provided for in Article 12 of 
Regulation (EC) No 882/2004(7), as follows:  
(8)[II.1.6.6.1.  for equine infectious anaemia (EIA), an agar -gel immuno -diffusion test (AGID or 
Coggins test) or an enzyme -linked immunosorbent assay (ELISA) with a 
negative result carried out on a blood sample taken on ……………….(6), being 
not less than 14 days following the date of commencement of the period referred 
to in point II.1.6.5, and the test was last carried out on a blood sample taken on 
…………………….(6); being not more than 90  days prior to the date of the 
collection of the ova(2)/embryos(2) intended for imports into the Union;]  
II.1.6.6.2.  for contagious equine metritis (CEM), an agent identification test carried out with 
a negative result on at least two specimens (swa bs) taken during the period 
referred to in point II.1.6.5. from at least the mucosal surfaces of the clitoral fossa 
and the clitoral sinuses of the donor mare  
(2)either  [II.1.6.6.2.1.  on two occasions with an interval of not less than 7 days 
on…………(6) and on………………..(6), in the case of isolation 
of Taylorella equigenitalis  after cultivation under microaerophilic 
conditions for a period of at least 7 days, set up within 24 hours 
after taking the specimens from the donor animal, or 48 hours 
where the specimens  are kept cool during transport,]  
(2)and/or  [II.1.6.6.2.2.  on one occasion on………………..(6), in the case of detection of 
genome of Taylorella equigenitalis  by a polymerase chain 
reaction (PCR) or real -time PCR , carried out within 48 hours 
after taking the sp ecimens from the donor animal,]  
The samples referred to in points II.1.6.6.2.1. and II.1.6.6.2.2. were in no case This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 843  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-B-ENTRY  
taken earlier than 7 days (systemic treatment) or 21 days (local treatment) after 
antimicrobial treatment of the donor stallion and were placed in transport 
medium with activated charcoal, such as Amies medium, before dispatch to the 
laboratory.  
II.1.6.7.  to the best of my knowledge and as far as I could ascertain, were not in contact with equidae 
suffering from an infectious or contagious disease during the period of 15 days immediately 
preceding the collection;  
II.1.6.8.  on the day of the collection of the ova(2)/embryos(2) did not show clinical signs of an 
infectious or contagious disease;  
II.1.7.  were collected(2)/produced(2) after the d ate on which the embryo collection(2)/production(2) team 
described in Box I.11 was approved by the competent authority of the exporting country;  
II.1.8.  were processed and stored under approved conditions for a period of at least 30 days immediately after 
their collection(2)/production(2), and were transported under conditions which satisfy the terms laid down 
in Chapter  III(II) of Annex D to Directive 92/65/EEC;  
II.2. The embryos described above were conceived by artificial insemination(1)/as a result of in vitro  
fertilisation(2) using semen meeting the requirements of Directive 92/65/EEC and coming from semen 
collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC(9) and 
located respectively in a Member State of the  Union or in a third country  or parts of the territory of a 
third country listed in columns 2 and 4 of Annex I to Commission Implementing Regulation (EU) 
2018/659 from which the import of equine semen collected from registered horses, registered equidae or  
equidae for breeding and production is authorised in accordance with Article 4 of Commission 
Implementing Regulation (EU) 2018/659 and indicated in columns 11, 12 and 13 of Annex I 
thereto.(10)(11); 
(12)[II.3.  The ova used for in vitro  production of the e mbryos described above comply with the requirements of 
Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1. to II.1.8. of 
this certificate.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the embryo collection team or embryo production team by 
which the ova/e mbryos were collected/produced, processed, stored and approved in accordance with 
Article 17(3)(b) of Directive 92/65/EEC and listed on the Commission website:  
http://ec.europa.e u/food/animal/semen_ova/equine/index_en.htm . 
Box I.19:  The identification of container and seal number shall be indicated.  
Box I.24:  Total number of packages  shall correspond to the number of containers.  
Box I.27:  “Type ”: Specify if in vivo  derived embryos, in vivo  derived ova, in vitro  produced embryos or 
micromanipulated embryos.  
 “Identification number ”: The donor identity shall correspond to the official identification of the 
animal.  
 “Date of  collection/production ”: The date of collection shall be indicate in the following format: 
dd/mm/yyyy.  
 
Part II:  
(1) Only third countries  or parts of the territory of third countries listed in column 1 of Annex X to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 844  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB-B-ENTRY  
Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] from which entry into Union of equine 
animals not for slaughter also authorised and as indicated in column 3 of that Annex.  
(2) Delete as appropriate.  
(3) Only embryo collection or production teams listed in accordance with Article 17(3)(b) of Directive 
92/65/EEC on the Commission website: https://ec.europa.eu/food/animals/semen/equine_en.  
(4) Council Directive 92/65/EEC of 13 July 1992 laying down animal health requirements governing trade in 
and imports into the Community of animals, semen, ova and embryos not subje ct to animal health 
requirements laid down in specific Community rules referred to in Annex A (I) to Directive 90/425/EEC 
(OJ L 268, 14.9.1992, p. 54).  
(5) Council Directive 2009/156/EC of 30 November 2009 on animal health conditions governing the 
movement  and importation from third countries of equidae (OJ L 192, 23.7.2010, p. 1).  
(6) Insert date. (follow Guidance in Part II of the Notes).  
(7) Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official 
controls pe rformed to ensure the verification of compliance with feed and food law, animal health and 
animal welfare rules (OJ L 165, 30.4.2004, p. 1).  
(8) The agar gel immunodiffusion test (AGID or Coggins test) or the ELISA for equine infectious anaemia are 
not req uired for donor equidae which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, ova and 
embryos have been introduced into Iceland from outside p rior to and during the period the ova or embryos 
were collected and the semen was used for fertilisation.  
(9) Only semen collection centres approved  by the competent authority of a third country, territory or zone 
thereof listed in Annex X to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ] for semen of 
equine animals or by the competent authority of a Member State . 
(10) Imports of equine semen are authorised from third countries listed in column 2 of Annex I to Commission 
Implementing Regulation (EU)  2018/659  provided that the semen was collected in the part of the territory 
of the third country detailed in column 4 from a donor stallion of the category of equidae positively 
indicated in column 11, 12 or 13 of Annex I thereto.  
(11) Does not apply to o ocytes.  
(12) Delete if none of the embryos in the consignment was produced by in vitro  fertilisation of oocytes.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 845  EN CHAPTER 65: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGNMENTS OF STOC KS OF OOCYTES AND EM BRYOS OF 
EQUINE ANIMALS COLLE CTED, PROCESSED AND STORED IN ACCORDANCE  
WITH DIRECTIVE 92/65 /EEC AFTER 31  AUGUST 2010 AND BEFO RE 1 
OCTOBER 2014, AND DI SPATCH ED AFTER 20 APRIL 20 21 BY AN EMBRYO 
COLLECTION OR PRODUC TION TEAM BY WHICH T HE OOCYTES OR 
EMBRYOS WERE COLLECT ED OR PRODUCED (MODEL ‘EQUI -OOCYTES -
EMB -C-ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 846  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 847  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB -C-ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned, official veterinarian, of the exporting country(1) ………………………………….… hereby  
 (name of exporting country ) 
certify that:  
II.1. The ova(2)/embryos(2) described above:  
II.1.2.  were collected(2)/produced(2) by the team(3) described in Box I.11, which had been approved and 
supervised in accordance with Chapter I(III) of Annex D to Directive 92/65/EEC and was subject 
to inspection by an official  veterinarian at least once every calendar year;  
II.1.3.  were collected(2)/produced(2), processed and stored in accordance with the requirements of Chapter 
III(II) of Annex D to Directive 92/65/EEC;  
II.1.4.  were collected at a place separated from other pa rts of the premises or holding which is in good 
repair and was cleaned and disinfected prior to the collection;  
II.1.5.  were examined, processed and packed in laboratory facilities which are not situated in a zone 
subject to prohibition or quarantine measu res as set out in Box II.1.6., in a section which is 
separated from the section for storing equipment and materials used in contact with donor animals 
and from the area where the donor animals are handled;  
II.1.6.  come from donor mares which:  
II.1.6.1.  were continuously resident for three months (or since entry if they were directly 
imported from a Member State of the European Union during the three months period) 
in the exporting country or, in the case of regionalisation according to Article 13 of 
Directi ve 2009/156/EC(4), in that part of the territory of the exporting country which was 
during that period  
 not considered to be infected with African horse sickness in accordance with 
Article 5(2)(a) and (b) of Directive 2009/156/EC,  
 free from Venezuelan equin e encephalomyelitis for at least 2 years,  
 free from glanders and dourine for at least 6 months;  
(2)either  [II.1.6.2.  originated from a country of export which was on the day of collection free of vesicular 
stomatitis for at least 6 months;]  
(2)or [II.1.6.2.  were tested by a virus neutralisation test for vesicular stomatitis on a blood sample taken 
on …………………(5) within 30 days prior to collection, with negative result at a serum 
dilution of 1 in 12;]  
(2)either  [II.1.6.3.  during the past 30 days prio r to collection have been located in holdings under 
veterinary supervision which fulfilled from the day of collection of ova(2)/embryos(2) 
until the date of their dispatch the conditions for a holding laid down in Article 4(5) of 
Directive 2009/156/EC, and  in particular:]  
(2)or [II.1.6.3.  during the past 30 days prior to collection have been located in holdings under 
veterinary supervision which fulfilled from the day of collection of ova(2)/embryos(2) 
until, in the case of frozen ova(2)/embryos(2), the period of 30 days mandatory storage at 
approved premises elapsed, the conditions for a holding laid down in Article 4(5) of 
Directive 2009/156/EC and in particular:]  
(2)either  [II.1.6.3.1.  following a case of a disease mentioned below not all the animals o f species 
susceptible to the disease located on the holding were slaughtered or killed 
and the holding has been free:  
 from any type of equine encephalomyelitis for at least 6 months, 
beginning on the day on which the equidae suffering from the disease 
are slaughtered,  
 from equine infectious anaemia for at least the period required to This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 848  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB -C-ENTRY  
obtain a negative result in an agar gel immunodiffusion test (Coggins 
tests) carried out on samples taken after the infected animals were 
slaughtered on two occasions three mon ths apart from each of the 
remaining equidae;  
 from vesicular stomatitis for at least 6 months from the last recorded 
case,  
 from rabies for at least one month from the last recorded case,  
 from anthrax for at least 15 days from the last recorded case,]  
(2)or [II.1.6.3.1.  following a case of a disease mentioned below all the animals of species 
susceptible to the disease located in the holding have been slaughtered or 
killed and the premises disinfected, the holding has been free for at least 30 
days from any t ype of equine encephalomyelitis, equine infectious anaemia, 
vesicular stomatitis and rabies or 15 days in the case of anthrax, beginning 
on the day on which following the destruction of the animals the 
disinfection of the premises was satisfactorily comple ted;] 
II.1.6.4.  during the past 30 days prior to collection have been kept in holdings each of them 
having been free from clinical signs of contagious equine metritis for at least 60 days;  
II.1.6.5.  have not been used for natural breeding during at least 3 0 days prior to the date of 
collection of ova or embryos and between the date of the first samples referred to in 
points II.1.6.6. and II.1.6.7. and the date of the  collection of ova and embryos;  
II.1.6.6.  have been subjected with negative result to an ag ar-gel immuno -diffusion test (Coggins 
test) or an ELISA for equine infectious anaemia carried out on a blood sample taken on 
……………….(5), being during the past 30 days prior to the date of the first collection of 
ova or embryos and the test was last carried  out on a sample of blood taken on 
…………………….(5), being not more than 90 days before the ova or embryos were 
collected(6);  
II.1.6.7.  have been subjected to an agent identification test for contagious equine metritis by 
isolation of Taylorella equigenitalis  after a cultivation of 7 to 14  days carried out with 
negative results in each case on samples taken during the past 30 days prior to the date 
of the first collection of ova or embryos from mucosal surfaces of the clitoral fossa and 
clitoral sinuses on two  consecutives oestrus periods on…………(5) and 
on………………..(5), and on an additional culture specimen taken during one of the 
oestrus periods from the endometrial cervix on……………….(5); 
II.1.6.8.  to the best of my knowledge and as far as I could ascertain, have not been in contact 
with equidae suffering from an infectious or contagious disease during the 15 days 
immediately preceding the collection;  
II.1.6.9.  have on the day of collection of ova(2)/embryos(2) not shown clinical signs of an 
infectious or contagiou s disease;  
II.1.7.  were collected(2)/produced(2) after the date on which the embryo collection(2)/production(2) team 
described in Box I.11 was approved by the competent authority of the exporting country;  
II.1.8.  were processed and stored under approved conditions for at least 30 days immediately after their 
collection(2)/production(2), and were transported under conditions which satisfy the terms laid down 
in Chapter  III(II) of Annex D to Directive 92/65/EEC;  
II.2. The embryos described above were concei ved by artificial insemination(2)/as a result of in vitro  
fertilisation(2) using semen meeting the requirements of Directive 92/65/EEC and coming from semen 
collection centres approved in accordance with Article 11(2) or 17(3)(b) of Directive 92/65/EEC and  
located respectively in a Member State of the European Union or in a third country  or parts of the territory 
of third country listed in columns 2 and 4 of Annex I to Commission Implementing Regulation (EU) 
2018/659 from which the import of equine semen co llected from registered horses, registered equidae or 
equidae for breeding and production is authorised in accordance with Article 4 of Commission This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 849  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB -C-ENTRY  
Implementing Regulation (EU) 2018/659  and indicated in columns 11, 12 and 13 of Annex I thereto.(7)(8); 
II.3. The ova used for in vitro  production of the embryos described above comply with the requirements of 
Annex D to Directive 92/65/EEC and in particular the requirements set up in points II.1.1. to II.1.8. of this 
certificate(2). 
 
Notes  
Guidance on the comple tion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box I.11:  The place of dispatch shall correspond to the embryo collection team or embryo production team by 
which the oocytes/embryos were collected/produced, processed, stored and approved in accordance 
with Article 17(3)(b) of Council Directive 92/65/EEC and listed on the Commission website:  
http://ec.europa.eu/food/animal/semen_ova/equine/index_en.htm . 
Box I.19:  The identification of container and seal number shall be indicated.  
Box I.24:  Total number of packages  shall correspond to the number of containers.  
Box I.27:  “Type” : specify if in vivo  derived embryos, in vivo  derived oocytes, in vitro  produced embryos or 
micromanipulated embryos.  
 “Identification number ”: The donor identity shall correspond to the official identification of the 
animal.  
 “Date of  collection/production ”: The date of collection shall be indicate in the following format: 
dd/mm/yyyy.  
 
Part II:  
(1) Only third countries  or parts of the territory of third countries listed in column 1 of Annex X to 
Implementing Regulation (EU) 2020/xx [SANTE/7140/2020 ] from which entry into the Union of equine 
animals not for slaughter are also authorised and as indicated in column 3 of that Annex.  
(2) Delete as appropriate.  
(3) Only embryo collection or production teams listed in accordance with Article  17(3)(b) of Directive 
92/65/EEC on the Commission website:  
https://ec.europa.eu/food/animals/semen/equine_en  
(4) OJ L 192, 23.7.2010, p. 1.  
(5) Insert date.  
(6) The agar gel immunodiffusion test (Coggins test) or the ELISA for equine infectious anaemia are not 
required for donor equine animals which have continuously resided in Iceland since birth, provided that 
Iceland has remained officially free of equine infectious anaemia and no equidae and their semen, oocytes 
and embryos have been introduced into Iceland from outside prior to and during the period the semen was 
collected.  
(7) Only semen collection centres approved  by the competent authority of a third country, territory or zone 
thereof listed in Annex X to Implementing Regulation (EU) 2020/… [ SANTE/7140/2020 ] for semen of 
equine animals or by the competent authority of a Member State . 
(8) Does not apply to oocytes.  
Official veterinarian  
Name (in capital letters)     This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 850  EN COUNTRY  Certificate model EQUI -OOCYTES -EMB -C-ENTRY  
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 851  EN CHAPTER 66: MODEL OFFICIAL CERTIFICATE  FOR THE ENTRY INTO T HE 
UNION OF CONSIGMENTS  OF: 
- semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 a nd before 1 October 2014;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, processed and stored in accordance with  
Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and before 21 A pril 2021;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 1 October 2014,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
PROCESSING ESTABLIS HMENT  (MODEL ‘EQUI -GP-PROCESSING -ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 852  EN I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 853  EN I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 854  EN COUNTRY  Certificate model EQUI -GP-PROCESSING -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that all relevant provisions of Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 are fulfilled and that in particular:  
II.1. The germinal product processing establishment(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ 
in vivo  derived embryos(2)/ in vitro  produced embryos(2)/ micromanipulated embryos(2) to be exported to 
the European Union was/were processed and stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of equine animals 
and listed in Annex X to Implementing Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
II.1.1.2.  in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma 
equiperdum ), equine infectious anaemia, infection with rabies  virus , anthrax, infection 
with equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are 
notifiable diseases;  
II.1.1.3 . free from African horse sickness for a period of at least 24 months immediately prior to 
collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 
days after its/their collection(2)/ production(2) in accordance with Article 22(2)(a) of 
Delegated Regulation (EU) 2020/ 692, and where no systematic vaccination against 
African  horse sickness has been carried out for a period of at least 12 months 
immediately prior to collection of the semen(2)/ oocytes(2)/ embryos(2) and for a period 
of 30 days after its/their collection(2)/ production(2) in accordance with Article 22(4)(b) 
of that Regulation;  
II.1.1.4 . where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 
months immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ 
embryos(2) and for a period of 30 days after its/their c ollection(2)/ production(2); 
(2)either  [II.1.1.5 . where infection with Burkholderia mallei  (glanders) was not reported for a period of at 
least 36 months immediately prior to collection(2)/ production(2) of the semen(2)/ 
oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2);] 
(2)or [II.1.1.5 . from the establishment of origin where infection with Burkholderia mallei  (glanders) 
was not reported for a period of at least 6 months immediately prior to collection(2)/ 
production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after 
its/their collection(2)/ production(2), and the Commission has recognised the surveillance 
programme carried out in breeding equine animals in the establishment of orig in to 
demonstrate absence of infection during that period of 6 months;]  
 (2)either  [II.1.1.6 . where dourine was not reported for a period of at least 24 months immediately prior to 
collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 
days after its/their collection(2)/ production(2);] 
(2)or [II.1.1.6 . from the establishment of origin where dourine was not reported for a period of at least 
6 months immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ 
embryos(2) and for a period of 30 days after its/their collection(2)/ production(2), and the 
Commission has recognised the surveillance programme carried out in breeding equine 
animals in the establishment of origin to demonstrate absence of in fection during that 
period of 6 months;]  
(2)either  [II.1.1.7 . where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months 
immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 855  EN COUNTRY  Certificate model EQUI -GP-PROCESSING -ENTRY  
and for a period of  30 days after its/their collection(2)/ production(2).] 
(2)or [II.1.1.7 . from the establishment of origin where surra ( Trypanosoma evansi ) was not reported 
for a period of at least 6 months immediately prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2), and the Commission has recognised the surveillance programme carried 
out in breeding equine animals in the establishment of origin to demonstrate absence of 
infection during that period of 6 months.]  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements  as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 4 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collec tion centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) complying with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to 
Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(4), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of equine 
animals in accordance with Regulation (EU) 2016/429 and Delegate d Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product processing establishment described in Box I.11. under 
conditions at least as strict as described in:  
(2)either  [Model EQUI -SEM -A-ENTRY(5);] 
(2)and/or  [Model EQUI -SEM -B-ENTRY(5);] 
(2)and/or  [Model EQUI -SEM -C-ENTRY(5);]  
(2)and/or  [Model EQUI -SEM -D-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -A-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -B-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -C-ENTRY (5);] 
 (2)and/or  [Model EQUI -GP-PROCESSIN G-ENTRY(5);] 
(2)and/or  [Model EQUI -GP-STORAGE -ENTRY(5);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in 
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product processing 
establishment under responsibility of the centre veterinarian, or by an official 
veterinarian, and the seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been clean ed and either disinfected or sterilised before use, or is single -use 
container;  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 856  EN COUNTRY  Certificate model EQUI -GP-PROCESSING -ENTRY  
II.2.5.3.  has been filled in with the cryogenic agent which not have been previously used for 
other products;  
(2)(6)[II.2.6.  are placed  in straws or other packages which are s ecurely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from each other by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product processing establishment of dispatch of the consignment of 
semen, oocytes or embryos. Only germinal product processing establishments listed in 
accordance with Article 23 3(3) of Regulation (EU) 2016/429 on the Commission 
website:  
  https://ec.europa.eu/food/animals/semen/equine_en   
Box reference I.12:  “Place of destination ”: Indicate the address and unique r egistration or approval 
number of the establishment of destination of the consignment of semen, oocytes or 
embryos.  
Box reference I.17:  “Accompanying documents ”: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the ooc ytes and/or embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored t o the germinal product 
processing establishment described in Box I.11. The original(s) of those document(s) 
or those certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be ind icated.  
Box reference I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
Identification mark : Indicate mark on the straw or other packages where semen, 
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collect ed, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 857  EN COUNTRY  Certificate model EQUI -GP-PROCESSING -ENTRY  
(1) Only germinal product processing establishments  listed in accordance with Article 233(3) of Regulation 
(EU) 2016/429 on the Commission website:  
 https://ec.europa.eu/food/animals/semen/equine_en   
(2) Delete  if not applicable.  
(3) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website:  
https://ec.europa.eu/food/animals/semen/equine_en   
(4) Only a third country, territory or zone thereof listed in Annex X to Implementing Regulation 2020/xx  
[SANTE/7140/2020 ] and the EU Member States.  
(5) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or th e germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product processing establishment of the se men, oocytes and/or 
embryos dispatch described in Box I.11 must be attached to this certificate.  
(6) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos and micromanipulated embryos of equine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 858  EN CHAPTER 67: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF CONSIGMENTS  OF: 
- semen of equine animals collected, processed and stored in accordance with Regulation (EU) 2016/429 
and Delegated Regulation (EU) 2020/ 692 after 20 April 2021;  
- stocks of semen of equine animals collected, processed and sto red in accordance with Directive 
92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC after 31 August 2010 and before 1 October 2014;  
- stocks of semen of equine animals collected, processed and stored in accordance with Directive 
92/65/EEC before 1 September 2010,  
- oocytes and embryos of equine animals collected or produced, processed and stored in accordance with 
Regulation (EU) 2016/429 and Delega ted Regulation (EU) 2020/ 692 after 20 April 2021 ; 
- stocks of oocytes and embryos of equine animals collected or produced, processed and stored in 
accordance with Directive 92/65/EEC after 30 September 2014 and before 21 April 2021;  
- stocks of oocytes and embryos of equine animals collected, processed and stored in accordance with 
Directive 92/65/EEC after 31 August 2010 and before 1 October 2014,  
AND DISPATCHED AFTER  20 APRIL 2021 FROM A  GERMINAL PRODUCT 
STORAGE CENTRE  (MODEL ‘EQUI -GP-STORAGE -ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17 Accompanying documents  
  
  Railway   Road vehicle   Type  Code  
 Identification   Country  ISO country code  
 Commercial document reference   
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
 Germinal products  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 859  EN I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23 
   This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 860  EN I.24 Total number of packages  I.25 Total quantity  I.26 
 I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 861  EN COUNTRY  Certificate model EQUI -GP-STORAGE -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify that:  
II.1. The germinal product storage centre(1) described in Box I.11. at which the semen(2)/ oocytes(2)/ in vivo  
derived embryos(2)/ in vitro  produced embryos(2)/ micromanipulated embryos(2) to be exported to the 
European Union was/were stored:  
II.1.1.  is located  a third country, territory or zone thereof  
II.1.1.1.  authorised for entry into the Union of semen(2)/ oocytes(2)/ embryos(2) of equine animals 
and listed in Annex X to Implementing Regulati on (EU) 2020/xx [ SANTE/7140/2020 ]; 
II.1.1.2.  in which African horse sickness, Venezuelan equine encephalomyelitis, infection with 
Burkholderia mallei  (glanders), surra ( Trypanosoma evansi ), dourine ( Trypanosoma 
equiperdum ), equine infectious anaemia, infection with rabies  virus , anthrax, infection 
with equine arteritis virus and contagious equine metritis ( Taylorella equigenitalis ) are 
notifiable diseases;  
II.1.1.3 . free from African horse sickness for a period of at least 24 months immediately prior t o 
collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 
days after its/their collection(2)/ production(2) in accordance with Article 22(2)(a) of 
Delegated Regulation (EU) 2020/ 692, and where no systematic vaccination against 
African horse sickness has been carried out for a period of at least 12 months 
immediately prior to collection of the semen(2)/ oocytes(2)/ embryos(2) and for a period 
of 30 days after its/their collection(2)/ production(2) in accordance with Artic le 22(4)(b) 
of that Regulation;  
II.1.1.4 . where Venezuelan equine encephalomyelitis was not reported for a period of at least 24 
months immediately prior  to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ 
embryos(2) and for a period of 30 days af ter its/their collection(2)/ production(2); 
(2)either  [II.1.1.5 . where infection with Burkholderia mallei  (glanders) was not reported for a period of at 
least 36  months immediately prior to collection(2)/ production(2) of the semen(2)/ 
oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2);] 
(2)or [II.1.1.5 . from the establishment of origin where infection with Burkholderia mallei  (glanders) 
was not reported for a period of at least 6 months immediately prior to collection(2)/ 
production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after 
its/their collection(2)/ production(2), and the Commis sion has recogn ised the surveillance 
programme carried out in breeding equine animals in the establishment of origin to 
demonstrate absence of infection during that period of 6 months;]  
 (2)either  [II.1.1.6 . where dourine was not reported for a period of at least 24 months immediately prior to 
collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 
days after its/their collection(2)/ production(2);] 
(2)or [II.1.1. 6. from the establishment of origin where dourine was not reported for  a period of at least 
6 months immediately prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ 
embryos(2) and for a period of 30 days after its/their collection(2)/ production(2), and the 
Commission has recognised the surveillance programme carried out in breeding equine 
animals in the establishment of origin to demonstrate absence of infection during that 
period of 6 months;]  
(2)either  [II.1.1.7 . where surra ( Trypanosoma evansi ) was not reported for a period of at least 24 months 
immediately  prior to collection(2)/ production(2) of the semen(2)/ oocytes(2)/ embryos(2) This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 862  EN COUNTRY  Certificate model EQUI -GP-STORAGE -ENTRY  
and for a period of 30 days after its/their collection(2)/ production(2).] 
(2)or [II.1.1.7 . from the establishment of origin where surra ( Trypanosoma evansi ) was not reported 
for a period of at least 6 months immediately prior to collection(2)/ production(2) of the 
semen(2)/ oocytes(2)/ embryos(2) and for a period of 30 days after its/their collection(2)/ 
production(2), and the Commission has recognised the surveillanc e programme carried 
out in breeding equine animals in the establishment of origin to demonstrate absence of 
infection during that period of 6 months.]  
II.1.2.  is approved  and listed by the competent authority of the third country or territory;  
II.1.3.  complies  with requirements  as regards responsibilities, operational procedures, facilities and 
equipment set out in Part 5 of Annex I to Delegated Regulation (EU) 2020/ 686.] 
II.2. The semen(2)/ oocytes(2)/ embryos(2) described in Part I is/are intended for  artificial reproduction and  
II.2.1.  has/have been collected or produced, processed and stored in a semen collection centre(2)(3)/ by an 
embryo collection team(2)(3)/ by an embryo production team(2)(3), and/or processed and stored in a 
germinal product processing establishment(2)(3), and/or stored in a germinal product storage 
centre(2)(3) complying with requirements as regards responsibilities, operational procedures, 
facilities and equipment set out in Part 1(2)/Part 2(2)/Part 3(2)/Part 4(2)/Part 5(2) of Annex I to 
Delegated Regulation (EU) 2020/ 686, and  
(2)either  [located in the exporting country;]  
(2)and/or  [located in ………………………….(4), and has been imported to the exporting country under 
conditions at least as strict as for entry into the Union of seme n(2)/ oocytes(2)/ embryos(2) of equine 
animals in accordance with Regulation (EU) 2016/429 and Delegated Regulation (EU) 2020/ 692;] 
II.2.2.  was/were moved to the germinal product storage centre described in Box I.11. under conditions at 
least as strict as described in:  
(2)either  [Model EQUI -SEM -A-ENTRY(5);] 
(2)and/or  [Model EQUI -SEM -B-ENTRY(5);] 
(2)and/or  [Model EQUI -SEM -C-ENTRY(5);]  
(2)and/or  [Model EQUI -SEM -D-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -A-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -B-ENTRY(5);] 
(2)and/or  [Model EQUI -OOCYTES -EMB -C-ENTRY (5);] 
(2)and/or  [Model EQUI -GP-PROCESSING -ENTRY (5);] 
(2)and/or  [Model EQUI -GP-STORAGE -ENTRY (5);] 
 (2)and/or  [Model  1 in Section A of Part 1 of Annex III to Regulation (EU) 2018/659(5);] 
(2)and/or  [Model  2 in Section B of Part 1 of Annex III to Regulation (EU) 2018/659(5);] 
(2)and/or  [Model  3 in Section C of Part 1 of Annex III to Regulation (EU) 2018/659(5);] 
(2)and/or  [Model  4 in Section D of Part 1 of Annex III to Regulation (EU) 2018/659(5);] 
(2)and/or  [Model  1 in Section A of Part 2 of Annex II to Decision 2010/471/EU(5);] 
(2)and/or  [Model  2 in Section B of Part 2 of Annex II to Decision 2010/471/EU(5);] 
(2)and/or  [Model  3 in Section C of Part 2 of Annex II to Decision 2010/471/EU(5);] 
(2)and/or  [Model in Annex to Commission  Decision 96/539/EC(5);] 
II.2.3.  has been  collected, processed and stored in accordance with animal health requirements set out in This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 863  EN COUNTRY  Certificate model EQUI -GP-STORAGE -ENTRY  
Annex III to Delegated Regulation (EU) 2020/ 686; 
II.2.4.  are placed  in straws or other packages on which the mark is applied in accordance with 
requirements provided for in Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark 
is indicated in Box I.27;  
II.2.5.  are transported  in a container which:  
II.2.5.1.  was sealed and numbered prior to the dispatch by the germinal product storage centre 
under responsibi lity of the centre veterinarian, or by an official veterinarian, and the 
seal bears the number as indicated in Box I.19;  
II.2.5.2.  has been cleaned and either disinfected or sterilised before use, or is single -use 
container;  
II.2.5.3.  has been filled in w ith the cryogenic agent which not have been previously used for 
other products.  
(2)(6)[II.2.6.  are placed  in straws or other packages which are securely and hermetically sealed;  
II.2.7.  are transported  in a container where they are separated from each othe r by physical compartments 
or by being placed in secondary protective bags.]  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [ IA FOOD SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number and the name and address of 
the germinal product storage centre of dispatch of the consignment of semen, oocytes 
and/or embryos. Only germinal product storage centre listed in accordance with 
Article 233(3) of Regulatio n (EU) 2016/429 on the Commission website:  
  https://ec.europa.eu/food/animals/semen/equine_en   
Box reference I.12:  “Place of destination ”: Indicate the address and unique registration or ap proval 
number of the establishment of destination of the consignment of semen, oocytes 
and/or embryos.  
Box reference I.17:  “Accompanying document ”s: Number (s) of related original certificate(s) shall 
correspond to the serial number of the individual official document(s) or health 
certificate(s) that accompanied the semen, oocytes and/or embryos described above 
from the semen collection centre where the semen was collected, and/or the embryo 
collection and/or production team by which the oocytes and/or  embryos were collected 
or produced, and/or the germinal product processing establishment where the semen, 
oocytes or embryos were processed and stored, and/or the germinal product storage 
centre where the semen, oocytes or embryos were stored to the germi nal product 
storage centre described in Box I.11. The original(s) of those document(s) or those 
certificate(s) or the officially endorsed copies thereof must be attached to this 
certificate.  
Box reference I.19:  Seal number shall be indicated.  
Box reference  I.24:  Total number of packages  shall correspond to the number of containers.  
Box reference I.27:  “Type”: Specify if semen, in vivo  derived embryos, in vivo  derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 864  EN COUNTRY  Certificate model EQUI -GP-STORAGE -ENTRY  
oocytes and/or embryos of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes and/or 
embryos of the consignment was/were collected or produced.   
“Approval or registration number of plant/establishment/centre ”: Indicate the unique 
approval number of the semen collection centre where the semen was collected, and/or 
of the embryo collection and/or production team by which the oocytes or embryos 
were collected or produced.  
“Quantity ”: Indicate number of straws or other packages with the same mark.  
 
Part II:  
(1) Only germinal product storage centres listed in accordance with A rticle 233(3) of Regulation (EU) 2016/429 
on the Commission website:  
 https://ec.europa.eu/food/animals/semen/equine_en  
(2) Delete if not applicable.  
(3) Only approved germinal product establishments listed in accordance with Article 233(3) of Regulation (EU) 
2016/429 on the Commission website: https://ec.europa.eu/food/animals/semen/equine_e n . 
(4) Only a third country, territory or zone thereof listed in Annex X to Implementing Regulation 2020/…  
[SANTE/7140/2020 ] and the EU Member States.  
(5) The original(s) of the document(s) or the health certificate(s) or the officially endorsed copies of  thereof that 
accompanied the semen, oocytes or embryos described above from the semen collection centre where the 
semen was collected, and/or the embryo collection or production team by which the oocytes and/or embryos 
were collected or produced, and/or t he germinal product processing establishment where the semen, oocytes 
or embryos were processed and stored, and/or the germinal product storage centre where the semen, oocytes 
or embryos were stored to the germinal product storage centre of the semen, oocy tes and/or embryos dispatch 
described in Box I.11 must be attached to this certificate.  
(6) Applicable  for the consignment where in one container semen, oocytes, in vivo  derived embryos, in vitro  
produced embryos  and micromanipulated embryos of equine animals are placed and transported.  
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 865  EN CHAPTER 68: MODEL OFFICIAL CER TIFICATE FOR THE ENT RY INTO THE 
UNION OF SEMEN, OOCYTES AND E MBRYOS OF TERRESTRIAL ANIMALS 
KEPT AT CONFINED EST ABLISHMENT WHICH WER E COLLECTED OR 
PRODUCED, PROCESSED AND STORED IN ACCORD ANCE WITH 
REGULATION (EU) 2016 /429 AND DELEGATED R EGULATION (EU) 2020/ 692 
(MODEL ‘GP -CONFINED -ENTRY’)  
COUNTRY  Official certificate to the EU  Part I: Description of consignment  I.1 Consignor/Exporter    I.2 Certificate reference  I.2a IMSOC reference  
 Name     
 Address   I.3 Central Competent Authority   QR CODE  
  
 Country  ISO country code  I.4 Local Competent Authority    
I.5 Consignee/Importer   I.6 Operator responsible for the consignment   
 Name    Name   
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.7 Country of origin  ISO country code  I.9 Country of destination  ISO country code  
I.8 Region of origin  Code  I.10 Region of destination  Code  
I.11 Place of dispatch   I.12 Place of destination   
 Name  Registration/Approval No   Name  Registration/Approval No  
 Address    Address   
 Country  ISO country code   Country  ISO country code  
I.13 Place of loading  I.14 Date and time of departure  
I.15 Means of transport    I.16 Entry Border Control Post  
  Aircraft   Vessel  I.17  
 
  Railway   Road vehicle   
 Identification   
 
I.18 Transport conditions   Ambient    Chilled   Frozen  
I.19 Container number/Seal number  
 Container No  Seal No   
I.20 Certified as or for  
   Germinal products    
I.21  For transit  I.22  For internal market  
 Third country  ISO country code  I.23  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 866  EN I.24 Total number of packages  I.25 Total quantity  I.26  
I.27 Description of consignment  
CN code  Species  Subspecies/Category    Identification number   Quantity  
        
Type   Approval or registration 
number of 
plant/establishment/centre   Identification 
mark  Date of collection/production   Test 
        
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 867  EN COUNTRY  Certificate model GP-CONFINED -ENTRY  Part II: Certification  II. Health information  II.a  Certificate reference  II.b.  IMSOC reference  
I, the undersigned official veterinarian, hereby certify, that:  
II.1. The semen(1)/ in vivo  derived embryos(1)/ oocytes(1)/ in vitro  produced embryos(1)/ 
micromanipulated embryos(1) described in Part I is(1)/are(1) intended for artificial reproduction and 
was(1)/were(1) obtained from the donor animals which  
II.1.1.  originate from a third country, territory or zone authoris ed for entry into the Union of 
the particular species and category of animals and listed in Annex II to Implementing 
Regulation (EU) 2020/xx [ SANTE/7140/2020 ]; 
II.1.2.  originate from a confined establishment in the third country, territory or zone of 
origin, which is included in a list of confined establishments, established in 
accordance with Article 29 of Delegated Regulation (EU) 2020/ 692, from which the 
entry of anim als of specific species into the Union may be authorised ; 
II.1.3.  do not come from an establishment, nor have been in contact with animals from an 
establishment, situated in a restricted zone established due to the occurrence of a 
category A disease, refer red to in the Annex to Implementing Regulation (EU) 
2018/1882, or of an emerging disease relevant for the species of those kept terrestrial 
animals;  
II.1.4.  come from an establishment where no category D disease, relevant for the species of 
those kept terr estrial animals as referred to in the Annex to Implementing Regulation 
(EU) 2018/1882, has been reported for a period of at least the preceding 30 days;  
II.1.5.  have remained in a single confined establishment of origin for a period of at least 30 
days pri or to the collection of the semen(1)/ oocytes(1)/ embryos(1) intended for entry 
into the Union;  
(1)(2)[II.1.6.  are bovine, porcine, ovine, caprine or equine animals and they are identified in 
accordance with Article 21  of Delegated Regulation (EU) 2020/ 692;] 
(1)(3)[II.1.6.  are terrestrial animals other than bovine, porcine, ovine, caprine or equine animals 
and they are identified and registered in accordance with the rules of the confined 
establishment;]  
II.1.7.  have been clinically examined by the establis hment veterinarian responsible for the 
activities carried out at the confined establishment and showed no diseases symptoms 
on the day of collection of the semen(1)/ oocytes(1)/ embryos(1); 
II.1.8.  as much as possible, were not used for natural breeding du ring a period of at least 30 
days prior to the date of collection of the semen(1)/ oocytes(1)/ embryos(1) and during 
the collection period.  
II.2. The semen(1)/ oocytes(1)/ embryos(1) described in Part I  
II.2.1.  is(1)/are(1) placed in straws or other packag es on which the mark is applied in 
accordance with requirements provided for in  
(1)(2)[Article 83(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in 
Box I.27;]  
(1)(3)[Article 119(a)  of Delegated Regulation (EU) 2020/ 692 and that mark is indicated in 
Box I.27; ] 
II.2.2.  is(1)/are(1) placed in a transport container which:  
II.2.2.1.  was sealed and numbered prior to the dispatch from the confined This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 868  EN COUNTRY  Certificate model GP-CONFINED -ENTRY  
establishment by the establishment veterinarian responsible for the 
activities of the confined establishment and the seal bears the number as 
indicated in Box I.19;  
II.2.2.2.  has been cleaned and either disinfected or sterilised before use, or is 
single -use container;  
II.2.2.3.  has been filled in with the cryogenic agent which not ha ve been 
previously used for other products.  
(1)(2)(4)[II.2.3.  are placed in straws or other packages which are securely and hermetically sealed;  
II.2.4.  are transported  in a container where they are separated from each other by physical 
compartments or by being placed in secondary protective bags.]  
II.3. The consignment of semen(1)/ oocytes(1)/ embryos(1)  
II.3.1.  is destined to a confined establishment in the Union, which is approved in accordance 
with Article 95 of Regulation (EU) 2016/429;  
II.3.2.  is tra nsported directly to the confined establishment as indicated in Box I.12.  
 
Notes  
Guidance on the completion of this official certificate is available in Chapter 4 of Annex I to Implementing 
Regulation (EU) 2020/… [IA FOOD  SANTE/7086/2020 ]. 
 
Part I:  
Box reference I.11:  “Place of dispatch ”: Indicate the unique approval number, if assigned by the 
competent authority, and the name and address of the confined establishment of 
dispatch of the consignment of semen, oocytes or embryos.  
Box reference I.12:  “Place of destination ”: Indicate the name, address and unique approval number of the 
confined establishment of destination in the Union of the consignment of semen, 
oocytes or embryos.  
Box reference I.27:  “Type ”: Specify if semen, in vivo  derived embryos, in vivo derived oocytes, in vitro  
produced embryos or micromanipulated embryos.  
  “Identification number ”: Indicate identification number of each donor animal.  
“Identification mark ”: Indicate mark on the straw or other packages where semen, 
oocytes or embryos  of the consignment are placed.  
“Date of  collection/production ”: Indicate the date on which semen, oocytes or 
embryos of the consignment were collected or produced.   
“Approval or registration number of plant/establishment ”: Indicate the unique 
approval nu mber, if assigned by the competent authority, and the name and address of 
the confined establishment of the collection or production of semen, oocytes or 
embryos of the consignment.  
“Quantity ”: Indicate number of straws or other packages with the same mark . 
 
Part II:  
(1) Delete  if not applicable.  
(2) Applicable for the consignment of semen, oocytes or embryos  of bovine, porcine, ovine, caprine or equine 
animals.  
(3) Applicable for the consignment of semen, oocytes or embryos of terrestrial animals other than bovine, 
porcine, ovine, caprine or equine animals . This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 869  EN COUNTRY  Certificate model GP-CONFINED -ENTRY  
(4) Applicable for the consignment where in one container  oocytes, in vivo  derived embryos, in vitro  produced 
embryos and micromanipulated embryos of bovine, porcine, ovine, caprine or equine  animals are placed and 
transporte d. 
Official veterinarian  
Name (in capital letters)     
Date   Qualification and title   
Stamp   Signature   
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 870  EN ANNEX III  
Annex III contains the following model official declarations : 
Model   
AT-TERRE -SEA  Chapter 1: Model declaration  by the master of the vessel: Addendum for 
transport of terrestrial animals entering the Union by sea  
EQUI -TRANS  Chapter 2: Model transhipment manifest of equidae  
 
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 871  EN CHAPTER 1: MODEL DECLARATION BY  THE MASTER OF THE VE SSEL: 
ADDENDUM FOR TRANSPO RT OF ANIMALS ENTERI NG THE UNION BY SEA 
(MODEL ‘AT-TERRE -SEA’)  
(To be completed and attached to the relevant official certificate where transport to the Union 
border includes transport by vessel, even for part of the journey)  
 
Declaration by the master of the vessel  
 
I, the undersigned master of the vessel (name ………………………………………………………………………………….. )  
declare that the animals referred to in attached animal health certificate N° …………….……………. have remained on board the 
vessel during the journey from …………….……………. in …………….……………. ( exporting country ) to 
…………….……………. in the European Union and that the vessel did not call at any place outside …………….……………. 
(exporting country ) en route to the European Union other than …………….……………. ( Ports of call en route ). Moreover, 
during the journey, these animals have not been in contact with other animals on board of a lower health status.  
 
Done at ………………………………………………………………..  on ………………………………………………………………..  
(Port of arrival)  (Date of arrival)  
Stamp  (Signature of the master)  
 (Name in capital letters and title)  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 872  EN CHAPTER 2: MODEL TRANSHIPMENT M ANIFEST OF EQUIDAE (MODEL 
‘EQUI -TRANS’)  
(To be completed and attached to the relevant official certificate where transport to the Union 
border includes transhipment from one aircraft to another aircraft or from one vessel to 
another vessel in a country not listed in [Annex I to Com mission Implementing Regulation 
(EU) 2018/659) ] 
 
 Serial Number:……………………………………………………..………..  
Reference N° of Air Cargo Transfer Manifest:……………………….……(1) 
Country where transhipment takes place:.…………………………….……….………………………………….…  
Airport (2)/Port (2) of 
arrival:.……………………………………….…………………………………….………………………………..…  
Date of arrival::.……………………………………….…………………….…………………….…………………..  
Date of transhipment:.……………………………………….………………………………………………………..  
Transferring Carrier:.……………………………………….………………………….……………………….……  
Receiving Carrier:.……………………………………….…………………………………….……………………  
Description of consignment:  Animal species:.……………………….……………………  
Total number of animals:……………………………………  
Serial N° of Health Certificate  
 Remarks  
  
  
  
 
I, the undersigned, official veterinarian (2)/customs officer (2) at the above airport (2)/port (2) declare that the transhipment took 
place under my supervision and in compliance with the following conditions:  
(a) the equidae were during the transhipment protected from attacks by insects vectors of  diseases transmissible to equidae;  
(b) the equidae did not come into contact with equidae of a different health status;  
(c) the crates, containers or jet -stalls and the surrounding airspace in the transport compartment were sprayed with an appropriate 
insect repellent in combination with an insecticide immediately after the closing of the doors of the aircraft  (2)/vessel (2). 
The consignment has been transhipped in full and apparent good order and conditions except as noted in the “Remarks” column.  
 
Done a t……………………….………………………………………………  on …………………….……………….…………………  
 
 
 
………..………………………………………………………………..  
(signature of the official veterinarian or customs officer)  
 
 
………..………………………………………………………………..  
(name in capital letters and title)  Stamp  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 873  EN (1) Keep empty if transhipment from vessel to vessel  
(2) Delete as appropriate  
  This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 874  EN ANNEX IV  
Correlation table referred to in Article 27(2) 
1. Decision  2010/470/EU  
Decision 2010/470/EU  This Regulation  
Article 1(a)  Article 12  (a)(b)(c)(d)  
Article 1(b)  Article 12  (e)(f)(g)  
Article 1(c)  Article 1 0 (a)(b)(c)  
Article 1(d)  Article 1 0 (d)(e)  
Article 1(e)  Article 1 1 (c)(d)  
Article 2(a)  Article 12  (a) 
Article 2(b)  Article 12  (b) 
Article 2(c)  Article 12  (c) 
Article 2(d)(i)  - 
Article 2(d)(ii))  Article 12  (d) 
Article 3(a)  Article 12  (e) 
Article 3(b)  Article 12  (f) 
Article 3(c)  Article 12  (g) 
Article 4(a)  Article 10  (a) 
Article 4(b)  Article 10  (b) 
Article 4(c)  Article 10  (c) 
Article 5(a)  Article 10  (d) 
Article 5(b)  Article 10  (e) 
Article 6(a)  Article 11  (c) 
Article 6(b) Article 11  (d) 
Annex I Part A  Annex I, Chapter 46 ( model EQUI -SEM -B-
INTRA)  
Annex I Part B  Annex I, Chapter 47 ( model EQUI -SEM -C-
INTRA)  
Annex I Part C  Annex I, Chapter 48 ( model EQUI -SEM -D-
INTRA)  
Annex I Part D  Annex I, Chapter 54 ( model EQUI -GP-
STORAGE -INTRA)  
Annex II Part A  Annex I, Chapter 50 ( model EQUI -
OOCYTES -EMB -B-INTRA)  
Annex II Part B  Annex I, Chapter 51 ( model EQUI -
OOCYTES -EMB -C-INTRA)  
Annex II Part C  Annex I, Chapter 52 ( model EQUI -
OOCYTES -EMB -D-INTRA)  
Annex III Part A  Annex  I, Chapter 31 ( model OV/CAP -SEM -
B-INTRA)  
Annex III Part B  Annex I, Chapter 32 ( model OV/CAP -SEM -
C-INTRA)  
Annex III Part C  Annex I, Chapter 37 ( model OV/CAP -GP-This draft has not been adopted or endorsed by the European Commission. Any views 
expressed are the preliminary views of the Commission services and may not in any 
circumstances be regarded as stating an official position of the Commission. The information 
transmitted is intended only for the Member State or entity to which it is addressed for 
discussions and may co ntain confidential and/or privileged material  
 
EN 875  EN STORAGE -INTRA)  
Annex IV Part A  Annex I, Chapter 34 ( model OV/CAP -
OOCYTES -EMB -B-INTRA)  
Annex IV Part B  Annex I, Chapter 35 ( model OV/CAP -
OOCYTES -EMB -C-INTRA)  
Annex V Part A  Annex I, Chapter 41 ( model POR -
OOCYTES -EMB -B-INTRA)  
Annex V Part B  Annex I, Chapter 42 ( model POR -
OOCYTES -EMB -C-INTRA)  
2. Decision  2019/294/EU  
Decision 2019/294/EU  This Regu lation  
Article 1  - 
Article 2(a)  Article 20  
Article 2(b)  - 
Annex Part 1  Annex II, Chapter 38 (CANIS -FELIS -
FERRETS)  
Annex Part 2  - 
 